<SEC-DOCUMENT>0001019687-12-000580.txt : 20120216
<SEC-HEADER>0001019687-12-000580.hdr.sgml : 20120216
<ACCEPTANCE-DATETIME>20120216104907
ACCESSION NUMBER:		0001019687-12-000580
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20111231
FILED AS OF DATE:		20120216
DATE AS OF CHANGE:		20120216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21846
		FILM NUMBER:		12618245

	BUSINESS ADDRESS:	
		STREET 1:		8910 UNIVERSITY CENTER LANE, SUITE 660
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-459-7800

	MAIL ADDRESS:	
		STREET 1:		8910 UNIVERSITY CENTER LANE, SUITE 660
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>aethlon_10q-123111.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 11pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<DIV STYLE="width: 100%; border-bottom: black 2pt solid; font-size: 1pt"></DIV>
<DIV STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 1pt">&nbsp;</DIV>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 6pt; margin-bottom: 0pt">UNITED
STATES<BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington,
D.C. 20549</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt">_________________</P>

<P STYLE="font-size: 12pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt">FORM
10-Q</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt">_________________</P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt"><FONT face="Wingdings"><FONT STYLE="font-family: Wingdings 2">&#83;</FONT></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt">For
the quarterly period ended:&nbsp;December 31, 2011</P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt">or</P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt">For
the transition period from: _____________ to _____________</P>

<P STYLE="text-align: center">_________________</P>

<P STYLE="font-weight: bold; font-size: 14pt; text-align: center; margin-top: 6pt; margin-bottom: 0pt">AETHLON MEDICAL, INC.</P>

<P STYLE="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt">(Exact
name of registrant as specified in its charter)</P>

<P STYLE="text-align: center">_________________</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
     <TD STYLE="width: 33%; font-size: 9pt; font-weight: bold; text-align: center">Nevada</TD>
     <TD STYLE="width: 34%; font-size: 9pt; font-weight: bold; text-align: center">000-21846</TD>
     <TD STYLE="width: 33%; font-size: 9pt; font-weight: bold; text-align: center">13-3632859</TD>
</TR>
<TR STYLE="vertical-align: top">
     <TD STYLE="font-size: 9pt; text-align: center">(State or Other Jurisdiction</TD>
     <TD STYLE="font-size: 9pt; text-align: center">(Commission</TD>
     <TD STYLE="font-size: 9pt; text-align: center">(I.R.S. Employer</TD>
</TR>
<TR STYLE="vertical-align: top">
     <TD STYLE="font-size: 9pt; text-align: center">of Incorporation or Organization)</TD>
     <TD STYLE="font-size: 9pt; text-align: center">File Number)</TD>
     <TD STYLE="font-size: 9pt; text-align: center">Identification No.)</TD>
</TR>
</TABLE>

<P STYLE="font-size: 9pt; text-align: center; margin-top: 12pt; margin-bottom: 6pt"><B>8910 UNIVERSITY CENTER LANE, SUITE
660, SAN DIEGO, CA 92122</B><BR>(Address of Principal Executive Offices) (Zip Code)</P>

<P STYLE="font-size: 9pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt"><B>(858)
459-7800<BR></B>(Registrant&rsquo;s telephone number, including area code)</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt">_________________</P>

<P STYLE="font-size: 9pt; text-align: justify; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings 2">&#83;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings 2">&#163;</FONT></P>

<P STYLE="font-size: 9pt; text-align: justify; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">Indicate by check mark whether
the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings 2">&#83;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></FONT></P>

<P STYLE="font-size: 9pt; text-align: justify; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">Indicate by check
mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &ldquo;large accelerated filer,&rdquo; accelerated filer&rdquo; and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
     <TD STYLE="width: 20%; font-size: 9pt; text-align: center">Large accelerated filer&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT></TD>
     <TD STYLE="width: 20%; font-size: 9pt; text-align: center">Accelerated filer&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT></TD>
     <TD STYLE="width: 35%; font-size: 9pt; text-align: center">Non-accelerated filer&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT></TD>
     <TD STYLE="width: 25%; font-size: 9pt; text-align: center">Smaller reporting company&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings 2">&#83;</FONT></TD>
</TR>
<TR STYLE="vertical-align: top">
     <TD STYLE="font-size: 9pt; text-align: center">&nbsp;</TD>
     <TD STYLE="font-size: 9pt; text-align: center">&nbsp;</TD>
     <TD STYLE="font-size: 9pt; text-align: center">(Do not check if smaller reporting company)</TD>
     <TD STYLE="font-size: 9pt; text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 9pt; text-align: left; text-indent: 0pt; margin-top: 6pt; margin-bottom: 6pt">Indicate by check mark whether
the registrant is a shell company (as defined in Rule 12b-2 of the Act).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings 2">&#83;</FONT></P>

<P STYLE="font-weight: bold; font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt"></P>

<P STYLE="font-size: 9pt; text-align: justify; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">As of February 15, 2012,
the registrant had outstanding 111,629,725 shares of common stock, $.001 par value.</P>



<P STYLE="font-size: 9pt; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<DIV STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 1pt">&nbsp;</DIV>
<DIV STYLE="width: 100%; border-bottom: black 2pt solid; font-size: 1pt">&nbsp;</DIV> <!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font-size: 9pt; text-align: left; text-indent: 1.5em; margin-top: 6pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font-size: 9pt; text-align: left; margin-top: 6pt; margin-bottom: 6pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD COLSPAN="2" STYLE="line-height: 115%">PART I. FINANCIAL INFORMATION</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 9%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 82%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 9%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 1.</TD>
    <TD STYLE="line-height: 115%">FINANCIAL STATEMENTS</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">CONDENSED CONSOLIDATED BALANCE SHEETS AT DECEMBER 31, 2011 (UNAUDITED) AND MARCH 31, 2011</TD>
    <TD STYLE="line-height: 115%; text-align: right">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTH PERIODS ENDED DECEMBER 31, 2011 AND 2010 (UNAUDITED)</TD>
    <TD STYLE="line-height: 115%; text-align: right">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTH PERIODS ENDED DECEMBER 31, 2011 AND 2010 (UNAUDITED)</TD>
    <TD STYLE="line-height: 115%; text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</TD>
    <TD STYLE="line-height: 115%; text-align: right">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 2.</TD>
    <TD STYLE="line-height: 115%">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</TD>
    <TD STYLE="line-height: 115%; text-align: right">26</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 3.</TD>
    <TD STYLE="line-height: 115%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</TD>
    <TD STYLE="line-height: 115%; text-align: right">32</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 4.</TD>
    <TD STYLE="line-height: 115%">CONTROLS AND PROCEDURES</TD>
    <TD STYLE="line-height: 115%; text-align: right">22</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">PART II.&nbsp;</TD>
    <TD STYLE="line-height: 115%">OTHER INFORMATION</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 1.</TD>
    <TD STYLE="line-height: 115%">LEGAL PROCEEDINGS</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 1A.</TD>
    <TD STYLE="line-height: 115%">RISK FACTORS</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 2.</TD>
    <TD STYLE="line-height: 115%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 3.</TD>
    <TD STYLE="line-height: 115%">DEFAULTS UPON SENIOR SECURITIES</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 4.</TD>
    <TD STYLE="line-height: 115%">MINE SAFETY DISCLOSURES</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 5.</TD>
    <TD STYLE="line-height: 115%">OTHER INFORMATION</TD>
    <TD STYLE="line-height: 115%; text-align: right">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">ITEM 6.</TD>
    <TD STYLE="line-height: 115%">EXHIBITS</TD>
    <TD STYLE="line-height: 115%; text-align: right">34</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">PART I. FINANCIAL INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">December 31,</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">March 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2011</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">(Unaudited)</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 64%; padding-left: 0.25in">Cash</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">354,804</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">15,704</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">193,749</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,732</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Note receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Interest receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,096</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">26,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29,711</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.5in">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">758,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">410,243</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,535</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,785</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Patents and patents pending, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,108</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">139,981</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt">Deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,210</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,210</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.5in">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">903,023</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">567,219</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>LIABILITIES AND STOCKHOLDERS' DEFICIT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">634,082</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">308,413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Due to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">617,570</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">617,570</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">584,796</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Convertible notes payable, net of discounts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,462,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,181,852</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,250,705</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,002,896</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Accrued liquidated damages</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">437,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">437,800</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Other current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,022,436</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">804,386</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,010,214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,542,917</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Commitments and Contingencies (Note 12)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Stockholders' Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -9pt; padding-left: 27pt">Common stock, par value $0.001 per share; 250,000,000 shares authorized as of December 31, 2011 and March 31, 2011; 108,977,508 and 77,467,361 shares issued and outstanding as of December 31, 2011 and March 31, 2011, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">108,980</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,469</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,869,870</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,418,778</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Deficit accumulated</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(52,086,041</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(48,471,945</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.5in">Total stockholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,107,191</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,975,698</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.5in">Total liabilities and stockholders' deficit</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">903,023</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">567,219</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Three and Nine Month Periods Ended December
31, 2011 and 2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Three Months <BR>Ended <BR>December 31, <BR>2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Three Months <BR>Ended <BR>December 31, <BR>2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Nine Months <BR>Ended <BR>December 31, <BR>2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Nine Months <BR>Ended <BR>December 31, <BR>2010</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-align: left">REVENUES</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 40%; padding-bottom: 1pt; text-indent: -7pt; padding-left: 14pt">Government contract revenue</TD><TD STYLE="width: 3%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">958,075</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">958,075</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -7pt; padding-left: 7pt">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">427,419</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">386,828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,037,613</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">889,161</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Payroll, consulting and related services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">487,959</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">534,747</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,553,514</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,350,825</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 7pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">384,025</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">125,126</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">623,712</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">378,701</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-indent: -7pt; padding-left: 28pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,299,403</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,046,701</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,214,839</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,618,687</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -7pt; padding-left: 7pt">OPERATING LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(341,328</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,046,701</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,256,764</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,618,687</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -7pt; padding-left: 7pt">OTHER EXPENSE (INCOME)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Loss on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">963,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,189,942</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Loss on settlement of accrued interest and damages</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,703</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">(Gain) on change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,940</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(430,077</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,596,442</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,098,954</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Interest and other debt expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">308,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">594,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,594,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,346,247</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -7pt; padding-left: 14pt">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(56</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,599</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(938</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(19,496</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -7pt; padding-left: 14pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(300,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">360,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-indent: -7pt; padding-left: 21pt">Total other expense (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,390</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">821,470</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,357,331</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,486,442</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -7pt; padding-left: 7pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(574,718</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,868,171</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,614,095</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8,105,129</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -7pt; padding-left: 7pt">BASIC AND DILUTED LOSS PER COMMON SHARE</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.04</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -7pt; padding-left: 7pt">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING &ndash; BASIC AND DILUTED</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">107,061,316</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">70,918,490</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">98,202,051</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">67,991,430</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Nine Month Periods Ended December
31, 2011 and 2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">December 31,</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2010</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 64%; padding-left: 0.25in">Net loss</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(3,614,095</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(8,105,129</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 27pt">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,858</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,301</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.5in">Stock based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">609,503</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,599,915</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in">Loss on debt extinguishment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,189,942</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -9pt; padding-left: 45pt">Fair market value of conditional warrants that subsequently were issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,652</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 45pt">Non cash interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">538,736</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,696,055</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-indent: -9pt; padding-left: 45pt">Fair market value of common stock, warrants and options issued for services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">328,327</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">590,734</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in">Change in fair value of derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,596,442</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,098,954</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.5in">Issuance of note in convertible note termination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">360,186</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in">Amortization of debt discount and deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,703,219</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,301,014</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.5in">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(183,367</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.75in">Prepaid expenses and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,557</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,260</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75in">Accounts payable and other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">728,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">152,246</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.75in">Due to related parties</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,101,086</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,512,964</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,735</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,541</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Additions to patents and patents pending</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,805</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,735</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,346</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Principal repayments of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in">Net proceeds from the issuance of convertible notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,256,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,105,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Proceeds from the issuance of common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">283,600</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Proceeds from collection of secured notes receivable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">200,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">300,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.25in">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,441,921</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,688,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Net increase in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">339,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,290</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cash at beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15,704</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">67,950</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Cash at end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">354,804</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">234,240</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(CONTINUED)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Nine Month Periods Ended December
30, 2011 and 2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Nine Months <BR>Ended <BR>December 31, <BR>2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Nine Months <BR>Ended <BR>December 31, <BR>2010</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-align: left">Supplemental disclosures of cash flow information:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="text-align: left">Cash paid during the period for:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 64%; padding-bottom: 2.5pt; padding-left: 9pt">Interest</TD><TD STYLE="width: 8%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">3,636</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 9pt">Income taxes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>Supplemental disclosures of non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 0.25in">Derivative liabilities recorded in connection with&nbsp;embedded conversion feature of convertible notes and/or warrants</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,980,347</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 9pt">Debt and accrued interest converted to common stock</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,812,386</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,075,550</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 0.25in">Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,037,901</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,708,600</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 9pt">Issuance of convertible notes in&nbsp;settlement of accrued legal fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">35,469</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 9pt">Reclassification of warrant derivative liability into equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">263,689</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 9pt">Issuance of shares in connection with restricted stock grant to officer</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">600</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">See accompanying notes.&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 31, 2011</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Aethlon Medical, Inc. (&quot;Aethlon&quot;, the &quot;Company&quot;,
&quot;we&quot; or &quot;us&quot;) is a medical device company focused on creating innovative devices that address unmet medical
needs in cancer, infectious disease and other life-threatening conditions. At the core of our developments is the Aethlon ADAPT&trade;
(Adaptive Dialysis-Like Affinity Platform Technology) system, a medical device platform that converges single or multiple affinity
drug agents with advanced plasma membrane technology to create therapeutic filtration devices that selectively remove harmful particles
from the entire circulatory system without loss of essential blood components. Approval to embark on human trials is still needed
to reach commercial viability of the Hemopurifier&reg; and approval by the U.S. Food and Drug Administration (&quot;FDA&quot;).
Successful outcomes of human trials will be required by the regulatory agencies of certain foreign countries where we intend to
sell this device. We have submitted an Investigational Device Exemption (&quot;IDE&quot;) to the FDA. Some of our patents may expire
before FDA approval or approval in a foreign country, if any, is obtained. However, we believe that certain patent applications
and/or other patents issued more recently will help protect the proprietary nature of the Hemopurifier(R) treatment technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In prior periods, Aethlon was classified as a development stage
enterprise under accounting principles generally accepted in the United States of America (&quot;GAAP&quot;) as it had not generated
revenues from its planned principal operations. In the three months ended December 31, 2011, we began to generate revenues from
a government contract and have emerged from the development stage. Subsequent to December 31, 2011, we recorded the first commercial
shipment of one of our products to a life sciences company for diagnostics use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Our common stock is quoted on the Over-the-Counter Bulletin Board
administered by the Financial Industry Regulatory Authority (&quot;OTCBB&quot;) under the symbol &quot;AEMD.OB.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and applicable
sections of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete
financial statements. In the opinion of management, all adjustments&nbsp;necessary to make the financial statements not misleading
have been included. The condensed consolidated balance sheet as of March 31, 2011 was derived from our audited financial statements.
Operating results for the nine months ended December 31, 2011 are not necessarily indicative of the results that may be expected
for the year ending March 31, 2012. For further information, refer to our Annual Report on Form 10-K for the year ended March
31, 2011, which includes audited financial statements and footnotes as of March 31, 2011 and for the years ended March 31, 2011
and 2010 and the period January 31, 1984 (Inception) through March 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 2. LIQUIDITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The accompanying unaudited condensed consolidated financial statements
have been prepared on a going concern basis, which contemplates, among other things, the realization of assets and the satisfaction
of liabilities in the ordinary course of business. We have experienced continuing losses from operations, are in default on certain
debt, have negative working capital of approximately $6,252,000, recurring losses from operations and an accumulated deficit of
approximately $52,086,000 at December 31, 2011, which among other matters, raises significant doubt about our ability to continue
as a going concern. We have not generated significant revenue or any profit from operations since inception. A significant amount
of additional capital will be necessary to advance the development of our products to the point at which they may become commercially
viable. Our current financial resources are insufficient to fund our capital expenditures, working capital and other cash requirements
(consisting of accounts payable, accrued liabilities, amounts due to related parties and amounts due under various notes payable)
for the fiscal year ending March 31, 2012 (&quot;fiscal 2012&quot;). Therefore we will be required to seek additional funds through
debt and/or equity financing arrangements to finance our current and long-term operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="color: black">On September 30, 2011, we </FONT>entered
into a contract with the United States of America, issued by SPAWAR Systems Center Pacific, pursuant to a contract award from the
Defense Advanced Research Projects Agency (&ldquo;DARPA&rdquo;). Under the DARPA award, we have been engaged to develop a therapeutic
device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers.
The award from DARPA is a fixed-price contract with potential total payments to us of $6,794,389 over the course of five years,
including payments of up to $1,975,047 in the first year. Fixed price contracts require the achievement of multiple, incremental
milestones to receive the full award during each year of the contract.&nbsp;&nbsp;Under the terms of the contract, we will perform
certain incremental work towards the achievement of specific milestones against which we will invoice the government for fixed
payment amounts.&nbsp;&nbsp;Assuming all such work is performed according to the contract terms, we will receive up to $1,975,047
of contract payments during the first twelve months of the contract with the aggregate payment amounts in years two through five
varying between approximately $775,000 and $1.6 million per year. DARPA has the option to extend the contract for years two through
five. Only the first year of the contract related to the $1,975,047 has been formally entered into as of the date of this Form
10-Q filing. The milestones are comprised of planning, engineering and clinical targets, the achievement of which in some cases
will require the participation and contribution of third party participants under the contract.&nbsp;&nbsp;There can be no assurance
that we alone, or with third party participants, will meet such milestones to the satisfaction of the government and in compliance
with the terms of the contract or that we will be paid the full amount of the contract revenues during any year of the contract
term.&nbsp;&nbsp;We commenced work under the contract in October 2011 (See below and Note 12 for additional information regarding
revenue recognition).</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of December 31, 2011, we received two initial payments under
the DARPA contract totaling $774,708 and billed the government for a third invoice in the amount of $183,367, which is shown
as an account receivable on the accompanying balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: black">Also during the three months ended December
31, 2011, we raised an additional $384,265 in net proceeds from a bridge financing that may yield up to $1 million in total gross
proceeds through the private placement of </FONT>convertible promissory notes and corresponding warrants with accredited investors
(see Note 5 &ndash; Convertible Notes for more details of this offering)<FONT STYLE="color: black"> per the terms of the subscription
agreement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition to the funds received to date under the DARPA contract
and under the bridge financing and beyond future fundings under the DARPA contract, we will require additional capital as our current
financial resources, while improved, remain insufficient to fund our working capital and other cash requirements for the remainder
of our fiscal year ending March 31, 2012. Therefore we will be required to seek additional funds through debt and/or equity financing
arrangements to finance our current and long-term operations. We are currently addressing our liquidity needs by exploring investment
capital opportunities through the private placement of common stock or issuance of additional debt, including the remaining portion
of the bridge financing. We believe that our access to additional capital, together with existing cash resources, will be sufficient
to meet our short term liquidity needs for fiscal 2012. However, no assurance can be given that we will receive any funds in connection
with our capital raising efforts on terms acceptable to the Company, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The unaudited condensed consolidated financial statements do not
include any adjustments relating to the recoverability of assets that might be necessary should we be unable to continue as a going
concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The summary of our significant accounting policies presented below
is designed to assist the reader in understanding our condensed consolidated financial statements. Such financial statements and
related notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting
policies conform to GAAP in all material respects, and have been consistently applied in preparing the accompanying&nbsp;condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">PRINCIPLES OF CONSOLIDATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The accompanying condensed consolidated financial statements include
the accounts of Aethlon Medical, Inc. and its wholly-owned subsidiary, Exosome Sciences, Inc., (collectively hereinafter referred
to as the &quot;Company&quot; or &quot;Aethlon&quot;). There exist no material intercompany transactions or balances between Aethlon
and its subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">LOSS PER COMMON SHARE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Basic loss per common share is computed by dividing net loss available
to common stockholders by the weighted average number of common shares assumed to be outstanding during the period of computation.
Diluted loss per common share is computed similar to basic loss per share except that the denominator is increased to include the
number of additional common shares that would have been outstanding if the potential common shares had been issued, and if the
additional common shares were dilutive. As we had net losses for all periods presented, basic and diluted loss per common share
are the same, since additional potential common shares have been excluded as their effect would be antidilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The potentially dilutive common shares outstanding for at December
31, 2011 and 2010, which include common shares underlying outstanding stock options, warrants and convertible debentures, were
114,215,775 and 81,138,329, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">PATENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We capitalize the cost of patents, some of which were acquired,
and amortize such costs over their estimated useful life, upon issuance of the patent, not to exceed the patent legal life.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RESEARCH AND DEVELOPMENT EXPENSES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We incurred research and development expenses during the three and
nine month periods ended December 31, 2011 and 2010, which are included in various operating expense line items in the accompanying
condensed consolidated statements of operations. Our research and development expenses in those periods were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">December 31,</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">2010</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 64%">Three months ended</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">536,079</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">127,918</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Nine months ended</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">864,443</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">317,345</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">FAIR VALUE OF FINANCIAL INSTRUMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The carrying amount of the Company's cash, accounts receivable,
accounts payable and accrued liabilities approximates their estimated fair values due to the short-term maturities of these financial
instruments. The fair value of certain convertible notes and related warrants at December 31, 2011 is $1,250,705 based upon a third
party valuation report that we commissioned. Warrants classified as derivative liabilities are reported at their estimated fair
value, with changes in fair value being reported in current period results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Management has concluded that it is not practical to determine the
estimated fair value of amounts due to related parties because the transactions cannot be assumed to have been consummated at arm's
length, the terms are not deemed to be market terms, there are no quoted values available for these instruments, and an independent
valuation would not be practicable due to the lack of data regarding similar instruments, if any, and the associated potential
costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">EQUITY INSTRUMENTS FOR SERVICES PROVIDED BY OTHER THAN EMPLOYEES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We account for transactions involving goods and services provided
by third parties where we issue equity instruments as part of the total consideration using the fair value of the consideration
received (i.e., the value of the goods or services) or the fair value of the equity instruments issued, whichever is more reliably
measurable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In transactions, when the value of the goods and/or services is
not readily determinable and (1) the fair value of the equity instruments is more reliably measurable and (2) the counterparty
receives equity instruments in full or partial settlement of the transactions, we use the following methodology:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(a)&nbsp;&nbsp;&nbsp;For transactions where goods have already been
delivered or services rendered, the equity instruments are issued on or about the date the performance is complete (and valued
on the date of issuance).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(b)&nbsp;&nbsp;&nbsp;For transactions where the instruments are
issued on a fully vested, non-forfeitable basis, the equity instruments are valued on or about the date of the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(c)&nbsp;&nbsp;&nbsp;For any transactions not meeting the criteria
in (a) or (b) above, we re-measure the consideration at each reporting date based on its then current stock value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We review our long-lived assets for impairment whenever events or
changes in circumstances indicate that their carrying amounts may not be recoverable. If the cost basis of a long-lived asset is
greater than the projected future undiscounted net cash flows from such asset (excluding interest), an impairment loss is recognized.
Impairment losses are calculated as the difference between the cost basis of an asset and its estimated fair value. We believe
that no impairment occurred at or during the three and nine months ended December 31, 2011 and 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BENEFICIAL CONVERSION FEATURE OF CONVERTIBLE NOTES PAYABLE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The convertible feature of certain notes payable provides for a
rate of conversion that is below the market value of our common stock. Such feature is normally characterized as a &quot;Beneficial
Conversion Feature&quot; (&quot;BCF&quot;). We record the estimated fair value of the BCF, when applicable, in the condensed consolidated
financial statements as a discount from the face amount of the notes. Such discounts are accreted to interest expense over the
term of the notes using the effective interest method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">REVENUE RECOGNITION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black">With
respect to revenue recognition, we entered into a contract with DARPA as discussed above and have recognized revenue during the
three months ended December 31, 2011 of $958,075 under such contract. We adopted the Milestone method of revenue recognition for
the DARPA contract under ASC 605-28 &ldquo;Revenue Recognition &ndash; Milestone Method&rdquo; and we believe we meet the requirements
under ASC 605-28 for reporting contract revenue under the Milestone Method for the quarter ended December 31, 2011.</FONT></P>

<P STYLE="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In order to account for this contract, the Company identifies the
deliverables included within the contract and evaluates which deliverables represent separate units of accounting based on if certain
criteria are met, including whether the delivered element has standalone value to the collaborator. The consideration received
is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the
separate units.</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone is an event having all of the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) There is substantive uncertainty at the date the arrangement
is entered into that the event will be achieved. A vendor&rsquo;s assessment that it expects to achieve a milestone does not necessarily
mean that there is not substantive uncertainty associated with achieving the milestone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(2) The event can only be achieved based in whole or in part on
either: (a) the vendor&rsquo;s performance; or (b) a specific outcome resulting from the vendor&rsquo;s performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(3) If achieved, the event would result in additional payments being
due to the vendor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone does not include events for which the occurrence is
either: (a) contingent solely upon the passage of time; or (b) the result of a counterparty&rsquo;s performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The policy for recognizing deliverable consideration contingent
upon achievement of a milestone must be applied consistently to similar deliverables.<BR>
<BR>
The assessment of whether a milestone is substantive is performed at the inception of the arrangement. The consideration earned
from the achievement of a milestone must meet all of the following for the milestone to be considered substantive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) The consideration is commensurate with either: (a) the vendor&rsquo;s
performance to achieve the milestone; or (b) the enhancement of the value of the delivered item or items as a result of a specific
outcome resulting from the vendor&rsquo;s performance to achieve the milestone;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(2) The consideration relates solely to past performance; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(3) The consideration is reasonable relative to all of the deliverables
and payment terms (including other potential milestone consideration) within the arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone is not considered substantive if any portion of the
associated milestone consideration relates to the remaining deliverables in the unit of accounting (i.e., it does not relate solely
to past performance). To recognize the milestone consideration in its entirety as revenue in the period in which the milestone
is achieved, the milestone must be substantive in its entirety. Milestone consideration cannot be bifurcated into substantive and
nonsubstantive components. In addition, if a portion of the consideration earned from achieving a milestone may be refunded or
adjusted based on future performance, the related milestone is not considered substantive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">See Note 12 for the additional disclosure information required under
ASC 605-28.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DERIVATIVE LIABILITIES AND CLASSIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We evaluate free-standing derivative instruments (or embedded derivatives)
to properly classify such instruments within equity or as liabilities in our financial statements. Our policy is to settle instruments
indexed to our common shares on a first-in-first-out basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The classification of a derivative instrument is reassessed at each
balance sheet date. If the classification changes as a result of events during a reporting period, the instrument is reclassified
as of the date of the event that caused the reclassification. There is no limit on the number of times a contract may be reclassified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 1, 2009 we adopted new guidance, as
codified in Financial Accounting Standards Board (&quot;FASB&quot;) Accounting Standards Codification (&quot;ASC&quot;)&nbsp;815-40,
<I>Derivatives and Hedging</I>, <I>Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&rsquo;s
Own Stock </I>(previously EITF 07-5), that requires us to apply a two-step model in determining whether a financial instrument
or an embedded feature is indexed to our own stock and thus enables it to qualify for equity classification. We have identified
several convertible debt or warrant agreements in which the embedded conversion feature or exercise price contains certain provisions
that may result in an adjustment of the conversion or exercise price, which results in the failure of the these instruments to
be considered to be indexed to our stock. Accordingly, under this guidance, we are required to record the estimated fair value
of these instruments as derivative liabilities (see Note 9).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We re-measure the estimated fair value of derivative liabilities
at each reporting period and record changes in fair value in other expense (income) in the current statement of operations.</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">REGISTRATION PAYMENT ARRANGEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We account for contingent obligations to make future payments or
otherwise transfer consideration under a registration payment arrangement separately from any related financing transaction agreements,
and any such contingent obligations are recognized only when it is determined that it is probable that the Company will become
obligated for future payments and the amount, or range of amounts, of such future payments can be reasonably estimated (see Note
7).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">STOCK-BASED COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Employee stock options and rights to purchase shares under stock
participation plans are accounted for under the fair value method. Accordingly, share-based compensation is measured when all granting
activities have been completed, generally the grant date, based on the fair value of the award. The exercise price of options is
generally equal to the market price of the Company's common stock (defined as the closing price as quoted on the OTCBB) on the
date of grant. Compensation cost recognized by the Company includes (a) compensation cost for all equity incentive awards granted
prior to, but not yet vested as of April 1, 2006, based on the grant-date fair value estimated in accordance with the original
provisions of the then current accounting standards, and (b) compensation cost for all equity incentive awards granted subsequent
to April 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of subsequent accounting standards.
We use a Binomial Lattice option pricing model for estimating fair value of options granted (see Note 10).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">INCOME TAXES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to the difference between the consolidated financial statements and their respective tax basis. Deferred
income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts reported for income tax purposes, and (b) tax credit carryforwards. We record a valuation
allowance for deferred tax assets when, based on our best estimate of taxable income (if any) in the foreseeable future, it is
more likely than not that some portion of the deferred tax assets may not be realized. At March 31, 2011 and December 31, 2011,
we had net deferred tax assets relating primarily to tax net operating loss carryforwards and a 100% valuation allowance on such
net deferred tax assets. We had no significant current tax provision for any period presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SIGNIFICANT RECENT ACCOUNTING PRONOUNCEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">There were no&nbsp;recent accounting pronouncements issued by the
FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, or the Securities and
Exchange Commission that in the opinion of&nbsp;management had, or are expected&nbsp;to have a material impact on our present or
future consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 4. NOTES PAYABLE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Notes payable, all current liabilities and unsecured, consist of
the following at December 31, 2011 and March 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center; padding-bottom: 1pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt"></TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; text-align: center">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt"></TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; text-align: center">March 31, 2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1pt; padding-left: 10pt"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center">Principal Balance </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;Accrued Interest </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center">Principal Balance</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center">Accrued Interest&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 40%">12% Notes payable, past due</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">185,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">291,377</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">185,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">270,562</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>10% Note payable, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,875</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD>Law Firm Note, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Tonaquint Note</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">360,186</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,776</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: 27pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">584,796</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">301,821</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">190,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">275,437</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">LAW FIRM NOTE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On August 2 2011, we entered into a Promissory Note with our intellectual
property law firm for the amount of $49,610, which represented the amount we owed to that firm. The Promissory Note calls for monthly
payments of $5,000 from August 2011 through December 2011. From the period August 2 through December 31, 2011, we made three $5,000
payments, and as a result, have reduced the note balance to $34,610 as of December 31, 2011. The note bears interest at 10% per
annum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">TONAQUINT NOTE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 28, 2011, we entered into a Termination Agreement with Tonaquint,
Inc. (See Note 5) under which both parties agreed that in consideration of the termination of a warrant, the waiving of all fees,
penalties, the creation of the selling program and other factors, we agreed to issue an unsecured non-convertible promissory note
(the &quot;New Note&quot;) in the principal amount of $360,186, which provides for annual interest at a rate of 6%, payable monthly
in either cash or our stock, at our option. The New Note has a maturity date of April 30, 2012.</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 5. CONVERTIBLE NOTES PAYABLE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Convertible Notes Payable consist of the following at December 31,
2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center"> Unamortized</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Net&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Accrued</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Principal</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Discount</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Interest&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 40%; padding-left: 10pt; text-indent: -10pt">Amended and Restated Series A 12% Convertible Notes, past due</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">900,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">900,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">135,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">2008 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,729</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">December 2006 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,608</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">May &amp; June 2009 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,321</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">July &amp; August 2009 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,773</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">October &amp; November 2009 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,688</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">February 2010 10% Convertible Note</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">240,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">240,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,920</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">April 2010 10% Convertible Note</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">September 2010 10% Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">368,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">368,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,361</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">April 2011 10% Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">400,400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(384,483</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,030</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">July and August 2011 10% Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">357,655</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(178,812</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,321</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">September 2011 Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">253,760</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(142,073</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,687</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">November 2011 Convertible Notes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">525,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(176,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">348,200</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14,085</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total &ndash; Convertible Notes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,344,993</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(882,168</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,462,825</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">432,461</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Convertible Notes Payable consisted of the following at March 31,
2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">Unamortized</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">Net</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">Accrued</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Principal</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Discount</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Interest</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 40%; padding-left: 10pt; text-indent: -10pt">Amended Series A 10% Convertible Notes, past due</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">900,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">900,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">33,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">2008 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,917</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">December 2006 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,696</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">May &amp; June 2009 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,292</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">July &amp; August 2009 10% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,020</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">October &amp; November 2009 10% Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,226</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,788</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">February 2010 10% Convertible Note</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">715,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">715,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,273</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">April 2010 10% Convertible Note</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(73,222</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,778</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,063</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">June 2010 12% Convertible Notes, past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">636</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">July 2010 6% Convertible Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">495,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(494,770</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">573</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,107</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">September 2010 10% Convertible Notes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">739,200</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(713,990</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">25,210</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">42,709</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total - Convertible Notes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,481,060</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,299,208</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,181,852</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">293,251</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">All of the Convertible Notes Payable in the above tables are unsecured
and are presently past due or will be due within one year of the December 31, 2011 balance sheet date. As a result, we expect to
amortize all of the remaining discounts during the first half of calendar year 2012.</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">AMENDED AND RESTATED SERIES A 12% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In June 2010, we entered into Amended and Restated 12% Series A
Convertible Promissory Notes (the &quot;Amended and Restated Notes&quot;) with the holders of certain promissory notes previously
issued by the Company (&ldquo;Amended Series A 10% Convertible Notes&rdquo; or the &quot;Prior Notes&quot;), and all amendments
to the Prior Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Amended and Restated Notes, in the principal amount of $900,000,
are convertible into an aggregate of 4,500,000 shares of our common stock subject to antidilution adjustments, including down round
price protection, and matured on December 31, 2010. In connection with the restructuring we paid $54,001 of accrued and default
interest through the date of the restructuring, liquidated damages of $205,000 and $54,003 of prepaid interest through the expiration
date in the aggregate amount of $313,004 through the issuance of units (&quot;Units&quot;) at a fixed rate of $0.20 per Unit, each
Unit consisting of one share of our common stock and one common stock purchase warrant to purchase one share of our common stock
at a fixed exercise price of $0.20 per share as prescribed in the Amended and Restated Note Agreement. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition to the extension of the expiration date of the Amended
and Restated Notes to December 31, 2010, we agreed to increase the annual interest&nbsp;rate from ten percent to twelve percent.
We also agreed to change the exercise prices on all of the warrants held by the noteholders to $0.20 per share, to change certain
formerly contingent warrants to non-contingent warrants and to extend the expiration date of their warrants to February 2016. The
following table summarizes the number of shares of our common stock issuable upon the conversion of the Amended and Restated Notes
or the exercise of the various warrants issued or issuable pursuant to the Amended and Restated Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 86%; line-height: 115%">Note Conversion</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$&nbsp;</TD>
    <TD STYLE="width: 11%; line-height: 115%; text-align: right">4,500,000</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="line-height: 115%">Warrants</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">11,646,125</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="line-height: 115%">Total</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">&nbsp; $</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">16,146,125</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For accounting purposes, the amendment of the 12% Series A Convertible
Notes was treated as a debt extinguishment in accordance with FASB ASC 470-50, Debt-Modifications and Extinguishments, as the terms
of the restructured agreements were deemed to be substantially different than those of the prior agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Based on conversion and exercise price re-set provisions included
in the Amended and Restated Notes&nbsp;warrant agreements, the embedded conversion feature and the related warrants, with an aggregate
estimated fair value of approximately $3,089,000,&nbsp;were classified as derivative liability instruments (See Note 9).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Consequently, at the amendment date we recorded a loss on extinguishment
of $2,226,924 as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 87%; line-height: 115%">Reacquisition price</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: right">4,385,925</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="line-height: 115%">Less carrying value of notes and related instruments&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(2,159,001</TD>
    <TD STYLE="line-height: 115%">)&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="line-height: 115%">Loss on extinguishment&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">2,226,924</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of December 31, 2010, the Amended and Restated Notes matured
and as of December 31, 2011 are in default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We have begun discussions with the noteholders regarding an extension
to the notes but there can be no assurance that we will be able to do so on terms that we deem acceptable or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2008 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">One 2008 10% Convertible Note in the amount of $25,000 which matured
in January 2010 remains outstanding at December 31, 2011. This note is convertible into our common stock at $0.50 per share. During
the fiscal year ended March 31, 2011 we agreed to convert the $20,000 principal and related accrued interest of $5,562 of one holder
of the 2008 10% Convertible Note into 127,808 shares of common stock based upon a conversion ratio of $0.20 per share rather than
at the stated conversion ratio of $0.50 per share. As a result of this change, we recorded a charge of $15,337 as interest expense
in the fiscal year ended March 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DECEMBER 2006 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, $17,000 of the December 2006 10% Notes remained
outstanding and in default. These notes are convertible into our common stock at $0.17 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">MAY &amp; JUNE 2009 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In May and June 2009, we raised an aggregate amount of $350,000
from the sale to accredited investors of 10% convertible notes (&quot;May &amp; June 2009 10% Convertible Notes&quot;). The May
&amp; June 2009 10% Convertible Notes matured at various dates between November 2010 through December 2010 and are convertible
into our common stock at a fixed conversion price of $0.20 per share prior to maturity. Upon conversion of the May and June 2009
10% Convertible Notes, the&nbsp;note holders will receive a matching three year warrant to purchase unregistered shares of our
common stock at a price of $0.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">After consideration of the warrants, we recorded a discount associated
with the beneficial conversion feature of $233,735 related to the May &amp; June 2009 10% Convertible Notes and we amortized that
discount over the terms of the respective convertible notes using the effective interest method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the May &amp; June 2009 10% Convertible
Notes have taken place during the fiscal years ended March 31, 2011 and 2010:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Fiscal Year<BR>
Ended</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Fiscal Year<BR>
Ended</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">March 31, 2010</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">March 31, 2011</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 72%; line-height: 115%">Principal converted</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; line-height: 115%; text-align: right">50,000</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; line-height: 115%; text-align: right">100,000</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Accrued interest converted</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: right">2,803</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: right">15,039</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Warrants issued</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">250,000</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">500,000</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As a result of the warrant issuances, we recorded charges of $31,550
and $74,652 as additional interest expense in the fiscal years ended March 31, 2010 and 2011, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On or about June 23, 2011, the holder of the two remaining <FONT STYLE="color: black">May
&amp; June 2009 10% Convertible Notes, John Barsell,</FONT> filed a complaint against us entitled <I>John E. Barsell v. Aethlon
Medical, Inc</I>., in the Superior Court of the State of California for the County of San Diego, Case No. 37-2011-00093374 (the
&ldquo;Lawsuit&rdquo;). The complaint alleged breach of contract in connection with certain notes in the aggregate principal amount
of $200,000 issued by us to Barsell in 2009. <FONT STYLE="color: black">On August 15, 2011, we and Barsell signed a Settlement
Agreement under which we agreed to repay the notes and related accrued interest in cash or in common stock, at the election of
the Company, on a monthly basis over approximately a ten month period of time. In exchange, Barsell dismissed the Lawsuit without
prejudice. The agreed monthly payments are $25,000 if in cash or $30,000 if in stock with $25,000 of the $30,000 amount going towards
principal reduction and the remaining $5,000 as a penalty for paying in stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Following the Settlement Agreement and through December 31, 2011,
Barsell converted $125,000 of principal into 2,437,425 shares of our common stock over five monthly issuances. Those share issuances
also covered $25,000 in penalties as noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the remaining principal balance of $75,000
was in default (see Note 13).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">JULY &amp; AUGUST 2009 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In July and August 2009, we raised an aggregate amount of $668,250
from the sale to three investment funds of 10% convertible notes (&quot;July &amp; August 2009 10% Convertible Notes&quot;). Each
note carried a one-year term and is convertible into our common stock at 80% of market with a floor of $0.15 cents and a ceiling
of $0.25 cents per share. As additional consideration, the investors also received 1,336,500 three year warrants to purchase our
common stock at $0.50 per share, although that exercise price is subject to change based on certain conditions. The conversion
feature may additionally be adjusted in the event of future financing by the Company. Because the conversion feature and warrant
exercise price each can be reset based on future events, they are classified as derivative liability instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Based on the initial estimated fair value of the conversion feature
and warrants, we recorded a discount associated with the derivative liability of $475,762, which was amortized using the effective
interest method over the one-year term of the notes. Deferred financing costs incurred in connection with this financing totaled
$60,750, which were capitalized and are being amortized using the effective interest method over the one-year term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the July &amp; August 2009 10% Convertible
Notes have taken place during the fiscal years ended March 31, 2011 and 2010:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Fiscal Year<BR>
Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Fiscal Year<BR>
Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">March 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">March 31, 2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 56%">Principal converted</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">330,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">250,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accrued interest converted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,559</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,698</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the remaining principal balance of $32,500
was in default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">OCTOBER &amp; NOVEMBER 2009 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In October and November 2009, we raised $430,000 from the sale to
accredited investors of 10% convertible notes (&quot;October &amp; November 2009 10% Convertible Notes&quot;). The October &amp;
November 2009 10% Convertible Notes mature at various dates between April 2011 and May 2011 and are convertible into our common
stock at a fixed&nbsp;conversion price of $0.25 per share prior to maturity. The investors also received matching three year warrants
to purchase unregistered shares of our common stock at a price of $0.25 per share.&nbsp;&nbsp;We measured the fair value of the
warrants and the beneficial conversion feature of the notes and recorded a 100% discount against the principal of the notes. We
are amortizing this discount using the effective interest method over the term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the October &amp; November 2009 10%
Convertible Notes took place during the fiscal years ended March 31, 2011 and 2010:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Fiscal Year<BR>
Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Fiscal Year<BR>
Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">March 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">March 31, 2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 62%">Principal converted</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">70,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">175,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accrued interest converted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the October &amp; November 2009 10%
Convertible Notes took place during the nine months ended December 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months<BR>
Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31,<BR>
2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 60%">Principal converted</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">130,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accrued interest converted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,288</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Deferred financing costs of $20,250 incurred in connection with
this financing were issued in the form of a convertible note with warrants on the same terms as those received by the investors.&nbsp;&nbsp;We
capitalized the $20,250 of deferred financing costs and amortized them over the term of the notes using the effective interest
method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the remaining principal balance of $75,000
was in default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">FEBRUARY 2010 10% CONVERTIBLE NOTE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On February 12, 2010, we raised $280,015 in cash and received a
secured promissory note in the amount of $300,000 in exchange for the issuance by the Company of a $660,000 principal amount 10%
convertible promissory note (the &quot;Note&quot;) to Gemini Master Fund, Ltd. (&quot;Gemini&quot;). The Note included an original
issue discount of ten percent, or $60,000, and an origination fee of three percent, or $9,000. We also paid legal fees of $10,985.
The Note issued by the Company matured in February 2011. The terms of the promissory note included a maturity date of April 1,
2011, and allowed for prepayments of principal and interest by Gemini beginning on September 1, 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The conversion price per share initially was equal to eighty percent
(80%) of the average of the three lowest closing bid prices of our common stock as reported by Bloomberg L.P. on the Principal
Market for the ten (10) trading days preceding the conversion date, subject to a maximum price per share of $0.30 and a minimum
price per share of $0.20 (the &quot;Floor Price&quot;). The Note is convertible into a maximum of 3,300,000 shares of our common
stock at the minimum price per share of $0.20. The investor also received 660,000 three-year warrants to purchase shares of our
common stock at $0.50 per share, although that exercise price is subject to change based on certain conditions. The conversion
feature, including the Floor Price, may additionally be adjusted in the event of future financing by the Company. Because the conversion
feature and warrant exercise price each can be reset based on future events, they have been classified as derivative liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Note also contains other standard adjustment features for stock
splits, recapitalizations and similar occurrences. The Note contains standard events of default related to payment, performance
of certain covenants and bankruptcy events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We recorded a debt discount of $478,476 based on the estimated fair
value of the derivative liabilities associated with the warrants and embedded conversion feature which was amortized using the
effective interest method over the term of the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In November 2010, certain terms of the Note were modified pursuant
to a Settlement Agreement (the &quot;Modified Agreement&quot;) which provides for the modification of the conversion price formula
to equal eighty percent (80%) of the average of the three lowest closing bid prices of the common stock as reported by Bloomberg
L.P. on the Principal Market for the twenty (20) trading days preceding the conversion date in lieu of the ten (10) trading days
preceding the conversion date.</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">According to the modified terms, the previous conversion floor price
was replaced with a maximum share limitation under which the maximum number of shares of common stock that may be issued to the
holder of the Note pursuant to a conversion of the Note, combined with an exercise of the Exchange Warrant (as defined below),
shall not exceed a cap determined by (a) dividing the sum of (i) the face amount of the Note, plus (ii) an amount equal to all
interest that would accrue under the Note during its term (assuming no payments of principal or interest are made prior to the
maturity date of the Note), by a price per share of common stock equal to $0.20 (subject to equitable adjustment) and (b) then
adding the sum calculated pursuant to the foregoing clause (a) to the maximum number of warrant shares (as defined in the Exchange
Warrant) that may be acquired by the holder thereof upon exercise of the Exchange Warrant (regardless of whether such exercise
is a cashless exercise). In addition, the &quot;maximum ownership percentage&quot; under the Note was increased to 9.99%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition to the modifications of the note, we agreed to exchange
the original warrant for a new common stock purchase warrant (the &quot;Exchange Warrant&quot;) for the purchase of 2,727,272 shares
of common stock at an initial exercise price of $0.231 per share. The Exchange Warrant provides for anti-dilution adjustment to
the exercise price in the event of the issuance of securities by the Company below the exercise price, subject to certain exceptions
as set forth in the Exchange Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition, the Modified Agreement provided that Gemini deliver
to us $253,794.09 by wire transfer in full payment of the promissory note, which represents the outstanding principal balance thereof
plus all accrued but unpaid interest thereon less the origination fee due to Gemini under the original transaction documents less
reimbursement of Gemini's legal expenses. In accordance with the settlement, we delivered to Gemini 286,483 freely tradable shares
of common stock in full satisfaction of the remaining number of shares of common stock due under certain conversion notices, for
a total of $75,000, previously delivered by Gemini to the Company. The Modified Agreement provided for the mutual release of all
claims related to the dispute and the revocation of all prior notices of default sent by the Company and Gemini to each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In connection with the modification to the note and the issuance
of the Exchange Warrant, the maximum number of shares issuable pursuant to the maximum share limitation and the exercise in full
of the Exchange Warrant was 6,357,272.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As provisions of the Modified Agreement resulted in terms that were
deemed to be substantially different from the original terms, the exchange of debt instruments was accounted for as a debt extinguishment
and we recorded a loss on extinguishment of debt in the amount of $963,018 in the fiscal year ended March 31, 2011 as shown below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 70%">Reacquisition price</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">1,854,767</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Less carrying value of notes and related instruments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(891,749</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt">Loss on extinguishment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">963,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On March 21, 2011, we entered into an Extension Agreement (the &quot;Extension
Agreement&quot;) with Gemini.&nbsp;&nbsp;The Extension Agreement provides for, among other things, the extension of the Maturity
Date to October 1, 2011, and an amendment and restatement of the Note to reflect the revised principal amount of $740,578, which
amount includes accrued interest of $58,981, the remaining principal balance of $585,000 and a 15% premium to the principal and
accrued interest amount in consideration for the extension. In addition, the Note as amended provides for a new &quot;share cap
formula&quot; such that the number of shares of Common Stock issuable upon conversion of the Note shall not exceed a cap determined
by (a) dividing the sum of (i) the revised principal amount of the Note ($740,578), plus (ii) an amount equal to all interest that
would accrue under the Note during its term (assuming no payments of principal or interest are made after March 21, 2011 but prior
to the Maturity Date), by a price per share of Common Stock equal to $0.16 (subject to adjustment as set forth in the Note) and
(b) then adding the sum calculated pursuant to the foregoing clause to the maximum aggregate number of shares of Common Stock issuable
under certain warrants held by Gemini (regardless of whether such exercise is a cashless exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As provisions of the Extension Agreement resulted in terms that
were deemed to be substantially different from the original terms, the exchange of debt instruments was accounted for as a debt
extinguishment and we recorded a loss on extinguishment of debt in the amount of $47,701 in the fiscal year ended March 31, 2011
as shown below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 70%">Reacquisition price</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">773,582</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Less carrying value of notes and related instruments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(725,881</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt">Loss on extinguishment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">47,701</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the February 2010 10% Convertible Note
have taken place during the nine months ended December 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months<BR>
Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31,<BR>
2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 67%">Principal converted</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">475,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accrued interest converted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,403</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On December 29, 2011, we agreed with Gemini to extend the expiration
date of the Note to April 1, 2012. There was no fee or any other consideration exchanged in connection with the extension.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">APRIL 2010 10% CONVERTIBLE NOTE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In April 2010, we raised $75,000 from the sale to an accredited
investor of a 10% convertible note. The convertible note matures in October 2011 and is convertible into our common stock at a
fixed conversion price of $0.25 per share prior to maturity. The investor also received three year warrants to purchase 300,000
unregistered shares of our common stock at a price of $0.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We measured the fair value of the warrants and the beneficial conversion
feature of the notes and recorded a 100% discount against the principal of the notes. We are amortizing this discount using the
effective interest method over the term of the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the principal balance of $75,000 was in default.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">JUNE 2010 12% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In June 2010, in connection with the present and past negotiations
with the law firm representing the holders of the &quot;Amended and Restated Notes,&quot; we issued two convertible notes to that
law firm (&ldquo;June 2010 12% Convertible Notes&rdquo;) totaling $64,153 on the same terms as the Amended and Restated Notes.
That amount represented the amount of their legal fees plus accrued interest. During the fiscal year ended March 31, 2011, the
holder converted to common stock one of the convertible notes in the amount of $42,964.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A NAME="OLE_LINK3">During the three months ended September 30,
2011, the holder converted the remaining principal balance of $21,189 and accrued interest of $2,598 to shares of our common stock
per the terms of the convertible note. </A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">JULY 2010 6% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In July 2010, we entered into a Note and Warrant Purchase Agreement
(the &quot;Purchase Agreement&quot;) with Tonaquint, Inc., a Utah corporation (the &quot;Investor&quot;) whereby we issued and
sold, and the Investor purchased: (i) a Convertible Promissory Note of the Company in the principal amount of $890,000 (the &quot;Company
Note&quot;) and (ii) a Warrant to purchase common stock of the Company (the &quot;Warrant&quot;). As consideration for the issuance
and sale of the Company Note and Warrant, the Investor paid cash in the amount of $400,000 and issued two Secured Trust Deed Notes
to us (the &quot;Trust Notes&quot;) each in the principal amount of $200,000. The variance of $90,000 represents fees and expenses
paid by us and an original issue discount which was recorded as deferred offering costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company Note is convertible into shares of the Company's common
stock, at the option of the Investor, at a price per share equal to (a) the principal and interest due under the Company Note divided
by (b) 80% of the average of the closing bid price for the three (3) trading days with the lowest closing bid prices during the
twenty (20) trading days immediately preceding the conversion date (the &ldquo;Conversion Price&rdquo;). In no event shall the
Conversion Price be greater than the &quot;Ceiling Price&quot;, which is $0.30 per share. The principal and interest subject to
conversion under the Note shall be eligible for conversion in tranches (&quot;Tranches&quot;), as follows: (1) an initial Tranche
in an amount equal to $450,000 and any interest and/or fees accrued thereon under the terms of the Company Note and the other Transaction
Documents (as defined below and in the Purchase Agreement), and (2) two additional subsequent Tranches each in an amount equal
to $220,000 and any interest or fees accrued thereon under the terms of the Company Note or the other Transaction Documents. The
first subsequent Tranche shall correspond to payment of the first Trust Note and the second subsequent Tranche shall correspond
to payment of the second Trust Note (as defined in the Purchase Agreement). The Investor's right to convert any of the subsequent
Tranches is conditioned upon the Investor&rsquo;s payment in full of the Trust Notes corresponding to such subsequent Tranche.&nbsp;&nbsp;Accordingly,
principal and interest under the Company Note may only be converted by the Investor in proportion to the amounts paid under each
of the Trust Notes.&nbsp;&nbsp;However, up to $450,000 may be converted at the Investor's option at any time, representing amounts
paid by the Investor on the closing of the transaction on July 15, 2010 (the &quot;Closing&quot;).&nbsp;&nbsp;The Company Note
bears interest at a rate of 6% per annum. The maturity date of the Company Note is July 15, 2011. The Company Note contains &quot;anti-dilution&quot;
protection, such that if the Company issues and sells common stock, or securities convertible into or exercisable for common stock
of the Company, at a price per share that is less than the applicable Conversion Price, then the Conversion Price is adjusted downward
to match such lower issuance price. However, in no event will the Conversion Price based on anti-dilution adjustments be lower
than the &quot;Floor Price&quot; which is $0.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The number of shares of Common Stock that may be issued to the lender
pursuant to a conversion of this Note, combined with an exercise of the Warrant, shall not exceed a cap determined by (a) dividing
the sum of (i) the face amount of this Note, plus (ii) an amount equal to all interest that would accrue under this Note during
its term (assuming no payments of principal or interest are made prior to the Maturity Date), by a price per share of Common Stock
equal to $0.20 (the Floor Price).</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company Note also contains other standard adjustment features
for stock splits, recapitalizations and similar occurrences. The Company Note contains standard events of default related to payment,
performance of certain covenants and bankruptcy events. We have granted the Investor a security interest in the Trust Notes under
the terms of the Security Agreement. The sole collateral for the Company's payment and performance obligation under the Company
Note is the Trust Notes.&nbsp;&nbsp;The Warrant entitles the Investor to purchase 3,636,364 shares of common stock at an exercise
price of $0.231 per share. The Warrant contains &quot;anti-dilution&quot; protection, such that if we issue and sell common stock,
or securities convertible into or exercisable for common stock of the Company, at a price per share that is less than the applicable
exercise price, then the price is adjusted downward to match such lower issuance price. The Warrant also contains other standard
adjustment features for stock splits, recapitalizations and similar occurrences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We recorded a debt discount of $890,000 based on the estimated fair
value of the derivative liabilities associated with the warrants and embedded conversion feature which was amortized using the
effective interest method over the term of the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 28, 2011, we entered into a Termination Agreement with Tonaquint,
Inc. under which both parties agreed to terminate the warrant to prevent continuing dilution of our common stock and to eliminate
confusion or disagreement as to the number of shares of common stock available for issuance under the warrant in the future. Accordingly,
under the Termination Agreement we issued 3,599,913 shares of common stock upon the final exercise of the warrant, whereupon the
warrant was terminated and is of no further force or effect. The&nbsp;Termination Agreement also provides for a &quot;Common Stock
Sale Limitation&quot; on all of our common stock held by Tonaquint, Inc. Under the &quot;Common Stock Sale Limitation&quot;, the
daily limitation on the number of shares of common stock which Tonaquint, Inc. may sell into the market on any trading day is limited
to the greater of (i) $5,000 of sales amount, or (ii) 10% of the Average Daily Volume of our common stock sold on the Over The
Counter Bulletin Board, where the Average Daily Volume shall mean the average daily volume for the prior three month period as
reported on each trading day on Yahoo Finance with respect to our common stock. Under the terms of the Termination Agreement, Tonaquint,
Inc. has waived and released us from any obligation to pay or perform any fees, penalties, costs, or assessments that were or are
due, or would have become due, under the convertible note, the warrant and the note purchase agreement. In consideration of the
termination of the warrant, the waiving of all fees, penalties, the creation of the selling program and other factors, we agreed
to issue an unsecured non-convertible promissory note (the &quot;New Note&quot;) in the principal amount of $360,185, which provides
for annual interest at a rate of 6%, payable monthly in either cash or our stock, at our option. The New Note has a maturity date
of April 30, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SEPTEMBER 2010 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On September 3, 2010, we entered into a Subscription Agreement with
three accredited investors (the &ldquo;Purchasers&rdquo;)&nbsp;providing for the issuance and sale of convertible promissory notes
and corresponding warrants in the aggregate principal amount of $1,430,000. The initial closing under the Subscription Agreement
resulted in the issuance and sale of (i) convertible promissory notes in the aggregate principal amount of $743,600, (ii) five-year
warrants to purchase an aggregate of 3,718,000 shares of our common stock at an exercise price of $0.31125 per share, and (iii)
five-year warrants to purchase an aggregate of 3,718,000 shares of our common stock at an exercise price of $0.43575 per share.
The convertible promissory notes bear interest compounded monthly at the annual rate of ten percent (10%) and mature on September
3, 2011. The aggregate gross cash proceeds were $650,000, the balance of the principal amount representing a due diligence fee
and an original issuance discount. The convertible promissory notes are convertible at the option of the holders into shares of
our common stock at a price per share equal to eighty percent (80%) of the average of the three lowest closing bid prices of the
common stock as reported by Bloomberg L.P. for the principal market on which the common stock trades or is quoted for the ten (10)
trading days preceding the proposed conversion date. Subject to adjustment as described in the notes, the conversion price may
not be more than $0.30 nor less than $0.20. There are no registration requirements with respect to the shares of common stock underlying
the notes or the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following conversions of the September 2010 10% Convertible
Note have taken place during the nine months ended December 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months<BR>
Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31,<BR>
2011</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 57%">Principal converted</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">375,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accrued interest converted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,255</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the remaining principal balance of $368,100
was in default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">APRIL 2011 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In April 2011, we entered into a Subscription Agreement with two
accredited investors (the &ldquo;Purchasers&rdquo;) providing for the issuance and sale of convertible promissory notes and corresponding
warrants in the aggregate principal amount of $385,000. The closing under the Subscription Agreement resulted in the issuance and
sale by us of (i) convertible promissory notes in the aggregate principal amount of $385,000, (ii) five-year warrants to purchase
an aggregate of&nbsp;4,004,000 shares of our common stock at an exercise price of $0.125 per share, and (iii) five-year warrants
to purchase an aggregate of&nbsp;4,004,000 shares of our common stock at an exercise price of $0.175 per share. The convertible
promissory notes bear interest compounded monthly at the annual rate of ten percent (10%) and mature on April 1, 2012.&nbsp;&nbsp;The
aggregate gross cash proceeds to us were $350,000, the balance of the principal amount representing a due diligence fee and an
original issuance discount. The convertible promissory notes are convertible at the option of the holders into shares of common
stock of the Registrant at a price per share equal to eighty percent (80%) of the average of the three lowest closing bid prices
of the common stock as reported by Bloomberg L.P. for the principal market on which the common stock trades or is quoted for the
ten (10) trading days preceding the proposed conversion date. Subject to adjustment as described in the notes, the conversion price
may not be more than $0.20 nor less than $0.10. There are no registration requirements with respect to the shares of common stock
underlying the notes or the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition, we issued (i) five-year warrants to purchase an aggregate
of 812,500 shares of our common stock at an exercise price of $0.125 per share, and (iii) five-year warrants to purchase an aggregate
of&nbsp;812,500 shares of our common stock at an exercise price of $0.175 per share to the Purchasers. These warrants were issued
as an antidilution adjustment under certain common stock purchase warrants held by Purchasers that were acquired from us in September
2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the outstanding principal balance was $400,400.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">JULY &amp; AUGUST 2011 10% CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the three months ended September 30, 2011, we raised $357,656
in 10% convertible notes. Those notes had a fixed conversion price of $0.09 per share and carried an interest rate of 10%. The
convertible notes mature in July and August 2012. We also issued those investors five year warrants to purchase 3,973,957 shares
of common stock at $0.125 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We measured the fair value of the warrants and the beneficial conversion
feature of the notes and recorded a $257,926 discount against the principal of the notes. We are amortizing this discount using
the effective interest method over the term of the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SEPTEMBER 2011 CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On September 23, 2011, we entered into a Subscription Agreement
with two accredited investors (the &ldquo;Purchasers&rdquo;) providing for the issuance and sale of convertible promissory notes
and corresponding warrants in the aggregate principal amount of $253,760. The warrants carried a five-year term to purchase an
aggregate of 3,625,143 shares of our common stock at an exercise price of $0.10 per share. The convertible promissory notes do
not bear an interest rate and mature on September 23, 2012. The aggregate net cash proceeds to us were $175,000, the balance of
the principal amount representing a due diligence fee and an original issuance discount. The convertible promissory notes are convertible
at the option of the holders into shares of our common stock at a price per share equal to seven cents. Subject to adjustments
as described in the notes, the conversion price may not be more than seven cents. There are no registration requirements with respect
to the shares of common stock underlying the notes or the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We measured the fair value of the warrants and the beneficial conversion
feature of the notes and recorded a $168,804 discount against the principal of the notes. We are amortizing this discount using
the effective interest method over the term of the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOVEMBER 2011 CONVERTIBLE NOTES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In November 2011, we raised $525,000 in 5% Original Issue Discount
Unsecured Convertible Debentures from five accredited investors pursuant to which the investors purchased an aggregate principal
amount of $525,000 for an aggregate purchase price of $500,000. The debentures bear interest at 20% per annum and mature on April
20, 2012. The debentures will be convertible at the option of the holders at any time into shares of our common stock, at a conversion
price equal to $0.0779, subject to adjustment. In connection with the debentures, the purchasers received warrants to purchase
3,369,706 shares of our Common Stock. The warrants are exercisable for a period of five years from the date of issuance at an
exercise price of $0.11, subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Until December 31, 2012, upon any proposed issuance by us of our
common stock or equivalents (or a combination thereof as defined in the subscription agreement) for cash consideration, the purchasers
may elect, in their sole discretion, to exchange all or some of the debentures then held by such purchaser for any securities issued
in a subsequent financing on a $1.00 for $1.00 basis, provided, however , this right shall not apply with respect to (i) an Exempt
Issuance (as defined in the debenture) or (ii) an underwritten public offering of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A FINRA registered broker-dealer was engaged as placement agent
in connection with the private placement.&nbsp;&nbsp;We paid the placement agent a cash fee in the amount of $50,000 (representing
a 8% sales commission and a 2% unaccountable expense allowance) and will issue the placement agent or its designees warrants to
purchase an aggregate of 808,729 shares of common stock at $0.11 per share. The warrants issued to the placement agent may be exercised
on a cashless basis. In the event the placement agent exercises the warrants on a cashless basis, we will not receive any proceeds.</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The securities sold in the private placement were not registered
under the Securities Act, or the securities laws of any state, and were offered and sold in reliance on the exemption from registration
afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities
laws, which exempt transactions by an issuer not involving any public offering. The investors are &ldquo;accredited investors&rdquo;
as such term is defined in Regulation D promulgated under the Securities Act.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the interest payable on these notes totaled
$14,085.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 6. EQUITY TRANSACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the nine months ended December 31, 2011, we issued 24,413,568
shares of restricted common stock in exchange for the partial or full conversion of principal and interest of several convertible
notes payable in an aggregate amount of $1,806,879 at an average conversion price of $0.07 per share based upon the conversion
formulae in the respective notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the nine months ended December 31, 2011, we issued 3,292,029
shares of stock to service providers for services valued at $328,327 based upon the fair value of the shares issued. Of that aggregate
number, 2,864,488 shares of common stock were issued to consultants pursuant to our S-8 registration statements covering our Amended
and Restated 2003 Consultant Stock Plan or 2010 Stock Incentive Plan for services valued at $272,077 based upon the fair value
of the shares issued. The services were for regulatory affairs, primarily managing our hepatitis C trial in India, and corporate
communications.&nbsp;&nbsp;The average issuance price on the S-8 issuances was approximately $0.09 per share. Additionally, we
issued 427,541 restricted shares of common stock to service providers for investor relations valued at $56,250 based upon the fair
value of the shares issued. The average issuance price on the restricted share issuances was approximately $0.13 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the nine months ended December 31, 2011, we issued 3,699,914
shares of restricted common stock related to net warrant cashless exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In May 2011, we agreed to modify three warrants held by an institutional
investor as the result of antidilution protection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In May 2011, our Board ratified a six month consulting agreement
with a consultant to provide public relations and corporate communications services. We agreed to pay the consultant a monthly
fee of $1,500 in cash and a one-time stock-based payment of six months&rsquo; worth of shares based upon a rate of $5,000 per month,
or a total of $30,000, to be paid in restricted stock. Based upon the closing price of the date of the approval by our Board, the
one-time restricted share payment was in the amount of 200,000 restricted shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 7. ACCRUED LIQUIDATED DAMAGES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We account for contingent obligations to make future payments or
otherwise transfer consideration under a registration payment arrangement separately from any related financing transaction agreements,
and any such contingent obligations are recognized only when it is determined that it is probable that we will become obligated
for future payments and the amount, or range of amounts, of such future payments can be reasonably estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We have entered into registration payment arrangements in connection
with certain financing arrangements that require us to register the shares of common stock underlying the convertible debt and
warrants issued in these financing transactions. Under these agreements we are liable for liquidated damages to the investors if
we fail to file and/or maintain effective registration statements covering the specified underlying shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Since we have either failed to file, or failed to maintain the registration
obligations under these agreements, as of December 31, 2011 and March 31, 2011 we have accrued estimated aggregate liquidated damages
of $437,800 in connection with the liquidated damage provisions of these agreements, which we believe represents our maximum exposure
under these provisions.&nbsp;&nbsp;Accordingly, we do not expect to accrue any further liquidated damages in connection with these
agreements.&nbsp;&nbsp;The actual amount of liquidated damages paid, if any, may differ from our estimates as it is our intention
to negotiate with the investors the settlement of liquidated damages due and, as such, the ultimate amounts we may actually pay
may be less than the amount currently accrued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 8. OTHER CURRENT LIABILITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011 and March 31, 2011, our other current liabilities
were comprised of the following items:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.1pt; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">December 31,</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">March 31,</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">2011</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">2011</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 72%; line-height: 115%">Accrued interest</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; line-height: 115%; text-align: right">734,282</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; line-height: 115%; text-align: right">525,336</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="line-height: 115%">Accrued legal fees</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">240,242</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">236,902</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="line-height: 115%">Deferred rent</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">5,324</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">5,784</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="line-height: 115%">Other</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">42,588</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">36,364</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 0.25in; line-height: 115%">Total other current liabilities</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,022,436</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">804,386</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: White"><FONT STYLE="background-color: white"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: White"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: White"><FONT STYLE="background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of the date of this report, various promissory and convertible
notes payable in the aggregate principal amount of $1,792,210 (as identified in Notes 4 and 5 above) have reached maturity and
are past due. We are continually reviewing other financing arrangements to retire all past due notes. At December 31, 2011, we
had accrued interest in the amount of $639,958 associated with these defaulted notes in accrued liabilities payable, which are
included in the accrued interest numbers noted above (see Notes 4 and 5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 9. FAIR VALUE MEASUREMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We follow FASB ASC 820, &quot;FAIR VALUE MEASUREMENTS AND DISCLOSURES&quot;
(&ldquo;ASC 820&rdquo;) in connection with financial assets and liabilities measured at fair value on a recurring basis subsequent
to initial recognition. The guidance applies to our derivative liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ASC 820 requires that assets and liabilities carried at fair value
will be classified and disclosed in one of the following three categories: We measure the fair value of applicable financial and
non-financial assets based on the following fair value hierarchy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 1: Quoted market prices in active markets for identical assets
or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 2: Observable market based inputs or unobservable inputs that
are corroborated by market data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 3: Unobservable inputs that are not corroborated by market
data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The hierarchy noted above requires us to minimize the use of unobservable
inputs and to use observable market data, if available, when determining fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The fair value of our recorded derivative liabilities is determined
based on unobservable inputs that are not corroborated by market data, which is a Level 3 classification. We record derivative
liabilities on our balance sheet at fair value with changes in fair value recorded in our consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Our fair value measurements at the December 31, 2011 reporting
date are classified based on the valuation technique level noted in the table below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
Description</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
December 31,<BR>
2011</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">Quoted Prices<BR>
in<BR>
Active Markets for<BR>
Identical Assets<BR>
(Level 1)</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">Significant<BR>
Other<BR>
Observable<BR>
Inputs<BR>
(Level 2)</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
Significant<BR>
Unobservable Inputs<BR>
(Level 3)</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 44%; line-height: 115%">Derivative Liabilities</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,250,705</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">--</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">--</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,250,705</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Total</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,250,705</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">--</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">--</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,250,705</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Prior to the third fiscal quarter ended December
31, 2010 (&ldquo;Q3 2011&rdquo;), the fair value estimate relating to an aggregate of 25,066,944 warrants classified as derivative
liabilities had been based on a Black-Scholes valuation model.&nbsp;&nbsp;During Q3 2011, we changed to a binomial lattice model
for valuation of these warrants as we determined that use of a binomial lattice model was more representative of fair value in
the circumstances. In accordance with accounting guidance in ASC 820-10, Fair Value Measurements and Disclosures, this was accounted
for as a change in accounting estimate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following outlines the significant weighted average assumptions
used to estimate the fair value information presented, in connection with our April 2011 convertible notes, July &amp; August 2011
10% convertible notes and the September 2011 convertible notes and with respect to warrant and embedded conversion option derivative
instruments utilizing the Binomial Lattice option pricing model:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; line-height: 115%; text-align: center">Nine Months Ended December 31, 2011</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Risk free interest rate</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.02% - 2.24%</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">Average expected life</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.25 - 5 years</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Expected volatility</TD>
    <TD STYLE="line-height: 115%; text-align: center">51.9% - 128.5%</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 115%">Expected dividends</TD>
    <TD STYLE="line-height: 115%; text-align: center">None</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The table below sets forth a summary of changes in the fair value
of our Level 3 financial instruments for the nine months ended December 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="width: 9%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
April 1,<BR>
2011</TD>
    <TD STYLE="width: 3%; line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="width: 13%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
Recorded<BR>
New Derivative<BR>
Liabilities</TD>
    <TD STYLE="width: 3%; line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="width: 14%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">Change in<BR>
estimated fair<BR>
value recognized<BR>
in results<BR>
of operations</TD>
    <TD STYLE="width: 3%; line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="width: 12%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">Reclassification<BR>
of Derivative<BR>
Liability to<BR>
Paid in<BR>
capital</TD>
    <TD STYLE="width: 5%; line-height: 115%; padding-bottom: 1pt">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
&nbsp;</TD>
    <TD STYLE="width: 17%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">&nbsp;<BR>
&nbsp;<BR>
&nbsp;<BR>
December 31,<BR>
2011</TD>
</TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Derivative liabilities</TD>
    <TD STYLE="line-height: 115%; text-align: center">$ 2,002,896</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">$ 1,107,940</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">($ 1,596,442)</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">($ 263,689)</TD>
    <TD STYLE="line-height: 115%; text-align: center">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">$1,250,705</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The fair value of derivative liabilities that we recorded in the
nine months ended December 31, 2011 was related to our April 2011 convertible note, July &amp; August 2011 10% convertible notes
and the September 2011 convertible note offerings (see Note 5) and was based upon an independent&nbsp;valuation report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The table below sets forth a summary of changes in the fair value
of our Level 3 derivative liabilities for the nine months ended December 31, 2010:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Fair Value at <BR>March 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Recorded Fair <BR>Value of <BR>Derivative <BR>Liabilities <BR>in the nine month period ended December 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Change in <BR>Estimated Fair <BR>Value Recognized <BR>in Results of <BR>Operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Fair Value at <BR>December 31, 2010</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 36%; padding-bottom: 2.5pt">Derivative liabilities</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">1,054,716</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">6,980,347</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">(2,098,954</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right">5,936,109</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The fair value of derivative liabilities that we recorded in the
nine months ended December 2010 was related to the restructuring of the Amended and Restated Convertible Notes and to the embedded
derivatives and associated warrants related to a number of our convertible note offerings (see Note 5) and was based upon an independent&nbsp;valuation
report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 10. STOCK COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table summarizes share-based compensation expenses
relating to shares and options granted and the effect on basic and diluted loss per common share during the three and nine months
ended December 31, 2011 and 2010:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 40%; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total share-based compensation expense</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">161,440</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">252,740</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">609,503</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">1,599,915</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total share-based compensation expense included in net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">161,440</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">252,740</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">609,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,599,915</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Basic and diluted loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table breaks out the components of our share-based
compensation expenses relating to shares and options granted and the effect on basic and diluted loss per common share during the
three and nine months ended December 31, 2011 and 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 40%; padding-left: 10pt; text-indent: -10pt">Vesting of stock options</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">64,773</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">153,898</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">319,503</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">875,171</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Incremental fair value of option modifications</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">499,188</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Vesting expense associated with CEO restricted stock grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">290,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,556</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Direct stock grants</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total share-based compensation expense</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">161,440</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">252,740</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">609,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,599,915</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total share-based compensation expense included in net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">161,440</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">252,740</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">609,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,599,915</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Basic and diluted loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We did not issue any stock options during the three and nine months
ended December 31, 2011. All of the stock-based compensation expense recorded during the nine months ended December 31, 2011 and
2010, which totaled $609,503 and $1,599,915, respectively, is included in payroll and related expense in the accompanying condensed
consolidated statements of operations.&nbsp; Stock-based compensation expense recorded during the three months ended December 31,
2011 had no impact on basic and diluted loss per common share and the stock-based compensation expense recorded during the three
months ended December 31, 2010 increased basic and diluted loss per common share by $0.01. Stock-based compensation expense recorded
during the nine months ended December 31, 2011 increased basic and diluted loss per common share by $0.01 and the stock-based compensation
expense recorded during the nine months ended December 31, 2010 increased basic and diluted loss per common share by $0.02.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We review share-based compensation on a quarterly basis for changes
to the estimate of expected award forfeitures based on actual forfeiture experience. The cumulative effect of adjusting the forfeiture
rate for all expense amortization is recognized in the period the forfeiture estimate is changed. The effect of forfeiture adjustments
for the nine months ended December 31, 2011 was insignificant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The expected volatility is based on the historic volatility. The
expected life of options granted is based on the &quot;simplified method&quot; as described in the SEC's guidance due to changes
in the vesting terms and contractual life of current option grants compared to our historical grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Options outstanding that have vested and are expected to vest as
of December 31, 2011 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15pt; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Weighted</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Weighted</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Average</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Average</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Remaining</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Number of</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Exercise</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; text-align: center">Contractual</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">Shares</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">Price</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: center">Term in Years</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 61%; line-height: 115%">Vested</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: right">17,562,026</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: right">0.33</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: center">6.18</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Expected to vest</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">2,116,667</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: right">0.25</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">8.75</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 0.25in; line-height: 115%">Total</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">19,678,693</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2011, there was approximately $969,836 of unrecognized
compensation cost related to share-based payments, including the restricted stock grant, which is expected to be recognized over
a weighted average period of 1.08 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On December 31, 2011, our stock options had a negative intrinsic
value since the closing price on that date of $0.05 per share was below the weighted average exercise price of our stock options</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In July 2011, our Board ratified a one year consulting agreement
with a consultant to provide corporate advisory services. We agreed to pay the consultant a monthly fee of $5,000 in common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 11.&nbsp;&nbsp;WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A summary of warrant activity during the nine months ended December
31, 2011 is presented below:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.05pt; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Range of Exercise</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Price</B></P></TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Weighted Average</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Exercise</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Price</B></P></TD>
    <TD STYLE="line-height: 115%; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 61%; line-height: 115%">Warrants outstanding at March 31, 2011</TD>
    <TD STYLE="width: 1%; line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: right">38,675,169</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">$</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: center">0.15 - $0.50</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 115%; text-align: center">$0.31</TD>
    <TD STYLE="width: 1%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Exercised</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">(1,209,623</TD>
    <TD STYLE="line-height: 115%">)</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.231</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Issued</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">22,914,533</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.10 - $0.125</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Cancelled/Expired</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(4,428,757</TD>
    <TD STYLE="line-height: 115%">)</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.17 - $0.50</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="line-height: 115%">Warrants outstanding at December 31, 2011</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%; text-align: right">55,951,322</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.10 - $0.25</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">$0.15</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 115%">Warrants exercisable at December 31, 2011</TD>
    <TD STYLE="line-height: 115%; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">55,951,322</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">$</TD>
    <TD STYLE="line-height: 115%; text-align: center">0.10 - $0.25</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%; text-align: center">$0.15</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following outlines the significant weighted average assumptions
used to estimate the fair value information presented, with respect to warrants utilizing the Binomial Lattice option pricing model
at, and during the nine months ended December 31, 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 60%">Risk free interest rate</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: center">0.10% - 2.24%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Average expected life</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">0.78 - 5 years</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD>Expected volatility</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">82.1% - 86.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expected dividends</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">None</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 12. &nbsp;DARPA CONTRACT AND RELATED REVENUE RECOGNITION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As discussed in Note 1, we entered into a government contract with
DARPA on September 30, 2011 and commenced work on such contract in October 2011. Only the base year (year one contract) is effective
for the parties. Years two through five are subject to DARPA exercising their option to enter into contracts for those years. The
year one contract contains eight milestones for which three have been achieved during the quarter ended December 31, 2011 as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Milestone 2.2.1.1 &ndash; Write requirements definition for the
extracorporeal blood purification system and acquire necessary equipment with a milestone payment of $358,284. Management considers
this milestone to be substantive as it was not dependent on the passage of time nor was it based solely on another party's efforts.
We worked on this concept for a number of months beginning with a presentation to DARPA in late 2010. We subsequently filed for
IP protection on certain of the key concepts in March 2011 and our management visited selected potential vendors to work out many
of the details in the summer of 2011 before we were awarded the contract on September 30, 2011. We ordered the breadboard device
from one of our vendors before the milestone payment was made. We designed the breadboard prototype and then presented the design
to DARPA in order to achieve the milestone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Milestone 2.2.1.2 -- Fabricate breadboard prototypes for anticoagulation-free
anti-sepsis extracorporeal system (ASEPSYS) device. Fabricate prototype blood tubing sets. Acquire anti-thrombogenic surface modified
hollow fiber plasma separators with a milestone payment $183,367. Management considers this milestone to be substantive as it was
not dependent on the passage of time nor was it based solely on another party's efforts. The consideration for this milestone covers
the cost of having the breadboard prototype developed to our specifications, hiring an engineer to supervise the project, acquiring
specially coated cartridges and associated overhead. The report was accepted by the contracting officer's representative and the
invoice was submitted thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Milestone 2.2.2.1 &ndash; Begin to develop the ADAPT device to efficiently
capture sepsis precursors and acquire important equipment and supplies with a milestone payment of $426,424. Management considers
this milestone to be substantive as it was not dependent on the passage of time nor was it based solely on another party's efforts.
It was critically important to obtain certain pieces of lab equipment as early as possible after winning the contract in order
to measure the binding ability of sepsis precursors. We demonstrated that we were able to capture one of the identified possible
sepsis precursors as part of our submission for approval. The consideration was also designed to cover the salaries of new and
existing scientists, lab space, materials as well as fringe and corporate overhead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 13. COMMITMENTS AND CONTINGENCIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">From time to time, claims are made against us in the ordinary course
of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable
outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products
or engaging in other activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The occurrence of an unfavorable outcome in any specific period
could have a material adverse effect on our results of operations for that period or future periods. Other than the Barsell matter
discussed earlier, we are not presently a party to any pending or threatened material legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">LEASES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In October 2009, we entered into two new leases for office and laboratory
space. The terms of the new leases are three years and two years, respectively, and the initial base lease payments are $6,045
per month and $1,667 per month, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On October 4, 2011 we entered into an amendment to extend our lease
for our laboratory by an additional three years. The amendment also included additional tenant improvements in the approximate
amount of $30,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 14. NOTE RECEIVABLE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On July 15, 2010, we received two Secured Trust Deed Notes to us
(the &quot;Trust Notes&quot;) each in the principal amount of $200,000 in connection with our issuance of a $890,000 principal
amount 6% convertible promissory note to one accredited investor (See Note 5).&nbsp;&nbsp;The Trust Notes bear interest payable
to us at five percent per annum and have maturity dates of September 15, 2011 and November 15, 2011. We recognize interest income
on the Investor Note and Trust Notes as it is earned under the terms of the notes. The Investor Note and Trust Notes have prepayment
options.</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In February 2011, the investor paid the initial $200,000 amount
to us along with related accrued interest of $5,945.&nbsp;&nbsp;During the three months ended June 30, 2011, the investor paid
the second $200,000 amount to us along with accrued interest of $7,863. As a result, we no longer show a note receivable on our
condensed consolidated balance sheet as of December 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NOTE 15. RELATED PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Due to working capital shortages, we have not been able to repay
certain members of our senior management and board members for expenses incurred on behalf of the Company and occasionally have
been unable to pay those individuals for their services. As of December 31, 2011 and March 31, 2011, we owed our senior management
and board members $617,570, which is shown as due to related parties on the accompanying balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 16. SUBSEQUENT EVENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Management has evaluated events subsequent to December 31, 2011
through the date that the accompanying condensed consolidated financial statements were filed with the Securities and Exchange
Commission for transactions and other events which may require adjustment of and/or disclosure in such financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In January 2012, we shipped a diagnostic product that isolated exosomes
from blood serum to a life sciences company and invoiced them for $1,432. We received payment in full under that invoice in February
2012. This represents our first commercial sale, which will be recorded in the March 2012 quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the period January 1, 2012 through February 15, 2012, we
issued 2,255,188 shares of restricted common stock in exchange for the partial or full conversion of principal and interest of
several convertible notes payable in an aggregate amount of $111,795 at an average conversion price of $0.05 per share based upon
the conversion formulae in the respective notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the period January 1, 2012 through February 15, 2012, we
issued 109,529 shares of common stock to a service provider for services valued at $7,667 based upon the fair value of the shares
issued. All of those shares were issued pursuant to our S-8 registration statements covering our Amended and Restated 2003 Consultant
Stock Plan or 2010 Stock Incentive Plan. The services were for exosome-related research.&nbsp;&nbsp;The issuance price on the S-8
issuance was approximately $0.07 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the period January 1, 2012 through February 15, 2012, we
issued 287,500 shares of restricted common stock as a patent license payment valued at $17,250.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="page_3"></A>ITEM 2. MANAGEMENT'S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The following discussion of our financial condition and results
of operations should be read in conjunction with, and is qualified in its entirety by, the condensed consolidated financial statements
and notes thereto included in Item 1 in this Quarterly Report on Form 10-Q. This item contains forward-looking statements that
involve risks and uncertainties. Actual results may differ materially from those indicated in such forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">FORWARD LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">All statements, other than statements of historical fact, included
in this Form 10-Q are, or may be deemed to be, &quot;forward-looking statements&quot; within the meaning of Section 27A of the
Securities Act of 1933, as amended (the &quot;Securities Act&quot;), and Section 21E of the Exchange Act. Such forward-looking
statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance,
or achievements of Aethlon Medical, Inc. (&quot;we&quot;, &quot;us&quot; or &quot;the Company&quot;) to be materially different
from any future results, performance, or achievements expressed or implied by such forward-looking statements contained in this
Form 10-Q. Such potential risks and uncertainties include, without limitation, completion of our capital-raising activities, FDA
approval of our products, other regulations, patent protection of our proprietary technology, product liability exposure, uncertainty
of market acceptance, competition, technological change, and other risk factors detailed herein and in other of our filings with
the Securities and Exchange Commission. The forward-looking statements are made as of the date of this Form 10-Q, and we assume
no obligation to update the forward-looking statements, or to update the reasons actual results could differ from those projected
in such forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">THE COMPANY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We are a medical device company focused on creating innovative devices
that address unmet medical needs in cancer, infectious disease and other life-threatening conditions. At the core of our developments
is the Aethlon ADAPT&trade; (Adaptive Dialysis-Like Affinity Platform Technology) system, a medical device platform that converges
single or multiple affinity drug agents with advanced plasma membrane technology to create therapeutic filtration devices that
selectively remove harmful particles from the entire circulatory system without loss of essential blood components. Approval to
embark on human trials is still needed to reach commercial viability of the Hemopurifier&reg; and approval by the U.S. Food and
Drug Administration (&quot;FDA&quot;). Successful outcomes of human trials will be required by the regulatory agencies of certain
foreign countries where we intend to sell this device. We have submitted an Investigational Device Exemption (&quot;IDE&quot;)
to the FDA. Some of our patents may expire before FDA approval or approval in a foreign country, if any, is obtained. However,
we believe that certain patent applications and/or other patents issued more recently will help protect the proprietary nature
of the Hemopurifier&reg; treatment technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">WHERE YOU CAN FIND MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We are subject to the informational requirements of the Securities
Exchange Act and must file reports, proxy statements and other information with the SEC. The reports, information statements and
other information we file with the Commission can be inspected and copied at the Commission Public Reference Room, 100 F Street,
N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at (800)
SEC-0330. The Commission also maintains a Web site (http://www.sec.gov) that contains reports, proxy and information statements
and other information regarding registrants, like us, which file electronically with the Commission. Our headquarters are located
at 8910 University Center Lane, Suite 660, San Diego, CA 92122. Our phone number at that address is (858) 459-7800. Our Web site
is http://www.aethlonmedical.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RESULTS OF OPERATIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">THREE MONTHS ENDED DECEMBER 31, 2011 COMPARED TO THE THREE MONTHS
ENDED DECEMBER 31, 2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Revenues</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="color: black">We recorded government contract
revenue of $958,075 in the three months ended December 31, 2011. This revenue arose from work performed under our government contract.
On September 30, 2011, we </FONT>entered into a contract with the United States of America, issued by SPAWAR Systems Center Pacific,
pursuant to a contract award from the Defense Advanced Research Projects Agency (&ldquo;DARPA&rdquo;). Under the DARPA award, we
have been engaged to develop a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results
in the death of combat-injured soldiers. The award from DARPA is a fixed-price contract with potential total payments to us of
$6,794,389 over the course of five years, including payments of up to $1,975,047 in the first year. Fixed price contracts require
the achievement of multiple, incremental milestones to receive the full award during each year of the contract.&nbsp;&nbsp;Under
the terms of the contract, we will perform certain incremental work towards the achievement of specific milestones against which
we will invoice the government for fixed payment amounts.&nbsp;&nbsp;Assuming all such work is performed according to the contract
terms, we will receive up to $1,975,047 of contract payments during the first twelve months of the contract with the aggregate
payment amounts in years two through five varying between approximately $775,000 and $1.6 million. DARPA has the option to enter
into the contract for years two through five. Only the contract related to the $1,975,047 has been formally entered into as of
the date of this Form 10-Q filing. The milestones are comprised of planning, engineering and clinical targets, the achievement
of which in some cases will require the participation and contribution of third party participants under the contract.&nbsp;&nbsp;There
can be no assurance that we alone, or with third party participants, will meet such milestones to the satisfaction of the government
and in compliance with the terms of the contract or that we will be paid the full amount of the contract revenues during any year
of the contract term.&nbsp;&nbsp;We commenced work under the contract in October 2011.</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of December 31, 2011, we received two initial payments under
the DARPA contract totaling $774,708 and have billed the government for a third invoice in the amount of $183,367, which is shown
as an account receivable on our balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Operating Expenses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Consolidated operating expenses for the three months ended December
31, 2011 were $1,299,403 in comparison with $1,046,701 for the comparable quarter a year ago. This increase of $252,702, or 24%,
was due to an increase in general and administrative expenses of $258,899 and an increase in professional fees of $40,591, which
were partially offset by a decrease in payroll and&nbsp;related expenses of $46,788.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $258,899 increase in general and administrative expenses was
primarily due to $237,367 of supplies and equipment purchased for the DARPA contract with no comparable expense in the 2010 period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $40,591 increase in our professional fees was largely due to
an increase in our scientific consulting expense of $109,446, which in turn was primarily due to the cost of the Hepatitis C (HCV)
trial in India. We also incurred approximately $40,000 of professional fees related to our DARPA contract. Those increases were
partially offset by decreases of $67,075 in legal fees, $32,875 in marketing expenses and a reduction in our Board fees due to
a timing difference between periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $46,788 decrease in payroll and related expenses was primarily
due to a number of stock option grants in the '10 period that included upfront vesting. The expense related to stock options was
$252,740 in the '10 period and $161,191 in the '11 period, a $91,549 decrease. Excluding the change in stock option-related expense,
our payroll increased by $44,761 as a result of hiring three new scientists for the DARPA project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Other Expenses (Income)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Other expenses (income) consist primarily of the change in the fair
value of our derivative liability, debt extinguishment charges other expense and interest expense. Other expenses for the three
months ended December 31, 2011 were $233,390 in comparison with other expenses of $821,470 for the comparable quarter a year ago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Change in Fair Value of Derivative Liability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Both periods include changes in the fair value of derivative liability.
For the three months ended December 31, 2011, the change in the estimated fair value of derivative liability was a gain of $74,940
and for the three months ended December 31, 2010, the change in estimated fair value was a gain of $430,077.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Interest Expense</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Interest expense was $308,386 for the three months ended December
31, 2011 compared to $594,128 in the corresponding prior period, a decrease of $285,742. The various components of our interest
expense are shown in the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Quarter Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Quarter Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Change</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 46%; padding-left: 10pt; text-indent: -10pt">Interest Expense</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">127,654</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">113,005</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">14,649</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Amortization of Deferred Financing Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,616</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(94,437</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Interest recorded in connection with issuance of conditional warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,652</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,652</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Amortization of Note Discounts</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">123,553</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">254,855</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(131,302</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total Interest Expense</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">308,386</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">594,128</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(285,742</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As noted in the above table, the three most significant factors
in the $285,742 decrease in interest expense were (a) the $131,302 reduction in the amortization of note discounts, (b) the $74,652
in interest recorded in the 2010 period in connection with the issuance of conditional warrants with no comparable charge in the
2011 period and (c) the $94,437 reduction in amortization of deferred financing costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Loss on Extinguishment of Debt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In the three months ended December 31, 2010, we modified the conversion
terms of the February 2010 convertible note and related warrant and as a result, we recorded a loss on extinguishment of debt in
the amount of $963,018.&nbsp;&nbsp;That charge was calculated based on the change in fair value of the embedded conversion feature
of the Note and in the warrants exchanged both immediately prior to and immediately after the Settlement date, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 57%; padding-left: 10pt; text-indent: -10pt">Reacquisition price</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,854,767</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Less carrying value of notes and related instruments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(891,749</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Loss on extinguishment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">963,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We had no loss on extinguishment of debt in the three months ended
December 31, 2011.</P>

<P STYLE="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Net Loss</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As a result of our government contract revenue more than offsetting
the increased expenses noted above, we recorded a consolidated net loss of approximately $575,000 and $1,868,000 for the quarters
ended December 31, 2011 and 2010, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Basic and diluted loss per common share were ($0.01) for the three
month period ended December 31, 2011 compared to ($0.03) for the period ended December 31, 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NINE MONTHS ENDED DECEMBER 31, 2011 COMPARED TO THE NINE MONTHS
ENDED DECEMBER 31, 2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Revenues</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We recorded government contract revenue of $958,075 in the nine
months ended December 31, 2011 as discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Operating Expenses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Consolidated operating expenses for the nine months ended December
31, 2011 were $3,214,839 in comparison with $3,618,687 for the comparable period a year ago. This decrease of $403,848, or 11%,
was primarily due to a decrease in payroll and&nbsp;related expenses of $797,311, which was partially offset by increases in general
and administrative expenses of $245,011 and in professional fees of $148,452.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $797,311 decrease in payroll and related expenses was primarily
due to a one-time charge of $491,377 related to the extensions to certain stock option agreements and a number of stock option
grants in the '10 period that included upfront vesting. The expense related to stock options was $1,550,908 in the '10 period
and $609,502 in the '11 period, a $941,406 decrease. Excluding the change related to stock options, our payroll would have increased
by $ 144,095. $88,918 of that payroll increase was due to having our new president on our payroll for the entire nine month period
in 2011 versus approximately 2 months in the 2010 period. The remainder of the increase was primarily due to hiring three new
scientists in the December 2011 quarter to assist with the DARPA project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $245,011 increase in general and administrative expenses was
primarily due to $237,367 of supplies and equipment purchased for the DARPA contract with no comparable expense in the 2010 period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The $148,452 increase in our professional fees was largely due
to an increase in our scientific consulting expense of $251,103, which in turn was primarily due to the cost of the HCV clinical
trial in India. We also incurred approximately $40,000 of professional fees related to our DARPA contract. Those increases were
partially offset by decreases of $89,806 of business development expenses and $44,065 in our accounting fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Other Expenses (Income)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Other expenses (income) consist primarily of the change in the
fair value of our derivative liability, debt extinguishment charges other expense and interest expense. Other expenses for the
nine months ended December 31, 2011 were $1,357,331 in comparison with $4,486,442 for the comparable period a year ago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Change in Fair Value of Derivative Liability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Both periods include changes in the fair value of derivative liability.
For the nine months ended December 31, 2011, the change in the estimated fair value of derivative liability was a gain of $1,596,442
and for the nine months ended December 31, 2010, the change in estimated fair value was a gain of $2,098,954.</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Loss on Extinguishment of Debt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In June 2010, we entered into Amended and Restated 12% Series A
Convertible Promissory Notes (the &quot;Amended and Restated Notes&quot;) with the holders of certain promissory notes previously
issued by the Company (&ldquo;Amended Series A 10% Convertible Notes&rdquo; or&nbsp;&nbsp;the &quot;Prior Notes&quot;), and all
amendments to the Prior Notes. In connection with amendments to the Prior Notes, during the three months ended June 30, 2010,
we recorded a loss on extinguishment of debt of $2,226,924 and a related loss on settlement of accrued interest and damages of
$68,703.&nbsp;&nbsp;There were no comparable expenses in the three months ended June 30, 2011.&nbsp; For accounting purposes,
the amendment of the 12% Series A Convertible Notes was treated as a debt extinguishment in accordance with FASB ASC 470-50, Debt
Modifications and Extinguishments as the terms of the restructured agreements were deemed to be substantially different from those
of the prior agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Based on conversion and exercise price re-set provisions included
in the amended convertible debt and new and amendment warrant agreements, the embedded conversion feature of the Amended and Restated
12% Convertible Notes and the related warrants were classified as derivative liability instruments (See Note 9).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Consequently, at the amendment date we recorded a loss on extinguishment
of $2,226,924 as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 57%">Reacquisition Price</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">4,385,925</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Less carrying value of notes and related instruments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,159,001</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt">Loss on extinguishment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,226,924</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In the three months ended December 31, 2010, we modified the conversion
terms of the February 2010 convertible note and related warrant and as a result, we recorded a loss on extinguishment of debt in
the amount of $963,018.&nbsp;&nbsp;That charge was calculated based on the change in fair value of the embedded conversion feature
of the Note and in the warrants exchanged both immediately prior to and immediately after the Settlement date, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 57%">Reacquisition price</TD><TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,854,767</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Less carrying value of notes and related instruments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(891,749</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 2.5pt">Loss on extinguishment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">963,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The combination of the $2,226,924 loss on extinguishment related
to the Amended and Restated Notes and the $963,018 loss on extinguishment related to the February 2010 convertible note resulted
in a total loss on extinguishment of $3,189,942 for the nine months ended December 31, 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We had no loss on extinguishment of debt in the nine months ended
December 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Interest Expense</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Interest expense was $2,594,526 for the nine months ended December
31, 2011 compared to $3,346,247 in the corresponding prior period, a decrease of $751,721. The various components of our interest
expense are shown in the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Nine Months Ended</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2011</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, 2010</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid">Change</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="width: 46%; padding-left: 10pt; text-indent: -10pt">Interest Expense</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">352,571</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">341,231</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">11,340</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Amortization of Deferred Financing Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">243,878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242,893</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Liquidated Damages</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">392,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(392,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Interest recorded in connection with issuance of conditional warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,652</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,652</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Interest recorded in connection with warrant extension</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138,468</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(138,468</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Interest recorded in connection with additional derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">538,736</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,103,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(564,546</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(233,228,228)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Amortization of Note Discounts</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,459,341</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,053,721</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">405,620</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total Interest Expense</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,594,526</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,346,247</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(751,721</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As noted in the above table, the most significant factors in the
$751,721 decrease in interest expense were (a) the $564,546 change in the adjustment to derivative liabilities between the periods,
(b) the $392,000 charge for liquidated damages in the 2010 period with no comparable charge in the 2011 period, and (c) the $138,468
charge taken in the 2010 period related to the extension of certain warrants with no comparable charge in the 2011 period, all
of which were partially offset by the combined $405,620 increase in amortization of note discounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Net Loss</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As a result of the combination of recording revenue and the decreased
expenses noted above, we recorded a consolidated net loss of approximately $3,614,000 and $8,105,000 for the nine month periods
ended December 31, 2011 and 2010, respectively.</P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Basic and diluted loss per common share were ($0.04) for the nine
month period ended December 31, 2011 compared to ($0.12) for the nine month period ended December 31, 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">LIQUIDITY AND CAPITAL RESOURCES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We are a medical device company that has begun to generate revenues
from a government contract. We are focused on creating innovative devices that address unmet medical needs in cancer, infectious
disease and other life-threatening conditions. At the core of our developments is the Aethlon ADAPT&trade; (Adaptive Dialysis-Like
Affinity Platform Technology) system, a medical device platform that converges single or multiple affinity drug agents with advanced
plasma membrane technology to create therapeutic filtration devices that selectively remove harmful particles from the entire circulatory
system without loss of essential blood components. Approval to embark on human trials is still needed to reach commercial viability
of the Hemopurifier&reg; and approval by the U.S. Food and Drug Administration (&quot;FDA&quot;). Successful outcomes of human
trials will be required by the regulatory agencies of certain foreign countries where we intend to sell this device. We have submitted
an Investigational Device Exemption (&quot;IDE&quot;) to the FDA. Some of our patents may expire before FDA approval or approval
in a foreign country, if any, is obtained. However, we believe that certain patent applications and/or other patents issued more
recently will help protect the proprietary nature of the Hemopurifier&reg; treatment technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">To date, we have funded our capital requirements for the current
operations from revenue from our government contract, net funds received from the public and private sale of debt and equity securities,
as well as from the issuance of common stock in exchange for services. Our cash position at December 31, 2011 was approximately
$355,000 compared to approximately $16,000, at March 31, 2011, representing an increase of approximately $339,000. During the nine
months ended December 31, 2011, operating activities used net cash of approximately $1,101,000, while we received approximately
$1,442,000 from financing activities from the issuance of convertible notes and the collection of secured notes receivable. In
addition, during this period we used approximately $2,000 in investing activities related to expenditures related to fixed asset
acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the nine month period ended December 31, 2011, net cash used
in operating activities resulted primarily from our&nbsp;net loss of approximately $3,614,000 offset by the amortization of note
discounts of approximately $1,703,000, non-cash interest expense of $539,000, a non-cash charge of $360,186 related to the termination
of the Tonaquint financing arrangement, the fair market value of common stock of approximately $328,000 issued in payment for services,
approximately $610,000 in stock-based compensation and the net change in operating assets and liabilities of approximately $556,000.&nbsp;&nbsp;Those
factors were partially offset by the non-cash gain of approximately $1,596,000 relating to the change in the estimated fair value
of derivative liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="color: black">On September 30, 2011, we </FONT>entered
into a contract with the United States of America, issued by SPAWAR Systems Center Pacific, pursuant to a contract award from the
Defense Advanced Research Projects Agency (&ldquo;DARPA&rdquo;). Under the DARPA award, we have been engaged to develop a therapeutic
device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers.
The contract program will utilize the Aethlon ADAPT<SUP>tm</SUP> system as a core technology component underlying an extracorporeal
blood purification device that selectively clears multiple sepsis-enabling particles from circulation to promote recovery and prevent
sepsis. Under the contract program, we will also introduce a novel blood pump strategy to reduce or eliminate the systemic administration
of anticoagulants normally required during extracorporeal device therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The award from DARPA is a fixed-price contract with potential total
payments to us of $6,794,389 over the course of five years, including payments of up to $1,975,047 in the first year. Years two
through five are at DARPA&rsquo;s discretion. Fixed price contracts require the achievement of multiple, incremental milestones
to receive the full award during each year of the contract.&nbsp;&nbsp;Under the terms of the contract, we will perform certain
incremental work towards the achievement of specific milestones against which we will invoice the government for fixed payment
amounts.&nbsp;&nbsp;Assuming all such work is performed according to the contract terms, we will receive up to $1,975,047 of contract
payments during the first twelve months of the contract with the aggregate payment amounts in years two through five approximating
$4.8 million, assuming DARPA exercises their option to extend the contract for years two through five.. The milestones are comprised
of planning, engineering and clinical targets, the achievement of which in some cases will require the participation and contribution
of third party participants under the contract.&nbsp;&nbsp;We will be subject to quarterly reviews by the government to assess
performance, milestone achievement and any required modification of the milestone and payment schedules under the contract. There
can be no assurance that we alone, or with third party participants, will meet such milestones to the satisfaction of the government
and in compliance with the terms of the contract or that we will be paid the full amount of the contract revenues during any year
of the contract term.&nbsp;&nbsp;We commenced work under the contract in October 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the three months ended December 31, 2011, we received payments
under the DARPA contract in the amount of $774,708 and invoiced the government for an additional $183,367 for total revenue recognized
of $958,075.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A decrease in working capital during the nine months ended December
31, 2011 in the amount of approximately $119,000 changed our negative working capital position to approximately ($6,252,000) at
December 31, 2011 from a negative working capital of approximately ($6,133,000) at March 31, 2011.&nbsp;&nbsp;The most significant
factors in the decrease in working capital noted above were the collection of a $200,000 note receivable and an increase in notes
payable of approximately $395,000 and in accounts payable of approximately $326,000, which were partially offset by our $183,367
receivable related to the DARPA contract and the increase in our cash position of approximately $339,000 noted above.</P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: black"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition to the funds received to date under the DARPA
contract and the fundings  under the bridge financing and beyond additional billings under the DARPA contract, we will
require additional capital as our current financial resources, while improved, remain insufficient to fund our working
capital and other cash requirements for the remainder of our fiscal year ending March 31, 2012. Therefore we will be required
to seek additional funds through debt and/or equity financing arrangements to finance our current and long-term operations.
We are currently addressing our liquidity needs by exploring investment capital opportunities through the private placement
of common stock or issuance of additional debt, including the remaining portion of the bridge financing. We believe that our
access to additional capital, together with existing cash resources, will be sufficient to meet our short term liquidity
needs for fiscal 2012. However, no assurance can be given that we will receive any funds in connection with our capital
raising efforts on terms acceptable to the Company, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We plan to continue research and development activities related
to our Hemopurifier(R) platform technology, with particular emphasis on the advancement of our treatment for &quot;Category A&quot;
pathogens as defined by the Federal Government under Project Bioshield and the All Hazards Preparedness Act of 2006. The Company
has filed an Investigational Device Exemption (&quot;IDE&quot;) with the FDA in order to proceed with human safety studies of the
Hemopurifier(R). Such studies, complemented by planned IN VIVO and appropriate animal IN VITRO studies, should allow us to proceed
to the Premarket Approval (&quot;PMA&quot;) process. The PMA process is the last major FDA hurdle in determining the safety and
effectiveness of Class III medical devices (of which the Hemopurifier(R) is one).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Subject to the availability of working capital and to fundings under
the DARPA contract, we anticipate continuing to increase spending on research and development over the next 12 months. Additionally,
associated with our anticipated increase in research and development expenditures, we anticipate purchasing additional amounts
of equipment during this period to support our laboratory and testing operations. Operations to date have consumed substantial
capital without generating revenues, although the DARPA funding in the December 2011 quarter represents our first revenues, and
will continue to require substantial and increasing capital funds to conduct necessary research and development and pre-clinical
and clinical testing of our Hemopurifier(R) products, as well as market any of those products that receive regulatory approval.
We do not expect to generate revenue from operations for the foreseeable future, and our ability to meet our cash obligations as
they become due and payable is dependent for at least the next several years on our ability to sell securities, borrow funds or
a combination thereof. Future capital requirements will depend upon many factors, including progress with pre-clinical testing
and clinical trials, the number and breadth of our clinical programs, the time and costs involved in preparing, filing, prosecuting,
maintaining and enforcing patent claims and other proprietary rights, the time and costs involved in obtaining regulatory approvals,
competing technological and market developments, as well as our ability to establish collaborative arrangements, effective commercialization,
marketing activities and other arrangements. We expect to continue to incur increasing negative cash flows and net losses for the
foreseeable future, and presently require a minimum of $180,000 per month to sustain operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At the date of this filing, we plan to invest significantly into
purchases of our raw materials and into our contract manufacturing arrangement subject to successfully raising additional capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">CRITICAL ACCOUNTING POLICIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of condensed consolidated financial statements in
conformity with accounting principles generally accepted in the United States of America requires the Company to make a number
of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of expenses during
the reporting period. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other
factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results
may differ from these estimates under different future conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We believe that the estimates and assumptions that are most important
to the portrayal of our financial condition and results of operations, in that they require the most difficult, subjective or complex
judgments, form the basis for the accounting policies deemed to be most critical to us. These critical accounting policies relate
to measurement of stock purchase warrants issued with notes payable, beneficial conversion feature of convertible notes payable,
impairment of intangible assets, stock compensation, the classification of warrant obligations and evaluation of contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">With the exception of revenue recognition matters, our critical
accounting policies have not changed since filing of our annual report on Form 10-K for the year ended March 31, 2011. We believe
estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should
future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial condition
or results of operations.</P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black">With
respect to revenue recognition, we entered into a contract with DARPA as discussed above and have recognized revenue during the
three months ended December 31, 2011 of $958,075 under such contract. We adopted the Milestone method of revenue recognition for
the DARPA contract under ASC 605-28 &ldquo;Revenue Recognition &ndash; Milestone Method&rdquo; and we believe we meet the requirements
under ASC 605-28 for reporting contract revenue under the Milestone Method for the quarter ended December 31, 2011.</FONT></P>

<P STYLE="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In order to account for this contract, the Company identifies the
deliverables included within the contract and evaluates which deliverables represent separate units of accounting based on if certain
criteria are met, including whether the delivered element has standalone value to the collaborator. The consideration received
is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the
separate units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone is an event having all of the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) There is substantive uncertainty at the date the arrangement
is entered into that the event will be achieved. A vendor&rsquo;s assessment that it expects to achieve a milestone does not necessarily
mean that there is not substantive uncertainty associated with achieving the milestone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(2) The event can only be achieved based in whole or in part on
either: (a) the vendor&rsquo;s performance; or (b) a specific outcome resulting from the vendor&rsquo;s performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(3) If achieved, the event would result in additional payments being
due to the vendor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone does not include events for which the occurrence is
either: (a) contingent solely upon the passage of time; or (b) the result of a counterparty&rsquo;s performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The policy for recognizing deliverable consideration contingent
upon achievement of a milestone must be applied consistently to similar deliverables.<BR>
<BR>
The assessment of whether a milestone is substantive is performed at the inception of the arrangement. The consideration earned
from the achievement of a milestone must meet all of the following for the milestone to be considered substantive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) The consideration is commensurate with either: (a) the vendor&rsquo;s
performance to achieve the milestone; or (b) the enhancement of the value of the delivered item or items as a result of a specific
outcome resulting from the vendor&rsquo;s performance to achieve the milestone;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(2) The consideration relates solely to past performance; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(3) The consideration is reasonable relative to all of the deliverables
and payment terms (including other potential milestone consideration) within the arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A milestone is not considered substantive if any portion of the
associated milestone consideration relates to the remaining deliverables in the unit of accounting (i.e., it does not relate solely
to past performance). To recognize the milestone consideration in its entirety as revenue in the period in which the milestone
is achieved, the milestone must be substantive in its entirety. Milestone consideration cannot be bifurcated into substantive and
nonsubstantive components. In addition, if a portion of the consideration earned from achieving a milestone may be refunded or
adjusted based on future performance, the related milestone is not considered substantive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">OFF-BALANCE SHEET ARRANGEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We have no obligations required to be disclosed herein as off-balance
sheet arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As a Smaller Reporting Company as defined by rule 12b-2 of the Exchange
Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required
to provide the information requested by this item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 4. CONTROLS AND PROCEDURES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DISCLOSURE CONTROLS AND PROCEDURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Under the supervision and with the participation of our management,
including our Chief Executive Officer (&quot;CEO&quot;) and our Chief Financial Officer (&quot;CFO&quot;), we evaluated the effectiveness
of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange
Act) as of a date as of the end of the period covered by this Quarterly Report.</P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Based on such evaluation, our CEO and CFO concluded that, as of
the end of such period, our disclosure controls and procedures are not effective in recording, processing, summarizing and reporting,
on a timely basis, information required to be disclosed by us in the reports that we file or submit under the Exchange Act and
are not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange
Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding
required disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">There have been no changes in our internal control over financial
reporting during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">PART II. OTHER INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 1. LEGAL PROCEEDINGS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">From time to time, claims are made against us in the ordinary course
of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable
outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products
or engaging in other activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The occurrence of an unfavorable outcome in any specific period
could have a material adverse effect on our results of operations for that period or future periods. Other than as set forth here,
we are not presently a party to any pending or threatened legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 1A. RISK FACTORS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As a Smaller Reporting Company as defined by rule 12b-2 of the Exchange
Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required
to provide the information requested by this item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the quarter ended December 31, 2011, we issued the following
securities which were not registered under the Securities Act of 1933, as amended, and have not been included previously in a Current
Report on Form 8-K. We did not employ any form of general solicitation or advertising in connection with the offer and sale of
the securities described below. In addition, we believe the purchasers of the securities are &quot;ACCREDITED INVESTORS&quot; for
the purpose of Rule 501 of the Securities Act. For these reasons, among others, the offer and sale of the following securities
were made in reliance on the exemption from registration provided by Section 4(2) of the Securities Act or Regulation D promulgated
by the SEC under the Securities Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">During the three months ended December 31, 2011, we issued 7,036,702
shares of restricted common stock to holders of notes issued by the Company in exchange for the partial or full conversion of principal
and interest of several convertible notes payable in an aggregate amount of $337,999 at an average conversion price of $0.05 per
share based upon the conversion formulae in the respective notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 3. DEFAULTS UPON SENIOR SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of the date of this report, various promissory and convertible
notes payable in the aggregate principal amount of $1,792,210 have reached maturity and are past due. We are continually reviewing
other financing arrangements to retire all past due notes. At December 31, 2011, we had accrued interest in the amount of $639,958
associated with these notes and accrued liabilities payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 4. MINE SAFETY DISCLOSURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 5. OTHER INFORMATION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(a)&#9;None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(b)&#9;There have been no changes to the procedures by which security
holders may recommend nominees to our board of directors.</P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ITEM 6.&nbsp;&nbsp;EXHIBITS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(a) Exhibits. The following documents are filed as part of this
report:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 115%">3.1</TD>
    <TD STYLE="width: 95%; line-height: 115%">Articles of Incorporation of Aethlon Medical, Inc., as amended (1)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">3.2</TD>
    <TD STYLE="line-height: 115%">Bylaws of Aethlon Medical, Inc. (1)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">10.1</TD>
    <TD STYLE="line-height: 115%">Form of Subscription Agreement dated November 10, 2011 (2)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">10.2</TD>
    <TD STYLE="line-height: 115%">Form of OID Debenture dated November 10, 2011 (2)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">10.3</TD>
    <TD STYLE="line-height: 115%">Form of Common Stock Purchase Warrant dated November 10, 2011 (2)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">31.1</TD>
    <TD STYLE="line-height: 115%">Certification of Principal Executive Officer pursuant to Securities Exchange Act rules 13a- 14(a) and 15d-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002*</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">31.2</TD>
    <TD STYLE="line-height: 115%">Certification of Principal Financial Officer pursuant to Securities Exchange Act rules 13a- 14(a) and 15d-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002*</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">32.1</TD>
    <TD STYLE="line-height: 115%">Certification of Principal Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002*</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">32.2</TD>
    <TD STYLE="line-height: 115%">Certification of Principal Financial Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002*</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">101</TD>
    <TD STYLE="line-height: 115%">Interactive Data Files</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white"></FONT>* Filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17pt; text-align: right">(1)&nbsp;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Incorporated by reference to the exhibit of the same number to the Company's Quarterly
Report on Form 10-Q for the period ended September 30, 2009.&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17pt; text-align: right">&nbsp;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 17pt; text-align: right">(2)&nbsp;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Incorporated by reference to the filing of such exhibit with the Company&rsquo;s Quarterly
Report on Form 10-Q dated November 18, 2011.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.05pt; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">AETHLON MEDICAL, INC.</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 6%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 33%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 13%; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">Date: February 16, 2012&nbsp;</TD>
    <TD STYLE="line-height: 115%">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; line-height: 115%">/s/&nbsp;JAMES B. FRAKES</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%">JAMES B. FRAKES</TD>
    <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">CHIEF FINANCIAL OFFICER</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">CHIEF ACCOUNTING OFFICER</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>aethlon_10q-ex3101.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Publicease, Inc.-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="100%">
</div>

<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> EXHIBIT 31.1</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, James Joyce, certify that:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;I have reviewed this Quarterly Report on Form 10-Q of Aethlon Medical, Inc.;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: February 16, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;JAMES A. JOYCE</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">JAMES A. JOYCE</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CHIEF EXECUTIVE OFFICER</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(PRINCIPAL EXECUTIVE OFFICER )</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>aethlon_10q-ex3102.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Publicease, Inc.-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="100%">
</div>

<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> EXHIBIT 31.2</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, James Frakes, certify that:</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;I have reviewed this Quarterly Report on Form 10-Q of Aethlon Medical, Inc.;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: justify; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: justify;">
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: February 16, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;JAMES B. FRAKES</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">JAMES B. FRAKES</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CHIEF FINANCIAL OFFICER</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(PRINCIPAL FINANCIAL OFFICER)</font></div>
</td>
<td align="left" valign="top" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>aethlon_10q-ex3201.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Publicease-->
    <!--Document Created using EDGARizerAgent 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<hr style="COLOR: black" align="center" noshade size="1" width="100%">
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 32.1</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AS ADOPTED PURSUANT TO</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Quarterly Report of Aethlon Medical, Inc. (the &#8220;Registrant&#8221;) on Form 10-Q for the three month period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof, I, James A. Joyce, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, the Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Aethlon Medical, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated: February 16, 2012</font></div>
</td>
<td align="left" valign="bottom" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ JAMES A. JOYCE</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James A. Joyce</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aethlon Medical, Inc.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Aethlon Medical, Inc. and will be retained by Aethlon Medical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>aethlon_10q-ex3202.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Publicease, Inc.-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="100%">
</div>

<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> EXHIBIT 32.2</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AS ADOPTED PURSUANT TO</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Quarterly Report of Aethlon Medical, Inc. (the &#8220;Registrant&#8221;) on Form 10-Q for the three month period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof, I, James B. Frakes, Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Based on my knowledge, the Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;The information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Aethlon Medical, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated: February 16, 2012</font></div>
</td>
<td align="left" valign="bottom" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ JAMES B. FRAKES</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James B. Frakes</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="36%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aethlon Medical, Inc.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>aemd-20111231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:aemd="http://www.aethlonmedical.com/20111231" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="aemd-20111231.xsd"/>
  <context id="c0_AsOf31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Mar2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2011-03-31</instant>
    </period>
  </context>
  <context id="c2_From1Oct2011To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c3_From1Apr2011To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <startDate>2011-04-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c4_From1Oct2010To31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c5_From1Apr2010To31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c6_AsOf31Mar2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2010-03-31</instant>
    </period>
  </context>
  <context id="c7_AsOf31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c8_AsOf15Feb2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2012-02-15</instant>
    </period>
  </context>
  <context id="c9_AsOf30Sep2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPerShare">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <us-gaap:Cash unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">354804</us-gaap:Cash>
  <us-gaap:Cash unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">15704</us-gaap:Cash>
  <us-gaap:DeferredFinanceCostsNet unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">193749</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:DeferredFinanceCostsNet unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">157732</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">183367</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:NotesAndLoansReceivableNetCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">200000</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:InterestReceivable unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">7096</us-gaap:InterestReceivable>
  <us-gaap:PrepaidExpenseAndOtherAssets unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">26250</us-gaap:PrepaidExpenseAndOtherAssets>
  <us-gaap:PrepaidExpenseAndOtherAssets unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">29711</us-gaap:PrepaidExpenseAndOtherAssets>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">758170</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">410243</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">2535</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">7785</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">133108</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">139981</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:DepositsAssets unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">9210</us-gaap:DepositsAssets>
  <us-gaap:DepositsAssets unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">9210</us-gaap:DepositsAssets>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">903023</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">567219</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">634082</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">308413</us-gaap:AccountsPayableCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">617570</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">617570</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">584796</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">190000</us-gaap:NotesPayableCurrent>
  <us-gaap:ConvertibleNotesPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">2462825</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:ConvertibleNotesPayableCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">2181852</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1250705</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">2002896</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">437800</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">437800</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1022436</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">804386</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">7010214</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">6542917</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf31Dec2011" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Mar2011" xs:nil="true"/>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">108980</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">77469</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPerShare" contextRef="c0_AsOf31Dec2011" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPerShare" contextRef="c1_AsOf31Mar2011" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Mar2011" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">108977508</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Mar2011" decimals="INF">77467361</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">108977508</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Mar2011" decimals="INF">77467361</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">45869870</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">42418778</us-gaap:AdditionalPaidInCapital>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">52086041</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">48471945</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">-6107191</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">-5975698</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">903023</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Mar2011" decimals="0">567219</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:Revenues unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">958075</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">958075</us-gaap:Revenues>
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">427419</us-gaap:ProfessionalFees>
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">386828</us-gaap:ProfessionalFees>
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1037613</us-gaap:ProfessionalFees>
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">889161</us-gaap:ProfessionalFees>
  <us-gaap:LaborAndRelatedExpense unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">487959</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">534747</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1553514</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">2350825</us-gaap:LaborAndRelatedExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">384025</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">125126</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">623712</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">378701</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">1299403</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">1046701</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">3214839</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">3618687</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">-341328</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">-1046701</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-2256764</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-3618687</us-gaap:OperatingIncomeLoss>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">-963018</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-3189942</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:PaymentsOfDebtExtinguishmentCosts unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-68703</us-gaap:PaymentsOfDebtExtinguishmentCosts>
  <us-gaap:UnrealizedGainLossOnDerivatives unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">74940</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">430077</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1596442</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">2098954</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:InterestAndDebtExpense unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">308386</us-gaap:InterestAndDebtExpense>
  <us-gaap:InterestAndDebtExpense unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">594128</us-gaap:InterestAndDebtExpense>
  <us-gaap:InterestAndDebtExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">2594526</us-gaap:InterestAndDebtExpense>
  <us-gaap:InterestAndDebtExpense unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">3346247</us-gaap:InterestAndDebtExpense>
  <us-gaap:InterestAndOtherIncome unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">56</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">5599</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">938</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">19496</us-gaap:InterestAndOtherIncome>
  <us-gaap:OtherNonoperatingIncomeExpense unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">300000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-360185</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">-233390</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">-821470</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-1357331</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-4486442</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c2_From1Oct2011To31Dec2011" decimals="0">-574718</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c4_From1Oct2010To31Dec2010" decimals="0">-1868171</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-3614095</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-8105129</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c2_From1Oct2011To31Dec2011" decimals="2">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c4_From1Oct2010To31Dec2010" decimals="2">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c3_From1Apr2011To31Dec2011" decimals="2">-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c5_From1Apr2010To31Dec2010" decimals="2">-0.12</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c2_From1Oct2011To31Dec2011" decimals="INF">107061316</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c4_From1Oct2010To31Dec2010" decimals="INF">70918490</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c3_From1Apr2011To31Dec2011" decimals="INF">98202051</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c5_From1Apr2010To31Dec2010" decimals="INF">67991430</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">13858</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">14301</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">609503</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1599915</us-gaap:ShareBasedCompensation>
  <us-gaap:ProceedsFromIssuanceOfWarrants unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">74652</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:OtherNoncashExpense unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">538736</us-gaap:OtherNoncashExpense>
  <us-gaap:OtherNoncashExpense unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1696055</us-gaap:OtherNoncashExpense>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">328327</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">590734</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <aemd:IssuanceOfNoteInConvertibleNoteTermination unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">360186</aemd:IssuanceOfNoteInConvertibleNoteTermination>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1703219</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1301014</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-183367</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">10557</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">52260</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">728432</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">152246</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">20000</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-1101086</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-1512964</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1735</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">2541</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireIntangibleAssets unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">6805</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">-1735</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">-9346</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">15000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:ProceedsFromConvertibleDebt unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1256921</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ProceedsFromConvertibleDebt unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1105000</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">283600</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromCollectionOfNotesReceivable unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">200000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
  <us-gaap:ProceedsFromCollectionOfNotesReceivable unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">300000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1441921</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1688600</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashPeriodIncreaseDecrease unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">339100</us-gaap:CashPeriodIncreaseDecrease>
  <us-gaap:CashPeriodIncreaseDecrease unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">166290</us-gaap:CashPeriodIncreaseDecrease>
  <us-gaap:Cash unitRef="usd" contextRef="c6_AsOf31Mar2010" decimals="0">67950</us-gaap:Cash>
  <us-gaap:Cash unitRef="usd" contextRef="c7_AsOf31Dec2010" decimals="0">234240</us-gaap:Cash>
  <us-gaap:InterestPaidNet unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">3636</us-gaap:InterestPaidNet>
  <us-gaap:IncomeTaxesPaidNet unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" xs:nil="true"/>
  <us-gaap:IncomeTaxesPaidNet unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" xs:nil="true"/>
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">6980347</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
  <aemd:DebtAndAccruedInterestConvertedToCommonStock unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1812386</aemd:DebtAndAccruedInterestConvertedToCommonStock>
  <aemd:DebtAndAccruedInterestConvertedToCommonStock unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1075550</aemd:DebtAndAccruedInterestConvertedToCommonStock>
  <aemd:DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">1037901</aemd:DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd>
  <aemd:DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">1708600</aemd:DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd>
  <aemd:IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">35469</aemd:IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees>
  <aemd:ReclassificationOfWarrantDerivativeLiabilityIntoEquity unitRef="usd" contextRef="c3_From1Apr2011To31Dec2011" decimals="0">263689</aemd:ReclassificationOfWarrantDerivativeLiabilityIntoEquity>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c5_From1Apr2010To31Dec2010" decimals="0">600</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <dei:EntityRegistrantName contextRef="c3_From1Apr2011To31Dec2011">Aethlon Medical Inc.</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c3_From1Apr2011To31Dec2011">10-Q</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c3_From1Apr2011To31Dec2011">--03-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c8_AsOf15Feb2012" decimals="INF">111629725</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c9_AsOf30Sep2010" decimals="0">24500000</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c3_From1Apr2011To31Dec2011">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c3_From1Apr2011To31Dec2011">0000882291</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c3_From1Apr2011To31Dec2011">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c3_From1Apr2011To31Dec2011">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c3_From1Apr2011To31Dec2011">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c3_From1Apr2011To31Dec2011">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c3_From1Apr2011To31Dec2011">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c3_From1Apr2011To31Dec2011">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c3_From1Apr2011To31Dec2011">2011-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Aethlon Medical, Inc. (&quot;Aethlon&quot;, the &quot;Company&quot;, &quot;we&quot; or&#xd;
      &quot;us&quot;) is a medical device company focused on creating&#xd;
      innovative devices that address unmet medical needs in&#xd;
      cancer, infectious disease and other life-threatening&#xd;
      conditions. At the core of our developments is the Aethlon&#xd;
      ADAPT&amp;#8482; (Adaptive Dialysis-Like Affinity Platform&#xd;
      Technology) system, a medical device platform that converges&#xd;
      single or multiple affinity drug agents with advanced plasma&#xd;
      membrane technology to create therapeutic filtration devices&#xd;
      that selectively remove harmful particles from the entire&#xd;
      circulatory system without loss of essential blood&#xd;
      components. Approval to embark on human trials is still&#xd;
      needed to reach commercial viability of the&#xd;
      Hemopurifier&amp;#174; and approval by the U.S. Food and Drug&#xd;
      Administration (&quot;FDA&quot;). Successful outcomes of human trials&#xd;
      will be required by the regulatory agencies of certain&#xd;
      foreign countries where we intend to sell this device. We&#xd;
      have submitted an Investigational Device Exemption (&quot;IDE&quot;) to&#xd;
      the FDA. Some of our patents may expire before FDA approval&#xd;
      or approval in a foreign country, if any, is obtained.&#xd;
      However, we believe that certain patent applications and/or&#xd;
      other patents issued more recently will help protect the&#xd;
      proprietary nature of the Hemopurifier(R) treatment&#xd;
      technology.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In prior periods, Aethlon was classified as a development&#xd;
      stage enterprise under accounting principles generally&#xd;
      accepted in the United States of America (&quot;GAAP&quot;) as it had&#xd;
      not generated revenues from its planned principal operations.&#xd;
      In the three months ended December 31, 2011, we began to&#xd;
      generate revenues from a government contract and have emerged&#xd;
      from the development stage. Subsequent to December 31, 2011,&#xd;
      we recorded the first commercial shipment of one of our&#xd;
      products to a life sciences company for diagnostics use.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Our common stock is quoted on the Over-the-Counter Bulletin&#xd;
      Board administered by the Financial Industry Regulatory&#xd;
      Authority (&quot;OTCBB&quot;) under the symbol &quot;AEMD.OB.&quot;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The accompanying unaudited condensed consolidated financial&#xd;
      statements have been prepared in accordance with GAAP for&#xd;
      interim financial information and with the instructions to&#xd;
      Form 10-Q and applicable sections of Regulation S-X.&#xd;
      Accordingly, they do not include all of the information and&#xd;
      footnotes required by GAAP for complete financial statements.&#xd;
      In the opinion of management, all adjustments&amp;#160;necessary&#xd;
      to make the financial statements not misleading have been&#xd;
      included. The condensed consolidated balance sheet as of&#xd;
      March 31, 2011 was derived from our audited financial&#xd;
      statements. Operating results for the nine months ended&#xd;
      December 31, 2011 are not necessarily indicative of the&#xd;
      results that may be expected for the year ending March 31,&#xd;
      2012. For further information, refer to our Annual Report on&#xd;
      Form 10-K for the year ended March 31, 2011, which includes&#xd;
      audited financial statements and footnotes as of March 31,&#xd;
      2011 and for the years ended March 31, 2011 and 2010 and the&#xd;
      period January 31, 1984 (Inception) through March 31, 2011.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 2. LIQUIDITY&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The accompanying unaudited condensed consolidated financial&#xd;
      statements have been prepared on a going concern basis, which&#xd;
      contemplates, among other things, the realization of assets&#xd;
      and the satisfaction of liabilities in the ordinary course of&#xd;
      business. We have experienced continuing losses from&#xd;
      operations, are in default on certain debt, have negative&#xd;
      working capital of approximately $6,252,000, recurring losses&#xd;
      from operations and an accumulated deficit of approximately&#xd;
      $52,086,000 at December 31, 2011, which among other matters,&#xd;
      raises significant doubt about our ability to continue as a&#xd;
      going concern. We have not generated significant revenue or&#xd;
      any profit from operations since inception. A significant&#xd;
      amount of additional capital will be necessary to advance the&#xd;
      development of our products to the point at which they may&#xd;
      become commercially viable. Our current financial resources&#xd;
      are insufficient to fund our capital expenditures, working&#xd;
      capital and other cash requirements (consisting of accounts&#xd;
      payable, accrued liabilities, amounts due to related parties&#xd;
      and amounts due under various notes payable) for the fiscal&#xd;
      year ending March 31, 2012 (&quot;fiscal 2012&quot;). Therefore we will&#xd;
      be required to seek additional funds through debt and/or&#xd;
      equity financing arrangements to finance our current and&#xd;
      long-term operations.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt&quot;&gt;&#xd;
      &lt;font style=&quot;color: black&quot;&gt;On September 30, 2011, we&lt;/font&gt;&#xd;
      entered into a contract with the United States of America,&#xd;
      issued by SPAWAR Systems Center Pacific, pursuant to a&#xd;
      contract award from the Defense Advanced Research Projects&#xd;
      Agency (&amp;#8220;DARPA&amp;#8221;). Under the DARPA award, we have&#xd;
      been engaged to develop a therapeutic device to reduce the&#xd;
      incidence of sepsis, a fatal bloodstream infection that often&#xd;
      results in the death of combat-injured soldiers. The award&#xd;
      from DARPA is a fixed-price contract with potential total&#xd;
      payments to us of $6,794,389 over the course of five years,&#xd;
      including payments of up to $1,975,047 in the first year.&#xd;
      Fixed price contracts require the achievement of multiple,&#xd;
      incremental milestones to receive the full award during each&#xd;
      year of the contract.&amp;#160;&amp;#160;Under the terms of the&#xd;
      contract, we will perform certain incremental work towards&#xd;
      the achievement of specific milestones against which we will&#xd;
      invoice the government for fixed payment&#xd;
      amounts.&amp;#160;&amp;#160;Assuming all such work is performed&#xd;
      according to the contract terms, we will receive up to&#xd;
      $1,975,047 of contract payments during the first twelve&#xd;
      months of the contract with the aggregate payment amounts in&#xd;
      years two through five varying between approximately $775,000&#xd;
      and $1.6 million per year. DARPA has the option to extend the&#xd;
      contract for years two through five. Only the first year of&#xd;
      the contract related to the $1,975,047 has been formally&#xd;
      entered into as of the date of this Form 10-Q filing. The&#xd;
      milestones are comprised of planning, engineering and&#xd;
      clinical targets, the achievement of which in some cases will&#xd;
      require the participation and contribution of third party&#xd;
      participants under the contract.&amp;#160;&amp;#160;There can be no&#xd;
      assurance that we alone, or with third party participants,&#xd;
      will meet such milestones to the satisfaction of the&#xd;
      government and in compliance with the terms of the contract&#xd;
      or that we will be paid the full amount of the contract&#xd;
      revenues during any year of the contract term.&amp;#160;&amp;#160;We&#xd;
      commenced work under the contract in October 2011 (See below&#xd;
      and Note 12 for additional information regarding revenue&#xd;
      recognition).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As of December 31, 2011, we received two initial payments&#xd;
      under the DARPA contract totaling $774,708 and billed the&#xd;
      government for a third invoice in the amount of $183,367,&#xd;
      which is shown as an account receivable on the accompanying&#xd;
      balance sheet .&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      &lt;font style=&quot;color: black&quot;&gt;Also during the three months ended&#xd;
      December 31, 2011, we raised an additional $384,265 in net&#xd;
      proceeds from a bridge financing that may yield up to $1&#xd;
      million in total gross proceeds through the private placement&#xd;
      of&lt;/font&gt; convertible promissory notes and corresponding&#xd;
      warrants with accredited investors (see Note 5 &amp;#8211;&#xd;
      Convertible Notes for more details of this offering) &lt;font style=&quot;color: black&quot;&gt;per the terms of the subscription&#xd;
      agreement.&lt;/font&gt;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In addition to the funds received to date under the DARPA&#xd;
      contract and under the bridge financing and beyond future&#xd;
      fundings under the DARPA contract, we will require additional&#xd;
      capital as our current financial resources, while improved,&#xd;
      remain insufficient to fund our working capital and other&#xd;
      cash requirements for the remainder of our fiscal year ending&#xd;
      March 31, 2012. Therefore we will be required to seek&#xd;
      additional funds through debt and/or equity financing&#xd;
      arrangements to finance our current and long-term operations.&#xd;
      We are currently addressing our liquidity needs by exploring&#xd;
      investment capital opportunities through the private&#xd;
      placement of common stock or issuance of additional debt,&#xd;
      including the remaining portion of the bridge financing. We&#xd;
      believe that our access to additional capital, together with&#xd;
      existing cash resources, will be sufficient to meet our short&#xd;
      term liquidity needs for fiscal 2012. However, no assurance&#xd;
      can be given that we will receive any funds in connection&#xd;
      with our capital raising efforts on terms acceptable to the&#xd;
      Company, if at all.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The unaudited condensed consolidated financial statements do&#xd;
      not include any adjustments relating to the recoverability of&#xd;
      assets that might be necessary should we be unable to&#xd;
      continue as a going concern.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:LiquidityDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The summary of our significant accounting policies presented&#xd;
      below is designed to assist the reader in understanding our&#xd;
      condensed consolidated financial statements. Such financial&#xd;
      statements and related notes are the representations of our&#xd;
      management, who are responsible for their integrity and&#xd;
      objectivity. These accounting policies conform to GAAP in all&#xd;
      material respects, and have been consistently applied in&#xd;
      preparing the accompanying&amp;#160;condensed consolidated&#xd;
      financial statements.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      PRINCIPLES OF CONSOLIDATION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The accompanying condensed consolidated financial statements&#xd;
      include the accounts of Aethlon Medical, Inc. and its&#xd;
      wholly-owned subsidiary, Exosome Sciences, Inc.,&#xd;
      (collectively hereinafter referred to as the &quot;Company&quot; or&#xd;
      &quot;Aethlon&quot;). There exist no material intercompany transactions&#xd;
      or balances between Aethlon and its subsidiary.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      LOSS PER COMMON SHARE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Basic loss per common share is computed by dividing net loss&#xd;
      available to common stockholders by the weighted average&#xd;
      number of common shares assumed to be outstanding during the&#xd;
      period of computation. Diluted loss per common share is&#xd;
      computed similar to basic loss per share except that the&#xd;
      denominator is increased to include the number of additional&#xd;
      common shares that would have been outstanding if the&#xd;
      potential common shares had been issued, and if the&#xd;
      additional common shares were dilutive. As we had net losses&#xd;
      for all periods presented, basic and diluted loss per common&#xd;
      share are the same, since additional potential common shares&#xd;
      have been excluded as their effect would be antidilutive.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The potentially dilutive common shares outstanding for at&#xd;
      December 31, 2011 and 2010, which include common shares&#xd;
      underlying outstanding stock options, warrants and&#xd;
      convertible debentures, were 114,215,775 and 81,138,329,&#xd;
      respectively.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      PATENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We capitalize the cost of patents, some of which were&#xd;
      acquired, and amortize such costs over their estimated useful&#xd;
      life, upon issuance of the patent, not to exceed the patent&#xd;
      legal life.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      RESEARCH AND DEVELOPMENT EXPENSES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We incurred research and development expenses during the&#xd;
      three and nine month periods ended December 31, 2011 and&#xd;
      2010, which are included in various operating expense line&#xd;
      items in the accompanying condensed consolidated statements&#xd;
      of operations. Our research and development expenses in those&#xd;
      periods were as follows:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          December 31,&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          December 31,&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          2010&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 64%&quot;&gt;&#xd;
          Three months ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 8%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; text-align: right&quot;&gt;&#xd;
          536,079&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 2%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; text-align: right&quot;&gt;&#xd;
          127,918&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          Nine months ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          864,443&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          317,345&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      FAIR VALUE OF FINANCIAL INSTRUMENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The carrying amount of the Company&apos;s cash, accounts&#xd;
      receivable, accounts payable and accrued liabilities&#xd;
      approximates their estimated fair values due to the&#xd;
      short-term maturities of these financial instruments. The&#xd;
      fair value of certain convertible notes and related warrants&#xd;
      at December 31, 2011 is $1,250,705 based upon a third party&#xd;
      valuation report that we commissioned. Warrants classified as&#xd;
      derivative liabilities are reported at their estimated fair&#xd;
      value, with changes in fair value being reported in current&#xd;
      period results of operations.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Management has concluded that it is not practical to&#xd;
      determine the estimated fair value of amounts due to related&#xd;
      parties because the transactions cannot be assumed to have&#xd;
      been consummated at arm&apos;s length, the terms are not deemed to&#xd;
      be market terms, there are no quoted values available for&#xd;
      these instruments, and an independent valuation would not be&#xd;
      practicable due to the lack of data regarding similar&#xd;
      instruments, if any, and the associated potential costs.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      EQUITY INSTRUMENTS FOR SERVICES PROVIDED BY OTHER THAN&#xd;
      EMPLOYEES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We account for transactions involving goods and services&#xd;
      provided by third parties where we issue equity instruments&#xd;
      as part of the total consideration using the fair value of&#xd;
      the consideration received (i.e., the value of the goods or&#xd;
      services) or the fair value of the equity instruments issued,&#xd;
      whichever is more reliably measurable.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In transactions, when the value of the goods and/or services&#xd;
      is not readily determinable and (1) the fair value of the&#xd;
      equity instruments is more reliably measurable and (2) the&#xd;
      counterparty receives equity instruments in full or partial&#xd;
      settlement of the transactions, we use the following&#xd;
      methodology:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (a)&amp;#160;&amp;#160;&amp;#160;For transactions where goods have&#xd;
      already been delivered or services rendered, the equity&#xd;
      instruments are issued on or about the date the performance&#xd;
      is complete (and valued on the date of issuance).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (b)&amp;#160;&amp;#160;&amp;#160;For transactions where the instruments&#xd;
      are issued on a fully vested, non-forfeitable basis, the&#xd;
      equity instruments are valued on or about the date of the&#xd;
      contract.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (c)&amp;#160;&amp;#160;&amp;#160;For any transactions not meeting the&#xd;
      criteria in (a) or (b) above, we re-measure the consideration&#xd;
      at each reporting date based on its then current stock value.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We review our long-lived assets for impairment whenever&#xd;
      events or changes in circumstances indicate that their&#xd;
      carrying amounts may not be recoverable. If the cost basis of&#xd;
      a long-lived asset is greater than the projected future&#xd;
      undiscounted net cash flows from such asset (excluding&#xd;
      interest), an impairment loss is recognized. Impairment&#xd;
      losses are calculated as the difference between the cost&#xd;
      basis of an asset and its estimated fair value. We believe&#xd;
      that no impairment occurred at or during the three and nine&#xd;
      months ended December 31, 2011 and 2010.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      BENEFICIAL CONVERSION FEATURE OF CONVERTIBLE NOTES PAYABLE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The convertible feature of certain notes payable provides for&#xd;
      a rate of conversion that is below the market value of our&#xd;
      common stock. Such feature is normally characterized as a&#xd;
      &quot;Beneficial Conversion Feature&quot; (&quot;BCF&quot;). We record the&#xd;
      estimated fair value of the BCF, when applicable, in the&#xd;
      condensed consolidated financial statements as a discount&#xd;
      from the face amount of the notes. Such discounts are&#xd;
      accreted to interest expense over the term of the notes using&#xd;
      the effective interest method.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      REVENUE RECOGNITION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0&quot;&gt;&#xd;
      &lt;font style=&quot;font-family: Times New Roman, Times, Serif; color: black&quot;&gt;With&#xd;
      respect to revenue recognition, we entered into a contract&#xd;
      with DARPA as discussed above and have recognized revenue&#xd;
      during the three months ended December 31, 2011 of $958,075&#xd;
      under such contract. We adopted the Milestone method of&#xd;
      revenue recognition for the DARPA contract under ASC 605-28&#xd;
      &amp;#8220;Revenue Recognition &amp;#8211; Milestone Method&amp;#8221;&#xd;
      and we believe we meet the requirements under ASC 605-28 for&#xd;
      reporting contract revenue under the Milestone Method for the&#xd;
      quarter ended December 31, 2011.&lt;/font&gt;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In order to account for this contract, the Company identifies&#xd;
      the deliverables included within the contract and evaluates&#xd;
      which deliverables represent separate units of accounting&#xd;
      based on if certain criteria are met, including whether the&#xd;
      delivered element has standalone value to the collaborator.&#xd;
      The consideration received is allocated among the separate&#xd;
      units of accounting, and the applicable revenue recognition&#xd;
      criteria are applied to each of the separate units.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      A milestone is an event having all of the following&#xd;
      characteristics:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (1) There is substantive uncertainty at the date the&#xd;
      arrangement is entered into that the event will be achieved.&#xd;
      A vendor&amp;#8217;s assessment that it expects to achieve a&#xd;
      milestone does not necessarily mean that there is not&#xd;
      substantive uncertainty associated with achieving the&#xd;
      milestone.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (2) The event can only be achieved based in whole or in part&#xd;
      on either: (a) the vendor&amp;#8217;s performance; or (b) a&#xd;
      specific outcome resulting from the vendor&amp;#8217;s&#xd;
      performance.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (3) If achieved, the event would result in additional&#xd;
      payments being due to the vendor.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      A milestone does not include events for which the occurrence&#xd;
      is either: (a) contingent solely upon the passage of time; or&#xd;
      (b) the result of a counterparty&amp;#8217;s performance.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The policy for recognizing deliverable consideration&#xd;
      contingent upon achievement of a milestone must be applied&#xd;
      consistently to similar deliverables.&lt;br /&gt;&#xd;
      &lt;br /&gt;&#xd;
      The assessment of whether a milestone is substantive is&#xd;
      performed at the inception of the arrangement. The&#xd;
      consideration earned from the achievement of a milestone must&#xd;
      meet all of the following for the milestone to be considered&#xd;
      substantive:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (1) The consideration is commensurate with either: (a) the&#xd;
      vendor&amp;#8217;s performance to achieve the milestone; or (b)&#xd;
      the enhancement of the value of the delivered item or items&#xd;
      as a result of a specific outcome resulting from the&#xd;
      vendor&amp;#8217;s performance to achieve the milestone;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (2) The consideration relates solely to past performance; and&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      (3) The consideration is reasonable relative to all of the&#xd;
      deliverables and payment terms (including other potential&#xd;
      milestone consideration) within the arrangement.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      A milestone is not considered substantive if any portion of&#xd;
      the associated milestone consideration relates to the&#xd;
      remaining deliverables in the unit of accounting (i.e., it&#xd;
      does not relate solely to past performance). To recognize the&#xd;
      milestone consideration in its entirety as revenue in the&#xd;
      period in which the milestone is achieved, the milestone must&#xd;
      be substantive in its entirety. Milestone consideration&#xd;
      cannot be bifurcated into substantive and nonsubstantive&#xd;
      components. In addition, if a portion of the consideration&#xd;
      earned from achieving a milestone may be refunded or adjusted&#xd;
      based on future performance, the related milestone is not&#xd;
      considered substantive.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      See Note 12 for the additional disclosure information&#xd;
      required under ASC 605-28.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      DERIVATIVE LIABILITIES AND CLASSIFICATION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We evaluate free-standing derivative instruments (or embedded&#xd;
      derivatives) to properly classify such instruments within&#xd;
      equity or as liabilities in our financial statements. Our&#xd;
      policy is to settle instruments indexed to our common shares&#xd;
      on a first-in-first-out basis.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The classification of a derivative instrument is reassessed&#xd;
      at each balance sheet date. If the classification changes as&#xd;
      a result of events during a reporting period, the instrument&#xd;
      is reclassified as of the date of the event that caused the&#xd;
      reclassification. There is no limit on the number of times a&#xd;
      contract may be reclassified.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;&gt;&#xd;
      On April 1, 2009 we adopted new guidance, as codified in&#xd;
      Financial Accounting Standards Board (&quot;FASB&quot;) Accounting&#xd;
      Standards Codification (&quot;ASC&quot;)&amp;#160;815-40, &lt;i&gt;Derivatives&#xd;
      and Hedging&lt;/i&gt;, &lt;i&gt;Accounting for Derivative Financial&#xd;
      Instruments Indexed to, and Potentially Settled in, a&#xd;
      Company&amp;#8217;s Own Stock&lt;/i&gt; (previously EITF 07-5), that&#xd;
      requires us to apply a two-step model in determining whether&#xd;
      a financial instrument or an embedded feature is indexed to&#xd;
      our own stock and thus enables it to qualify for equity&#xd;
      classification. We have identified several convertible debt&#xd;
      or warrant agreements in which the embedded conversion&#xd;
      feature or exercise price contains certain provisions that&#xd;
      may result in an adjustment of the conversion or exercise&#xd;
      price, which results in the failure of the these instruments&#xd;
      to be considered to be indexed to our stock. Accordingly,&#xd;
      under this guidance, we are required to record the estimated&#xd;
      fair value of these instruments as derivative liabilities&#xd;
      (see Note 9).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We re-measure the estimated fair value of derivative&#xd;
      liabilities at each reporting period and record changes in&#xd;
      fair value in other expense (income) in the current statement&#xd;
      of operations.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      REGISTRATION PAYMENT ARRANGEMENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We account for contingent obligations to make future payments&#xd;
      or otherwise transfer consideration under a registration&#xd;
      payment arrangement separately from any related financing&#xd;
      transaction agreements, and any such contingent obligations&#xd;
      are recognized only when it is determined that it is probable&#xd;
      that the Company will become obligated for future payments&#xd;
      and the amount, or range of amounts, of such future payments&#xd;
      can be reasonably estimated (see Note 7).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      STOCK-BASED COMPENSATION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Employee stock options and rights to purchase shares under&#xd;
      stock participation plans are accounted for under the fair&#xd;
      value method. Accordingly, share-based compensation is&#xd;
      measured when all granting activities have been completed,&#xd;
      generally the grant date, based on the fair value of the&#xd;
      award. The exercise price of options is generally equal to&#xd;
      the market price of the Company&apos;s common stock (defined as&#xd;
      the closing price as quoted on the OTCBB) on the date of&#xd;
      grant. Compensation cost recognized by the Company includes&#xd;
      (a) compensation cost for all equity incentive awards granted&#xd;
      prior to, but not yet vested as of April 1, 2006, based on&#xd;
      the grant-date fair value estimated in accordance with the&#xd;
      original provisions of the then current accounting standards,&#xd;
      and (b) compensation cost for all equity incentive awards&#xd;
      granted subsequent to April 1, 2006, based on the grant-date&#xd;
      fair value estimated in accordance with the provisions of&#xd;
      subsequent accounting standards. We use a Binomial Lattice&#xd;
      option pricing model for estimating fair value of options&#xd;
      granted (see Note 10).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      INCOME TAXES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Deferred tax assets and liabilities are recognized for the&#xd;
      future tax consequences attributable to the difference&#xd;
      between the consolidated financial statements and their&#xd;
      respective tax basis. Deferred income taxes reflect the net&#xd;
      tax effects of (a) temporary differences between the carrying&#xd;
      amounts of assets and liabilities for financial reporting&#xd;
      purposes and the amounts reported for income tax purposes,&#xd;
      and (b) tax credit carryforwards. We record a valuation&#xd;
      allowance for deferred tax assets when, based on our best&#xd;
      estimate of taxable income (if any) in the foreseeable&#xd;
      future, it is more likely than not that some portion of the&#xd;
      deferred tax assets may not be realized. At March 31, 2011&#xd;
      and December 31, 2011, we had net deferred tax assets&#xd;
      relating primarily to tax net operating loss carryforwards&#xd;
      and a 100% valuation allowance on such net deferred tax&#xd;
      assets. We had no significant current tax provision for any&#xd;
      period presented.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      SIGNIFICANT RECENT ACCOUNTING PRONOUNCEMENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      There were no&amp;#160;recent accounting pronouncements issued by&#xd;
      the FASB (including its Emerging Issues Task Force), the&#xd;
      American Institute of Certified Public Accountants, or the&#xd;
      Securities and Exchange Commission that in the opinion&#xd;
      of&amp;#160;management had, or are expected&amp;#160;to have a&#xd;
      material impact on our present or future consolidated&#xd;
      financial statements.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 4. NOTES PAYABLE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Notes payable, all current liabilities and unsecured, consist&#xd;
      of the following at December 31, 2011 and March 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-bottom: 1pt; padding-left: 10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;7&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;7&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          March 31, 2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-bottom: 1pt; padding-left: 10pt&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          Principal Balance&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          &amp;#160;Accrued Interest&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          Principal Balance&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;border-bottom: Black 1pt solid; text-align: center&quot;&gt;&#xd;
          Accrued Interest&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 40%&quot;&gt;&#xd;
          12% Notes payable, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          185,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          291,377&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          185,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          270,562&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          10% Note payable, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          5,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          6,188&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          5,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          4,875&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Law Firm Note, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          34,610&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          2,480&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&amp;#160;&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&amp;#160;&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          Tonaquint Note&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          360,186&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          1,776&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&amp;#160;&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&amp;#160;&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-indent: 27pt&quot;&gt;&#xd;
          Total&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          584,796&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          301,821&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          190,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          275,437&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      LAW FIRM NOTE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On August 2 2011, we entered into a Promissory Note with our&#xd;
      intellectual property law firm for the amount of $49,610,&#xd;
      which represented the amount we owed to that firm. The&#xd;
      Promissory Note calls for monthly payments of $5,000 from&#xd;
      August 2011 through December 2011. From the period August 2&#xd;
      through December 31, 2011, we made three $5,000 payments, and&#xd;
      as a result, have reduced the note balance to $34,610 as of&#xd;
      December 31, 2011. The note bears interest at 10% per annum.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      TONAQUINT NOTE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On June 28, 2011, we entered into a Termination Agreement&#xd;
      with Tonaquint, Inc. (See Note 5) under which both parties&#xd;
      agreed that in consideration of the termination of a warrant,&#xd;
      the waiving of all fees, penalties, the creation of the&#xd;
      selling program and other factors, we agreed to issue an&#xd;
      unsecured non-convertible promissory note (the &quot;New Note&quot;) in&#xd;
      the principal amount of $360,186, which provides for annual&#xd;
      interest at a rate of 6%, payable monthly in either cash or&#xd;
      our stock, at our option. The New Note has a maturity date of&#xd;
      April 30, 2012.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DebtDisclosureTextBlock>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKXSGWYX2df0BifibFVhseKPQ==] CSR-->
  <us-gaap:LongTermDebtTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 5. CONVERTIBLE NOTES PAYABLE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Convertible Notes Payable consist of the following at&#xd;
      December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Unamortized&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Net&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Accrued&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Principal&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Discount&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Amount&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Interest&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 40%; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Amended and Restated Series A 12% Convertible Notes, past&#xd;
          due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          900,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          900,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          135,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          2008 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          25,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          25,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          10,729&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          December 2006 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          17,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          17,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          12,608&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          May &amp;amp; June 2009 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          61,321&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          July &amp;amp; August 2009 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          32,500&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          32,500&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          39,773&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          October &amp;amp; November 2009 10% Convertible Notes, past&#xd;
          due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          19,688&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          February 2010 10% Convertible Note&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          240,578&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          240,578&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          21,920&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          April 2010 10% Convertible Note&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          13,625&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          September 2010 10% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          368,100&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          368,100&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          58,361&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          April 2011 10% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          400,400&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (384,483&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          15,917&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          30,030&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          July and August 2011 10% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          357,655&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (178,812&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          178,843&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          15,321&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          September 2011 Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          253,760&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (142,073&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          111,687&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          November 2011 Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          525,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          (176,800&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          348,200&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          14,085&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Total &amp;#8211; Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          3,344,993&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (882,168&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          2,462,825&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          432,461&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Convertible Notes Payable consisted of the following at March&#xd;
      31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          Unamortized&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          Net&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          Accrued&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Principal&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Discount&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Amount&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Interest&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 40%; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Amended Series A 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          900,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          900,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          33,750&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          2008 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          25,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          25,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          7,917&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          December 2006 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          17,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          17,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          10,696&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          May &amp;amp; June 2009 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          200,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          200,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          33,292&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          July &amp;amp; August 2009 10% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          87,500&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          87,500&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          32,020&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          October &amp;amp; November 2009 10% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          205,250&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (17,226&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          188,024&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          30,788&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          February 2010 10% Convertible Note&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          715,578&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          715,578&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          59,273&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          April 2010 10% Convertible Note&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          75,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (73,222&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          1,778&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          7,063&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          June 2010 12% Convertible Notes, past due&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          21,189&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          21,189&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          636&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          July 2010 6% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          495,343&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          (494,770&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          573&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          35,107&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          September 2010 10% Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          739,200&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          (713,990&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          25,210&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          42,709&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total -&#xd;
          Convertible Notes&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          3,481,060&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (1,299,208&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          2,181,852&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          293,251&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      All of the Convertible Notes Payable in the above tables are&#xd;
      unsecured and are presently past due or will be due within&#xd;
      one year of the December 31, 2011 balance sheet date. As a&#xd;
      result, we expect to amortize all of the remaining discounts&#xd;
      during the first half of calendar year 2012.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      AMENDED AND RESTATED SERIES A 12% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In June 2010, we entered into Amended and Restated 12% Series&#xd;
      A Convertible Promissory Notes (the &quot;Amended and Restated&#xd;
      Notes&quot;) with the holders of certain promissory notes&#xd;
      previously issued by the Company (&amp;#8220;Amended Series A 10%&#xd;
      Convertible Notes&amp;#8221; or the &quot;Prior Notes&quot;), and all&#xd;
      amendments to the Prior Notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The Amended and Restated Notes, in the principal amount of&#xd;
      $900,000, are convertible into an aggregate of 4,500,000&#xd;
      shares of our common stock subject to antidilution&#xd;
      adjustments, including down round price protection, and&#xd;
      matured on December 31, 2010. In connection with the&#xd;
      restructuring we paid $54,001 of accrued and default interest&#xd;
      through the date of the restructuring, liquidated damages of&#xd;
      $205,000 and $54,003 of prepaid interest through the&#xd;
      expiration date in the aggregate amount of $313,004 through&#xd;
      the issuance of units (&quot;Units&quot;) at a fixed rate of $0.20 per&#xd;
      Unit, each Unit consisting of one share of our common stock&#xd;
      and one common stock purchase warrant to purchase one share&#xd;
      of our common stock at a fixed exercise price of $0.20 per&#xd;
      share as prescribed in the Amended and Restated Note&#xd;
      Agreement. &amp;#160;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In addition to the extension of the expiration date of the&#xd;
      Amended and Restated Notes to December 31, 2010, we agreed to&#xd;
      increase the annual interest&amp;#160;rate from ten percent to&#xd;
      twelve percent. We also agreed to change the exercise prices&#xd;
      on all of the warrants held by the noteholders to $0.20 per&#xd;
      share, to change certain formerly contingent warrants to&#xd;
      non-contingent warrants and to extend the expiration date of&#xd;
      their warrants to February 2016. The following table&#xd;
      summarizes the number of shares of our common stock issuable&#xd;
      upon the conversion of the Amended and Restated Notes or the&#xd;
      exercise of the various warrants issued or issuable pursuant&#xd;
      to the Amended and Restated Notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 86%; line-height: 115%&quot;&gt;&#xd;
          Note Conversion&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          4,500,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Warrants&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          11,646,125&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Total&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          &amp;#160; $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          16,146,125&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      For accounting purposes, the amendment of the 12% Series A&#xd;
      Convertible Notes was treated as a debt extinguishment in&#xd;
      accordance with FASB ASC 470-50, Debt-Modifications and&#xd;
      Extinguishments, as the terms of the restructured agreements&#xd;
      were deemed to be substantially different than those of the&#xd;
      prior agreements.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Based on conversion and exercise price re-set provisions&#xd;
      included in the Amended and Restated Notes&amp;#160;warrant&#xd;
      agreements, the embedded conversion feature and the related&#xd;
      warrants, with an aggregate estimated fair value of&#xd;
      approximately $3,089,000,&amp;#160;were classified as derivative&#xd;
      liability instruments (See Note 9).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Consequently, at the amendment date we recorded a loss on&#xd;
      extinguishment of $2,226,924 as follows:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 87%; line-height: 115%&quot;&gt;&#xd;
          Reacquisition price&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          4,385,925&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Less carrying value of notes and related&#xd;
          instruments&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          (2,159,001&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          )&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Loss on extinguishment&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          2,226,924&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As of December 31, 2010, the Amended and Restated Notes&#xd;
      matured and as of December 31, 2011 are in default.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We have begun discussions with the noteholders regarding an&#xd;
      extension to the notes but there can be no assurance that we&#xd;
      will be able to do so on terms that we deem acceptable or at&#xd;
      all.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      2008 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      One 2008 10% Convertible Note in the amount of $25,000 which&#xd;
      matured in January 2010 remains outstanding at December 31,&#xd;
      2011. This note is convertible into our common stock at $0.50&#xd;
      per share. During the fiscal year ended March 31, 2011 we&#xd;
      agreed to convert the $20,000 principal and related accrued&#xd;
      interest of $5,562 of one holder of the 2008 10% Convertible&#xd;
      Note into 127,808 shares of common stock based upon a&#xd;
      conversion ratio of $0.20 per share rather than at the stated&#xd;
      conversion ratio of $0.50 per share. As a result of this&#xd;
      change, we recorded a charge of $15,337 as interest expense&#xd;
      in the fiscal year ended March 31, 2011.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      DECEMBER 2006 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, $17,000 of the December 2006 10% Notes&#xd;
      remained outstanding and in default. These notes are&#xd;
      convertible into our common stock at $0.17 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      MAY &amp;amp; JUNE 2009 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In May and June 2009, we raised an aggregate amount of&#xd;
      $350,000 from the sale to accredited investors of 10%&#xd;
      convertible notes (&quot;May &amp;amp; June 2009 10% Convertible&#xd;
      Notes&quot;). The May &amp;amp; June 2009 10% Convertible Notes&#xd;
      matured at various dates between November 2010 through&#xd;
      December 2010 and are convertible into our common stock at a&#xd;
      fixed conversion price of $0.20 per share prior to maturity.&#xd;
      Upon conversion of the May and June 2009 10% Convertible&#xd;
      Notes, the&amp;#160;note holders will receive a matching three&#xd;
      year warrant to purchase unregistered shares of our common&#xd;
      stock at a price of $0.20 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      After consideration of the warrants, we recorded a discount&#xd;
      associated with the beneficial conversion feature of $233,735&#xd;
      related to the May &amp;amp; June 2009 10% Convertible Notes and&#xd;
      we amortized that discount over the terms of the respective&#xd;
      convertible notes using the effective interest method.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the May &amp;amp; June 2009 10%&#xd;
      Convertible Notes have taken place during the fiscal years&#xd;
      ended March 31, 2011 and 2010:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          March 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          March 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 72%; line-height: 115%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          50,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          100,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          2,803&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          15,039&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Warrants issued&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          250,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          500,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As a result of the warrant issuances, we recorded charges of&#xd;
      $31,550 and $74,652 as additional interest expense in the&#xd;
      fiscal years ended March 31, 2010 and 2011, respectively.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On or about June 23, 2011, the holder of the two remaining&#xd;
      &lt;font style=&quot;color: black&quot;&gt;May &amp;amp; June 2009 10%&#xd;
      Convertible Notes, John Barsell,&lt;/font&gt; filed a complaint&#xd;
      against us entitled &lt;i&gt;John E. Barsell v. Aethlon Medical,&#xd;
      Inc&lt;/i&gt;., in the Superior Court of the State of California&#xd;
      for the County of San Diego, Case No. 37-2011-00093374 (the&#xd;
      &amp;#8220;Lawsuit&amp;#8221;). The complaint alleged breach of&#xd;
      contract in connection with certain notes in the aggregate&#xd;
      principal amount of $200,000 issued by us to Barsell in 2009.&#xd;
      &lt;font style=&quot;color: black&quot;&gt;On August 15, 2011, we and Barsell&#xd;
      signed a Settlement Agreement under which we agreed to repay&#xd;
      the notes and related accrued interest in cash or in common&#xd;
      stock, at the election of the Company, on a monthly basis&#xd;
      over approximately a ten month period of time. In exchange,&#xd;
      Barsell dismissed the Lawsuit without prejudice. The agreed&#xd;
      monthly payments are $25,000 if in cash or $30,000 if in&#xd;
      stock with $25,000 of the $30,000 amount going towards&#xd;
      principal reduction and the remaining $5,000 as a penalty for&#xd;
      paying in stock.&lt;/font&gt;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Following the Settlement Agreement and through December 31,&#xd;
      2011, Barsell converted $125,000 of principal into 2,437,425&#xd;
      shares of our common stock over five monthly issuances. Those&#xd;
      share issuances also covered $25,000 in penalties as noted&#xd;
      above.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the remaining principal balance of&#xd;
      $75,000 was in default (see Note 13).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      JULY &amp;amp; AUGUST 2009 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In July and August 2009, we raised an aggregate amount of&#xd;
      $668,250 from the sale to three investment funds of 10%&#xd;
      convertible notes (&quot;July &amp;amp; August 2009 10% Convertible&#xd;
      Notes&quot;). Each note carried a one-year term and is convertible&#xd;
      into our common stock at 80% of market with a floor of $0.15&#xd;
      cents and a ceiling of $0.25 cents per share. As additional&#xd;
      consideration, the investors also received 1,336,500 three&#xd;
      year warrants to purchase our common stock at $0.50 per&#xd;
      share, although that exercise price is subject to change&#xd;
      based on certain conditions. The conversion feature may&#xd;
      additionally be adjusted in the event of future financing by&#xd;
      the Company. Because the conversion feature and warrant&#xd;
      exercise price each can be reset based on future events, they&#xd;
      are classified as derivative liability instruments.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Based on the initial estimated fair value of the conversion&#xd;
      feature and warrants, we recorded a discount associated with&#xd;
      the derivative liability of $475,762, which was amortized&#xd;
      using the effective interest method over the one-year term of&#xd;
      the notes. Deferred financing costs incurred in connection&#xd;
      with this financing totaled $60,750, which were capitalized&#xd;
      and are being amortized using the effective interest method&#xd;
      over the one-year term of the notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the July &amp;amp; August 2009 10%&#xd;
      Convertible Notes have taken place during the fiscal years&#xd;
      ended March 31, 2011 and 2010:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          March 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          March 31, 2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 56%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 8%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; text-align: right&quot;&gt;&#xd;
          330,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 8%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; text-align: right&quot;&gt;&#xd;
          250,750&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          22,559&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          10,698&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the remaining principal balance of&#xd;
      $32,500 was in default.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      OCTOBER &amp;amp; NOVEMBER 2009 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In October and November 2009, we raised $430,000 from the&#xd;
      sale to accredited investors of 10% convertible notes&#xd;
      (&quot;October &amp;amp; November 2009 10% Convertible Notes&quot;). The&#xd;
      October &amp;amp; November 2009 10% Convertible Notes mature at&#xd;
      various dates between April 2011 and May 2011 and are&#xd;
      convertible into our common stock at a fixed&amp;#160;conversion&#xd;
      price of $0.25 per share prior to maturity. The investors&#xd;
      also received matching three year warrants to purchase&#xd;
      unregistered shares of our common stock at a price of $0.25&#xd;
      per share.&amp;#160;&amp;#160;We measured the fair value of the&#xd;
      warrants and the beneficial conversion feature of the notes&#xd;
      and recorded a 100% discount against the principal of the&#xd;
      notes. We are amortizing this discount using the effective&#xd;
      interest method over the term of the notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the October &amp;amp; November 2009&#xd;
      10% Convertible Notes took place during the fiscal years&#xd;
      ended March 31, 2011 and 2010:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Fiscal Year&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          March 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          March 31, 2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 62%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 8%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; text-align: right&quot;&gt;&#xd;
          70,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 2%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; text-align: right&quot;&gt;&#xd;
          175,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          8,750&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the October &amp;amp; November 2009&#xd;
      10% Convertible Notes took place during the nine months ended&#xd;
      December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 80%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 60%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; text-align: right&quot;&gt;&#xd;
          130,250&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          21,288&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Deferred financing costs of $20,250 incurred in connection&#xd;
      with this financing were issued in the form of a convertible&#xd;
      note with warrants on the same terms as those received by the&#xd;
      investors.&amp;#160;&amp;#160;We capitalized the $20,250 of deferred&#xd;
      financing costs and amortized them over the term of the notes&#xd;
      using the effective interest method.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the remaining principal balance of&#xd;
      $75,000 was in default.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      FEBRUARY 2010 10% CONVERTIBLE NOTE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On February 12, 2010, we raised $280,015 in cash and received&#xd;
      a secured promissory note in the amount of $300,000 in&#xd;
      exchange for the issuance by the Company of a $660,000&#xd;
      principal amount 10% convertible promissory note (the &quot;Note&quot;)&#xd;
      to Gemini Master Fund, Ltd. (&quot;Gemini&quot;). The Note included an&#xd;
      original issue discount of ten percent, or $60,000, and an&#xd;
      origination fee of three percent, or $9,000. We also paid&#xd;
      legal fees of $10,985. The Note issued by the Company matured&#xd;
      in February 2011. The terms of the promissory note included a&#xd;
      maturity date of April 1, 2011, and allowed for prepayments&#xd;
      of principal and interest by Gemini beginning on September 1,&#xd;
      2010.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The conversion price per share initially was equal to eighty&#xd;
      percent (80%) of the average of the three lowest closing bid&#xd;
      prices of our common stock as reported by Bloomberg L.P. on&#xd;
      the Principal Market for the ten (10) trading days preceding&#xd;
      the conversion date, subject to a maximum price per share of&#xd;
      $0.30 and a minimum price per share of $0.20 (the &quot;Floor&#xd;
      Price&quot;). The Note is convertible into a maximum of 3,300,000&#xd;
      shares of our common stock at the minimum price per share of&#xd;
      $0.20. The investor also received 660,000 three-year warrants&#xd;
      to purchase shares of our common stock at $0.50 per share,&#xd;
      although that exercise price is subject to change based on&#xd;
      certain conditions. The conversion feature, including the&#xd;
      Floor Price, may additionally be adjusted in the event of&#xd;
      future financing by the Company. Because the conversion&#xd;
      feature and warrant exercise price each can be reset based on&#xd;
      future events, they have been classified as derivative&#xd;
      liabilities.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The Note also contains other standard adjustment features for&#xd;
      stock splits, recapitalizations and similar occurrences. The&#xd;
      Note contains standard events of default related to payment,&#xd;
      performance of certain covenants and bankruptcy events.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We recorded a debt discount of $478,476 based on the&#xd;
      estimated fair value of the derivative liabilities associated&#xd;
      with the warrants and embedded conversion feature which was&#xd;
      amortized using the effective interest method over the term&#xd;
      of the note.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In November 2010, certain terms of the Note were modified&#xd;
      pursuant to a Settlement Agreement (the &quot;Modified Agreement&quot;)&#xd;
      which provides for the modification of the conversion price&#xd;
      formula to equal eighty percent (80%) of the average of the&#xd;
      three lowest closing bid prices of the common stock as&#xd;
      reported by Bloomberg L.P. on the Principal Market for the&#xd;
      twenty (20) trading days preceding the conversion date in&#xd;
      lieu of the ten (10) trading days preceding the conversion&#xd;
      date.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      According to the modified terms, the previous conversion&#xd;
      floor price was replaced with a maximum share limitation&#xd;
      under which the maximum number of shares of common stock that&#xd;
      may be issued to the holder of the Note pursuant to a&#xd;
      conversion of the Note, combined with an exercise of the&#xd;
      Exchange Warrant (as defined below), shall not exceed a cap&#xd;
      determined by (a) dividing the sum of (i) the face amount of&#xd;
      the Note, plus (ii) an amount equal to all interest that&#xd;
      would accrue under the Note during its term (assuming no&#xd;
      payments of principal or interest are made prior to the&#xd;
      maturity date of the Note), by a price per share of common&#xd;
      stock equal to $0.20 (subject to equitable adjustment) and&#xd;
      (b) then adding the sum calculated pursuant to the foregoing&#xd;
      clause (a) to the maximum number of warrant shares (as&#xd;
      defined in the Exchange Warrant) that may be acquired by the&#xd;
      holder thereof upon exercise of the Exchange Warrant&#xd;
      (regardless of whether such exercise is a cashless exercise).&#xd;
      In addition, the &quot;maximum ownership percentage&quot; under the&#xd;
      Note was increased to 9.99%.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In addition to the modifications of the note, we agreed to&#xd;
      exchange the original warrant for a new common stock purchase&#xd;
      warrant (the &quot;Exchange Warrant&quot;) for the purchase of&#xd;
      2,727,272 shares of common stock at an initial exercise price&#xd;
      of $0.231 per share. The Exchange Warrant provides for&#xd;
      anti-dilution adjustment to the exercise price in the event&#xd;
      of the issuance of securities by the Company below the&#xd;
      exercise price, subject to certain exceptions as set forth in&#xd;
      the Exchange Warrant.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In addition, the Modified Agreement provided that Gemini&#xd;
      deliver to us $253,794.09 by wire transfer in full payment of&#xd;
      the promissory note, which represents the outstanding&#xd;
      principal balance thereof plus all accrued but unpaid&#xd;
      interest thereon less the origination fee due to Gemini under&#xd;
      the original transaction documents less reimbursement of&#xd;
      Gemini&apos;s legal expenses. In accordance with the settlement,&#xd;
      we delivered to Gemini 286,483 freely tradable shares of&#xd;
      common stock in full satisfaction of the remaining number of&#xd;
      shares of common stock due under certain conversion notices,&#xd;
      for a total of $75,000, previously delivered by Gemini to the&#xd;
      Company. The Modified Agreement provided for the mutual&#xd;
      release of all claims related to the dispute and the&#xd;
      revocation of all prior notices of default sent by the&#xd;
      Company and Gemini to each other.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In connection with the modification to the note and the&#xd;
      issuance of the Exchange Warrant, the maximum number of&#xd;
      shares issuable pursuant to the maximum share limitation and&#xd;
      the exercise in full of the Exchange Warrant was 6,357,272.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As provisions of the Modified Agreement resulted in terms&#xd;
      that were deemed to be substantially different from the&#xd;
      original terms, the exchange of debt instruments was&#xd;
      accounted for as a debt extinguishment and we recorded a loss&#xd;
      on extinguishment of debt in the amount of $963,018 in the&#xd;
      fiscal year ended March 31, 2011 as shown below:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 70%&quot;&gt;&#xd;
          Reacquisition price&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 18%; text-align: right&quot;&gt;&#xd;
          1,854,767&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          Less carrying value of notes and related instruments&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          (891,749&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          Loss on extinguishment&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          963,018&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On March 21, 2011, we entered into an Extension Agreement&#xd;
      (the &quot;Extension Agreement&quot;) with Gemini.&amp;#160;&amp;#160;The&#xd;
      Extension Agreement provides for, among other things, the&#xd;
      extension of the Maturity Date to October 1, 2011, and an&#xd;
      amendment and restatement of the Note to reflect the revised&#xd;
      principal amount of $740,578, which amount includes accrued&#xd;
      interest of $58,981, the remaining principal balance of&#xd;
      $585,000 and a 15% premium to the principal and accrued&#xd;
      interest amount in consideration for the extension. In&#xd;
      addition, the Note as amended provides for a new &quot;share cap&#xd;
      formula&quot; such that the number of shares of Common Stock&#xd;
      issuable upon conversion of the Note shall not exceed a cap&#xd;
      determined by (a) dividing the sum of (i) the revised&#xd;
      principal amount of the Note ($740,578), plus (ii) an amount&#xd;
      equal to all interest that would accrue under the Note during&#xd;
      its term (assuming no payments of principal or interest are&#xd;
      made after March 21, 2011 but prior to the Maturity Date), by&#xd;
      a price per share of Common Stock equal to $0.16 (subject to&#xd;
      adjustment as set forth in the Note) and (b) then adding the&#xd;
      sum calculated pursuant to the foregoing clause to the&#xd;
      maximum aggregate number of shares of Common Stock issuable&#xd;
      under certain warrants held by Gemini (regardless of whether&#xd;
      such exercise is a cashless exercise).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As provisions of the Extension Agreement resulted in terms&#xd;
      that were deemed to be substantially different from the&#xd;
      original terms, the exchange of debt instruments was&#xd;
      accounted for as a debt extinguishment and we recorded a loss&#xd;
      on extinguishment of debt in the amount of $47,701 in the&#xd;
      fiscal year ended March 31, 2011 as shown below:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 70%&quot;&gt;&#xd;
          Reacquisition price&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 18%; text-align: right&quot;&gt;&#xd;
          773,582&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          Less carrying value of notes and related instruments&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          (725,881&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          Loss on extinguishment&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          47,701&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the February 2010 10%&#xd;
      Convertible Note have taken place during the nine months&#xd;
      ended December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 90%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 67%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; text-align: right&quot;&gt;&#xd;
          475,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          19,403&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On December 29, 2011, we agreed with Gemini to extend the&#xd;
      expiration date of the Note to April 1, 2012. There was no&#xd;
      fee or any other consideration exchanged in connection with&#xd;
      the extension.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      APRIL 2010 10% CONVERTIBLE NOTE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In April 2010, we raised $75,000 from the sale to an&#xd;
      accredited investor of a 10% convertible note. The&#xd;
      convertible note matures in October 2011 and is convertible&#xd;
      into our common stock at a fixed conversion price of $0.25&#xd;
      per share prior to maturity. The investor also received three&#xd;
      year warrants to purchase 300,000 unregistered shares of our&#xd;
      common stock at a price of $0.25 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We measured the fair value of the warrants and the beneficial&#xd;
      conversion feature of the notes and recorded a 100% discount&#xd;
      against the principal of the notes. We are amortizing this&#xd;
      discount using the effective interest method over the term of&#xd;
      the note.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the principal balance of $75,000 was in&#xd;
      default.&amp;#160;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      JUNE 2010 12% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In June 2010, in connection with the present and past&#xd;
      negotiations with the law firm representing the holders of&#xd;
      the &quot;Amended and Restated Notes,&quot; we issued two convertible&#xd;
      notes to that law firm (&amp;#8220;June 2010 12% Convertible&#xd;
      Notes&amp;#8221;) totaling $64,153 on the same terms as the&#xd;
      Amended and Restated Notes. That amount represented the&#xd;
      amount of their legal fees plus accrued interest. During the&#xd;
      fiscal year ended March 31, 2011, the holder converted to&#xd;
      common stock one of the convertible notes in the amount of&#xd;
      $42,964.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      &lt;a id=&quot;OLE_LINK3&quot; name=&quot;OLE_LINK3&quot;&gt;During the three months&#xd;
      ended September 30, 2011, the holder converted the remaining&#xd;
      principal balance of $21,189 and accrued interest of $2,598&#xd;
      to shares of our common stock per the terms of the&#xd;
      convertible note.&lt;/a&gt;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      JULY 2010 6% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In July 2010, we entered into a Note and Warrant Purchase&#xd;
      Agreement (the &quot;Purchase Agreement&quot;) with Tonaquint, Inc., a&#xd;
      Utah corporation (the &quot;Investor&quot;) whereby we issued and sold,&#xd;
      and the Investor purchased: (i) a Convertible Promissory Note&#xd;
      of the Company in the principal amount of $890,000 (the&#xd;
      &quot;Company Note&quot;) and (ii) a Warrant to purchase common stock&#xd;
      of the Company (the &quot;Warrant&quot;). As consideration for the&#xd;
      issuance and sale of the Company Note and Warrant, the&#xd;
      Investor paid cash in the amount of $400,000 and issued two&#xd;
      Secured Trust Deed Notes to us (the &quot;Trust Notes&quot;) each in&#xd;
      the principal amount of $200,000. The variance of $90,000&#xd;
      represents fees and expenses paid by us and an original issue&#xd;
      discount which was recorded as deferred offering costs.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The Company Note is convertible into shares of the Company&apos;s&#xd;
      common stock, at the option of the Investor, at a price per&#xd;
      share equal to (a) the principal and interest due under the&#xd;
      Company Note divided by (b) 80% of the average of the closing&#xd;
      bid price for the three (3) trading days with the lowest&#xd;
      closing bid prices during the twenty (20) trading days&#xd;
      immediately preceding the conversion date (the&#xd;
      &amp;#8220;Conversion Price&amp;#8221;). In no event shall the&#xd;
      Conversion Price be greater than the &quot;Ceiling Price&quot;, which&#xd;
      is $0.30 per share. The principal and interest subject to&#xd;
      conversion under the Note shall be eligible for conversion in&#xd;
      tranches (&quot;Tranches&quot;), as follows: (1) an initial Tranche in&#xd;
      an amount equal to $450,000 and any interest and/or fees&#xd;
      accrued thereon under the terms of the Company Note and the&#xd;
      other Transaction Documents (as defined below and in the&#xd;
      Purchase Agreement), and (2) two additional subsequent&#xd;
      Tranches each in an amount equal to $220,000 and any interest&#xd;
      or fees accrued thereon under the terms of the Company Note&#xd;
      or the other Transaction Documents. The first subsequent&#xd;
      Tranche shall correspond to payment of the first Trust Note&#xd;
      and the second subsequent Tranche shall correspond to payment&#xd;
      of the second Trust Note (as defined in the Purchase&#xd;
      Agreement). The Investor&apos;s right to convert any of the&#xd;
      subsequent Tranches is conditioned upon the Investor&amp;#8217;s&#xd;
      payment in full of the Trust Notes corresponding to such&#xd;
      subsequent Tranche.&amp;#160;&amp;#160;Accordingly, principal and&#xd;
      interest under the Company Note may only be converted by the&#xd;
      Investor in proportion to the amounts paid under each of the&#xd;
      Trust Notes.&amp;#160;&amp;#160;However, up to $450,000 may be&#xd;
      converted at the Investor&apos;s option at any time, representing&#xd;
      amounts paid by the Investor on the closing of the&#xd;
      transaction on July 15, 2010 (the &quot;Closing&quot;).&amp;#160;&amp;#160;The&#xd;
      Company Note bears interest at a rate of 6% per annum. The&#xd;
      maturity date of the Company Note is July 15, 2011. The&#xd;
      Company Note contains &quot;anti-dilution&quot; protection, such that&#xd;
      if the Company issues and sells common stock, or securities&#xd;
      convertible into or exercisable for common stock of the&#xd;
      Company, at a price per share that is less than the&#xd;
      applicable Conversion Price, then the Conversion Price is&#xd;
      adjusted downward to match such lower issuance price.&#xd;
      However, in no event will the Conversion Price based on&#xd;
      anti-dilution adjustments be lower than the &quot;Floor Price&quot;&#xd;
      which is $0.20 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The number of shares of Common Stock that may be issued to&#xd;
      the lender pursuant to a conversion of this Note, combined&#xd;
      with an exercise of the Warrant, shall not exceed a cap&#xd;
      determined by (a) dividing the sum of (i) the face amount of&#xd;
      this Note, plus (ii) an amount equal to all interest that&#xd;
      would accrue under this Note during its term (assuming no&#xd;
      payments of principal or interest are made prior to the&#xd;
      Maturity Date), by a price per share of Common Stock equal to&#xd;
      $0.20 (the Floor Price).&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The Company Note also contains other standard adjustment&#xd;
      features for stock splits, recapitalizations and similar&#xd;
      occurrences. The Company Note contains standard events of&#xd;
      default related to payment, performance of certain covenants&#xd;
      and bankruptcy events. We have granted the Investor a&#xd;
      security interest in the Trust Notes under the terms of the&#xd;
      Security Agreement. The sole collateral for the Company&apos;s&#xd;
      payment and performance obligation under the Company Note is&#xd;
      the Trust Notes.&amp;#160;&amp;#160;The Warrant entitles the Investor&#xd;
      to purchase 3,636,364 shares of common stock at an exercise&#xd;
      price of $0.231 per share. The Warrant contains&#xd;
      &quot;anti-dilution&quot; protection, such that if we issue and sell&#xd;
      common stock, or securities convertible into or exercisable&#xd;
      for common stock of the Company, at a price per share that is&#xd;
      less than the applicable exercise price, then the price is&#xd;
      adjusted downward to match such lower issuance price. The&#xd;
      Warrant also contains other standard adjustment features for&#xd;
      stock splits, recapitalizations and similar occurrences.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We recorded a debt discount of $890,000 based on the&#xd;
      estimated fair value of the derivative liabilities associated&#xd;
      with the warrants and embedded conversion feature which was&#xd;
      amortized using the effective interest method over the term&#xd;
      of the note.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On June 28, 2011, we entered into a Termination Agreement&#xd;
      with Tonaquint, Inc. under which both parties agreed to&#xd;
      terminate the warrant to prevent continuing dilution of our&#xd;
      common stock and to eliminate confusion or disagreement as to&#xd;
      the number of shares of common stock available for issuance&#xd;
      under the warrant in the future. Accordingly, under the&#xd;
      Termination Agreement we issued 3,599,913 shares of common&#xd;
      stock upon the final exercise of the warrant, whereupon the&#xd;
      warrant was terminated and is of no further force or effect.&#xd;
      The&amp;#160;Termination Agreement also provides for a &quot;Common&#xd;
      Stock Sale Limitation&quot; on all of our common stock held by&#xd;
      Tonaquint, Inc. Under the &quot;Common Stock Sale Limitation&quot;, the&#xd;
      daily limitation on the number of shares of common stock&#xd;
      which Tonaquint, Inc. may sell into the market on any trading&#xd;
      day is limited to the greater of (i) $5,000 of sales amount,&#xd;
      or (ii) 10% of the Average Daily Volume of our common stock&#xd;
      sold on the Over The Counter Bulletin Board, where the&#xd;
      Average Daily Volume shall mean the average daily volume for&#xd;
      the prior three month period as reported on each trading day&#xd;
      on Yahoo Finance with respect to our common stock. Under the&#xd;
      terms of the Termination Agreement, Tonaquint, Inc. has&#xd;
      waived and released us from any obligation to pay or perform&#xd;
      any fees, penalties, costs, or assessments that were or are&#xd;
      due, or would have become due, under the convertible note,&#xd;
      the warrant and the note purchase agreement. In consideration&#xd;
      of the termination of the warrant, the waiving of all fees,&#xd;
      penalties, the creation of the selling program and other&#xd;
      factors, we agreed to issue an unsecured non-convertible&#xd;
      promissory note (the &quot;New Note&quot;) in the principal amount of&#xd;
      $360,185, which provides for annual interest at a rate of 6%,&#xd;
      payable monthly in either cash or our stock, at our option.&#xd;
      The New Note has a maturity date of April 30, 2012.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      SEPTEMBER 2010 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On September 3, 2010, we entered into a Subscription&#xd;
      Agreement with three accredited investors (the&#xd;
      &amp;#8220;Purchasers&amp;#8221;)&amp;#160;providing for the issuance and&#xd;
      sale of convertible promissory notes and corresponding&#xd;
      warrants in the aggregate principal amount of $1,430,000. The&#xd;
      initial closing under the Subscription Agreement resulted in&#xd;
      the issuance and sale of (i) convertible promissory notes in&#xd;
      the aggregate principal amount of $743,600, (ii) five-year&#xd;
      warrants to purchase an aggregate of 3,718,000 shares of our&#xd;
      common stock at an exercise price of $0.31125 per share, and&#xd;
      (iii) five-year warrants to purchase an aggregate of&#xd;
      3,718,000 shares of our common stock at an exercise price of&#xd;
      $0.43575 per share. The convertible promissory notes bear&#xd;
      interest compounded monthly at the annual rate of ten percent&#xd;
      (10%) and mature on September 3, 2011. The aggregate gross&#xd;
      cash proceeds were $650,000, the balance of the principal&#xd;
      amount representing a due diligence fee and an original&#xd;
      issuance discount. The convertible promissory notes are&#xd;
      convertible at the option of the holders into shares of our&#xd;
      common stock at a price per share equal to eighty percent&#xd;
      (80%) of the average of the three lowest closing bid prices&#xd;
      of the common stock as reported by Bloomberg L.P. for the&#xd;
      principal market on which the common stock trades or is&#xd;
      quoted for the ten (10) trading days preceding the proposed&#xd;
      conversion date. Subject to adjustment as described in the&#xd;
      notes, the conversion price may not be more than $0.30 nor&#xd;
      less than $0.20. There are no registration requirements with&#xd;
      respect to the shares of common stock underlying the notes or&#xd;
      the warrants.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following conversions of the September 2010 10%&#xd;
      Convertible Note have taken place during the nine months&#xd;
      ended December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 80%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months&lt;br /&gt;&#xd;
          Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 57%&quot;&gt;&#xd;
          Principal converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; text-align: right&quot;&gt;&#xd;
          375,500&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Accrued interest converted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          19,255&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the remaining principal balance of&#xd;
      $368,100 was in default.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      APRIL 2011 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In April 2011, we entered into a Subscription Agreement with&#xd;
      two accredited investors (the &amp;#8220;Purchasers&amp;#8221;)&#xd;
      providing for the issuance and sale of convertible promissory&#xd;
      notes and corresponding warrants in the aggregate principal&#xd;
      amount of $385,000. The closing under the Subscription&#xd;
      Agreement resulted in the issuance and sale by us of (i)&#xd;
      convertible promissory notes in the aggregate principal&#xd;
      amount of $385,000, (ii) five-year warrants to purchase an&#xd;
      aggregate of&amp;#160;4,004,000 shares of our common stock at an&#xd;
      exercise price of $0.125 per share, and (iii) five-year&#xd;
      warrants to purchase an aggregate of&amp;#160;4,004,000 shares of&#xd;
      our common stock at an exercise price of $0.175 per share.&#xd;
      The convertible promissory notes bear interest compounded&#xd;
      monthly at the annual rate of ten percent (10%) and mature on&#xd;
      April 1, 2012.&amp;#160;&amp;#160;The aggregate gross cash proceeds&#xd;
      to us were $350,000, the balance of the principal amount&#xd;
      representing a due diligence fee and an original issuance&#xd;
      discount. The convertible promissory notes are convertible at&#xd;
      the option of the holders into shares of common stock of the&#xd;
      Registrant at a price per share equal to eighty percent (80%)&#xd;
      of the average of the three lowest closing bid prices of the&#xd;
      common stock as reported by Bloomberg L.P. for the principal&#xd;
      market on which the common stock trades or is quoted for the&#xd;
      ten (10) trading days preceding the proposed conversion date.&#xd;
      Subject to adjustment as described in the notes, the&#xd;
      conversion price may not be more than $0.20 nor less than&#xd;
      $0.10. There are no registration requirements with respect to&#xd;
      the shares of common stock underlying the notes or the&#xd;
      warrants.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In addition, we issued (i) five-year warrants to purchase an&#xd;
      aggregate of 812,500 shares of our common stock at an&#xd;
      exercise price of $0.125 per share, and (iii) five-year&#xd;
      warrants to purchase an aggregate of&amp;#160;812,500 shares of&#xd;
      our common stock at an exercise price of $0.175 per share to&#xd;
      the Purchasers. These warrants were issued as an antidilution&#xd;
      adjustment under certain common stock purchase warrants held&#xd;
      by Purchasers that were acquired from us in September 2010.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the outstanding principal balance was&#xd;
      $400,400.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      JULY &amp;amp; AUGUST 2011 10% CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the three months ended September 30, 2011, we raised&#xd;
      $357,656 in 10% convertible notes. Those notes had a fixed&#xd;
      conversion price of $0.09 per share and carried an interest&#xd;
      rate of 10%. The convertible notes mature in July and August&#xd;
      2012. We also issued those investors five year warrants to&#xd;
      purchase 3,973,957 shares of common stock at $0.125 per&#xd;
      share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We measured the fair value of the warrants and the beneficial&#xd;
      conversion feature of the notes and recorded a $257,926&#xd;
      discount against the principal of the notes. We are&#xd;
      amortizing this discount using the effective interest method&#xd;
      over the term of the note.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      SEPTEMBER 2011 CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On September 23, 2011, we entered into a Subscription&#xd;
      Agreement with two accredited investors (the&#xd;
      &amp;#8220;Purchasers&amp;#8221;) providing for the issuance and sale&#xd;
      of convertible promissory notes and corresponding warrants in&#xd;
      the aggregate principal amount of $253,760. The warrants&#xd;
      carried a five-year term to purchase an aggregate of&#xd;
      3,625,143 shares of our common stock at an exercise price of&#xd;
      $0.10 per share. The convertible promissory notes do not bear&#xd;
      an interest rate and mature on September 23, 2012. The&#xd;
      aggregate net cash proceeds to us were $175,000, the balance&#xd;
      of the principal amount representing a due diligence fee and&#xd;
      an original issuance discount. The convertible promissory&#xd;
      notes are convertible at the option of the holders into&#xd;
      shares of our common stock at a price per share equal to&#xd;
      seven cents. Subject to adjustments as described in the&#xd;
      notes, the conversion price may not be more than seven cents.&#xd;
      There are no registration requirements with respect to the&#xd;
      shares of common stock underlying the notes or the warrants.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We measured the fair value of the warrants and the beneficial&#xd;
      conversion feature of the notes and recorded a $168,804&#xd;
      discount against the principal of the notes. We are&#xd;
      amortizing this discount using the effective interest method&#xd;
      over the term of the note.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOVEMBER 2011 CONVERTIBLE NOTES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In November 2011, we raised $525,000 in 5% Original Issue&#xd;
      Discount Unsecured Convertible Debentures from five&#xd;
      accredited investors pursuant to which the investors&#xd;
      purchased an aggregate principal amount of $525,000 for an&#xd;
      aggregate purchase price of $500,000. The debentures bear&#xd;
      interest at 20% per annum and mature on April 20, 2012. The&#xd;
      debentures will be convertible at the option of the holders&#xd;
      at any time into shares of our common stock, at a conversion&#xd;
      price equal to $0.0779, subject to adjustment. In connection&#xd;
      with the debentures, the purchasers received warrants to&#xd;
      purchase 3,369,706 shares of our Common Stock. The warrants&#xd;
      are exercisable for a period of five years from the date of&#xd;
      issuance at an exercise price of $0.11, subject to&#xd;
      adjustment.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Until December 31, 2012, upon any proposed issuance by us of&#xd;
      our common stock or equivalents (or a combination thereof as&#xd;
      defined in the subscription agreement) for cash&#xd;
      consideration, the purchasers may elect, in their sole&#xd;
      discretion, to exchange all or some of the debentures then&#xd;
      held by such purchaser for any securities issued in a&#xd;
      subsequent financing on a $1.00 for $1.00 basis, provided,&#xd;
      however , this right shall not apply with respect to (i) an&#xd;
      Exempt Issuance (as defined in the debenture) or (ii) an&#xd;
      underwritten public offering of our common stock.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      A FINRA registered broker-dealer was engaged as placement&#xd;
      agent in connection with the private placement.&amp;#160;&amp;#160;We&#xd;
      paid the placement agent a cash fee in the amount of $50,000&#xd;
      (representing a 8% sales commission and a 2% unaccountable&#xd;
      expense allowance) and will issue the placement agent or its&#xd;
      designees warrants to purchase an aggregate of 808,729 shares&#xd;
      of common stock at $0.11 per share. The warrants issued to&#xd;
      the placement agent may be exercised on a cashless basis. In&#xd;
      the event the placement agent exercises the warrants on a&#xd;
      cashless basis, we will not receive any proceeds.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The securities sold in the private placement were not&#xd;
      registered under the Securities Act, or the securities laws&#xd;
      of any state, and were offered and sold in reliance on the&#xd;
      exemption from registration afforded by Section 4(2) and&#xd;
      Regulation D (Rule 506) under the Securities Act and&#xd;
      corresponding provisions of state securities laws, which&#xd;
      exempt transactions by an issuer not involving any public&#xd;
      offering. The investors are &amp;#8220;accredited&#xd;
      investors&amp;#8221; as such term is defined in Regulation D&#xd;
      promulgated under the Securities Act.&amp;#160;&amp;#160;&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, the interest payable on these notes&#xd;
      totaled $14,085.&amp;#160;&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 6. EQUITY TRANSACTIONS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the nine months ended December 31, 2011, we issued&#xd;
      24,413,568 shares of restricted common stock in exchange for&#xd;
      the partial or full conversion of principal and interest of&#xd;
      several convertible notes payable in an aggregate amount of&#xd;
      $1,806,879 at an average conversion price of $0.07 per share&#xd;
      based upon the conversion formulae in the respective notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the nine months ended December 31, 2011, we issued&#xd;
      3,292,029 shares of stock to service providers for services&#xd;
      valued at $328,327 based upon the fair value of the shares&#xd;
      issued. Of that aggregate number, 2,864,488 shares of common&#xd;
      stock were issued to consultants pursuant to our S-8&#xd;
      registration statements covering our Amended and Restated&#xd;
      2003 Consultant Stock Plan or 2010 Stock Incentive Plan for&#xd;
      services valued at $272,077 based upon the fair value of the&#xd;
      shares issued. The services were for regulatory affairs,&#xd;
      primarily managing our hepatitis C trial in India, and&#xd;
      corporate communications.&amp;#160;&amp;#160;The average issuance&#xd;
      price on the S-8 issuances was approximately $0.09 per share.&#xd;
      Additionally, we issued 427,541 restricted shares of common&#xd;
      stock to service providers for investor relations valued at&#xd;
      $56,250 based upon the fair value of the shares issued. The&#xd;
      average issuance price on the restricted share issuances was&#xd;
      approximately $0.13 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the nine months ended December 31, 2011, we issued&#xd;
      3,699,914 shares of restricted common stock related to net&#xd;
      warrant cashless exercises.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In May 2011, we agreed to modify three warrants held by an&#xd;
      institutional investor as the result of antidilution&#xd;
      protection.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In May 2011, our Board ratified a six month consulting&#xd;
      agreement with a consultant to provide public relations and&#xd;
      corporate communications services. We agreed to pay the&#xd;
      consultant a monthly fee of $1,500 in cash and a one-time&#xd;
      stock-based payment of six months&amp;#8217; worth of shares&#xd;
      based upon a rate of $5,000 per month, or a total of $30,000,&#xd;
      to be paid in restricted stock. Based upon the closing price&#xd;
      of the date of the approval by our Board, the one-time&#xd;
      restricted share payment was in the amount of 200,000&#xd;
      restricted shares.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <aemd:AccruedLiquidatedDamagesDisclosureText contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 7. ACCRUED LIQUIDATED DAMAGES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We account for contingent obligations to make future payments&#xd;
      or otherwise transfer consideration under a registration&#xd;
      payment arrangement separately from any related financing&#xd;
      transaction agreements, and any such contingent obligations&#xd;
      are recognized only when it is determined that it is probable&#xd;
      that we will become obligated for future payments and the&#xd;
      amount, or range of amounts, of such future payments can be&#xd;
      reasonably estimated.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We have entered into registration payment arrangements in&#xd;
      connection with certain financing arrangements that require&#xd;
      us to register the shares of common stock underlying the&#xd;
      convertible debt and warrants issued in these financing&#xd;
      transactions. Under these agreements we are liable for&#xd;
      liquidated damages to the investors if we fail to file and/or&#xd;
      maintain effective registration statements covering the&#xd;
      specified underlying shares of common stock.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Since we have either failed to file, or failed to maintain&#xd;
      the registration obligations under these agreements, as of&#xd;
      December 31, 2011 and March 31, 2011 we have accrued&#xd;
      estimated aggregate liquidated damages of $437,800 in&#xd;
      connection with the liquidated damage provisions of these&#xd;
      agreements, which we believe represents our maximum exposure&#xd;
      under these provisions.&amp;#160;&amp;#160;Accordingly, we do not&#xd;
      expect to accrue any further liquidated damages in connection&#xd;
      with these agreements.&amp;#160;&amp;#160;The actual amount of&#xd;
      liquidated damages paid, if any, may differ from our&#xd;
      estimates as it is our intention to negotiate with the&#xd;
      investors the settlement of liquidated damages due and, as&#xd;
      such, the ultimate amounts we may actually pay may be less&#xd;
      than the amount currently accrued.&#xd;
    &lt;/p&gt;&lt;br/&gt;</aemd:AccruedLiquidatedDamagesDisclosureText>
  <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 8. OTHER CURRENT LIABILITIES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011 and March 31, 2011, our other current&#xd;
      liabilities were comprised of the following items:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.1pt; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          December 31,&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          March 31,&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;width: 72%; line-height: 115%&quot;&gt;&#xd;
          Accrued interest&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          734,282&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          525,336&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Accrued legal fees&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          240,242&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          236,902&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Deferred rent&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          5,324&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          5,784&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Other&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          42,588&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          36,364&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(233,228,228)&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 0.25in; line-height: 115%&quot;&gt;&#xd;
          Total other current liabilities&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          1,022,436&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          804,386&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As of the date of this report, various promissory and&#xd;
      convertible notes payable in the aggregate principal amount&#xd;
      of $1,792,210 (as identified in Notes 4 and 5 above) have&#xd;
      reached maturity and are past due. We are continually&#xd;
      reviewing other financing arrangements to retire all past due&#xd;
      notes. At December 31, 2011, we had accrued interest in the&#xd;
      amount of $639,958 associated with these defaulted notes in&#xd;
      accrued liabilities payable, which are included in the&#xd;
      accrued interest numbers noted above (see Notes 4 and 5).&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 9. FAIR VALUE MEASUREMENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We follow FASB ASC 820, &quot;FAIR VALUE MEASUREMENTS AND&#xd;
      DISCLOSURES&quot; (&amp;#8220;ASC 820&amp;#8221;) in connection with&#xd;
      financial assets and liabilities measured at fair value on a&#xd;
      recurring basis subsequent to initial recognition. The&#xd;
      guidance applies to our derivative liabilities.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      ASC 820 requires that assets and liabilities carried at fair&#xd;
      value will be classified and disclosed in one of the&#xd;
      following three categories: We measure the fair value of&#xd;
      applicable financial and non-financial assets based on the&#xd;
      following fair value hierarchy:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Level 1: Quoted market prices in active markets for identical&#xd;
      assets or liabilities.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Level 2: Observable market based inputs or unobservable&#xd;
      inputs that are corroborated by market data.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Level 3: Unobservable inputs that are not corroborated by&#xd;
      market data.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The hierarchy noted above requires us to minimize the use of&#xd;
      unobservable inputs and to use observable market data, if&#xd;
      available, when determining fair value.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The fair value of our recorded derivative liabilities is&#xd;
      determined based on unobservable inputs that are not&#xd;
      corroborated by market data, which is a Level 3&#xd;
      classification. We record derivative liabilities on our&#xd;
      balance sheet at fair value with changes in fair value&#xd;
      recorded in our consolidated statements of operations.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Our fair value measurements at the December 31, 2011&#xd;
      reporting date are classified based on the valuation&#xd;
      technique level noted in the table below:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          Description&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          December 31,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Quoted Prices&lt;br /&gt;&#xd;
          in&lt;br /&gt;&#xd;
          Active Markets for&lt;br /&gt;&#xd;
          Identical Assets&lt;br /&gt;&#xd;
          (Level 1)&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Significant&lt;br /&gt;&#xd;
          Other&lt;br /&gt;&#xd;
          Observable&lt;br /&gt;&#xd;
          Inputs&lt;br /&gt;&#xd;
          (Level 2)&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          Significant&lt;br /&gt;&#xd;
          Unobservable Inputs&lt;br /&gt;&#xd;
          (Level 3)&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 44%; line-height: 115%&quot;&gt;&#xd;
          Derivative Liabilities&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          1,250,705&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          --&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          --&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          1,250,705&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Total&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          1,250,705&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          --&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          --&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          1,250,705&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Prior to the third fiscal quarter ended December 31, 2010&#xd;
      (&amp;#8220;Q3 2011&amp;#8221;), the fair value estimate relating to&#xd;
      an aggregate of 25,066,944 warrants classified as derivative&#xd;
      liabilities had been based on a Black-Scholes valuation&#xd;
      model.&amp;#160;&amp;#160;During Q3 2011, we changed to a binomial&#xd;
      lattice model for valuation of these warrants as we&#xd;
      determined that use of a binomial lattice model was more&#xd;
      representative of fair value in the circumstances. In&#xd;
      accordance with accounting guidance in ASC 820-10, Fair Value&#xd;
      Measurements and Disclosures, this was accounted for as a&#xd;
      change in accounting estimate.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following outlines the significant weighted average&#xd;
      assumptions used to estimate the fair value information&#xd;
      presented, in connection with our April 2011 convertible&#xd;
      notes, July &amp;amp; August 2011 10% convertible notes and the&#xd;
      September 2011 convertible notes and with respect to warrant&#xd;
      and embedded conversion option derivative instruments&#xd;
      utilizing the Binomial Lattice option pricing model:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;&#xd;
        &lt;td style=&quot;width: 50%; border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 50%; border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          Nine Months Ended December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Risk free interest rate&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.02% - 2.24%&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Average expected life&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.25 - 5 years&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Expected volatility&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          51.9% - 128.5%&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Expected dividends&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          None&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The table below sets forth a summary of changes in the fair&#xd;
      value of our Level 3 financial instruments for the nine&#xd;
      months ended December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;&#xd;
        &lt;td style=&quot;width: 21%; line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 9%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          April 1,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 13%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          Recorded&lt;br /&gt;&#xd;
          New Derivative&lt;br /&gt;&#xd;
          Liabilities&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 14%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Change in&lt;br /&gt;&#xd;
          estimated fair&lt;br /&gt;&#xd;
          value recognized&lt;br /&gt;&#xd;
          in results&lt;br /&gt;&#xd;
          of operations&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 12%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Reclassification&lt;br /&gt;&#xd;
          of Derivative&lt;br /&gt;&#xd;
          Liability to&lt;br /&gt;&#xd;
          Paid in&lt;br /&gt;&#xd;
          capital&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 5%; line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 17%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          &amp;#160;&lt;br /&gt;&#xd;
          December 31,&lt;br /&gt;&#xd;
          2011&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: top; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Derivative liabilities&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          $ 2,002,896&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          $ 1,107,940&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          ($ 1,596,442)&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          ($ 263,689)&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          $1,250,705&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The fair value of derivative liabilities that we recorded in&#xd;
      the nine months ended December 31, 2011 was related to our&#xd;
      April 2011 convertible note, July &amp;amp; August 2011 10%&#xd;
      convertible notes and the September 2011 convertible note&#xd;
      offerings (see Note 5) and was based upon an&#xd;
      independent&amp;#160;valuation report.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The table below sets forth a summary of changes in the fair&#xd;
      value of our Level 3 derivative liabilities for the nine&#xd;
      months ended December 31, 2010:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Fair Value at&lt;br /&gt;&#xd;
          March 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Recorded Fair&lt;br /&gt;&#xd;
          Value of&lt;br /&gt;&#xd;
          Derivative&lt;br /&gt;&#xd;
          Liabilities&lt;br /&gt;&#xd;
          in the nine month period ended December 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Change in&lt;br /&gt;&#xd;
          Estimated Fair&lt;br /&gt;&#xd;
          Value Recognized&lt;br /&gt;&#xd;
          in Results of&lt;br /&gt;&#xd;
          Operations&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Fair Value at&lt;br /&gt;&#xd;
          December 31, 2010&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 36%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          Derivative liabilities&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          1,054,716&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          6,980,347&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (2,098,954&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 11%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          5,936,109&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The fair value of derivative liabilities that we recorded in&#xd;
      the nine months ended December 2010 was related to the&#xd;
      restructuring of the Amended and Restated Convertible Notes&#xd;
      and to the embedded derivatives and associated warrants&#xd;
      related to a number of our convertible note offerings (see&#xd;
      Note 5) and was based upon an independent&amp;#160;valuation&#xd;
      report.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 10. STOCK COMPENSATION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following table summarizes share-based compensation&#xd;
      expenses relating to shares and options granted and the&#xd;
      effect on basic and diluted loss per common share during the&#xd;
      three and nine months ended December 31, 2011 and 2010:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Three Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Three Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2010&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 40%; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Total share-based compensation expense&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          161,440&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          252,740&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          609,503&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%; padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          1,599,915&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Total share-based compensation expense included in net&#xd;
          loss&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          161,440&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          252,740&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          609,503&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          1,599,915&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Basic and diluted loss per common share&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.00&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.01&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.01&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.02&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following table breaks out the components of our&#xd;
      share-based compensation expenses relating to shares and&#xd;
      options granted and the effect on basic and diluted loss per&#xd;
      common share during the three and nine months ended December&#xd;
      31, 2011 and 2010.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Three Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Three Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months Ended&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;&gt;&#xd;
          Nine Months Ended&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;text-align: center; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2010&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          December 31, 2010&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 40%; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Vesting of stock options&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          64,773&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          153,898&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          319,503&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 3%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; text-align: right&quot;&gt;&#xd;
          875,171&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Incremental fair value of option modifications&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          2,175&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          499,188&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Vesting expense associated with CEO restricted stock&#xd;
          grant&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          96,667&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          96,667&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          290,000&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          225,556&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Direct stock grants&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 1pt solid; text-align: right&quot;&gt;&#xd;
          &amp;#8212;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 1pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Total share-based compensation expense&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          161,440&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          252,740&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          609,503&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          1,599,915&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Total share-based compensation expense included in net&#xd;
          loss&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          161,440&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          252,740&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          609,503&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          1,599,915&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt&quot;&gt;&#xd;
          Basic and diluted loss per common share&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.00&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.01&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.01&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: left&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: Black 2.5pt double; text-align: right&quot;&gt;&#xd;
          (0.02&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;padding-bottom: 2.5pt; text-align: left&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We did not issue any stock options during the three and nine&#xd;
      months ended December 31, 2011. All of the stock-based&#xd;
      compensation expense recorded during the nine months ended&#xd;
      December 31, 2011 and 2010, which totaled $609,503 and&#xd;
      $1,599,915, respectively, is included in payroll and related&#xd;
      expense in the accompanying condensed consolidated statements&#xd;
      of operations.&amp;#160; Stock-based compensation expense&#xd;
      recorded during the three months ended December 31, 2011 had&#xd;
      no impact on basic and diluted loss per common share and the&#xd;
      stock-based compensation expense recorded during the three&#xd;
      months ended December 31, 2010 increased basic and diluted&#xd;
      loss per common share by $0.01. Stock-based compensation&#xd;
      expense recorded during the nine months ended December 31,&#xd;
      2011 increased basic and diluted loss per common share by&#xd;
      $0.01 and the stock-based compensation expense recorded&#xd;
      during the nine months ended December 31, 2010 increased&#xd;
      basic and diluted loss per common share by $0.02.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      We review share-based compensation on a quarterly basis for&#xd;
      changes to the estimate of expected award forfeitures based&#xd;
      on actual forfeiture experience. The cumulative effect of&#xd;
      adjusting the forfeiture rate for all expense amortization is&#xd;
      recognized in the period the forfeiture estimate is changed.&#xd;
      The effect of forfeiture adjustments for the nine months&#xd;
      ended December 31, 2011 was insignificant.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The expected volatility is based on the historic volatility.&#xd;
      The expected life of options granted is based on the&#xd;
      &quot;simplified method&quot; as described in the SEC&apos;s guidance due to&#xd;
      changes in the vesting terms and contractual life of current&#xd;
      option grants compared to our historical grants.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Options outstanding that have vested and are expected to vest&#xd;
      as of December 31, 2011 are as follows:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15pt; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Weighted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Weighted&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Average&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Average&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Remaining&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Number of&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Exercise&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          Contractual&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          Shares&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          Price&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: center&quot;&gt;&#xd;
          Term in Years&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 61%; line-height: 115%&quot;&gt;&#xd;
          Vested&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          17,562,026&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          0.33&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: center&quot;&gt;&#xd;
          6.18&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Expected to vest&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          2,116,667&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          0.25&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          8.75&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;padding-left: 0.25in; line-height: 115%&quot;&gt;&#xd;
          Total&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          19,678,693&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      At December 31, 2011, there was approximately $969,836 of&#xd;
      unrecognized compensation cost related to share-based&#xd;
      payments, including the restricted stock grant, which is&#xd;
      expected to be recognized over a weighted average period of&#xd;
      1.08 years.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On December 31, 2011, our stock options had a negative&#xd;
      intrinsic value since the closing price on that date of $0.05&#xd;
      per share was below the weighted average exercise price of&#xd;
      our stock options&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In July 2011, our Board ratified a one year consulting&#xd;
      agreement with a consultant to provide corporate advisory&#xd;
      services. We agreed to pay the consultant a monthly fee of&#xd;
      $5,000 in common stock.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 11.&amp;#160;&amp;#160;WARRANTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      A summary of warrant activity during the nine months ended&#xd;
      December 31, 2011 is presented below:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.05pt; border-collapse: collapse&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;line-height: 115%; font-weight: bold; text-align: center; border-bottom: Black 1pt solid&quot;&gt;&#xd;
          Amount&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;&#xd;
            &lt;b&gt;Range of Exercise&lt;/b&gt;&#xd;
          &lt;/p&gt;&#xd;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;&#xd;
            &lt;b&gt;Price&lt;/b&gt;&#xd;
          &lt;/p&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td colspan=&quot;2&quot; style=&quot;border-bottom: Black 1pt solid&quot;&gt;&#xd;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;&#xd;
            &lt;b&gt;Weighted Average&lt;/b&gt;&#xd;
          &lt;/p&gt;&#xd;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;&#xd;
            &lt;b&gt;Exercise&lt;/b&gt;&#xd;
          &lt;/p&gt;&#xd;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;&#xd;
            &lt;b&gt;Price&lt;/b&gt;&#xd;
          &lt;/p&gt;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; padding-bottom: 1pt&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 61%; line-height: 115%&quot;&gt;&#xd;
          Warrants outstanding at March 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: right&quot;&gt;&#xd;
          38,675,169&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.15 - $0.50&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 10%; line-height: 115%; text-align: center&quot;&gt;&#xd;
          $0.31&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Exercised&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          (1,209,623&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.231&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Issued&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          22,914,533&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.10 - $0.125&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Cancelled/Expired&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          (4,428,757&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          )&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.17 - $0.50&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Warrants outstanding at December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 1pt solid; line-height: 115%; text-align: right&quot;&gt;&#xd;
          55,951,322&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.10 - $0.25&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          $0.15&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; &quot;&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          Warrants exercisable at December 31, 2011&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: right&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;border-bottom: black 2.25pt double; line-height: 115%; text-align: right&quot;&gt;&#xd;
          55,951,322&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          $&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          0.10 - $0.25&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%; text-align: center&quot;&gt;&#xd;
          $0.15&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;line-height: 115%&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The following outlines the significant weighted average&#xd;
      assumptions used to estimate the fair value information&#xd;
      presented, with respect to warrants utilizing the Binomial&#xd;
      Lattice option pricing model at, and during the nine months&#xd;
      ended December 31, 2011:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 80%; font: 10pt Times New Roman, Times, Serif&quot;&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td style=&quot;width: 60%&quot;&gt;&#xd;
          Risk free interest rate&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 18%; text-align: center&quot;&gt;&#xd;
          0.10% - 2.24%&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Average expected life&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          0.78 - 5 years&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: #EEEEEE&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Expected volatility&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          82.1% - 86.6%&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;&#xd;
        &lt;td&gt;&#xd;
          Expected dividends&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: center&quot;&gt;&#xd;
          None&#xd;
        &lt;/td&gt;&#xd;
        &lt;td style=&quot;text-align: left&quot;&gt;&#xd;
          &amp;#160;&#xd;
        &lt;/td&gt;&#xd;
      &lt;/tr&gt;&#xd;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 12. &amp;#160;DARPA CONTRACT AND RELATED REVENUE RECOGNITION&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      As discussed in Note 1, we entered into a government contract&#xd;
      with DARPA on September 30, 2011 and commenced work on such&#xd;
      contract in October 2011. Only the base year (year one&#xd;
      contract) is effective for the parties. Years two through&#xd;
      five are subject to DARPA exercising their option to enter&#xd;
      into contracts for those years. The year one contract&#xd;
      contains eight milestones for which three have been achieved&#xd;
      during the quarter ended December 31, 2011 as follows:&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Milestone 2.2.1.1 &amp;#8211; Write requirements definition for&#xd;
      the extracorporeal blood purification system and acquire&#xd;
      necessary equipment with a milestone payment of $358,284.&#xd;
      Management considers this milestone to be substantive as it&#xd;
      was not dependent on the passage of time nor was it based&#xd;
      solely on another party&apos;s efforts. We worked on this concept&#xd;
      for a number of months beginning with a presentation to DARPA&#xd;
      in late 2010. We subsequently filed for IP protection on&#xd;
      certain of the key concepts in March 2011 and our management&#xd;
      visited selected potential vendors to work out many of the&#xd;
      details in the summer of 2011 before we were awarded the&#xd;
      contract on September 30, 2011. We ordered the breadboard&#xd;
      device from one of our vendors before the milestone payment&#xd;
      was made. We designed the breadboard prototype and then&#xd;
      presented the design to DARPA in order to achieve the&#xd;
      milestone.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Milestone 2.2.1.2 -- Fabricate breadboard prototypes for&#xd;
      anticoagulation-free anti-sepsis extracorporeal system&#xd;
      (ASEPSYS) device. Fabricate prototype blood tubing sets.&#xd;
      Acquire anti-thrombogenic surface modified hollow fiber&#xd;
      plasma separators with a milestone payment $183,367.&#xd;
      Management considers this milestone to be substantive as it&#xd;
      was not dependent on the passage of time nor was it based&#xd;
      solely on another party&apos;s efforts. The consideration for this&#xd;
      milestone covers the cost of having the breadboard prototype&#xd;
      developed to our specifications, hiring an engineer to&#xd;
      supervise the project, acquiring specially coated cartridges&#xd;
      and associated overhead. The report was accepted by the&#xd;
      contracting officer&apos;s representative and the invoice was&#xd;
      submitted thereafter.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Milestone 2.2.2.1 &amp;#8211; Begin to develop the ADAPT device&#xd;
      to efficiently capture sepsis precursors and acquire&#xd;
      important equipment and supplies with a milestone payment of&#xd;
      $426,424. Management considers this milestone to be&#xd;
      substantive as it was not dependent on the passage of time&#xd;
      nor was it based solely on another party&apos;s efforts. It was&#xd;
      critically important to obtain certain pieces of lab&#xd;
      equipment as early as possible after winning the contract in&#xd;
      order to measure the binding ability of sepsis precursors. We&#xd;
      demonstrated that we were able to capture one of the&#xd;
      identified possible sepsis precursors as part of our&#xd;
      submission for approval. The consideration was also designed&#xd;
      to cover the salaries of new and existing scientists, lab&#xd;
      space, materials as well as fringe and corporate overhead.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 13. COMMITMENTS AND CONTINGENCIES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      LEGAL MATTERS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      From time to time, claims are made against us in the ordinary&#xd;
      course of business, which could result in litigation. Claims&#xd;
      and associated litigation are subject to inherent&#xd;
      uncertainties and unfavorable outcomes could occur, such as&#xd;
      monetary damages, fines, penalties or injunctions prohibiting&#xd;
      us from selling one or more products or engaging in other&#xd;
      activities.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      The occurrence of an unfavorable outcome in any specific&#xd;
      period could have a material adverse effect on our results of&#xd;
      operations for that period or future periods. Other than the&#xd;
      Barsell matter discussed earlier, we are not presently a&#xd;
      party to any pending or threatened material legal&#xd;
      proceedings.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      LEASES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In October 2009, we entered into two new leases for office&#xd;
      and laboratory space. The terms of the new leases are three&#xd;
      years and two years, respectively, and the initial base lease&#xd;
      payments are $6,045 per month and $1,667 per month,&#xd;
      respectively.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On October 4, 2011 we entered into an amendment to extend our&#xd;
      lease for our laboratory by an additional three years. The&#xd;
      amendment also included additional tenant improvements in the&#xd;
      approximate amount of $30,000.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 14. NOTE RECEIVABLE&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      On July 15, 2010, we received two Secured Trust Deed Notes to&#xd;
      us (the &quot;Trust Notes&quot;) each in the principal amount of&#xd;
      $200,000 in connection with our issuance of a $890,000&#xd;
      principal amount 6% convertible promissory note to one&#xd;
      accredited investor (See Note 5).&amp;#160;&amp;#160;The Trust Notes&#xd;
      bear interest payable to us at five percent per annum and&#xd;
      have maturity dates of September 15, 2011 and November 15,&#xd;
      2011. We recognize interest income on the Investor Note and&#xd;
      Trust Notes as it is earned under the terms of the notes. The&#xd;
      Investor Note and Trust Notes have prepayment options.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In February 2011, the investor paid the initial $200,000&#xd;
      amount to us along with related accrued interest of&#xd;
      $5,945.&amp;#160;&amp;#160;During the three months ended June 30,&#xd;
      2011, the investor paid the second $200,000 amount to us&#xd;
      along with accrued interest of $7,863. As a result, we no&#xd;
      longer show a note receivable on our condensed consolidated&#xd;
      balance sheet as of December 31, 2011.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      NOTE 15. RELATED PARTIES&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Due to working capital shortages, we have not been able to&#xd;
      repay certain members of our senior management and board&#xd;
      members for expenses incurred on behalf of the Company and&#xd;
      occasionally have been unable to pay those individuals for&#xd;
      their services. As of December 31, 2011 and March 31, 2011,&#xd;
      we owed our senior management and board members $617,570,&#xd;
      which is shown as due to related parties on the accompanying&#xd;
      balance sheet.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="c3_From1Apr2011To31Dec2011">&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Note 16. SUBSEQUENT EVENTS&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      Management has evaluated events subsequent to December 31,&#xd;
      2011 through the date that the accompanying condensed&#xd;
      consolidated financial statements were filed with the&#xd;
      Securities and Exchange Commission for transactions and other&#xd;
      events which may require adjustment of and/or disclosure in&#xd;
      such financial statements.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      In January 2012, we shipped a diagnostic product that&#xd;
      isolated exosomes from blood serum to a life sciences company&#xd;
      and invoiced them for $1,432. We received payment in full&#xd;
      under that invoice in February 2012. This represents our&#xd;
      first commercial sale, which will be recorded in the March&#xd;
      2012 quarter.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the period January 1, 2012 through February 15, 2012,&#xd;
      we issued 2,255,188 shares of restricted common stock in&#xd;
      exchange for the partial or full conversion of principal and&#xd;
      interest of several convertible notes payable in an aggregate&#xd;
      amount of $111,795 at an average conversion price of $0.05&#xd;
      per share based upon the conversion formulae in the&#xd;
      respective notes.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the period January 1, 2012 through February 15, 2012,&#xd;
      we issued 109,529 shares of common stock to a service&#xd;
      provider for services valued at $7,667 based upon the fair&#xd;
      value of the shares issued. All of those shares were issued&#xd;
      pursuant to our S-8 registration statements covering our&#xd;
      Amended and Restated 2003 Consultant Stock Plan or 2010 Stock&#xd;
      Incentive Plan. The services were for exosome-related&#xd;
      research.&amp;#160;&amp;#160;The issuance price on the S-8 issuance&#xd;
      was approximately $0.07 per share.&#xd;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;&#xd;
      During the period January 1, 2012 through February 15, 2012,&#xd;
      we issued 287,500 shares of restricted common stock as a&#xd;
      patent license payment valued at $17,250.&#xd;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>aemd-20111231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<xs:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://www.aethlonmedical.com/20111231" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" elementFormDefault="qualified" xmlns:aemd="http://www.aethlonmedical.com/20111231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20111231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20111231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20111231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20111231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet" id="aemd_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals" id="aemd_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement" id="aemd_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/ConsolidatedCashFlow" id="aemd_ConsolidatedCashFlow">
        <link:definition>004 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note" id="aemd_Note">
        <link:definition>005 - Disclosure - NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note0" id="aemd_Note0">
        <link:definition>006 - Disclosure - NOTE 2. LIQUIDITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note00" id="aemd_Note00">
        <link:definition>007 - Disclosure - NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note000" id="aemd_Note000">
        <link:definition>008 - Disclosure - NOTE 4. NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note0000" id="aemd_Note0000">
        <link:definition>009 - Disclosure - NOTE 5. CONVERTIBLE NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note00000" id="aemd_Note00000">
        <link:definition>010 - Disclosure - NOTE 6. EQUITY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note000000" id="aemd_Note000000">
        <link:definition>011 - Disclosure - NOTE 7. ACCRUED LIQUIDATED DAMAGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note0000000" id="aemd_Note0000000">
        <link:definition>012 - Disclosure - NOTE 8. OTHER CURRENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note00000000" id="aemd_Note00000000">
        <link:definition>013 - Disclosure - NOTE 9. FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKXDVnhhUJh6PE1QLw7nn+1FQ==] CSR-->
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note000000000" id="aemd_Note000000000">
        <link:definition>014 - Disclosure - NOTE 10. STOCK COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note0000000000" id="aemd_Note0000000000">
        <link:definition>015 - Disclosure - NOTE 11. WARRANTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note00000000000" id="aemd_Note00000000000">
        <link:definition>016 - Disclosure - NOTE 12. DARPA CONTRACT AND RELATED REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note000000000000" id="aemd_Note000000000000">
        <link:definition>017 - Disclosure - NOTE 13. COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note0000000000000" id="aemd_Note0000000000000">
        <link:definition>018 - Disclosure - NOTE 13. NOTE RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note00000000000000" id="aemd_Note00000000000000">
        <link:definition>019 - Disclosure - NOTE 15. RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/Note000000000000000" id="aemd_Note000000000000000">
        <link:definition>020 - Disclosure - NOTE 16. SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aethlonmedical.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-types-2011-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="ConsolidatedBalanceSheetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_ConsolidatedBalanceSheetsAbstract"/>
  <xs:element name="CurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CurrentAssetsAbstract"/>
  <xs:element name="LiabilitiesAndStockholdersDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_LiabilitiesAndStockholdersDeficitAbstract"/>
  <xs:element name="CurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CurrentLiabilitiesAbstract"/>
  <xs:element name="StockholdersDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_StockholdersDeficitAbstract"/>
  <xs:element name="ConsolidatedStatementsOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_ConsolidatedStatementsOfOperationsAbstract"/>
  <xs:element name="OtherExpenseIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_OtherExpenseIncomeAbstract"/>
  <xs:element name="CondensedConsolidatedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract"/>
  <xs:element name="CashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
  <xs:element name="IssuanceOfNoteInConvertibleNoteTermination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aemd_IssuanceOfNoteInConvertibleNoteTermination"/>
  <xs:element name="ChangesInOperatingAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
  <xs:element name="CashFlowsFromInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CashFlowsFromInvestingActivitiesAbstract"/>
  <xs:element name="CashFlowsFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CashFlowsFromFinancingActivitiesAbstract"/>
  <xs:element name="SupplementalDisclosuresOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract"/>
  <xs:element name="CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CashPaidDuringThePeriodForAbstract"/>
  <xs:element name="SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract"/>
  <xs:element name="DebtAndAccruedInterestConvertedToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aemd_DebtAndAccruedInterestConvertedToCommonStock"/>
  <xs:element name="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd"/>
  <xs:element name="IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees"/>
  <xs:element name="ReclassificationOfWarrantDerivativeLiabilityIntoEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity"/>
  <xs:element name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract"/>
  <xs:element name="LiquidityDisclosurePolicyTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_LiquidityDisclosurePolicyTextBlockAbstract"/>
  <xs:element name="SignificantAccountingPoliciesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_SignificantAccountingPoliciesTextBlockAbstract"/>
  <xs:element name="DebtDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_DebtDisclosureTextBlockAbstract"/>
  <xs:element name="LongTermDebtTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_LongTermDebtTextBlockAbstract"/>
  <xs:element name="StockholdersEquityNoteDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
  <xs:element name="AccruedLiquidatedDamagesDisclosureTextAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_AccruedLiquidatedDamagesDisclosureTextAbstract"/>
  <xs:element name="AccruedLiquidatedDamagesDisclosureText" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_AccruedLiquidatedDamagesDisclosureText"/>
  <xs:element name="OtherLiabilitiesDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_OtherLiabilitiesDisclosureTextBlockAbstract"/>
  <xs:element name="FairValueDisclosuresTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_FairValueDisclosuresTextBlockAbstract"/>
  <xs:element name="ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract"/>
  <xs:element name="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract"/>
  <xs:element name="DeferredRevenueDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_DeferredRevenueDisclosureTextBlockAbstract"/>
  <xs:element name="CommitmentsAndContingenciesDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract"/>
  <xs:element name="LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract"/>
  <xs:element name="RelatedPartyTransactionsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
  <xs:element name="SubsequentEventsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_SubsequentEventsTextBlockAbstract"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aemd_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>aemd-20111231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheet" roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedIncomeStatement" roleURI="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedCashFlow" roleURI="http://www.aethlonmedical.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Cash" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DeferredFinanceCostsNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InterestReceivable" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DepositsAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ProfessionalFees" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_LaborAndRelatedExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKXRL2kezjh2HbKIKBOodf1xA==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestAndOtherIncome" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestAndDebtExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfNoteInConvertibleNoteTermination"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="aemd_IssuanceOfNoteInConvertibleNoteTermination" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>aemd-20111231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheet" roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedIncomeStatement" roleURI="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedCashFlow" roleURI="http://www.aethlonmedical.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note" roleURI="http://www.aethlonmedical.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0" roleURI="http://www.aethlonmedical.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00" roleURI="http://www.aethlonmedical.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000" roleURI="http://www.aethlonmedical.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000" roleURI="http://www.aethlonmedical.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000" roleURI="http://www.aethlonmedical.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000" roleURI="http://www.aethlonmedical.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000" roleURI="http://www.aethlonmedical.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000" roleURI="http://www.aethlonmedical.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000000" roleURI="http://www.aethlonmedical.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000000" roleURI="http://www.aethlonmedical.com/role/Note00000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000000000" roleURI="http://www.aethlonmedical.com/role/Note0000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000000000" roleURI="http://www.aethlonmedical.com/role/Note00000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#DocumentAndEntityInformation" roleURI="http://www.aethlonmedical.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="aemd_CurrentAssetsAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="aemd_CurrentAssetsAbstract" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_Cash" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_DeferredFinanceCostsNet" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="5"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_AssetsCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DepositsAssets" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_Assets" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_LiabilitiesAndStockholdersDeficitAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_LiabilitiesAndStockholdersDeficitAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="aemd_CurrentLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:to="aemd_CurrentLiabilitiesAbstract" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="6"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1"/>
    <loc xlink:type="locator" xlink:label="aemd_StockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_StockholdersDeficitAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:to="aemd_StockholdersDeficitAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_StockholdersDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_StockholdersDeficitAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_StockholdersDeficitAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_StockholdersEquity" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_OperatingExpenses" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3"/>
    <loc xlink:type="locator" xlink:label="aemd_OtherExpenseIncomeAbstract" xlink:href="aemd-20111231.xsd#aemd_OtherExpenseIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_OtherExpenseIncomeAbstract" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_InterestAndDebtExpense" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="5"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="6"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="7"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_CashFlowsFromOperatingActivitiesAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ShareBasedCompensation" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_OtherNoncashExpense" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="4"/>
    <loc xlink:type="locator" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfNoteInConvertibleNoteTermination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="aemd_IssuanceOfNoteInConvertibleNoteTermination" order="5"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="6"/>
    <loc xlink:type="locator" xlink:label="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" order="7"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_CashFlowsFromInvestingActivitiesAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_CashFlowsFromFinancingActivitiesAbstract" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Cash" order="5"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKXXSog53TD5zm63noN+Kp0Jg==] CSR-->
    <loc xlink:type="locator" xlink:label="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract" order="6"/>
    <loc xlink:type="locator" xlink:label="aemd_CashPaidDuringThePeriodForAbstract" xlink:href="aemd-20111231.xsd#aemd_CashPaidDuringThePeriodForAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_CashPaidDuringThePeriodForAbstract" order="7"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_InterestPaidNet" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="1"/>
    <loc xlink:type="locator" xlink:label="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" order="8"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" order="9"/>
    <loc xlink:type="locator" xlink:label="aemd_DebtAndAccruedInterestConvertedToCommonStock" xlink:href="aemd-20111231.xsd#aemd_DebtAndAccruedInterestConvertedToCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="aemd_DebtAndAccruedInterestConvertedToCommonStock" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:href="aemd-20111231.xsd#aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" order="10"/>
    <loc xlink:type="locator" xlink:label="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity" xlink:href="aemd-20111231.xsd#aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="2"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureText" xlink:href="aemd-20111231.xsd#aemd_AccruedLiquidatedDamagesDisclosureText"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aemd_AccruedLiquidatedDamagesDisclosureText" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityRegistrantName" order="0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentType" order="1"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityPublicFloat" order="4"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentFlag" order="5"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentDescription" order="6"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCentralIndexKey" order="7"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityFilerCategory" order="10"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>aemd-20111231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="aemd_ConsolidatedBalanceSheetsAbstract" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_ConsolidatedBalanceSheetsAbstract_lbl" xml:lang="en-US">Consolidated Balance Sheets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ConsolidatedBalanceSheetsAbstract" xlink:to="aemd_ConsolidatedBalanceSheetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ConsolidatedBalanceSheetsAbstract_lbl0" xml:lang="en-US">Consolidated Balance Sheets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ConsolidatedBalanceSheetsAbstract" xlink:to="aemd_ConsolidatedBalanceSheetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">ASSETS [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_CurrentAssetsAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="aemd_CurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CurrentAssetsAbstract" xlink:to="aemd_CurrentAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Deferred financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xml:lang="en-US">Note receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US">Interest receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Patents and patents pending, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_LiabilitiesAndStockholdersDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_LiabilitiesAndStockholdersDeficitAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:to="aemd_LiabilitiesAndStockholdersDeficitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_LiabilitiesAndStockholdersDeficitAbstract_lbl0" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&apos; DEFICIT [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_LiabilitiesAndStockholdersDeficitAbstract" xlink:to="aemd_LiabilitiesAndStockholdersDeficitAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_CurrentLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="aemd_CurrentLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CurrentLiabilitiesAbstract" xlink:to="aemd_CurrentLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Convertible notes payable, net of discounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liquidated damages</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_StockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_StockholdersDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_StockholdersDeficitAbstract_lbl" xml:lang="en-US">Stockholders&apos; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_StockholdersDeficitAbstract" xlink:to="aemd_StockholdersDeficitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_StockholdersDeficitAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Deficit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_StockholdersDeficitAbstract" xlink:to="aemd_StockholdersDeficitAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $0.001 per share; 250,000,000 shares authorized as of December 31, 2011 and March 31, 2011; 108,977,508 and 77,467,361 shares issued and outstanding as of December 31, 2011 and March 31, 2011, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US">Deficit accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&apos; deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_ConsolidatedStatementsOfOperationsAbstract" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedStatementsOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_ConsolidatedStatementsOfOperationsAbstract_lbl" xml:lang="en-US">Consolidated Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ConsolidatedStatementsOfOperationsAbstract" xlink:to="aemd_ConsolidatedStatementsOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ConsolidatedStatementsOfOperationsAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ConsolidatedStatementsOfOperationsAbstract" xlink:to="aemd_ConsolidatedStatementsOfOperationsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl0" xml:lang="en-US">REVENUES [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Government contract revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING EXPENSES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">OPERATING EXPENSES [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Payroll, consulting and related services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">OPERATING LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_OtherExpenseIncomeAbstract" xlink:href="aemd-20111231.xsd#aemd_OtherExpenseIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_OtherExpenseIncomeAbstract_lbl" xml:lang="en-US">OTHER EXPENSE (INCOME)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="aemd_OtherExpenseIncomeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_OtherExpenseIncomeAbstract_lbl0" xml:lang="en-US">OTHER EXPENSE (INCOME) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_OtherExpenseIncomeAbstract" xlink:to="aemd_OtherExpenseIncomeAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on extinguishment of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xml:lang="en-US">Loss on settlement of accrued interest and damages</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">(Gain) on change in fair value of derivative liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Interest and other debt expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">BASIC AND DILUTED LOSS PER COMMON SHARE (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING &#8211; BASIC AND DILUTED (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:href="aemd-20111231.xsd#aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract_lbl" xml:lang="en-US">Condensed Consolidated Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract_lbl0" xml:lang="en-US">Condensed Consolidated Statements of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:to="aemd_CashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CashFlowsFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromOperatingActivitiesAbstract" xlink:to="aemd_CashFlowsFromOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Loss on debt extinguishment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Fair market value of conditional warrants that subsequently were issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Non cash interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Fair market value of common stock, warrants and options issued for services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl0" xml:lang="en-US">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfNoteInConvertibleNoteTermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl" xml:lang="en-US">Issuance of note in convertible note termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:to="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl0" xml:lang="en-US">Issuance of note in convertible note termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:to="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discount and deferred financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Changes in operating assets and liabilities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xml:lang="en-US">Due to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CashFlowsFromInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:to="aemd_CashFlowsFromInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CashFlowsFromInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from investing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromInvestingActivitiesAbstract" xlink:to="aemd_CashFlowsFromInvestingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Additions to patents and patents pending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CashFlowsFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="aemd_CashFlowsFromFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CashFlowsFromFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from financing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashFlowsFromFinancingActivitiesAbstract" xlink:to="aemd_CashFlowsFromFinancingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Principal repayments of notes payable</label>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKX1rbGa/yyWuo5014JY6RztA==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Net proceeds from the issuance of convertible notes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from the issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xml:lang="en-US">Proceeds from collection of secured notes receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Cash_lbl1" xml:lang="en-US">Cash at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl1"/>
    <loc xlink:type="locator" xlink:label="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract" xlink:to="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental disclosures of cash flow information: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract" xlink:to="aemd_SupplementalDisclosuresOfCashFlowInformationAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_CashPaidDuringThePeriodForAbstract" xlink:href="aemd-20111231.xsd#aemd_CashPaidDuringThePeriodForAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_CashPaidDuringThePeriodForAbstract_lbl" xml:lang="en-US">Cash paid during the period for:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashPaidDuringThePeriodForAbstract" xlink:to="aemd_CashPaidDuringThePeriodForAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CashPaidDuringThePeriodForAbstract_lbl0" xml:lang="en-US">Cash paid during the period for: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CashPaidDuringThePeriodForAbstract" xlink:to="aemd_CashPaidDuringThePeriodForAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract_lbl" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" xlink:to="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" xlink:to="aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xml:lang="en-US">Derivative liabilities recorded in connection with embedded conversion feature of convertible notes and/or warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_DebtAndAccruedInterestConvertedToCommonStock" xlink:href="aemd-20111231.xsd#aemd_DebtAndAccruedInterestConvertedToCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_DebtAndAccruedInterestConvertedToCommonStock_lbl" xml:lang="en-US">Debt and accrued interest converted to common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DebtAndAccruedInterestConvertedToCommonStock" xlink:to="aemd_DebtAndAccruedInterestConvertedToCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_DebtAndAccruedInterestConvertedToCommonStock_lbl0" xml:lang="en-US">Debt and accrued interest converted to common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DebtAndAccruedInterestConvertedToCommonStock" xlink:to="aemd_DebtAndAccruedInterestConvertedToCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:href="aemd-20111231.xsd#aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd_lbl" xml:lang="en-US">Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd_lbl0" xml:lang="en-US">Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees_lbl" xml:lang="en-US">Issuance of convertible notes in settlement of accrued legal fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" xlink:to="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees_lbl0" xml:lang="en-US">Issuance of convertible notes in settlement of accrued legal fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" xlink:to="aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity" xlink:href="aemd-20111231.xsd#aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity_lbl" xml:lang="en-US">Reclassification of warrant derivative liability into equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity" xlink:to="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity_lbl0" xml:lang="en-US">Reclassification of warrant derivative liability into equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity" xlink:to="aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of shares in connection with restricted stock grant to officer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract" xlink:to="aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_LiquidityDisclosurePolicyTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LiquidityDisclosurePolicyTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_LiquidityDisclosurePolicyTextBlockAbstract_lbl" xml:lang="en-US">NOTE 2. LIQUIDITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_LiquidityDisclosurePolicyTextBlockAbstract" xlink:to="aemd_LiquidityDisclosurePolicyTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiquidityDisclosureTextBlock_lbl" xml:lang="en-US">Liquidity Disclosure [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidityDisclosureTextBlock" xlink:to="us-gaap_LiquidityDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_SignificantAccountingPoliciesTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_SignificantAccountingPoliciesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_SignificantAccountingPoliciesTextBlockAbstract_lbl" xml:lang="en-US">NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SignificantAccountingPoliciesTextBlockAbstract" xlink:to="aemd_SignificantAccountingPoliciesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_DebtDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_DebtDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_DebtDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 4. NOTES PAYABLE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DebtDisclosureTextBlockAbstract" xlink:to="aemd_DebtDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_LongTermDebtTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LongTermDebtTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_LongTermDebtTextBlockAbstract_lbl" xml:lang="en-US">NOTE 5. CONVERTIBLE NOTES PAYABLE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_LongTermDebtTextBlockAbstract" xlink:to="aemd_LongTermDebtTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-term Debt [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 6. EQUITY TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="aemd_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureTextAbstract" xlink:href="aemd-20111231.xsd#aemd_AccruedLiquidatedDamagesDisclosureTextAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureTextAbstract_lbl" xml:lang="en-US">NOTE 7. ACCRUED LIQUIDATED DAMAGES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AccruedLiquidatedDamagesDisclosureTextAbstract" xlink:to="aemd_AccruedLiquidatedDamagesDisclosureTextAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureText" xlink:href="aemd-20111231.xsd#aemd_AccruedLiquidatedDamagesDisclosureText"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureText_lbl" xml:lang="en-US">Accrued Liquidated Damages Disclosure Text</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AccruedLiquidatedDamagesDisclosureText" xlink:to="aemd_AccruedLiquidatedDamagesDisclosureText_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureText_lbl0" xml:lang="en-US">Accrued Liquidated Damages Disclosure Text</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AccruedLiquidatedDamagesDisclosureText" xlink:to="aemd_AccruedLiquidatedDamagesDisclosureText_lbl0"/>
    <loc xlink:type="locator" xlink:label="aemd_OtherLiabilitiesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_OtherLiabilitiesDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_OtherLiabilitiesDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 8. OTHER CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_OtherLiabilitiesDisclosureTextBlockAbstract" xlink:to="aemd_OtherLiabilitiesDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_FairValueDisclosuresTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_FairValueDisclosuresTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_FairValueDisclosuresTextBlockAbstract_lbl" xml:lang="en-US">NOTE 9. FAIR VALUE MEASUREMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_FairValueDisclosuresTextBlockAbstract" xlink:to="aemd_FairValueDisclosuresTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract_lbl" xml:lang="en-US">NOTE 10. STOCK COMPENSATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract" xlink:to="aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Shareholders&apos; Equity and Share-based Payments [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract_lbl" xml:lang="en-US">NOTE 11. WARRANTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract" xlink:to="aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Stockholders&apos; Equity Note, Warrants or Rights [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_DeferredRevenueDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_DeferredRevenueDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_DeferredRevenueDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 12. DARPA CONTRACT AND RELATED REVENUE RECOGNITION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DeferredRevenueDisclosureTextBlockAbstract" xlink:to="aemd_DeferredRevenueDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock_lbl" xml:lang="en-US">Deferred Revenue Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 13. COMMITMENTS AND CONTINGENCIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract" xlink:to="aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 13. NOTE RECEIVABLE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract" xlink:to="aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">NOTE 15. RELATED PARTIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_SubsequentEventsTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_SubsequentEventsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_SubsequentEventsTextBlockAbstract_lbl" xml:lang="en-US">NOTE 16. SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_SubsequentEventsTextBlockAbstract" xlink:to="aemd_SubsequentEventsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Statement, Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aemd_DocumentAndEntityInformationAbstract" xlink:href="aemd-20111231.xsd#aemd_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_DocumentAndEntityInformationAbstract" xlink:to="aemd_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_AccruedLiquidatedDamagesDisclosureText_lbl1" xml:lang="en-US">AccruedLiquidatedDamagesDisclosureText</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_AccruedLiquidatedDamagesDisclosureText" xlink:to="aemd_AccruedLiquidatedDamagesDisclosureText_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl1" xml:lang="en-US">IssuanceOfNoteInConvertibleNoteTermination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aemd_IssuanceOfNoteInConvertibleNoteTermination" xlink:to="aemd_IssuanceOfNoteInConvertibleNoteTermination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl0" xml:lang="en-US">Interest and Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US">Gains (Losses) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl1" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl0" xml:lang="en-US">Repayments of Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl0" xml:lang="en-US">Payments of Debt Extinguishment Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0" xml:lang="en-US">Development Stage Enterprise, Deficit Accumulated During Development Stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>aemd-20111231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Feb 16 15:34:33 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheet" roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedIncomeStatement" roleURI="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedCashFlow" roleURI="http://www.aethlonmedical.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note" roleURI="http://www.aethlonmedical.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0" roleURI="http://www.aethlonmedical.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00" roleURI="http://www.aethlonmedical.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000" roleURI="http://www.aethlonmedical.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000" roleURI="http://www.aethlonmedical.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000" roleURI="http://www.aethlonmedical.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000" roleURI="http://www.aethlonmedical.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000" roleURI="http://www.aethlonmedical.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000" roleURI="http://www.aethlonmedical.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000000" roleURI="http://www.aethlonmedical.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000000" roleURI="http://www.aethlonmedical.com/role/Note00000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note0000000000000" roleURI="http://www.aethlonmedical.com/role/Note0000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note00000000000000" roleURI="http://www.aethlonmedical.com/role/Note00000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#aemd_Note000000000000000" roleURI="http://www.aethlonmedical.com/role/Note000000000000000"/>
  <roleRef xlink:type="simple" xlink:href="aemd-20111231.xsd#DocumentAndEntityInformation" roleURI="http://www.aethlonmedical.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentAssetsAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="CurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_DeferredFinanceCostsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DepositsAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_Assets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesAndStockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_LiabilitiesAndStockholdersDeficitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="LiabilitiesAndStockholdersDeficitAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersDeficitAbstract" xlink:to="CurrentLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersDeficitAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockholdersDeficitAbstract" xlink:href="aemd-20111231.xsd#aemd_StockholdersDeficitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersDeficitAbstract" xlink:to="StockholdersDeficitAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersDeficitAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersDeficitAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfOperationsAbstract" xlink:href="aemd-20111231.xsd#aemd_ConsolidatedStatementsOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfOperationsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_OperatingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="OtherExpenseIncomeAbstract" xlink:href="aemd-20111231.xsd#aemd_OtherExpenseIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherExpenseIncomeAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_InterestAndDebtExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpenseIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="CondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:href="aemd-20111231.xsd#aemd_CondensedConsolidatedStatementsOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_OtherNoncashExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfNoteInConvertibleNoteTermination" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfNoteInConvertibleNoteTermination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="IssuanceOfNoteInConvertibleNoteTermination" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="ChangesInOperatingAssetsAndLiabilitiesAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromInvestingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_CashFlowsFromFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Cash" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Cash_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SupplementalDisclosuresOfCashFlowInformationAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="SupplementalDisclosuresOfCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:href="aemd-20111231.xsd#aemd_CashPaidDuringThePeriodForAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashPaidDuringThePeriodForAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" xlink:href="aemd-20111231.xsd#aemd_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebtAndAccruedInterestConvertedToCommonStock" xlink:href="aemd-20111231.xsd#aemd_DebtAndAccruedInterestConvertedToCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="DebtAndAccruedInterestConvertedToCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:href="aemd-20111231.xsd#aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+/L8ALnfx7gOXctiXWkmWM/f70bhPxq0NBN1YPDlpJR+HkOhm/ERo7X09acv/GfuHV9/NZNBlpGzI33R1MSCAfA0EM7K3C30Rp9kyyNMTq/o3E7RfNn04TItC4iKKWnmMdPCXRgnlPER1hqx5ATsyyFUB6+d3Kgl3+5tttcCHJpqOVpu72PNKXtTp5OrkEN0lkVgHNmHiuww==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" xlink:href="aemd-20111231.xsd#aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReclassificationOfWarrantDerivativeLiabilityIntoEquity" xlink:href="aemd-20111231.xsd#aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="ReclassificationOfWarrantDerivativeLiabilityIntoEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note">
    <loc xlink:type="locator" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0">
    <loc xlink:type="locator" xlink:label="LiquidityDisclosurePolicyTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LiquidityDisclosurePolicyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityDisclosurePolicyTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_SignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000">
    <loc xlink:type="locator" xlink:label="DebtDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_DebtDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="LongTermDebtTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LongTermDebtTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="AccruedLiquidatedDamagesDisclosureTextAbstract" xlink:href="aemd-20111231.xsd#aemd_AccruedLiquidatedDamagesDisclosureTextAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiquidatedDamagesDisclosureTextAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="AccruedLiquidatedDamagesDisclosureText" xlink:href="aemd-20111231.xsd#aemd_AccruedLiquidatedDamagesDisclosureText"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AccruedLiquidatedDamagesDisclosureText" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="OtherLiabilitiesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_OtherLiabilitiesDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherLiabilitiesDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="FairValueDisclosuresTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_FairValueDisclosuresTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityAndShareBasedPaymentsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTableTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000000">
    <loc xlink:type="locator" xlink:label="DeferredRevenueDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_DeferredRevenueDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredRevenueDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000000">
    <loc xlink:type="locator" xlink:label="CommitmentsAndContingenciesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_CommitmentsAndContingenciesDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note0000000000000">
    <loc xlink:type="locator" xlink:label="LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNotesTradeAndOtherReceivablesDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note00000000000000">
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/Note000000000000000">
    <loc xlink:type="locator" xlink:label="SubsequentEventsTextBlockAbstract" xlink:href="aemd-20111231.xsd#aemd_SubsequentEventsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.aethlonmedical.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="aemd-20111231.xsd#aemd_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="15.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 4. NOTES PAYABLE<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 4. NOTES PAYABLE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Notes payable, all current liabilities and unsecured, consist

      of the following at December 31, 2011 and March 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; ">

        <td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

        </td>

        <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">

          December 31, 2011

        </td>

        <td style="padding-bottom: 1pt">

        </td>

        <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">

          March 31, 2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt">

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">

          Principal Balance

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">

          &#160;Accrued Interest

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">

          Principal Balance

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">

          Accrued Interest&#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 40%">

          12% Notes payable, past due

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          185,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          291,377

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          185,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          270,562

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          10% Note payable, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          5,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          6,188

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          5,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          4,875

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td>

          Law Firm Note, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          34,610

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          2,480

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;&#160;&#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;&#160;&#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 1pt">

          Tonaquint Note

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          360,186

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          1,776

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;&#160;&#160;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;&#160;&#160;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-bottom: 2.5pt; text-indent: 27pt">

          Total

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          584,796

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          301,821

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          190,000

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          275,437

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      LAW FIRM NOTE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On August 2 2011, we entered into a Promissory Note with our

      intellectual property law firm for the amount of $49,610,

      which represented the amount we owed to that firm. The

      Promissory Note calls for monthly payments of $5,000 from

      August 2011 through December 2011. From the period August 2

      through December 31, 2011, we made three $5,000 payments, and

      as a result, have reduced the note balance to $34,610 as of

      December 31, 2011. The note bears interest at 10% per annum.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      TONAQUINT NOTE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On June 28, 2011, we entered into a Termination Agreement

      with Tonaquint, Inc. (See Note 5) under which both parties

      agreed that in consideration of the termination of a warrant,

      the waiving of all fees, penalties, the creation of the

      selling program and other factors, we agreed to issue an

      unsecured non-convertible promissory note (the "New Note") in

      the principal amount of $360,186, which provides for annual

      interest at a rate of 6%, payable monthly in either cash or

      our stock, at our option. The New Note has a maturity date of

      April 30, 2012.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A
M,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3=E
M,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N9&5N<V5D7T-O;G-O;&ED871E9%]3=&%T96UE/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3D]415\Q7TY!
M5%5215]/1E]"55-)3D534U]!3D1?/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3D]415\R7TQ)455)1$E463PO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P
M-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DY/5$5?,U]354U-05)97T]&7U-)
M1TY)1DE#04Y47SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DY/5$5?-%].3U1%4U]005E!0DQ%/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^3D]415\U7T-/3E9%4E1)0DQ%7TY/5$537U!!
M64%"/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3D]4
M15\V7T5154E465]44D%.4T%#5$E/3E,\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3$N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y.3U1%7S=?04-#4E5%1%],25%5241!5$5$7T1!
M34$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,3(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.3U1%
M7SA?3U1(15)?0U524D5.5%],24%"24Q)5$D\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y.3U1%7SE?1D%)4E]604Q515]-14%355)%
M345.5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.
M3U1%7S$P7U-43T-+7T-/35!%3E-!5$E/3CPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-2YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/DY/5$5?,3%?5T%24D%.5%,\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.3U1%7S$R7T1!4E!!7T-/
M3E1204-47T%.1%]214P\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3<N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y.3U1%7S$S7T-/34U)5$U%3E137T%.1%]#3TY424X\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,3@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.3U1%7S$S7TY/5$5?
M4D5#14E604),13PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q.2YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DY/5$5?,35?4D5,051%1%]005)42453/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(P+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^3D]415\Q-E]354)315%514Y47T5614Y4
M4SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970R,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@(#PO>#I%>&-E;%=O<FMS:&5E=',^#0H@(#QX.E-T>6QE<VAE970@
M2%)E9CTS1")7;W)K<VAE971S+W)E<&]R="YC<W,B+SX-"B`@/'@Z06-T:79E
M4VAE970^,#PO>#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T<G5C='5R
M93Y&86QS93PO>#I0<F]T96-T4W1R=6-T=7)E/@T*("`\>#I0<F]T96-T5VEN
M9&]W<SY&86QS93PO>#I0<F]T96-T5VEN9&]W<SX-"B`\+W@Z17AC96Q7;W)K
M8F]O:SX-"CPO>&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-
M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC<F]S
M;V9T($5X8V5L(%A0(&]R(&YE=V5R+CPO<#X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC
M7V$S-S@U-S)D,S0R9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y
M-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%5E)!13X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY$;V-U;65N="!!;F0@16YT:71Y($EN9F]R;6%T:6]N("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#$U+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P
M,3`\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1&]C=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;B!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N
M=&ET>2!296=I<W1R86YT($YA;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/D%E=&AL;VX@365D:6-A;"!);F,N/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4>7!E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ,"U1/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#=7)R96YT($9I
M<V-A;"!996%R($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XM+3`S+3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T
M<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q,2PV
M,CDL-S(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%;G1I='D@4'5B;&EC($9L;V%T/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(T+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M96YD;65N="!&;&%G/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#YF86QS93QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-E
M;G1R86P@26YD97@@2V5Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XP,#`P.#@R,CDQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@0W5R<F5N="!297!O<G1I;F<@4W1A='5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y997,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!6
M;VQU;G1A<GD@1FEL97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#Y.;SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YT:71Y($9I;&5R($-A=&5G;W)Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#Y3;6%L;&5R(%)E<&]R=&EN9R!#;VUP86YY/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I
M='D@5V5L;"UK;F]W;B!396%S;VYE9"!)<W-U97(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/DYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!097)I;V0@16YD($1A=&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D1E8R`S,2P-"@D),C`Q
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&]C=6UE;G0@1FES8V%L(%EE87(@1F]C=7,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C(P,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@
M1F]C=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E$S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC9E\S
M8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S
M-#)F+U=O<FMS:&5E=',O4VAE970P,BYH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15%%04<^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0Q/CQS=')O;F<^0V]N<V]L:61A=&5D($)A;&%N8V4@4VAE
M971S("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@87-S971S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,S4T+#@P-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,34L-S`T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$969E<G)E9"!F:6YA;F-I;F<@8V]S=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Y,RPW-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-3<L-S,R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!R96-E:79A
M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#,L,S8W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.
M;W1E(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DEN=&5R97-T(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<L,#DV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O
M=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C8L,C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,CDL-S$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!A<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<U."PQ-S`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,3`L,C0S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]P97)T>2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-3,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-RPW.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A=&5N=',@86YD('!A=&5N=',@
M<&5N9&EN9RP@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,S,L,3`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3,Y+#DX,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5P;W-I=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDL,C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.2PR,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDP,RPP,C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-C<L,C$Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D-U<G)E;G0@3&EA8FEL:71I97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-C,T+#`X,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P."PT,3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1U92!T;R!R
M96QA=&5D('!A<G1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8Q-RPU-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV,3<L-3<P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.;W1E<R!P87EA8FQE/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU.#0L-SDV/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DP+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@
M;F]T97,@<&%Y86)L92P@;F5T(&]F(&1I<V-O=6YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BPT-C(L.#(U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ.#$L.#4R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T
M:79E(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#(U,"PW,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#`P,BPX.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@;&EQ=6ED871E9"!D86UA
M9V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S<L.#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#,W
M+#@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W1H97(@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PP,C(L-#,V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`T+#,X-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-U
M<G)E;G0@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<L,#$P+#(Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8L-30R+#DQ-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N=',@86YD($-O;G1I
M;F=E;F-I97,@*$YO=&4@,3(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH
M;VQD97)S)R!$969I8VET/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R('9A;'5E("0P+C`P,2!P
M97(@<VAA<F4[(#(U,"PP,#`L,#`P('-H87)E<R!A=71H;W)I>F5D(&%S(&]F
M($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"!-87)C:"`S,2P@,C`Q,3L@,3`X+#DW
M-RPU,#@@86YD(#<W+#0V-RPS-C$@<VAA<F5S(&ES<W5E9"!A;F0@;W5T<W1A
M;F1I;F<@87,@;V8@1&5C96UB97(@,S$L(#(P,3$@86YD($UA<F-H(#,Q+"`R
M,#$Q+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P."PY.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW-RPT-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%D9&ET:6]N86P@<&%I9"UI;B!C87!I=&%L
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-2PX-CDL.#<P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#(L
M-#$X+#<W.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&5F:6-I="!A8V-U;75L871E9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-3(L,#@V+#`T,2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T."PT-S$L.30U*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L
M('-T;V-K:&]L9&5R<^*`F2!D969I8VET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@V+#$P-RPQ.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-2PY-S4L-CDX*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&QI86)I
M;&ET:65S(&%N9"!S=&]C:VAO;&1E<G,G(&1E9FEC:70\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@.3`S+#`R,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-38W+#(Q.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?.3=E,#`Y8V9?,V(S
M8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R
M9B]7;W)K<VAE971S+U-H965T,#,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5#14%#/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,3X\<W1R;VYG/D-O;G-O;&ED871E9"!"86QA;F-E(%-H965T
M<R`H4&%R96YT:&5T:6-A;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@
M<&%R('9A;'5E("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O
M8VL@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(U,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!I
M<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P."PY-S<L
M-3`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-S<L-#8W+#,V,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(&]U='-T86YD:6YG/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#@L.3<W+#4P.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<W+#0V-RPS
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW
M93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R9@T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A
M,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E=#`T+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M44Q!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VYS;VQI9&%T960@4W1A
M=&5M96YT<R!O9B!/<&5R871I;VYS("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E)%5D5.5453/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D=O=F5R;FUE;G0@8V]N=')A8W0@<F5V96YU93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y-3@L,#<U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y-3@L,#<U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D]015)!5$E.1R!%6%!%3E-%4SPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]F97-S:6]N86P@9F5E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#(W+#0Q.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X-BPX,C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`S
M-RPV,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX.#DL,38Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y087ER;VQL+"!C;VYS=6QT:6YG(&%N9"!R96QA=&5D
M('-E<G9I8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.#<L
M.34Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-3,T+#<T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L-34S+#4Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L,S4P+#@R-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N97)A;"!A;F0@861M
M:6YI<W1R871I=F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X
M-"PP,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,C4L,3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C(S+#<Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,W."PW,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O<&5R871I;F<@
M97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,CDY
M+#0P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,#0V+#<P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,L,C$T+#@S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-C$X+#8X-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]015)!5$E.1R!,
M3U-3/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-#$L,S(X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M,#0V+#<P,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@R+#(U-BPW-C0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,RPV,3@L-C@W*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/5$A%4B!%
M6%!%3E-%("A)3D-/344I/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DQO<W,@;VX@97AT:6YG=6ES:&UE;G0@;V8@9&5B=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38S+#`Q.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,3@Y+#DT
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3&]S<R!O;B!S971T;&5M96YT(&]F(&%C8W)U960@:6YT97)E<W0@86YD
M(&1A;6%G97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X+#<P
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^*$=A:6XI(&]N(&-H86YG92!I;B!F86ER('9A;'5E(&]F(&1E<FEV871I
M=F4@;&EA8FEL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W
M-"PY-#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-#,P+#`W-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q+#4Y-BPT-#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPP.3@L.34T*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@
M86YD(&]T:&5R(&1E8G0@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,P."PS.#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU.30L,3(X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU.30L-3(V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPS-#8L,C0W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M;G1E<F5S="!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#4V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#4L-3DY*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#DS."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q.2PT.38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,S`P+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-C`L,3@U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;W1H97(@
M97AP96YS92`H:6YC;VUE*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C,S+#,Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@R,2PT-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#,U-RPS,S$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#0X-BPT-#(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.150@3$]3
M4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U-S0L-S$X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,2PX-C@L,3<Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H,RPV,30L,#DU*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H."PQ,#4L,3(Y*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0D%324,@04Y$
M($1)3%54140@3$]34R!015(@0T]-34].(%-(05)%("AI;B!$;VQL87)S('!E
M<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XP
M,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#`N,#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@P+C`T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,"XQ,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=%24=(5$5$($%615)!1T4@3E5-
M0D52($]&($-/34U/3B!32$%215,@3U544U1!3D1)3D<@XH"3($)!4TE#($%.
M1"!$24Q55$5$("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,#<L,#8Q+#,Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<P+#DQ."PT.3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY."PR,#(L,#4Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C<L.3DQ
M+#0S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDW93`P.6-F7S-B,V)?-#0T95]B-SEC
M7V$S-S@U-S)D,S0R9B]7;W)K<VAE971S+U-H965T,#4N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5#6D%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;F1E;G-E9"!#;VYS
M;VQI9&%T960@4W1A=&5M96YT<R!O9B!#87-H($9L;W=S("A54T0@)"D\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$P
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D-A<V@@9FQO=W,@9G)O;2!O<&5R871I;F<@86-T:79I=&EE<SH\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,RPV,30L,#DU*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M."PQ,#4L,3(Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#@U.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#,P,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O
M8VL@8F%S960@8V]M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV,#DL-3`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PU.3DL.3$U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;W-S(&]N(&1E8G0@97AT:6YG
M=6ES:&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,3@Y
M+#DT,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F%I<B!M87)K970@=F%L=64@;V8@8V]N9&ET:6]N86P@=V%R<F%N
M=',@=&AA="!S=6)S97%U96YT;'D@=V5R92!I<W-U960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<T+#8U,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]N(&-A<V@@:6YT97)E<W0@
M97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,X+#<S
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L-CDV+#`U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1F%I<B!M87)K970@=F%L=64@;V8@8V]M;6]N('-T;V-K
M+"!W87)R86YT<R!A;F0@;W!T:6]N<R!I<W-U960@9F]R('-E<G9I8V5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,C@L,S(W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3DP+#<S-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0VAA;F=E(&EN(&9A:7(@=F%L=64@;V8@9&5R:79A=&EV92!L:6%B:6QI=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PU.38L-#0R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L
M,#DX+#DU-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DES<W5A;F-E(&]F(&YO=&4@:6X@8V]N=F5R=&EB;&4@;F]T
M92!T97)M:6YA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S8P+#$X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06UO<G1I>F%T:6]N(&]F(&1E8G0@9&ES8V]U;G0@86YD(&1E
M9F5R<F5D(&9I;F%N8VEN9R!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PW,#,L,C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PS,#$L,#$T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-H86YG97,@
M:6X@;W!E<F%T:6YG(&%S<V5T<R!A;F0@;&EA8FEL:71I97,Z/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S(')E
M8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$X,RPS
M-C<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O=&AE<B!A<W-E=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#4U-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R+#(V,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C;W5N
M=',@<&%Y86)L92!A;F0@;W1H97(@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S(X+#0S,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,BPR-#8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1U
M92!T;R!R96QA=&5D('!A<G1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('5S960@:6X@;W!E<F%T:6YG(&%C
M=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,3`Q
M+#`X-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#4Q,BPY-C0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O;2!I;G9E
M<W1I;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4'5R8VAA<V5S(&]F('!R;W!E<G1Y(&%N9"!E<75I
M<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-S,U*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L
M-30Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^061D:71I;VYS('1O('!A=&5N=',@86YD('!A=&5N=',@<&5N9&EN
M9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BPX,#4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&-A<V@@=7-E9"!I;B!I;G9E<W1I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,2PW,S4I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.2PS-#8I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A
M<V@@9FQO=W,@9G)O;2!F:6YA;F-I;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')I;F-I<&%L(')E
M<&%Y;65N=',@;V8@;F]T97,@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,34L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T('!R;V-E961S(&9R;VT@=&AE(&ES
M<W5A;F-E(&]F(&-O;G9E<G1I8FQE(&YO=&5S('!A>6%B;&4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C4V+#DR,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,3`U+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!T:&4@:7-S=6%N8V4@;V8@8V]M;6]N('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.#,L-C`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F
M<F]M(&-O;&QE8W1I;VX@;V8@<V5C=7)E9"!N;W1E<R!R96-E:79A8FQE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!C87-H('!R;W9I9&5D(&)Y(&9I;F%N8VEN9R!A8W1I=FET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0T,2PY,C$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8X."PV
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@:6YC<F5A<V4@:6X@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S,Y+#$P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$V-BPR.3`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@870@8F5G:6YN:6YG
M(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L
M-S`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-C<L.34P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87-H(&%T(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,U-"PX,#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S0L,C0P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A
M<V@@<&%I9"!D=7)I;F<@=&AE('!E<FEO9"!F;W(Z/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#8S-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE('1A>&5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D1E<FEV871I=F4@;&EA8FEL:71I97,@<F5C;W)D960@:6X@
M8V]N;F5C=&EO;B!W:71H(&5M8F5D9&5D(&-O;G9E<G-I;VX@9F5A='5R92!O
M9B!C;VYV97)T:6)L92!N;W1E<R!A;F0O;W(@=V%R<F%N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8L.3@P+#,T-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5B="!A;F0@86-C
M<G5E9"!I;G1E<F5S="!C;VYV97)T960@=&\@8V]M;6]N('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@Q,BPS.#8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`W-2PU-3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E8G0@9&ES8V]U;G0@<F5C;W)D960@:6X@8V]N;F5C=&EO;B!W:71H(&)E
M;F5F:6-I86P@8V]N=F5R<VEO;B!F96%T=7)E(&]F(&-O;G9E<G1I8FQE(&YO
M=&5S(&%N9"!R96QA=&5D('=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#`S-RPY,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<P."PV,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O
M;G9E<G1I8FQE(&YO=&5S(&EN('-E='1L96UE;G0@;V8@86-C<G5E9"!L96=A
M;"!F965S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-2PT-CD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E8VQA<W-I9FEC871I;VX@;V8@=V%R<F%N="!D97)I=F%T:79E(&QI86)I
M;&ET>2!I;G1O(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C8S+#8X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^27-S=6%N8V4@;V8@<VAA<F5S(&EN(&-O;FYE8W1I;VX@
M=VET:"!R97-T<FEC=&5D('-T;V-K(&=R86YT('1O(&]F9FEC97(\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-C`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC9E\S8C-B7S0T-&5?
M8C<Y8U]A,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F+U=O<FMS
M:&5E=',O4VAE970P-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/DY/5$4@,2X@3D%455)%($]&($)54TE.15-3($%.1"!"05-)
M4R!/1B!04D5314Y4051)3TX\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W)G86YI>F%T:6]N+"!#;VYS;VQI9&%T:6]N(&%N9"!0
M<F5S96YT871I;VX@;V8@1FEN86YC:6%L(%-T871E;65N=',@1&ES8VQO<W5R
M92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@(`T*("`@("`@3D]412`Q+B!.0515
M4D4@3T8@0E5324Y%4U,@04Y$($)!4TE3($]&(%!215-%3E1!5$E/3@T*("`@
M(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*
M("`@("`@065T:&QO;B!-961I8V%L+"!);F,N("@B065T:&QO;B(L('1H92`B
M0V]M<&%N>2(L(")W92(@;W(-"B`@(`T*("`@("`@(G5S(BD@:7,@82!M961I
M8V%L(&1E=FEC92!C;VUP86YY(&9O8W5S960@;VX@8W)E871I;F<-"B`@("`@
M#0H@("`@("!I;FYO=F%T:79E(&1E=FEC97,@=&AA="!A9&1R97-S('5N;65T
M(&UE9&EC86P@;F5E9',@:6X-"B`-"B`@("`@(&-A;F-E<BP@:6YF96-T:6]U
M<R!D:7-E87-E(&%N9"!O=&AE<B!L:69E+71H<F5A=&5N:6YG#0H@("`@(`T*
M("`@("`@8V]N9&ET:6]N<RX@070@=&AE(&-O<F4@;V8@;W5R(&1E=F5L;W!M
M96YT<R!I<R!T:&4@065T:&QO;@T*("`@("`-"B`@("`@($%$05!4)B,X-#@R
M.R`H061A<'1I=F4@1&EA;'ES:7,M3&EK92!!9F9I;FET>2!0;&%T9F]R;0T*
M("`@("`-"B`@("`@(%1E8VAN;VQO9WDI('-Y<W1E;2P@82!M961I8V%L(&1E
M=FEC92!P;&%T9F]R;2!T:&%T(&-O;G9E<F=E<PT*("`-"B`@("`@('-I;F=L
M92!O<B!M=6QT:7!L92!A9F9I;FET>2!D<G5G(&%G96YT<R!W:71H(&%D=F%N
M8V5D('!L87-M80T*("`-"B`@("`@(&UE;6)R86YE('1E8VAN;VQO9WD@=&\@
M8W)E871E('1H97)A<&5U=&EC(&9I;'1R871I;VX@9&5V:6-E<PT*("`-"B`@
M("`@('1H870@<V5L96-T:79E;'D@<F5M;W9E(&AA<FUF=6P@<&%R=&EC;&5S
M(&9R;VT@=&AE(&5N=&ER90T*("`@(`T*("`@("`@8VER8W5L871O<GD@<WES
M=&5M('=I=&AO=70@;&]S<R!O9B!E<W-E;G1I86P@8FQO;V0-"B`@#0H@("`@
M("!C;VUP;VYE;G1S+B!!<'!R;W9A;"!T;R!E;6)A<FL@;VX@:'5M86X@=')I
M86QS(&ES('-T:6QL#0H@(`T*("`@("`@;F5E9&5D('1O(')E86-H(&-O;6UE
M<F-I86P@=FEA8FEL:71Y(&]F('1H90T*("`@("`-"B`@("`@($AE;6]P=7)I
M9FEE<B8C,3<T.R!A;F0@87!P<F]V86P@8GD@=&AE(%4N4RX@1F]O9"!A;F0@
M1')U9PT*("`@#0H@("`@("!!9&UI;FES=')A=&EO;B`H(D9$02(I+B!3=6-C
M97-S9G5L(&]U=&-O;65S(&]F(&AU;6%N('1R:6%L<PT*(`T*("`@("`@=VEL
M;"!B92!R97%U:7)E9"!B>2!T:&4@<F5G=6QA=&]R>2!A9V5N8VEE<R!O9B!C
M97)T86EN#0H@#0H@("`@("!F;W)E:6=N(&-O=6YT<FEE<R!W:&5R92!W92!I
M;G1E;F0@=&\@<V5L;"!T:&ES(&1E=FEC92X@5V4-"B`@("`-"B`@("`@(&AA
M=F4@<W5B;6ET=&5D(&%N($EN=F5S=&EG871I;VYA;"!$979I8V4@17AE;7!T
M:6]N("@B241%(BD@=&\-"B`@(`T*("`@("`@=&AE($9$02X@4V]M92!O9B!O
M=7(@<&%T96YT<R!M87D@97AP:7)E(&)E9F]R92!&1$$@87!P<F]V86P-"B`-
M"B`@("`@(&]R(&%P<')O=F%L(&EN(&$@9F]R96EG;B!C;W5N=')Y+"!I9B!A
M;GDL(&ES(&]B=&%I;F5D+@T*(`T*("`@("`@2&]W979E<BP@=V4@8F5L:65V
M92!T:&%T(&-E<G1A:6X@<&%T96YT(&%P<&QI8V%T:6]N<R!A;F0O;W(-"B`-
M"B`@("`@(&]T:&5R('!A=&5N=',@:7-S=65D(&UO<F4@<F5C96YT;'D@=VEL
M;"!H96QP('!R;W1E8W0@=&AE#0H@("`-"B`@("`@('!R;W!R:65T87)Y(&YA
M='5R92!O9B!T:&4@2&5M;W!U<FEF:65R*%(I('1R96%T;65N=`T*("`@#0H@
M("`@("!T96-H;F]L;V=Y+@T*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!);B!P<FEO<B!P97)I;V1S+"!!
M971H;&]N('=A<R!C;&%S<VEF:65D(&%S(&$@9&5V96QO<&UE;G0-"B`@("`-
M"B`@("`@('-T86=E(&5N=&5R<')I<V4@=6YD97(@86-C;W5N=&EN9R!P<FEN
M8VEP;&5S(&=E;F5R86QL>0T*(`T*("`@("`@86-C97!T960@:6X@=&AE(%5N
M:71E9"!3=&%T97,@;V8@06UE<FEC82`H(D=!05`B*2!A<R!I="!H860-"B`-
M"B`@("`@(&YO="!G96YE<F%T960@<F5V96YU97,@9G)O;2!I=',@<&QA;FYE
M9"!P<FEN8VEP86P@;W!E<F%T:6]N<RX-"B`@(`T*("`@("`@26X@=&AE('1H
M<F5E(&UO;G1H<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2P@=V4@8F5G86X@
M=&\-"B`@(`T*("`@("`@9V5N97)A=&4@<F5V96YU97,@9G)O;2!A(&=O=F5R
M;FUE;G0@8V]N=')A8W0@86YD(&AA=F4@96UE<F=E9`T*("`@#0H@("`@("!F
M<F]M('1H92!D979E;&]P;65N="!S=&%G92X@4W5B<V5Q=65N="!T;R!$96-E
M;6)E<B`S,2P@,C`Q,2P-"B`@#0H@("`@("!W92!R96-O<F1E9"!T:&4@9FER
M<W0@8V]M;65R8VEA;"!S:&EP;65N="!O9B!O;F4@;V8@;W5R#0H@(`T*("`@
M("`@<')O9'5C=',@=&\@82!L:69E('-C:65N8V5S(&-O;7!A;GD@9F]R(&1I
M86=N;W-T:6-S('5S92X-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3W5R(&-O;6UO;B!S=&]C:R!I<R!Q
M=6]T960@;VX@=&AE($]V97(M=&AE+4-O=6YT97(@0G5L;&5T:6X-"B`-"B`@
M("`@($)O87)D(&%D;6EN:7-T97)E9"!B>2!T:&4@1FEN86YC:6%L($EN9'5S
M=')Y(%)E9W5L871O<GD-"B`@#0H@("`@("!!=71H;W)I='D@*")/5$-"0B(I
M('5N9&5R('1H92!S>6UB;VP@(D%%340N3T(N(@T*("`@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5&AE(&%C
M8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!F
M:6YA;F-I86P-"B`-"B`@("`@('-T871E;65N=',@:&%V92!B965N('!R97!A
M<F5D(&EN(&%C8V]R9&%N8V4@=VET:"!'04%0(&9O<@T*("`@(`T*("`@("`@
M:6YT97)I;2!F:6YA;F-I86P@:6YF;W)M871I;VX@86YD('=I=&@@=&AE(&EN
M<W1R=6-T:6]N<R!T;PT*("`@("`-"B`@("`@($9O<FT@,3`M42!A;F0@87!P
M;&EC86)L92!S96-T:6]N<R!O9B!296=U;&%T:6]N(%,M6"X-"B`@("`-"B`@
M("`@($%C8V]R9&EN9VQY+"!T:&5Y(&1O(&YO="!I;F-L=61E(&%L;"!O9B!T
M:&4@:6YF;W)M871I;VX@86YD#0H@#0H@("`@("!F;V]T;F]T97,@<F5Q=6ER
M960@8GD@1T%!4"!F;W(@8V]M<&QE=&4@9FEN86YC:6%L('-T871E;65N=',N
M#0H@("`-"B`@("`@($EN('1H92!O<&EN:6]N(&]F(&UA;F%G96UE;G0L(&%L
M;"!A9&IU<W1M96YT<R8C,38P.VYE8V5S<V%R>0T*(`T*("`@("`@=&\@;6%K
M92!T:&4@9FEN86YC:6%L('-T871E;65N=',@;F]T(&UI<VQE861I;F<@:&%V
M92!B965N#0H@("`@#0H@("`@("!I;F-L=61E9"X@5&AE(&-O;F1E;G-E9"!C
M;VYS;VQI9&%T960@8F%L86YC92!S:&5E="!A<R!O9@T*("`@#0H@("`@("!-
M87)C:"`S,2P@,C`Q,2!W87,@9&5R:79E9"!F<F]M(&]U<B!A=61I=&5D(&9I
M;F%N8VEA;`T*("`@("`-"B`@("`@('-T871E;65N=',N($]P97)A=&EN9R!R
M97-U;'1S(&9O<B!T:&4@;FEN92!M;VYT:',@96YD960-"B`@#0H@("`@("!$
M96-E;6)E<B`S,2P@,C`Q,2!A<F4@;F]T(&YE8V5S<V%R:6QY(&EN9&EC871I
M=F4@;V8@=&AE#0H@(`T*("`@("`@<F5S=6QT<R!T:&%T(&UA>2!B92!E>'!E
M8W1E9"!F;W(@=&AE('EE87(@96YD:6YG($UA<F-H(#,Q+`T*("`@("`-"B`@
M("`@(#(P,3(N($9O<B!F=7)T:&5R(&EN9F]R;6%T:6]N+"!R969E<B!T;R!O
M=7(@06YN=6%L(%)E<&]R="!O;@T*("`-"B`@("`@($9O<FT@,3`M2R!F;W(@
M=&AE('EE87(@96YD960@36%R8V@@,S$L(#(P,3$L('=H:6-H(&EN8VQU9&5S
M#0H@#0H@("`@("!A=61I=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N9"!F
M;V]T;F]T97,@87,@;V8@36%R8V@@,S$L#0H@("`@(`T*("`@("`@,C`Q,2!A
M;F0@9F]R('1H92!Y96%R<R!E;F1E9"!-87)C:"`S,2P@,C`Q,2!A;F0@,C`Q
M,"!A;F0@=&AE#0H@(`T*("`@("`@<&5R:6]D($IA;G5A<GD@,S$L(#$Y.#0@
M*$EN8V5P=&EO;BD@=&AR;W5G:"!-87)C:"`S,2P@,C`Q,2X-"B`-"B`@("`\
M+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R9@T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC9E\S8C-B7S0T-&5?
M8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E=#`W+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3D]412`R+B!,25%5
M241)5%D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&EQ=6ED:71Y($1I<V-L;W-U<F4@6U!O;&EC>2!497AT($)L;V-K73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!.3U1%(#(N($Q)455)1$E460T*("`@(`T*("`@
M(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@
M5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P-"B`-"B`@("`@('-T871E;65N=',@:&%V92!B965N
M('!R97!A<F5D(&]N(&$@9V]I;F<@8V]N8V5R;B!B87-I<RP@=VAI8V@-"B`@
M(`T*("`@("`@8V]N=&5M<&QA=&5S+"!A;6]N9R!O=&AE<B!T:&EN9W,L('1H
M92!R96%L:7IA=&EO;B!O9B!A<W-E=',-"B`-"B`@("`@(&%N9"!T:&4@<V%T
M:7-F86-T:6]N(&]F(&QI86)I;&ET:65S(&EN('1H92!O<F1I;F%R>2!C;W5R
M<V4@;V8-"B`@(`T*("`@("`@8G5S:6YE<W,N(%=E(&AA=F4@97AP97)I96YC
M960@8V]N=&EN=6EN9R!L;W-S97,@9G)O;0T*("`@(`T*("`@("`@;W!E<F%T
M:6]N<RP@87)E(&EN(&1E9F%U;'0@;VX@8V5R=&%I;B!D96)T+"!H879E(&YE
M9V%T:79E#0H@("`@#0H@("`@("!W;W)K:6YG(&-A<&ET86P@;V8@87!P<F]X
M:6UA=&5L>2`D-BPR-3(L,#`P+"!R96-U<G)I;F<@;&]S<V5S#0H@("`-"B`@
M("`@(&9R;VT@;W!E<F%T:6]N<R!A;F0@86X@86-C=6UU;&%T960@9&5F:6-I
M="!O9B!A<'!R;WAI;6%T96QY#0H@#0H@("`@("`D-3(L,#@V+#`P,"!A="!$
M96-E;6)E<B`S,2P@,C`Q,2P@=VAI8V@@86UO;F<@;W1H97(@;6%T=&5R<RP-
M"B`@#0H@("`@("!R86ES97,@<VEG;FEF:6-A;G0@9&]U8G0@86)O=70@;W5R
M(&%B:6QI='D@=&\@8V]N=&EN=64@87,@80T*(`T*("`@("`@9V]I;F<@8V]N
M8V5R;BX@5V4@:&%V92!N;W0@9V5N97)A=&5D('-I9VYI9FEC86YT(')E=F5N
M=64@;W(-"B`-"B`@("`@(&%N>2!P<F]F:70@9G)O;2!O<&5R871I;VYS('-I
M;F-E(&EN8V5P=&EO;BX@02!S:6=N:69I8V%N=`T*("`@(`T*("`@("`@86UO
M=6YT(&]F(&%D9&ET:6]N86P@8V%P:71A;"!W:6QL(&)E(&YE8V5S<V%R>2!T
M;R!A9'9A;F-E('1H90T*("`@#0H@("`@("!D979E;&]P;65N="!O9B!O=7(@
M<')O9'5C=',@=&\@=&AE('!O:6YT(&%T('=H:6-H('1H97D@;6%Y#0H@("`@
M(`T*("`@("`@8F5C;VUE(&-O;6UE<F-I86QL>2!V:6%B;&4N($]U<B!C=7)R
M96YT(&9I;F%N8VEA;"!R97-O=7)C97,-"B`-"B`@("`@(&%R92!I;G-U9F9I
M8VEE;G0@=&\@9G5N9"!O=7(@8V%P:71A;"!E>'!E;F1I='5R97,L('=O<FMI
M;F<-"B`@("`@#0H@("`@("!C87!I=&%L(&%N9"!O=&AE<B!C87-H(')E<75I
M<F5M96YT<R`H8V]N<VES=&EN9R!O9B!A8V-O=6YT<PT*(`T*("`@("`@<&%Y
M86)L92P@86-C<G5E9"!L:6%B:6QI=&EE<RP@86UO=6YT<R!D=64@=&\@<F5L
M871E9"!P87)T:65S#0H@(`T*("`@("`@86YD(&%M;W5N=',@9'5E('5N9&5R
M('9A<FEO=7,@;F]T97,@<&%Y86)L92D@9F]R('1H92!F:7-C86P-"B`-"B`@
M("`@('EE87(@96YD:6YG($UA<F-H(#,Q+"`R,#$R("@B9FES8V%L(#(P,3(B
M*2X@5&AE<F5F;W)E('=E('=I;&P-"B`@(`T*("`@("`@8F4@<F5Q=6ER960@
M=&\@<V5E:R!A9&1I=&EO;F%L(&9U;F1S('1H<F]U9V@@9&5B="!A;F0O;W(-
M"B`@(`T*("`@("`@97%U:71Y(&9I;F%N8VEN9R!A<G)A;F=E;65N=',@=&\@
M9FEN86YC92!O=7(@8W5R<F5N="!A;F0-"B`@(`T*("`@("`@;&]N9RUT97)M
M(&]P97)A=&EO;G,N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`@,"`Q,'!T)SX-"B`@#0H@("`@("`\9F]N="!S='EL93TS1"=C;VQO
M<CH@8FQA8VLG/D]N(%-E<'1E;6)E<B`S,"P@,C`Q,2P@=V4\+V9O;G0^#0H@
M("`-"B`@("`@(&5N=&5R960@:6YT;R!A(&-O;G1R86-T('=I=&@@=&AE(%5N
M:71E9"!3=&%T97,@;V8@06UE<FEC82P-"B`@("`@#0H@("`@("!I<W-U960@
M8GD@4U!!5T%2(%-Y<W1E;7,@0V5N=&5R(%!A8VEF:6,L('!U<G-U86YT('1O
M(&$-"B`-"B`@("`@(&-O;G1R86-T(&%W87)D(&9R;VT@=&AE($1E9F5N<V4@
M061V86YC960@4F5S96%R8V@@4')O:F5C=',-"B`@("`@#0H@("`@("!!9V5N
M8WD@*"8C.#(R,#M$05)0028C.#(R,3LI+B!5;F1E<B!T:&4@1$%24$$@87=A
M<F0L('=E(&AA=F4-"B`@("`@#0H@("`@("!B965N(&5N9V%G960@=&\@9&5V
M96QO<"!A('1H97)A<&5U=&EC(&1E=FEC92!T;R!R961U8V4@=&AE#0H@("`@
M(`T*("`@("`@:6YC:61E;F-E(&]F('-E<'-I<RP@82!F871A;"!B;&]O9'-T
M<F5A;2!I;F9E8W1I;VX@=&AA="!O9G1E;@T*("`@#0H@("`@("!R97-U;'1S
M(&EN('1H92!D96%T:"!O9B!C;VUB870M:6YJ=7)E9"!S;VQD:65R<RX@5&AE
M(&%W87)D#0H@("`@(`T*("`@("`@9G)O;2!$05)002!I<R!A(&9I>&5D+7!R
M:6-E(&-O;G1R86-T('=I=&@@<&]T96YT:6%L('1O=&%L#0H@("`@#0H@("`@
M("!P87EM96YT<R!T;R!U<R!O9B`D-BPW.30L,S@Y(&]V97(@=&AE(&-O=7)S
M92!O9B!F:79E('EE87)S+`T*(`T*("`@("`@:6YC;'5D:6YG('!A>6UE;G1S
M(&]F('5P('1O("0Q+#DW-2PP-#<@:6X@=&AE(&9I<G-T('EE87(N#0H@("`@
M#0H@("`@("!&:7AE9"!P<FEC92!C;VYT<F%C=',@<F5Q=6ER92!T:&4@86-H
M:65V96UE;G0@;V8@;75L=&EP;&4L#0H@("`@(`T*("`@("`@:6YC<F5M96YT
M86P@;6EL97-T;VYE<R!T;R!R96-E:79E('1H92!F=6QL(&%W87)D(&1U<FEN
M9R!E86-H#0H@(`T*("`@("`@>65A<B!O9B!T:&4@8V]N=')A8W0N)B,Q-C`[
M)B,Q-C`[56YD97(@=&AE('1E<FUS(&]F('1H90T*("`@("`-"B`@("`@(&-O
M;G1R86-T+"!W92!W:6QL('!E<F9O<FT@8V5R=&%I;B!I;F-R96UE;G1A;"!W
M;W)K('1O=V%R9',-"B`@("`@#0H@("`@("!T:&4@86-H:65V96UE;G0@;V8@
M<W!E8VEF:6,@;6EL97-T;VYE<R!A9V%I;G-T('=H:6-H('=E('=I;&P-"B`@
M#0H@("`@("!I;G9O:6-E('1H92!G;W9E<FYM96YT(&9O<B!F:7AE9"!P87EM
M96YT#0H@(`T*("`@("`@86UO=6YT<RXF(S$V,#LF(S$V,#M!<W-U;6EN9R!A
M;&P@<W5C:"!W;W)K(&ES('!E<F9O<FUE9`T*("`@("`-"B`@("`@(&%C8V]R
M9&EN9R!T;R!T:&4@8V]N=')A8W0@=&5R;7,L('=E('=I;&P@<F5C96EV92!U
M<"!T;PT*(`T*("`@("`@)#$L.3<U+#`T-R!O9B!C;VYT<F%C="!P87EM96YT
M<R!D=7)I;F<@=&AE(&9I<G-T('1W96QV90T*("`-"B`@("`@(&UO;G1H<R!O
M9B!T:&4@8V]N=')A8W0@=VET:"!T:&4@86=G<F5G871E('!A>6UE;G0@86UO
M=6YT<R!I;@T*("`-"B`@("`@('EE87)S('1W;R!T:')O=6=H(&9I=F4@=F%R
M>6EN9R!B971W965N(&%P<')O>&EM871E;'D@)#<W-2PP,#`-"B`@(`T*("`@
M("`@86YD("0Q+C8@;6EL;&EO;B!P97(@>65A<BX@1$%24$$@:&%S('1H92!O
M<'1I;VX@=&\@97AT96YD('1H90T*("`@#0H@("`@("!C;VYT<F%C="!F;W(@
M>65A<G,@='=O('1H<F]U9V@@9FEV92X@3VYL>2!T:&4@9FER<W0@>65A<B!O
M9@T*(`T*("`@("`@=&AE(&-O;G1R86-T(')E;&%T960@=&\@=&AE("0Q+#DW
M-2PP-#<@:&%S(&)E96X@9F]R;6%L;'D-"B`@(`T*("`@("`@96YT97)E9"!I
M;G1O(&%S(&]F('1H92!D871E(&]F('1H:7,@1F]R;2`Q,"U1(&9I;&EN9RX@
M5&AE#0H@("`@#0H@("`@("!M:6QE<W1O;F5S(&%R92!C;VUP<FES960@;V8@
M<&QA;FYI;F<L(&5N9VEN965R:6YG(&%N9`T*("`@("`-"B`@("`@(&-L:6YI
M8V%L('1A<F=E=',L('1H92!A8VAI979E;65N="!O9B!W:&EC:"!I;B!S;VUE
M(&-A<V5S('=I;&P-"B`@(`T*("`@("`@<F5Q=6ER92!T:&4@<&%R=&EC:7!A
M=&EO;B!A;F0@8V]N=')I8G5T:6]N(&]F('1H:7)D('!A<G1Y#0H@("`@#0H@
M("`@("!P87)T:6-I<&%N=',@=6YD97(@=&AE(&-O;G1R86-T+B8C,38P.R8C
M,38P.U1H97)E(&-A;B!B92!N;PT*("`@(`T*("`@("`@87-S=7)A;F-E('1H
M870@=V4@86QO;F4L(&]R('=I=&@@=&AI<F0@<&%R='D@<&%R=&EC:7!A;G1S
M+`T*("`@("`-"B`@("`@('=I;&P@;65E="!S=6-H(&UI;&5S=&]N97,@=&\@
M=&AE('-A=&ES9F%C=&EO;B!O9B!T:&4-"B`@("`-"B`@("`@(&=O=F5R;FUE
M;G0@86YD(&EN(&-O;7!L:6%N8V4@=VET:"!T:&4@=&5R;7,@;V8@=&AE(&-O
M;G1R86-T#0H@#0H@("`@("!O<B!T:&%T('=E('=I;&P@8F4@<&%I9"!T:&4@
M9G5L;"!A;6]U;G0@;V8@=&AE(&-O;G1R86-T#0H@(`T*("`@("`@<F5V96YU
M97,@9'5R:6YG(&%N>2!Y96%R(&]F('1H92!C;VYT<F%C="!T97)M+B8C,38P
M.R8C,38P.U=E#0H@("`@(`T*("`@("`@8V]M;65N8V5D('=O<FL@=6YD97(@
M=&AE(&-O;G1R86-T(&EN($]C=&]B97(@,C`Q,2`H4V5E(&)E;&]W#0H@(`T*
M("`@("`@86YD($YO=&4@,3(@9F]R(&%D9&ET:6]N86P@:6YF;W)M871I;VX@
M<F5G87)D:6YG(')E=F5N=64-"B`@(`T*("`@("`@<F5C;V=N:71I;VXI+@T*
M("`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@
M("`-"B`@("`@($%S(&]F($1E8V5M8F5R(#,Q+"`R,#$Q+"!W92!R96-E:79E
M9"!T=V\@:6YI=&EA;"!P87EM96YT<PT*("`@(`T*("`@("`@=6YD97(@=&AE
M($1!4E!!(&-O;G1R86-T('1O=&%L:6YG("0W-S0L-S`X(&%N9"!B:6QL960@
M=&AE#0H@("`@#0H@("`@("!G;W9E<FYM96YT(&9O<B!A('1H:7)D(&EN=F]I
M8V4@:6X@=&AE(&%M;W5N="!O9B`D,3@S+#,V-RP-"B`@("`-"B`@("`@('=H
M:6-H(&ES('-H;W=N(&%S(&%N(&%C8V]U;G0@<F5C96EV86)L92!O;B!T:&4@
M86-C;VUP86YY:6YG#0H@#0H@("`@("!B86QA;F-E('-H965T("X-"B`@#0H@
M("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@
M("`\9F]N="!S='EL93TS1"=C;VQO<CH@8FQA8VLG/D%L<V\@9'5R:6YG('1H
M92!T:')E92!M;VYT:',@96YD960-"B`@("`-"B`@("`@($1E8V5M8F5R(#,Q
M+"`R,#$Q+"!W92!R86ES960@86X@861D:71I;VYA;"`D,S@T+#(V-2!I;B!N
M970-"B`@("`@#0H@("`@("!P<F]C965D<R!F<F]M(&$@8G)I9&=E(&9I;F%N
M8VEN9R!T:&%T(&UA>2!Y:65L9"!U<"!T;R`D,0T*("`@#0H@("`@("!M:6QL
M:6]N(&EN('1O=&%L(&=R;W-S('!R;V-E961S('1H<F]U9V@@=&AE('!R:79A
M=&4@<&QA8V5M96YT#0H@("`-"B`@("`@(&]F/"]F;VYT/B!C;VYV97)T:6)L
M92!P<F]M:7-S;W)Y(&YO=&5S(&%N9"!C;W)R97-P;VYD:6YG#0H@("`@#0H@
M("`@("!W87)R86YT<R!W:71H(&%C8W)E9&ET960@:6YV97-T;W)S("AS964@
M3F]T92`U("8C.#(Q,3L-"B`@("`@#0H@("`@("!#;VYV97)T:6)L92!.;W1E
M<R!F;W(@;6]R92!D971A:6QS(&]F('1H:7,@;V9F97)I;F<I(#QF;VYT('-T
M>6QE/3-$)V-O;&]R.B!B;&%C:R<^<&5R('1H92!T97)M<R!O9B!T:&4@<W5B
M<V-R:7!T:6]N#0H@#0H@("`@("!A9W)E96UE;G0N/"]F;VYT/@T*("`@("`-
M"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@
M("`@($EN(&%D9&ET:6]N('1O('1H92!F=6YD<R!R96-E:79E9"!T;R!D871E
M('5N9&5R('1H92!$05)000T*("`@(`T*("`@("`@8V]N=')A8W0@86YD('5N
M9&5R('1H92!B<FED9V4@9FEN86YC:6YG(&%N9"!B97EO;F0@9G5T=7)E#0H@
M("`@#0H@("`@("!F=6YD:6YG<R!U;F1E<B!T:&4@1$%24$$@8V]N=')A8W0L
M('=E('=I;&P@<F5Q=6ER92!A9&1I=&EO;F%L#0H@("`-"B`@("`@(&-A<&ET
M86P@87,@;W5R(&-U<G)E;G0@9FEN86YC:6%L(')E<V]U<F-E<RP@=VAI;&4@
M:6UP<F]V960L#0H@#0H@("`@("!R96UA:6X@:6YS=69F:6-I96YT('1O(&9U
M;F0@;W5R('=O<FMI;F<@8V%P:71A;"!A;F0@;W1H97(-"B`@("`-"B`@("`@
M(&-A<V@@<F5Q=6ER96UE;G1S(&9O<B!T:&4@<F5M86EN9&5R(&]F(&]U<B!F
M:7-C86P@>65A<B!E;F1I;F<-"B`@(`T*("`@("`@36%R8V@@,S$L(#(P,3(N
M(%1H97)E9F]R92!W92!W:6QL(&)E(')E<75I<F5D('1O('-E96L-"B`@("`@
M#0H@("`@("!A9&1I=&EO;F%L(&9U;F1S('1H<F]U9V@@9&5B="!A;F0O;W(@
M97%U:71Y(&9I;F%N8VEN9PT*("`@("`-"B`@("`@(&%R<F%N9V5M96YT<R!T
M;R!F:6YA;F-E(&]U<B!C=7)R96YT(&%N9"!L;VYG+71E<FT@;W!E<F%T:6]N
M<RX-"B`@(`T*("`@("`@5V4@87)E(&-U<G)E;G1L>2!A9&1R97-S:6YG(&]U
M<B!L:7%U:61I='D@;F5E9',@8GD@97AP;&]R:6YG#0H@(`T*("`@("`@:6YV
M97-T;65N="!C87!I=&%L(&]P<&]R='5N:71I97,@=&AR;W5G:"!T:&4@<')I
M=F%T90T*("`@(`T*("`@("`@<&QA8V5M96YT(&]F(&-O;6UO;B!S=&]C:R!O
M<B!I<W-U86YC92!O9B!A9&1I=&EO;F%L(&1E8G0L#0H@("`@#0H@("`@("!I
M;F-L=61I;F<@=&AE(')E;6%I;FEN9R!P;W)T:6]N(&]F('1H92!B<FED9V4@
M9FEN86YC:6YG+B!790T*(`T*("`@("`@8F5L:65V92!T:&%T(&]U<B!A8V-E
M<W,@=&\@861D:71I;VYA;"!C87!I=&%L+"!T;V=E=&AE<B!W:71H#0H@(`T*
M("`@("`@97AI<W1I;F<@8V%S:"!R97-O=7)C97,L('=I;&P@8F4@<W5F9FEC
M:65N="!T;R!M965T(&]U<B!S:&]R=`T*("`@#0H@("`@("!T97)M(&QI<75I
M9&ET>2!N965D<R!F;W(@9FES8V%L(#(P,3(N($AO=V5V97(L(&YO(&%S<W5R
M86YC90T*(`T*("`@("`@8V%N(&)E(&=I=F5N('1H870@=V4@=VEL;"!R96-E
M:79E(&%N>2!F=6YD<R!I;B!C;VYN96-T:6]N#0H@("`@#0H@("`@("!W:71H
M(&]U<B!C87!I=&%L(')A:7-I;F<@969F;W)T<R!O;B!T97)M<R!A8V-E<'1A
M8FQE('1O('1H90T*(`T*("`@("`@0V]M<&%N>2P@:68@870@86QL+@T*(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@5&AE('5N875D:71E9"!C;VYD96YS960@8V]N<V]L:61A=&5D(&9I;F%N
M8VEA;"!S=&%T96UE;G1S(&1O#0H@(`T*("`@("`@;F]T(&EN8VQU9&4@86YY
M(&%D:G5S=&UE;G1S(')E;&%T:6YG('1O('1H92!R96-O=F5R86)I;&ET>2!O
M9@T*("`@#0H@("`@("!A<W-E=',@=&AA="!M:6=H="!B92!N96-E<W-A<GD@
M<VAO=6QD('=E(&)E('5N86)L92!T;PT*("`@("`-"B`@("`@(&-O;G1I;G5E
M(&%S(&$@9V]I;F<@8V]N8V5R;BX-"B`@("`@#0H@("`@/"]P/CQB<B\^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC
M9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W
M,F0S-#)F+U=O<FMS:&5E=',O4VAE970P."YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DY/5$4@,RX@4U5-34%262!/1B!324=.
M249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-I9VYI9FEC86YT($%C8V]U;G1I;F<@
M4&]L:6-I97,@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($Y/
M5$4@,RX@4U5-34%262!/1B!324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#
M2453#0H@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@(`T*("`@("`@5&AE('-U;6UA<GD@;V8@;W5R('-I9VYI9FEC86YT(&%C
M8V]U;G1I;F<@<&]L:6-I97,@<')E<V5N=&5D#0H@(`T*("`@("`@8F5L;W<@
M:7,@9&5S:6=N960@=&\@87-S:7-T('1H92!R96%D97(@:6X@=6YD97)S=&%N
M9&EN9R!O=7(-"B`-"B`@("`@(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN
M86YC:6%L('-T871E;65N=',N(%-U8V@@9FEN86YC:6%L#0H@#0H@("`@("!S
M=&%T96UE;G1S(&%N9"!R96QA=&5D(&YO=&5S(&%R92!T:&4@<F5P<F5S96YT
M871I;VYS(&]F(&]U<@T*(`T*("`@("`@;6%N86=E;65N="P@=VAO(&%R92!R
M97-P;VYS:6)L92!F;W(@=&AE:7(@:6YT96=R:71Y(&%N9`T*("`-"B`@("`@
M(&]B:F5C=&EV:71Y+B!4:&5S92!A8V-O=6YT:6YG('!O;&EC:65S(&-O;F9O
M<FT@=&\@1T%!4"!I;B!A;&P-"B`@(`T*("`@("`@;6%T97)I86P@<F5S<&5C
M=',L(&%N9"!H879E(&)E96X@8V]N<VES=&5N=&QY(&%P<&QI960@:6X-"B`@
M(`T*("`@("`@<')E<&%R:6YG('1H92!A8V-O;7!A;GEI;F<F(S$V,#MC;VYD
M96YS960@8V]N<V]L:61A=&5D#0H@("`@(`T*("`@("`@9FEN86YC:6%L('-T
M871E;65N=',N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`G/@T*("`@("`-"B`@("`@(%!224Y#25!,15,@3T8@0T].4T],241!5$E/
M3@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@(`T*("`@("`@5&AE(&%C8V]M<&%N>6EN9R!C;VYD96YS960@8V]N<V]L
M:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S#0H@(`T*("`@("`@:6YC;'5D
M92!T:&4@86-C;W5N=',@;V8@065T:&QO;B!-961I8V%L+"!);F,N(&%N9"!I
M=',-"B`@("`@#0H@("`@("!W:&]L;'DM;W=N960@<W5B<VED:6%R>2P@17AO
M<V]M92!38VEE;F-E<RP@26YC+BP-"B`@("`@#0H@("`@("`H8V]L;&5C=&EV
M96QY(&AE<F5I;F%F=&5R(')E9F5R<F5D('1O(&%S('1H92`B0V]M<&%N>2(@
M;W(-"B`@("`-"B`@("`@(")!971H;&]N(BDN(%1H97)E(&5X:7-T(&YO(&UA
M=&5R:6%L(&EN=&5R8V]M<&%N>2!T<F%N<V%C=&EO;G,-"B`@(`T*("`@("`@
M;W(@8F%L86YC97,@8F5T=V5E;B!!971H;&]N(&%N9"!I=',@<W5B<VED:6%R
M>2X-"B`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*
M("`@("`-"B`@("`@($Q/4U,@4$52($-/34U/3B!32$%210T*("`@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!"
M87-I8R!L;W-S('!E<B!C;VUM;VX@<VAA<F4@:7,@8V]M<'5T960@8GD@9&EV
M:61I;F<@;F5T(&QO<W,-"B`@#0H@("`@("!A=F%I;&%B;&4@=&\@8V]M;6]N
M('-T;V-K:&]L9&5R<R!B>2!T:&4@=V5I9VAT960@879E<F%G90T*("`@#0H@
M("`@("!N=6UB97(@;V8@8V]M;6]N('-H87)E<R!A<W-U;65D('1O(&)E(&]U
M='-T86YD:6YG(&1U<FEN9R!T:&4-"B`@#0H@("`@("!P97)I;V0@;V8@8V]M
M<'5T871I;VXN($1I;'5T960@;&]S<R!P97(@8V]M;6]N('-H87)E(&ES#0H@
M(`T*("`@("`@8V]M<'5T960@<VEM:6QA<B!T;R!B87-I8R!L;W-S('!E<B!S
M:&%R92!E>&-E<'0@=&AA="!T:&4-"B`@(`T*("`@("`@9&5N;VUI;F%T;W(@
M:7,@:6YC<F5A<V5D('1O(&EN8VQU9&4@=&AE(&YU;6)E<B!O9B!A9&1I=&EO
M;F%L#0H@(`T*("`@("`@8V]M;6]N('-H87)E<R!T:&%T('=O=6QD(&AA=F4@
M8F5E;B!O=71S=&%N9&EN9R!I9B!T:&4-"B`@("`@#0H@("`@("!P;W1E;G1I
M86P@8V]M;6]N('-H87)E<R!H860@8F5E;B!I<W-U960L(&%N9"!I9B!T:&4-
M"B`@(`T*("`@("`@861D:71I;VYA;"!C;VUM;VX@<VAA<F5S('=E<F4@9&EL
M=71I=F4N($%S('=E(&AA9"!N970@;&]S<V5S#0H@(`T*("`@("`@9F]R(&%L
M;"!P97)I;V1S('!R97-E;G1E9"P@8F%S:6,@86YD(&1I;'5T960@;&]S<R!P
M97(@8V]M;6]N#0H@(`T*("`@("`@<VAA<F4@87)E('1H92!S86UE+"!S:6YC
M92!A9&1I=&EO;F%L('!O=&5N=&EA;"!C;VUM;VX@<VAA<F5S#0H@(`T*("`@
M("`@:&%V92!B965N(&5X8VQU9&5D(&%S('1H96ER(&5F9F5C="!W;W5L9"!B
M92!A;G1I9&EL=71I=F4N#0H@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!4:&4@<&]T96YT:6%L;'D@9&EL
M=71I=F4@8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9R!F;W(@870-"B`@("`-
M"B`@("`@($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"`R,#$P+"!W:&EC:"!I;F-L
M=61E(&-O;6UO;B!S:&%R97,-"B`@#0H@("`@("!U;F1E<FQY:6YG(&]U='-T
M86YD:6YG('-T;V-K(&]P=&EO;G,L('=A<G)A;G1S(&%N9`T*("`-"B`@("`@
M(&-O;G9E<G1I8FQE(&1E8F5N='5R97,L('=E<F4@,3$T+#(Q-2PW-S4@86YD
M(#@Q+#$S."PS,CDL#0H@("`-"B`@("`@(')E<W!E8W1I=F5L>2X-"B`@("`@
M#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@
M("`@("!0051%3E13#0H@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!792!C87!I=&%L:7IE('1H92!C;W-T
M(&]F('!A=&5N=',L('-O;64@;V8@=VAI8V@@=V5R90T*("`@("`-"B`@("`@
M(&%C<75I<F5D+"!A;F0@86UO<G1I>F4@<W5C:"!C;W-T<R!O=F5R('1H96ER
M(&5S=&EM871E9"!U<V5F=6P-"B`@(`T*("`@("`@;&EF92P@=7!O;B!I<W-U
M86YC92!O9B!T:&4@<&%T96YT+"!N;W0@=&\@97AC965D('1H92!P871E;G0-
M"B`-"B`@("`@(&QE9V%L(&QI9F4N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%)%4T5!4D-(($%.1"!$
M159%3$]0345.5"!%6%!%3E-%4PT*("`@("`-"B`@("`\+W`^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E(&EN8W5R<F5D(')E
M<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<R!D=7)I;F<@=&AE#0H@
M("`-"B`@("`@('1H<F5E(&%N9"!N:6YE(&UO;G1H('!E<FEO9',@96YD960@
M1&5C96UB97(@,S$L(#(P,3$@86YD#0H@("`-"B`@("`@(#(P,3`L('=H:6-H
M(&%R92!I;F-L=61E9"!I;B!V87)I;W5S(&]P97)A=&EN9R!E>'!E;G-E(&QI
M;F4-"B`@("`@#0H@("`@("!I=&5M<R!I;B!T:&4@86-C;VUP86YY:6YG(&-O
M;F1E;G-E9"!C;VYS;VQI9&%T960@<W1A=&5M96YT<PT*(`T*("`@("`@;V8@
M;W!E<F%T:6]N<RX@3W5R(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E
M;G-E<R!I;B!T:&]S90T*("`@#0H@("`@("!P97)I;V1S('=E<F4@87,@9F]L
M;&]W<SH-"B`-"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P
M(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^#0H@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-
M"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@
M1&5C96UB97(@,S$L#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@1&5C96UB
M97(@,S$L#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R
M/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;2<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<B<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T
M('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@,C`Q,0T*("`@("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q<'0@<V]L:60G/@T*("`@("`-"B`@("`@("`@("`R,#$P#0H@("`@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`V-"4G/@T*("`@#0H@("`@("`@("`@5&AR
M964@;6]N=&AS(&5N9&5D#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E)SX-"B`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N.B!R
M:6=H="<^#0H@(`T*("`@("`@("`@(#4S-BPP-SD-"B`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`R)2<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("0-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$Q)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@
M("`Q,C<L.3$X#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G
M/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,BXU<'0G/@T*("`@(`T*("`@("`@("`@($YI;F4@;6]N=&AS(&5N9&5D#0H@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@.#8T+#0T,PT*("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B
M;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#,Q-RPS-#4-"B`@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M(#PO='(^#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P)SX-"B`@("`-"B`@("`@($9!25(@5D%,544@3T8@1DE.04Y#24%,($E.
M4U1254U%3E13#0H@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@5&AE(&-A<G)Y:6YG(&%M;W5N="!O9B!T:&4@
M0V]M<&%N>2=S(&-A<V@L(&%C8V]U;G1S#0H@("`-"B`@("`@(')E8V5I=F%B
M;&4L(&%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,-
M"B`@("`-"B`@("`@(&%P<')O>&EM871E<R!T:&5I<B!E<W1I;6%T960@9F%I
M<B!V86QU97,@9'5E('1O('1H90T*("`@#0H@("`@("!S:&]R="UT97)M(&UA
M='5R:71I97,@;V8@=&AE<V4@9FEN86YC:6%L(&EN<W1R=6UE;G1S+B!4:&4-
M"B`@("`-"B`@("`@(&9A:7(@=F%L=64@;V8@8V5R=&%I;B!C;VYV97)T:6)L
M92!N;W1E<R!A;F0@<F5L871E9"!W87)R86YT<PT*("`-"B`@("`@(&%T($1E
M8V5M8F5R(#,Q+"`R,#$Q(&ES("0Q+#(U,"PW,#4@8F%S960@=7!O;B!A('1H
M:7)D('!A<G1Y#0H@#0H@("`@("!V86QU871I;VX@<F5P;W)T('1H870@=V4@
M8V]M;6ES<VEO;F5D+B!787)R86YT<R!C;&%S<VEF:65D(&%S#0H@("`-"B`@
M("`@(&1E<FEV871I=F4@;&EA8FEL:71I97,@87)E(')E<&]R=&5D(&%T('1H
M96ER(&5S=&EM871E9"!F86ER#0H@#0H@("`@("!V86QU92P@=VET:"!C:&%N
M9V5S(&EN(&9A:7(@=F%L=64@8F5I;F<@<F5P;W)T960@:6X@8W5R<F5N=`T*
M(`T*("`@("`@<&5R:6]D(')E<W5L=',@;V8@;W!E<F%T:6]N<RX-"B`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M($UA;F%G96UE;G0@:&%S(&-O;F-L=61E9"!T:&%T(&ET(&ES(&YO="!P<F%C
M=&EC86P@=&\-"B`@("`-"B`@("`@(&1E=&5R;6EN92!T:&4@97-T:6UA=&5D
M(&9A:7(@=F%L=64@;V8@86UO=6YT<R!D=64@=&\@<F5L871E9`T*("`-"B`@
M("`@('!A<G1I97,@8F5C875S92!T:&4@=')A;G-A8W1I;VYS(&-A;FYO="!B
M92!A<W-U;65D('1O(&AA=F4-"B`@("`@#0H@("`@("!B965N(&-O;G-U;6UA
M=&5D(&%T(&%R;2=S(&QE;F=T:"P@=&AE('1E<FUS(&%R92!N;W0@9&5E;65D
M('1O#0H@("`-"B`@("`@(&)E(&UA<FME="!T97)M<RP@=&AE<F4@87)E(&YO
M('%U;W1E9"!V86QU97,@879A:6QA8FQE(&9O<@T*("`@(`T*("`@("`@=&AE
M<V4@:6YS=')U;65N=',L(&%N9"!A;B!I;F1E<&5N9&5N="!V86QU871I;VX@
M=V]U;&0@;F]T(&)E#0H@(`T*("`@("`@<')A8W1I8V%B;&4@9'5E('1O('1H
M92!L86-K(&]F(&1A=&$@<F5G87)D:6YG('-I;6EL87(-"B`@("`@#0H@("`@
M("!I;G-T<G5M96YT<RP@:68@86YY+"!A;F0@=&AE(&%S<V]C:6%T960@<&]T
M96YT:6%L(&-O<W1S+@T*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!%455)5%D@24Y35%)5345.5%,@1D]2
M(%-%4E9)0T53(%!23U9)1$5$($)9($]42$52(%1(04X-"B`-"B`@("`@($5-
M4$Q/645%4PT*(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M#0H@("`@(`T*("`@("`@5V4@86-C;W5N="!F;W(@=')A;G-A8W1I;VYS(&EN
M=F]L=FEN9R!G;V]D<R!A;F0@<V5R=FEC97,-"B`@(`T*("`@("`@<')O=FED
M960@8GD@=&AI<F0@<&%R=&EE<R!W:&5R92!W92!I<W-U92!E<75I='D@:6YS
M=')U;65N=',-"B`-"B`@("`@(&%S('!A<G0@;V8@=&AE('1O=&%L(&-O;G-I
M9&5R871I;VX@=7-I;F<@=&AE(&9A:7(@=F%L=64@;V8-"B`@("`@#0H@("`@
M("!T:&4@8V]N<VED97)A=&EO;B!R96-E:79E9"`H:2YE+BP@=&AE('9A;'5E
M(&]F('1H92!G;V]D<R!O<@T*(`T*("`@("`@<V5R=FEC97,I(&]R('1H92!F
M86ER('9A;'5E(&]F('1H92!E<75I='D@:6YS=')U;65N=',@:7-S=65D+`T*
M("`@#0H@("`@("!W:&EC:&5V97(@:7,@;6]R92!R96QI86)L>2!M96%S=7)A
M8FQE+@T*("`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/@T*("`@("`-"B`@("`@($EN('1R86YS86-T:6]N<RP@=VAE;B!T:&4@=F%L
M=64@;V8@=&AE(&=O;V1S(&%N9"]O<B!S97)V:6-E<PT*("`-"B`@("`@(&ES
M(&YO="!R96%D:6QY(&1E=&5R;6EN86)L92!A;F0@*#$I('1H92!F86ER('9A
M;'5E(&]F('1H90T*("`@(`T*("`@("`@97%U:71Y(&EN<W1R=6UE;G1S(&ES
M(&UO<F4@<F5L:6%B;'D@;65A<W5R86)L92!A;F0@*#(I('1H90T*("`@("`-
M"B`@("`@(&-O=6YT97)P87)T>2!R96-E:79E<R!E<75I='D@:6YS=')U;65N
M=',@:6X@9G5L;"!O<B!P87)T:6%L#0H@#0H@("`@("!S971T;&5M96YT(&]F
M('1H92!T<F%N<V%C=&EO;G,L('=E('5S92!T:&4@9F]L;&]W:6YG#0H@("`@
M#0H@("`@("!M971H;V1O;&]G>3H-"B`@("`-"B`@("`\+W`^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@("AA*28C,38P.R8C,38P
M.R8C,38P.T9O<B!T<F%N<V%C=&EO;G,@=VAE<F4@9V]O9',@:&%V90T*("`@
M#0H@("`@("!A;')E861Y(&)E96X@9&5L:79E<F5D(&]R('-E<G9I8V5S(')E
M;F1E<F5D+"!T:&4@97%U:71Y#0H@(`T*("`@("`@:6YS=')U;65N=',@87)E
M(&ES<W5E9"!O;B!O<B!A8F]U="!T:&4@9&%T92!T:&4@<&5R9F]R;6%N8V4-
M"B`-"B`@("`@(&ES(&-O;7!L971E("AA;F0@=F%L=65D(&]N('1H92!D871E
M(&]F(&ES<W5A;F-E*2X-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@("AB*28C,38P.R8C,38P.R8C,38P.T9O
M<B!T<F%N<V%C=&EO;G,@=VAE<F4@=&AE(&EN<W1R=6UE;G1S#0H@("`-"B`@
M("`@(&%R92!I<W-U960@;VX@82!F=6QL>2!V97-T960L(&YO;BUF;W)F96ET
M86)L92!B87-I<RP@=&AE#0H@("`-"B`@("`@(&5Q=6ET>2!I;G-T<G5M96YT
M<R!A<F4@=F%L=65D(&]N(&]R(&%B;W5T('1H92!D871E(&]F('1H90T*("`@
M(`T*("`@("`@8V]N=')A8W0N#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("`H8RDF(S$V,#LF(S$V,#LF(S$V
M,#M&;W(@86YY('1R86YS86-T:6]N<R!N;W0@;65E=&EN9R!T:&4-"B`-"B`@
M("`@(&-R:71E<FEA(&EN("AA*2!O<B`H8BD@86)O=F4L('=E(')E+6UE87-U
M<F4@=&AE(&-O;G-I9&5R871I;VX-"B`@(`T*("`@("`@870@96%C:"!R97!O
M<G1I;F<@9&%T92!B87-E9"!O;B!I=',@=&AE;B!C=7)R96YT('-T;V-K('9A
M;'5E+@T*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-
M"B`@("`@#0H@("`@("!)35!!25)-14Y4($]2($1)4U!/4T%,($]&($Q/3D<M
M3$E6140@05-31513#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5V4@<F5V:65W(&]U<B!L;VYG+6QI
M=F5D(&%S<V5T<R!F;W(@:6UP86ER;65N="!W:&5N979E<@T*("`-"B`@("`@
M(&5V96YT<R!O<B!C:&%N9V5S(&EN(&-I<F-U;7-T86YC97,@:6YD:6-A=&4@
M=&AA="!T:&5I<@T*(`T*("`@("`@8V%R<GEI;F<@86UO=6YT<R!M87D@;F]T
M(&)E(')E8V]V97)A8FQE+B!)9B!T:&4@8V]S="!B87-I<R!O9@T*("`@#0H@
M("`@("!A(&QO;F<M;&EV960@87-S970@:7,@9W)E871E<B!T:&%N('1H92!P
M<F]J96-T960@9G5T=7)E#0H@(`T*("`@("`@=6YD:7-C;W5N=&5D(&YE="!C
M87-H(&9L;W=S(&9R;VT@<W5C:"!A<W-E="`H97AC;'5D:6YG#0H@#0H@("`@
M("!I;G1E<F5S="DL(&%N(&EM<&%I<FUE;G0@;&]S<R!I<R!R96-O9VYI>F5D
M+B!);7!A:7)M96YT#0H@(`T*("`@("`@;&]S<V5S(&%R92!C86QC=6QA=&5D
M(&%S('1H92!D:69F97)E;F-E(&)E='=E96X@=&AE(&-O<W0-"B`@(`T*("`@
M("`@8F%S:7,@;V8@86X@87-S970@86YD(&ET<R!E<W1I;6%T960@9F%I<B!V
M86QU92X@5V4@8F5L:65V90T*("`@("`-"B`@("`@('1H870@;F\@:6UP86ER
M;65N="!O8V-U<G)E9"!A="!O<B!D=7)I;F<@=&AE('1H<F5E(&%N9"!N:6YE
M#0H@#0H@("`@("!M;VYT:',@96YD960@1&5C96UB97(@,S$L(#(P,3$@86YD
M(#(P,3`N#0H@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M#0H@("`@(`T*("`@("`@0D5.149)0TE!3"!#3TY615)324].($9%05154D4@
M3T8@0T].5D525$E"3$4@3D]415,@4$%904),10T*("`@("`-"B`@("`\+W`^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%1H92!C
M;VYV97)T:6)L92!F96%T=7)E(&]F(&-E<G1A:6X@;F]T97,@<&%Y86)L92!P
M<F]V:61E<R!F;W(-"B`@(`T*("`@("`@82!R871E(&]F(&-O;G9E<G-I;VX@
M=&AA="!I<R!B96QO=R!T:&4@;6%R:V5T('9A;'5E(&]F(&]U<@T*("`@("`-
M"B`@("`@(&-O;6UO;B!S=&]C:RX@4W5C:"!F96%T=7)E(&ES(&YO<FUA;&QY
M(&-H87)A8W1E<FEZ960@87,@80T*("`@(`T*("`@("`@(D)E;F5F:6-I86P@
M0V]N=F5R<VEO;B!&96%T=7)E(B`H(D)#1B(I+B!792!R96-O<F0@=&AE#0H@
M#0H@("`@("!E<W1I;6%T960@9F%I<B!V86QU92!O9B!T:&4@0D-&+"!W:&5N
M(&%P<&QI8V%B;&4L(&EN('1H90T*("`@#0H@("`@("!C;VYD96YS960@8V]N
M<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%S(&$@9&ES8V]U;G0-
M"B`@("`-"B`@("`@(&9R;VT@=&AE(&9A8V4@86UO=6YT(&]F('1H92!N;W1E
M<RX@4W5C:"!D:7-C;W5N=',@87)E#0H@("`@(`T*("`@("`@86-C<F5T960@
M=&\@:6YT97)E<W0@97AP96YS92!O=F5R('1H92!T97)M(&]F('1H92!N;W1E
M<R!U<VEN9PT*("`@#0H@("`@("!T:&4@969F96-T:79E(&EN=&5R97-T(&UE
M=&AO9"X-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-
M"B`@("`@#0H@("`@("!2159%3E5%(%)%0T]'3DE424].#0H@#0H@("`@/"]P
M/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!#86QI8G)I+"!(86QV971I
M8V$L(%-A;G,M4V5R:68[(&UA<F=I;CH@,"<^#0H@#0H@("`@("`\9F]N="!S
M='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&-O;&]R.B!B;&%C:R<^5VET:`T*("`@#0H@("`@("!R97-P96-T
M('1O(')E=F5N=64@<F5C;V=N:71I;VXL('=E(&5N=&5R960@:6YT;R!A(&-O
M;G1R86-T#0H@("`@(`T*("`@("`@=VET:"!$05)002!A<R!D:7-C=7-S960@
M86)O=F4@86YD(&AA=F4@<F5C;V=N:7IE9"!R979E;G5E#0H@("`@#0H@("`@
M("!D=7)I;F<@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!$96-E;6)E<B`S,2P@
M,C`Q,2!O9B`D.34X+#`W-0T*(`T*("`@("`@=6YD97(@<W5C:"!C;VYT<F%C
M="X@5V4@861O<'1E9"!T:&4@36EL97-T;VYE(&UE=&AO9"!O9@T*("`-"B`@
M("`@(')E=F5N=64@<F5C;V=N:71I;VX@9F]R('1H92!$05)002!C;VYT<F%C
M="!U;F1E<B!!4T,@-C`U+3(X#0H@#0H@("`@("`F(S@R,C`[4F5V96YU92!2
M96-O9VYI=&EO;B`F(S@R,3$[($UI;&5S=&]N92!-971H;V0F(S@R,C$[#0H@
M(`T*("`@("`@86YD('=E(&)E;&EE=F4@=V4@;65E="!T:&4@<F5Q=6ER96UE
M;G1S('5N9&5R($%30R`V,#4M,C@@9F]R#0H@(`T*("`@("`@<F5P;W)T:6YG
M(&-O;G1R86-T(')E=F5N=64@=6YD97(@=&AE($UI;&5S=&]N92!-971H;V0@
M9F]R('1H90T*("`@#0H@("`@("!Q=6%R=&5R(&5N9&5D($1E8V5M8F5R(#,Q
M+"`R,#$Q+CPO9F]N=#X-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!);B!O<F1E<B!T;R!A8V-O=6YT(&9O
M<B!T:&ES(&-O;G1R86-T+"!T:&4@0V]M<&%N>2!I9&5N=&EF:65S#0H@("`-
M"B`@("`@('1H92!D96QI=F5R86)L97,@:6YC;'5D960@=VET:&EN('1H92!C
M;VYT<F%C="!A;F0@979A;'5A=&5S#0H@#0H@("`@("!W:&EC:"!D96QI=F5R
M86)L97,@<F5P<F5S96YT('-E<&%R871E('5N:71S(&]F(&%C8V]U;G1I;F<-
M"B`@("`-"B`@("`@(&)A<V5D(&]N(&EF(&-E<G1A:6X@8W)I=&5R:6$@87)E
M(&UE="P@:6YC;'5D:6YG('=H971H97(@=&AE#0H@#0H@("`@("!D96QI=F5R
M960@96QE;65N="!H87,@<W1A;F1A;&]N92!V86QU92!T;R!T:&4@8V]L;&%B
M;W)A=&]R+@T*(`T*("`@("`@5&AE(&-O;G-I9&5R871I;VX@<F5C96EV960@
M:7,@86QL;V-A=&5D(&%M;VYG('1H92!S97!A<F%T90T*("`@("`-"B`@("`@
M('5N:71S(&]F(&%C8V]U;G1I;F<L(&%N9"!T:&4@87!P;&EC86)L92!R979E
M;G5E(')E8V]G;FET:6]N#0H@#0H@("`@("!C<FET97)I82!A<F4@87!P;&EE
M9"!T;R!E86-H(&]F('1H92!S97!A<F%T92!U;FET<RX-"B`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@02!M
M:6QE<W1O;F4@:7,@86X@979E;G0@:&%V:6YG(&%L;"!O9B!T:&4@9F]L;&]W
M:6YG#0H@("`-"B`@("`@(&-H87)A8W1E<FES=&EC<SH-"B`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@*#$I
M(%1H97)E(&ES('-U8G-T86YT:79E('5N8V5R=&%I;G1Y(&%T('1H92!D871E
M('1H90T*("`@(`T*("`@("`@87)R86YG96UE;G0@:7,@96YT97)E9"!I;G1O
M('1H870@=&AE(&5V96YT('=I;&P@8F4@86-H:65V960N#0H@(`T*("`@("`@
M02!V96YD;W(F(S@R,3<[<R!A<W-E<W-M96YT('1H870@:70@97AP96-T<R!T
M;R!A8VAI979E(&$-"B`@#0H@("`@("!M:6QE<W1O;F4@9&]E<R!N;W0@;F5C
M97-S87)I;'D@;65A;B!T:&%T('1H97)E(&ES(&YO=`T*("`@("`-"B`@("`@
M('-U8G-T86YT:79E('5N8V5R=&%I;G1Y(&%S<V]C:6%T960@=VET:"!A8VAI
M979I;F<@=&AE#0H@("`@(`T*("`@("`@;6EL97-T;VYE+@T*("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@("@R
M*2!4:&4@979E;G0@8V%N(&]N;'D@8F4@86-H:65V960@8F%S960@:6X@=VAO
M;&4@;W(@:6X@<&%R=`T*("`-"B`@("`@(&]N(&5I=&AE<CH@*&$I('1H92!V
M96YD;W(F(S@R,3<[<R!P97)F;W)M86YC93L@;W(@*&(I(&$-"B`-"B`@("`@
M('-P96-I9FEC(&]U=&-O;64@<F5S=6QT:6YG(&9R;VT@=&AE('9E;F1O<B8C
M.#(Q-SMS#0H@#0H@("`@("!P97)F;W)M86YC92X-"B`@("`-"B`@("`\+W`^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@("@S*2!)
M9B!A8VAI979E9"P@=&AE(&5V96YT('=O=6QD(')E<W5L="!I;B!A9&1I=&EO
M;F%L#0H@("`@(`T*("`@("`@<&%Y;65N=',@8F5I;F<@9'5E('1O('1H92!V
M96YD;W(N#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@02!M:6QE<W1O;F4@9&]E<R!N;W0@:6YC;'5D
M92!E=F5N=',@9F]R('=H:6-H('1H92!O8V-U<G)E;F-E#0H@(`T*("`@("`@
M:7,@96ET:&5R.B`H82D@8V]N=&EN9V5N="!S;VQE;'D@=7!O;B!T:&4@<&%S
M<V%G92!O9B!T:6UE.R!O<@T*("`@#0H@("`@("`H8BD@=&AE(')E<W5L="!O
M9B!A(&-O=6YT97)P87)T>28C.#(Q-SMS('!E<F9O<FUA;F-E+@T*("`@(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@5&AE('!O;&EC>2!F;W(@<F5C;V=N:7II;F<@9&5L:79E<F%B;&4@8V]N
M<VED97)A=&EO;@T*("`@(`T*("`@("`@8V]N=&EN9V5N="!U<&]N(&%C:&EE
M=F5M96YT(&]F(&$@;6EL97-T;VYE(&UU<W0@8F4@87!P;&EE9`T*("`@("`-
M"B`@("`@(&-O;G-I<W1E;G1L>2!T;R!S:6UI;&%R(&1E;&EV97)A8FQE<RX\
M8G(@+SX-"B`-"B`@("`@(#QB<B`O/@T*("`@(`T*("`@("`@5&AE(&%S<V5S
M<VUE;G0@;V8@=VAE=&AE<B!A(&UI;&5S=&]N92!I<R!S=6)S=&%N=&EV92!I
M<PT*("`-"B`@("`@('!E<F9O<FUE9"!A="!T:&4@:6YC97!T:6]N(&]F('1H
M92!A<G)A;F=E;65N="X@5&AE#0H@(`T*("`@("`@8V]N<VED97)A=&EO;B!E
M87)N960@9G)O;2!T:&4@86-H:65V96UE;G0@;V8@82!M:6QE<W1O;F4@;75S
M=`T*("`@#0H@("`@("!M965T(&%L;"!O9B!T:&4@9F]L;&]W:6YG(&9O<B!T
M:&4@;6EL97-T;VYE('1O(&)E(&-O;G-I9&5R960-"B`@#0H@("`@("!S=6)S
M=&%N=&EV93H-"B`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`G/@T*("`@("`-"B`@("`@("@Q*2!4:&4@8V]N<VED97)A=&EO;B!I<R!C
M;VUM96YS=7)A=&4@=VET:"!E:71H97(Z("AA*2!T:&4-"B`@("`@#0H@("`@
M("!V96YD;W(F(S@R,3<[<R!P97)F;W)M86YC92!T;R!A8VAI979E('1H92!M
M:6QE<W1O;F4[(&]R("AB*0T*("`@("`-"B`@("`@('1H92!E;FAA;F-E;65N
M="!O9B!T:&4@=F%L=64@;V8@=&AE(&1E;&EV97)E9"!I=&5M(&]R(&ET96US
M#0H@#0H@("`@("!A<R!A(')E<W5L="!O9B!A('-P96-I9FEC(&]U=&-O;64@
M<F5S=6QT:6YG(&9R;VT@=&AE#0H@("`@#0H@("`@("!V96YD;W(F(S@R,3<[
M<R!P97)F;W)M86YC92!T;R!A8VAI979E('1H92!M:6QE<W1O;F4[#0H@("`-
M"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@
M("`@("@R*2!4:&4@8V]N<VED97)A=&EO;B!R96QA=&5S('-O;&5L>2!T;R!P
M87-T('!E<F9O<FUA;F-E.R!A;F0-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@*#,I(%1H92!C;VYS:61E
M<F%T:6]N(&ES(')E87-O;F%B;&4@<F5L871I=F4@=&\@86QL(&]F('1H90T*
M("`@("`-"B`@("`@(&1E;&EV97)A8FQE<R!A;F0@<&%Y;65N="!T97)M<R`H
M:6YC;'5D:6YG(&]T:&5R('!O=&5N=&EA;`T*("`@(`T*("`@("`@;6EL97-T
M;VYE(&-O;G-I9&5R871I;VXI('=I=&AI;B!T:&4@87)R86YG96UE;G0N#0H@
M("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@
M(`T*("`@("`@02!M:6QE<W1O;F4@:7,@;F]T(&-O;G-I9&5R960@<W5B<W1A
M;G1I=F4@:68@86YY('!O<G1I;VX@;V8-"B`-"B`@("`@('1H92!A<W-O8VEA
M=&5D(&UI;&5S=&]N92!C;VYS:61E<F%T:6]N(')E;&%T97,@=&\@=&AE#0H@
M("`@(`T*("`@("`@<F5M86EN:6YG(&1E;&EV97)A8FQE<R!I;B!T:&4@=6YI
M="!O9B!A8V-O=6YT:6YG("AI+F4N+"!I=`T*("`@("`-"B`@("`@(&1O97,@
M;F]T(')E;&%T92!S;VQE;'D@=&\@<&%S="!P97)F;W)M86YC92DN(%1O(')E
M8V]G;FEZ92!T:&4-"B`@(`T*("`@("`@;6EL97-T;VYE(&-O;G-I9&5R871I
M;VX@:6X@:71S(&5N=&ER971Y(&%S(')E=F5N=64@:6X@=&AE#0H@("`@#0H@
M("`@("!P97)I;V0@:6X@=VAI8V@@=&AE(&UI;&5S=&]N92!I<R!A8VAI979E
M9"P@=&AE(&UI;&5S=&]N92!M=7-T#0H@("`-"B`@("`@(&)E('-U8G-T86YT
M:79E(&EN(&ET<R!E;G1I<F5T>2X@36EL97-T;VYE(&-O;G-I9&5R871I;VX-
M"B`@#0H@("`@("!C86YN;W0@8F4@8FEF=7)C871E9"!I;G1O('-U8G-T86YT
M:79E(&%N9"!N;VYS=6)S=&%N=&EV90T*("`@#0H@("`@("!C;VUP;VYE;G1S
M+B!);B!A9&1I=&EO;BP@:68@82!P;W)T:6]N(&]F('1H92!C;VYS:61E<F%T
M:6]N#0H@("`@(`T*("`@("`@96%R;F5D(&9R;VT@86-H:65V:6YG(&$@;6EL
M97-T;VYE(&UA>2!B92!R969U;F1E9"!O<B!A9&IU<W1E9`T*("`@#0H@("`@
M("!B87-E9"!O;B!F=71U<F4@<&5R9F]R;6%N8V4L('1H92!R96QA=&5D(&UI
M;&5S=&]N92!I<R!N;W0-"B`@("`-"B`@("`@(&-O;G-I9&5R960@<W5B<W1A
M;G1I=F4N#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@4V5E($YO=&4@,3(@9F]R('1H92!A9&1I=&EO
M;F%L(&1I<V-L;W-U<F4@:6YF;W)M871I;VX-"B`@("`@#0H@("`@("!R97%U
M:7)E9"!U;F1E<B!!4T,@-C`U+3(X+@T*("`@#0H@("`@/"]P/CQB<B\^/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!$15))5D%4259%($Q)
M04))3$E42453($%.1"!#3$%34TE&24-!5$E/3@T*("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!792!E=F%L
M=6%T92!F<F5E+7-T86YD:6YG(&1E<FEV871I=F4@:6YS=')U;65N=',@*&]R
M(&5M8F5D9&5D#0H@("`-"B`@("`@(&1E<FEV871I=F5S*2!T;R!P<F]P97)L
M>2!C;&%S<VEF>2!S=6-H(&EN<W1R=6UE;G1S('=I=&AI;@T*("`@(`T*("`@
M("`@97%U:71Y(&]R(&%S(&QI86)I;&ET:65S(&EN(&]U<B!F:6YA;F-I86P@
M<W1A=&5M96YT<RX@3W5R#0H@("`@#0H@("`@("!P;VQI8WD@:7,@=&\@<V5T
M=&QE(&EN<W1R=6UE;G1S(&EN9&5X960@=&\@;W5R(&-O;6UO;B!S:&%R97,-
M"B`@#0H@("`@("!O;B!A(&9I<G-T+6EN+69I<G-T+6]U="!B87-I<RX-"B`@
M#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@
M("`@("!4:&4@8VQA<W-I9FEC871I;VX@;V8@82!D97)I=F%T:79E(&EN<W1R
M=6UE;G0@:7,@<F5A<W-E<W-E9`T*(`T*("`@("`@870@96%C:"!B86QA;F-E
M('-H965T(&1A=&4N($EF('1H92!C;&%S<VEF:6-A=&EO;B!C:&%N9V5S(&%S
M#0H@(`T*("`@("`@82!R97-U;'0@;V8@979E;G1S(&1U<FEN9R!A(')E<&]R
M=&EN9R!P97)I;V0L('1H92!I;G-T<G5M96YT#0H@(`T*("`@("`@:7,@<F5C
M;&%S<VEF:65D(&%S(&]F('1H92!D871E(&]F('1H92!E=F5N="!T:&%T(&-A
M=7-E9"!T:&4-"B`-"B`@("`@(')E8VQA<W-I9FEC871I;VXN(%1H97)E(&ES
M(&YO(&QI;6ET(&]N('1H92!N=6UB97(@;V8@=&EM97,@80T*("`-"B`@("`@
M(&-O;G1R86-T(&UA>2!B92!R96-L87-S:69I960N#0H@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX-
M"B`-"B`@("`@($]N($%P<FEL(#$L(#(P,#D@=V4@861O<'1E9"!N97<@9W5I
M9&%N8V4L(&%S(&-O9&EF:65D(&EN#0H@("`-"B`@("`@($9I;F%N8VEA;"!!
M8V-O=6YT:6YG(%-T86YD87)D<R!";V%R9"`H(D9!4T(B*2!!8V-O=6YT:6YG
M#0H@("`-"B`@("`@(%-T86YD87)D<R!#;V1I9FEC871I;VX@*")!4T,B*28C
M,38P.S@Q-2TT,"P@/&D^1&5R:79A=&EV97,-"B`@("`@#0H@("`@("!A;F0@
M2&5D9VEN9SPO:3XL(#QI/D%C8V]U;G1I;F<@9F]R($1E<FEV871I=F4@1FEN
M86YC:6%L#0H@("`@#0H@("`@("!);G-T<G5M96YT<R!);F1E>&5D('1O+"!A
M;F0@4&]T96YT:6%L;'D@4V5T=&QE9"!I;BP@80T*("`@("`-"B`@("`@($-O
M;7!A;GDF(S@R,3<[<R!/=VX@4W1O8VL\+VD^("AP<F5V:6]U<VQY($5)5$8@
M,#<M-2DL('1H870-"B`@("`@#0H@("`@("!R97%U:7)E<R!U<R!T;R!A<'!L
M>2!A('1W;RUS=&5P(&UO9&5L(&EN(&1E=&5R;6EN:6YG('=H971H97(-"B`@
M#0H@("`@("!A(&9I;F%N8VEA;"!I;G-T<G5M96YT(&]R(&%N(&5M8F5D9&5D
M(&9E871U<F4@:7,@:6YD97AE9"!T;PT*(`T*("`@("`@;W5R(&]W;B!S=&]C
M:R!A;F0@=&AU<R!E;F%B;&5S(&ET('1O('%U86QI9GD@9F]R(&5Q=6ET>0T*
M("`-"B`@("`@(&-L87-S:69I8V%T:6]N+B!792!H879E(&ED96YT:69I960@
M<V5V97)A;"!C;VYV97)T:6)L92!D96)T#0H@#0H@("`@("!O<B!W87)R86YT
M(&%G<F5E;65N=',@:6X@=VAI8V@@=&AE(&5M8F5D9&5D(&-O;G9E<G-I;VX-
M"B`-"B`@("`@(&9E871U<F4@;W(@97AE<F-I<V4@<')I8V4@8V]N=&%I;G,@
M8V5R=&%I;B!P<F]V:7-I;VYS('1H870-"B`@("`@#0H@("`@("!M87D@<F5S
M=6QT(&EN(&%N(&%D:G5S=&UE;G0@;V8@=&AE(&-O;G9E<G-I;VX@;W(@97AE
M<F-I<V4-"B`@("`-"B`@("`@('!R:6-E+"!W:&EC:"!R97-U;'1S(&EN('1H
M92!F86EL=7)E(&]F('1H92!T:&5S92!I;G-T<G5M96YT<PT*("`-"B`@("`@
M('1O(&)E(&-O;G-I9&5R960@=&\@8F4@:6YD97AE9"!T;R!O=7(@<W1O8VLN
M($%C8V]R9&EN9VQY+`T*("`@(`T*("`@("`@=6YD97(@=&AI<R!G=6ED86YC
M92P@=V4@87)E(')E<75I<F5D('1O(')E8V]R9"!T:&4@97-T:6UA=&5D#0H@
M(`T*("`@("`@9F%I<B!V86QU92!O9B!T:&5S92!I;G-T<G5M96YT<R!A<R!D
M97)I=F%T:79E(&QI86)I;&ET:65S#0H@("`@#0H@("`@("`H<V5E($YO=&4@
M.2DN#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M#0H@("`@(`T*("`@("`@5V4@<F4M;65A<W5R92!T:&4@97-T:6UA=&5D(&9A
M:7(@=F%L=64@;V8@9&5R:79A=&EV90T*("`@(`T*("`@("`@;&EA8FEL:71I
M97,@870@96%C:"!R97!O<G1I;F<@<&5R:6]D(&%N9"!R96-O<F0@8VAA;F=E
M<R!I;@T*("`@("`-"B`@("`@(&9A:7(@=F%L=64@:6X@;W1H97(@97AP96YS
M92`H:6YC;VUE*2!I;B!T:&4@8W5R<F5N="!S=&%T96UE;G0-"B`@(`T*("`@
M("`@;V8@;W!E<F%T:6]N<RX-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%)%1TE35%)!5$E/3B!005E-14Y4
M($%24D%.1T5-14Y44PT*("`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E(&%C8V]U;G0@9F]R(&-O;G1I
M;F=E;G0@;V)L:6=A=&EO;G,@=&\@;6%K92!F=71U<F4@<&%Y;65N=',-"B`@
M(`T*("`@("`@;W(@;W1H97)W:7-E('1R86YS9F5R(&-O;G-I9&5R871I;VX@
M=6YD97(@82!R96=I<W1R871I;VX-"B`@(`T*("`@("`@<&%Y;65N="!A<G)A
M;F=E;65N="!S97!A<F%T96QY(&9R;VT@86YY(')E;&%T960@9FEN86YC:6YG
M#0H@("`@#0H@("`@("!T<F%N<V%C=&EO;B!A9W)E96UE;G1S+"!A;F0@86YY
M('-U8V@@8V]N=&EN9V5N="!O8FQI9V%T:6]N<PT*(`T*("`@("`@87)E(')E
M8V]G;FEZ960@;VYL>2!W:&5N(&ET(&ES(&1E=&5R;6EN960@=&AA="!I="!I
M<R!P<F]B86)L90T*("`@#0H@("`@("!T:&%T('1H92!#;VUP86YY('=I;&P@
M8F5C;VUE(&]B;&EG871E9"!F;W(@9G5T=7)E('!A>6UE;G1S#0H@("`@(`T*
M("`@("`@86YD('1H92!A;6]U;G0L(&]R(')A;F=E(&]F(&%M;W5N=',L(&]F
M('-U8V@@9G5T=7)E('!A>6UE;G1S#0H@(`T*("`@("`@8V%N(&)E(')E87-O
M;F%B;'D@97-T:6UA=&5D("AS964@3F]T92`W*2X-"B`@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@4U1/0TLM
M0D%3140@0T]-4$5.4T%424].#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!%;7!L;WEE92!S=&]C:R!O<'1I
M;VYS(&%N9"!R:6=H=',@=&\@<'5R8VAA<V4@<VAA<F5S('5N9&5R#0H@("`@
M(`T*("`@("`@<W1O8VL@<&%R=&EC:7!A=&EO;B!P;&%N<R!A<F4@86-C;W5N
M=&5D(&9O<B!U;F1E<B!T:&4@9F%I<@T*("`@("`-"B`@("`@('9A;'5E(&UE
M=&AO9"X@06-C;W)D:6YG;'DL('-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;B!I
M<PT*(`T*("`@("`@;65A<W5R960@=VAE;B!A;&P@9W)A;G1I;F<@86-T:79I
M=&EE<R!H879E(&)E96X@8V]M<&QE=&5D+`T*("`@("`-"B`@("`@(&=E;F5R
M86QL>2!T:&4@9W)A;G0@9&%T92P@8F%S960@;VX@=&AE(&9A:7(@=F%L=64@
M;V8@=&AE#0H@("`-"B`@("`@(&%W87)D+B!4:&4@97AE<F-I<V4@<')I8V4@
M;V8@;W!T:6]N<R!I<R!G96YE<F%L;'D@97%U86P@=&\-"B`@("`@#0H@("`@
M("!T:&4@;6%R:V5T('!R:6-E(&]F('1H92!#;VUP86YY)W,@8V]M;6]N('-T
M;V-K("AD969I;F5D(&%S#0H@("`@(`T*("`@("`@=&AE(&-L;W-I;F<@<')I
M8V4@87,@<75O=&5D(&]N('1H92!/5$-"0BD@;VX@=&AE(&1A=&4@;V8-"B`@
M(`T*("`@("`@9W)A;G0N($-O;7!E;G-A=&EO;B!C;W-T(')E8V]G;FEZ960@
M8GD@=&AE($-O;7!A;GD@:6YC;'5D97,-"B`-"B`@("`@("AA*2!C;VUP96YS
M871I;VX@8V]S="!F;W(@86QL(&5Q=6ET>2!I;F-E;G1I=F4@87=A<F1S(&=R
M86YT960-"B`@(`T*("`@("`@<')I;W(@=&\L(&)U="!N;W0@>65T('9E<W1E
M9"!A<R!O9B!!<')I;"`Q+"`R,#`V+"!B87-E9"!O;@T*("`@("`-"B`@("`@
M('1H92!G<F%N="UD871E(&9A:7(@=F%L=64@97-T:6UA=&5D(&EN(&%C8V]R
M9&%N8V4@=VET:"!T:&4-"B`@("`@#0H@("`@("!O<FEG:6YA;"!P<F]V:7-I
M;VYS(&]F('1H92!T:&5N(&-U<G)E;G0@86-C;W5N=&EN9R!S=&%N9&%R9',L
M#0H@("`-"B`@("`@(&%N9"`H8BD@8V]M<&5N<V%T:6]N(&-O<W0@9F]R(&%L
M;"!E<75I='D@:6YC96YT:79E(&%W87)D<PT*("`@(`T*("`@("`@9W)A;G1E
M9"!S=6)S97%U96YT('1O($%P<FEL(#$L(#(P,#8L(&)A<V5D(&]N('1H92!G
M<F%N="UD871E#0H@(`T*("`@("`@9F%I<B!V86QU92!E<W1I;6%T960@:6X@
M86-C;W)D86YC92!W:71H('1H92!P<F]V:7-I;VYS(&]F#0H@("`@#0H@("`@
M("!S=6)S97%U96YT(&%C8V]U;G1I;F<@<W1A;F1A<F1S+B!792!U<V4@82!"
M:6YO;6EA;"!,871T:6-E#0H@("`@(`T*("`@("`@;W!T:6]N('!R:6-I;F<@
M;6]D96P@9F]R(&5S=&EM871I;F<@9F%I<B!V86QU92!O9B!O<'1I;VYS#0H@
M("`@#0H@("`@("!G<F%N=&5D("AS964@3F]T92`Q,"DN#0H@("`@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!)
M3D-/344@5$%815,-"B`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@($1E9F5R<F5D('1A>"!A<W-E=',@86YD
M(&QI86)I;&ET:65S(&%R92!R96-O9VYI>F5D(&9O<B!T:&4-"B`@("`@#0H@
M("`@("!F=71U<F4@=&%X(&-O;G-E<75E;F-E<R!A='1R:6)U=&%B;&4@=&\@
M=&AE(&1I9F9E<F5N8V4-"B`-"B`@("`@(&)E='=E96X@=&AE(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@=&AE:7(-"B`@#0H@("`@
M("!R97-P96-T:79E('1A>"!B87-I<RX@1&5F97)R960@:6YC;VUE('1A>&5S
M(')E9FQE8W0@=&AE(&YE=`T*(`T*("`@("`@=&%X(&5F9F5C=',@;V8@*&$I
M('1E;7!O<F%R>2!D:69F97)E;F-E<R!B971W965N('1H92!C87)R>6EN9PT*
M("`@#0H@("`@("!A;6]U;G1S(&]F(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@
M9F]R(&9I;F%N8VEA;"!R97!O<G1I;F<-"B`@("`-"B`@("`@('!U<G!O<V5S
M(&%N9"!T:&4@86UO=6YT<R!R97!O<G1E9"!F;W(@:6YC;VUE('1A>"!P=7)P
M;W-E<RP-"B`@("`@#0H@("`@("!A;F0@*&(I('1A>"!C<F5D:70@8V%R<GEF
M;W)W87)D<RX@5V4@<F5C;W)D(&$@=F%L=6%T:6]N#0H@(`T*("`@("`@86QL
M;W=A;F-E(&9O<B!D969E<G)E9"!T87@@87-S971S('=H96XL(&)A<V5D(&]N
M(&]U<B!B97-T#0H@("`@#0H@("`@("!E<W1I;6%T92!O9B!T87AA8FQE(&EN
M8V]M92`H:68@86YY*2!I;B!T:&4@9F]R97-E96%B;&4-"B`-"B`@("`@(&9U
M='5R92P@:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA="!S;VUE('!O
M<G1I;VX@;V8@=&AE#0H@#0H@("`@("!D969E<G)E9"!T87@@87-S971S(&UA
M>2!N;W0@8F4@<F5A;&EZ960N($%T($UA<F-H(#,Q+"`R,#$Q#0H@("`@(`T*
M("`@("`@86YD($1E8V5M8F5R(#,Q+"`R,#$Q+"!W92!H860@;F5T(&1E9F5R
M<F5D('1A>"!A<W-E=',-"B`@("`@#0H@("`@("!R96QA=&EN9R!P<FEM87)I
M;'D@=&\@=&%X(&YE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S#0H@
M("`@(`T*("`@("`@86YD(&$@,3`P)2!V86QU871I;VX@86QL;W=A;F-E(&]N
M('-U8V@@;F5T(&1E9F5R<F5D('1A>`T*("`-"B`@("`@(&%S<V5T<RX@5V4@
M:&%D(&YO('-I9VYI9FEC86YT(&-U<G)E;G0@=&%X('!R;W9I<VEO;B!F;W(@
M86YY#0H@#0H@("`@("!P97)I;V0@<')E<V5N=&5D+@T*("`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@4TE'
M3DE&24-!3E0@4D5#14Y4($%#0T]53E1)3D<@4%)/3D]53D-%345.5%,-"B`-
M"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@
M("`@(%1H97)E('=E<F4@;F\F(S$V,#MR96-E;G0@86-C;W5N=&EN9R!P<F]N
M;W5N8V5M96YT<R!I<W-U960@8GD-"B`@#0H@("`@("!T:&4@1D%30B`H:6YC
M;'5D:6YG(&ET<R!%;65R9VEN9R!)<W-U97,@5&%S:R!&;W)C92DL('1H90T*
M("`@#0H@("`@("!!;65R:6-A;B!);G-T:71U=&4@;V8@0V5R=&EF:65D(%!U
M8FQI8R!!8V-O=6YT86YT<RP@;W(@=&AE#0H@("`@(`T*("`@("`@4V5C=7)I
M=&EE<R!A;F0@17AC:&%N9V4@0V]M;6ES<VEO;B!T:&%T(&EN('1H92!O<&EN
M:6]N#0H@#0H@("`@("!O9B8C,38P.VUA;F%G96UE;G0@:&%D+"!O<B!A<F4@
M97AP96-T960F(S$V,#MT;R!H879E(&$-"B`@("`-"B`@("`@(&UA=&5R:6%L
M(&EM<&%C="!O;B!O=7(@<')E<V5N="!O<B!F=71U<F4@8V]N<V]L:61A=&5D
M#0H@("`@(`T*("`@("`@9FEN86YC:6%L('-T871E;65N=',N#0H@("`-"B`@
M("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R9@T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC9E\S8C-B7S0T
M-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E=#`Y+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3D]412`T+B!.
M3U1%4R!005E!0DQ%/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1E8G0@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@(`T*("`@("`@3D]412`T+B!.3U1%4R!005E!0DQ%#0H@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($YO
M=&5S('!A>6%B;&4L(&%L;"!C=7)R96YT(&QI86)I;&ET:65S(&%N9"!U;G-E
M8W5R960L(&-O;G-I<W0-"B`@(`T*("`@("`@;V8@=&AE(&9O;&QO=VEN9R!A
M="!$96-E;6)E<B`S,2P@,C`Q,2!A;F0@36%R8V@@,S$L(#(P,3$Z#0H@("`@
M#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A
M8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`@#0H@("`@("`\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@)SX-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('!A9&1I
M;F<M8F]T=&]M.B`Q<'0[('!A9&1I;F<M;&5F=#H@,3!P="<^#0H@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@($1E8V5M8F5R(#,Q
M+"`R,#$Q#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX-"B`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#<@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("!-87)C:"`S,2P@,C`Q,0T*
M("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/@T*("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q
M<'0[('!A9&1I;F<M;&5F=#H@,3!P="<^#0H@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q
M<'0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E
M<B<^#0H@("`@(`T*("`@("`@("`@(%!R:6YC:7!A;"!"86QA;F-E#0H@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS
M1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#M!
M8V-R=65D($EN=&5R97-T#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`@
M(`T*("`@("`@("`@(%!R:6YC:7!A;"!"86QA;F-E#0H@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("!!8V-R=65D($EN=&5R97-T
M)B,Q-C`[#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^
M#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`T,"4G/@T*("`@#0H@
M("`@("`@("`@,3(E($YO=&5S('!A>6%B;&4L('!A<W0@9'5E#0H@("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,R4G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,3@U
M+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E)SX-"B`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R
M:6=H="<^#0H@(`T*("`@("`@("`@(#(Y,2PS-S<-"B`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`S)2<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("0-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$P)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@
M("`Q.#4L,#`P#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4G/@T*("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI
M9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,C<P+#4V,@T*("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@,3`E($YO=&4@<&%Y86)L92P@<&%S="!D=64-
M"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`U+#`P,`T*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@-BPQ.#@-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@(#4L,#`P#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`T+#@W-0T*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@("`@/'1D/@T*("`@
M(`T*("`@("`@("`@($QA=R!&:7)M($YO=&4L('!A<W0@9'5E#0H@("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`S-"PV,3`-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`R+#0X,`T*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@)B,X,C$R.R8C,38P.R8C,38P.PT*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C.#(Q,CLF
M(S$V,#LF(S$V,#L-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*
M("`@("`@("`@(%1O;F%Q=6EN="!.;W1E#0H@("`@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI
M9#L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`S-C`L,3@V
M#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P
M="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^#0H@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#$L-S<V#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#%P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`F(S@R,3([)B,Q-C`[)B,Q-C`[
M#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T
M)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E
M>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@)B,X,C$R.R8C,38P
M.R8C,38P.PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6EN9&5N=#H@,C=P="<^
M#0H@("`-"B`@("`@("`@("!4;W1A;`T*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`U
M.#0L-SDV#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@,S`Q+#@R,0T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT
M+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@(#$Y,"PP,#`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P
M=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`R-S4L-#,W#0H@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*
M("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@#0H@("`@("!,05<@1DE232!.3U1%#0H@("`@(`T*("`@(#PO<#X\8G(O
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3VX@075G=7-T
M(#(@,C`Q,2P@=V4@96YT97)E9"!I;G1O(&$@4')O;6ES<V]R>2!.;W1E('=I
M=&@@;W5R#0H@(`T*("`@("`@:6YT96QL96-T=6%L('!R;W!E<G1Y(&QA=R!F
M:7)M(&9O<B!T:&4@86UO=6YT(&]F("0T.2PV,3`L#0H@("`@#0H@("`@("!W
M:&EC:"!R97!R97-E;G1E9"!T:&4@86UO=6YT('=E(&]W960@=&\@=&AA="!F
M:7)M+B!4:&4-"B`-"B`@("`@(%!R;VUI<W-O<GD@3F]T92!C86QL<R!F;W(@
M;6]N=&AL>2!P87EM96YT<R!O9B`D-2PP,#`@9G)O;0T*("`@(`T*("`@("`@
M075G=7-T(#(P,3$@=&AR;W5G:"!$96-E;6)E<B`R,#$Q+B!&<F]M('1H92!P
M97)I;V0@075G=7-T(#(-"B`-"B`@("`@('1H<F]U9V@@1&5C96UB97(@,S$L
M(#(P,3$L('=E(&UA9&4@=&AR964@)#4L,#`P('!A>6UE;G1S+"!A;F0-"B`@
M(`T*("`@("`@87,@82!R97-U;'0L(&AA=F4@<F5D=6-E9"!T:&4@;F]T92!B
M86QA;F-E('1O("0S-"PV,3`@87,@;V8-"B`-"B`@("`@($1E8V5M8F5R(#,Q
M+"`R,#$Q+B!4:&4@;F]T92!B96%R<R!I;G1E<F5S="!A="`Q,"4@<&5R(&%N
M;G5M+@T*("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*
M("`@("`-"B`@("`@(%1/3D%154E.5"!.3U1%#0H@#0H@("`@/"]P/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!/;B!*=6YE(#(X
M+"`R,#$Q+"!W92!E;G1E<F5D(&EN=&\@82!497)M:6YA=&EO;B!!9W)E96UE
M;G0-"B`@("`-"B`@("`@('=I=&@@5&]N87%U:6YT+"!);F,N("A3964@3F]T
M92`U*2!U;F1E<B!W:&EC:"!B;W1H('!A<G1I97,-"B`@("`@#0H@("`@("!A
M9W)E960@=&AA="!I;B!C;VYS:61E<F%T:6]N(&]F('1H92!T97)M:6YA=&EO
M;B!O9B!A('=A<G)A;G0L#0H@("`-"B`@("`@('1H92!W86EV:6YG(&]F(&%L
M;"!F965S+"!P96YA;'1I97,L('1H92!C<F5A=&EO;B!O9B!T:&4-"B`@#0H@
M("`@("!S96QL:6YG('!R;V=R86T@86YD(&]T:&5R(&9A8W1O<G,L('=E(&%G
M<F5E9"!T;R!I<W-U92!A;@T*("`@#0H@("`@("!U;G-E8W5R960@;F]N+6-O
M;G9E<G1I8FQE('!R;VUI<W-O<GD@;F]T92`H=&AE(").97<@3F]T92(I(&EN
M#0H@("`-"B`@("`@('1H92!P<FEN8VEP86P@86UO=6YT(&]F("0S-C`L,3@V
M+"!W:&EC:"!P<F]V:61E<R!F;W(@86YN=6%L#0H@#0H@("`@("!I;G1E<F5S
M="!A="!A(')A=&4@;V8@-B4L('!A>6%B;&4@;6]N=&AL>2!I;B!E:71H97(@
M8V%S:"!O<@T*(`T*("`@("`@;W5R('-T;V-K+"!A="!O=7(@;W!T:6]N+B!4
M:&4@3F5W($YO=&4@:&%S(&$@;6%T=7)I='D@9&%T92!O9@T*("`@#0H@("`@
M("!!<')I;"`S,"P@,C`Q,BX-"B`@#0H@("`@/"]P/CQB<B\^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC9E\S8C-B
M7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F
M+U=O<FMS:&5E=',O4VAE970Q,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DY/5$4@-2X@0T].5D525$E"3$4@3D]415,@4$%9
M04),13QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M;VYG+71E<FT@1&5B="!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`-"B`@("`@
M($Y/5$4@-2X@0T].5D525$E"3$4@3D]415,@4$%904),10T*("`@("`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M($-O;G9E<G1I8FQE($YO=&5S(%!A>6%B;&4@8V]N<VES="!O9B!T:&4@9F]L
M;&]W:6YG(&%T#0H@("`@(`T*("`@("`@1&5C96UB97(@,S$L(#(P,3$Z#0H@
M("`@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L
M;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX-"B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('!A9&1I
M;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*
M("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SX-"B`@(`T*("`@("`@("`@(%5N86UO<G1I>F5D#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M#0H@("`-"B`@("`@("`@("!.970F(S$V,#L-"B`@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@
M("`@("`@("`@06-C<G5E9`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97([('!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI
M;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX-"B`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G/@T*("`@("`-
M"B`@("`@("`@("!0<FEN8VEP86P-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P
M="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED
M)SX-"B`@("`@#0H@("`@("`@("`@1&ES8V]U;G0-"B`@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M<'0@<V]L:60G/@T*("`@("`-"B`@("`@("`@("!!;6]U;G0-"B`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@26YT97)E<W0F(S$V
M,#L-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-#`E.R!P861D:6YG+6QE
M9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@("`-"B`@("`@("`@
M("!!;65N9&5D(&%N9"!297-T871E9"!397)I97,@02`Q,B4@0V]N=F5R=&EB
M;&4@3F]T97,L('!A<W0-"B`@(`T*("`@("`@("`@(&1U90T*("`@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`S)2<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$P)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`Y,#`L
M,#`P#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4G/@T*("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@#0H@("`@("`@("`@)B,X,C$R.PT*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,R4G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@
M.3`P+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E)SX-"B`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N
M.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#$S-2PP,#`-"B`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-
M"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T
M)SX-"B`-"B`@("`@("`@("`R,#`X(#$P)2!#;VYV97)T:6)L92!.;W1E<RP@
M<&%S="!D=64-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`@("`-"B`@("`@("`@("`R-2PP,#`-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F
M(S@R,3([#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@,C4L,#`P#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,3`L
M-S(Y#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X
M="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@("!$96-E;6)E<B`R,#`V
M(#$P)2!#;VYV97)T:6)L92!.;W1E<RP@<&%S="!D=64-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#$W+#`P,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q
M-RPP,#`-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`Q,BPV,#@-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H
M:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*(`T*("`@("`@("`@($UA
M>2`F86UP.R!*=6YE(#(P,#D@,3`E($-O;G9E<G1I8FQE($YO=&5S+"!P87-T
M(&1U90T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-
M"B`@("`@#0H@("`@("`@("`@-S4L,#`P#0H@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,X,C$R
M.PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@(#<U+#`P,`T*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#8Q+#,R,0T*
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD
M96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@2G5L>2`F86UP.R!!=6=U<W0@
M,C`P.2`Q,"4@0V]N=F5R=&EB;&4@3F]T97,L('!A<W0@9'5E#0H@("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`S,BPU,#`-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@,S(L-3`P#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,SDL-S<S#0H@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!7:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@
M("`@("!/8W1O8F5R("9A;7`[($YO=F5M8F5R(#(P,#D@,3`E($-O;G9E<G1I
M8FQE($YO=&5S+"!P87-T#0H@("`@(`T*("`@("`@("`@(&1U90T*("`@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@-S4L,#`P#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,X,C$R.PT*("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@(#<U+#`P,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#$Y+#8X.`T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P
M="<^#0H@#0H@("`@("`@("`@1F5B<G5A<GD@,C`Q,"`Q,"4@0V]N=F5R=&EB
M;&4@3F]T90T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(T,"PU-S@-"B`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@)B,X,C$R.PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(T,"PU-S@-"B`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@,C$L.3(P#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO
M='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E
M;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@("!!<')I;"`R,#$P(#$P)2!#;VYV
M97)T:6)L92!.;W1E#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@-S4L,#`P#0H@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@)B,X,C$R.PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@(#<U+#`P,`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#$S+#8R-0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R
M/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[
M('1E>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@4V5P=&5M8F5R
M(#(P,3`@,3`E($-O;G9E<G1I8FQE($YO=&5S#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,S8X
M+#$P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,S8X
M+#$P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`U."PS-C$-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H
M:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*(`T*("`@("`@("`@($%P
M<FEL(#(P,3$@,3`E($-O;G9E<G1I8FQE($YO=&5S#0H@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#0P,"PT,#`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@*#,X-"PT.#,-"B`@("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`I#0H@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@
M,34L.3$W#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@,S`L,#,P#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R
M9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-
M"B`@("`@("`@("!*=6QY(&%N9"!!=6=U<W0@,C`Q,2`Q,"4@0V]N=F5R=&EB
M;&4@3F]T97,-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@,S4W+#8U-0T*("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@
M("`H,3<X+#@Q,@T*("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`@("`-"B`@("`@("`@("`Q-S@L.#0S#0H@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#$U+#,R,0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R
M/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/@T*("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT
M.B`M,3!P="<^#0H@#0H@("`@("`@("`@4V5P=&5M8F5R(#(P,3$@0V]N=F5R
M=&EB;&4@3F]T97,-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,C4S+#<V,`T*("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`H,30R+#`W,PT*("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q,3$L-C@W#0H@("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@
M("`@("8C.#(Q,CL-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG
M/@T*("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#%P=#L@<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G
M/@T*("`-"B`@("`@("`@("!.;W9E;6)E<B`R,#$Q($-O;G9E<G1I8FQE($YO
M=&5S#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M
M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/@T*
M("`-"B`@("`@("`@("`U,C4L,#`P#0H@("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T
M.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*
M("`@("`@("`@("@Q-S8L.#`P#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P=#L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("D-"B`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F
M="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@
M("`@(#,T."PR,#`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@
M,30L,#@U#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[('1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M5VAI=&4G/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,BXU<'0[('!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z
M("TQ,'!T)SX-"B`@("`-"B`@("`@("`@("!4;W1A;"`F(S@R,3$[($-O;G9E
M<G1I8FQE($YO=&5S#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#,L,S0T+#DY,PT*
M("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU
M<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@
M*#@X,BPQ-C@-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`I#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R+C5P="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`R+#0V,BPX,C4-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T
M97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@(#0S,BPT-C$-"B`@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-
M"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`-
M"B`@("`@($-O;G9E<G1I8FQE($YO=&5S(%!A>6%B;&4@8V]N<VES=&5D(&]F
M('1H92!F;VQL;W=I;F<@870@36%R8V@-"B`@(`T*("`@("`@,S$L(#(P,3$Z
M#0H@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL
M<W!A8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`@#0H@("`@("`\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@)SX-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E
M>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97(G/@T*(`T*("`@("`@("`@(%5N86UO<G1I>F5D#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@#0H@("`@("`@
M("`@3F5T#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97(G/@T*(`T*("`@("`@("`@($%C8W)U960-"B`@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7
M:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`-"B`@("`@
M("`@("!0<FEN8VEP86P-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G/@T*("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`-"B`@("`@
M("`@("!$:7-C;W5N=`T*("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G/@T*("`@#0H@("`@("`@
M("`@06UO=6YT#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#%P="!S;VQI9"<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#%P="!S;VQI9"<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G
M/@T*("`@#0H@("`@("`@("`@26YT97)E<W0-"B`@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@-#`E.R!P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT
M.B`M,3!P="<^#0H@("`-"B`@("`@("`@("!!;65N9&5D(%-E<FEE<R!!(#$P
M)2!#;VYV97)T:6)L92!.;W1E<RP@<&%S="!D=64-"B`@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4G
M/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[
M('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@.3`P+#`P,`T*
M("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E)SX-"B`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H="<^
M#0H@(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#,E)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,3`E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#DP,"PP
M,#`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)2<^#0H@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P)3L@=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`S,RPW-3`-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*(`T*
M("`@("`@("`@(#(P,#@@,3`E($-O;G9E<G1I8FQE($YO=&5S+"!P87-T(&1U
M90T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@(#(U+#`P,`T*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C.#(Q,CL-
M"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`R-2PP,#`-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`W+#DQ-PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z
M("TQ,'!T)SX-"B`-"B`@("`@("`@("!$96-E;6)E<B`R,#`V(#$P)2!#;VYV
M97)T:6)L92!.;W1E<RP@<&%S="!D=64-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#$W+#`P,`T*
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q-RPP,#`-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`Q,"PV.38-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Q,'!T.R!T
M97AT+6EN9&5N=#H@+3$P<'0G/@T*(`T*("`@("`@("`@($UA>2`F86UP.R!*
M=6YE(#(P,#D@,3`E($-O;G9E<G1I8FQE($YO=&5S+"!P87-T(&1U90T*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@,C`P+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@,C`P+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`S,RPR.3(-"B`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@
M+3$P<'0G/@T*(`T*("`@("`@("`@($IU;'D@)F%M<#L@075G=7-T(#(P,#D@
M,3`E($-O;G9E<G1I8FQE($YO=&5S+"!P87-T(&1U90T*("`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@.#<L-3`P#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,X,C$R.PT*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#@W+#4P,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@(#,R+#`R,`T*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M5VAI=&4G/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE
M9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@
M3V-T;V)E<B`F86UP.R!.;W9E;6)E<B`R,#`Y(#$P)2!#;VYV97)T:6)L92!.
M;W1E<PT*("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@,C`U+#(U,`T*("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`H
M,3<L,C(V#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`I#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-
M"B`@("`@#0H@("`@("`@("`@,3@X+#`R-`T*("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`S,"PW
M.#@-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT
M+6EN9&5N=#H@+3$P<'0G/@T*(`T*("`@("`@("`@($9E8G)U87)Y(#(P,3`@
M,3`E($-O;G9E<G1I8FQE($YO=&4-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`W,34L-3<X
M#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`W,34L-3<X
M#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@(#4Y+#(W,PT*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G
M/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P
M<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@07!R:6P@
M,C`Q,"`Q,"4@0V]N=F5R=&EB;&4@3F]T90T*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#<U+#`P
M,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("@W,RPR,C(-"B`@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q+#<W.`T*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@-RPP-C,-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X
M*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z
M(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@2G5N
M92`R,#$P(#$R)2!#;VYV97)T:6)L92!.;W1E<RP@<&%S="!D=64-"B`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`R,2PQ.#D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@,C$L,3@Y#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@-C,V#0H@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L
M;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*(`T*("`@("`@
M("`@($IU;'D@,C`Q,"`V)2!#;VYV97)T:6)L92!.;W1E<PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@-#DU+#,T,PT*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`H-#DT+#<W,`T*("`@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("D-"B`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@
M("`U-S,-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@(#,U+#$P-PT*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,7!T.R!P861D:6YG+6QE9G0Z(#$P<'0[('1E
M>'0M:6YD96YT.B`M,3!P="<^#0H@(`T*("`@("`@("`@(%-E<'1E;6)E<B`R
M,#$P(#$P)2!#;VYV97)T:6)L92!.;W1E<PT*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX-"B`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[
M('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@-S,Y+#(P,`T*
M("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#%P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G
M/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`H-S$S+#DY,`T*("`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`Q<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`I#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`R-2PR,3`-"B`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#%P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`T,BPW,#D-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#%P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@<&%D9&EN9RUL969T
M.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U1O
M=&%L("T-"B`@(`T*("`@("`@("`@($-O;G9E<G1I8FQE($YO=&5S#0H@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-
M"B`@("`@#0H@("`@("`@("`@,RPT.#$L,#8P#0H@("`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`D#0H@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`H,2PR.3DL,C`X#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@
M("`@("`@("`@*0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,BPQ.#$L.#4R#0H@
M("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`R
M.3,L,C4Q#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T86)L93X\8G(O
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!!;&P@;V8@=&AE
M($-O;G9E<G1I8FQE($YO=&5S(%!A>6%B;&4@:6X@=&AE(&%B;W9E('1A8FQE
M<R!A<F4-"B`@#0H@("`@("!U;G-E8W5R960@86YD(&%R92!P<F5S96YT;'D@
M<&%S="!D=64@;W(@=VEL;"!B92!D=64@=VET:&EN#0H@("`@(`T*("`@("`@
M;VYE('EE87(@;V8@=&AE($1E8V5M8F5R(#,Q+"`R,#$Q(&)A;&%N8V4@<VAE
M970@9&%T92X@07,@80T*("`@("`-"B`@("`@(')E<W5L="P@=V4@97AP96-T
M('1O(&%M;W)T:7IE(&%L;"!O9B!T:&4@<F5M86EN:6YG(&1I<V-O=6YT<PT*
M("`-"B`@("`@(&1U<FEN9R!T:&4@9FER<W0@:&%L9B!O9B!C86QE;F1A<B!Y
M96%R(#(P,3(N#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!!345.1$5$($%.1"!215-4051%1"!315))15,@
M02`Q,B4@0T].5D525$E"3$4@3D]415,-"B`@(`T*("`@(#PO<#X\8G(O/CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@26X@2G5N92`R,#$P
M+"!W92!E;G1E<F5D(&EN=&\@06UE;F1E9"!A;F0@4F5S=&%T960@,3(E(%-E
M<FEE<PT*("`@#0H@("`@("!!($-O;G9E<G1I8FQE(%!R;VUI<W-O<GD@3F]T
M97,@*'1H92`B06UE;F1E9"!A;F0@4F5S=&%T960-"B`@("`-"B`@("`@($YO
M=&5S(BD@=VET:"!T:&4@:&]L9&5R<R!O9B!C97)T86EN('!R;VUI<W-O<GD@
M;F]T97,-"B`@("`-"B`@("`@('!R979I;W5S;'D@:7-S=65D(&)Y('1H92!#
M;VUP86YY("@F(S@R,C`[06UE;F1E9"!397)I97,@02`Q,"4-"B`@#0H@("`@
M("!#;VYV97)T:6)L92!.;W1E<R8C.#(R,3L@;W(@=&AE(")0<FEO<B!.;W1E
M<R(I+"!A;F0@86QL#0H@#0H@("`@("!A;65N9&UE;G1S('1O('1H92!0<FEO
M<B!.;W1E<RX-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!4:&4@06UE;F1E9"!A;F0@4F5S=&%T960@3F]T
M97,L(&EN('1H92!P<FEN8VEP86P@86UO=6YT(&]F#0H@("`@(`T*("`@("`@
M)#DP,"PP,#`L(&%R92!C;VYV97)T:6)L92!I;G1O(&%N(&%G9W)E9V%T92!O
M9B`T+#4P,"PP,#`-"B`@(`T*("`@("`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@
M<W1O8VL@<W5B:F5C="!T;R!A;G1I9&EL=71I;VX-"B`@#0H@("`@("!A9&IU
M<W1M96YT<RP@:6YC;'5D:6YG(&1O=VX@<F]U;F0@<')I8V4@<')O=&5C=&EO
M;BP@86YD#0H@(`T*("`@("`@;6%T=7)E9"!O;B!$96-E;6)E<B`S,2P@,C`Q
M,"X@26X@8V]N;F5C=&EO;B!W:71H('1H90T*("`@(`T*("`@("`@<F5S=')U
M8W1U<FEN9R!W92!P86ED("0U-"PP,#$@;V8@86-C<G5E9"!A;F0@9&5F875L
M="!I;G1E<F5S=`T*("`@#0H@("`@("!T:')O=6=H('1H92!D871E(&]F('1H
M92!R97-T<G5C='5R:6YG+"!L:7%U:61A=&5D(&1A;6%G97,@;V8-"B`@#0H@
M("`@("`D,C`U+#`P,"!A;F0@)#4T+#`P,R!O9B!P<F5P86ED(&EN=&5R97-T
M('1H<F]U9V@@=&AE#0H@("`@#0H@("`@("!E>'!I<F%T:6]N(&1A=&4@:6X@
M=&AE(&%G9W)E9V%T92!A;6]U;G0@;V8@)#,Q,RPP,#0@=&AR;W5G:`T*(`T*
M("`@("`@=&AE(&ES<W5A;F-E(&]F('5N:71S("@B56YI=',B*2!A="!A(&9I
M>&5D(')A=&4@;V8@)#`N,C`@<&5R#0H@(`T*("`@("`@56YI="P@96%C:"!5
M;FET(&-O;G-I<W1I;F<@;V8@;VYE('-H87)E(&]F(&]U<B!C;VUM;VX@<W1O
M8VL-"B`-"B`@("`@(&%N9"!O;F4@8V]M;6]N('-T;V-K('!U<F-H87-E('=A
M<G)A;G0@=&\@<'5R8VAA<V4@;VYE('-H87)E#0H@#0H@("`@("!O9B!O=7(@
M8V]M;6]N('-T;V-K(&%T(&$@9FEX960@97AE<F-I<V4@<')I8V4@;V8@)#`N
M,C`@<&5R#0H@("`@(`T*("`@("`@<VAA<F4@87,@<')E<V-R:6)E9"!I;B!T
M:&4@06UE;F1E9"!A;F0@4F5S=&%T960@3F]T90T*("`@(`T*("`@("`@06=R
M965M96YT+B`F(S$V,#L-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^#0H@("`@(`T*("`@("`@26X@861D:71I;VX@=&\@=&AE(&5X
M=&5N<VEO;B!O9B!T:&4@97AP:7)A=&EO;B!D871E(&]F('1H90T*("`@("`-
M"B`@("`@($%M96YD960@86YD(%)E<W1A=&5D($YO=&5S('1O($1E8V5M8F5R
M(#,Q+"`R,#$P+"!W92!A9W)E960@=&\-"B`@(`T*("`@("`@:6YC<F5A<V4@
M=&AE(&%N;G5A;"!I;G1E<F5S="8C,38P.W)A=&4@9G)O;2!T96X@<&5R8V5N
M="!T;PT*("`@(`T*("`@("`@='=E;'9E('!E<F-E;G0N(%=E(&%L<V\@86=R
M965D('1O(&-H86YG92!T:&4@97AE<F-I<V4@<')I8V5S#0H@(`T*("`@("`@
M;VX@86QL(&]F('1H92!W87)R86YT<R!H96QD(&)Y('1H92!N;W1E:&]L9&5R
M<R!T;R`D,"XR,"!P97(-"B`-"B`@("`@('-H87)E+"!T;R!C:&%N9V4@8V5R
M=&%I;B!F;W)M97)L>2!C;VYT:6YG96YT('=A<G)A;G1S('1O#0H@("`-"B`@
M("`@(&YO;BUC;VYT:6YG96YT('=A<G)A;G1S(&%N9"!T;R!E>'1E;F0@=&AE
M(&5X<&ER871I;VX@9&%T92!O9@T*("`-"B`@("`@('1H96ER('=A<G)A;G1S
M('1O($9E8G)U87)Y(#(P,38N(%1H92!F;VQL;W=I;F<@=&%B;&4-"B`@("`-
M"B`@("`@('-U;6UA<FEZ97,@=&AE(&YU;6)E<B!O9B!S:&%R97,@;V8@;W5R
M(&-O;6UO;B!S=&]C:R!I<W-U86)L90T*("`-"B`@("`@('5P;VX@=&AE(&-O
M;G9E<G-I;VX@;V8@=&AE($%M96YD960@86YD(%)E<W1A=&5D($YO=&5S(&]R
M('1H90T*("`-"B`@("`@(&5X97)C:7-E(&]F('1H92!V87)I;W5S('=A<G)A
M;G1S(&ES<W5E9"!O<B!I<W-U86)L92!P=7)S=6%N=`T*("`-"B`@("`@('1O
M('1H92!!;65N9&5D(&%N9"!297-T871E9"!.;W1E<RX-"B`-"B`@("`\+W`^
M/&)R+SX\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!W:61T:#H@,3`P)3L@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S92<^
M#0H@("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@V)3L@;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@("!.;W1E($-O;G9E<G-I;VX-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-
M"B`@("`@("`@("`D)B,Q-C`[#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&QI;F4M:&5I9VAT
M.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@#0H@("`@("`@("`@-"PU
M,#`L,#`P#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/@T*
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@("`@#0H@("`@("`@("`@5V%R<F%N=',-"B`@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#%P="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24G/@T*("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@
M<V]L:60[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^
M#0H@#0H@("`@("`@("`@,3$L-C0V+#$R-0T*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G
M8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("!4;W1A;`T*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH
M96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P.R`D#0H@("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@
M,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q
M-BPQ-#8L,3(U#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\
M+W1R/@T*("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@#0H@("`@("!&;W(@86-C;W5N=&EN9R!P=7)P;W-E<RP@=&AE
M(&%M96YD;65N="!O9B!T:&4@,3(E(%-E<FEE<R!!#0H@("`@(`T*("`@("`@
M0V]N=F5R=&EB;&4@3F]T97,@=V%S('1R96%T960@87,@82!D96)T(&5X=&EN
M9W5I<VAM96YT(&EN#0H@("`@#0H@("`@("!A8V-O<F1A;F-E('=I=&@@1D%3
M0B!!4T,@-#<P+34P+"!$96)T+4UO9&EF:6-A=&EO;G,@86YD#0H@(`T*("`@
M("`@17AT:6YG=6ES:&UE;G1S+"!A<R!T:&4@=&5R;7,@;V8@=&AE(')E<W1R
M=6-T=7)E9"!A9W)E96UE;G1S#0H@(`T*("`@("`@=V5R92!D965M960@=&\@
M8F4@<W5B<W1A;G1I86QL>2!D:69F97)E;G0@=&AA;B!T:&]S92!O9B!T:&4-
M"B`-"B`@("`@('!R:6]R(&%G<F5E;65N=',N#0H@("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!"87-E9"!O
M;B!C;VYV97)S:6]N(&%N9"!E>&5R8VES92!P<FEC92!R92US970@<')O=FES
M:6]N<PT*("`@#0H@("`@("!I;F-L=61E9"!I;B!T:&4@06UE;F1E9"!A;F0@
M4F5S=&%T960@3F]T97,F(S$V,#MW87)R86YT#0H@#0H@("`@("!A9W)E96UE
M;G1S+"!T:&4@96UB961D960@8V]N=F5R<VEO;B!F96%T=7)E(&%N9"!T:&4@
M<F5L871E9`T*(`T*("`@("`@=V%R<F%N=',L('=I=&@@86X@86=G<F5G871E
M(&5S=&EM871E9"!F86ER('9A;'5E(&]F#0H@("`-"B`@("`@(&%P<')O>&EM
M871E;'D@)#,L,#@Y+#`P,"PF(S$V,#MW97)E(&-L87-S:69I960@87,@9&5R
M:79A=&EV90T*(`T*("`@("`@;&EA8FEL:71Y(&EN<W1R=6UE;G1S("A3964@
M3F]T92`Y*2X-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!#;VYS97%U96YT;'DL(&%T('1H92!A;65N9&UE
M;G0@9&%T92!W92!R96-O<F1E9"!A(&QO<W,@;VX-"B`@("`-"B`@("`@(&5X
M=&EN9W5I<VAM96YT(&]F("0R+#(R-BPY,C0@87,@9F]L;&]W<SH-"B`@#0H@
M("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@=VED=&@Z(#$P,"4[(&)O<F1E<BUC;VQL87!S93H@8V]L
M;&%P<V4G/@T*("`@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR
M,C@I)SX-"B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X-R4[
M(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@4F5A8W%U:7-I
M=&EO;B!P<FEC90T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[(&QI
M;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@#0H@("`@
M("`@("`@-"PS.#4L.3(U#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z
M(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7
M:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@3&5S<R!C87)R>6EN9R!V86QU
M92!O9B!N;W1E<R!A;F0@<F5L871E9`T*(`T*("`@("`@("`@(&EN<W1R=6UE
M;G1S)B,Q-C`[#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED
M.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P="!S;VQI9#L@;&EN92UH96EG:'0Z
M(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`H,BPQ
M-3DL,#`Q#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`I)B,Q-C`[#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO
M='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-
M"B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@3&]S<R!O;B!E>'1I;F=U:7-H;65N="8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.PT*("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U
M<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`@("`-"B`@("`@("`@("`R+#(R-BPY,C0-"B`@("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T
M86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!!
M<R!O9B!$96-E;6)E<B`S,2P@,C`Q,"P@=&AE($%M96YD960@86YD(%)E<W1A
M=&5D($YO=&5S#0H@(`T*("`@("`@;6%T=7)E9"!A;F0@87,@;V8@1&5C96UB
M97(@,S$L(#(P,3$@87)E(&EN(&1E9F%U;'0N#0H@("`-"B`@("`\+W`^/&)R
M+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E(&AA=F4@
M8F5G=6X@9&ES8W5S<VEO;G,@=VET:"!T:&4@;F]T96AO;&1E<G,@<F5G87)D
M:6YG(&%N#0H@#0H@("`@("!E>'1E;G-I;VX@=&\@=&AE(&YO=&5S(&)U="!T
M:&5R92!C86X@8F4@;F\@87-S=7)A;F-E('1H870@=V4-"B`@#0H@("`@("!W
M:6QL(&)E(&%B;&4@=&\@9&\@<V\@;VX@=&5R;7,@=&AA="!W92!D965M(&%C
M8V5P=&%B;&4@;W(@870-"B`@#0H@("`@("!A;&PN#0H@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("`R,#`X(#$P
M)2!#3TY615)424),12!.3U1%4PT*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!/;F4@,C`P."`Q,"4@0V]N
M=F5R=&EB;&4@3F]T92!I;B!T:&4@86UO=6YT(&]F("0R-2PP,#`@=VAI8V@-
M"B`@#0H@("`@("!M871U<F5D(&EN($IA;G5A<GD@,C`Q,"!R96UA:6YS(&]U
M='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+`T*(`T*("`@("`@,C`Q,2X@5&AI
M<R!N;W1E(&ES(&-O;G9E<G1I8FQE(&EN=&\@;W5R(&-O;6UO;B!S=&]C:R!A
M="`D,"XU,`T*("`@#0H@("`@("!P97(@<VAA<F4N($1U<FEN9R!T:&4@9FES
M8V%L('EE87(@96YD960@36%R8V@@,S$L(#(P,3$@=V4-"B`@("`-"B`@("`@
M(&%G<F5E9"!T;R!C;VYV97)T('1H92`D,C`L,#`P('!R:6YC:7!A;"!A;F0@
M<F5L871E9"!A8V-R=65D#0H@#0H@("`@("!I;G1E<F5S="!O9B`D-2PU-C(@
M;V8@;VYE(&AO;&1E<B!O9B!T:&4@,C`P."`Q,"4@0V]N=F5R=&EB;&4-"B`@
M#0H@("`@("!.;W1E(&EN=&\@,3(W+#@P."!S:&%R97,@;V8@8V]M;6]N('-T
M;V-K(&)A<V5D('5P;VX@80T*("`@("`-"B`@("`@(&-O;G9E<G-I;VX@<F%T
M:6\@;V8@)#`N,C`@<&5R('-H87)E(')A=&AE<B!T:&%N(&%T('1H92!S=&%T
M960-"B`@(`T*("`@("`@8V]N=F5R<VEO;B!R871I;R!O9B`D,"XU,"!P97(@
M<VAA<F4N($%S(&$@<F5S=6QT(&]F('1H:7,-"B`@(`T*("`@("`@8VAA;F=E
M+"!W92!R96-O<F1E9"!A(&-H87)G92!O9B`D,34L,S,W(&%S(&EN=&5R97-T
M(&5X<&5N<V4-"B`-"B`@("`@(&EN('1H92!F:7-C86P@>65A<B!E;F1E9"!-
M87)C:"`S,2P@,C`Q,2X-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!$14-%34)%4B`R,#`V(#$P)2!#3TY6
M15)424),12!.3U1%4PT*("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@($%T($1E8V5M8F5R(#,Q+"`R,#$Q+"`D
M,3<L,#`P(&]F('1H92!$96-E;6)E<B`R,#`V(#$P)2!.;W1E<PT*("`-"B`@
M("`@(')E;6%I;F5D(&]U='-T86YD:6YG(&%N9"!I;B!D969A=6QT+B!4:&5S
M92!N;W1E<R!A<F4-"B`@("`-"B`@("`@(&-O;G9E<G1I8FQE(&EN=&\@;W5R
M(&-O;6UO;B!S=&]C:R!A="`D,"XQ-R!P97(@<VAA<F4N#0H@("`@(`T*("`@
M(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@
M34%9("9A;7`[($I53D4@,C`P.2`Q,"4@0T].5D525$E"3$4@3D]415,-"B`@
M#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@
M("`@("!);B!-87D@86YD($IU;F4@,C`P.2P@=V4@<F%I<V5D(&%N(&%G9W)E
M9V%T92!A;6]U;G0@;V8-"B`-"B`@("`@("0S-3`L,#`P(&9R;VT@=&AE('-A
M;&4@=&\@86-C<F5D:71E9"!I;G9E<W1O<G,@;V8@,3`E#0H@("`@(`T*("`@
M("`@8V]N=F5R=&EB;&4@;F]T97,@*")-87D@)F%M<#L@2G5N92`R,#`Y(#$P
M)2!#;VYV97)T:6)L90T*(`T*("`@("`@3F]T97,B*2X@5&AE($UA>2`F86UP
M.R!*=6YE(#(P,#D@,3`E($-O;G9E<G1I8FQE($YO=&5S#0H@("`@(`T*("`@
M("`@;6%T=7)E9"!A="!V87)I;W5S(&1A=&5S(&)E='=E96X@3F]V96UB97(@
M,C`Q,"!T:')O=6=H#0H@#0H@("`@("!$96-E;6)E<B`R,#$P(&%N9"!A<F4@
M8V]N=F5R=&EB;&4@:6YT;R!O=7(@8V]M;6]N('-T;V-K(&%T(&$-"B`@#0H@
M("`@("!F:7AE9"!C;VYV97)S:6]N('!R:6-E(&]F("0P+C(P('!E<B!S:&%R
M92!P<FEO<B!T;R!M871U<FET>2X-"B`@#0H@("`@("!5<&]N(&-O;G9E<G-I
M;VX@;V8@=&AE($UA>2!A;F0@2G5N92`R,#`Y(#$P)2!#;VYV97)T:6)L90T*
M("`@#0H@("`@("!.;W1E<RP@=&AE)B,Q-C`[;F]T92!H;VQD97)S('=I;&P@
M<F5C96EV92!A(&UA=&-H:6YG('1H<F5E#0H@("`@#0H@("`@("!Y96%R('=A
M<G)A;G0@=&\@<'5R8VAA<V4@=6YR96=I<W1E<F5D('-H87)E<R!O9B!O=7(@
M8V]M;6]N#0H@("`@(`T*("`@("`@<W1O8VL@870@82!P<FEC92!O9B`D,"XR
M,"!P97(@<VAA<F4N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@($%F=&5R(&-O;G-I9&5R871I;VX@;V8@
M=&AE('=A<G)A;G1S+"!W92!R96-O<F1E9"!A(&1I<V-O=6YT#0H@#0H@("`@
M("!A<W-O8VEA=&5D('=I=&@@=&AE(&)E;F5F:6-I86P@8V]N=F5R<VEO;B!F
M96%T=7)E(&]F("0R,S,L-S,U#0H@("`-"B`@("`@(')E;&%T960@=&\@=&AE
M($UA>2`F86UP.R!*=6YE(#(P,#D@,3`E($-O;G9E<G1I8FQE($YO=&5S(&%N
M9`T*(`T*("`@("`@=V4@86UO<G1I>F5D('1H870@9&ES8V]U;G0@;W9E<B!T
M:&4@=&5R;7,@;V8@=&AE(')E<W!E8W1I=F4-"B`-"B`@("`@(&-O;G9E<G1I
M8FQE(&YO=&5S('5S:6YG('1H92!E9F9E8W1I=F4@:6YT97)E<W0@;65T:&]D
M+@T*(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@
M(`T*("`@("`@5&AE(&9O;&QO=VEN9R!C;VYV97)S:6]N<R!O9B!T:&4@36%Y
M("9A;7`[($IU;F4@,C`P.2`Q,"4-"B`@#0H@("`@("!#;VYV97)T:6)L92!.
M;W1E<R!H879E('1A:V5N('!L86-E(&1U<FEN9R!T:&4@9FES8V%L('EE87)S
M#0H@("`@(`T*("`@("`@96YD960@36%R8V@@,S$L(#(P,3$@86YD(#(P,3`Z
M#0H@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P
M<V4Z(&-O;&QA<'-E)SX-"B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA
M;&EG;CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@1FES8V%L(%EE87(\8G(@
M+SX-"B`@("`-"B`@("`@("`@("!%;F1E9`T*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q
M-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@#0H@
M("`@("`@("`@1FES8V%L(%EE87(\8G(@+SX-"B`@("`-"B`@("`@("`@("!%
M;F1E9`T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-
M"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`-"B`@("`@("`@
M("!-87)C:"`S,2P@,C`Q,`T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)3L@
M=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`-"B`@("`@("`@("!-87)C:"`S
M,2P@,C`Q,0T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-S(E.R!L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@(`T*("`@("`@("`@(%!R:6YC:7!A;"!C;VYV97)T960-
M"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!L:6YE+6AE:6=H=#H@
M,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*(`T*("`@("`@("`@(#4P+#`P
M,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&QI;F4M
M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@#0H@("`@("`@
M("`@,3`P+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[("<^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("!!
M8V-R=65D(&EN=&5R97-T(&-O;G9E<G1E9`T*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q
M,34E)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@(#(L.#`S
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@
M)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*
M("`@(`T*("`@("`@("`@(#$U+#`S.0T*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%
M145%)SX-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@(%=A<G)A;G1S(&ES<W5E9`T*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*
M("`@(`T*("`@("`@("`@(#(U,"PP,#`-"B`@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q
M-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@
M-3`P+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\
M+W1R/@T*("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@#0H@("`@("!!<R!A(')E<W5L="!O9B!T:&4@=V%R<F%N="!I
M<W-U86YC97,L('=E(')E8V]R9&5D(&-H87)G97,@;V8-"B`@#0H@("`@("`D
M,S$L-34P(&%N9"`D-S0L-C4R(&%S(&%D9&ET:6]N86P@:6YT97)E<W0@97AP
M96YS92!I;B!T:&4-"B`@("`-"B`@("`@(&9I<V-A;"!Y96%R<R!E;F1E9"!-
M87)C:"`S,2P@,C`Q,"!A;F0@,C`Q,2P@<F5S<&5C=&EV96QY+@T*("`@(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@3VX@;W(@86)O=70@2G5N92`R,RP@,C`Q,2P@=&AE(&AO;&1E<B!O9B!T
M:&4@='=O(')E;6%I;FEN9PT*("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$
M)V-O;&]R.B!B;&%C:R<^36%Y("9A;7`[($IU;F4@,C`P.2`Q,"4-"B`@#0H@
M("`@("!#;VYV97)T:6)L92!.;W1E<RP@2F]H;B!"87)S96QL+#PO9F]N=#X@
M9FEL960@82!C;VUP;&%I;G0-"B`@("`@#0H@("`@("!A9V%I;G-T('5S(&5N
M=&ET;&5D(#QI/DIO:&X@12X@0F%R<V5L;"!V+B!!971H;&]N($UE9&EC86PL
M#0H@#0H@("`@("!);F,\+VD^+BP@:6X@=&AE(%-U<&5R:6]R($-O=7)T(&]F
M('1H92!3=&%T92!O9B!#86QI9F]R;FEA#0H@#0H@("`@("!F;W(@=&AE($-O
M=6YT>2!O9B!386X@1&EE9V\L($-A<V4@3F\N(#,W+3(P,3$M,#`P.3,S-S0@
M*'1H90T*(`T*("`@("`@)B,X,C(P.TQA=W-U:70F(S@R,C$[*2X@5&AE(&-O
M;7!L86EN="!A;&QE9V5D(&)R96%C:"!O9@T*("`@("`-"B`@("`@(&-O;G1R
M86-T(&EN(&-O;FYE8W1I;VX@=VET:"!C97)T86EN(&YO=&5S(&EN('1H92!A
M9V=R96=A=&4-"B`@("`@#0H@("`@("!P<FEN8VEP86P@86UO=6YT(&]F("0R
M,#`L,#`P(&ES<W5E9"!B>2!U<R!T;R!"87)S96QL(&EN(#(P,#DN#0H@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)V-O;&]R.B!B;&%C:R<^3VX@075G=7-T
M(#$U+"`R,#$Q+"!W92!A;F0@0F%R<V5L;`T*("`@(`T*("`@("`@<VEG;F5D
M(&$@4V5T=&QE;65N="!!9W)E96UE;G0@=6YD97(@=VAI8V@@=V4@86=R965D
M('1O(')E<&%Y#0H@(`T*("`@("`@=&AE(&YO=&5S(&%N9"!R96QA=&5D(&%C
M8W)U960@:6YT97)E<W0@:6X@8V%S:"!O<B!I;B!C;VUM;VX-"B`-"B`@("`@
M('-T;V-K+"!A="!T:&4@96QE8W1I;VX@;V8@=&AE($-O;7!A;GDL(&]N(&$@
M;6]N=&AL>2!B87-I<PT*("`@(`T*("`@("`@;W9E<B!A<'!R;WAI;6%T96QY
M(&$@=&5N(&UO;G1H('!E<FEO9"!O9B!T:6UE+B!);B!E>&-H86YG92P-"B`-
M"B`@("`@($)A<G-E;&P@9&ES;6ES<V5D('1H92!,87=S=6ET('=I=&AO=70@
M<')E:G5D:6-E+B!4:&4@86=R965D#0H@#0H@("`@("!M;VYT:&QY('!A>6UE
M;G1S(&%R92`D,C4L,#`P(&EF(&EN(&-A<V@@;W(@)#,P+#`P,"!I9B!I;@T*
M("`@#0H@("`@("!S=&]C:R!W:71H("0R-2PP,#`@;V8@=&AE("0S,"PP,#`@
M86UO=6YT(&=O:6YG('1O=V%R9',-"B`-"B`@("`@('!R:6YC:7!A;"!R961U
M8W1I;VX@86YD('1H92!R96UA:6YI;F<@)#4L,#`P(&%S(&$@<&5N86QT>2!F
M;W(-"B`@(`T*("`@("`@<&%Y:6YG(&EN('-T;V-K+CPO9F]N=#X-"B`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M($9O;&QO=VEN9R!T:&4@4V5T=&QE;65N="!!9W)E96UE;G0@86YD('1H<F]U
M9V@@1&5C96UB97(@,S$L#0H@#0H@("`@("`R,#$Q+"!"87)S96QL(&-O;G9E
M<G1E9"`D,3(U+#`P,"!O9B!P<FEN8VEP86P@:6YT;R`R+#0S-RPT,C4-"B`@
M#0H@("`@("!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!O=F5R(&9I=F4@
M;6]N=&AL>2!I<W-U86YC97,N(%1H;W-E#0H@("`-"B`@("`@('-H87)E(&ES
M<W5A;F-E<R!A;'-O(&-O=F5R960@)#(U+#`P,"!I;B!P96YA;'1I97,@87,@
M;F]T960-"B`@("`@#0H@("`@("!A8F]V92X-"B`@(`T*("`@(#PO<#X\8G(O
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@070@1&5C96UB
M97(@,S$L(#(P,3$L('1H92!R96UA:6YI;F<@<')I;F-I<&%L(&)A;&%N8V4@
M;V8-"B`@(`T*("`@("`@)#<U+#`P,"!W87,@:6X@9&5F875L="`H<V5E($YO
M=&4@,3,I+@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@2E5,62`F86UP.R!!54=54U0@,C`P.2`Q,"4@
M0T].5D525$E"3$4@3D]415,-"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!);B!*=6QY(&%N9"!!=6=U
M<W0@,C`P.2P@=V4@<F%I<V5D(&%N(&%G9W)E9V%T92!A;6]U;G0@;V8-"B`@
M("`-"B`@("`@("0V-C@L,C4P(&9R;VT@=&AE('-A;&4@=&\@=&AR964@:6YV
M97-T;65N="!F=6YD<R!O9B`Q,"4-"B`@#0H@("`@("!C;VYV97)T:6)L92!N
M;W1E<R`H(DIU;'D@)F%M<#L@075G=7-T(#(P,#D@,3`E($-O;G9E<G1I8FQE
M#0H@("`@#0H@("`@("!.;W1E<R(I+B!%86-H(&YO=&4@8V%R<FEE9"!A(&]N
M92UY96%R('1E<FT@86YD(&ES(&-O;G9E<G1I8FQE#0H@("`-"B`@("`@(&EN
M=&\@;W5R(&-O;6UO;B!S=&]C:R!A="`X,"4@;V8@;6%R:V5T('=I=&@@82!F
M;&]O<B!O9B`D,"XQ-0T*("`-"B`@("`@(&-E;G1S(&%N9"!A(&-E:6QI;F<@
M;V8@)#`N,C4@8V5N=',@<&5R('-H87)E+B!!<R!A9&1I=&EO;F%L#0H@#0H@
M("`@("!C;VYS:61E<F%T:6]N+"!T:&4@:6YV97-T;W)S(&%L<V\@<F5C96EV
M960@,2PS,S8L-3`P('1H<F5E#0H@("`@(`T*("`@("`@>65A<B!W87)R86YT
M<R!T;R!P=7)C:&%S92!O=7(@8V]M;6]N('-T;V-K(&%T("0P+C4P('!E<@T*
M("`-"B`@("`@('-H87)E+"!A;'1H;W5G:"!T:&%T(&5X97)C:7-E('!R:6-E
M(&ES('-U8FIE8W0@=&\@8VAA;F=E#0H@("`-"B`@("`@(&)A<V5D(&]N(&-E
M<G1A:6X@8V]N9&ET:6]N<RX@5&AE(&-O;G9E<G-I;VX@9F5A='5R92!M87D-
M"B`@#0H@("`@("!A9&1I=&EO;F%L;'D@8F4@861J=7-T960@:6X@=&AE(&5V
M96YT(&]F(&9U='5R92!F:6YA;F-I;F<@8GD-"B`@#0H@("`@("!T:&4@0V]M
M<&%N>2X@0F5C875S92!T:&4@8V]N=F5R<VEO;B!F96%T=7)E(&%N9"!W87)R
M86YT#0H@(`T*("`@("`@97AE<F-I<V4@<')I8V4@96%C:"!C86X@8F4@<F5S
M970@8F%S960@;VX@9G5T=7)E(&5V96YT<RP@=&AE>0T*("`@#0H@("`@("!A
M<F4@8VQA<W-I9FEE9"!A<R!D97)I=F%T:79E(&QI86)I;&ET>2!I;G-T<G5M
M96YT<RX-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M#0H@("`@(`T*("`@("`@0F%S960@;VX@=&AE(&EN:71I86P@97-T:6UA=&5D
M(&9A:7(@=F%L=64@;V8@=&AE(&-O;G9E<G-I;VX-"B`-"B`@("`@(&9E871U
M<F4@86YD('=A<G)A;G1S+"!W92!R96-O<F1E9"!A(&1I<V-O=6YT(&%S<V]C
M:6%T960@=VET:`T*("`-"B`@("`@('1H92!D97)I=F%T:79E(&QI86)I;&ET
M>2!O9B`D-#<U+#<V,BP@=VAI8V@@=V%S(&%M;W)T:7IE9`T*("`@(`T*("`@
M("`@=7-I;F<@=&AE(&5F9F5C=&EV92!I;G1E<F5S="!M971H;V0@;W9E<B!T
M:&4@;VYE+7EE87(@=&5R;2!O9@T*("`@#0H@("`@("!T:&4@;F]T97,N($1E
M9F5R<F5D(&9I;F%N8VEN9R!C;W-T<R!I;F-U<G)E9"!I;B!C;VYN96-T:6]N
M#0H@("`@(`T*("`@("`@=VET:"!T:&ES(&9I;F%N8VEN9R!T;W1A;&5D("0V
M,"PW-3`L('=H:6-H('=E<F4@8V%P:71A;&EZ960-"B`-"B`@("`@(&%N9"!A
M<F4@8F5I;F<@86UO<G1I>F5D('5S:6YG('1H92!E9F9E8W1I=F4@:6YT97)E
M<W0@;65T:&]D#0H@#0H@("`@("!O=F5R('1H92!O;F4M>65A<B!T97)M(&]F
M('1H92!N;W1E<RX-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^#0H@("`@(`T*("`@("`@5&AE(&9O;&QO=VEN9R!C;VYV97)S:6]N
M<R!O9B!T:&4@2G5L>2`F86UP.R!!=6=U<W0@,C`P.2`Q,"4-"B`@("`@#0H@
M("`@("!#;VYV97)T:6)L92!.;W1E<R!H879E('1A:V5N('!L86-E(&1U<FEN
M9R!T:&4@9FES8V%L('EE87)S#0H@("`@(`T*("`@("`@96YD960@36%R8V@@
M,S$L(#(P,3$@86YD(#(P,3`Z#0H@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C
M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H
M.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97(G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@
M("`-"B`@("`@("`@("!&:7-C86P@665A<CQB<B`O/@T*("`@(`T*("`@("`@
M("`@($5N9&5D#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@($9I<V-A;"!996%R
M/&)R("\^#0H@("`@#0H@("`@("`@("`@16YD960-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@
M("`@36%R8V@@,S$L(#(P,3`-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^
M#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-
M"B`@("`@#0H@("`@("`@("`@36%R8V@@,S$L(#(P,3$-"B`@("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M
M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#4V)2<^#0H@("`-"B`@("`@("`@("!0<FEN8VEP
M86P@8V]N=F5R=&5D#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)2<^#0H@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$R)3L@=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`S,S`L,#`P#0H@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@."4G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q,B4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@
M,C4P+#<U,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-
M"B`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@06-C<G5E9"!I
M;G1E<F5S="!C;VYV97)T960-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(R+#4U.0T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@
M,3`L-CDX#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^
M#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-
M"B`@("`-"B`@("`@($%T($1E8V5M8F5R(#,Q+"`R,#$Q+"!T:&4@<F5M86EN
M:6YG('!R:6YC:7!A;"!B86QA;F-E(&]F#0H@("`-"B`@("`@("0S,BPU,#`@
M=V%S(&EN(&1E9F%U;'0N#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3T-43T)%4B`F86UP.R!.3U9%
M34)%4B`R,#`Y(#$P)2!#3TY615)424),12!.3U1%4PT*("`@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($EN
M($]C=&]B97(@86YD($YO=F5M8F5R(#(P,#DL('=E(')A:7-E9"`D-#,P+#`P
M,"!F<F]M('1H90T*("`@(`T*("`@("`@<V%L92!T;R!A8V-R961I=&5D(&EN
M=F5S=&]R<R!O9B`Q,"4@8V]N=F5R=&EB;&4@;F]T97,-"B`@("`@#0H@("`@
M("`H(D]C=&]B97(@)F%M<#L@3F]V96UB97(@,C`P.2`Q,"4@0V]N=F5R=&EB
M;&4@3F]T97,B*2X@5&AE#0H@("`@#0H@("`@("!/8W1O8F5R("9A;7`[($YO
M=F5M8F5R(#(P,#D@,3`E($-O;G9E<G1I8FQE($YO=&5S(&UA='5R92!A=`T*
M("`@("`-"B`@("`@('9A<FEO=7,@9&%T97,@8F5T=V5E;B!!<')I;"`R,#$Q
M(&%N9"!-87D@,C`Q,2!A;F0@87)E#0H@("`@(`T*("`@("`@8V]N=F5R=&EB
M;&4@:6YT;R!O=7(@8V]M;6]N('-T;V-K(&%T(&$@9FEX960F(S$V,#MC;VYV
M97)S:6]N#0H@#0H@("`@("!P<FEC92!O9B`D,"XR-2!P97(@<VAA<F4@<')I
M;W(@=&\@;6%T=7)I='DN(%1H92!I;G9E<W1O<G,-"B`@("`-"B`@("`@(&%L
M<V\@<F5C96EV960@;6%T8VAI;F<@=&AR964@>65A<B!W87)R86YT<R!T;R!P
M=7)C:&%S90T*(`T*("`@("`@=6YR96=I<W1E<F5D('-H87)E<R!O9B!O=7(@
M8V]M;6]N('-T;V-K(&%T(&$@<')I8V4@;V8@)#`N,C4-"B`-"B`@("`@('!E
M<B!S:&%R92XF(S$V,#LF(S$V,#M792!M96%S=7)E9"!T:&4@9F%I<B!V86QU
M92!O9B!T:&4-"B`@("`@#0H@("`@("!W87)R86YT<R!A;F0@=&AE(&)E;F5F
M:6-I86P@8V]N=F5R<VEO;B!F96%T=7)E(&]F('1H92!N;W1E<PT*(`T*("`@
M("`@86YD(')E8V]R9&5D(&$@,3`P)2!D:7-C;W5N="!A9V%I;G-T('1H92!P
M<FEN8VEP86P@;V8@=&AE#0H@("`@#0H@("`@("!N;W1E<RX@5V4@87)E(&%M
M;W)T:7II;F<@=&AI<R!D:7-C;W5N="!U<VEN9R!T:&4@969F96-T:79E#0H@
M("`@(`T*("`@("`@:6YT97)E<W0@;65T:&]D(&]V97(@=&AE('1E<FT@;V8@
M=&AE(&YO=&5S+@T*("`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@(%1H92!F;VQL;W=I;F<@8V]N=F5R<VEO
M;G,@;V8@=&AE($]C=&]B97(@)F%M<#L@3F]V96UB97(@,C`P.0T*(`T*("`@
M("`@,3`E($-O;G9E<G1I8FQE($YO=&5S('1O;VL@<&QA8V4@9'5R:6YG('1H
M92!F:7-C86P@>65A<G,-"B`@(`T*("`@("`@96YD960@36%R8V@@,S$L(#(P
M,3$@86YD(#(P,3`Z#0H@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<&%D
M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E
M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX-
M"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P
M86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@
M("`@("`@("!&:7-C86P@665A<CQB<B`O/@T*("`@(`T*("`@("`@("`@($5N
M9&5D#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@($9I<V-A;"!996%R/&)R("\^
M#0H@("`@#0H@("`@("`@("`@16YD960-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P
M86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@36%R
M8V@@,S$L(#(P,3`-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@
M#0H@("`@("`@("`@36%R8V@@,S$L(#(P,3$-"B`@("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#8R)2<^#0H@("`-"B`@("`@("`@("!0<FEN8VEP86P@8V]N
M=F5R=&5D#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`X)2<^#0H@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$R)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*
M("`-"B`@("`@("`@("`W,"PP,#`-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#(E
M)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3(E
M.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#$W-2PP,#`-
M"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@("`-"B`@
M("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@($%C8W)U960@:6YT97)E<W0@
M8V]N=F5R=&5D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`X+#<U,`T*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@
M("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`-"B`@
M("`@(%1H92!F;VQL;W=I;F<@8V]N=F5R<VEO;G,@;V8@=&AE($]C=&]B97(@
M)F%M<#L@3F]V96UB97(@,C`P.0T*(`T*("`@("`@,3`E($-O;G9E<G1I8FQE
M($YO=&5S('1O;VL@<&QA8V4@9'5R:6YG('1H92!N:6YE(&UO;G1H<R!E;F1E
M9`T*("`@#0H@("`@("!$96-E;6)E<B`S,2P@,C`Q,3H-"B`@("`@#0H@("`@
M/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS
M1#`@<W1Y;&4],T0G=VED=&@Z(#@P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^#0H@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("!.:6YE($UO;G1H<SQB<B`O
M/@T*("`@(`T*("`@("`@("`@($5N9&5D#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@($1E
M8V5M8F5R(#,Q+#QB<B`O/@T*("`@("`-"B`@("`@("`@("`R,#$Q#0H@("`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`V,"4G/@T*("`@#0H@("`@("`@("`@
M4')I;F-I<&%L(&-O;G9E<G1E9`T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E)SX-"B`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$R)3L@=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`Q,S`L,C4P#0H@("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/@T*("`@#0H@("`@("`@(#QT
M9#X-"B`@("`-"B`@("`@("`@("!!8V-R=65D(&EN=&5R97-T(&-O;G9E<G1E
M9`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@
M#0H@("`@("`@("`@,C$L,C@X#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@(#PO='(^#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`-"B`@("`@($1E9F5R<F5D(&9I;F%N8VEN9R!C
M;W-T<R!O9B`D,C`L,C4P(&EN8W5R<F5D(&EN(&-O;FYE8W1I;VX-"B`@("`@
M#0H@("`@("!W:71H('1H:7,@9FEN86YC:6YG('=E<F4@:7-S=65D(&EN('1H
M92!F;W)M(&]F(&$@8V]N=F5R=&EB;&4-"B`@#0H@("`@("!N;W1E('=I=&@@
M=V%R<F%N=',@;VX@=&AE('-A;64@=&5R;7,@87,@=&AO<V4@<F5C96EV960@
M8GD@=&AE#0H@("`-"B`@("`@(&EN=F5S=&]R<RXF(S$V,#LF(S$V,#M792!C
M87!I=&%L:7IE9"!T:&4@)#(P+#(U,"!O9B!D969E<G)E9`T*("`@("`-"B`@
M("`@(&9I;F%N8VEN9R!C;W-T<R!A;F0@86UO<G1I>F5D('1H96T@;W9E<B!T
M:&4@=&5R;2!O9B!T:&4@;F]T97,-"B`@(`T*("`@("`@=7-I;F<@=&AE(&5F
M9F5C=&EV92!I;G1E<F5S="!M971H;V0N#0H@("`-"B`@("`\+W`^/&)R+SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($%T($1E8V5M8F5R
M(#,Q+"`R,#$Q+"!T:&4@<F5M86EN:6YG('!R:6YC:7!A;"!B86QA;F-E(&]F
M#0H@("`-"B`@("`@("0W-2PP,#`@=V%S(&EN(&1E9F%U;'0N#0H@("`@(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@1D5"4E5!4ED@,C`Q,"`Q,"4@0T].5D525$E"3$4@3D]410T*(`T*("`@
M(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@
M3VX@1F5B<G5A<GD@,3(L(#(P,3`L('=E(')A:7-E9"`D,C@P+#`Q-2!I;B!C
M87-H(&%N9"!R96-E:79E9`T*("`@#0H@("`@("!A('-E8W5R960@<')O;6ES
M<V]R>2!N;W1E(&EN('1H92!A;6]U;G0@;V8@)#,P,"PP,#`@:6X-"B`-"B`@
M("`@(&5X8VAA;F=E(&9O<B!T:&4@:7-S=6%N8V4@8GD@=&AE($-O;7!A;GD@
M;V8@82`D-C8P+#`P,`T*(`T*("`@("`@<')I;F-I<&%L(&%M;W5N="`Q,"4@
M8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N;W1E("AT:&4@(DYO=&4B*0T*("`@
M#0H@("`@("!T;R!'96UI;FD@36%S=&5R($9U;F0L($QT9"X@*")'96UI;FDB
M*2X@5&AE($YO=&4@:6YC;'5D960@86X-"B`@#0H@("`@("!O<FEG:6YA;"!I
M<W-U92!D:7-C;W5N="!O9B!T96X@<&5R8V5N="P@;W(@)#8P+#`P,"P@86YD
M(&%N#0H@("`@(`T*("`@("`@;W)I9VEN871I;VX@9F5E(&]F('1H<F5E('!E
M<F-E;G0L(&]R("0Y+#`P,"X@5V4@86QS;R!P86ED#0H@("`@#0H@("`@("!L
M96=A;"!F965S(&]F("0Q,"PY.#4N(%1H92!.;W1E(&ES<W5E9"!B>2!T:&4@
M0V]M<&%N>2!M871U<F5D#0H@("`-"B`@("`@(&EN($9E8G)U87)Y(#(P,3$N
M(%1H92!T97)M<R!O9B!T:&4@<')O;6ES<V]R>2!N;W1E(&EN8VQU9&5D(&$-
M"B`@(`T*("`@("`@;6%T=7)I='D@9&%T92!O9B!!<')I;"`Q+"`R,#$Q+"!A
M;F0@86QL;W=E9"!F;W(@<')E<&%Y;65N=',-"B`-"B`@("`@(&]F('!R:6YC
M:7!A;"!A;F0@:6YT97)E<W0@8GD@1V5M:6YI(&)E9VEN;FEN9R!O;B!397!T
M96UB97(@,2P-"B`@(`T*("`@("`@,C`Q,"X-"B`@#0H@("`@/"]P/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!4:&4@8V]N=F5R
M<VEO;B!P<FEC92!P97(@<VAA<F4@:6YI=&EA;&QY('=A<R!E<75A;"!T;R!E
M:6=H='D-"B`@#0H@("`@("!P97)C96YT("@X,"4I(&]F('1H92!A=F5R86=E
M(&]F('1H92!T:')E92!L;W=E<W0@8VQO<VEN9R!B:60-"B`@#0H@("`@("!P
M<FEC97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A<R!R97!O<G1E9"!B>2!";&]O
M;6)E<F<@3"Y0+B!O;@T*(`T*("`@("`@=&AE(%!R:6YC:7!A;"!-87)K970@
M9F]R('1H92!T96X@*#$P*2!T<F%D:6YG(&1A>7,@<')E8V5D:6YG#0H@(`T*
M("`@("`@=&AE(&-O;G9E<G-I;VX@9&%T92P@<W5B:F5C="!T;R!A(&UA>&EM
M=6T@<')I8V4@<&5R('-H87)E(&]F#0H@(`T*("`@("`@)#`N,S`@86YD(&$@
M;6EN:6UU;2!P<FEC92!P97(@<VAA<F4@;V8@)#`N,C`@*'1H92`B1FQO;W(-
M"B`@(`T*("`@("`@4')I8V4B*2X@5&AE($YO=&4@:7,@8V]N=F5R=&EB;&4@
M:6YT;R!A(&UA>&EM=6T@;V8@,RPS,#`L,#`P#0H@(`T*("`@("`@<VAA<F5S
M(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@=&AE(&UI;FEM=6T@<')I8V4@<&5R
M('-H87)E(&]F#0H@(`T*("`@("`@)#`N,C`N(%1H92!I;G9E<W1O<B!A;'-O
M(')E8V5I=F5D(#8V,"PP,#`@=&AR964M>65A<B!W87)R86YT<PT*("`@#0H@
M("`@("!T;R!P=7)C:&%S92!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A
M="`D,"XU,"!P97(@<VAA<F4L#0H@("`@(`T*("`@("`@86QT:&]U9V@@=&AA
M="!E>&5R8VES92!P<FEC92!I<R!S=6)J96-T('1O(&-H86YG92!B87-E9"!O
M;@T*("`@("`-"B`@("`@(&-E<G1A:6X@8V]N9&ET:6]N<RX@5&AE(&-O;G9E
M<G-I;VX@9F5A='5R92P@:6YC;'5D:6YG('1H90T*("`@(`T*("`@("`@1FQO
M;W(@4')I8V4L(&UA>2!A9&1I=&EO;F%L;'D@8F4@861J=7-T960@:6X@=&AE
M(&5V96YT(&]F#0H@("`@#0H@("`@("!F=71U<F4@9FEN86YC:6YG(&)Y('1H
M92!#;VUP86YY+B!"96-A=7-E('1H92!C;VYV97)S:6]N#0H@(`T*("`@("`@
M9F5A='5R92!A;F0@=V%R<F%N="!E>&5R8VES92!P<FEC92!E86-H(&-A;B!B
M92!R97-E="!B87-E9"!O;@T*("`@#0H@("`@("!F=71U<F4@979E;G1S+"!T
M:&5Y(&AA=F4@8F5E;B!C;&%S<VEF:65D(&%S(&1E<FEV871I=F4-"B`-"B`@
M("`@(&QI86)I;&ET:65S+@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5&AE($YO=&4@86QS;R!C;VYT
M86EN<R!O=&AE<B!S=&%N9&%R9"!A9&IU<W1M96YT(&9E871U<F5S(&9O<@T*
M("`@#0H@("`@("!S=&]C:R!S<&QI=',L(')E8V%P:71A;&EZ871I;VYS(&%N
M9"!S:6UI;&%R(&]C8W5R<F5N8V5S+B!4:&4-"B`@#0H@("`@("!.;W1E(&-O
M;G1A:6YS('-T86YD87)D(&5V96YT<R!O9B!D969A=6QT(')E;&%T960@=&\@
M<&%Y;65N="P-"B`@#0H@("`@("!P97)F;W)M86YC92!O9B!C97)T86EN(&-O
M=F5N86YT<R!A;F0@8F%N:W)U<'1C>2!E=F5N=',N#0H@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5V4@<F5C
M;W)D960@82!D96)T(&1I<V-O=6YT(&]F("0T-S@L-#<V(&)A<V5D(&]N('1H
M90T*("`@(`T*("`@("`@97-T:6UA=&5D(&9A:7(@=F%L=64@;V8@=&AE(&1E
M<FEV871I=F4@;&EA8FEL:71I97,@87-S;V-I871E9`T*("`@#0H@("`@("!W
M:71H('1H92!W87)R86YT<R!A;F0@96UB961D960@8V]N=F5R<VEO;B!F96%T
M=7)E('=H:6-H('=A<PT*(`T*("`@("`@86UO<G1I>F5D('5S:6YG('1H92!E
M9F9E8W1I=F4@:6YT97)E<W0@;65T:&]D(&]V97(@=&AE('1E<FT-"B`-"B`@
M("`@(&]F('1H92!N;W1E+@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@26X@3F]V96UB97(@,C`Q,"P@
M8V5R=&%I;B!T97)M<R!O9B!T:&4@3F]T92!W97)E(&UO9&EF:65D#0H@("`@
M#0H@("`@("!P=7)S=6%N="!T;R!A(%-E='1L96UE;G0@06=R965M96YT("AT
M:&4@(DUO9&EF:65D($%G<F5E;65N="(I#0H@("`-"B`@("`@('=H:6-H('!R
M;W9I9&5S(&9O<B!T:&4@;6]D:69I8V%T:6]N(&]F('1H92!C;VYV97)S:6]N
M('!R:6-E#0H@#0H@("`@("!F;W)M=6QA('1O(&5Q=6%L(&5I9VAT>2!P97)C
M96YT("@X,"4I(&]F('1H92!A=F5R86=E(&]F('1H90T*(`T*("`@("`@=&AR
M964@;&]W97-T(&-L;W-I;F<@8FED('!R:6-E<R!O9B!T:&4@8V]M;6]N('-T
M;V-K(&%S#0H@#0H@("`@("!R97!O<G1E9"!B>2!";&]O;6)E<F<@3"Y0+B!O
M;B!T:&4@4')I;F-I<&%L($UA<FME="!F;W(@=&AE#0H@("`@(`T*("`@("`@
M='=E;G1Y("@R,"D@=')A9&EN9R!D87ES('!R96-E9&EN9R!T:&4@8V]N=F5R
M<VEO;B!D871E(&EN#0H@("`@#0H@("`@("!L:65U(&]F('1H92!T96X@*#$P
M*2!T<F%D:6YG(&1A>7,@<')E8V5D:6YG('1H92!C;VYV97)S:6]N#0H@("`@
M(`T*("`@("`@9&%T92X-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!!8V-O<F1I;F<@=&\@=&AE(&UO9&EF
M:65D('1E<FUS+"!T:&4@<')E=FEO=7,@8V]N=F5R<VEO;@T*("`@#0H@("`@
M("!F;&]O<B!P<FEC92!W87,@<F5P;&%C960@=VET:"!A(&UA>&EM=6T@<VAA
M<F4@;&EM:71A=&EO;@T*("`@#0H@("`@("!U;F1E<B!W:&EC:"!T:&4@;6%X
M:6UU;2!N=6UB97(@;V8@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!T:&%T#0H@
M("`-"B`@("`@(&UA>2!B92!I<W-U960@=&\@=&AE(&AO;&1E<B!O9B!T:&4@
M3F]T92!P=7)S=6%N="!T;R!A#0H@("`@(`T*("`@("`@8V]N=F5R<VEO;B!O
M9B!T:&4@3F]T92P@8V]M8FEN960@=VET:"!A;B!E>&5R8VES92!O9B!T:&4-
M"B`@(`T*("`@("`@17AC:&%N9V4@5V%R<F%N="`H87,@9&5F:6YE9"!B96QO
M=RDL('-H86QL(&YO="!E>&-E960@82!C87`-"B`-"B`@("`@(&1E=&5R;6EN
M960@8GD@*&$I(&1I=FED:6YG('1H92!S=6T@;V8@*&DI('1H92!F86-E(&%M
M;W5N="!O9@T*("`-"B`@("`@('1H92!.;W1E+"!P;'5S("AI:2D@86X@86UO
M=6YT(&5Q=6%L('1O(&%L;"!I;G1E<F5S="!T:&%T#0H@("`-"B`@("`@('=O
M=6QD(&%C8W)U92!U;F1E<B!T:&4@3F]T92!D=7)I;F<@:71S('1E<FT@*&%S
M<W5M:6YG(&YO#0H@("`-"B`@("`@('!A>6UE;G1S(&]F('!R:6YC:7!A;"!O
M<B!I;G1E<F5S="!A<F4@;6%D92!P<FEO<B!T;R!T:&4-"B`@#0H@("`@("!M
M871U<FET>2!D871E(&]F('1H92!.;W1E*2P@8GD@82!P<FEC92!P97(@<VAA
M<F4@;V8@8V]M;6]N#0H@("`@(`T*("`@("`@<W1O8VL@97%U86P@=&\@)#`N
M,C`@*'-U8FIE8W0@=&\@97%U:71A8FQE(&%D:G5S=&UE;G0I(&%N9`T*("`@
M("`-"B`@("`@("AB*2!T:&5N(&%D9&EN9R!T:&4@<W5M(&-A;&-U;&%T960@
M<'5R<W5A;G0@=&\@=&AE(&9O<F5G;VEN9PT*("`-"B`@("`@(&-L875S92`H
M82D@=&\@=&AE(&UA>&EM=6T@;G5M8F5R(&]F('=A<G)A;G0@<VAA<F5S("AA
M<PT*(`T*("`@("`@9&5F:6YE9"!I;B!T:&4@17AC:&%N9V4@5V%R<F%N="D@
M=&AA="!M87D@8F4@86-Q=6ER960@8GD@=&AE#0H@(`T*("`@("`@:&]L9&5R
M('1H97)E;V8@=7!O;B!E>&5R8VES92!O9B!T:&4@17AC:&%N9V4@5V%R<F%N
M=`T*("`@(`T*("`@("`@*')E9V%R9&QE<W,@;V8@=VAE=&AE<B!S=6-H(&5X
M97)C:7-E(&ES(&$@8V%S:&QE<W,@97AE<F-I<V4I+@T*("`@#0H@("`@("!)
M;B!A9&1I=&EO;BP@=&AE(")M87AI;75M(&]W;F5R<VAI<"!P97)C96YT86=E
M(B!U;F1E<B!T:&4-"B`@("`-"B`@("`@($YO=&4@=V%S(&EN8W)E87-E9"!T
M;R`Y+CDY)2X-"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P)SX-"B`@("`@#0H@("`@("!);B!A9&1I=&EO;B!T;R!T:&4@;6]D:69I
M8V%T:6]N<R!O9B!T:&4@;F]T92P@=V4@86=R965D('1O#0H@("`@(`T*("`@
M("`@97AC:&%N9V4@=&AE(&]R:6=I;F%L('=A<G)A;G0@9F]R(&$@;F5W(&-O
M;6UO;B!S=&]C:R!P=7)C:&%S90T*("`@#0H@("`@("!W87)R86YT("AT:&4@
M(D5X8VAA;F=E(%=A<G)A;G0B*2!F;W(@=&AE('!U<F-H87-E(&]F#0H@("`@
M#0H@("`@("`R+#<R-RPR-S(@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!A="!A
M;B!I;FET:6%L(&5X97)C:7-E('!R:6-E#0H@("`-"B`@("`@(&]F("0P+C(S
M,2!P97(@<VAA<F4N(%1H92!%>&-H86YG92!787)R86YT('!R;W9I9&5S(&9O
M<@T*(`T*("`@("`@86YT:2UD:6QU=&EO;B!A9&IU<W1M96YT('1O('1H92!E
M>&5R8VES92!P<FEC92!I;B!T:&4@979E;G0-"B`-"B`@("`@(&]F('1H92!I
M<W-U86YC92!O9B!S96-U<FET:65S(&)Y('1H92!#;VUP86YY(&)E;&]W('1H
M90T*(`T*("`@("`@97AE<F-I<V4@<')I8V4L('-U8FIE8W0@=&\@8V5R=&%I
M;B!E>&-E<'1I;VYS(&%S('-E="!F;W)T:"!I;@T*("`@#0H@("`@("!T:&4@
M17AC:&%N9V4@5V%R<F%N="X-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@26X@861D:71I;VXL('1H92!-
M;V1I9FEE9"!!9W)E96UE;G0@<')O=FED960@=&AA="!'96UI;FD-"B`@(`T*
M("`@("`@9&5L:79E<B!T;R!U<R`D,C4S+#<Y-"XP.2!B>2!W:7)E('1R86YS
M9F5R(&EN(&9U;&P@<&%Y;65N="!O9@T*("`@#0H@("`@("!T:&4@<')O;6ES
M<V]R>2!N;W1E+"!W:&EC:"!R97!R97-E;G1S('1H92!O=71S=&%N9&EN9PT*
M("`@("`-"B`@("`@('!R:6YC:7!A;"!B86QA;F-E('1H97)E;V8@<&QU<R!A
M;&P@86-C<G5E9"!B=70@=6YP86ED#0H@("`@(`T*("`@("`@:6YT97)E<W0@
M=&AE<F5O;B!L97-S('1H92!O<FEG:6YA=&EO;B!F964@9'5E('1O($=E;6EN
M:2!U;F1E<@T*("`@#0H@("`@("!T:&4@;W)I9VEN86P@=')A;G-A8W1I;VX@
M9&]C=6UE;G1S(&QE<W,@<F5I;6)U<G-E;65N="!O9@T*("`@#0H@("`@("!'
M96UI;FDG<R!L96=A;"!E>'!E;G-E<RX@26X@86-C;W)D86YC92!W:71H('1H
M92!S971T;&5M96YT+`T*(`T*("`@("`@=V4@9&5L:79E<F5D('1O($=E;6EN
M:2`R.#8L-#@S(&9R965L>2!T<F%D86)L92!S:&%R97,@;V8-"B`@(`T*("`@
M("`@8V]M;6]N('-T;V-K(&EN(&9U;&P@<V%T:7-F86-T:6]N(&]F('1H92!R
M96UA:6YI;F<@;G5M8F5R(&]F#0H@(`T*("`@("`@<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:R!D=64@=6YD97(@8V5R=&%I;B!C;VYV97)S:6]N(&YO=&EC97,L
M#0H@(`T*("`@("`@9F]R(&$@=&]T86P@;V8@)#<U+#`P,"P@<')E=FEO=7-L
M>2!D96QI=F5R960@8GD@1V5M:6YI('1O('1H90T*("`@#0H@("`@("!#;VUP
M86YY+B!4:&4@36]D:69I960@06=R965M96YT('!R;W9I9&5D(&9O<B!T:&4@
M;75T=6%L#0H@(`T*("`@("`@<F5L96%S92!O9B!A;&P@8VQA:6US(')E;&%T
M960@=&\@=&AE(&1I<W!U=&4@86YD('1H90T*("`@(`T*("`@("`@<F5V;V-A
M=&EO;B!O9B!A;&P@<')I;W(@;F]T:6-E<R!O9B!D969A=6QT('-E;G0@8GD@
M=&AE#0H@#0H@("`@("!#;VUP86YY(&%N9"!'96UI;FD@=&\@96%C:"!O=&AE
M<BX-"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-
M"B`@("`@#0H@("`@("!);B!C;VYN96-T:6]N('=I=&@@=&AE(&UO9&EF:6-A
M=&EO;B!T;R!T:&4@;F]T92!A;F0@=&AE#0H@(`T*("`@("`@:7-S=6%N8V4@
M;V8@=&AE($5X8VAA;F=E(%=A<G)A;G0L('1H92!M87AI;75M(&YU;6)E<B!O
M9@T*("`-"B`@("`@('-H87)E<R!I<W-U86)L92!P=7)S=6%N="!T;R!T:&4@
M;6%X:6UU;2!S:&%R92!L:6UI=&%T:6]N(&%N9`T*("`-"B`@("`@('1H92!E
M>&5R8VES92!I;B!F=6QL(&]F('1H92!%>&-H86YG92!787)R86YT('=A<R`V
M+#,U-RPR-S(N#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!!<R!P<F]V:7-I;VYS(&]F('1H92!-;V1I9FEE
M9"!!9W)E96UE;G0@<F5S=6QT960@:6X@=&5R;7,-"B`@("`-"B`@("`@('1H
M870@=V5R92!D965M960@=&\@8F4@<W5B<W1A;G1I86QL>2!D:69F97)E;G0@
M9G)O;2!T:&4-"B`@#0H@("`@("!O<FEG:6YA;"!T97)M<RP@=&AE(&5X8VAA
M;F=E(&]F(&1E8G0@:6YS=')U;65N=',@=V%S#0H@("`@#0H@("`@("!A8V-O
M=6YT960@9F]R(&%S(&$@9&5B="!E>'1I;F=U:7-H;65N="!A;F0@=V4@<F5C
M;W)D960@82!L;W-S#0H@("`-"B`@("`@(&]N(&5X=&EN9W5I<VAM96YT(&]F
M(&1E8G0@:6X@=&AE(&%M;W5N="!O9B`D.38S+#`Q."!I;B!T:&4-"B`@("`@
M#0H@("`@("!F:7-C86P@>65A<B!E;F1E9"!-87)C:"`S,2P@,C`Q,2!A<R!S
M:&]W;B!B96QO=SH-"B`@("`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP
M861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P
M,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-S`E)SX-"B`@(`T*
M("`@("`@("`@(%)E86-Q=6ES:71I;VX@<')I8V4-"B`@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P
M)2<^#0H@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M."4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,2PX-30L
M-S8W#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^#0H@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G
M/@T*("`-"B`@("`@("`@("!,97-S(&-A<G)Y:6YG('9A;'5E(&]F(&YO=&5S
M(&%N9"!R96QA=&5D(&EN<W1R=6UE;G1S#0H@("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX-"B`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[
M('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@*#@Y,2PW-#D-
M"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@*0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR
M,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@($QO<W,@;VX@97AT
M:6YG=6ES:&UE;G0-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Y-C,L,#$X#0H@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!/;B!-87)C:"`R,2P@,C`Q,2P@
M=V4@96YT97)E9"!I;G1O(&%N($5X=&5N<VEO;B!!9W)E96UE;G0-"B`@("`-
M"B`@("`@("AT:&4@(D5X=&5N<VEO;B!!9W)E96UE;G0B*2!W:71H($=E;6EN
M:2XF(S$V,#LF(S$V,#M4:&4-"B`@("`@#0H@("`@("!%>'1E;G-I;VX@06=R
M965M96YT('!R;W9I9&5S(&9O<BP@86UO;F<@;W1H97(@=&AI;F=S+"!T:&4-
M"B`@("`-"B`@("`@(&5X=&5N<VEO;B!O9B!T:&4@36%T=7)I='D@1&%T92!T
M;R!/8W1O8F5R(#$L(#(P,3$L(&%N9"!A;@T*("`@(`T*("`@("`@86UE;F1M
M96YT(&%N9"!R97-T871E;65N="!O9B!T:&4@3F]T92!T;R!R969L96-T('1H
M92!R979I<V5D#0H@(`T*("`@("`@<')I;F-I<&%L(&%M;W5N="!O9B`D-S0P
M+#4W."P@=VAI8V@@86UO=6YT(&EN8VQU9&5S(&%C8W)U960-"B`-"B`@("`@
M(&EN=&5R97-T(&]F("0U."PY.#$L('1H92!R96UA:6YI;F<@<')I;F-I<&%L
M(&)A;&%N8V4@;V8-"B`@#0H@("`@("`D-3@U+#`P,"!A;F0@82`Q-24@<')E
M;6EU;2!T;R!T:&4@<')I;F-I<&%L(&%N9"!A8V-R=65D#0H@(`T*("`@("`@
M:6YT97)E<W0@86UO=6YT(&EN(&-O;G-I9&5R871I;VX@9F]R('1H92!E>'1E
M;G-I;VXN($EN#0H@#0H@("`@("!A9&1I=&EO;BP@=&AE($YO=&4@87,@86UE
M;F1E9"!P<F]V:61E<R!F;W(@82!N97<@(G-H87)E(&-A<`T*(`T*("`@("`@
M9F]R;75L82(@<W5C:"!T:&%T('1H92!N=6UB97(@;V8@<VAA<F5S(&]F($-O
M;6UO;B!3=&]C:PT*("`-"B`@("`@(&ES<W5A8FQE('5P;VX@8V]N=F5R<VEO
M;B!O9B!T:&4@3F]T92!S:&%L;"!N;W0@97AC965D(&$@8V%P#0H@#0H@("`@
M("!D971E<FUI;F5D(&)Y("AA*2!D:79I9&EN9R!T:&4@<W5M(&]F("AI*2!T
M:&4@<F5V:7-E9`T*("`@("`-"B`@("`@('!R:6YC:7!A;"!A;6]U;G0@;V8@
M=&AE($YO=&4@*"0W-#`L-3<X*2P@<&QU<R`H:6DI(&%N(&%M;W5N=`T*("`-
M"B`@("`@(&5Q=6%L('1O(&%L;"!I;G1E<F5S="!T:&%T('=O=6QD(&%C8W)U
M92!U;F1E<B!T:&4@3F]T92!D=7)I;F<-"B`@(`T*("`@("`@:71S('1E<FT@
M*&%S<W5M:6YG(&YO('!A>6UE;G1S(&]F('!R:6YC:7!A;"!O<B!I;G1E<F5S
M="!A<F4-"B`-"B`@("`@(&UA9&4@869T97(@36%R8V@@,C$L(#(P,3$@8G5T
M('!R:6]R('1O('1H92!-871U<FET>2!$871E*2P@8GD-"B`@(`T*("`@("`@
M82!P<FEC92!P97(@<VAA<F4@;V8@0V]M;6]N(%-T;V-K(&5Q=6%L('1O("0P
M+C$V("AS=6)J96-T('1O#0H@(`T*("`@("`@861J=7-T;65N="!A<R!S970@
M9F]R=&@@:6X@=&AE($YO=&4I(&%N9"`H8BD@=&AE;B!A9&1I;F<@=&AE#0H@
M(`T*("`@("`@<W5M(&-A;&-U;&%T960@<'5R<W5A;G0@=&\@=&AE(&9O<F5G
M;VEN9R!C;&%U<V4@=&\@=&AE#0H@#0H@("`@("!M87AI;75M(&%G9W)E9V%T
M92!N=6UB97(@;V8@<VAA<F5S(&]F($-O;6UO;B!3=&]C:R!I<W-U86)L90T*
M(`T*("`@("`@=6YD97(@8V5R=&%I;B!W87)R86YT<R!H96QD(&)Y($=E;6EN
M:2`H<F5G87)D;&5S<R!O9B!W:&5T:&5R#0H@(`T*("`@("`@<W5C:"!E>&5R
M8VES92!I<R!A(&-A<VAL97-S(&5X97)C:7-E*2X-"B`@("`@#0H@("`@/"]P
M/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!!<R!P
M<F]V:7-I;VYS(&]F('1H92!%>'1E;G-I;VX@06=R965M96YT(')E<W5L=&5D
M(&EN('1E<FUS#0H@("`@(`T*("`@("`@=&AA="!W97)E(&1E96UE9"!T;R!B
M92!S=6)S=&%N=&EA;&QY(&1I9F9E<F5N="!F<F]M('1H90T*("`-"B`@("`@
M(&]R:6=I;F%L('1E<FUS+"!T:&4@97AC:&%N9V4@;V8@9&5B="!I;G-T<G5M
M96YT<R!W87,-"B`@("`-"B`@("`@(&%C8V]U;G1E9"!F;W(@87,@82!D96)T
M(&5X=&EN9W5I<VAM96YT(&%N9"!W92!R96-O<F1E9"!A(&QO<W,-"B`@(`T*
M("`@("`@;VX@97AT:6YG=6ES:&UE;G0@;V8@9&5B="!I;B!T:&4@86UO=6YT
M(&]F("0T-RPW,#$@:6X@=&AE#0H@("`@#0H@("`@("!F:7-C86P@>65A<B!E
M;F1E9"!-87)C:"`S,2P@,C`Q,2!A<R!S:&]W;B!B96QO=SH-"B`@("`@#0H@
M("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN
M9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@-S`E)SX-"B`@(`T*("`@("`@("`@(%)E86-Q=6ES:71I
M;VX@<')I8V4-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P)2<^#0H@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`@#0H@("`@("`@("`@-S<S+#4X,@T*("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@($QE<W,@8V%R
M<GEI;F<@=F%L=64@;V8@;F]T97,@86YD(')E;&%T960@:6YS=')U;65N=',-
M"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-
M"B`@("`@("`@("`H-S(U+#@X,0T*("`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`I#0H@(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B!R9V(H,C,S+#(R."PR,C@I)SX-"B`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@
M("`@("`@("`@3&]S<R!O;B!E>'1I;F=U:7-H;65N=`T*("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@(#0W+#<P,0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T
M86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!4
M:&4@9F]L;&]W:6YG(&-O;G9E<G-I;VYS(&]F('1H92!&96)R=6%R>2`R,#$P
M(#$P)0T*("`-"B`@("`@($-O;G9E<G1I8FQE($YO=&4@:&%V92!T86ME;B!P
M;&%C92!D=7)I;F<@=&AE(&YI;F4@;6]N=&AS#0H@("`-"B`@("`@(&5N9&5D
M($1E8V5M8F5R(#,Q+"`R,#$Q.@T*(`T*("`@(#PO<#X\8G(O/CQT86)L92!C
M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H
M.B`Y,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/@T*("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@
M#0H@("`@("`@("`@3FEN92!-;VYT:',\8G(@+SX-"B`@("`-"B`@("`@("`@
M("!%;F1E9`T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^
M#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@
M<V]L:60G/@T*("`@("`-"B`@("`@("`@("!$96-E;6)E<B`S,2P\8G(@+SX-
M"B`@("`@#0H@("`@("`@("`@,C`Q,0T*("`@("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B
M*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@-C<E)SX-"B`@(`T*("`@("`@("`@(%!R:6YC:7!A;"!C;VYV97)T
M960-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$P)2<^#0H@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@
M#0H@("`@("`@("`@-#<U+#`P,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L
M;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@
M("`@06-C<G5E9"!I;G1E<F5S="!C;VYV97)T960-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#$Y+#0P
M,PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@
M#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@
M#0H@("`@("!/;B!$96-E;6)E<B`R.2P@,C`Q,2P@=V4@86=R965D('=I=&@@
M1V5M:6YI('1O(&5X=&5N9"!T:&4-"B`@("`-"B`@("`@(&5X<&ER871I;VX@
M9&%T92!O9B!T:&4@3F]T92!T;R!!<')I;"`Q+"`R,#$R+B!4:&5R92!W87,@
M;F\-"B`@("`@#0H@("`@("!F964@;W(@86YY(&]T:&5R(&-O;G-I9&5R871I
M;VX@97AC:&%N9V5D(&EN(&-O;FYE8W1I;VX@=VET:`T*(`T*("`@("`@=&AE
M(&5X=&5N<VEO;BX-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`G/@T*("`@("`-"B`@("`@($%04DE,(#(P,3`@,3`E($-/3E9%4E1)0DQ%
M($Y/5$4-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M#0H@("`@(`T*("`@("`@26X@07!R:6P@,C`Q,"P@=V4@<F%I<V5D("0W-2PP
M,#`@9G)O;2!T:&4@<V%L92!T;R!A;@T*("`@(`T*("`@("`@86-C<F5D:71E
M9"!I;G9E<W1O<B!O9B!A(#$P)2!C;VYV97)T:6)L92!N;W1E+B!4:&4-"B`@
M#0H@("`@("!C;VYV97)T:6)L92!N;W1E(&UA='5R97,@:6X@3V-T;V)E<B`R
M,#$Q(&%N9"!I<R!C;VYV97)T:6)L90T*(`T*("`@("`@:6YT;R!O=7(@8V]M
M;6]N('-T;V-K(&%T(&$@9FEX960@8V]N=F5R<VEO;B!P<FEC92!O9B`D,"XR
M-0T*("`@("`-"B`@("`@('!E<B!S:&%R92!P<FEO<B!T;R!M871U<FET>2X@
M5&AE(&EN=F5S=&]R(&%L<V\@<F5C96EV960@=&AR964-"B`@(`T*("`@("`@
M>65A<B!W87)R86YT<R!T;R!P=7)C:&%S92`S,#`L,#`P('5N<F5G:7-T97)E
M9"!S:&%R97,@;V8@;W5R#0H@(`T*("`@("`@8V]M;6]N('-T;V-K(&%T(&$@
M<')I8V4@;V8@)#`N,C4@<&5R('-H87)E+@T*("`@("`-"B`@("`\+W`^/&)R
M+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E(&UE87-U
M<F5D('1H92!F86ER('9A;'5E(&]F('1H92!W87)R86YT<R!A;F0@=&AE(&)E
M;F5F:6-I86P-"B`@(`T*("`@("`@8V]N=F5R<VEO;B!F96%T=7)E(&]F('1H
M92!N;W1E<R!A;F0@<F5C;W)D960@82`Q,#`E(&1I<V-O=6YT#0H@(`T*("`@
M("`@86=A:6YS="!T:&4@<')I;F-I<&%L(&]F('1H92!N;W1E<RX@5V4@87)E
M(&%M;W)T:7II;F<@=&AI<PT*("`@("`-"B`@("`@(&1I<V-O=6YT('5S:6YG
M('1H92!E9F9E8W1I=F4@:6YT97)E<W0@;65T:&]D(&]V97(@=&AE('1E<FT@
M;V8-"B`@(`T*("`@("`@=&AE(&YO=&4N#0H@#0H@("`@/"]P/CQB<B\^/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!!="!$96-E;6)E<B`S
M,2P@,C`Q,2P@=&AE('!R:6YC:7!A;"!B86QA;F-E(&]F("0W-2PP,#`@=V%S
M(&EN#0H@("`-"B`@("`@(&1E9F%U;'0N)B,Q-C`[#0H@("`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@2E5.
M12`R,#$P(#$R)2!#3TY615)424),12!.3U1%4PT*("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!);B!*=6YE
M(#(P,3`L(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@<')E<V5N="!A;F0@<&%S
M=`T*("`@("`-"B`@("`@(&YE9V]T:6%T:6]N<R!W:71H('1H92!L87<@9FER
M;2!R97!R97-E;G1I;F<@=&AE(&AO;&1E<G,@;V8-"B`@("`@#0H@("`@("!T
M:&4@(D%M96YD960@86YD(%)E<W1A=&5D($YO=&5S+"(@=V4@:7-S=65D('1W
M;R!C;VYV97)T:6)L90T*(`T*("`@("`@;F]T97,@=&\@=&AA="!L87<@9FER
M;2`H)B,X,C(P.TIU;F4@,C`Q,"`Q,B4@0V]N=F5R=&EB;&4-"B`@#0H@("`@
M("!.;W1E<R8C.#(R,3LI('1O=&%L:6YG("0V-"PQ-3,@;VX@=&AE('-A;64@
M=&5R;7,@87,@=&AE#0H@#0H@("`@("!!;65N9&5D(&%N9"!297-T871E9"!.
M;W1E<RX@5&AA="!A;6]U;G0@<F5P<F5S96YT960@=&AE#0H@(`T*("`@("`@
M86UO=6YT(&]F('1H96ER(&QE9V%L(&9E97,@<&QU<R!A8V-R=65D(&EN=&5R
M97-T+B!$=7)I;F<@=&AE#0H@(`T*("`@("`@9FES8V%L('EE87(@96YD960@
M36%R8V@@,S$L(#(P,3$L('1H92!H;VQD97(@8V]N=F5R=&5D('1O#0H@("`@
M#0H@("`@("!C;VUM;VX@<W1O8VL@;VYE(&]F('1H92!C;VYV97)T:6)L92!N
M;W1E<R!I;B!T:&4@86UO=6YT(&]F#0H@("`@(`T*("`@("`@)#0R+#DV-"X-
M"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@
M("`@#0H@("`@("`\82!I9#TS1$],15],24Y+,R!N86UE/3-$3TQ%7TQ)3DLS
M/D1U<FEN9R!T:&4@=&AR964@;6]N=&AS#0H@#0H@("`@("!E;F1E9"!397!T
M96UB97(@,S`L(#(P,3$L('1H92!H;VQD97(@8V]N=F5R=&5D('1H92!R96UA
M:6YI;F<-"B`@#0H@("`@("!P<FEN8VEP86P@8F%L86YC92!O9B`D,C$L,3@Y
M(&%N9"!A8V-R=65D(&EN=&5R97-T(&]F("0R+#4Y.`T*(`T*("`@("`@=&\@
M<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@<&5R('1H92!T97)M<R!O9B!T
M:&4-"B`@#0H@("`@("!C;VYV97)T:6)L92!N;W1E+CPO83X-"B`@("`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M($I53%D@,C`Q,"`V)2!#3TY615)424),12!.3U1%4PT*("`-"B`@("`\+W`^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($EN($IU
M;'D@,C`Q,"P@=V4@96YT97)E9"!I;G1O(&$@3F]T92!A;F0@5V%R<F%N="!0
M=7)C:&%S90T*("`@(`T*("`@("`@06=R965M96YT("AT:&4@(E!U<F-H87-E
M($%G<F5E;65N="(I('=I=&@@5&]N87%U:6YT+"!);F,N+"!A#0H@(`T*("`@
M("`@571A:"!C;W)P;W)A=&EO;B`H=&AE("));G9E<W1O<B(I('=H97)E8GD@
M=V4@:7-S=65D(&%N9"!S;VQD+`T*("`@#0H@("`@("!A;F0@=&AE($EN=F5S
M=&]R('!U<F-H87-E9#H@*&DI(&$@0V]N=F5R=&EB;&4@4')O;6ES<V]R>2!.
M;W1E#0H@("`-"B`@("`@(&]F('1H92!#;VUP86YY(&EN('1H92!P<FEN8VEP
M86P@86UO=6YT(&]F("0X.3`L,#`P("AT:&4-"B`@#0H@("`@("`B0V]M<&%N
M>2!.;W1E(BD@86YD("AI:2D@82!787)R86YT('1O('!U<F-H87-E(&-O;6UO
M;B!S=&]C:PT*(`T*("`@("`@;V8@=&AE($-O;7!A;GD@*'1H92`B5V%R<F%N
M="(I+B!!<R!C;VYS:61E<F%T:6]N(&9O<B!T:&4-"B`@(`T*("`@("`@:7-S
M=6%N8V4@86YD('-A;&4@;V8@=&AE($-O;7!A;GD@3F]T92!A;F0@5V%R<F%N
M="P@=&AE#0H@#0H@("`@("!);G9E<W1O<B!P86ED(&-A<V@@:6X@=&AE(&%M
M;W5N="!O9B`D-#`P+#`P,"!A;F0@:7-S=65D('1W;PT*(`T*("`@("`@4V5C
M=7)E9"!4<G5S="!$965D($YO=&5S('1O('5S("AT:&4@(E1R=7-T($YO=&5S
M(BD@96%C:"!I;@T*("`@("`-"B`@("`@('1H92!P<FEN8VEP86P@86UO=6YT
M(&]F("0R,#`L,#`P+B!4:&4@=F%R:6%N8V4@;V8@)#DP+#`P,`T*("`@(`T*
M("`@("`@<F5P<F5S96YT<R!F965S(&%N9"!E>'!E;G-E<R!P86ED(&)Y('5S
M(&%N9"!A;B!O<FEG:6YA;"!I<W-U90T*("`@#0H@("`@("!D:7-C;W5N="!W
M:&EC:"!W87,@<F5C;W)D960@87,@9&5F97)R960@;V9F97)I;F<@8V]S=',N
M#0H@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@
M(`T*("`@("`@5&AE($-O;7!A;GD@3F]T92!I<R!C;VYV97)T:6)L92!I;G1O
M('-H87)E<R!O9B!T:&4@0V]M<&%N>2=S#0H@(`T*("`@("`@8V]M;6]N('-T
M;V-K+"!A="!T:&4@;W!T:6]N(&]F('1H92!);G9E<W1O<BP@870@82!P<FEC
M92!P97(-"B`-"B`@("`@('-H87)E(&5Q=6%L('1O("AA*2!T:&4@<')I;F-I
M<&%L(&%N9"!I;G1E<F5S="!D=64@=6YD97(@=&AE#0H@#0H@("`@("!#;VUP
M86YY($YO=&4@9&EV:61E9"!B>2`H8BD@.#`E(&]F('1H92!A=F5R86=E(&]F
M('1H92!C;&]S:6YG#0H@("`-"B`@("`@(&)I9"!P<FEC92!F;W(@=&AE('1H
M<F5E("@S*2!T<F%D:6YG(&1A>7,@=VET:"!T:&4@;&]W97-T#0H@("`-"B`@
M("`@(&-L;W-I;F<@8FED('!R:6-E<R!D=7)I;F<@=&AE('1W96YT>2`H,C`I
M('1R861I;F<@9&%Y<PT*(`T*("`@("`@:6UM961I871E;'D@<')E8V5D:6YG
M('1H92!C;VYV97)S:6]N(&1A=&4@*'1H90T*("`@#0H@("`@("`F(S@R,C`[
M0V]N=F5R<VEO;B!0<FEC928C.#(R,3LI+B!);B!N;R!E=F5N="!S:&%L;"!T
M:&4-"B`@("`-"B`@("`@($-O;G9E<G-I;VX@4')I8V4@8F4@9W)E871E<B!T
M:&%N('1H92`B0V5I;&EN9R!0<FEC92(L('=H:6-H#0H@#0H@("`@("!I<R`D
M,"XS,"!P97(@<VAA<F4N(%1H92!P<FEN8VEP86P@86YD(&EN=&5R97-T('-U
M8FIE8W0@=&\-"B`@("`-"B`@("`@(&-O;G9E<G-I;VX@=6YD97(@=&AE($YO
M=&4@<VAA;&P@8F4@96QI9VEB;&4@9F]R(&-O;G9E<G-I;VX@:6X-"B`@(`T*
M("`@("`@=')A;F-H97,@*")4<F%N8VAE<R(I+"!A<R!F;VQL;W=S.B`H,2D@
M86X@:6YI=&EA;"!4<F%N8VAE(&EN#0H@(`T*("`@("`@86X@86UO=6YT(&5Q
M=6%L('1O("0T-3`L,#`P(&%N9"!A;GD@:6YT97)E<W0@86YD+V]R(&9E97,-
M"B`@(`T*("`@("`@86-C<G5E9"!T:&5R96]N('5N9&5R('1H92!T97)M<R!O
M9B!T:&4@0V]M<&%N>2!.;W1E(&%N9"!T:&4-"B`-"B`@("`@(&]T:&5R(%1R
M86YS86-T:6]N($1O8W5M96YT<R`H87,@9&5F:6YE9"!B96QO=R!A;F0@:6X@
M=&AE#0H@("`-"B`@("`@(%!U<F-H87-E($%G<F5E;65N="DL(&%N9"`H,BD@
M='=O(&%D9&ET:6]N86P@<W5B<V5Q=65N=`T*(`T*("`@("`@5')A;F-H97,@
M96%C:"!I;B!A;B!A;6]U;G0@97%U86P@=&\@)#(R,"PP,#`@86YD(&%N>2!I
M;G1E<F5S=`T*("`@#0H@("`@("!O<B!F965S(&%C8W)U960@=&AE<F5O;B!U
M;F1E<B!T:&4@=&5R;7,@;V8@=&AE($-O;7!A;GD@3F]T90T*(`T*("`@("`@
M;W(@=&AE(&]T:&5R(%1R86YS86-T:6]N($1O8W5M96YT<RX@5&AE(&9I<G-T
M('-U8G-E<75E;G0-"B`@(`T*("`@("`@5')A;F-H92!S:&%L;"!C;W)R97-P
M;VYD('1O('!A>6UE;G0@;V8@=&AE(&9I<G-T(%1R=7-T($YO=&4-"B`-"B`@
M("`@(&%N9"!T:&4@<V5C;VYD('-U8G-E<75E;G0@5')A;F-H92!S:&%L;"!C
M;W)R97-P;VYD('1O('!A>6UE;G0-"B`@(`T*("`@("`@;V8@=&AE('-E8V]N
M9"!4<G5S="!.;W1E("AA<R!D969I;F5D(&EN('1H92!0=7)C:&%S90T*("`@
M(`T*("`@("`@06=R965M96YT*2X@5&AE($EN=F5S=&]R)W,@<FEG:'0@=&\@
M8V]N=F5R="!A;GD@;V8@=&AE#0H@#0H@("`@("!S=6)S97%U96YT(%1R86YC
M:&5S(&ES(&-O;F1I=&EO;F5D('5P;VX@=&AE($EN=F5S=&]R)B,X,C$W.W,-
M"B`-"B`@("`@('!A>6UE;G0@:6X@9G5L;"!O9B!T:&4@5')U<W0@3F]T97,@
M8V]R<F5S<&]N9&EN9R!T;R!S=6-H#0H@("`-"B`@("`@('-U8G-E<75E;G0@
M5')A;F-H92XF(S$V,#LF(S$V,#M!8V-O<F1I;F=L>2P@<')I;F-I<&%L(&%N
M9`T*("`-"B`@("`@(&EN=&5R97-T('5N9&5R('1H92!#;VUP86YY($YO=&4@
M;6%Y(&]N;'D@8F4@8V]N=F5R=&5D(&)Y('1H90T*("`-"B`@("`@($EN=F5S
M=&]R(&EN('!R;W!O<G1I;VX@=&\@=&AE(&%M;W5N=',@<&%I9"!U;F1E<B!E
M86-H(&]F('1H90T*("`-"B`@("`@(%1R=7-T($YO=&5S+B8C,38P.R8C,38P
M.TAO=V5V97(L('5P('1O("0T-3`L,#`P(&UA>2!B90T*("`@(`T*("`@("`@
M8V]N=F5R=&5D(&%T('1H92!);G9E<W1O<B=S(&]P=&EO;B!A="!A;GD@=&EM
M92P@<F5P<F5S96YT:6YG#0H@(`T*("`@("`@86UO=6YT<R!P86ED(&)Y('1H
M92!);G9E<W1O<B!O;B!T:&4@8VQO<VEN9R!O9B!T:&4-"B`@#0H@("`@("!T
M<F%N<V%C=&EO;B!O;B!*=6QY(#$U+"`R,#$P("AT:&4@(D-L;W-I;F<B*2XF
M(S$V,#LF(S$V,#M4:&4-"B`@("`@#0H@("`@("!#;VUP86YY($YO=&4@8F5A
M<G,@:6YT97)E<W0@870@82!R871E(&]F(#8E('!E<B!A;FYU;2X@5&AE#0H@
M("`@(`T*("`@("`@;6%T=7)I='D@9&%T92!O9B!T:&4@0V]M<&%N>2!.;W1E
M(&ES($IU;'D@,34L(#(P,3$N(%1H90T*("`-"B`@("`@($-O;7!A;GD@3F]T
M92!C;VYT86EN<R`B86YT:2UD:6QU=&EO;B(@<')O=&5C=&EO;BP@<W5C:"!T
M:&%T#0H@#0H@("`@("!I9B!T:&4@0V]M<&%N>2!I<W-U97,@86YD('-E;&QS
M(&-O;6UO;B!S=&]C:RP@;W(@<V5C=7)I=&EE<PT*(`T*("`@("`@8V]N=F5R
M=&EB;&4@:6YT;R!O<B!E>&5R8VES86)L92!F;W(@8V]M;6]N('-T;V-K(&]F
M('1H90T*("`-"B`@("`@($-O;7!A;GDL(&%T(&$@<')I8V4@<&5R('-H87)E
M('1H870@:7,@;&5S<R!T:&%N('1H90T*("`@#0H@("`@("!A<'!L:6-A8FQE
M($-O;G9E<G-I;VX@4')I8V4L('1H96X@=&AE($-O;G9E<G-I;VX@4')I8V4@
M:7,-"B`@("`-"B`@("`@(&%D:G5S=&5D(&1O=VYW87)D('1O(&UA=&-H('-U
M8V@@;&]W97(@:7-S=6%N8V4@<')I8V4N#0H@("`@(`T*("`@("`@2&]W979E
M<BP@:6X@;F\@979E;G0@=VEL;"!T:&4@0V]N=F5R<VEO;B!0<FEC92!B87-E
M9"!O;@T*("`-"B`@("`@(&%N=&DM9&EL=71I;VX@861J=7-T;65N=',@8F4@
M;&]W97(@=&AA;B!T:&4@(D9L;V]R(%!R:6-E(@T*("`@(`T*("`@("`@=VAI
M8V@@:7,@)#`N,C`@<&5R('-H87)E+@T*("`-"B`@("`\+W`^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%1H92!N=6UB97(@;V8@
M<VAA<F5S(&]F($-O;6UO;B!3=&]C:R!T:&%T(&UA>2!B92!I<W-U960@=&\-
M"B`@("`@#0H@("`@("!T:&4@;&5N9&5R('!U<G-U86YT('1O(&$@8V]N=F5R
M<VEO;B!O9B!T:&ES($YO=&4L(&-O;6)I;F5D#0H@("`@(`T*("`@("`@=VET
M:"!A;B!E>&5R8VES92!O9B!T:&4@5V%R<F%N="P@<VAA;&P@;F]T(&5X8V5E
M9"!A(&-A<`T*("`-"B`@("`@(&1E=&5R;6EN960@8GD@*&$I(&1I=FED:6YG
M('1H92!S=6T@;V8@*&DI('1H92!F86-E(&%M;W5N="!O9@T*("`-"B`@("`@
M('1H:7,@3F]T92P@<&QU<R`H:6DI(&%N(&%M;W5N="!E<75A;"!T;R!A;&P@
M:6YT97)E<W0@=&AA=`T*("`@(`T*("`@("`@=V]U;&0@86-C<G5E('5N9&5R
M('1H:7,@3F]T92!D=7)I;F<@:71S('1E<FT@*&%S<W5M:6YG(&YO#0H@("`@
M#0H@("`@("!P87EM96YT<R!O9B!P<FEN8VEP86P@;W(@:6YT97)E<W0@87)E
M(&UA9&4@<')I;W(@=&\@=&AE#0H@(`T*("`@("`@36%T=7)I='D@1&%T92DL
M(&)Y(&$@<')I8V4@<&5R('-H87)E(&]F($-O;6UO;B!3=&]C:R!E<75A;"!T
M;PT*("`@#0H@("`@("`D,"XR,"`H=&AE($9L;V]R(%!R:6-E*2X-"B`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M(%1H92!#;VUP86YY($YO=&4@86QS;R!C;VYT86EN<R!O=&AE<B!S=&%N9&%R
M9"!A9&IU<W1M96YT#0H@("`-"B`@("`@(&9E871U<F5S(&9O<B!S=&]C:R!S
M<&QI=',L(')E8V%P:71A;&EZ871I;VYS(&%N9"!S:6UI;&%R#0H@("`-"B`@
M("`@(&]C8W5R<F5N8V5S+B!4:&4@0V]M<&%N>2!.;W1E(&-O;G1A:6YS('-T
M86YD87)D(&5V96YT<R!O9@T*("`@(`T*("`@("`@9&5F875L="!R96QA=&5D
M('1O('!A>6UE;G0L('!E<F9O<FUA;F-E(&]F(&-E<G1A:6X@8V]V96YA;G1S
M#0H@(`T*("`@("`@86YD(&)A;FMR=7!T8WD@979E;G1S+B!792!H879E(&=R
M86YT960@=&AE($EN=F5S=&]R(&$-"B`@("`@#0H@("`@("!S96-U<FET>2!I
M;G1E<F5S="!I;B!T:&4@5')U<W0@3F]T97,@=6YD97(@=&AE('1E<FUS(&]F
M('1H90T*(`T*("`@("`@4V5C=7)I='D@06=R965M96YT+B!4:&4@<V]L92!C
M;VQL871E<F%L(&9O<B!T:&4@0V]M<&%N>2=S#0H@("`@#0H@("`@("!P87EM
M96YT(&%N9"!P97)F;W)M86YC92!O8FQI9V%T:6]N('5N9&5R('1H92!#;VUP
M86YY($YO=&4@:7,-"B`@#0H@("`@("!T:&4@5')U<W0@3F]T97,N)B,Q-C`[
M)B,Q-C`[5&AE(%=A<G)A;G0@96YT:71L97,@=&AE($EN=F5S=&]R#0H@#0H@
M("`@("!T;R!P=7)C:&%S92`S+#8S-BPS-C0@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:R!A="!A;B!E>&5R8VES90T*(`T*("`@("`@<')I8V4@;V8@)#`N,C,Q
M('!E<B!S:&%R92X@5&AE(%=A<G)A;G0@8V]N=&%I;G,-"B`@("`-"B`@("`@
M(")A;G1I+61I;'5T:6]N(B!P<F]T96-T:6]N+"!S=6-H('1H870@:68@=V4@
M:7-S=64@86YD('-E;&P-"B`@("`@#0H@("`@("!C;VUM;VX@<W1O8VLL(&]R
M('-E8W5R:71I97,@8V]N=F5R=&EB;&4@:6YT;R!O<B!E>&5R8VES86)L90T*
M(`T*("`@("`@9F]R(&-O;6UO;B!S=&]C:R!O9B!T:&4@0V]M<&%N>2P@870@
M82!P<FEC92!P97(@<VAA<F4@=&AA="!I<PT*("`@#0H@("`@("!L97-S('1H
M86X@=&AE(&%P<&QI8V%B;&4@97AE<F-I<V4@<')I8V4L('1H96X@=&AE('!R
M:6-E(&ES#0H@("`@(`T*("`@("`@861J=7-T960@9&]W;G=A<F0@=&\@;6%T
M8V@@<W5C:"!L;W=E<B!I<W-U86YC92!P<FEC92X@5&AE#0H@("`@#0H@("`@
M("!787)R86YT(&%L<V\@8V]N=&%I;G,@;W1H97(@<W1A;F1A<F0@861J=7-T
M;65N="!F96%T=7)E<R!F;W(-"B`@#0H@("`@("!S=&]C:R!S<&QI=',L(')E
M8V%P:71A;&EZ871I;VYS(&%N9"!S:6UI;&%R(&]C8W5R<F5N8V5S+@T*("`@
M#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@
M("`@("!792!R96-O<F1E9"!A(&1E8G0@9&ES8V]U;G0@;V8@)#@Y,"PP,#`@
M8F%S960@;VX@=&AE#0H@("`@#0H@("`@("!E<W1I;6%T960@9F%I<B!V86QU
M92!O9B!T:&4@9&5R:79A=&EV92!L:6%B:6QI=&EE<R!A<W-O8VEA=&5D#0H@
M("`-"B`@("`@('=I=&@@=&AE('=A<G)A;G1S(&%N9"!E;6)E9&1E9"!C;VYV
M97)S:6]N(&9E871U<F4@=VAI8V@@=V%S#0H@#0H@("`@("!A;6]R=&EZ960@
M=7-I;F<@=&AE(&5F9F5C=&EV92!I;G1E<F5S="!M971H;V0@;W9E<B!T:&4@
M=&5R;0T*(`T*("`@("`@;V8@=&AE(&YO=&4N#0H@("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!/;B!*=6YE
M(#(X+"`R,#$Q+"!W92!E;G1E<F5D(&EN=&\@82!497)M:6YA=&EO;B!!9W)E
M96UE;G0-"B`@("`-"B`@("`@('=I=&@@5&]N87%U:6YT+"!);F,N('5N9&5R
M('=H:6-H(&)O=&@@<&%R=&EE<R!A9W)E960@=&\-"B`@#0H@("`@("!T97)M
M:6YA=&4@=&AE('=A<G)A;G0@=&\@<')E=F5N="!C;VYT:6YU:6YG(&1I;'5T
M:6]N(&]F(&]U<@T*(`T*("`@("`@8V]M;6]N('-T;V-K(&%N9"!T;R!E;&EM
M:6YA=&4@8V]N9G5S:6]N(&]R(&1I<V%G<F5E;65N="!A<R!T;PT*("`@#0H@
M("`@("!T:&4@;G5M8F5R(&]F('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@879A
M:6QA8FQE(&9O<B!I<W-U86YC90T*(`T*("`@("`@=6YD97(@=&AE('=A<G)A
M;G0@:6X@=&AE(&9U='5R92X@06-C;W)D:6YG;'DL('5N9&5R('1H90T*("`-
M"B`@("`@(%1E<FUI;F%T:6]N($%G<F5E;65N="!W92!I<W-U960@,RPU.3DL
M.3$S('-H87)E<R!O9B!C;VUM;VX-"B`@("`@#0H@("`@("!S=&]C:R!U<&]N
M('1H92!F:6YA;"!E>&5R8VES92!O9B!T:&4@=V%R<F%N="P@=VAE<F5U<&]N
M('1H90T*(`T*("`@("`@=V%R<F%N="!W87,@=&5R;6EN871E9"!A;F0@:7,@
M;V8@;F\@9G5R=&AE<B!F;W)C92!O<B!E9F9E8W0N#0H@(`T*("`@("`@5&AE
M)B,Q-C`[5&5R;6EN871I;VX@06=R965M96YT(&%L<V\@<')O=FED97,@9F]R
M(&$@(D-O;6UO;@T*("`@(`T*("`@("`@4W1O8VL@4V%L92!,:6UI=&%T:6]N
M(B!O;B!A;&P@;V8@;W5R(&-O;6UO;B!S=&]C:R!H96QD(&)Y#0H@("`@#0H@
M("`@("!4;VYA<75I;G0L($EN8RX@56YD97(@=&AE(")#;VUM;VX@4W1O8VL@
M4V%L92!,:6UI=&%T:6]N(BP@=&AE#0H@("`-"B`@("`@(&1A:6QY(&QI;6ET
M871I;VX@;VX@=&AE(&YU;6)E<B!O9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K
M#0H@("`-"B`@("`@('=H:6-H(%1O;F%Q=6EN="P@26YC+B!M87D@<V5L;"!I
M;G1O('1H92!M87)K970@;VX@86YY('1R861I;F<-"B`@(`T*("`@("`@9&%Y
M(&ES(&QI;6ET960@=&\@=&AE(&=R96%T97(@;V8@*&DI("0U+#`P,"!O9B!S
M86QE<R!A;6]U;G0L#0H@(`T*("`@("`@;W(@*&EI*2`Q,"4@;V8@=&AE($%V
M97)A9V4@1&%I;'D@5F]L=6UE(&]F(&]U<B!C;VUM;VX@<W1O8VL-"B`-"B`@
M("`@('-O;&0@;VX@=&AE($]V97(@5&AE($-O=6YT97(@0G5L;&5T:6X@0F]A
M<F0L('=H97)E('1H90T*(`T*("`@("`@079E<F%G92!$86EL>2!6;VQU;64@
M<VAA;&P@;65A;B!T:&4@879E<F%G92!D86EL>2!V;VQU;64@9F]R#0H@(`T*
M("`@("`@=&AE('!R:6]R('1H<F5E(&UO;G1H('!E<FEO9"!A<R!R97!O<G1E
M9"!O;B!E86-H('1R861I;F<@9&%Y#0H@(`T*("`@("`@;VX@66%H;V\@1FEN
M86YC92!W:71H(')E<W!E8W0@=&\@;W5R(&-O;6UO;B!S=&]C:RX@56YD97(@
M=&AE#0H@(`T*("`@("`@=&5R;7,@;V8@=&AE(%1E<FUI;F%T:6]N($%G<F5E
M;65N="P@5&]N87%U:6YT+"!);F,N(&AA<PT*("`-"B`@("`@('=A:79E9"!A
M;F0@<F5L96%S960@=7,@9G)O;2!A;GD@;V)L:6=A=&EO;B!T;R!P87D@;W(@
M<&5R9F]R;0T*("`-"B`@("`@(&%N>2!F965S+"!P96YA;'1I97,L(&-O<W1S
M+"!O<B!A<W-E<W-M96YT<R!T:&%T('=E<F4@;W(@87)E#0H@#0H@("`@("!D
M=64L(&]R('=O=6QD(&AA=F4@8F5C;VUE(&1U92P@=6YD97(@=&AE(&-O;G9E
M<G1I8FQE(&YO=&4L#0H@("`@(`T*("`@("`@=&AE('=A<G)A;G0@86YD('1H
M92!N;W1E('!U<F-H87-E(&%G<F5E;65N="X@26X@8V]N<VED97)A=&EO;@T*
M("`@#0H@("`@("!O9B!T:&4@=&5R;6EN871I;VX@;V8@=&AE('=A<G)A;G0L
M('1H92!W86EV:6YG(&]F(&%L;"!F965S+`T*(`T*("`@("`@<&5N86QT:65S
M+"!T:&4@8W)E871I;VX@;V8@=&AE('-E;&QI;F<@<')O9W)A;2!A;F0@;W1H
M97(-"B`@(`T*("`@("`@9F%C=&]R<RP@=V4@86=R965D('1O(&ES<W5E(&%N
M('5N<V5C=7)E9"!N;VXM8V]N=F5R=&EB;&4-"B`@(`T*("`@("`@<')O;6ES
M<V]R>2!N;W1E("AT:&4@(DYE=R!.;W1E(BD@:6X@=&AE('!R:6YC:7!A;"!A
M;6]U;G0@;V8-"B`-"B`@("`@("0S-C`L,3@U+"!W:&EC:"!P<F]V:61E<R!F
M;W(@86YN=6%L(&EN=&5R97-T(&%T(&$@<F%T92!O9B`V)2P-"B`@(`T*("`@
M("`@<&%Y86)L92!M;VYT:&QY(&EN(&5I=&AE<B!C87-H(&]R(&]U<B!S=&]C
M:RP@870@;W5R(&]P=&EO;BX-"B`-"B`@("`@(%1H92!.97<@3F]T92!H87,@
M82!M871U<FET>2!D871E(&]F($%P<FEL(#,P+"`R,#$R+@T*("`@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!3
M15!414U"15(@,C`Q,"`Q,"4@0T].5D525$E"3$4@3D]415,-"B`@(`T*("`@
M(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@
M3VX@4V5P=&5M8F5R(#,L(#(P,3`L('=E(&5N=&5R960@:6YT;R!A(%-U8G-C
M<FEP=&EO;@T*("`@(`T*("`@("`@06=R965M96YT('=I=&@@=&AR964@86-C
M<F5D:71E9"!I;G9E<W1O<G,@*'1H90T*("`@#0H@("`@("`F(S@R,C`[4'5R
M8VAA<V5R<R8C.#(R,3LI)B,Q-C`[<')O=FED:6YG(&9O<B!T:&4@:7-S=6%N
M8V4@86YD#0H@("`@(`T*("`@("`@<V%L92!O9B!C;VYV97)T:6)L92!P<F]M
M:7-S;W)Y(&YO=&5S(&%N9"!C;W)R97-P;VYD:6YG#0H@#0H@("`@("!W87)R
M86YT<R!I;B!T:&4@86=G<F5G871E('!R:6YC:7!A;"!A;6]U;G0@;V8@)#$L
M-#,P+#`P,"X@5&AE#0H@("`-"B`@("`@(&EN:71I86P@8VQO<VEN9R!U;F1E
M<B!T:&4@4W5B<V-R:7!T:6]N($%G<F5E;65N="!R97-U;'1E9"!I;@T*("`-
M"B`@("`@('1H92!I<W-U86YC92!A;F0@<V%L92!O9B`H:2D@8V]N=F5R=&EB
M;&4@<')O;6ES<V]R>2!N;W1E<R!I;@T*("`-"B`@("`@('1H92!A9V=R96=A
M=&4@<')I;F-I<&%L(&%M;W5N="!O9B`D-S0S+#8P,"P@*&EI*2!F:79E+7EE
M87(-"B`@("`@#0H@("`@("!W87)R86YT<R!T;R!P=7)C:&%S92!A;B!A9V=R
M96=A=&4@;V8@,RPW,3@L,#`P('-H87)E<R!O9B!O=7(-"B`@#0H@("`@("!C
M;VUM;VX@<W1O8VL@870@86X@97AE<F-I<V4@<')I8V4@;V8@)#`N,S$Q,C4@
M<&5R('-H87)E+"!A;F0-"B`@#0H@("`@("`H:6EI*2!F:79E+7EE87(@=V%R
M<F%N=',@=&\@<'5R8VAA<V4@86X@86=G<F5G871E(&]F#0H@("`@#0H@("`@
M("`S+#<Q."PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@86X@
M97AE<F-I<V4@<')I8V4@;V8-"B`@#0H@("`@("`D,"XT,S4W-2!P97(@<VAA
M<F4N(%1H92!C;VYV97)T:6)L92!P<F]M:7-S;W)Y(&YO=&5S(&)E87(-"B`@
M("`-"B`@("`@(&EN=&5R97-T(&-O;7!O=6YD960@;6]N=&AL>2!A="!T:&4@
M86YN=6%L(')A=&4@;V8@=&5N('!E<F-E;G0-"B`@(`T*("`@("`@*#$P)2D@
M86YD(&UA='5R92!O;B!397!T96UB97(@,RP@,C`Q,2X@5&AE(&%G9W)E9V%T
M92!G<F]S<PT*("`@("`-"B`@("`@(&-A<V@@<')O8V5E9',@=V5R92`D-C4P
M+#`P,"P@=&AE(&)A;&%N8V4@;V8@=&AE('!R:6YC:7!A;`T*("`@(`T*("`@
M("`@86UO=6YT(')E<')E<V5N=&EN9R!A(&1U92!D:6QI9V5N8V4@9F5E(&%N
M9"!A;B!O<FEG:6YA;`T*("`-"B`@("`@(&ES<W5A;F-E(&1I<V-O=6YT+B!4
M:&4@8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N;W1E<R!A<F4-"B`@#0H@("`@
M("!C;VYV97)T:6)L92!A="!T:&4@;W!T:6]N(&]F('1H92!H;VQD97)S(&EN
M=&\@<VAA<F5S(&]F(&]U<@T*(`T*("`@("`@8V]M;6]N('-T;V-K(&%T(&$@
M<')I8V4@<&5R('-H87)E(&5Q=6%L('1O(&5I9VAT>2!P97)C96YT#0H@("`@
M#0H@("`@("`H.#`E*2!O9B!T:&4@879E<F%G92!O9B!T:&4@=&AR964@;&]W
M97-T(&-L;W-I;F<@8FED('!R:6-E<PT*(`T*("`@("`@;V8@=&AE(&-O;6UO
M;B!S=&]C:R!A<R!R97!O<G1E9"!B>2!";&]O;6)E<F<@3"Y0+B!F;W(@=&AE
M#0H@("`@#0H@("`@("!P<FEN8VEP86P@;6%R:V5T(&]N('=H:6-H('1H92!C
M;VUM;VX@<W1O8VL@=')A9&5S(&]R(&ES#0H@(`T*("`@("`@<75O=&5D(&9O
M<B!T:&4@=&5N("@Q,"D@=')A9&EN9R!D87ES('!R96-E9&EN9R!T:&4@<')O
M<&]S960-"B`-"B`@("`@(&-O;G9E<G-I;VX@9&%T92X@4W5B:F5C="!T;R!A
M9&IU<W1M96YT(&%S(&1E<V-R:6)E9"!I;B!T:&4-"B`@("`@#0H@("`@("!N
M;W1E<RP@=&AE(&-O;G9E<G-I;VX@<')I8V4@;6%Y(&YO="!B92!M;W)E('1H
M86X@)#`N,S`@;F]R#0H@("`@(`T*("`@("`@;&5S<R!T:&%N("0P+C(P+B!4
M:&5R92!A<F4@;F\@<F5G:7-T<F%T:6]N(')E<75I<F5M96YT<R!W:71H#0H@
M(`T*("`@("`@<F5S<&5C="!T;R!T:&4@<VAA<F5S(&]F(&-O;6UO;B!S=&]C
M:R!U;F1E<FQY:6YG('1H92!N;W1E<R!O<@T*("`@#0H@("`@("!T:&4@=V%R
M<F%N=',N#0H@("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@5&AE(&9O;&QO=VEN9R!C;VYV97)S:6]N<R!O
M9B!T:&4@4V5P=&5M8F5R(#(P,3`@,3`E#0H@("`-"B`@("`@($-O;G9E<G1I
M8FQE($YO=&4@:&%V92!T86ME;B!P;&%C92!D=7)I;F<@=&AE(&YI;F4@;6]N
M=&AS#0H@("`-"B`@("`@(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q.@T*(`T*
M("`@(#PO<#X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P('-T>6QE/3-$)W=I9'1H.B`X,"4[(&9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`-"B`@("`@(#QT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@3FEN92!-;VYT:',\
M8G(@+SX-"B`@("`-"B`@("`@("`@("!%;F1E9`T*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX-"B`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G/@T*("`@("`-"B`@("`@("`@
M("!$96-E;6)E<B`S,2P\8G(@+SX-"B`@("`@#0H@("`@("`@("`@,C`Q,0T*
M("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-3<E)SX-"B`@(`T*("`@("`@
M("`@(%!R:6YC:7!A;"!C;VYV97)T960-"B`@("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P)2<^#0H@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E
M>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,S<U+#4P,`T*("`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T
M<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@
M("`\=&0^#0H@("`@#0H@("`@("`@("`@06-C<G5E9"!I;G1E<F5S="!C;VYV
M97)T960-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@(#$Y+#(U-0T*("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!!="!$96-E;6)E<B`S,2P@
M,C`Q,2P@=&AE(')E;6%I;FEN9R!P<FEN8VEP86P@8F%L86YC92!O9@T*("`@
M#0H@("`@("`D,S8X+#$P,"!W87,@:6X@9&5F875L="X-"B`-"B`@("`\+W`^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($%04DE,
M(#(P,3$@,3`E($-/3E9%4E1)0DQ%($Y/5$53#0H@("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!);B!!<')I
M;"`R,#$Q+"!W92!E;G1E<F5D(&EN=&\@82!3=6)S8W)I<'1I;VX@06=R965M
M96YT('=I=&@-"B`@#0H@("`@("!T=V\@86-C<F5D:71E9"!I;G9E<W1O<G,@
M*'1H92`F(S@R,C`[4'5R8VAA<V5R<R8C.#(R,3LI#0H@("`@(`T*("`@("`@
M<')O=FED:6YG(&9O<B!T:&4@:7-S=6%N8V4@86YD('-A;&4@;V8@8V]N=F5R
M=&EB;&4@<')O;6ES<V]R>0T*("`@#0H@("`@("!N;W1E<R!A;F0@8V]R<F5S
M<&]N9&EN9R!W87)R86YT<R!I;B!T:&4@86=G<F5G871E('!R:6YC:7!A;`T*
M(`T*("`@("`@86UO=6YT(&]F("0S.#4L,#`P+B!4:&4@8VQO<VEN9R!U;F1E
M<B!T:&4@4W5B<V-R:7!T:6]N#0H@#0H@("`@("!!9W)E96UE;G0@<F5S=6QT
M960@:6X@=&AE(&ES<W5A;F-E(&%N9"!S86QE(&)Y('5S(&]F("AI*0T*("`@
M#0H@("`@("!C;VYV97)T:6)L92!P<F]M:7-S;W)Y(&YO=&5S(&EN('1H92!A
M9V=R96=A=&4@<')I;F-I<&%L#0H@(`T*("`@("`@86UO=6YT(&]F("0S.#4L
M,#`P+"`H:6DI(&9I=F4M>65A<B!W87)R86YT<R!T;R!P=7)C:&%S92!A;@T*
M("`@("`-"B`@("`@(&%G9W)E9V%T92!O9B8C,38P.S0L,#`T+#`P,"!S:&%R
M97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A="!A;@T*(`T*("`@("`@97AE<F-I
M<V4@<')I8V4@;V8@)#`N,3(U('!E<B!S:&%R92P@86YD("AI:6DI(&9I=F4M
M>65A<@T*("`-"B`@("`@('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E
M9V%T92!O9B8C,38P.S0L,#`T+#`P,"!S:&%R97,@;V8-"B`@#0H@("`@("!O
M=7(@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F("0P+C$W
M-2!P97(@<VAA<F4N#0H@("`@(`T*("`@("`@5&AE(&-O;G9E<G1I8FQE('!R
M;VUI<W-O<GD@;F]T97,@8F5A<B!I;G1E<F5S="!C;VUP;W5N9&5D#0H@("`@
M#0H@("`@("!M;VYT:&QY(&%T('1H92!A;FYU86P@<F%T92!O9B!T96X@<&5R
M8V5N="`H,3`E*2!A;F0@;6%T=7)E(&]N#0H@("`-"B`@("`@($%P<FEL(#$L
M(#(P,3(N)B,Q-C`[)B,Q-C`[5&AE(&%G9W)E9V%T92!G<F]S<R!C87-H('!R
M;V-E961S#0H@("`@#0H@("`@("!T;R!U<R!W97)E("0S-3`L,#`P+"!T:&4@
M8F%L86YC92!O9B!T:&4@<')I;F-I<&%L(&%M;W5N=`T*("`@#0H@("`@("!R
M97!R97-E;G1I;F<@82!D=64@9&EL:6=E;F-E(&9E92!A;F0@86X@;W)I9VEN
M86P@:7-S=6%N8V4-"B`@("`-"B`@("`@(&1I<V-O=6YT+B!4:&4@8V]N=F5R
M=&EB;&4@<')O;6ES<V]R>2!N;W1E<R!A<F4@8V]N=F5R=&EB;&4@870-"B`@
M(`T*("`@("`@=&AE(&]P=&EO;B!O9B!T:&4@:&]L9&5R<R!I;G1O('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL@;V8@=&AE#0H@(`T*("`@("`@4F5G:7-T<F%N
M="!A="!A('!R:6-E('!E<B!S:&%R92!E<75A;"!T;R!E:6=H='D@<&5R8V5N
M="`H.#`E*0T*("`@#0H@("`@("!O9B!T:&4@879E<F%G92!O9B!T:&4@=&AR
M964@;&]W97-T(&-L;W-I;F<@8FED('!R:6-E<R!O9B!T:&4-"B`@#0H@("`@
M("!C;VUM;VX@<W1O8VL@87,@<F5P;W)T960@8GD@0FQO;VUB97)G($PN4"X@
M9F]R('1H92!P<FEN8VEP86P-"B`@#0H@("`@("!M87)K970@;VX@=VAI8V@@
M=&AE(&-O;6UO;B!S=&]C:R!T<F%D97,@;W(@:7,@<75O=&5D(&9O<B!T:&4-
M"B`@#0H@("`@("!T96X@*#$P*2!T<F%D:6YG(&1A>7,@<')E8V5D:6YG('1H
M92!P<F]P;W-E9"!C;VYV97)S:6]N(&1A=&4N#0H@("`-"B`@("`@(%-U8FIE
M8W0@=&\@861J=7-T;65N="!A<R!D97-C<FEB960@:6X@=&AE(&YO=&5S+"!T
M:&4-"B`@("`-"B`@("`@(&-O;G9E<G-I;VX@<')I8V4@;6%Y(&YO="!B92!M
M;W)E('1H86X@)#`N,C`@;F]R(&QE<W,@=&AA;@T*("`@(`T*("`@("`@)#`N
M,3`N(%1H97)E(&%R92!N;R!R96=I<W1R871I;VX@<F5Q=6ER96UE;G1S('=I
M=&@@<F5S<&5C="!T;PT*("`@#0H@("`@("!T:&4@<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:R!U;F1E<FQY:6YG('1H92!N;W1E<R!O<B!T:&4-"B`-"B`@("`@
M('=A<G)A;G1S+@T*(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^#0H@("`@(`T*("`@("`@26X@861D:71I;VXL('=E(&ES<W5E9"`H:2D@
M9FEV92UY96%R('=A<G)A;G1S('1O('!U<F-H87-E(&%N#0H@(`T*("`@("`@
M86=G<F5G871E(&]F(#@Q,BPU,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O
M8VL@870@86X-"B`@("`@#0H@("`@("!E>&5R8VES92!P<FEC92!O9B`D,"XQ
M,C4@<&5R('-H87)E+"!A;F0@*&EI:2D@9FEV92UY96%R#0H@(`T*("`@("`@
M=V%R<F%N=',@=&\@<'5R8VAA<V4@86X@86=G<F5G871E(&]F)B,Q-C`[.#$R
M+#4P,"!S:&%R97,@;V8-"B`@("`@#0H@("`@("!O=7(@8V]M;6]N('-T;V-K
M(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F("0P+C$W-2!P97(@<VAA<F4@=&\-
M"B`@#0H@("`@("!T:&4@4'5R8VAA<V5R<RX@5&AE<V4@=V%R<F%N=',@=V5R
M92!I<W-U960@87,@86X@86YT:61I;'5T:6]N#0H@("`-"B`@("`@(&%D:G5S
M=&UE;G0@=6YD97(@8V5R=&%I;B!C;VUM;VX@<W1O8VL@<'5R8VAA<V4@=V%R
M<F%N=',@:&5L9`T*("`-"B`@("`@(&)Y(%!U<F-H87-E<G,@=&AA="!W97)E
M(&%C<75I<F5D(&9R;VT@=7,@:6X@4V5P=&5M8F5R(#(P,3`N#0H@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!!
M="!$96-E;6)E<B`S,2P@,C`Q,2P@=&AE(&]U='-T86YD:6YG('!R:6YC:7!A
M;"!B86QA;F-E('=A<PT*(`T*("`@("`@)#0P,"PT,#`N#0H@#0H@("`@/"]P
M/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!*54Q9
M("9A;7`[($%51U535"`R,#$Q(#$P)2!#3TY615)424),12!.3U1%4PT*("`@
M("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-
M"B`@("`@($1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D(%-E<'1E;6)E
M<B`S,"P@,C`Q,2P@=V4@<F%I<V5D#0H@#0H@("`@("`D,S4W+#8U-B!I;B`Q
M,"4@8V]N=F5R=&EB;&4@;F]T97,N(%1H;W-E(&YO=&5S(&AA9"!A(&9I>&5D
M#0H@("`@(`T*("`@("`@8V]N=F5R<VEO;B!P<FEC92!O9B`D,"XP.2!P97(@
M<VAA<F4@86YD(&-A<G)I960@86X@:6YT97)E<W0-"B`-"B`@("`@(')A=&4@
M;V8@,3`E+B!4:&4@8V]N=F5R=&EB;&4@;F]T97,@;6%T=7)E(&EN($IU;'D@
M86YD($%U9W5S=`T*("`-"B`@("`@(#(P,3(N(%=E(&%L<V\@:7-S=65D('1H
M;W-E(&EN=F5S=&]R<R!F:79E('EE87(@=V%R<F%N=',@=&\-"B`@("`@#0H@
M("`@("!P=7)C:&%S92`S+#DW,RPY-3<@<VAA<F5S(&]F(&-O;6UO;B!S=&]C
M:R!A="`D,"XQ,C4@<&5R#0H@(`T*("`@("`@<VAA<F4N#0H@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E
M(&UE87-U<F5D('1H92!F86ER('9A;'5E(&]F('1H92!W87)R86YT<R!A;F0@
M=&AE(&)E;F5F:6-I86P-"B`@(`T*("`@("`@8V]N=F5R<VEO;B!F96%T=7)E
M(&]F('1H92!N;W1E<R!A;F0@<F5C;W)D960@82`D,C4W+#DR-@T*("`-"B`@
M("`@(&1I<V-O=6YT(&%G86EN<W0@=&AE('!R:6YC:7!A;"!O9B!T:&4@;F]T
M97,N(%=E(&%R90T*("`@#0H@("`@("!A;6]R=&EZ:6YG('1H:7,@9&ES8V]U
M;G0@=7-I;F<@=&AE(&5F9F5C=&EV92!I;G1E<F5S="!M971H;V0-"B`@#0H@
M("`@("!O=F5R('1H92!T97)M(&]F('1H92!N;W1E+@T*("`@#0H@("`@/"]P
M/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!315!4
M14U"15(@,C`Q,2!#3TY615)424),12!.3U1%4PT*("`@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3VX@4V5P
M=&5M8F5R(#(S+"`R,#$Q+"!W92!E;G1E<F5D(&EN=&\@82!3=6)S8W)I<'1I
M;VX-"B`@("`@#0H@("`@("!!9W)E96UE;G0@=VET:"!T=V\@86-C<F5D:71E
M9"!I;G9E<W1O<G,@*'1H90T*(`T*("`@("`@)B,X,C(P.U!U<F-H87-E<G,F
M(S@R,C$[*2!P<F]V:61I;F<@9F]R('1H92!I<W-U86YC92!A;F0@<V%L90T*
M(`T*("`@("`@;V8@8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N;W1E<R!A;F0@
M8V]R<F5S<&]N9&EN9R!W87)R86YT<R!I;@T*("`@#0H@("`@("!T:&4@86=G
M<F5G871E('!R:6YC:7!A;"!A;6]U;G0@;V8@)#(U,RPW-C`N(%1H92!W87)R
M86YT<PT*("`@#0H@("`@("!C87)R:65D(&$@9FEV92UY96%R('1E<FT@=&\@
M<'5R8VAA<V4@86X@86=G<F5G871E(&]F#0H@("`@#0H@("`@("`S+#8R-2PQ
M-#,@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@86X@97AE<F-I<V4@
M<')I8V4@;V8-"B`@#0H@("`@("`D,"XQ,"!P97(@<VAA<F4N(%1H92!C;VYV
M97)T:6)L92!P<F]M:7-S;W)Y(&YO=&5S(&1O(&YO="!B96%R#0H@("`-"B`@
M("`@(&%N(&EN=&5R97-T(')A=&4@86YD(&UA='5R92!O;B!397!T96UB97(@
M,C,L(#(P,3(N(%1H90T*(`T*("`@("`@86=G<F5G871E(&YE="!C87-H('!R
M;V-E961S('1O('5S('=E<F4@)#$W-2PP,#`L('1H92!B86QA;F-E#0H@(`T*
M("`@("`@;V8@=&AE('!R:6YC:7!A;"!A;6]U;G0@<F5P<F5S96YT:6YG(&$@
M9'5E(&1I;&EG96YC92!F964@86YD#0H@(`T*("`@("`@86X@;W)I9VEN86P@
M:7-S=6%N8V4@9&ES8V]U;G0N(%1H92!C;VYV97)T:6)L92!P<F]M:7-S;W)Y
M#0H@("`@#0H@("`@("!N;W1E<R!A<F4@8V]N=F5R=&EB;&4@870@=&AE(&]P
M=&EO;B!O9B!T:&4@:&]L9&5R<R!I;G1O#0H@(`T*("`@("`@<VAA<F5S(&]F
M(&]U<B!C;VUM;VX@<W1O8VL@870@82!P<FEC92!P97(@<VAA<F4@97%U86P@
M=&\-"B`@(`T*("`@("`@<V5V96X@8V5N=',N(%-U8FIE8W0@=&\@861J=7-T
M;65N=',@87,@9&5S8W)I8F5D(&EN('1H90T*("`-"B`@("`@(&YO=&5S+"!T
M:&4@8V]N=F5R<VEO;B!P<FEC92!M87D@;F]T(&)E(&UO<F4@=&AA;B!S979E
M;B!C96YT<RX-"B`@(`T*("`@("`@5&AE<F4@87)E(&YO(')E9VES=')A=&EO
M;B!R97%U:7)E;65N=',@=VET:"!R97-P96-T('1O('1H90T*("`@("`-"B`@
M("`@('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=6YD97)L>6EN9R!T:&4@;F]T
M97,@;W(@=&AE('=A<G)A;G1S+@T*("`-"B`@("`\+W`^/&)R+SX\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%=E(&UE87-U<F5D('1H92!F
M86ER('9A;'5E(&]F('1H92!W87)R86YT<R!A;F0@=&AE(&)E;F5F:6-I86P-
M"B`@(`T*("`@("`@8V]N=F5R<VEO;B!F96%T=7)E(&]F('1H92!N;W1E<R!A
M;F0@<F5C;W)D960@82`D,38X+#@P-`T*("`-"B`@("`@(&1I<V-O=6YT(&%G
M86EN<W0@=&AE('!R:6YC:7!A;"!O9B!T:&4@;F]T97,N(%=E(&%R90T*("`@
M#0H@("`@("!A;6]R=&EZ:6YG('1H:7,@9&ES8V]U;G0@=7-I;F<@=&AE(&5F
M9F5C=&EV92!I;G1E<F5S="!M971H;V0-"B`@#0H@("`@("!O=F5R('1H92!T
M97)M(&]F('1H92!N;W1E+@T*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!.3U9%34)%4B`R,#$Q($-/3E9%
M4E1)0DQ%($Y/5$53#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@($EN($YO=F5M8F5R(#(P,3$L('=E(')A
M:7-E9"`D-3(U+#`P,"!I;B`U)2!/<FEG:6YA;"!)<W-U90T*("`@(`T*("`@
M("`@1&ES8V]U;G0@56YS96-U<F5D($-O;G9E<G1I8FQE($1E8F5N='5R97,@
M9G)O;2!F:79E#0H@("`-"B`@("`@(&%C8W)E9&ET960@:6YV97-T;W)S('!U
M<G-U86YT('1O('=H:6-H('1H92!I;G9E<W1O<G,-"B`@("`-"B`@("`@('!U
M<F-H87-E9"!A;B!A9V=R96=A=&4@<')I;F-I<&%L(&%M;W5N="!O9B`D-3(U
M+#`P,"!F;W(@86X-"B`@("`@#0H@("`@("!A9V=R96=A=&4@<'5R8VAA<V4@
M<')I8V4@;V8@)#4P,"PP,#`N(%1H92!D96)E;G1U<F5S(&)E87(-"B`@("`-
M"B`@("`@(&EN=&5R97-T(&%T(#(P)2!P97(@86YN=6T@86YD(&UA='5R92!O
M;B!!<')I;"`R,"P@,C`Q,BX@5&AE#0H@#0H@("`@("!D96)E;G1U<F5S('=I
M;&P@8F4@8V]N=F5R=&EB;&4@870@=&AE(&]P=&EO;B!O9B!T:&4@:&]L9&5R
M<PT*(`T*("`@("`@870@86YY('1I;64@:6YT;R!S:&%R97,@;V8@;W5R(&-O
M;6UO;B!S=&]C:RP@870@82!C;VYV97)S:6]N#0H@(`T*("`@("`@<')I8V4@
M97%U86P@=&\@)#`N,#<W.2P@<W5B:F5C="!T;R!A9&IU<W1M96YT+B!);B!C
M;VYN96-T:6]N#0H@(`T*("`@("`@=VET:"!T:&4@9&5B96YT=7)E<RP@=&AE
M('!U<F-H87-E<G,@<F5C96EV960@=V%R<F%N=',@=&\-"B`@(`T*("`@("`@
M<'5R8VAA<V4@,RPS-CDL-S`V('-H87)E<R!O9B!O=7(@0V]M;6]N(%-T;V-K
M+B!4:&4@=V%R<F%N=',-"B`-"B`@("`@(&%R92!E>&5R8VES86)L92!F;W(@
M82!P97)I;V0@;V8@9FEV92!Y96%R<R!F<F]M('1H92!D871E(&]F#0H@#0H@
M("`@("!I<W-U86YC92!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XQ,2P@
M<W5B:F5C="!T;PT*("`-"B`@("`@(&%D:G5S=&UE;G0N#0H@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@(%5N
M=&EL($1E8V5M8F5R(#,Q+"`R,#$R+"!U<&]N(&%N>2!P<F]P;W-E9"!I<W-U
M86YC92!B>2!U<R!O9@T*("`-"B`@("`@(&]U<B!C;VUM;VX@<W1O8VL@;W(@
M97%U:79A;&5N=',@*&]R(&$@8V]M8FEN871I;VX@=&AE<F5O9B!A<PT*("`-
M"B`@("`@(&1E9FEN960@:6X@=&AE('-U8G-C<FEP=&EO;B!A9W)E96UE;G0I
M(&9O<B!C87-H#0H@("`@#0H@("`@("!C;VYS:61E<F%T:6]N+"!T:&4@<'5R
M8VAA<V5R<R!M87D@96QE8W0L(&EN('1H96ER('-O;&4-"B`-"B`@("`@(&1I
M<V-R971I;VXL('1O(&5X8VAA;F=E(&%L;"!O<B!S;VUE(&]F('1H92!D96)E
M;G1U<F5S('1H96X-"B`@("`@#0H@("`@("!H96QD(&)Y('-U8V@@<'5R8VAA
M<V5R(&9O<B!A;GD@<V5C=7)I=&EE<R!I<W-U960@:6X@80T*("`@("`-"B`@
M("`@('-U8G-E<75E;G0@9FEN86YC:6YG(&]N(&$@)#$N,#`@9F]R("0Q+C`P
M(&)A<VES+"!P<F]V:61E9"P-"B`@("`@#0H@("`@("!H;W=E=F5R("P@=&AI
M<R!R:6=H="!S:&%L;"!N;W0@87!P;'D@=VET:"!R97-P96-T('1O("AI*2!A
M;@T*(`T*("`@("`@17AE;7!T($ES<W5A;F-E("AA<R!D969I;F5D(&EN('1H
M92!D96)E;G1U<F4I(&]R("AI:2D@86X-"B`@(`T*("`@("`@=6YD97)W<FET
M=&5N('!U8FQI8R!O9F9E<FEN9R!O9B!O=7(@8V]M;6]N('-T;V-K+@T*(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@02!&24Y202!R96=I<W1E<F5D(&)R;VME<BUD96%L97(@=V%S(&5N9V%G
M960@87,@<&QA8V5M96YT#0H@("`@#0H@("`@("!A9V5N="!I;B!C;VYN96-T
M:6]N('=I=&@@=&AE('!R:79A=&4@<&QA8V5M96YT+B8C,38P.R8C,38P.U=E
M#0H@#0H@("`@("!P86ED('1H92!P;&%C96UE;G0@86=E;G0@82!C87-H(&9E
M92!I;B!T:&4@86UO=6YT(&]F("0U,"PP,#`-"B`@#0H@("`@("`H<F5P<F5S
M96YT:6YG(&$@."4@<V%L97,@8V]M;6ES<VEO;B!A;F0@82`R)2!U;F%C8V]U
M;G1A8FQE#0H@("`@(`T*("`@("`@97AP96YS92!A;&QO=V%N8V4I(&%N9"!W
M:6QL(&ES<W5E('1H92!P;&%C96UE;G0@86=E;G0@;W(@:71S#0H@(`T*("`@
M("`@9&5S:6=N965S('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E9V%T
M92!O9B`X,#@L-S(Y('-H87)E<PT*("`@#0H@("`@("!O9B!C;VUM;VX@<W1O
M8VL@870@)#`N,3$@<&5R('-H87)E+B!4:&4@=V%R<F%N=',@:7-S=65D('1O
M#0H@("`@(`T*("`@("`@=&AE('!L86-E;65N="!A9V5N="!M87D@8F4@97AE
M<F-I<V5D(&]N(&$@8V%S:&QE<W,@8F%S:7,N($EN#0H@(`T*("`@("`@=&AE
M(&5V96YT('1H92!P;&%C96UE;G0@86=E;G0@97AE<F-I<V5S('1H92!W87)R
M86YT<R!O;B!A#0H@("`@#0H@("`@("!C87-H;&5S<R!B87-I<RP@=V4@=VEL
M;"!N;W0@<F5C96EV92!A;GD@<')O8V5E9',N#0H@#0H@("`@/"]P/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!4:&4@<V5C=7)I
M=&EE<R!S;VQD(&EN('1H92!P<FEV871E('!L86-E;65N="!W97)E(&YO=`T*
M("`@("`-"B`@("`@(')E9VES=&5R960@=6YD97(@=&AE(%-E8W5R:71I97,@
M06-T+"!O<B!T:&4@<V5C=7)I=&EE<R!L87=S#0H@#0H@("`@("!O9B!A;GD@
M<W1A=&4L(&%N9"!W97)E(&]F9F5R960@86YD('-O;&0@:6X@<F5L:6%N8V4@
M;VX@=&AE#0H@("`@(`T*("`@("`@97AE;7!T:6]N(&9R;VT@<F5G:7-T<F%T
M:6]N(&%F9F]R9&5D(&)Y(%-E8W1I;VX@-"@R*2!A;F0-"B`@(`T*("`@("`@
M4F5G=6QA=&EO;B!$("A2=6QE(#4P-BD@=6YD97(@=&AE(%-E8W5R:71I97,@
M06-T(&%N9`T*("`@(`T*("`@("`@8V]R<F5S<&]N9&EN9R!P<F]V:7-I;VYS
M(&]F('-T871E('-E8W5R:71I97,@;&%W<RP@=VAI8V@-"B`@(`T*("`@("`@
M97AE;7!T('1R86YS86-T:6]N<R!B>2!A;B!I<W-U97(@;F]T(&EN=F]L=FEN
M9R!A;GD@<'5B;&EC#0H@("`@#0H@("`@("!O9F9E<FEN9RX@5&AE(&EN=F5S
M=&]R<R!A<F4@)B,X,C(P.V%C8W)E9&ET960-"B`-"B`@("`@(&EN=F5S=&]R
M<R8C.#(R,3L@87,@<W5C:"!T97)M(&ES(&1E9FEN960@:6X@4F5G=6QA=&EO
M;B!$#0H@(`T*("`@("`@<')O;75L9V%T960@=6YD97(@=&AE(%-E8W5R:71I
M97,@06-T+B8C,38P.R8C,38P.PT*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@070@1&5C96UB97(@,S$L
M(#(P,3$L('1H92!I;G1E<F5S="!P87EA8FQE(&]N('1H97-E(&YO=&5S#0H@
M("`@#0H@("`@("!T;W1A;&5D("0Q-"PP.#4N)B,Q-C`[#0H@("`-"B`@("`\
M+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R9@T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC9E\S8C-B7S0T-&5?
M8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E=#$Q+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3D]412`V+B!%455)
M5%D@5%)!3E-!0U1)3TY3/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-T;V-K:&]L9&5R<R<@17%U:71Y($YO=&4@1&ES8VQO<W5R
M92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`-"B`@("`@($Y/5$4@-BX@15%5
M2519(%1204Y304-424].4PT*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@1'5R:6YG('1H92!N:6YE(&UO
M;G1H<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2P@=V4@:7-S=65D#0H@("`@
M#0H@("`@("`R-"PT,3,L-38X('-H87)E<R!O9B!R97-T<FEC=&5D(&-O;6UO
M;B!S=&]C:R!I;B!E>&-H86YG92!F;W(-"B`@#0H@("`@("!T:&4@<&%R=&EA
M;"!O<B!F=6QL(&-O;G9E<G-I;VX@;V8@<')I;F-I<&%L(&%N9"!I;G1E<F5S
M="!O9@T*(`T*("`@("`@<V5V97)A;"!C;VYV97)T:6)L92!N;W1E<R!P87EA
M8FQE(&EN(&%N(&%G9W)E9V%T92!A;6]U;G0@;V8-"B`-"B`@("`@("0Q+#@P
M-BPX-SD@870@86X@879E<F%G92!C;VYV97)S:6]N('!R:6-E(&]F("0P+C`W
M('!E<B!S:&%R90T*("`-"B`@("`@(&)A<V5D('5P;VX@=&AE(&-O;G9E<G-I
M;VX@9F]R;75L864@:6X@=&AE(')E<W!E8W1I=F4@;F]T97,N#0H@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!$
M=7)I;F<@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q
M+"!W92!I<W-U960-"B`@("`-"B`@("`@(#,L,CDR+#`R.2!S:&%R97,@;V8@
M<W1O8VL@=&\@<V5R=FEC92!P<F]V:61E<G,@9F]R('-E<G9I8V5S#0H@#0H@
M("`@("!V86QU960@870@)#,R."PS,C<@8F%S960@=7!O;B!T:&4@9F%I<B!V
M86QU92!O9B!T:&4@<VAA<F5S#0H@("`@(`T*("`@("`@:7-S=65D+B!/9B!T
M:&%T(&%G9W)E9V%T92!N=6UB97(L(#(L.#8T+#0X."!S:&%R97,@;V8@8V]M
M;6]N#0H@(`T*("`@("`@<W1O8VL@=V5R92!I<W-U960@=&\@8V]N<W5L=&%N
M=',@<'5R<W5A;G0@=&\@;W5R(%,M.`T*("`@(`T*("`@("`@<F5G:7-T<F%T
M:6]N('-T871E;65N=',@8V]V97)I;F<@;W5R($%M96YD960@86YD(%)E<W1A
M=&5D#0H@("`@#0H@("`@("`R,#`S($-O;G-U;'1A;G0@4W1O8VL@4&QA;B!O
M<B`R,#$P(%-T;V-K($EN8V5N=&EV92!0;&%N(&9O<@T*(`T*("`@("`@<V5R
M=FEC97,@=F%L=65D(&%T("0R-S(L,#<W(&)A<V5D('5P;VX@=&AE(&9A:7(@
M=F%L=64@;V8@=&AE#0H@(`T*("`@("`@<VAA<F5S(&ES<W5E9"X@5&AE('-E
M<G9I8V5S('=E<F4@9F]R(')E9W5L871O<GD@869F86ER<RP-"B`@(`T*("`@
M("`@<')I;6%R:6QY(&UA;F%G:6YG(&]U<B!H97!A=&ET:7,@0R!T<FEA;"!I
M;B!);F1I82P@86YD#0H@#0H@("`@("!C;W)P;W)A=&4@8V]M;75N:6-A=&EO
M;G,N)B,Q-C`[)B,Q-C`[5&AE(&%V97)A9V4@:7-S=6%N8V4-"B`@#0H@("`@
M("!P<FEC92!O;B!T:&4@4RTX(&ES<W5A;F-E<R!W87,@87!P<F]X:6UA=&5L
M>2`D,"XP.2!P97(@<VAA<F4N#0H@("`-"B`@("`@($%D9&ET:6]N86QL>2P@
M=V4@:7-S=65D(#0R-RPU-#$@<F5S=')I8W1E9"!S:&%R97,@;V8@8V]M;6]N
M#0H@#0H@("`@("!S=&]C:R!T;R!S97)V:6-E('!R;W9I9&5R<R!F;W(@:6YV
M97-T;W(@<F5L871I;VYS('9A;'5E9"!A=`T*(`T*("`@("`@)#4V+#(U,"!B
M87-E9"!U<&]N('1H92!F86ER('9A;'5E(&]F('1H92!S:&%R97,@:7-S=65D
M+B!4:&4-"B`-"B`@("`@(&%V97)A9V4@:7-S=6%N8V4@<')I8V4@;VX@=&AE
M(')E<W1R:6-T960@<VAA<F4@:7-S=6%N8V5S('=A<PT*("`-"B`@("`@(&%P
M<')O>&EM871E;'D@)#`N,3,@<&5R('-H87)E+@T*("`-"B`@("`\+W`^/&)R
M+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($1U<FEN9R!T
M:&4@;FEN92!M;VYT:',@96YD960@1&5C96UB97(@,S$L(#(P,3$L('=E(&ES
M<W5E9`T*("`@(`T*("`@("`@,RPV.3DL.3$T('-H87)E<R!O9B!R97-T<FEC
M=&5D(&-O;6UO;B!S=&]C:R!R96QA=&5D('1O(&YE=`T*("`@("`-"B`@("`@
M('=A<G)A;G0@8V%S:&QE<W,@97AE<F-I<V5S+@T*("`@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@26X@36%Y
M(#(P,3$L('=E(&%G<F5E9"!T;R!M;V1I9GD@=&AR964@=V%R<F%N=',@:&5L
M9"!B>2!A;@T*("`@("`-"B`@("`@(&EN<W1I='5T:6]N86P@:6YV97-T;W(@
M87,@=&AE(')E<W5L="!O9B!A;G1I9&EL=71I;VX-"B`@("`-"B`@("`@('!R
M;W1E8W1I;VXN#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`G/@T*("`@("`-"B`@("`@($EN($UA>2`R,#$Q+"!O=7(@0F]A<F0@<F%T
M:69I960@82!S:7@@;6]N=&@@8V]N<W5L=&EN9PT*(`T*("`@("`@86=R965M
M96YT('=I=&@@82!C;VYS=6QT86YT('1O('!R;W9I9&4@<'5B;&EC(')E;&%T
M:6]N<R!A;F0-"B`-"B`@("`@(&-O<G!O<F%T92!C;VUM=6YI8V%T:6]N<R!S
M97)V:6-E<RX@5V4@86=R965D('1O('!A>2!T:&4-"B`@#0H@("`@("!C;VYS
M=6QT86YT(&$@;6]N=&AL>2!F964@;V8@)#$L-3`P(&EN(&-A<V@@86YD(&$@
M;VYE+71I;64-"B`@("`-"B`@("`@('-T;V-K+6)A<V5D('!A>6UE;G0@;V8@
M<VEX(&UO;G1H<R8C.#(Q-SL@=V]R=&@@;V8@<VAA<F5S#0H@(`T*("`@("`@
M8F%S960@=7!O;B!A(')A=&4@;V8@)#4L,#`P('!E<B!M;VYT:"P@;W(@82!T
M;W1A;"!O9B`D,S`L,#`P+`T*("`@#0H@("`@("!T;R!B92!P86ED(&EN(')E
M<W1R:6-T960@<W1O8VLN($)A<V5D('5P;VX@=&AE(&-L;W-I;F<@<')I8V4-
M"B`@#0H@("`@("!O9B!T:&4@9&%T92!O9B!T:&4@87!P<F]V86P@8GD@;W5R
M($)O87)D+"!T:&4@;VYE+71I;64-"B`-"B`@("`@(')E<W1R:6-T960@<VAA
M<F4@<&%Y;65N="!W87,@:6X@=&AE(&%M;W5N="!O9B`R,#`L,#`P#0H@("`@
M(`T*("`@("`@<F5S=')I8W1E9"!S:&%R97,N#0H@("`@(`T*("`@(#PO<#X\
M8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDW93`P.6-F7S-B,V)?-#0T95]B-SEC
M7V$S-S@U-S)D,S0R9B]7;W)K<VAE971S+U-H965T,3(N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.3U1%(#<N($%#0U)5140@
M3$E154E$051%1"!$04U!1T53/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8W)U960@3&EQ=6ED871E9"!$86UA9V5S($1I<V-L
M;W-U<F4@5&5X=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P)SX-"B`@#0H@("`@("!.3U1%(#<N($%#0U)5140@
M3$E154E$051%1"!$04U!1T53#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!792!A8V-O=6YT(&9O<B!C;VYT
M:6YG96YT(&]B;&EG871I;VYS('1O(&UA:V4@9G5T=7)E('!A>6UE;G1S#0H@
M("`-"B`@("`@(&]R(&]T:&5R=VES92!T<F%N<V9E<B!C;VYS:61E<F%T:6]N
M('5N9&5R(&$@<F5G:7-T<F%T:6]N#0H@("`-"B`@("`@('!A>6UE;G0@87)R
M86YG96UE;G0@<V5P87)A=&5L>2!F<F]M(&%N>2!R96QA=&5D(&9I;F%N8VEN
M9PT*("`@(`T*("`@("`@=')A;G-A8W1I;VX@86=R965M96YT<RP@86YD(&%N
M>2!S=6-H(&-O;G1I;F=E;G0@;V)L:6=A=&EO;G,-"B`-"B`@("`@(&%R92!R
M96-O9VYI>F5D(&]N;'D@=VAE;B!I="!I<R!D971E<FUI;F5D('1H870@:70@
M:7,@<')O8F%B;&4-"B`@(`T*("`@("`@=&AA="!W92!W:6QL(&)E8V]M92!O
M8FQI9V%T960@9F]R(&9U='5R92!P87EM96YT<R!A;F0@=&AE#0H@("`@#0H@
M("`@("!A;6]U;G0L(&]R(')A;F=E(&]F(&%M;W5N=',L(&]F('-U8V@@9G5T
M=7)E('!A>6UE;G1S(&-A;B!B90T*(`T*("`@("`@<F5A<V]N86)L>2!E<W1I
M;6%T960N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/@T*("`@("`-"B`@("`@(%=E(&AA=F4@96YT97)E9"!I;G1O(')E9VES=')A
M=&EO;B!P87EM96YT(&%R<F%N9V5M96YT<R!I;@T*("`@(`T*("`@("`@8V]N
M;F5C=&EO;B!W:71H(&-E<G1A:6X@9FEN86YC:6YG(&%R<F%N9V5M96YT<R!T
M:&%T(')E<75I<F4-"B`-"B`@("`@('5S('1O(')E9VES=&5R('1H92!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K('5N9&5R;'EI;F<@=&AE#0H@("`-"B`@("`@
M(&-O;G9E<G1I8FQE(&1E8G0@86YD('=A<G)A;G1S(&ES<W5E9"!I;B!T:&5S
M92!F:6YA;F-I;F<-"B`@#0H@("`@("!T<F%N<V%C=&EO;G,N(%5N9&5R('1H
M97-E(&%G<F5E;65N=',@=V4@87)E(&QI86)L92!F;W(-"B`-"B`@("`@(&QI
M<75I9&%T960@9&%M86=E<R!T;R!T:&4@:6YV97-T;W)S(&EF('=E(&9A:6P@
M=&\@9FEL92!A;F0O;W(-"B`@(`T*("`@("`@;6%I;G1A:6X@969F96-T:79E
M(')E9VES=')A=&EO;B!S=&%T96UE;G1S(&-O=F5R:6YG('1H90T*("`-"B`@
M("`@('-P96-I9FEE9"!U;F1E<FQY:6YG('-H87)E<R!O9B!C;VUM;VX@<W1O
M8VLN#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@
M("`@#0H@("`@("!3:6YC92!W92!H879E(&5I=&AE<B!F86EL960@=&\@9FEL
M92P@;W(@9F%I;&5D('1O(&UA:6YT86EN#0H@("`@(`T*("`@("`@=&AE(')E
M9VES=')A=&EO;B!O8FQI9V%T:6]N<R!U;F1E<B!T:&5S92!A9W)E96UE;G1S
M+"!A<R!O9@T*("`@("`-"B`@("`@($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"!-
M87)C:"`S,2P@,C`Q,2!W92!H879E(&%C8W)U960-"B`@("`-"B`@("`@(&5S
M=&EM871E9"!A9V=R96=A=&4@;&EQ=6ED871E9"!D86UA9V5S(&]F("0T,S<L
M.#`P(&EN#0H@("`@(`T*("`@("`@8V]N;F5C=&EO;B!W:71H('1H92!L:7%U
M:61A=&5D(&1A;6%G92!P<F]V:7-I;VYS(&]F('1H97-E#0H@("`@#0H@("`@
M("!A9W)E96UE;G1S+"!W:&EC:"!W92!B96QI979E(')E<')E<V5N=',@;W5R
M(&UA>&EM=6T@97AP;W-U<F4-"B`@#0H@("`@("!U;F1E<B!T:&5S92!P<F]V
M:7-I;VYS+B8C,38P.R8C,38P.T%C8V]R9&EN9VQY+"!W92!D;R!N;W0-"B`@
M#0H@("`@("!E>'!E8W0@=&\@86-C<G5E(&%N>2!F=7)T:&5R(&QI<75I9&%T
M960@9&%M86=E<R!I;B!C;VYN96-T:6]N#0H@("`-"B`@("`@('=I=&@@=&AE
M<V4@86=R965M96YT<RXF(S$V,#LF(S$V,#M4:&4@86-T=6%L(&%M;W5N="!O
M9@T*("`@(`T*("`@("`@;&EQ=6ED871E9"!D86UA9V5S('!A:60L(&EF(&%N
M>2P@;6%Y(&1I9F9E<B!F<F]M(&]U<@T*("`@(`T*("`@("`@97-T:6UA=&5S
M(&%S(&ET(&ES(&]U<B!I;G1E;G1I;VX@=&\@;F5G;W1I871E('=I=&@@=&AE
M#0H@#0H@("`@("!I;G9E<W1O<G,@=&AE('-E='1L96UE;G0@;V8@;&EQ=6ED
M871E9"!D86UA9V5S(&1U92!A;F0L(&%S#0H@("`@(`T*("`@("`@<W5C:"P@
M=&AE('5L=&EM871E(&%M;W5N=',@=V4@;6%Y(&%C='5A;&QY('!A>2!M87D@
M8F4@;&5S<PT*("`@("`-"B`@("`@('1H86X@=&AE(&%M;W5N="!C=7)R96YT
M;'D@86-C<G5E9"X-"B`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P.6-F7S-B,V)?-#0T95]B
M-SEC7V$S-S@U-S)D,S0R9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H
M965T<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^3D]412`X+B!/5$A%4B!#55)214Y4($Q)04))3$E42453/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R($QI
M86)I;&ET:65S($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`-
M"B`@("`@($Y/5$4@."X@3U1(15(@0U524D5.5"!,24%"24Q)5$E%4PT*("`@
M("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-
M"B`@("`@($%T($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"!-87)C:"`S,2P@,C`Q
M,2P@;W5R(&]T:&5R(&-U<G)E;G0-"B`@("`@#0H@("`@("!L:6%B:6QI=&EE
M<R!W97)E(&-O;7!R:7-E9"!O9B!T:&4@9F]L;&]W:6YG(&ET96US.@T*("`-
M"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+6QE9G0Z(#`N,7!T
M.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX-"B`@("`@#0H@("`@("`\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@
M1&5C96UB97(@,S$L#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@($UA
M<F-H(#,Q+`T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P="!S;VQI9#L@;&EN
M92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`@#0H@
M("`@("`@("`@,C`Q,0T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X
M="UA;&EG;CH@8V5N=&5R)SX-"B`@("`-"B`@("`@("`@("`R,#$Q#0H@("`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<R)3L@;&EN92UH96EG:'0Z(#$Q
M-24G/@T*("`-"B`@("`@("`@("!!8V-R=65D(&EN=&5R97-T#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@
M("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$Q)3L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M
M86QI9VXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`W,S0L,C@R#0H@("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&QI;F4M:&5I9VAT.B`Q
M,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@#0H@("`@("`@("`@-3(U+#,S
M-@T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-
M"B`@("`@("`@("!!8V-R=65D(&QE9V%L(&9E97,-"B`@("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`-"B`@("`@
M("`@("`R-#`L,C0R#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@(#(S-BPY,#(-"B`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z(')G8B@R,S,L,C(X+#(R."DG/@T*("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-
M"B`@("`@("`@("!$969E<G)E9"!R96YT#0H@("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q
M-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@
M-2PS,C0-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@
M<FEG:'0G/@T*("`@(`T*("`@("`@("`@(#4L-S@T#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@5VAI=&4G/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@($]T:&5R#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`Q<'0@<V]L:60[(&QI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@
M<FEG:'0G/@T*(`T*("`@("`@("`@(#0R+#4X.`T*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P
M="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`-"B`@("`@("`@("`S-BPS-C0-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G
M/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B
M*#(S,RPR,C@L,C(X*2<^#0H@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6QE9G0Z(#`N,C5I;CL@;&EN92UH96EG:'0Z(#$Q-24G/@T*("`-
M"B`@("`@("`@("!4;W1A;"!O=&AE<B!C=7)R96YT(&QI86)I;&ET:65S#0H@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH
M96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24[('1E
M>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,2PP,C(L-#,V
M#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE
M.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@("`@)`T*("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@
M,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`X
M,#0L,S@V#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO
M='(^#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`-"B`@("`@($%S(&]F('1H92!D871E(&]F('1H:7,@<F5P;W)T
M+"!V87)I;W5S('!R;VUI<W-O<GD@86YD#0H@("`@(`T*("`@("`@8V]N=F5R
M=&EB;&4@;F]T97,@<&%Y86)L92!I;B!T:&4@86=G<F5G871E('!R:6YC:7!A
M;"!A;6]U;G0-"B`-"B`@("`@(&]F("0Q+#<Y,BPR,3`@*&%S(&ED96YT:69I
M960@:6X@3F]T97,@-"!A;F0@-2!A8F]V92D@:&%V90T*("`@(`T*("`@("`@
M<F5A8VAE9"!M871U<FET>2!A;F0@87)E('!A<W0@9'5E+B!792!A<F4@8V]N
M=&EN=6%L;'D-"B`@("`@#0H@("`@("!R979I97=I;F<@;W1H97(@9FEN86YC
M:6YG(&%R<F%N9V5M96YT<R!T;R!R971I<F4@86QL('!A<W0@9'5E#0H@("`-
M"B`@("`@(&YO=&5S+B!!="!$96-E;6)E<B`S,2P@,C`Q,2P@=V4@:&%D(&%C
M8W)U960@:6YT97)E<W0@:6X@=&AE#0H@#0H@("`@("!A;6]U;G0@;V8@)#8S
M.2PY-3@@87-S;V-I871E9"!W:71H('1H97-E(&1E9F%U;'1E9"!N;W1E<R!I
M;@T*(`T*("`@("`@86-C<G5E9"!L:6%B:6QI=&EE<R!P87EA8FQE+"!W:&EC
M:"!A<F4@:6YC;'5D960@:6X@=&AE#0H@#0H@("`@("!A8V-R=65D(&EN=&5R
M97-T(&YU;6)E<G,@;F]T960@86)O=F4@*'-E92!.;W1E<R`T(&%N9"`U*2X-
M"B`@("`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U
M-S)D,S0R9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC
M9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E
M=#$T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3D]412`Y+B!&04E2(%9!3%5%($U%05-54D5-14Y44SQB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E($1I<V-L;W-U
M<F5S(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`-"B`@("`@($Y/5$4@.2X@1D%)
M4B!604Q512!-14%355)%345.5%,-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5V4@9F]L;&]W($9!4T(@
M05-#(#@R,"P@(D9!25(@5D%,544@345!4U5214U%3E13($%.1`T*("`@(`T*
M("`@("`@1$E30TQ/4U5215,B("@F(S@R,C`[05-#(#@R,"8C.#(R,3LI(&EN
M(&-O;FYE8W1I;VX@=VET:`T*("`@("`-"B`@("`@(&9I;F%N8VEA;"!A<W-E
M=',@86YD(&QI86)I;&ET:65S(&UE87-U<F5D(&%T(&9A:7(@=F%L=64@;VX@
M80T*("`-"B`@("`@(')E8W5R<FEN9R!B87-I<R!S=6)S97%U96YT('1O(&EN
M:71I86P@<F5C;V=N:71I;VXN(%1H90T*(`T*("`@("`@9W5I9&%N8V4@87!P
M;&EE<R!T;R!O=7(@9&5R:79A=&EV92!L:6%B:6QI=&EE<RX-"B`@("`-"B`@
M("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@
M($%30R`X,C`@<F5Q=6ER97,@=&AA="!A<W-E=',@86YD(&QI86)I;&ET:65S
M(&-A<G)I960@870@9F%I<@T*("`-"B`@("`@('9A;'5E('=I;&P@8F4@8VQA
M<W-I9FEE9"!A;F0@9&ES8VQO<V5D(&EN(&]N92!O9B!T:&4-"B`@("`-"B`@
M("`@(&9O;&QO=VEN9R!T:')E92!C871E9V]R:65S.B!792!M96%S=7)E('1H
M92!F86ER('9A;'5E(&]F#0H@("`-"B`@("`@(&%P<&QI8V%B;&4@9FEN86YC
M:6%L(&%N9"!N;VXM9FEN86YC:6%L(&%S<V5T<R!B87-E9"!O;B!T:&4-"B`@
M("`@#0H@("`@("!F;VQL;W=I;F<@9F%I<B!V86QU92!H:65R87)C:'DZ#0H@
M("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-
M"B`@("`@($QE=F5L(#$Z(%%U;W1E9"!M87)K970@<')I8V5S(&EN(&%C=&EV
M92!M87)K971S(&9O<B!I9&5N=&EC86P-"B`@(`T*("`@("`@87-S971S(&]R
M(&QI86)I;&ET:65S+@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3&5V96P@,CH@3V)S97)V86)L92!M
M87)K970@8F%S960@:6YP=71S(&]R('5N;V)S97)V86)L90T*("`-"B`@("`@
M(&EN<'5T<R!T:&%T(&%R92!C;W)R;V)O<F%T960@8GD@;6%R:V5T(&1A=&$N
M#0H@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@
M#0H@("`@("!,979E;"`S.B!5;F]B<V5R=F%B;&4@:6YP=71S('1H870@87)E
M(&YO="!C;W)R;V)O<F%T960@8GD-"B`@("`-"B`@("`@(&UA<FME="!D871A
M+@T*("`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@(`T*("`@("`@5&AE(&AI97)A<F-H>2!N;W1E9"!A8F]V92!R97%U:7)E
M<R!U<R!T;R!M:6YI;6EZ92!T:&4@=7-E(&]F#0H@(`T*("`@("`@=6YO8G-E
M<G9A8FQE(&EN<'5T<R!A;F0@=&\@=7-E(&]B<V5R=F%B;&4@;6%R:V5T(&1A
M=&$L(&EF#0H@("`@#0H@("`@("!A=F%I;&%B;&4L('=H96X@9&5T97)M:6YI
M;F<@9F%I<B!V86QU92X-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@(%1H92!F86ER('9A;'5E(&]F(&]U<B!R
M96-O<F1E9"!D97)I=F%T:79E(&QI86)I;&ET:65S(&ES#0H@("`-"B`@("`@
M(&1E=&5R;6EN960@8F%S960@;VX@=6YO8G-E<G9A8FQE(&EN<'5T<R!T:&%T
M(&%R92!N;W0-"B`@("`-"B`@("`@(&-O<G)O8F]R871E9"!B>2!M87)K970@
M9&%T82P@=VAI8V@@:7,@82!,979E;"`S#0H@("`@#0H@("`@("!C;&%S<VEF
M:6-A=&EO;BX@5V4@<F5C;W)D(&1E<FEV871I=F4@;&EA8FEL:71I97,@;VX@
M;W5R#0H@(`T*("`@("`@8F%L86YC92!S:&5E="!A="!F86ER('9A;'5E('=I
M=&@@8VAA;F=E<R!I;B!F86ER('9A;'5E#0H@#0H@("`@("!R96-O<F1E9"!I
M;B!O=7(@8V]N<V]L:61A=&5D('-T871E;65N=',@;V8@;W!E<F%T:6]N<RX-
M"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-
M"B`@("`@($]U<B!F86ER('9A;'5E(&UE87-U<F5M96YT<R!A="!T:&4@1&5C
M96UB97(@,S$L(#(P,3$-"B`@("`-"B`@("`@(')E<&]R=&EN9R!D871E(&%R
M92!C;&%S<VEF:65D(&)A<V5D(&]N('1H92!V86QU871I;VX-"B`@("`-"B`@
M("`@('1E8VAN:7%U92!L979E;"!N;W1E9"!I;B!T:&4@=&%B;&4@8F5L;W<Z
M#0H@("`-"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!W:61T:#H@,3`P)3L@8F]R9&5R+6-O;&QA
M<'-E.B!C;VQL87!S92<^#0H@("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,7!T('-O;&ED)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-
M"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P
M.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@
M("`@("`@("!$97-C<FEP=&EO;@T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D
M9&EN9RUB;W1T;VTZ(#%P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^
M#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@
M("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q<'0@<V]L:60G/@T*("`@(`T*("`@("`@("`@("8C,38P.SQB<B`O
M/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@
M("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@($1E8V5M8F5R(#,Q+#QB
M<B`O/@T*("`@("`-"B`@("`@("`@("`R,#$Q#0H@("`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@
M#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@("`F(S$V
M,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@
M#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@("`F(S$V
M,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E
M<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`@#0H@("`@("`@("`@
M475O=&5D(%!R:6-E<SQB<B`O/@T*(`T*("`@("`@("`@(&EN/&)R("\^#0H@
M("`@(`T*("`@("`@("`@($%C=&EV92!-87)K971S(&9O<CQB<B`O/@T*(`T*
M("`@("`@("`@($ED96YT:6-A;"!!<W-E=',\8G(@+SX-"B`@("`-"B`@("`@
M("`@("`H3&5V96P@,2D-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('!A9&1I
M;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*
M("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@("`F
M(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('!A9&1I
M;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*
M("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@("`F
M(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED)SX-"B`@("`-"B`@("`@("`@("!3:6=N:69I8V%N=#QB
M<B`O/@T*("`@(`T*("`@("`@("`@($]T:&5R/&)R("\^#0H@("`-"B`@("`@
M("`@("!/8G-E<G9A8FQE/&)R("\^#0H@("`-"B`@("`@("`@("!);G!U=',\
M8G(@+SX-"B`@("`-"B`@("`@("`@("`H3&5V96P@,BD-"B`@("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24[('!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@
M("`@("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^
M#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@
M("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24[('!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@
M("`@("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^
M#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@
M("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O
M/@T*("`@#0H@("`@("`@("`@4VEG;FEF:6-A;G0\8G(@+SX-"B`@("`-"B`@
M("`@("`@("!5;F]B<V5R=F%B;&4@26YP=71S/&)R("\^#0H@(`T*("`@("`@
M("`@("A,979E;"`S*0T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D9&EN
M9RUB;W1T;VTZ(#%P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@
M("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C
M,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T5%145%12<^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#0T)3L@;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@("!$97)I=F%T:79E($QI86)I
M;&ET:65S#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#(N,C5P="!D;W5B;&4[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`@
M#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`Q+#(U,"PW,#4-"B`@("`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@(`T*
M("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$Q)3L@8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI
M9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@+2T-"B`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T
M(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@("`D
M#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q,24[(&)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D
M;W5B;&4[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^
M#0H@(`T*("`@("`@("`@("TM#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI
M;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[(&)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(&QI
M;F4M:&5I9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@)`T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,3$E.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE
M+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@
M("`@("`Q+#(U,"PW,#4-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[("<^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("!4;W1A;`T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O
M=6)L93L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("0-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN92UH96EG
M:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@,2PR-3`L-S`U#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@
M("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L
M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`M+0T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N
M,C5P="!D;W5B;&4[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@
M("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(&QI
M;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@("TM#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR
M-7!T(&1O=6)L93L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@
M("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@;&EN
M92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@,2PR-3`L-S`U#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/@T*("`@(`T*("`@("`@4')I;W(@=&\@=&AE('1H
M:7)D(&9I<V-A;"!Q=6%R=&5R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$P#0H@
M("`@#0H@("`@("`H)B,X,C(P.U$S(#(P,3$F(S@R,C$[*2P@=&AE(&9A:7(@
M=F%L=64@97-T:6UA=&4@<F5L871I;F<@=&\-"B`@("`@#0H@("`@("!A;B!A
M9V=R96=A=&4@;V8@,C4L,#8V+#DT-"!W87)R86YT<R!C;&%S<VEF:65D(&%S
M(&1E<FEV871I=F4-"B`@#0H@("`@("!L:6%B:6QI=&EE<R!H860@8F5E;B!B
M87-E9"!O;B!A($)L86-K+5-C:&]L97,@=F%L=6%T:6]N#0H@(`T*("`@("`@
M;6]D96PN)B,Q-C`[)B,Q-C`[1'5R:6YG(%$S(#(P,3$L('=E(&-H86YG960@
M=&\@82!B:6YO;6EA;`T*("`@#0H@("`@("!L871T:6-E(&UO9&5L(&9O<B!V
M86QU871I;VX@;V8@=&AE<V4@=V%R<F%N=',@87,@=V4-"B`@(`T*("`@("`@
M9&5T97)M:6YE9"!T:&%T('5S92!O9B!A(&)I;F]M:6%L(&QA='1I8V4@;6]D
M96P@=V%S(&UO<F4-"B`@(`T*("`@("`@<F5P<F5S96YT871I=F4@;V8@9F%I
M<B!V86QU92!I;B!T:&4@8VER8W5M<W1A;F-E<RX@26X-"B`@("`@#0H@("`@
M("!A8V-O<F1A;F-E('=I=&@@86-C;W5N=&EN9R!G=6ED86YC92!I;B!!4T,@
M.#(P+3$P+"!&86ER(%9A;'5E#0H@("`-"B`@("`@($UE87-U<F5M96YT<R!A
M;F0@1&ES8VQO<W5R97,L('1H:7,@=V%S(&%C8V]U;G1E9"!F;W(@87,@80T*
M("`@(`T*("`@("`@8VAA;F=E(&EN(&%C8V]U;G1I;F<@97-T:6UA=&4N#0H@
M(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*
M("`@("`@5&AE(&9O;&QO=VEN9R!O=71L:6YE<R!T:&4@<VEG;FEF:6-A;G0@
M=V5I9VAT960@879E<F%G90T*("`-"B`@("`@(&%S<W5M<'1I;VYS('5S960@
M=&\@97-T:6UA=&4@=&AE(&9A:7(@=F%L=64@:6YF;W)M871I;VX-"B`@#0H@
M("`@("!P<F5S96YT960L(&EN(&-O;FYE8W1I;VX@=VET:"!O=7(@07!R:6P@
M,C`Q,2!C;VYV97)T:6)L90T*("`@#0H@("`@("!N;W1E<RP@2G5L>2`F86UP
M.R!!=6=U<W0@,C`Q,2`Q,"4@8V]N=F5R=&EB;&4@;F]T97,@86YD('1H90T*
M("`@("`-"B`@("`@(%-E<'1E;6)E<B`R,#$Q(&-O;G9E<G1I8FQE(&YO=&5S
M(&%N9"!W:71H(')E<W!E8W0@=&\@=V%R<F%N=`T*("`-"B`@("`@(&%N9"!E
M;6)E9&1E9"!C;VYV97)S:6]N(&]P=&EO;B!D97)I=F%T:79E(&EN<W1R=6UE
M;G1S#0H@("`@(`T*("`@("`@=71I;&EZ:6YG('1H92!":6YO;6EA;"!,871T
M:6-E(&]P=&EO;B!P<FEC:6YG(&UO9&5L.@T*("`@(`T*("`@(#PO<#X\8G(O
M/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE
M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX-"B`@
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<"<^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4P)3L@8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U
M)2<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4P)3L@8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U
M)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`-"B`@("`@("`@("!.:6YE
M($UO;G1H<R!%;F1E9"!$96-E;6)E<B`S,2P@,C`Q,0T*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B86-K9W)O=6YD+6-O;&]R.B`C
M145%145%)SX-"B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@(%)I<VL@9G)E92!I;G1E<F5S
M="!R871E#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E
M;G1E<B<^#0H@("`@(`T*("`@("`@("`@(#`N,#(E("T@,BXR-"4-"B`@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@)SX-"B`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@
M(`T*("`@("`@("`@($%V97)A9V4@97AP96-T960@;&EF90T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`@#0H@("`@
M("`@("`@,"XR-2`M(#4@>65A<G,-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!T;W`[(&)A8VMG<F]U;F0M8V]L;W(Z("-%145%144G
M/@T*("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@17AP96-T960@=F]L871I;&ET>0T*("`@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@
M("`@#0H@("`@("`@("`@-3$N.24@+2`Q,C@N-24-"B`@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[("<^#0H@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("!%>'!E8W1E9"!D:79I9&5N9',-"B`@("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@3F]N
M90T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*
M("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@
M("`@#0H@("`@("!4:&4@=&%B;&4@8F5L;W<@<V5T<R!F;W)T:"!A('-U;6UA
M<GD@;V8@8VAA;F=E<R!I;B!T:&4@9F%I<@T*(`T*("`@("`@=F%L=64@;V8@
M;W5R($QE=F5L(#,@9FEN86YC:6%L(&EN<W1R=6UE;G1S(&9O<B!T:&4@;FEN
M90T*("`-"B`@("`@(&UO;G1H<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,3H-
M"B`@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P
M<V4Z(&-O;&QA<'-E)SX-"B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ('1O<"<^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#(Q)3L@;&EN92UH96EG:'0Z(#$Q-24[('!A9&1I;F<M8F]T
M=&]M.B`Q<'0G/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-
M"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P
M.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@.24[(&QI;F4M:&5I9VAT.B`Q,34E
M.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P
M="!S;VQI9"<^#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*
M("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[
M/&)R("\^#0H@("`-"B`@("`@("`@("!!<')I;"`Q+#QB<B`O/@T*(`T*("`@
M("`@("`@(#(P,3$-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E.R!L:6YE+6AE:6=H=#H@,3$U
M)3L@<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P
M.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@
M("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB
M<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$S)3L@;&EN
M92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@#0H@
M("`@("`@("`@4F5C;W)D960\8G(@+SX-"B`-"B`@("`@("`@("!.97<@1&5R
M:79A=&EV93QB<B`O/@T*("`-"B`@("`@("`@("!,:6%B:6QI=&EE<PT*("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,R4[(&QI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O='1O;3H@
M,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@
M("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O
M/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,30E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L
M:60G/@T*("`@(`T*("`@("`@("`@($-H86YG92!I;CQB<B`O/@T*("`-"B`@
M("`@("`@("!E<W1I;6%T960@9F%I<CQB<B`O/@T*("`-"B`@("`@("`@("!V
M86QU92!R96-O9VYI>F5D/&)R("\^#0H@("`@#0H@("`@("`@("`@:6X@<F5S
M=6QT<SQB<B`O/@T*("`@#0H@("`@("`@("`@;V8@;W!E<F%T:6]N<PT*("`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`S)3L@;&EN92UH96EG:'0Z(#$Q-24[('!A9&1I;F<M8F]T=&]M
M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@
M("`@("`@("8C,38P.SQB<B`O/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R
M("\^#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q,B4[(&QI;F4M:&5I9VAT.B`Q,34E.R!T
M97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S
M;VQI9"<^#0H@("`@#0H@("`@("`@("`@4F5C;&%S<VEF:6-A=&EO;CQB<B`O
M/@T*("`@(`T*("`@("`@("`@(&]F($1E<FEV871I=F4\8G(@+SX-"B`-"B`@
M("`@("`@("!,:6%B:6QI='D@=&\\8G(@+SX-"B`@("`@#0H@("`@("`@("`@
M4&%I9"!I;CQB<B`O/@T*("`@("`-"B`@("`@("`@("!C87!I=&%L#0H@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@-24[(&QI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O='1O;3H@
M,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@
M("`@("`F(S$V,#L\8G(@+SX-"B`@(`T*("`@("`@("`@("8C,38P.SQB<B`O
M/@T*("`@#0H@("`@("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,3<E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L
M:60G/@T*("`@(`T*("`@("`@("`@("8C,38P.SQB<B`O/@T*("`@#0H@("`@
M("`@("`@)B,Q-C`[/&)R("\^#0H@("`-"B`@("`@("`@("`F(S$V,#L\8G(@
M+SX-"B`@(`T*("`@("`@("`@($1E8V5M8F5R(#,Q+#QB<B`O/@T*("`@("`-
M"B`@("`@("`@("`R,#$Q#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@=&]P)SX-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@=&]P.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@
M(`T*("`@("`@("`@($1E<FEV871I=F4@;&EA8FEL:71I97,-"B`@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M
M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*("`@("`-"B`@
M("`@("`@("`D(#(L,#`R+#@Y-@T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T
M97AT+6%L:6=N.B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("`D(#$L,3`W
M+#DT,`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT
M97(G/@T*("`@("`-"B`@("`@("`@("`H)"`Q+#4Y-BPT-#(I#0H@("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`@
M#0H@("`@("`@("`@*"0@,C8S+#8X.2D-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[
M('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*
M("`@("`-"B`@("`@("`@("`D,2PR-3`L-S`U#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@(`T*("`@("`@5&AE(&9A:7(@=F%L
M=64@;V8@9&5R:79A=&EV92!L:6%B:6QI=&EE<R!T:&%T('=E(')E8V]R9&5D
M(&EN#0H@(`T*("`@("`@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($1E8V5M8F5R
M(#,Q+"`R,#$Q('=A<R!R96QA=&5D('1O(&]U<@T*("`@("`-"B`@("`@($%P
M<FEL(#(P,3$@8V]N=F5R=&EB;&4@;F]T92P@2G5L>2`F86UP.R!!=6=U<W0@
M,C`Q,2`Q,"4-"B`-"B`@("`@(&-O;G9E<G1I8FQE(&YO=&5S(&%N9"!T:&4@
M4V5P=&5M8F5R(#(P,3$@8V]N=F5R=&EB;&4@;F]T90T*("`@(`T*("`@("`@
M;V9F97)I;F=S("AS964@3F]T92`U*2!A;F0@=V%S(&)A<V5D('5P;VX@86X-
M"B`-"B`@("`@(&EN9&5P96YD96YT)B,Q-C`[=F%L=6%T:6]N(')E<&]R="X-
M"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@
M("`@#0H@("`@("!4:&4@=&%B;&4@8F5L;W<@<V5T<R!F;W)T:"!A('-U;6UA
M<GD@;V8@8VAA;F=E<R!I;B!T:&4@9F%I<@T*(`T*("`@("`@=F%L=64@;V8@
M;W5R($QE=F5L(#,@9&5R:79A=&EV92!L:6%B:6QI=&EE<R!F;W(@=&AE(&YI
M;F4-"B`@(`T*("`@("`@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$P
M.@T*("`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C
M96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@
M("`@#0H@("`@("`@("`@1F%I<B!686QU92!A=#QB<B`O/@T*(`T*("`@("`@
M("`@($UA<F-H(#,Q+"`R,#$P#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G
M/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^
M#0H@("`@(`T*("`@("`@("`@(%)E8V]R9&5D($9A:7(\8G(@+SX-"B`-"B`@
M("`@("`@("!686QU92!O9CQB<B`O/@T*(`T*("`@("`@("`@($1E<FEV871I
M=F4\8G(@+SX-"B`@(`T*("`@("`@("`@($QI86)I;&ET:65S/&)R("\^#0H@
M("`@#0H@("`@("`@("`@:6X@=&AE(&YI;F4@;6]N=&@@<&5R:6]D(&5N9&5D
M($1E8V5M8F5R(#(P,3`-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@
M("`@#0H@("`@("`@("`@0VAA;F=E(&EN/&)R("\^#0H@(`T*("`@("`@("`@
M($5S=&EM871E9"!&86ER/&)R("\^#0H@(`T*("`@("`@("`@(%9A;'5E(%)E
M8V]G;FEZ960\8G(@+SX-"B`@("`-"B`@("`@("`@("!I;B!297-U;'1S(&]F
M/&)R("\^#0H@#0H@("`@("`@("`@3W!E<F%T:6]N<PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P
M="!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@($9A:7(@5F%L=64@870\8G(@
M+SX-"B`-"B`@("`@("`@("!$96-E;6)E<B`S,2P@,C`Q,`T*("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M
M8V]L;W(Z("-%145%144G/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`S-B4[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@#0H@("`@
M("`@("`@1&5R:79A=&EV92!L:6%B:6QI=&EE<PT*("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E.R!P
M861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("0-
M"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$Q)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#$L,#4T
M+#<Q-@T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,R4[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@
M("`@("`@-BPY.#`L,S0W#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T
M;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-
M"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`-"B`@("`@("`@("`H,BPP.3@L.34T#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D
M:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@*0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,R4[('!A9&1I;F<M8F]T=&]M.B`R+C5P
M="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@#0H@("`@("`@("`@-2PY,S8L,3`Y#0H@("`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-
M"B`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^
M#0H@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@(#PO=&%B;&4^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@(`T*("`@("`@5&AE(&9A
M:7(@=F%L=64@;V8@9&5R:79A=&EV92!L:6%B:6QI=&EE<R!T:&%T('=E(')E
M8V]R9&5D(&EN#0H@(`T*("`@("`@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($1E
M8V5M8F5R(#(P,3`@=V%S(')E;&%T960@=&\@=&AE#0H@#0H@("`@("!R97-T
M<G5C='5R:6YG(&]F('1H92!!;65N9&5D(&%N9"!297-T871E9"!#;VYV97)T
M:6)L92!.;W1E<PT*(`T*("`@("`@86YD('1O('1H92!E;6)E9&1E9"!D97)I
M=F%T:79E<R!A;F0@87-S;V-I871E9"!W87)R86YT<PT*("`-"B`@("`@(')E
M;&%T960@=&\@82!N=6UB97(@;V8@;W5R(&-O;G9E<G1I8FQE(&YO=&4@;V9F
M97)I;F=S("AS964-"B`@("`@#0H@("`@("!.;W1E(#4I(&%N9"!W87,@8F%S
M960@=7!O;B!A;B!I;F1E<&5N9&5N="8C,38P.W9A;'5A=&EO;@T*("`-"B`@
M("`@(')E<&]R="X-"B`@("`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P.6-F7S-B,V)?-#0T
M95]B-SEC7V$S-S@U-S)D,S0R9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R
M:W-H965T<R]3:&5E=#$U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^3D]412`Q,"X@4U1/0TL@0T]-4$5.4T%424]./&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E:&]L9&5R
M<R<@17%U:71Y(&%N9"!3:&%R92UB87-E9"!087EM96YT<R!;5&5X="!";&]C
M:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3D]412`Q,"X@4U1/0TL@0T]-4$5.
M4T%424].#0H@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX-"B`@("`@#0H@("`@("!4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ
M97,@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N#0H@(`T*("`@("`@97AP96YS
M97,@<F5L871I;F<@=&\@<VAA<F5S(&%N9"!O<'1I;VYS(&=R86YT960@86YD
M('1H90T*("`-"B`@("`@(&5F9F5C="!O;B!B87-I8R!A;F0@9&EL=71E9"!L
M;W-S('!E<B!C;VUM;VX@<VAA<F4@9'5R:6YG('1H90T*("`-"B`@("`@('1H
M<F5E(&%N9"!N:6YE(&UO;G1H<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2!A
M;F0@,C`Q,#H-"B`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG
M/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/@T*("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^
M#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("!4
M:')E92!-;VYT:',@16YD960-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@
M5&AR964@36]N=&AS($5N9&5D#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@
M($YI;F4@36]N=&AS($5N9&5D#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@
M3FEN92!-;VYT:',@16YD960-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R.R!P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M
M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@1&5C96UB97(@,S$L
M(#(P,3$-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&)O
M<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`@(`T*("`@("`@
M("`@($1E8V5M8F5R(#,Q+"`R,#$P#0H@("`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T
M)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G
M/@T*("`@("`-"B`@("`@("`@("!$96-E;6)E<B`S,2P@,C`Q,0T*("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@1&5C96UB97(@
M,S$L(#(P,3`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO
M='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R.R!P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M
M,3!P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A
M;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/@T*("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L
M<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-#`E.R!P861D:6YG
M+6)O='1O;3H@,BXU<'0[('!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E
M;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@("!4;W1A;"!S:&%R92UB87-E9"!C
M;VUP96YS871I;VX@97AP96YS90T*("`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUB
M;W1T;VTZ(#(N-7!T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`D#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q,"4[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`Q-C$L-#0P#0H@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4[('!A
M9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)`T*
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,3`E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B
M;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,C4R+#<T
M,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#,E.R!P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$P)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@
M(#8P.2PU,#,-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T
M.R!T97AT+6%L:6=N.B!L969T)SX-"B`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`S)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@
M("`@("`@("`Q+#4Y.2PY,34-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D:6YG+6)O
M='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T
M<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N
M=#H@+3$P<'0G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-%145%144G
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R+C5P=#L@<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P
M<'0G/@T*("`@(`T*("`@("`@("`@(%1O=&%L('-H87)E+6)A<V5D(&-O;7!E
M;G-A=&EO;B!E>'!E;G-E(&EN8VQU9&5D(&EN(&YE=`T*("`@("`-"B`@("`@
M("`@("!L;W-S#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`Q-C$L-#0P#0H@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B
M;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,C4R
M+#<T,`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L
M969T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@
M("`@(#8P.2PU,#,-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA
M;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`Q+#4Y.2PY,34-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N
M-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G
M/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-%145%144G/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@
M<&%D9&EN9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*("`@
M(`T*("`@("`@("`@($)A<VEC(&%N9"!D:6QU=&5D(&QO<W,@<&5R(&-O;6UO
M;B!S:&%R90T*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@*#`N,#`-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`-"B`@
M("`@("`@("`I#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`D
M#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`H,"XP,0T*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@
M("`@("`@("D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-
M"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L
M:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("@P+C`Q#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@
M("`@("`@*0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@*#`N,#(-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`-"B`@("`@
M("`@("`I#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^
M#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-
M"B`@("`-"B`@("`@(%1H92!F;VQL;W=I;F<@=&%B;&4@8G)E86MS(&]U="!T
M:&4@8V]M<&]N96YT<R!O9B!O=7(-"B`@("`-"B`@("`@('-H87)E+6)A<V5D
M(&-O;7!E;G-A=&EO;B!E>'!E;G-E<R!R96QA=&EN9R!T;R!S:&%R97,@86YD
M#0H@("`-"B`@("`@(&]P=&EO;G,@9W)A;G1E9"!A;F0@=&AE(&5F9F5C="!O
M;B!B87-I8R!A;F0@9&EL=71E9"!L;W-S('!E<@T*("`-"B`@("`@(&-O;6UO
M;B!S:&%R92!D=7)I;F<@=&AE('1H<F5E(&%N9"!N:6YE(&UO;G1H<R!E;F1E
M9"!$96-E;6)E<@T*("`-"B`@("`@(#,Q+"`R,#$Q(&%N9"`R,#$P+@T*("`@
M("`-"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS
M<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^#0H@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!P861D:6YG
M+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@(%1H<F5E($UO;G1H
M<R!%;F1E9`T*("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("!4:')E92!-;VYT
M:',@16YD960-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@3FEN92!-;VYT
M:',@16YD960-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("!.:6YE($UO;G1H
M<R!%;F1E9`T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T
M<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VTG/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([('!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ
M,'!T)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L
M:60G/@T*("`@("`-"B`@("`@("`@("!$96-E;6)E<B`S,2P@,C`Q,0T*("`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X]
M,T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@1&5C96UB
M97(@,S$L(#(P,3`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^#0H@("`@(`T*
M("`@("`@("`@($1E8V5M8F5R(#,Q+"`R,#$Q#0H@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,7!T)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@
M<V]L:60G/@T*("`@("`-"B`@("`@("`@("!$96-E;6)E<B`S,2P@,C`Q,`T*
M("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z("-%145%144G/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`T,"4[('!A9&1I;F<M;&5F=#H@,3!P=#L@=&5X
M="UI;F1E;G0Z("TQ,'!T)SX-"B`@(`T*("`@("`@("`@(%9E<W1I;F<@;V8@
M<W1O8VL@;W!T:6]N<PT*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4G/@T*("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N
M.B!R:6=H="<^#0H@(`T*("`@("`@("`@(#8T+#<W,PT*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,R4G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@(`T*("`@
M("`@("`@(#$U,RPX.3@-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)2<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@
M;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[
M('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@,S$Y+#4P,PT*
M("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E)SX-"B`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P)3L@=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`X-S4L,3<Q#0H@("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@5VAI=&4G/@T*("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@
M#0H@("`@("`@("`@26YC<F5M96YT86P@9F%I<B!V86QU92!O9B!O<'1I;VX@
M;6]D:69I8V%T:6]N<PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`R+#$W-0T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,X,C$R.PT*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M(#0Y.2PQ.#@-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO
M='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0[('1E>'0M
M:6YD96YT.B`M,3!P="<^#0H@#0H@("`@("`@("`@5F5S=&EN9R!E>'!E;G-E
M(&%S<V]C:6%T960@=VET:"!#14\@<F5S=')I8W1E9"!S=&]C:PT*("`@#0H@
M("`@("`@("`@9W)A;G0-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#DV+#8V-PT*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@
M("`@(#DV+#8V-PT*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(Y,"PP,#`-"B`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@,C(U+#4U-@T*("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P=#L@<&%D9&EN
M9RUL969T.B`Q,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/@T*("`-"B`@("`@
M("`@("!$:7)E8W0@<W1O8VL@9W)A;G1S#0H@("`@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`Q<'0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI
M9#L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`F(S@R,3([
M#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T
M)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E
M>'0M86QI9VXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@)B,X,C$R.PT*("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P
M="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^#0H@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!R:6=H="<^#0H@(`T*("`@("`@("`@("8C.#(Q,CL-"B`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#%P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L
M:60[('1E>'0M86QI9VXZ(&QE9G0G/@T*(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M<FEG:'0G/@T*("`-"B`@("`@("`@("`F(S@R,3([#0H@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R
M/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T5%145%12<^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!P861D
M:6YG+6QE9G0Z(#$P<'0[('1E>'0M:6YD96YT.B`M,3!P="<^#0H@("`@#0H@
M("`@("`@("`@5&]T86P@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N
M<V4-"B`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,38Q+#0T,`T*("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(U,BPW-#`-"B`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^
M#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`V,#DL
M-3`S#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE
M9G0G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@,2PU.3DL.3$U#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X
M="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD
M+6-O;&]R.B!7:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C
M,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('!A9&1I;F<M
M;&5F=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`@("`-"B`@("`@
M("`@("!4;W1A;"!S:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS92!I
M;F-L=61E9"!I;B!N970-"B`@("`@#0H@("`@("`@("`@;&]S<PT*("`@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-
M"B`@("`@#0H@("`@("`@("`@,38Q+#0T,`T*("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#(N-7!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@(#(U,BPW-#`-"B`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`D
M#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`V,#DL-3`S#0H@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`-
M"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@,2PU.3DL
M.3$U#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@=&5X="UA;&EG;CH@
M;&5F="<^#0H@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7
M:&ET92<^#0H@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#H@,3!P=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9#X-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9#X-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B`C145%145%)SX-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('!A9&1I;F<M;&5F=#H@,3!P
M=#L@=&5X="UI;F1E;G0Z("TQ,'!T)SX-"B`@("`-"B`@("`@("`@("!"87-I
M8R!A;F0@9&EL=71E9"!L;W-S('!E<B!C;VUM;VX@<VAA<F4-"B`@("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("@P+C`P#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T
M.R!T97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@*0T*("`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,BXU<'0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@*#`N,#$-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[
M('1E>'0M86QI9VXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`I#0H@(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C5P="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`H,"XP,0T*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@(`T*("`@("`@("`@("D-"B`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#(N-7!T)SX-"B`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXU<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@("@P+C`R#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R!T
M97AT+6%L:6=N.B!L969T)SX-"B`@#0H@("`@("`@("`@*0T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@/"]T86)L
M93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@#0H@("`@("!792!D
M:60@;F]T(&ES<W5E(&%N>2!S=&]C:R!O<'1I;VYS(&1U<FEN9R!T:&4@=&AR
M964@86YD(&YI;F4-"B`@#0H@("`@("!M;VYT:',@96YD960@1&5C96UB97(@
M,S$L(#(P,3$N($%L;"!O9B!T:&4@<W1O8VLM8F%S960-"B`-"B`@("`@(&-O
M;7!E;G-A=&EO;B!E>'!E;G-E(')E8V]R9&5D(&1U<FEN9R!T:&4@;FEN92!M
M;VYT:',@96YD960-"B`@("`@#0H@("`@("!$96-E;6)E<B`S,2P@,C`Q,2!A
M;F0@,C`Q,"P@=VAI8V@@=&]T86QE9"`D-C`Y+#4P,R!A;F0-"B`-"B`@("`@
M("0Q+#4Y.2PY,34L(')E<W!E8W1I=F5L>2P@:7,@:6YC;'5D960@:6X@<&%Y
M<F]L;"!A;F0@<F5L871E9`T*("`-"B`@("`@(&5X<&5N<V4@:6X@=&AE(&%C
M8V]M<&%N>6EN9R!C;VYD96YS960@8V]N<V]L:61A=&5D('-T871E;65N=',-
M"B`@(`T*("`@("`@;V8@;W!E<F%T:6]N<RXF(S$V,#L@4W1O8VLM8F%S960@
M8V]M<&5N<V%T:6]N(&5X<&5N<V4-"B`@("`-"B`@("`@(')E8V]R9&5D(&1U
M<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q
M(&AA9`T*("`-"B`@("`@(&YO(&EM<&%C="!O;B!B87-I8R!A;F0@9&EL=71E
M9"!L;W-S('!E<B!C;VUM;VX@<VAA<F4@86YD('1H90T*("`-"B`@("`@('-T
M;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E(')E8V]R9&5D(&1U<FEN
M9R!T:&4@=&AR964-"B`@("`@#0H@("`@("!M;VYT:',@96YD960@1&5C96UB
M97(@,S$L(#(P,3`@:6YC<F5A<V5D(&)A<VEC(&%N9"!D:6QU=&5D#0H@("`@
M(`T*("`@("`@;&]S<R!P97(@8V]M;6]N('-H87)E(&)Y("0P+C`Q+B!3=&]C
M:RUB87-E9"!C;VUP96YS871I;VX-"B`@(`T*("`@("`@97AP96YS92!R96-O
M<F1E9"!D=7)I;F<@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#,Q
M+`T*("`@("`-"B`@("`@(#(P,3$@:6YC<F5A<V5D(&)A<VEC(&%N9"!D:6QU
M=&5D(&QO<W,@<&5R(&-O;6UO;B!S:&%R92!B>0T*("`@(`T*("`@("`@)#`N
M,#$@86YD('1H92!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS92!R
M96-O<F1E9`T*("`-"B`@("`@(&1U<FEN9R!T:&4@;FEN92!M;VYT:',@96YD
M960@1&5C96UB97(@,S$L(#(P,3`@:6YC<F5A<V5D#0H@("`-"B`@("`@(&)A
M<VEC(&%N9"!D:6QU=&5D(&QO<W,@<&5R(&-O;6UO;B!S:&%R92!B>2`D,"XP
M,BX-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@
M("`-"B`@("`@(%=E(')E=FEE=R!S:&%R92UB87-E9"!C;VUP96YS871I;VX@
M;VX@82!Q=6%R=&5R;'D@8F%S:7,@9F]R#0H@#0H@("`@("!C:&%N9V5S('1O
M('1H92!E<W1I;6%T92!O9B!E>'!E8W1E9"!A=V%R9"!F;W)F96ET=7)E<R!B
M87-E9`T*(`T*("`@("`@;VX@86-T=6%L(&9O<F9E:71U<F4@97AP97)I96YC
M92X@5&AE(&-U;75L871I=F4@969F96-T(&]F#0H@("`@#0H@("`@("!A9&IU
M<W1I;F<@=&AE(&9O<F9E:71U<F4@<F%T92!F;W(@86QL(&5X<&5N<V4@86UO
M<G1I>F%T:6]N(&ES#0H@("`-"B`@("`@(')E8V]G;FEZ960@:6X@=&AE('!E
M<FEO9"!T:&4@9F]R9F5I='5R92!E<W1I;6%T92!I<R!C:&%N9V5D+@T*("`-
M"B`@("`@(%1H92!E9F9E8W0@;V8@9F]R9F5I='5R92!A9&IU<W1M96YT<R!F
M;W(@=&AE(&YI;F4@;6]N=&AS#0H@("`-"B`@("`@(&5N9&5D($1E8V5M8F5R
M(#,Q+"`R,#$Q('=A<R!I;G-I9VYI9FEC86YT+@T*("`@(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5&AE(&5X
M<&5C=&5D('9O;&%T:6QI='D@:7,@8F%S960@;VX@=&AE(&AI<W1O<FEC('9O
M;&%T:6QI='DN#0H@(`T*("`@("`@5&AE(&5X<&5C=&5D(&QI9F4@;V8@;W!T
M:6]N<R!G<F%N=&5D(&ES(&)A<V5D(&]N('1H90T*("`@(`T*("`@("`@(G-I
M;7!L:69I960@;65T:&]D(B!A<R!D97-C<FEB960@:6X@=&AE(%-%0R=S(&=U
M:61A;F-E(&1U92!T;PT*("`@#0H@("`@("!C:&%N9V5S(&EN('1H92!V97-T
M:6YG('1E<FUS(&%N9"!C;VYT<F%C='5A;"!L:69E(&]F(&-U<G)E;G0-"B`@
M#0H@("`@("!O<'1I;VX@9W)A;G1S(&-O;7!A<F5D('1O(&]U<B!H:7-T;W)I
M8V%L(&=R86YT<RX-"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX-"B`@("`@#0H@("`@("!/<'1I;VYS(&]U='-T86YD:6YG('1H
M870@:&%V92!V97-T960@86YD(&%R92!E>'!E8W1E9"!T;R!V97-T#0H@("`-
M"B`@("`@(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$Q(&%R92!A<R!F;VQL;W=S
M.@T*(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM;&5F=#H@
M,"XQ-7!T.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX-"B`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG
M:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT
M+6%L:6=N.B!C96YT97(G/@T*("`-"B`@("`@("`@("!796EG:'1E9`T*("`@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI
M;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E
M;G1E<B<^#0H@(`T*("`@("`@("`@(%=E:6=H=&5D#0H@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG
M:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G
M/@T*("`-"B`@("`@("`@("!!=F5R86=E#0H@("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M
M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*("`-"B`@("`@
M("`@("!!=F5R86=E#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@(%)E
M;6%I;FEN9PT*("`@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M)SX-"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT
M97(G/@T*("`-"B`@("`@("`@("!.=6UB97(@;V8-"B`@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG
M:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G
M/@T*("`-"B`@("`@("`@("!%>&5R8VES90T*("`@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q
M,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS
M1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@
M#0H@("`@("`@("`@0V]N=')A8W1U86P-"B`@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G
M/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q
M<'0@<V]L:60[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT
M97(G/@T*("`@(`T*("`@("`@("`@(%-H87)E<PT*("`-"B`@("`@("`@/"]T
M9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`-"B`@("`@("`@
M("!0<FEC90T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`Q<'0@<V]L:60[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C
M96YT97(G/@T*("`@(`T*("`@("`@("`@(%1E<FT@:6X@665A<G,-"B`@("`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M
M:&5I9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@
M("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*
M("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T5%145%
M12<^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8Q)3L@
M;&EN92UH96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@("!697-T960-"B`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@("`@
M)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$P)3L@;&EN92UH96EG:'0Z(#$Q
M-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`Q-RPU-C(L
M,#(V#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!L:6YE
M+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*(`T*("`@("`@
M("`@(#`N,S,-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L
M:6YE+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$P)3L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E;G1E
M<B<^#0H@(`T*("`@("`@("`@(#8N,3@-"B`@("`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[("<^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("!%>'!E8W1E9"!T;R!V97-T#0H@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P
M="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT
M)SX-"B`-"B`@("`@("`@("`R+#$Q-BPV-C<-"B`@("`@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M(#`N,C4-"B`@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@
M("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@
M("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI
M9VXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@(#@N-S4-"B`@("`@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@(T5%145%12<^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.B`P+C(U:6X[(&QI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@#0H@("`@("`@("`@5&]T86P-"B`-"B`@("`@("`@/"]T9#X-"B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^
M#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#(N,C5P="!D;W5B;&4[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@
M9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`Q.2PV-S@L-CDS#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH
M96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE
M+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI
M;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@
M(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@
M(`T*("`@("`@070@1&5C96UB97(@,S$L(#(P,3$L('1H97)E('=A<R!A<'!R
M;WAI;6%T96QY("0Y-CDL.#,V(&]F#0H@("`@#0H@("`@("!U;G)E8V]G;FEZ
M960@8V]M<&5N<V%T:6]N(&-O<W0@<F5L871E9"!T;R!S:&%R92UB87-E9`T*
M("`@("`-"B`@("`@('!A>6UE;G1S+"!I;F-L=61I;F<@=&AE(')E<W1R:6-T
M960@<W1O8VL@9W)A;G0L('=H:6-H(&ES#0H@("`-"B`@("`@(&5X<&5C=&5D
M('1O(&)E(')E8V]G;FEZ960@;W9E<B!A('=E:6=H=&5D(&%V97)A9V4@<&5R
M:6]D(&]F#0H@#0H@("`@("`Q+C`X('EE87)S+@T*("`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!/;B!$96-E
M;6)E<B`S,2P@,C`Q,2P@;W5R('-T;V-K(&]P=&EO;G,@:&%D(&$@;F5G871I
M=F4-"B`-"B`@("`@(&EN=')I;G-I8R!V86QU92!S:6YC92!T:&4@8VQO<VEN
M9R!P<FEC92!O;B!T:&%T(&1A=&4@;V8@)#`N,#4-"B`@(`T*("`@("`@<&5R
M('-H87)E('=A<R!B96QO=R!T:&4@=V5I9VAT960@879E<F%G92!E>&5R8VES
M92!P<FEC92!O9@T*("`@("`-"B`@("`@(&]U<B!S=&]C:R!O<'1I;VYS#0H@
M("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@
M#0H@("`@("!);B!*=6QY(#(P,3$L(&]U<B!";V%R9"!R871I9FEE9"!A(&]N
M92!Y96%R(&-O;G-U;'1I;F<-"B`-"B`@("`@(&%G<F5E;65N="!W:71H(&$@
M8V]N<W5L=&%N="!T;R!P<F]V:61E(&-O<G!O<F%T92!A9'9I<V]R>0T*("`@
M(`T*("`@("`@<V5R=FEC97,N(%=E(&%G<F5E9"!T;R!P87D@=&AE(&-O;G-U
M;'1A;G0@82!M;VYT:&QY(&9E92!O9@T*("`@("`-"B`@("`@("0U+#`P,"!I
M;B!C;VUM;VX@<W1O8VLN#0H@("`@(`T*("`@(#PO<#X\8G(O/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?.3=E,#`Y8V9?,V(S
M8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R
M9B]7;W)K<VAE971S+U-H965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY.3U1%(#$Q+B!705)204Y44SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!3=&]C
M:VAO;&1E<G,G($5Q=6ET>2!.;W1E+"!787)R86YT<R!O<B!2:6=H=',@6U1A
M8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@(`T*("`@("`@3D]412`Q,2XF
M(S$V,#LF(S$V,#M705)204Y44PT*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!!('-U;6UA<GD@;V8@=V%R
M<F%N="!A8W1I=FET>2!D=7)I;F<@=&AE(&YI;F4@;6]N=&AS(&5N9&5D#0H@
M("`@(`T*("`@("`@1&5C96UB97(@,S$L(#(P,3$@:7,@<')E<V5N=&5D(&)E
M;&]W.@T*("`@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM
M;&5F=#H@,"XP-7!T.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX-"B`-
M"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-
M"B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[
M('!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H=#L@<&%D9&EN
M9RUB;W1T;VTZ(#%P="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*
M("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H=#H@8F]L
M9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M<'0@<V]L:60G/@T*("`@#0H@("`@("`@("`@06UO=6YT#0H@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ
M(#%P="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@
M("`@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,#L@
M=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`\8CY286YG
M92!O9B!%>&5R8VES93PO8CX-"B`@("`-"B`@("`@("`@("`\+W`^#0H@#0H@
M("`@("`@("`@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O
M;3H@,#L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`\
M8CY0<FEC93PO8CX-"B`@#0H@("`@("`@("`@/"]P/@T*(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT
M.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SX-"B`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ(#%P
M="<^#0H@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,7!T('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,#L@=&5X
M="UA;&EG;CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`\8CY796EG:'1E
M9"!!=F5R86=E/"]B/@T*("`@#0H@("`@("`@("`@/"]P/@T*(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`[
M('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@("`@/&(^17AE
M<F-I<V4\+V(^#0H@("`@(`T*("`@("`@("`@(#PO<#X-"B`-"B`@("`@("`@
M("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!T
M97AT+6%L:6=N.B!C96YT97(G/@T*("`-"B`@("`@("`@("`@(#QB/E!R:6-E
M/"]B/@T*("`-"B`@("`@("`@("`\+W`^#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[
M('!A9&1I;F<M8F]T=&]M.B`Q<'0G/@T*(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B`C145%145%)SX-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@-C$E.R!L:6YE+6AE:6=H=#H@,3$U)2<^#0H@(`T*
M("`@("`@("`@(%=A<G)A;G1S(&]U='-T86YD:6YG(&%T($UA<F-H(#,Q+"`R
M,#$Q#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA
M;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@
M("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,3`E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG
M;CH@<FEG:'0G/@T*(`T*("`@("`@("`@(#,X+#8W-2PQ-CD-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V,#L-
M"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-
M"B`@("`@("`@("`D#0H@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[(&QI;F4M:&5I9VAT.B`Q,34E
M.R!T97AT+6%L:6=N.B!C96YT97(G/@T*("`-"B`@("`@("`@("`P+C$U("T@
M)#`N-3`-"B`@(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/@T*(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q
M-24G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH
M96EG:'0Z(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M,"4[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*
M("`-"B`@("`@("`@("`D,"XS,0T*(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z
M(#$Q-24G/@T*(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R`G/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@
M("`@("`@17AE<F-I<V5D#0H@("`@(`T*("`@("`@("`\+W1D/@T*("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT
M+6%L:6=N.B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*
M("`@("`@("`@("@Q+#(P.2PV,C,-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("D-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("0-"B`@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@(#`N,C,Q#0H@#0H@
M("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@
M("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C145%145%
M)SX-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@
M,3$U)2<^#0H@("`@(`T*("`@("`@("`@($ES<W5E9`T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`R,BPY,30L-3,S#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG
M:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@
M("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M
M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)`T*("`-"B`@("`@
M("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE
M:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX-"B`@("`@#0H@("`@
M("`@("`@,"XQ,"`M("0P+C$R-0T*("`@(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-
M"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G
M/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q
M,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`\+W1R/@T*
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@)SX-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@($-A;F-E;&QE9"]%>'!I<F5D
M#0H@("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*
M("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K
M(#%P="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24G/@T*("`-"B`@("`@("`@
M("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@<V]L:60[(&QI
M;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^#0H@#0H@("`@
M("`@("`@*#0L-#(X+#<U-PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@*0T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@,"XQ-R`M("0P+C4P#0H@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E
M)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-%
M145%144G/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@5V%R<F%N=',@;W5T<W1A
M;F1I;F<@870@1&5C96UB97(@,S$L(#(P,3$-"B`@#0H@("`@("`@(#PO=&0^
M#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q
M-24[('1E>'0M86QI9VXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`F(S$V
M,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@<V]L:60[(&QI;F4M:&5I
M9VAT.B`Q,34E)SX-"B`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X
M="UA;&EG;CH@<FEG:'0G/@T*(`T*("`@("`@("`@(#4U+#DU,2PS,C(-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L
M:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`D#0H@
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*("`@
M("`-"B`@("`@("`@("`P+C$P("T@)#`N,C4-"B`@(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q
M,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO
M=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z
M(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I
M9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/@T*("`@("`-"B`@("`@
M("`@("`D,"XQ-0T*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M/"]T<CX-"B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[("<^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G;&EN
M92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("!787)R86YT<R!E
M>&5R8VES86)L92!A="!$96-E;6)E<B`S,2P@,C`Q,0T*("`-"B`@("`@("`@
M/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4[
M(&QI;F4M:&5I9VAT.B`Q,34E)SX-"B`-"B`@("`@("`@("`F(S$V,#L-"B`-
M"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H
M=#H@,3$U)3L@=&5X="UA;&EG;CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@
M("`U-2PY-3$L,S(R#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@
M("`@("`@("`F(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*
M("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@
M#0H@("`@("`@("`@)`T*("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@,"XQ,"`M("0P+C(U#0H@
M("`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=L:6YE+6AE:6=H=#H@,3$U)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P
M.PT*(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX-"B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[#0H@#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G;&EN92UH96EG:'0Z(#$Q-24G/@T*("`@("`-"B`@("`@("`@("`F
M(S$V,#L-"B`-"B`@("`@("`@/"]T9#X-"B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R
M)SX-"B`@("`@#0H@("`@("`@("`@)#`N,34-"B`-"B`@("`@("`@/"]T9#X-
M"B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U
M)2<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D
M/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`\+W1A8FQE/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`-"B`@("`@(%1H92!F;VQL;W=I
M;F<@;W5T;&EN97,@=&AE('-I9VYI9FEC86YT('=E:6=H=&5D(&%V97)A9V4-
M"B`@#0H@("`@("!A<W-U;7!T:6]N<R!U<V5D('1O(&5S=&EM871E('1H92!F
M86ER('9A;'5E(&EN9F]R;6%T:6]N#0H@(`T*("`@("`@<')E<V5N=&5D+"!W
M:71H(')E<W!E8W0@=&\@=V%R<F%N=',@=71I;&EZ:6YG('1H92!":6YO;6EA
M;`T*("`@("`-"B`@("`@($QA='1I8V4@;W!T:6]N('!R:6-I;F<@;6]D96P@
M870L(&%N9"!D=7)I;F<@=&AE(&YI;F4@;6]N=&AS#0H@#0H@("`@("!E;F1E
M9"!$96-E;6)E<B`S,2P@,C`Q,3H-"B`-"B`@("`\+W`^/&)R+SX\=&%B;&4@
M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T
M:#H@.#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX-"B`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T5%145%12<^#0H@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8P)2<^#0H@("`-"B`@("`@
M("`@("!2:7-K(&9R964@:6YT97)E<W0@<F%T90T*("`@(`T*("`@("`@("`\
M+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("8C,38P.PT*
M(`T*("`@("`@("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(&-E;G1E<B<^#0H@("`-"B`@("`@
M("`@("`P+C$P)2`M(#(N,C0E#0H@("`@#0H@("`@("`@(#PO=&0^#0H@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L
M;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@
M("`@079E<F%G92!E>'!E8W1E9"!L:69E#0H@(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@("`\+W1D/@T*
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^#0H@#0H@("`@("`@("`@,"XW."`M(#4@>65A<G,-"B`@("`@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@
M("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@("`@/'1R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M
M8V]L;W(Z("-%145%144G/@T*("`@("`-"B`@("`@("`@/'1D/@T*("`@(`T*
M("`@("`@("`@($5X<&5C=&5D('9O;&%T:6QI='D-"B`@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`X,BXQ)2`M(#@V+C8E#0H@("`@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@
M#0H@("`@("`@(#PO=&0^#0H@("`@(`T*("`@("`@/"]T<CX-"B`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z(%=H:71E)SX-"B`@(`T*("`@("`@("`\=&0^#0H@("`@
M#0H@("`@("`@("`@17AP96-T960@9&EV:61E;F1S#0H@("`@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@)B,Q-C`[#0H@#0H@("`@("`@
M(#PO=&0^#0H@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("!.;VYE#0H@("`@(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("8C,38P.PT*(`T*("`@("`@
M("`\+W1D/@T*("`@("`-"B`@("`@(#PO='(^#0H@("`-"B`@("`\+W1A8FQE
M/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A,S<X-3<R9#,T,F8-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3=E,#`Y8V9?,V(S8E\T-#1E7V(W
M.6-?83,W.#4W,F0S-#)F+U=O<FMS:&5E=',O4VAE970Q-RYH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DY/5$4@,3(N($1!4E!!
M($-/3E1204-4($%.1"!214Q!5$5$(%)%5D5.544@4D5#3T=.251)3TX\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@
M4F5V96YU92!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`-"B`@
M("`@($Y/5$4@,3(N("8C,38P.T1!4E!!($-/3E1204-4($%.1"!214Q!5$5$
M(%)%5D5.544@4D5#3T=.251)3TX-"B`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!!<R!D:7-C=7-S960@:6X@
M3F]T92`Q+"!W92!E;G1E<F5D(&EN=&\@82!G;W9E<FYM96YT(&-O;G1R86-T
M#0H@("`-"B`@("`@('=I=&@@1$%24$$@;VX@4V5P=&5M8F5R(#,P+"`R,#$Q
M(&%N9"!C;VUM96YC960@=V]R:R!O;B!S=6-H#0H@#0H@("`@("!C;VYT<F%C
M="!I;B!/8W1O8F5R(#(P,3$N($]N;'D@=&AE(&)A<V4@>65A<B`H>65A<B!O
M;F4-"B`-"B`@("`@(&-O;G1R86-T*2!I<R!E9F9E8W1I=F4@9F]R('1H92!P
M87)T:65S+B!996%R<R!T=V\@=&AR;W5G:`T*("`@(`T*("`@("`@9FEV92!A
M<F4@<W5B:F5C="!T;R!$05)002!E>&5R8VES:6YG('1H96ER(&]P=&EO;B!T
M;R!E;G1E<@T*("`@("`-"B`@("`@(&EN=&\@8V]N=')A8W1S(&9O<B!T:&]S
M92!Y96%R<RX@5&AE('EE87(@;VYE(&-O;G1R86-T#0H@("`@(`T*("`@("`@
M8V]N=&%I;G,@96EG:'0@;6EL97-T;VYE<R!F;W(@=VAI8V@@=&AR964@:&%V
M92!B965N(&%C:&EE=F5D#0H@(`T*("`@("`@9'5R:6YG('1H92!Q=6%R=&5R
M(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q(&%S(&9O;&QO=W,Z#0H@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!-
M:6QE<W1O;F4@,BXR+C$N,2`F(S@R,3$[(%=R:71E(')E<75I<F5M96YT<R!D
M969I;FET:6]N(&9O<@T*("`@("`-"B`@("`@('1H92!E>'1R86-O<G!O<F5A
M;"!B;&]O9"!P=7)I9FEC871I;VX@<WES=&5M(&%N9"!A8W%U:7)E#0H@("`-
M"B`@("`@(&YE8V5S<V%R>2!E<75I<&UE;G0@=VET:"!A(&UI;&5S=&]N92!P
M87EM96YT(&]F("0S-3@L,C@T+@T*("`@(`T*("`@("`@36%N86=E;65N="!C
M;VYS:61E<G,@=&AI<R!M:6QE<W1O;F4@=&\@8F4@<W5B<W1A;G1I=F4@87,@
M:70-"B`-"B`@("`@('=A<R!N;W0@9&5P96YD96YT(&]N('1H92!P87-S86=E
M(&]F('1I;64@;F]R('=A<R!I="!B87-E9`T*("`@(`T*("`@("`@<V]L96QY
M(&]N(&%N;W1H97(@<&%R='DG<R!E9F9O<G1S+B!792!W;W)K960@;VX@=&AI
M<R!C;VYC97!T#0H@(`T*("`@("`@9F]R(&$@;G5M8F5R(&]F(&UO;G1H<R!B
M96=I;FYI;F<@=VET:"!A('!R97-E;G1A=&EO;B!T;R!$05)000T*("`@#0H@
M("`@("!I;B!L871E(#(P,3`N(%=E('-U8G-E<75E;G1L>2!F:6QE9"!F;W(@
M25`@<')O=&5C=&EO;B!O;@T*("`@#0H@("`@("!C97)T86EN(&]F('1H92!K
M97D@8V]N8V5P=',@:6X@36%R8V@@,C`Q,2!A;F0@;W5R(&UA;F%G96UE;G0-
M"B`@#0H@("`@("!V:7-I=&5D('-E;&5C=&5D('!O=&5N=&EA;"!V96YD;W)S
M('1O('=O<FL@;W5T(&UA;GD@;V8@=&AE#0H@("`@(`T*("`@("`@9&5T86EL
M<R!I;B!T:&4@<W5M;65R(&]F(#(P,3$@8F5F;W)E('=E('=E<F4@87=A<F1E
M9"!T:&4-"B`@(`T*("`@("`@8V]N=')A8W0@;VX@4V5P=&5M8F5R(#,P+"`R
M,#$Q+B!792!O<F1E<F5D('1H92!B<F5A9&)O87)D#0H@("`@#0H@("`@("!D
M979I8V4@9G)O;2!O;F4@;V8@;W5R('9E;F1O<G,@8F5F;W)E('1H92!M:6QE
M<W1O;F4@<&%Y;65N=`T*(`T*("`@("`@=V%S(&UA9&4N(%=E(&1E<VEG;F5D
M('1H92!B<F5A9&)O87)D('!R;W1O='EP92!A;F0@=&AE;@T*("`-"B`@("`@
M('!R97-E;G1E9"!T:&4@9&5S:6=N('1O($1!4E!!(&EN(&]R9&5R('1O(&%C
M:&EE=F4@=&AE#0H@("`@(`T*("`@("`@;6EL97-T;VYE+@T*("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($UI
M;&5S=&]N92`R+C(N,2XR("TM($9A8G)I8V%T92!B<F5A9&)O87)D('!R;W1O
M='EP97,@9F]R#0H@("`-"B`@("`@(&%N=&EC;V%G=6QA=&EO;BUF<F5E(&%N
M=&DM<V5P<VES(&5X=')A8V]R<&]R96%L('-Y<W1E;0T*(`T*("`@("`@*$%3
M15!365,I(&1E=FEC92X@1F%B<FEC871E('!R;W1O='EP92!B;&]O9"!T=6)I
M;F<@<V5T<RX-"B`@(`T*("`@("`@06-Q=6ER92!A;G1I+71H<F]M8F]G96YI
M8R!S=7)F86-E(&UO9&EF:65D(&AO;&QO=R!F:6)E<@T*("`-"B`@("`@('!L
M87-M82!S97!A<F%T;W)S('=I=&@@82!M:6QE<W1O;F4@<&%Y;65N="`D,3@S
M+#,V-RX-"B`@("`-"B`@("`@($UA;F%G96UE;G0@8V]N<VED97)S('1H:7,@
M;6EL97-T;VYE('1O(&)E('-U8G-T86YT:79E(&%S(&ET#0H@#0H@("`@("!W
M87,@;F]T(&1E<&5N9&5N="!O;B!T:&4@<&%S<V%G92!O9B!T:6UE(&YO<B!W
M87,@:70@8F%S960-"B`@("`-"B`@("`@('-O;&5L>2!O;B!A;F]T:&5R('!A
M<G1Y)W,@969F;W)T<RX@5&AE(&-O;G-I9&5R871I;VX@9F]R('1H:7,-"B`@
M(`T*("`@("`@;6EL97-T;VYE(&-O=F5R<R!T:&4@8V]S="!O9B!H879I;F<@
M=&AE(&)R96%D8F]A<F0@<')O=&]T>7!E#0H@(`T*("`@("`@9&5V96QO<&5D
M('1O(&]U<B!S<&5C:69I8V%T:6]N<RP@:&ER:6YG(&%N(&5N9VEN965R('1O
M#0H@#0H@("`@("!S=7!E<G9I<V4@=&AE('!R;VIE8W0L(&%C<75I<FEN9R!S
M<&5C:6%L;'D@8V]A=&5D(&-A<G1R:61G97,-"B`@#0H@("`@("!A;F0@87-S
M;V-I871E9"!O=F5R:&5A9"X@5&AE(')E<&]R="!W87,@86-C97!T960@8GD@
M=&AE#0H@(`T*("`@("`@8V]N=')A8W1I;F<@;V9F:6-E<B=S(')E<')E<V5N
M=&%T:79E(&%N9"!T:&4@:6YV;VEC92!W87,-"B`@(`T*("`@("`@<W5B;6ET
M=&5D('1H97)E869T97(N#0H@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($UI;&5S=&]N92`R+C(N,BXQ("8C
M.#(Q,3L@0F5G:6X@=&\@9&5V96QO<"!T:&4@041!4%0@9&5V:6-E#0H@("`@
M(`T*("`@("`@=&\@969F:6-I96YT;'D@8V%P='5R92!S97!S:7,@<')E8W5R
M<V]R<R!A;F0@86-Q=6ER90T*("`@(`T*("`@("`@:6UP;W)T86YT(&5Q=6EP
M;65N="!A;F0@<W5P<&QI97,@=VET:"!A(&UI;&5S=&]N92!P87EM96YT(&]F
M#0H@(`T*("`@("`@)#0R-BPT,C0N($UA;F%G96UE;G0@8V]N<VED97)S('1H
M:7,@;6EL97-T;VYE('1O(&)E#0H@("`-"B`@("`@('-U8G-T86YT:79E(&%S
M(&ET('=A<R!N;W0@9&5P96YD96YT(&]N('1H92!P87-S86=E(&]F('1I;64-
M"B`@("`@#0H@("`@("!N;W(@=V%S(&ET(&)A<V5D('-O;&5L>2!O;B!A;F]T
M:&5R('!A<G1Y)W,@969F;W)T<RX@270@=V%S#0H@("`@(`T*("`@("`@8W)I
M=&EC86QL>2!I;7!O<G1A;G0@=&\@;V)T86EN(&-E<G1A:6X@<&EE8V5S(&]F
M(&QA8@T*("`@(`T*("`@("`@97%U:7!M96YT(&%S(&5A<FQY(&%S('!O<W-I
M8FQE(&%F=&5R('=I;FYI;F<@=&AE(&-O;G1R86-T(&EN#0H@(`T*("`@("`@
M;W)D97(@=&\@;65A<W5R92!T:&4@8FEN9&EN9R!A8FEL:71Y(&]F('-E<'-I
M<R!P<F5C=7)S;W)S+B!790T*("`@#0H@("`@("!D96UO;G-T<F%T960@=&AA
M="!W92!W97)E(&%B;&4@=&\@8V%P='5R92!O;F4@;V8@=&AE#0H@("`@#0H@
M("`@("!I9&5N=&EF:65D('!O<W-I8FQE('-E<'-I<R!P<F5C=7)S;W)S(&%S
M('!A<G0@;V8@;W5R#0H@("`@#0H@("`@("!S=6)M:7-S:6]N(&9O<B!A<'!R
M;W9A;"X@5&AE(&-O;G-I9&5R871I;VX@=V%S(&%L<V\@9&5S:6=N960-"B`@
M#0H@("`@("!T;R!C;W9E<B!T:&4@<V%L87)I97,@;V8@;F5W(&%N9"!E>&ES
M=&EN9R!S8VEE;G1I<W1S+"!L86(-"B`@("`-"B`@("`@('-P86-E+"!M871E
M<FEA;',@87,@=V5L;"!A<R!F<FEN9V4@86YD(&-O<G!O<F%T92!O=F5R:&5A
M9"X-"B`@("`@#0H@("`@/"]P/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\Y-V4P,#EC9E\S8C-B7S0T-&5?8C<Y8U]A
M,S<X-3<R9#,T,F8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3=E
M,#`Y8V9?,V(S8E\T-#1E7V(W.6-?83,W.#4W,F0S-#)F+U=O<FMS:&5E=',O
M4VAE970Q."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/DY/5$4@,3,N($-/34U)5$U%3E13($%.1"!#3TY424Y'14Y#2453/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UI=&UE
M;G1S(&%N9"!#;VYT:6YG96YC:65S($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@#0H@("`@("!.3U1%(#$S+B!#3TU-251-14Y44R!!3D0@
M0T].5$E.1T5.0TE%4PT*("`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($Q%1T%,($U!5%1%4E,-"B`@("`@
M#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@
M("`@("!&<F]M('1I;64@=&\@=&EM92P@8VQA:6US(&%R92!M861E(&%G86EN
M<W0@=7,@:6X@=&AE(&]R9&EN87)Y#0H@("`-"B`@("`@(&-O=7)S92!O9B!B
M=7-I;F5S<RP@=VAI8V@@8V]U;&0@<F5S=6QT(&EN(&QI=&EG871I;VXN($-L
M86EM<PT*("`-"B`@("`@(&%N9"!A<W-O8VEA=&5D(&QI=&EG871I;VX@87)E
M('-U8FIE8W0@=&\@:6YH97)E;G0-"B`-"B`@("`@('5N8V5R=&%I;G1I97,@
M86YD('5N9F%V;W)A8FQE(&]U=&-O;65S(&-O=6QD(&]C8W5R+"!S=6-H(&%S
M#0H@#0H@("`@("!M;VYE=&%R>2!D86UA9V5S+"!F:6YE<RP@<&5N86QT:65S
M(&]R(&EN:G5N8W1I;VYS('!R;VAI8FET:6YG#0H@("`-"B`@("`@('5S(&9R
M;VT@<V5L;&EN9R!O;F4@;W(@;6]R92!P<F]D=6-T<R!O<B!E;F=A9VEN9R!I
M;B!O=&AE<@T*("`@(`T*("`@("`@86-T:79I=&EE<RX-"B`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@5&AE
M(&]C8W5R<F5N8V4@;V8@86X@=6YF879O<F%B;&4@;W5T8V]M92!I;B!A;GD@
M<W!E8VEF:6,-"B`@(`T*("`@("`@<&5R:6]D(&-O=6QD(&AA=F4@82!M871E
M<FEA;"!A9'9E<G-E(&5F9F5C="!O;B!O=7(@<F5S=6QT<R!O9@T*("`@#0H@
M("`@("!O<&5R871I;VYS(&9O<B!T:&%T('!E<FEO9"!O<B!F=71U<F4@<&5R
M:6]D<RX@3W1H97(@=&AA;B!T:&4-"B`@#0H@("`@("!"87)S96QL(&UA='1E
M<B!D:7-C=7-S960@96%R;&EE<BP@=V4@87)E(&YO="!P<F5S96YT;'D@80T*
M("`@#0H@("`@("!P87)T>2!T;R!A;GD@<&5N9&EN9R!O<B!T:')E871E;F5D
M(&UA=&5R:6%L(&QE9V%L#0H@#0H@("`@("!P<F]C965D:6YG<RX-"B`@("`-
M"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@
M("`@($Q%05-%4PT*("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P)SX-"B`@("`@#0H@("`@("!);B!/8W1O8F5R(#(P,#DL('=E(&5N=&5R
M960@:6YT;R!T=V\@;F5W(&QE87-E<R!F;W(@;V9F:6-E#0H@("`@(`T*("`@
M("`@86YD(&QA8F]R871O<GD@<W!A8V4N(%1H92!T97)M<R!O9B!T:&4@;F5W
M(&QE87-E<R!A<F4@=&AR964-"B`-"B`@("`@('EE87)S(&%N9"!T=V\@>65A
M<G,L(')E<W!E8W1I=F5L>2P@86YD('1H92!I;FET:6%L(&)A<V4@;&5A<V4-
M"B`@(`T*("`@("`@<&%Y;65N=',@87)E("0V+#`T-2!P97(@;6]N=&@@86YD
M("0Q+#8V-R!P97(@;6]N=&@L#0H@("`-"B`@("`@(')E<W!E8W1I=F5L>2X-
M"B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@
M("`@#0H@("`@("!/;B!/8W1O8F5R(#0L(#(P,3$@=V4@96YT97)E9"!I;G1O
M(&%N(&%M96YD;65N="!T;R!E>'1E;F0@;W5R#0H@("`-"B`@("`@(&QE87-E
M(&9O<B!O=7(@;&%B;W)A=&]R>2!B>2!A;B!A9&1I=&EO;F%L('1H<F5E('EE
M87)S+B!4:&4-"B`@("`@#0H@("`@("!A;65N9&UE;G0@86QS;R!I;F-L=61E
M9"!A9&1I=&EO;F%L('1E;F%N="!I;7!R;W9E;65N=',@:6X@=&AE#0H@("`-
M"B`@("`@(&%P<')O>&EM871E(&%M;W5N="!O9B`D,S`L,#`P+@T*("`-"B`@
M("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7SDW93`P.6-F7S-B,V)?-#0T95]B-SEC7V$S-S@U-S)D,S0R9@T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y-V4P,#EC9E\S8C-B7S0T
M-&5?8C<Y8U]A,S<X-3<R9#,T,F8O5V]R:W-H965T<R]3:&5E=#$Y+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3D]412`Q,RX@
M3D]412!214-%259!0DQ%/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DQO86YS+"!.;W1E<RP@5')A9&4@86YD($]T:&5R(%)E8V5I
M=F%B;&5S($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-
M"B`@("`@($Y/5$4@,30N($Y/5$4@4D5#14E604),10T*(`T*("`@(#PO<#X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@("`@3VX@2G5L
M>2`Q-2P@,C`Q,"P@=V4@<F5C96EV960@='=O(%-E8W5R960@5')U<W0@1&5E
M9"!.;W1E<R!T;PT*("`@#0H@("`@("!U<R`H=&AE(")4<G5S="!.;W1E<R(I
M(&5A8V@@:6X@=&AE('!R:6YC:7!A;"!A;6]U;G0@;V8-"B`-"B`@("`@("0R
M,#`L,#`P(&EN(&-O;FYE8W1I;VX@=VET:"!O=7(@:7-S=6%N8V4@;V8@82`D
M.#DP+#`P,`T*(`T*("`@("`@<')I;F-I<&%L(&%M;W5N="`V)2!C;VYV97)T
M:6)L92!P<F]M:7-S;W)Y(&YO=&4@=&\@;VYE#0H@#0H@("`@("!A8V-R961I
M=&5D(&EN=F5S=&]R("A3964@3F]T92`U*2XF(S$V,#LF(S$V,#M4:&4@5')U
M<W0@3F]T97,-"B`@("`@#0H@("`@("!B96%R(&EN=&5R97-T('!A>6%B;&4@
M=&\@=7,@870@9FEV92!P97)C96YT('!E<B!A;FYU;2!A;F0-"B`@("`-"B`@
M("`@(&AA=F4@;6%T=7)I='D@9&%T97,@;V8@4V5P=&5M8F5R(#$U+"`R,#$Q
M(&%N9"!.;W9E;6)E<B`Q-2P-"B`@("`@#0H@("`@("`R,#$Q+B!792!R96-O
M9VYI>F4@:6YT97)E<W0@:6YC;VUE(&]N('1H92!);G9E<W1O<B!.;W1E(&%N
M9`T*(`T*("`@("`@5')U<W0@3F]T97,@87,@:70@:7,@96%R;F5D('5N9&5R
M('1H92!T97)M<R!O9B!T:&4@;F]T97,N(%1H90T*("`@#0H@("`@("!);G9E
M<W1O<B!.;W1E(&%N9"!4<G5S="!.;W1E<R!H879E('!R97!A>6UE;G0@;W!T
M:6]N<RX-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*
M("`@("`-"B`@("`@($EN($9E8G)U87)Y(#(P,3$L('1H92!I;G9E<W1O<B!P
M86ED('1H92!I;FET:6%L("0R,#`L,#`P#0H@("`-"B`@("`@(&%M;W5N="!T
M;R!U<R!A;&]N9R!W:71H(')E;&%T960@86-C<G5E9"!I;G1E<F5S="!O9@T*
M("`@#0H@("`@("`D-2PY-#4N)B,Q-C`[)B,Q-C`[1'5R:6YG('1H92!T:')E
M92!M;VYT:',@96YD960@2G5N92`S,"P-"B`@#0H@("`@("`R,#$Q+"!T:&4@
M:6YV97-T;W(@<&%I9"!T:&4@<V5C;VYD("0R,#`L,#`P(&%M;W5N="!T;R!U
M<PT*("`@#0H@("`@("!A;&]N9R!W:71H(&%C8W)U960@:6YT97)E<W0@;V8@
M)#<L.#8S+B!!<R!A(')E<W5L="P@=V4@;F\-"B`@("`-"B`@("`@(&QO;F=E
M<B!S:&]W(&$@;F]T92!R96-E:79A8FQE(&]N(&]U<B!C;VYD96YS960@8V]N
M<V]L:61A=&5D#0H@#0H@("`@("!B86QA;F-E('-H965T(&%S(&]F($1E8V5M
M8F5R(#,Q+"`R,#$Q+@T*("`@("`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P.6-F7S-B,V)?
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M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3D]412`Q-2X@4D5,051%1"!005)42453/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E;&%T960@4&%R
M='D@5')A;G-A8W1I;VYS($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/@T*("`@("`-"B`@("`@($Y/5$4@,34N(%)%3$%4140@4$%25$E%4PT*(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^#0H@("`@(`T*("`@
M("`@1'5E('1O('=O<FMI;F<@8V%P:71A;"!S:&]R=&%G97,L('=E(&AA=F4@
M;F]T(&)E96X@86)L92!T;PT*("`@("`-"B`@("`@(')E<&%Y(&-E<G1A:6X@
M;65M8F5R<R!O9B!O=7(@<V5N:6]R(&UA;F%G96UE;G0@86YD(&)O87)D#0H@
M("`-"B`@("`@(&UE;6)E<G,@9F]R(&5X<&5N<V5S(&EN8W5R<F5D(&]N(&)E
M:&%L9B!O9B!T:&4@0V]M<&%N>2!A;F0-"B`@("`@#0H@("`@("!O8V-A<VEO
M;F%L;'D@:&%V92!B965N('5N86)L92!T;R!P87D@=&AO<V4@:6YD:79I9'5A
M;',@9F]R#0H@("`@(`T*("`@("`@=&AE:7(@<V5R=FEC97,N($%S(&]F($1E
M8V5M8F5R(#,Q+"`R,#$Q(&%N9"!-87)C:"`S,2P@,C`Q,2P-"B`-"B`@("`@
M('=E(&]W960@;W5R('-E;FEO<B!M86YA9V5M96YT(&%N9"!B;V%R9"!M96UB
M97)S("0V,3<L-3<P+`T*("`@(`T*("`@("`@=VAI8V@@:7,@<VAO=VX@87,@
M9'5E('1O(')E;&%T960@<&%R=&EE<R!O;B!T:&4@86-C;VUP86YY:6YG#0H@
M(`T*("`@("`@8F%L86YC92!S:&5E="X-"B`-"B`@("`\+W`^/&)R+SX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P.6-F
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^3D]412`Q-BX@4U5"4T51545.5"!%5D5.
M5%,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B
M<V5Q=65N="!%=F5N=',@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`-"B`@("`@
M($YO=&4@,38N(%-50E-%455%3E0@159%3E13#0H@("`-"B`@("`\+W`^/&)R
M+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($UA;F%G96UE
M;G0@:&%S(&5V86QU871E9"!E=F5N=',@<W5B<V5Q=65N="!T;R!$96-E;6)E
M<B`S,2P-"B`@("`@#0H@("`@("`R,#$Q('1H<F]U9V@@=&AE(&1A=&4@=&AA
M="!T:&4@86-C;VUP86YY:6YG(&-O;F1E;G-E9`T*("`@("`-"B`@("`@(&-O
M;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!W97)E(&9I;&5D('=I
M=&@@=&AE#0H@("`@(`T*("`@("`@4V5C=7)I=&EE<R!A;F0@17AC:&%N9V4@
M0V]M;6ES<VEO;B!F;W(@=')A;G-A8W1I;VYS(&%N9"!O=&AE<@T*("`@#0H@
M("`@("!E=F5N=',@=VAI8V@@;6%Y(')E<75I<F4@861J=7-T;65N="!O9B!A
M;F0O;W(@9&ES8VQO<W5R92!I;@T*(`T*("`@("`@<W5C:"!F:6YA;F-I86P@
M<W1A=&5M96YT<RX-"B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^#0H@("`@(`T*("`@("`@26X@2F%N=6%R>2`R,#$R+"!W92!S:&EP
M<&5D(&$@9&EA9VYO<W1I8R!P<F]D=6-T('1H870-"B`@("`@#0H@("`@("!I
M<V]L871E9"!E>&]S;VUE<R!F<F]M(&)L;V]D('-E<G5M('1O(&$@;&EF92!S
M8VEE;F-E<R!C;VUP86YY#0H@("`-"B`@("`@(&%N9"!I;G9O:6-E9"!T:&5M
M(&9O<B`D,2PT,S(N(%=E(')E8V5I=F5D('!A>6UE;G0@:6X@9G5L;`T*("`@
M(`T*("`@("`@=6YD97(@=&AA="!I;G9O:6-E(&EN($9E8G)U87)Y(#(P,3(N
M(%1H:7,@<F5P<F5S96YT<R!O=7(-"B`@(`T*("`@("`@9FER<W0@8V]M;65R
M8VEA;"!S86QE+"!W:&EC:"!W:6QL(&)E(')E8V]R9&5D(&EN('1H92!-87)C
M:`T*("`@("`-"B`@("`@(#(P,3(@<75A<G1E<BX-"B`@("`@#0H@("`@/"]P
M/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX-"B`@("`@#0H@("`@("!$=7)I
M;F<@=&AE('!E<FEO9"!*86YU87)Y(#$L(#(P,3(@=&AR;W5G:"!&96)R=6%R
M>2`Q-2P@,C`Q,BP-"B`@#0H@("`@("!W92!I<W-U960@,BPR-34L,3@X('-H
M87)E<R!O9B!R97-T<FEC=&5D(&-O;6UO;B!S=&]C:R!I;@T*("`@#0H@("`@
M("!E>&-H86YG92!F;W(@=&AE('!A<G1I86P@;W(@9G5L;"!C;VYV97)S:6]N
M(&]F('!R:6YC:7!A;"!A;F0-"B`@#0H@("`@("!I;G1E<F5S="!O9B!S979E
M<F%L(&-O;G9E<G1I8FQE(&YO=&5S('!A>6%B;&4@:6X@86X@86=G<F5G871E
M#0H@("`-"B`@("`@(&%M;W5N="!O9B`D,3$Q+#<Y-2!A="!A;B!A=F5R86=E
M(&-O;G9E<G-I;VX@<')I8V4@;V8@)#`N,#4-"B`@("`@#0H@("`@("!P97(@
M<VAA<F4@8F%S960@=7!O;B!T:&4@8V]N=F5R<VEO;B!F;W)M=6QA92!I;B!T
M:&4-"B`@(`T*("`@("`@<F5S<&5C=&EV92!N;W1E<RX-"B`@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/@T*("`@("`-"B`@("`@($1U
M<FEN9R!T:&4@<&5R:6]D($IA;G5A<GD@,2P@,C`Q,B!T:')O=6=H($9E8G)U
M87)Y(#$U+"`R,#$R+`T*("`-"B`@("`@('=E(&ES<W5E9"`Q,#DL-3(Y('-H
M87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@82!S97)V:6-E#0H@("`@(`T*("`@
M("`@<')O=FED97(@9F]R('-E<G9I8V5S('9A;'5E9"!A="`D-RPV-C<@8F%S
M960@=7!O;B!T:&4@9F%I<@T*("`@("`-"B`@("`@('9A;'5E(&]F('1H92!S
M:&%R97,@:7-S=65D+B!!;&P@;V8@=&AO<V4@<VAA<F5S('=E<F4@:7-S=65D
M#0H@#0H@("`@("!P=7)S=6%N="!T;R!O=7(@4RTX(')E9VES=')A=&EO;B!S
M=&%T96UE;G1S(&-O=F5R:6YG(&]U<@T*("`@#0H@("`@("!!;65N9&5D(&%N
M9"!297-T871E9"`R,#`S($-O;G-U;'1A;G0@4W1O8VL@4&QA;B!O<B`R,#$P
M(%-T;V-K#0H@("`-"B`@("`@($EN8V5N=&EV92!0;&%N+B!4:&4@<V5R=FEC
M97,@=V5R92!F;W(@97AO<V]M92UR96QA=&5D#0H@("`@(`T*("`@("`@<F5S
M96%R8V@N)B,Q-C`[)B,Q-C`[5&AE(&ES<W5A;F-E('!R:6-E(&]N('1H92!3
M+3@@:7-S=6%N8V4-"B`@("`-"B`@("`@('=A<R!A<'!R;WAI;6%T96QY("0P
M+C`W('!E<B!S:&%R92X-"B`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/@T*("`@("`-"B`@("`@($1U<FEN9R!T:&4@<&5R:6]D($IA;G5A
M<GD@,2P@,C`Q,B!T:')O=6=H($9E8G)U87)Y(#$U+"`R,#$R+`T*("`-"B`@
M("`@('=E(&ES<W5E9"`R.#<L-3`P('-H87)E<R!O9B!R97-T<FEC=&5D(&-O
M;6UO;B!S=&]C:R!A<R!A#0H@("`-"B`@("`@('!A=&5N="!L:6-E;G-E('!A
M>6UE;G0@=F%L=65D(&%T("0Q-RPR-3`N#0H@("`-"B`@("`\+W`^/&)R+SX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDW93`P
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M2%)E9CTS1")3:&5E=#`R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970P,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#0N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`U+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970P-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`X+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P.2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,3`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#$Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,BYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3,N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#$T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970Q-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,38N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$W+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970Q."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,3DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(P+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,2YH=&UL(B\^#0H\+WAM
M;#X-"BTM+2TM+3U?3F5X=%!A<G1?.3=E,#`Y8V9?,V(S8E\T-#1E7V(W.6-?
083,W.#4W,F0S-#)F+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The summary of our significant accounting policies presented

      below is designed to assist the reader in understanding our

      condensed consolidated financial statements. Such financial

      statements and related notes are the representations of our

      management, who are responsible for their integrity and

      objectivity. These accounting policies conform to GAAP in all

      material respects, and have been consistently applied in

      preparing the accompanying&#160;condensed consolidated

      financial statements.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      PRINCIPLES OF CONSOLIDATION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The accompanying condensed consolidated financial statements

      include the accounts of Aethlon Medical, Inc. and its

      wholly-owned subsidiary, Exosome Sciences, Inc.,

      (collectively hereinafter referred to as the "Company" or

      "Aethlon"). There exist no material intercompany transactions

      or balances between Aethlon and its subsidiary.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      LOSS PER COMMON SHARE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Basic loss per common share is computed by dividing net loss

      available to common stockholders by the weighted average

      number of common shares assumed to be outstanding during the

      period of computation. Diluted loss per common share is

      computed similar to basic loss per share except that the

      denominator is increased to include the number of additional

      common shares that would have been outstanding if the

      potential common shares had been issued, and if the

      additional common shares were dilutive. As we had net losses

      for all periods presented, basic and diluted loss per common

      share are the same, since additional potential common shares

      have been excluded as their effect would be antidilutive.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The potentially dilutive common shares outstanding for at

      December 31, 2011 and 2010, which include common shares

      underlying outstanding stock options, warrants and

      convertible debentures, were 114,215,775 and 81,138,329,

      respectively.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      PATENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We capitalize the cost of patents, some of which were

      acquired, and amortize such costs over their estimated useful

      life, upon issuance of the patent, not to exceed the patent

      legal life.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      RESEARCH AND DEVELOPMENT EXPENSES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We incurred research and development expenses during the

      three and nine month periods ended December 31, 2011 and

      2010, which are included in various operating expense line

      items in the accompanying condensed consolidated statements

      of operations. Our research and development expenses in those

      periods were as follows:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          December 31,

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          December 31,

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          2011

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          2010

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 64%">

          Three months ended

        </td>

        <td style="width: 8%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 11%; text-align: right">

          536,079

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 2%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 11%; text-align: right">

          127,918

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 2.5pt">

          Nine months ended

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          864,443

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          317,345

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      FAIR VALUE OF FINANCIAL INSTRUMENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The carrying amount of the Company's cash, accounts

      receivable, accounts payable and accrued liabilities

      approximates their estimated fair values due to the

      short-term maturities of these financial instruments. The

      fair value of certain convertible notes and related warrants

      at December 31, 2011 is $1,250,705 based upon a third party

      valuation report that we commissioned. Warrants classified as

      derivative liabilities are reported at their estimated fair

      value, with changes in fair value being reported in current

      period results of operations.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Management has concluded that it is not practical to

      determine the estimated fair value of amounts due to related

      parties because the transactions cannot be assumed to have

      been consummated at arm's length, the terms are not deemed to

      be market terms, there are no quoted values available for

      these instruments, and an independent valuation would not be

      practicable due to the lack of data regarding similar

      instruments, if any, and the associated potential costs.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      EQUITY INSTRUMENTS FOR SERVICES PROVIDED BY OTHER THAN

      EMPLOYEES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We account for transactions involving goods and services

      provided by third parties where we issue equity instruments

      as part of the total consideration using the fair value of

      the consideration received (i.e., the value of the goods or

      services) or the fair value of the equity instruments issued,

      whichever is more reliably measurable.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In transactions, when the value of the goods and/or services

      is not readily determinable and (1) the fair value of the

      equity instruments is more reliably measurable and (2) the

      counterparty receives equity instruments in full or partial

      settlement of the transactions, we use the following

      methodology:

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (a)&#160;&#160;&#160;For transactions where goods have

      already been delivered or services rendered, the equity

      instruments are issued on or about the date the performance

      is complete (and valued on the date of issuance).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (b)&#160;&#160;&#160;For transactions where the instruments

      are issued on a fully vested, non-forfeitable basis, the

      equity instruments are valued on or about the date of the

      contract.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (c)&#160;&#160;&#160;For any transactions not meeting the

      criteria in (a) or (b) above, we re-measure the consideration

      at each reporting date based on its then current stock value.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We review our long-lived assets for impairment whenever

      events or changes in circumstances indicate that their

      carrying amounts may not be recoverable. If the cost basis of

      a long-lived asset is greater than the projected future

      undiscounted net cash flows from such asset (excluding

      interest), an impairment loss is recognized. Impairment

      losses are calculated as the difference between the cost

      basis of an asset and its estimated fair value. We believe

      that no impairment occurred at or during the three and nine

      months ended December 31, 2011 and 2010.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      BENEFICIAL CONVERSION FEATURE OF CONVERTIBLE NOTES PAYABLE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The convertible feature of certain notes payable provides for

      a rate of conversion that is below the market value of our

      common stock. Such feature is normally characterized as a

      "Beneficial Conversion Feature" ("BCF"). We record the

      estimated fair value of the BCF, when applicable, in the

      condensed consolidated financial statements as a discount

      from the face amount of the notes. Such discounts are

      accreted to interest expense over the term of the notes using

      the effective interest method.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      REVENUE RECOGNITION

    </p><br/><p style="font: 10pt Calibri, Halvetica, Sans-Serif; margin: 0">

      <font style="font-family: Times New Roman, Times, Serif; color: black">With

      respect to revenue recognition, we entered into a contract

      with DARPA as discussed above and have recognized revenue

      during the three months ended December 31, 2011 of $958,075

      under such contract. We adopted the Milestone method of

      revenue recognition for the DARPA contract under ASC 605-28

      &#8220;Revenue Recognition &#8211; Milestone Method&#8221;

      and we believe we meet the requirements under ASC 605-28 for

      reporting contract revenue under the Milestone Method for the

      quarter ended December 31, 2011.</font>

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In order to account for this contract, the Company identifies

      the deliverables included within the contract and evaluates

      which deliverables represent separate units of accounting

      based on if certain criteria are met, including whether the

      delivered element has standalone value to the collaborator.

      The consideration received is allocated among the separate

      units of accounting, and the applicable revenue recognition

      criteria are applied to each of the separate units.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      A milestone is an event having all of the following

      characteristics:

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (1) There is substantive uncertainty at the date the

      arrangement is entered into that the event will be achieved.

      A vendor&#8217;s assessment that it expects to achieve a

      milestone does not necessarily mean that there is not

      substantive uncertainty associated with achieving the

      milestone.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (2) The event can only be achieved based in whole or in part

      on either: (a) the vendor&#8217;s performance; or (b) a

      specific outcome resulting from the vendor&#8217;s

      performance.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (3) If achieved, the event would result in additional

      payments being due to the vendor.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      A milestone does not include events for which the occurrence

      is either: (a) contingent solely upon the passage of time; or

      (b) the result of a counterparty&#8217;s performance.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The policy for recognizing deliverable consideration

      contingent upon achievement of a milestone must be applied

      consistently to similar deliverables.<br />

      <br />

      The assessment of whether a milestone is substantive is

      performed at the inception of the arrangement. The

      consideration earned from the achievement of a milestone must

      meet all of the following for the milestone to be considered

      substantive:

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (1) The consideration is commensurate with either: (a) the

      vendor&#8217;s performance to achieve the milestone; or (b)

      the enhancement of the value of the delivered item or items

      as a result of a specific outcome resulting from the

      vendor&#8217;s performance to achieve the milestone;

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (2) The consideration relates solely to past performance; and

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      (3) The consideration is reasonable relative to all of the

      deliverables and payment terms (including other potential

      milestone consideration) within the arrangement.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      A milestone is not considered substantive if any portion of

      the associated milestone consideration relates to the

      remaining deliverables in the unit of accounting (i.e., it

      does not relate solely to past performance). To recognize the

      milestone consideration in its entirety as revenue in the

      period in which the milestone is achieved, the milestone must

      be substantive in its entirety. Milestone consideration

      cannot be bifurcated into substantive and nonsubstantive

      components. In addition, if a portion of the consideration

      earned from achieving a milestone may be refunded or adjusted

      based on future performance, the related milestone is not

      considered substantive.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      See Note 12 for the additional disclosure information

      required under ASC 605-28.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      DERIVATIVE LIABILITIES AND CLASSIFICATION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We evaluate free-standing derivative instruments (or embedded

      derivatives) to properly classify such instruments within

      equity or as liabilities in our financial statements. Our

      policy is to settle instruments indexed to our common shares

      on a first-in-first-out basis.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The classification of a derivative instrument is reassessed

      at each balance sheet date. If the classification changes as

      a result of events during a reporting period, the instrument

      is reclassified as of the date of the event that caused the

      reclassification. There is no limit on the number of times a

      contract may be reclassified.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">

      On April 1, 2009 we adopted new guidance, as codified in

      Financial Accounting Standards Board ("FASB") Accounting

      Standards Codification ("ASC")&#160;815-40, <i>Derivatives

      and Hedging</i>, <i>Accounting for Derivative Financial

      Instruments Indexed to, and Potentially Settled in, a

      Company&#8217;s Own Stock</i> (previously EITF 07-5), that

      requires us to apply a two-step model in determining whether

      a financial instrument or an embedded feature is indexed to

      our own stock and thus enables it to qualify for equity

      classification. We have identified several convertible debt

      or warrant agreements in which the embedded conversion

      feature or exercise price contains certain provisions that

      may result in an adjustment of the conversion or exercise

      price, which results in the failure of the these instruments

      to be considered to be indexed to our stock. Accordingly,

      under this guidance, we are required to record the estimated

      fair value of these instruments as derivative liabilities

      (see Note 9).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We re-measure the estimated fair value of derivative

      liabilities at each reporting period and record changes in

      fair value in other expense (income) in the current statement

      of operations.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      REGISTRATION PAYMENT ARRANGEMENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We account for contingent obligations to make future payments

      or otherwise transfer consideration under a registration

      payment arrangement separately from any related financing

      transaction agreements, and any such contingent obligations

      are recognized only when it is determined that it is probable

      that the Company will become obligated for future payments

      and the amount, or range of amounts, of such future payments

      can be reasonably estimated (see Note 7).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      STOCK-BASED COMPENSATION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Employee stock options and rights to purchase shares under

      stock participation plans are accounted for under the fair

      value method. Accordingly, share-based compensation is

      measured when all granting activities have been completed,

      generally the grant date, based on the fair value of the

      award. The exercise price of options is generally equal to

      the market price of the Company's common stock (defined as

      the closing price as quoted on the OTCBB) on the date of

      grant. Compensation cost recognized by the Company includes

      (a) compensation cost for all equity incentive awards granted

      prior to, but not yet vested as of April 1, 2006, based on

      the grant-date fair value estimated in accordance with the

      original provisions of the then current accounting standards,

      and (b) compensation cost for all equity incentive awards

      granted subsequent to April 1, 2006, based on the grant-date

      fair value estimated in accordance with the provisions of

      subsequent accounting standards. We use a Binomial Lattice

      option pricing model for estimating fair value of options

      granted (see Note 10).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      INCOME TAXES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Deferred tax assets and liabilities are recognized for the

      future tax consequences attributable to the difference

      between the consolidated financial statements and their

      respective tax basis. Deferred income taxes reflect the net

      tax effects of (a) temporary differences between the carrying

      amounts of assets and liabilities for financial reporting

      purposes and the amounts reported for income tax purposes,

      and (b) tax credit carryforwards. We record a valuation

      allowance for deferred tax assets when, based on our best

      estimate of taxable income (if any) in the foreseeable

      future, it is more likely than not that some portion of the

      deferred tax assets may not be realized. At March 31, 2011

      and December 31, 2011, we had net deferred tax assets

      relating primarily to tax net operating loss carryforwards

      and a 100% valuation allowance on such net deferred tax

      assets. We had no significant current tax provision for any

      period presented.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      SIGNIFICANT RECENT ACCOUNTING PRONOUNCEMENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      There were no&#160;recent accounting pronouncements issued by

      the FASB (including its Emerging Issues Task Force), the

      American Institute of Certified Public Accountants, or the

      Securities and Exchange Commission that in the opinion

      of&#160;management had, or are expected&#160;to have a

      material impact on our present or future consolidated

      financial statements.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">$ 354,804<span></span></td>
        <td class="nump">$ 15,704<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
        <td class="nump">193,749<span></span></td>
        <td class="nump">157,732<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
        <td class="nump">183,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Note receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,096<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">26,250<span></span></td>
        <td class="nump">29,711<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">758,170<span></span></td>
        <td class="nump">410,243<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">2,535<span></span></td>
        <td class="nump">7,785<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Patents and patents pending, net</a></td>
        <td class="nump">133,108<span></span></td>
        <td class="nump">139,981<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits</a></td>
        <td class="nump">9,210<span></span></td>
        <td class="nump">9,210<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">903,023<span></span></td>
        <td class="nump">567,219<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CurrentLiabilitiesAbstract', window );"><strong>Current Liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">634,082<span></span></td>
        <td class="nump">308,413<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
        <td class="nump">617,570<span></span></td>
        <td class="nump">617,570<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
        <td class="nump">584,796<span></span></td>
        <td class="nump">190,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible notes payable, net of discounts</a></td>
        <td class="nump">2,462,825<span></span></td>
        <td class="nump">2,181,852<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
        <td class="nump">1,250,705<span></span></td>
        <td class="nump">2,002,896<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued liquidated damages</a></td>
        <td class="nump">437,800<span></span></td>
        <td class="nump">437,800<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
        <td class="nump">1,022,436<span></span></td>
        <td class="nump">804,386<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">7,010,214<span></span></td>
        <td class="nump">6,542,917<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 12)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_StockholdersDeficitAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 250,000,000 shares authorized as of December 31, 2011 and March 31, 2011; 108,977,508 and 77,467,361 shares issued and outstanding as of December 31, 2011 and March 31, 2011, respectively</a></td>
        <td class="nump">108,980<span></span></td>
        <td class="nump">77,469<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">45,869,870<span></span></td>
        <td class="nump">42,418,778<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Deficit accumulated</a></td>
        <td class="num">(52,086,041)<span></span></td>
        <td class="num">(48,471,945)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; deficit</a></td>
        <td class="num">(6,107,191)<span></span></td>
        <td class="num">(5,975,698)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
        <td class="nump">$ 903,023<span></span></td>
        <td class="nump">$ 567,219<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CurrentAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CurrentAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CurrentLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CurrentLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_StockholdersDeficitAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_StockholdersDeficitAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br> -Section S99<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Publisher FASB<br><br><br><br> -Paragraph 1<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 25<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Section 45<br><br><br><br> -SubTopic 10<br><br><br><br> -Topic 210<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Paragraph 1<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrestricted cash available for day-to-day operating needs, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7<br><br><br><br> -Footnote 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 5<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertibleNotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 21<br><br><br><br> -Paragraph 16<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28555-108399<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredFinanceCostsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepositsAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FIN39-1<br><br><br><br> -Paragraph 10A, 10B<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 4, 17<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Chapter 3<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 7<br><br><br><br> -Paragraph 11<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 4<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 57<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DueToRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 42, 45<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph ((a)(1),(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>An amount representing an agreement for an unconditional promise by the maker to pay the Company (holder) a definite sum of money within one year from the balance sheet date (or the normal operating cycle, whichever is longer), net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375948&amp;loc=d3e4531-111522<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesAndLoansReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Chapter 3<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6911-107765<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e7018-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6911-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6904-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Chapter 3<br><br><br><br> -Section A<br><br><br><br> -Paragraph 8<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 15<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amount for an unclassified balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs and the carrying amount as of the balance sheet date of assets not otherwise specified in the taxonomy. Also includes assets not individually reported in the financial statements, or not separately disclosed in notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph b, c<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A3<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Aethlon Medical, Inc. ("Aethlon", the "Company", "we" or

      "us") is a medical device company focused on creating

      innovative devices that address unmet medical needs in

      cancer, infectious disease and other life-threatening

      conditions. At the core of our developments is the Aethlon

      ADAPT&#8482; (Adaptive Dialysis-Like Affinity Platform

      Technology) system, a medical device platform that converges

      single or multiple affinity drug agents with advanced plasma

      membrane technology to create therapeutic filtration devices

      that selectively remove harmful particles from the entire

      circulatory system without loss of essential blood

      components. Approval to embark on human trials is still

      needed to reach commercial viability of the

      Hemopurifier&#174; and approval by the U.S. Food and Drug

      Administration ("FDA"). Successful outcomes of human trials

      will be required by the regulatory agencies of certain

      foreign countries where we intend to sell this device. We

      have submitted an Investigational Device Exemption ("IDE") to

      the FDA. Some of our patents may expire before FDA approval

      or approval in a foreign country, if any, is obtained.

      However, we believe that certain patent applications and/or

      other patents issued more recently will help protect the

      proprietary nature of the Hemopurifier(R) treatment

      technology.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In prior periods, Aethlon was classified as a development

      stage enterprise under accounting principles generally

      accepted in the United States of America ("GAAP") as it had

      not generated revenues from its planned principal operations.

      In the three months ended December 31, 2011, we began to

      generate revenues from a government contract and have emerged

      from the development stage. Subsequent to December 31, 2011,

      we recorded the first commercial shipment of one of our

      products to a life sciences company for diagnostics use.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Our common stock is quoted on the Over-the-Counter Bulletin

      Board administered by the Financial Industry Regulatory

      Authority ("OTCBB") under the symbol "AEMD.OB."

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The accompanying unaudited condensed consolidated financial

      statements have been prepared in accordance with GAAP for

      interim financial information and with the instructions to

      Form 10-Q and applicable sections of Regulation S-X.

      Accordingly, they do not include all of the information and

      footnotes required by GAAP for complete financial statements.

      In the opinion of management, all adjustments&#160;necessary

      to make the financial statements not misleading have been

      included. The condensed consolidated balance sheet as of

      March 31, 2011 was derived from our audited financial

      statements. Operating results for the nine months ended

      December 31, 2011 are not necessarily indicative of the

      results that may be expected for the year ending March 31,

      2012. For further information, refer to our Annual Report on

      Form 10-K for the year ended March 31, 2011, which includes

      audited financial statements and footnotes as of March 31,

      2011 and for the years ended March 31, 2011 and 2010 and the

      period January 31, 1984 (Inception) through March 31, 2011.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 720<br><br> -SubTopic 15<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122524<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=d3e5614-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6970148&amp;loc=SL6228881-111685<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name Statement of Position (SOP)<br><br> -Publisher AICPA<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 272<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS140-4/FIN46(R)-8<br><br> -Paragraph 8, C1, C7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name FASB Interpretation (FIN)<br><br> -Publisher FASB<br><br> -Number 46R<br><br> -Paragraph 4, 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 852<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2209116<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2134480<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 2-6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 235<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472506&amp;loc=d3e38932-110933<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122150<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359553&amp;loc=d3e288-107754<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 2. LIQUIDITY<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidityDisclosureTextBlock', window );">Liquidity Disclosure [Policy Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 2. LIQUIDITY

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The accompanying unaudited condensed consolidated financial

      statements have been prepared on a going concern basis, which

      contemplates, among other things, the realization of assets

      and the satisfaction of liabilities in the ordinary course of

      business. We have experienced continuing losses from

      operations, are in default on certain debt, have negative

      working capital of approximately $6,252,000, recurring losses

      from operations and an accumulated deficit of approximately

      $52,086,000 at December 31, 2011, which among other matters,

      raises significant doubt about our ability to continue as a

      going concern. We have not generated significant revenue or

      any profit from operations since inception. A significant

      amount of additional capital will be necessary to advance the

      development of our products to the point at which they may

      become commercially viable. Our current financial resources

      are insufficient to fund our capital expenditures, working

      capital and other cash requirements (consisting of accounts

      payable, accrued liabilities, amounts due to related parties

      and amounts due under various notes payable) for the fiscal

      year ending March 31, 2012 ("fiscal 2012"). Therefore we will

      be required to seek additional funds through debt and/or

      equity financing arrangements to finance our current and

      long-term operations.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">

      <font style="color: black">On September 30, 2011, we</font>

      entered into a contract with the United States of America,

      issued by SPAWAR Systems Center Pacific, pursuant to a

      contract award from the Defense Advanced Research Projects

      Agency (&#8220;DARPA&#8221;). Under the DARPA award, we have

      been engaged to develop a therapeutic device to reduce the

      incidence of sepsis, a fatal bloodstream infection that often

      results in the death of combat-injured soldiers. The award

      from DARPA is a fixed-price contract with potential total

      payments to us of $6,794,389 over the course of five years,

      including payments of up to $1,975,047 in the first year.

      Fixed price contracts require the achievement of multiple,

      incremental milestones to receive the full award during each

      year of the contract.&#160;&#160;Under the terms of the

      contract, we will perform certain incremental work towards

      the achievement of specific milestones against which we will

      invoice the government for fixed payment

      amounts.&#160;&#160;Assuming all such work is performed

      according to the contract terms, we will receive up to

      $1,975,047 of contract payments during the first twelve

      months of the contract with the aggregate payment amounts in

      years two through five varying between approximately $775,000

      and $1.6 million per year. DARPA has the option to extend the

      contract for years two through five. Only the first year of

      the contract related to the $1,975,047 has been formally

      entered into as of the date of this Form 10-Q filing. The

      milestones are comprised of planning, engineering and

      clinical targets, the achievement of which in some cases will

      require the participation and contribution of third party

      participants under the contract.&#160;&#160;There can be no

      assurance that we alone, or with third party participants,

      will meet such milestones to the satisfaction of the

      government and in compliance with the terms of the contract

      or that we will be paid the full amount of the contract

      revenues during any year of the contract term.&#160;&#160;We

      commenced work under the contract in October 2011 (See below

      and Note 12 for additional information regarding revenue

      recognition).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As of December 31, 2011, we received two initial payments

      under the DARPA contract totaling $774,708 and billed the

      government for a third invoice in the amount of $183,367,

      which is shown as an account receivable on the accompanying

      balance sheet .

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      <font style="color: black">Also during the three months ended

      December 31, 2011, we raised an additional $384,265 in net

      proceeds from a bridge financing that may yield up to $1

      million in total gross proceeds through the private placement

      of</font> convertible promissory notes and corresponding

      warrants with accredited investors (see Note 5 &#8211;

      Convertible Notes for more details of this offering) <font style="color: black">per the terms of the subscription

      agreement.</font>

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In addition to the funds received to date under the DARPA

      contract and under the bridge financing and beyond future

      fundings under the DARPA contract, we will require additional

      capital as our current financial resources, while improved,

      remain insufficient to fund our working capital and other

      cash requirements for the remainder of our fiscal year ending

      March 31, 2012. Therefore we will be required to seek

      additional funds through debt and/or equity financing

      arrangements to finance our current and long-term operations.

      We are currently addressing our liquidity needs by exploring

      investment capital opportunities through the private

      placement of common stock or issuance of additional debt,

      including the remaining portion of the bridge financing. We

      believe that our access to additional capital, together with

      existing cash resources, will be sufficient to meet our short

      term liquidity needs for fiscal 2012. However, no assurance

      can be given that we will receive any funds in connection

      with our capital raising efforts on terms acceptable to the

      Company, if at all.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The unaudited condensed consolidated financial statements do

      not include any adjustments relating to the recoverability of

      assets that might be necessary should we be unable to

      continue as a going concern.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidityDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiquidityDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ECEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
        <td class="nump">250,000,000<span></span></td>
        <td class="nump">250,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued</a></td>
        <td class="nump">108,977,508<span></span></td>
        <td class="nump">77,467,361<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding</a></td>
        <td class="nump">108,977,508<span></span></td>
        <td class="nump">77,467,361<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 12. DARPA CONTRACT AND RELATED REVENUE RECOGNITION<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureTextBlock', window );">Deferred Revenue Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 12. &#160;DARPA CONTRACT AND RELATED REVENUE RECOGNITION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As discussed in Note 1, we entered into a government contract

      with DARPA on September 30, 2011 and commenced work on such

      contract in October 2011. Only the base year (year one

      contract) is effective for the parties. Years two through

      five are subject to DARPA exercising their option to enter

      into contracts for those years. The year one contract

      contains eight milestones for which three have been achieved

      during the quarter ended December 31, 2011 as follows:

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Milestone 2.2.1.1 &#8211; Write requirements definition for

      the extracorporeal blood purification system and acquire

      necessary equipment with a milestone payment of $358,284.

      Management considers this milestone to be substantive as it

      was not dependent on the passage of time nor was it based

      solely on another party's efforts. We worked on this concept

      for a number of months beginning with a presentation to DARPA

      in late 2010. We subsequently filed for IP protection on

      certain of the key concepts in March 2011 and our management

      visited selected potential vendors to work out many of the

      details in the summer of 2011 before we were awarded the

      contract on September 30, 2011. We ordered the breadboard

      device from one of our vendors before the milestone payment

      was made. We designed the breadboard prototype and then

      presented the design to DARPA in order to achieve the

      milestone.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Milestone 2.2.1.2 -- Fabricate breadboard prototypes for

      anticoagulation-free anti-sepsis extracorporeal system

      (ASEPSYS) device. Fabricate prototype blood tubing sets.

      Acquire anti-thrombogenic surface modified hollow fiber

      plasma separators with a milestone payment $183,367.

      Management considers this milestone to be substantive as it

      was not dependent on the passage of time nor was it based

      solely on another party's efforts. The consideration for this

      milestone covers the cost of having the breadboard prototype

      developed to our specifications, hiring an engineer to

      supervise the project, acquiring specially coated cartridges

      and associated overhead. The report was accepted by the

      contracting officer's representative and the invoice was

      submitted thereafter.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Milestone 2.2.2.1 &#8211; Begin to develop the ADAPT device

      to efficiently capture sepsis precursors and acquire

      important equipment and supplies with a milestone payment of

      $426,424. Management considers this milestone to be

      substantive as it was not dependent on the passage of time

      nor was it based solely on another party's efforts. It was

      critically important to obtain certain pieces of lab

      equipment as early as possible after winning the contract in

      order to measure the binding ability of sepsis precursors. We

      demonstrated that we were able to capture one of the

      identified possible sepsis precursors as part of our

      submission for approval. The consideration was also designed

      to cover the salaries of new and existing scientists, lab

      space, materials as well as fringe and corporate overhead.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.3(b).Q1(c),(b).Q2,(c).Q3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br> -Number 5<br><br> -Paragraph 83, 84<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EVRAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Feb. 15, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Aethlon Medical Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--03-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">111,629,725<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 24,500,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000882291<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Dec. 31,
         2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document as an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, and Other.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 13. COMMITMENTS AND CONTINGENCIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 13. COMMITMENTS AND CONTINGENCIES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      LEGAL MATTERS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      From time to time, claims are made against us in the ordinary

      course of business, which could result in litigation. Claims

      and associated litigation are subject to inherent

      uncertainties and unfavorable outcomes could occur, such as

      monetary damages, fines, penalties or injunctions prohibiting

      us from selling one or more products or engaging in other

      activities.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The occurrence of an unfavorable outcome in any specific

      period could have a material adverse effect on our results of

      operations for that period or future periods. Other than the

      Barsell matter discussed earlier, we are not presently a

      party to any pending or threatened material legal

      proceedings.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      LEASES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In October 2009, we entered into two new leases for office

      and laboratory space. The terms of the new leases are three

      years and two years, respectively, and the initial base lease

      payments are $6,045 per month and $1,667 per month,

      respectively.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On October 4, 2011 we entered into an amendment to extend our

      lease for our laboratory by an additional three years. The

      amendment also included additional tenant improvements in the

      approximate amount of $30,000.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14435-108349<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 14<br><br> -Paragraph 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 9, 10, 11, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQLAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Government contract revenue</a></td>
        <td class="nump">$ 958,075<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 958,075<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
        <td class="nump">427,419<span></span></td>
        <td class="nump">386,828<span></span></td>
        <td class="nump">1,037,613<span></span></td>
        <td class="nump">889,161<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Payroll, consulting and related services</a></td>
        <td class="nump">487,959<span></span></td>
        <td class="nump">534,747<span></span></td>
        <td class="nump">1,553,514<span></span></td>
        <td class="nump">2,350,825<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">384,025<span></span></td>
        <td class="nump">125,126<span></span></td>
        <td class="nump">623,712<span></span></td>
        <td class="nump">378,701<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">1,299,403<span></span></td>
        <td class="nump">1,046,701<span></span></td>
        <td class="nump">3,214,839<span></span></td>
        <td class="nump">3,618,687<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
        <td class="num">(341,328)<span></span></td>
        <td class="num">(1,046,701)<span></span></td>
        <td class="num">(2,256,764)<span></span></td>
        <td class="num">(3,618,687)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_OtherExpenseIncomeAbstract', window );"><strong>OTHER EXPENSE (INCOME)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">963,018<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,189,942<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Loss on settlement of accrued interest and damages</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">68,703<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">(Gain) on change in fair value of derivative liability</a></td>
        <td class="num">(74,940)<span></span></td>
        <td class="num">(430,077)<span></span></td>
        <td class="num">(1,596,442)<span></span></td>
        <td class="num">(2,098,954)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest and other debt expenses</a></td>
        <td class="nump">308,386<span></span></td>
        <td class="nump">594,128<span></span></td>
        <td class="nump">2,594,526<span></span></td>
        <td class="nump">3,346,247<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
        <td class="num">(56)<span></span></td>
        <td class="num">(5,599)<span></span></td>
        <td class="num">(938)<span></span></td>
        <td class="num">(19,496)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(300,000)<span></span></td>
        <td class="nump">360,185<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense (income)</a></td>
        <td class="nump">233,390<span></span></td>
        <td class="nump">821,470<span></span></td>
        <td class="nump">1,357,331<span></span></td>
        <td class="nump">4,486,442<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
        <td class="num">$ (574,718)<span></span></td>
        <td class="num">$ (1,868,171)<span></span></td>
        <td class="num">$ (3,614,095)<span></span></td>
        <td class="num">$ (8,105,129)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">BASIC AND DILUTED LOSS PER COMMON SHARE (in Dollars per share)</a></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="num">$ (0.03)<span></span></td>
        <td class="num">$ (0.04)<span></span></td>
        <td class="num">$ (0.12)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING &#x2013; BASIC AND DILUTED (in Shares)</a></td>
        <td class="nump">107,061,316<span></span></td>
        <td class="nump">70,918,490<span></span></td>
        <td class="nump">98,202,051<span></span></td>
        <td class="nump">67,991,430<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_OtherExpenseIncomeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_OtherExpenseIncomeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of its extinguishment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12355-112629<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 26<br><br> -Paragraph 20, 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12317-112629<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainsLossesOnExtinguishmentOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 34<br><br> -Paragraph 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestAndDebtExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestAndOtherIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LaborAndRelatedExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 7<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for incremental, external costs directly pertaining to an early extinguishment of debt, including legal costs and prepayment penalties, and excluding interest and repayment of debt principal.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfDebtExtinguishmentCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 946<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 946<br><br> -SubTopic 225<br><br> -Section 45<br><br> -Paragraph 3<br><br> -Subparagraph (k)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6488370&amp;loc=d3e13550-115849<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfessionalFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 1<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenuesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 171<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 7. ACCRUED LIQUIDATED DAMAGES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_AccruedLiquidatedDamagesDisclosureText', window );">Accrued Liquidated Damages Disclosure Text</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 7. ACCRUED LIQUIDATED DAMAGES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We account for contingent obligations to make future payments

      or otherwise transfer consideration under a registration

      payment arrangement separately from any related financing

      transaction agreements, and any such contingent obligations

      are recognized only when it is determined that it is probable

      that we will become obligated for future payments and the

      amount, or range of amounts, of such future payments can be

      reasonably estimated.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We have entered into registration payment arrangements in

      connection with certain financing arrangements that require

      us to register the shares of common stock underlying the

      convertible debt and warrants issued in these financing

      transactions. Under these agreements we are liable for

      liquidated damages to the investors if we fail to file and/or

      maintain effective registration statements covering the

      specified underlying shares of common stock.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Since we have either failed to file, or failed to maintain

      the registration obligations under these agreements, as of

      December 31, 2011 and March 31, 2011 we have accrued

      estimated aggregate liquidated damages of $437,800 in

      connection with the liquidated damage provisions of these

      agreements, which we believe represents our maximum exposure

      under these provisions.&#160;&#160;Accordingly, we do not

      expect to accrue any further liquidated damages in connection

      with these agreements.&#160;&#160;The actual amount of

      liquidated damages paid, if any, may differ from our

      estimates as it is our intention to negotiate with the

      investors the settlement of liquidated damages due and, as

      such, the ultimate amounts we may actually pay may be less

      than the amount currently accrued.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_AccruedLiquidatedDamagesDisclosureText">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accrued Liquidated Damages Disclosure Text</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_AccruedLiquidatedDamagesDisclosureText</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 6. EQUITY TRANSACTIONS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 6. EQUITY TRANSACTIONS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the nine months ended December 31, 2011, we issued

      24,413,568 shares of restricted common stock in exchange for

      the partial or full conversion of principal and interest of

      several convertible notes payable in an aggregate amount of

      $1,806,879 at an average conversion price of $0.07 per share

      based upon the conversion formulae in the respective notes.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the nine months ended December 31, 2011, we issued

      3,292,029 shares of stock to service providers for services

      valued at $328,327 based upon the fair value of the shares

      issued. Of that aggregate number, 2,864,488 shares of common

      stock were issued to consultants pursuant to our S-8

      registration statements covering our Amended and Restated

      2003 Consultant Stock Plan or 2010 Stock Incentive Plan for

      services valued at $272,077 based upon the fair value of the

      shares issued. The services were for regulatory affairs,

      primarily managing our hepatitis C trial in India, and

      corporate communications.&#160;&#160;The average issuance

      price on the S-8 issuances was approximately $0.09 per share.

      Additionally, we issued 427,541 restricted shares of common

      stock to service providers for investor relations valued at

      $56,250 based upon the fair value of the shares issued. The

      average issuance price on the restricted share issuances was

      approximately $0.13 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the nine months ended December 31, 2011, we issued

      3,699,914 shares of restricted common stock related to net

      warrant cashless exercises.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In May 2011, we agreed to modify three warrants held by an

      institutional investor as the result of antidilution

      protection.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In May 2011, our Board ratified a six month consulting

      agreement with a consultant to provide public relations and

      corporate communications services. We agreed to pay the

      consultant a monthly fee of $1,500 in cash and a one-time

      stock-based payment of six months&#8217; worth of shares

      based upon a rate of $5,000 per month, or a total of $30,000,

      to be paid in restricted stock. Based upon the closing price

      of the date of the approval by our Board, the one-time

      restricted share payment was in the amount of 200,000

      restricted shares.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph d<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 1<br><br> -Section B<br><br> -Paragraph 7, 11A<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 21: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 22: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 23: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 13. NOTE RECEIVABLE<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 14. NOTE RECEIVABLE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On July 15, 2010, we received two Secured Trust Deed Notes to

      us (the "Trust Notes") each in the principal amount of

      $200,000 in connection with our issuance of a $890,000

      principal amount 6% convertible promissory note to one

      accredited investor (See Note 5).&#160;&#160;The Trust Notes

      bear interest payable to us at five percent per annum and

      have maturity dates of September 15, 2011 and November 15,

      2011. We recognize interest income on the Investor Note and

      Trust Notes as it is earned under the terms of the notes. The

      Investor Note and Trust Notes have prepayment options.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In February 2011, the investor paid the initial $200,000

      amount to us along with related accrued interest of

      $5,945.&#160;&#160;During the three months ended June 30,

      2011, the investor paid the second $200,000 amount to us

      along with accrued interest of $7,863. As a result, we no

      longer show a note receivable on our condensed consolidated

      balance sheet as of December 31, 2011.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for claims held for amounts due a company. Examples include trade accounts receivables, notes receivables, loans receivables.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6965416&amp;loc=d3e5066-111524<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 9<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 01-6<br><br> -Paragraph 13<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6965416&amp;loc=d3e5162-111524<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 3, 4<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.3,4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph k<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6965416&amp;loc=d3e5074-111524<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 10. STOCK COMPENSATION<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Shareholders' Equity and Share-based Payments [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 10. STOCK COMPENSATION

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following table summarizes share-based compensation

      expenses relating to shares and options granted and the

      effect on basic and diluted loss per common share during the

      three and nine months ended December 31, 2011 and 2010:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Three Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Three Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2011

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2011

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2010

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 40%; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Total share-based compensation expense

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 10%; border-bottom: Black 2.5pt double; text-align: right">

          161,440

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 10%; border-bottom: Black 2.5pt double; text-align: right">

          252,740

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 10%; border-bottom: Black 2.5pt double; text-align: right">

          609,503

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 10%; border-bottom: Black 2.5pt double; text-align: right">

          1,599,915

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Total share-based compensation expense included in net

          loss

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          161,440

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          252,740

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          609,503

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          1,599,915

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Basic and diluted loss per common share

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.00

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.01

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.01

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.02

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following table breaks out the components of our

      share-based compensation expenses relating to shares and

      options granted and the effect on basic and diluted loss per

      common share during the three and nine months ended December

      31, 2011 and 2010.

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Three Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Three Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2011

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2011

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31, 2010

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 40%; padding-left: 10pt; text-indent: -10pt">

          Vesting of stock options

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 10%; text-align: right">

          64,773

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 10%; text-align: right">

          153,898

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 10%; text-align: right">

          319,503

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 10%; text-align: right">

          875,171

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          Incremental fair value of option modifications

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          2,175

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          499,188

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-left: 10pt; text-indent: -10pt">

          Vesting expense associated with CEO restricted stock

          grant

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          96,667

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          96,667

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          290,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          225,556

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">

          Direct stock grants

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          &#8212;

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Total share-based compensation expense

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          161,440

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          252,740

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          609,503

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          1,599,915

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Total share-based compensation expense included in net

          loss

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          161,440

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          252,740

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          609,503

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          1,599,915

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Basic and diluted loss per common share

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.00

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.01

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.01

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (0.02

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We did not issue any stock options during the three and nine

      months ended December 31, 2011. All of the stock-based

      compensation expense recorded during the nine months ended

      December 31, 2011 and 2010, which totaled $609,503 and

      $1,599,915, respectively, is included in payroll and related

      expense in the accompanying condensed consolidated statements

      of operations.&#160; Stock-based compensation expense

      recorded during the three months ended December 31, 2011 had

      no impact on basic and diluted loss per common share and the

      stock-based compensation expense recorded during the three

      months ended December 31, 2010 increased basic and diluted

      loss per common share by $0.01. Stock-based compensation

      expense recorded during the nine months ended December 31,

      2011 increased basic and diluted loss per common share by

      $0.01 and the stock-based compensation expense recorded

      during the nine months ended December 31, 2010 increased

      basic and diluted loss per common share by $0.02.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We review share-based compensation on a quarterly basis for

      changes to the estimate of expected award forfeitures based

      on actual forfeiture experience. The cumulative effect of

      adjusting the forfeiture rate for all expense amortization is

      recognized in the period the forfeiture estimate is changed.

      The effect of forfeiture adjustments for the nine months

      ended December 31, 2011 was insignificant.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The expected volatility is based on the historic volatility.

      The expected life of options granted is based on the

      "simplified method" as described in the SEC's guidance due to

      changes in the vesting terms and contractual life of current

      option grants compared to our historical grants.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Options outstanding that have vested and are expected to vest

      as of December 31, 2011 are as follows:

    </p><br/><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15pt; border-collapse: collapse">

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Weighted

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Weighted

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Average

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Average

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Remaining

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Number of

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Exercise

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Contractual

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          Shares

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          Price

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          Term in Years

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 61%; line-height: 115%">

          Vested

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 10%; line-height: 115%; text-align: right">

          17,562,026

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 10%; line-height: 115%; text-align: right">

          0.33

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 10%; line-height: 115%; text-align: center">

          6.18

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Expected to vest

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          2,116,667

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: right">

          0.25

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          8.75

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="padding-left: 0.25in; line-height: 115%">

          Total

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          19,678,693

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, there was approximately $969,836 of

      unrecognized compensation cost related to share-based

      payments, including the restricted stock grant, which is

      expected to be recognized over a weighted average period of

      1.08 years.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On December 31, 2011, our stock options had a negative

      intrinsic value since the closing price on that date of $0.05

      per share was below the weighted average exercise price of

      our stock options

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In July 2011, our Board ratified a one year consulting

      agreement with a consultant to provide corporate advisory

      services. We agreed to pay the consultant a monthly fee of

      $5,000 in common stock.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Also includes disclosure of compensation-related costs for equity-based compensation which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details, and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 8. OTHER CURRENT LIABILITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 8. OTHER CURRENT LIABILITIES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011 and March 31, 2011, our other current

      liabilities were comprised of the following items:

    </p><br/><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.1pt; border-collapse: collapse">

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          December 31,

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          March 31,

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          2011

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          2011

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 72%; line-height: 115%">

          Accrued interest

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 11%; line-height: 115%; text-align: right">

          734,282

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 11%; line-height: 115%; text-align: right">

          525,336

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="line-height: 115%">

          Accrued legal fees

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          240,242

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          236,902

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="line-height: 115%">

          Deferred rent

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          5,324

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          5,784

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="line-height: 115%">

          Other

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          42,588

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          36,364

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 0.25in; line-height: 115%">

          Total other current liabilities

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          1,022,436

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          804,386

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As of the date of this report, various promissory and

      convertible notes payable in the aggregate principal amount

      of $1,792,210 (as identified in Notes 4 and 5 above) have

      reached maturity and are past due. We are continually

      reviewing other financing arrangements to retire all past due

      notes. At December 31, 2011, we had accrued interest in the

      amount of $639,958 associated with these defaulted notes in

      accrued liabilities payable, which are included in the

      accrued interest numbers noted above (see Notes 4 and 5).

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for other liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20, 24<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20,24)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 9. FAIR VALUE MEASUREMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 9. FAIR VALUE MEASUREMENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We follow FASB ASC 820, "FAIR VALUE MEASUREMENTS AND

      DISCLOSURES" (&#8220;ASC 820&#8221;) in connection with

      financial assets and liabilities measured at fair value on a

      recurring basis subsequent to initial recognition. The

      guidance applies to our derivative liabilities.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      ASC 820 requires that assets and liabilities carried at fair

      value will be classified and disclosed in one of the

      following three categories: We measure the fair value of

      applicable financial and non-financial assets based on the

      following fair value hierarchy:

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Level 1: Quoted market prices in active markets for identical

      assets or liabilities.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Level 2: Observable market based inputs or unobservable

      inputs that are corroborated by market data.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Level 3: Unobservable inputs that are not corroborated by

      market data.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The hierarchy noted above requires us to minimize the use of

      unobservable inputs and to use observable market data, if

      available, when determining fair value.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The fair value of our recorded derivative liabilities is

      determined based on unobservable inputs that are not

      corroborated by market data, which is a Level 3

      classification. We record derivative liabilities on our

      balance sheet at fair value with changes in fair value

      recorded in our consolidated statements of operations.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Our fair value measurements at the December 31, 2011

      reporting date are classified based on the valuation

      technique level noted in the table below:

    </p><br/><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          Description

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          December 31,<br />

          2011

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          Quoted Prices<br />

          in<br />

          Active Markets for<br />

          Identical Assets<br />

          (Level 1)

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          Significant<br />

          Other<br />

          Observable<br />

          Inputs<br />

          (Level 2)

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          Significant<br />

          Unobservable Inputs<br />

          (Level 3)

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 44%; line-height: 115%">

          Derivative Liabilities

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          1,250,705

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          --

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          --

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="width: 11%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          1,250,705

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Total

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          1,250,705

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          --

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          --

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          1,250,705

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Prior to the third fiscal quarter ended December 31, 2010

      (&#8220;Q3 2011&#8221;), the fair value estimate relating to

      an aggregate of 25,066,944 warrants classified as derivative

      liabilities had been based on a Black-Scholes valuation

      model.&#160;&#160;During Q3 2011, we changed to a binomial

      lattice model for valuation of these warrants as we

      determined that use of a binomial lattice model was more

      representative of fair value in the circumstances. In

      accordance with accounting guidance in ASC 820-10, Fair Value

      Measurements and Disclosures, this was accounted for as a

      change in accounting estimate.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following outlines the significant weighted average

      assumptions used to estimate the fair value information

      presented, in connection with our April 2011 convertible

      notes, July &amp; August 2011 10% convertible notes and the

      September 2011 convertible notes and with respect to warrant

      and embedded conversion option derivative instruments

      utilizing the Binomial Lattice option pricing model:

    </p><br/><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">

      <tr style="vertical-align: top">

        <td style="width: 50%; border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="width: 50%; border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          Nine Months Ended December 31, 2011

        </td>

      </tr>

      <tr style="vertical-align: top; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Risk free interest rate

        </td>

        <td style="line-height: 115%; text-align: center">

          0.02% - 2.24%

        </td>

      </tr>

      <tr style="vertical-align: top; ">

        <td style="line-height: 115%">

          Average expected life

        </td>

        <td style="line-height: 115%; text-align: center">

          0.25 - 5 years

        </td>

      </tr>

      <tr style="vertical-align: top; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Expected volatility

        </td>

        <td style="line-height: 115%; text-align: center">

          51.9% - 128.5%

        </td>

      </tr>

      <tr style="vertical-align: top; ">

        <td style="line-height: 115%">

          Expected dividends

        </td>

        <td style="line-height: 115%; text-align: center">

          None

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The table below sets forth a summary of changes in the fair

      value of our Level 3 financial instruments for the nine

      months ended December 31, 2011:

    </p><br/><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">

        <td style="width: 21%; line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="width: 9%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          April 1,<br />

          2011

        </td>

        <td style="width: 3%; line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="width: 13%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          Recorded<br />

          New Derivative<br />

          Liabilities

        </td>

        <td style="width: 3%; line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="width: 14%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          Change in<br />

          estimated fair<br />

          value recognized<br />

          in results<br />

          of operations

        </td>

        <td style="width: 3%; line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="width: 12%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          Reclassification<br />

          of Derivative<br />

          Liability to<br />

          Paid in<br />

          capital

        </td>

        <td style="width: 5%; line-height: 115%; padding-bottom: 1pt">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;<br />

          &#160;

        </td>

        <td style="width: 17%; line-height: 115%; text-align: center; border-bottom: Black 1pt solid">

          &#160;<br />

          &#160;<br />

          &#160;<br />

          December 31,<br />

          2011

        </td>

      </tr>

      <tr style="vertical-align: top">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: top; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Derivative liabilities

        </td>

        <td style="line-height: 115%; text-align: center">

          $ 2,002,896

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          $ 1,107,940

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          ($ 1,596,442)

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          ($ 263,689)

        </td>

        <td style="line-height: 115%; text-align: center">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          $1,250,705

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The fair value of derivative liabilities that we recorded in

      the nine months ended December 31, 2011 was related to our

      April 2011 convertible note, July &amp; August 2011 10%

      convertible notes and the September 2011 convertible note

      offerings (see Note 5) and was based upon an

      independent&#160;valuation report.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The table below sets forth a summary of changes in the fair

      value of our Level 3 derivative liabilities for the nine

      months ended December 31, 2010:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Fair Value at<br />

          March 31, 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Recorded Fair<br />

          Value of<br />

          Derivative<br />

          Liabilities<br />

          in the nine month period ended December 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Change in<br />

          Estimated Fair<br />

          Value Recognized<br />

          in Results of<br />

          Operations

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Fair Value at<br />

          December 31, 2010

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 36%; padding-bottom: 2.5pt">

          Derivative liabilities

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right">

          1,054,716

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right">

          6,980,347

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right">

          (2,098,954

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="width: 3%; padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right">

          5,936,109

        </td>

        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The fair value of derivative liabilities that we recorded in

      the nine months ended December 2010 was related to the

      restructuring of the Amended and Restated Convertible Notes

      and to the embedded derivatives and associated warrants

      related to a number of our convertible note offerings (see

      Note 5) and was based upon an independent&#160;valuation

      report.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19296-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 159<br><br> -Paragraph 17-22, 27, 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15C, 15D<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13504-108611<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15A<br><br> -Subparagraph a-d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13537-108611<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 44A, 44B<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19207-110258<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 3, 10, 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15B<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32, 33, 34<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 11. WARRANTS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 11.&#160;&#160;WARRANTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      A summary of warrant activity during the nine months ended

      December 31, 2011 is presented below:

    </p><br/><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.05pt; border-collapse: collapse">

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right; padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">

          Amount

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: Black 1pt solid">

          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">

            <b>Range of Exercise</b>

          </p>

          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">

            <b>Price</b>

          </p>

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: Black 1pt solid">

          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">

            <b>Weighted Average</b>

          </p>

          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">

            <b>Exercise</b>

          </p>

          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">

            <b>Price</b>

          </p>

        </td>

        <td style="line-height: 115%; padding-bottom: 1pt">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 61%; line-height: 115%">

          Warrants outstanding at March 31, 2011

        </td>

        <td style="width: 1%; line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 10%; line-height: 115%; text-align: right">

          38,675,169

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 10%; line-height: 115%; text-align: center">

          0.15 - $0.50

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 10%; line-height: 115%; text-align: center">

          $0.31

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Exercised

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          (1,209,623

        </td>

        <td style="line-height: 115%">

          )

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: center">

          0.231

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Issued

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          22,914,533

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: center">

          0.10 - $0.125

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Cancelled/Expired

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          (4,428,757

        </td>

        <td style="line-height: 115%">

          )

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: center">

          0.17 - $0.50

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Warrants outstanding at December 31, 2011

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          55,951,322

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: center">

          0.10 - $0.25

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          $0.15

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Warrants exercisable at December 31, 2011

        </td>

        <td style="line-height: 115%; text-align: right">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          55,951,322

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: center">

          0.10 - $0.25

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: center">

          $0.15

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following outlines the significant weighted average

      assumptions used to estimate the fair value information

      presented, with respect to warrants utilizing the Binomial

      Lattice option pricing model at, and during the nine months

      ended December 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 60%">

          Risk free interest rate

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 18%; text-align: center">

          0.10% - 2.24%

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Average expected life

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center">

          0.78 - 5 years

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td>

          Expected volatility

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center">

          82.1% - 86.6%

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Expected dividends

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center">

          None

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number D-98<br><br> -Paragraph 2<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph i<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 16. SUBSEQUENT EVENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Note 16. SUBSEQUENT EVENTS

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Management has evaluated events subsequent to December 31,

      2011 through the date that the accompanying condensed

      consolidated financial statements were filed with the

      Securities and Exchange Commission for transactions and other

      events which may require adjustment of and/or disclosure in

      such financial statements.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In January 2012, we shipped a diagnostic product that

      isolated exosomes from blood serum to a life sciences company

      and invoiced them for $1,432. We received payment in full

      under that invoice in February 2012. This represents our

      first commercial sale, which will be recorded in the March

      2012 quarter.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the period January 1, 2012 through February 15, 2012,

      we issued 2,255,188 shares of restricted common stock in

      exchange for the partial or full conversion of principal and

      interest of several convertible notes payable in an aggregate

      amount of $111,795 at an average conversion price of $0.05

      per share based upon the conversion formulae in the

      respective notes.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the period January 1, 2012 through February 15, 2012,

      we issued 109,529 shares of common stock to a service

      provider for services valued at $7,667 based upon the fair

      value of the shares issued. All of those shares were issued

      pursuant to our S-8 registration statements covering our

      Amended and Restated 2003 Consultant Stock Plan or 2010 Stock

      Incentive Plan. The services were for exosome-related

      research.&#160;&#160;The issuance price on the S-8 issuance

      was approximately $0.07 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the period January 1, 2012 through February 15, 2012,

      we issued 287,500 shares of restricted common stock as a

      patent license payment valued at $17,250.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ECZAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CashFlowsFromOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (3,614,095)<span></span></td>
        <td class="num">$ (8,105,129)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">13,858<span></span></td>
        <td class="nump">14,301<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
        <td class="nump">609,503<span></span></td>
        <td class="nump">1,599,915<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,189,942<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Fair market value of conditional warrants that subsequently were issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">74,652<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non cash interest expense</a></td>
        <td class="nump">538,736<span></span></td>
        <td class="nump">1,696,055<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Fair market value of common stock, warrants and options issued for services</a></td>
        <td class="nump">328,327<span></span></td>
        <td class="nump">590,734<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivative liabilities</a></td>
        <td class="num">(1,596,442)<span></span></td>
        <td class="num">(2,098,954)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_IssuanceOfNoteInConvertibleNoteTermination', window );">Issuance of note in convertible note termination</a></td>
        <td class="nump">360,186<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and deferred financing costs</a></td>
        <td class="nump">1,703,219<span></span></td>
        <td class="nump">1,301,014<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
        <td class="num">(183,367)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
        <td class="nump">10,557<span></span></td>
        <td class="nump">52,260<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other current liabilities</a></td>
        <td class="nump">728,432<span></span></td>
        <td class="nump">152,246<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Due to related parties</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(1,101,086)<span></span></td>
        <td class="num">(1,512,964)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CashFlowsFromInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
        <td class="num">(1,735)<span></span></td>
        <td class="num">(2,541)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Additions to patents and patents pending</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6,805)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
        <td class="num">(1,735)<span></span></td>
        <td class="num">(9,346)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CashFlowsFromFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal repayments of notes payable</a></td>
        <td class="num">(15,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from the issuance of convertible notes payable</a></td>
        <td class="nump">1,256,921<span></span></td>
        <td class="nump">1,105,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">283,600<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of secured notes receivable</a></td>
        <td class="nump">200,000<span></span></td>
        <td class="nump">300,000<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">1,441,921<span></span></td>
        <td class="nump">1,688,600<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Net increase in cash</a></td>
        <td class="nump">339,100<span></span></td>
        <td class="nump">166,290<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at beginning of period</a></td>
        <td class="nump">15,704<span></span></td>
        <td class="nump">67,950<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at end of period</a></td>
        <td class="nump">354,804<span></span></td>
        <td class="nump">234,240<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
        <td class="nump">3,636<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Derivative liabilities recorded in connection with embedded conversion feature of convertible notes and/or warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,980,347<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_DebtAndAccruedInterestConvertedToCommonStock', window );">Debt and accrued interest converted to common stock</a></td>
        <td class="nump">1,812,386<span></span></td>
        <td class="nump">1,075,550<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd', window );">Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants</a></td>
        <td class="nump">1,037,901<span></span></td>
        <td class="nump">1,708,600<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees', window );">Issuance of convertible notes in settlement of accrued legal fees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">35,469<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity', window );">Reclassification of warrant derivative liability into equity</a></td>
        <td class="nump">263,689<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of shares in connection with restricted stock grant to officer</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 600<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CashFlowsFromFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CashFlowsFromFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CashFlowsFromInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CashFlowsFromInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CashFlowsFromOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CashFlowsFromOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_CashPaidDuringThePeriodForAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_CashPaidDuringThePeriodForAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_ChangesInOperatingAssetsAndLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_DebtAndAccruedInterestConvertedToCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt and accrued interest converted to common stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_DebtAndAccruedInterestConvertedToCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_DebtDiscountRecordedInConnectionWithBeneficialConversionFeatureOfConvertibleNotesAnd</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance of convertible notes in settlement of accrued legal fees</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_IssuanceOfConvertibleNotesInSettlementOfAccruedLegalFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_IssuanceOfNoteInConvertibleNoteTermination">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance of note in convertible note termination</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_IssuanceOfNoteInConvertibleNoteTermination</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification of warrant derivative liability into equity</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aemd_ReclassificationOfWarrantDerivativeLiabilityIntoEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aemd_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of interest expense representing the noncash expenses charged against earnings in the period to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include Noncash Interest Expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCostsAndDiscounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrestricted cash available for day-to-day operating needs, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) in cash, excluding cash equivalents, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet. For example, an entity that aggregates cash equivalents with investments discloses the balance of cash excluding cash equivalents on the balance sheet and the change in cash excluding cash equivalents on the statement of cash flows. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Beneficial Conversion Feature<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 98-5<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 00-27<br><br> -Paragraph 56<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of its extinguishment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12355-112629<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 26<br><br> -Paragraph 20, 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12317-112629<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainsLossesOnExtinguishmentOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 27<br><br> -Subparagraph f<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaidNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or  income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 27<br><br> -Subparagraph e<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaidNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The fair value of restricted stock or stock options granted to nonemployees as payment for services rendered or acknowledged claims.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other expenses or losses included in net income that result in no cash outflows or inflows in the period and are not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNoncashExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromCollectionOfNotesReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromConvertibleDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 20<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>34
<FILENAME>0001019687-12-000580-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001019687-12-000580-xbrl.zip
M4$L#!!0````(`"]64$#D9]L6BZ(``"?5!0`1`!P`865M9"TR,#$Q,3(S,2YX
M;6Q55`D``XHE/4^*)3U/=7@+``$$)0X```0Y`0``Y%WK<^,VDO]^5?<_\&:W
M4I,JR^93)#V.JS26G=5E8CNV9Y-\VH)(2.(.'PI!VM;^]=<-DA)?DB"1SDSJ
MIBJQ38+H7S?ZA28`7OS/8"#]2$,:DX2ZTG0E>5?OD^![:2!=1<'RT?&D29C`
M72?QGBE<"Y]I#'_#_462+,_/SEY>7DX=:,H<+Z8L2F.',KP@#0:7$O[[[_^Z
M0")7,442Y]+3(I5NZ%12AI)BG&OZN:9)GY^N)%56U.PA>.)U&OO2:^"'[(=W
M)4)X^32*YV>J+&MG7L@2$CKT7=;R'.]Z![9W-P^4&P_/LIM%TY0-DM62;M#,
M")ORQL4=>$I1!K(RT)3B(=\+O^R`@[>GA&W@^#L:__8)6I?0S`E9MH+!&RU8
M/!;IJF+NDD[6HGB`T,"MM"8T6?A1&%#7<XB/0\S)*.J&B$MKTF34.9U'SV=P
MHP73:T-`+QK'H]BV?<;OKINRMG:`6SG[[>=/C\Z"!F2P'E^N0Y)T@3V<,W[S
M@<XDWN,YCM8/[Y@7+'T4/;^VB.GLAW?(\J#@Z?25N>_.+K..G`B,X#61/!")
M(_]KQ.YFFC*F#C9^=YEI.?[_@H:)EZPNUQ?@DN?BQ9D'1L.AT`HGA82N)C^]
MNY3AGV6IJJU<G&T>*_=_MB%07%K2V(O<*DDNB.22BUQ10>079\6U=4^;YS(>
MSW(FBYZJ3"LYTS^3^*_`M*SUP;3ZKYLX"I0[)\%.GZ)O><R!T3@9@XO-1UT&
M6[LXVUR5I')K&KJEMIF&%->.%):6"6NTC/]RPI+U/UM8>EFSY(VPY&]=6/(!
MFB7W)"RCK%E_+6&):U9?PAI6'/6W***2HY9[<M1F)21_\TSW$Y(MSK1B0#*-
MN?.WS;0ZD-6!8G1FVLY&6GZDR[_"2,OV0)./83H-O8SC%-+03?\7`24LC>EE
MGJV??WX<7YP5%Z5-?_A\Z>]R=_<T?ER0&-/DO%/7>P:.*US@`[=I@//"*+[<
MW!"!L.[DK-Y+M?\Q#:/`"XM[;33XE.Z<(5S6PN>&2KVOM:0WO.V13$9D(Y0]
M$-H[R^9?YU>$+22\]X#S"AQ"*1]@?J$QA9!<ZG@!\6&6`RJM&;HEZQ=GY=Z.
M(%)/V:M$%,-LI5$A,:8S&L?4O0')PL3J*F()NZ7)\:PIMF;J]H;L%@*7/0#9
MR[ZIJ8<#&3E.E(8)>Z`.]9[)U*?0ZBJ%1\,N8K$T;6ANT.RBTH!T&R64C4+W
M4T3"@W'MEI**3E'>X-I+J@&.5X\H2S:-CT=CRO9P@Z79\V65]'U,E\1SKU^7
M-&044-\E"QJ/&*,).WZHU*%JE"2RB\BEU`^@/6-DFXIR'*#L:F?M-0U+,4LR
MJ73;M"!1HKO9UA59U351HO=Q!"$W6=W[$(9!*-=_I-XR@):=O)EJ:$99\MMI
M-%3S.#A[[,.TCH,#ID3"N0<FE$D16ER_.G[J>N'\QRAR7SS?[^#<-$V1K8KA
M[J76#$5=,>X)!YIM6TI7C&.ZC)B7L*X^QE85N1R:RKVVA$91HKM%<!#1SAS*
MFJPVK+<IT:Y,&4-356P!.GG`O2<KC"2=7>)0TV5+;0;T:O^774'L9EZ3+5W1
M#@0Q3NE3]$!]?%ES3^+$H]T#Q%`QC7*`V$ZCQ::.PK-;,%WP\!2H+S4Q+-TL
MYS0MG;<D_@="V./Y[)84;R^$_$4@.LA>!:+J0]522U%L-Z&&7SH>UYXD2[$4
MRU"/QC6&^?XSP7>HGSPR]7RO%[M2(!4U9:/LM;>3:0M7QX':.V=0K;)2'P8J
M2U<=)TZIVZ>L=,VTRGJ^FTX]4SX>U9XLMCNJ7A5*5B&I'M;P"`];GY*Q9%VS
MQ)!4@/0I#E,&@2BE*HF()/H4PM#055LQ#P-P%06!EV"FCU-U<%0))*TT=."9
M@T3QRLY#S__A70+*B&_">Z+3X%B$3A0^)I'SY9_$3W<6$/:IMV5;<MF)5WON
M1GO?Y$P?VKM);Z,,*<E=_)A@=L+;%@7<"IAU55=8(-J[2_E4EI564-MH[A11
M%Z`[I-<_4-Z"C=)D$<7>?ZB[`9A7@86%.+F]P3J`+-<J93N(]8ELA]3>!MF$
ML;2SO-`.3=,H%P6V$+KL`\X^(:%IFMJP7;^J:/8+Z"Y-\%T/%@K^!"F5J.T3
ME3BP'N15P=6<;;LNA+`H)/X]\=Q)>$667D(ZE)ATPQK:5J4&V4ZB'S![<CI5
M5RS3M(X!,Z;/U(]XF0Y\VIQ>8Y%[&7N,CNG,<[P$<L,T2/E,=9S&(-[Z$QTF
MHZIL#65=*6?N7='4BPMORMZ>88&YMF+KQANRQPU@$?DNC1F66Y/5\:,Q&"HR
MX"V-1K/W%@4Z#,)NB0T,VS3`K@Z$4,I1(2_L4R;UJN$^2I?]`3NLS'@@L`=0
MJS#=G39O7XM8DY%AR69)R8N^&PFF"-'M:_J.)'H?1S/*&/>%-[0?CG75U,O"
MK]-H9C6'H-B^4J]6;+6&EFJ]%0K1@5!DS1R6:[ZM,(['L7TI7FWV;MG*4#E$
M&I_(-(K!6/(R;/[^LA?]L$S;*!MG*Z6ZKS@8CJBB&)INZN:;PQ'6&,/0C$J-
M8PN>KH!$54?5(.4MEX#%`&6;6'QH-W(#+_18$O.:8X^*I%FZ7`:VAV13QSM@
M%-4N1344=?AU,(JJW%#53$7].AA%M5`S83JA=,!XM\15;Y`SYBUZ"76*:MNZ
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M#;T+RF+5+21"F1+WEUW+5N6%;SNEYLK%`^$(3]-L75&M-X<CJF`JX#%4`?%T
M!22<]6CZ4"W/8P\&Q-_H9V&O#_TQVH53HM(=B[#R&+8M@*8S'N'ZG-:NR34X
M'=&(JHYBZVT+^5O$T[+&Y#8*HVK.U*/1:[5WI;LIMB['.0J?<"ZK#2%),PX`
M6%\Y>`0XX>F'JFF:75E*^*:XA%-;"^:)YI^'2W@P%<TP-4T1!-8#,N'$5=>M
M:CIS"#*:]#RM-4S=+$]-*A0Z`!"?S<*<33&570B.A'"`X2NZ;!MO`$%8*2Q%
M-A35%H=P3>(0](452W(^$N8YF!YX?IJ45VUL7Q4DI",J@)-/R]6&/90O>\<I
MI$HY3NTKXA32MQRG_A5Q"BEEAK-<23X,YZ_4FR_@\N@9/-N<WJ;!E,9WL\8*
M%M[+GC4S0HJ:+^LQY:&B*:4,Z"`@+8;6)R-"FIPM`Y)MQ=++`?]P/MZ,#2%%
MYVS8EBJKX-F^23:$[("S,31M6]&U_D9C3)<QD""X<`E^]RG^@N\_@BA.O/_P
MZ[V43C3+*`5W$;)M>^`Z816>N8"`E8Y8"\=$73QA#W*HWB0YA`2A'%W:*=77
M+!T,1UA8,`FV%6,_GL9R!(=2ER$17':)V_'O9K^2."9A/W594Q^6M_+L)EA_
M89)/N!S"%CW.!0S-,AO[+JID=DR(!<$(#]S0'LI&RRRS@J9:+%C+C2]V`ALH
MY'<3Q8\T?O8<\#GQE4^\H*=W?Y:FEJM/AP!H%(+Z0B\J8<.634WOB!Z/*RP]
MB=O0)F%M7]H3C?FI*#UY&%Y^`#4]D'3;JMN2B[R;9:=N0"SBKT%XPL:RO:J]
M1!A3UJJ[@`6)-[<]]X!:V`HAU,CEA3E'HX9)6DP)KFK-?D["YODB_10T:L>8
MB!!N?<=0?RP_U*(XI.7@$S3$E\\9QD[\(D#:"KM],R3L:%1U*/\9#-7VEF,2
MU-C%V,<(F:JEE\_M.0Z)D-)U94D\3U)5??@U6*IN>>_G#6.E?GX@@O8R%AY-
M!3D:'N/E?EQ]AO1Q$JZ738SP8.K>M&N@@,N5RV\AQ>DWB\>]0!<NSRE8G"LO
M<^D`O5BI\!2-G#]2+Z9;#Y/I)SY7CM$1IMVRI+H7W,+*;I0WR_2*NW[^3!]P
MAY:\2\QUDI="VCR!G(^]A2%6=$*<N+@+.1"YL!W:FK[??X@A?X#87"P9*I\R
MT<^*E8JGWD:J==O">KI<2OGWK>\2QJ4:0UM5VJ?G-7J[2@<'0!,.U)`>5H1V
M)+3-Q*FT;[(7AV3!!&T+OE:B;?MS2ASY/G6RV097B7YG"_6S!05)MV]@Z0I:
M>-5+;Z"W.(;UM*Y??ZKHNE*Q*G'R=4WN![AX+<JR*CI]/'#^&#]WMYZ6]E(:
MT6RELLU^*[667?9'(1,7X5"U.R#;A:%^VG@MXS!MHT;X<!+UL[WKNX5T56^C
MT;Z8"?=?[SEC4;P6IK4L8LH)M,_&HH`^D5>,K5U0M)R7TH72#C7:2PDCW21D
M<#];P[P.@1]IR+=0$S^[B#O_;BA)TK@7E1[:EJR5%Q\>`Z121\4.-O/J8C3S
MCJC[%`F&:F&';"FJMBZE'D*]-`R](A=V)[)I&&C6O2`OJI80*Z/8Q1[@V3`+
MH[]ZR6+'^&$F4SV$#8#TM8G6QO=\;X;R:TM">*Q-.8N^?YHDRFEJM?$D?*1)
MXM-L7T=1`*/S_C8M:P8_HJD3CHI3`2'YA#$/!))7[?/7.LTC\59@.M'^8PB$
MDVL(3E;!RW$PFI&:&W%V$DYV'$:61?!CES:C79'8(W6@95_)8"41[(0F+VZX
MU#N_YA]U>*!SOJ<S3&Y)0$6%?CG*/HHF_9Q]%4V"T'MZ<;:MVQ+5<>3P4/6T
M6HI34^3!+UGOY<<W`X5W\F/A;L!.B?\[)?%U]CT982*#XILLNWIKR*_#<4/U
M[Y@T%DPI"B2P)NZ\%J-7\BF;!^[3J>\Y-WY$=F9#]>^+U,Q*-_()8&O'-<(C
M&"$71^G&)W-A^<^`&,T(5#JX;+!T!7=BXD]"E[[^1%?"%,I?.MG:VV53A+DR
M/-`EOH@,YWCJ6LJ$R?Z.W\_8UUOKV/TS\B'DD'AUX_E@UL(4;Z,RP5HOK93X
MK2M0\'D4BPOT$10$GI/6O/"/9Y)P529?Z?JRA?:OU/=_"J,7B"^$12'$5G1N
M\9'<;NFMQ05MC/L&KHA+%XVUZHUJ/6VEE7GJPZC]HK71*O544=BB57;_4!>(
M_R\^TK2UMT;M["Z>DS!_/P]!AT6^YY)\1=@]>"CHH/KNGOC\W$)>=<6\RH_P
MTS)/@/"CC\FZ*-SO_.3#4F+)RJ<_?/='&B4?9O#DN:3(RT1Z\@((OK?T17J(
M`A*>9!=.I$?@9?9!"D@\]\)S2<X>_&X.__WMU?V0\8;_;N^>KB7E5+H=/7U^
MN);N;J2/GQ\GM]>/C]+H=BQ]'#U.'O'J_</UX_7MT^AI<G>;=U%T@@#/EKQO
M^&T:GQ6_]H]:V@"OQ>83'IRE]]DC^<WLCQ,I65`I^SVWW.)&]O.%9C^E*"[H
M%%2R&RG+?GXO>4PB4OZ15`@>N')'<K(^I1GJ*74E`(4%%_043=A>&$994I8_
MS@`=!"WBNJ!$F$<%,*$O*(18?81GLGZ*/AQ,7>,3N#[CJ3G8F>LQ7E""$"E%
M^&Y?\KT9'20+_EW>L!4**&!V<!T[E48)%Q)D_52*9E*4Q@BO.`V-(=]XOY!K
M<S3&H_NG[TBP_/`W2[?4#]+[D4N6G,TQ6,**>6SPR?L"/<QF7HAI\+U/DED4
M!\V^GJBS"",_FJ^^E]B*@0F=-(6^S!_/I.?P+'!.64V[&3#N`T>Q%*1^XBWA
M=U(`<.-T+I$Y9^\%YC8P!,\H6!?[9@&I=1708`J9'I62-3PIB;*1IBB<F"QI
MFGB.-/-\?GP(Z$$^Q+6N.&1&>3D99+R28AI$("G(=()9ZDM+?%_N^*`:,W`*
M7/#X;;*8U@P/AM"+'3S!#L-9)BK.2I0FDH\;0V`H0:GP89#<U(\BMP8%=1?"
M!\@`=&"YC$$W?60+F"7Q%U3E10H6*B4Q],#5@"6>[]=Z034%N<%S(`UG@;T&
M-$87*#T74P_$`IPTA_L?P/P2$G?\'ENF08JI?^":3`I$TQ67PN?3QU/I!KC@
M=\<P@'5[+1_?`N!S=W`S'N4&?"H]I@Z,"$,Y@YBPE,;%5&:S:FW\TR-3"JSQ
M%ZEN`2:F\T+TI#@8&3H"RTQ(W6)!4ZDW![^`D^L86[Z`PE#IA8(1@WURV8%&
M@.P7(.-,;4ZE7YLCOB"@*"R=!EZ"FRT`<_ZR<4ZR,RBE<68@UZ\T6):%,!E?
M%UXLB>IR0X9`2B`>W`6:>X`EN@ZPCH"L)/JZ!.9!#L@*-ET/3I53,+7UJ'DA
MV&V5]15XK1F@QI\@KBF*BKJGU3[^$;V`[P$']X($?0_^R,T\DVT.#`GY^:27
MH4:<%?Y[#89[PH(-+SM--D`&8NK`-3`]/KH+ZB\E``VFG925M.@';BUAU#"[
ME,*LS)EI<T5YWS^`9-$=H,ML"'CM-4ZKM[Y.])R`$"';`>'PI`>>+N+I"X&L
M+2\HH()AP"N%@H9",GYN)PV+PS4A@KD@=)*M!,)L&2Z#=2S1G\VS<Y;\576<
MH#%=HCK#V'([!P<-?_'\B1L53)5B&.E"E7\<C>X+70:`7@)FX5:[#*,DIX8]
MQ<5IB-RA>J`,X./#$'U]!@ZT-=\!B>&P/GB3#!9&4PKZ$R8+!ARCRX,LC>+&
M"TE33O`;]TJNM'-T)@TK*P#5\!!I#NX_#OG*%4P+8P)ZB"Z.6SNDD!#:W'IG
MZ]A0&IUL--#)31FX*[P"CJ4)LN:_7[A!\(H?[W'FQ2PI>W&VR-?5H&<("P=1
MZP6LQ$T=D"V0)#S_D!AXQ1!SG$V.!(F%1^9A!"[+@72'T6_"'N[2F/,+!L!X
M*1V\$S;/TCF4R1V,$.13='"%>@W"_)CZN"6DYND_1B0&J\G#$"W%B_6T`-3)
M32%$K6!&6820FBCS0[LA:N8:?_=T]?%CH?*9A6&?;!5,(S_/4D?7/X]/[SZ>
MYGQ^"TGZ$V!$3\`'/ZL5D=3EQHW9)RY&Y;_ELRGX8U9(J2I6MIY*938QI10]
M&(54*7,;2"5V,7_+DCET$:AM#7^%\3;V@@TA3*,AD<P2!C0Z_CQ*U^.OG)PL
MOFRL>=/7#2:@6+8KLA4,1[@6@='\*3"4?)"Q]\?!;Z<-0"..'!/5%9^I0&8:
M<?<%CLE/71`@1*@\W-2@UI.,*`FQAEU)50I!<!,$A:4ESC=2W>;RHB7H,1`#
M^J`#X%NP]0F'1-Q_@Q;SI_.T;2A_""DF5R2N.7CP"`'Y0G/GTB3/^0T\YE/"
M2XKK,6X9/BX4]Y3KUA8EFA*?:P);4)A,$1R&.G\_DQ@2U<(A\JCG8KT<51`=
M*^8_A:K6=+(6_0H)2NNEER!_!M,-QL6.+,/\JQHW:N;><-`2?E8!95+(TX-4
MQ0M=GNT\TVHN7?124.6I$N9LD+1"V@:JB#SD4%:4Q(@!8:YET.0+JS^8:L?2
M+(UY%E52O1,@-4,/%'$QC<(PA=',RF/2>G98-Y*?&A@`5G48('@N//@['^1:
M(MX8CK("H0%N#(`/^1[^E/R9#2;6"HHWPVHQ_Z4I]BR#DOZ7@!3`I^-CBFWI
MTOM)B%D-R.M[S!RB=+ZH]5Q)>UL==&F35L_EI\:)KQZX#)#OZMLK596&C5>K
M0#$_37[Y/!E/GG[__Q3ET.=#IH@$H#.8"X7@Z)C'<JNI>S@^:`'629`?`NYG
MGD^(8(X9SME)/HO%$\*RB`(F0_CBX)K=96HOX89.-B-.T=8O;93($W<>R`BO
MK:<QHRU^=YHR<(:,X>0V3V]?T8(HK[P@9B],D46?'_G'G7$C"&Q2]1/N*3VL
MM,P(>#]>?,MGB2Z=0JCB-$(ZYXZST=-+%'_A`LT_"X$BP.GKJP>N#DLS?Q^>
MJ(9Z(LLR>CTGC>,-N-:,?(,M2PIX:E)\9P!AXJ<'&G2J$O\[4K3^K[UWX6H<
M2=9%_XKN/M5W46L+VF^;[MFSEHNB>IBI@AJ@NJ?O66>=)=LR:%J6W'I`,;_^
M1D0^E,I,&0,&RZ`ZI_<`ME*9D9&1\?QB@&]U0);;C`R2D^JFPCB@V*2Z:I]X
M`9(Q!1.<(L2@P\_B?`*WX@2]1'3-<0<->K,8_7TR^\IS*C%>L7ME.TM]#;=Q
M'-TH1S,`5CX'*N@$`]:8XFYRN7G@C-41C<V#Y>?,)O%D"PZYD\)M(S42,DN8
MB\]FXZM6E/!_*`8-<O<22)#AAC#JDZX&]ZPI$"8^@6D5!A0P$CK"0C#-R-+@
MG<.*FPPD.+QQ:EQYQ-QI/D>NX=;</$<?+X["5XH'"#VY(+)1%C".MKA[^=<+
M%S$6_`I=D4F=/912`:6N$UEY.4]Y4DN6.^[BQY@=H0H"EV\*:%.P]>009(R_
M9#5`&G?2"5$>8);-#>@[Z-1F=SE_W7MY5<\I-E2>DU6M(2U&6%#L*?J3]`5>
MHA..'%JW/C&,(:T4MQ]YZ/P_5%[#K4CEY8[RIN2&*L;Q6>K'7*2Q.I2A<<6I
MCIO*&M.S?>7<(17\8IP0SOL^'/-%M;?B^:Y`^'_X_<I0$KX$ARV]9QJ'<?*3
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M;/)$YL1`</T/#WMN=W3HH(N.!\FX;@-ONN&6@UOF#&;`D/-3#`E?SY<X\+NV
M>SCLNZW>4*R>N=MP'-,[\`D7XY07(PU\>MJ;7J.'7%Q<(M!EXWE,",?O`0$6
M0>BG61SY*=MWK&7@]GF.QCUQ](PRKQR,Z6AGG>0M=TJ(:1T4;H#BIX)C46RE
ME5$@,8@K1#':513@$^J<.GN\Y&#>.$G+6;)0)04S&,^SNF[O"J&EQ6U>O@$*
MDMW$`3L1JI,6KZ(YVQFVO_J]QNXT*T7&('D6=`?`(M,<7XVK`=;E*_8M/.X)
M)Y'0121C$UD+JHF=)%[3M,J"\>BD\0$DA_+=+C@RN_7#&]W<Y6X,;>\+&>Q=
M726H;?MB8'G!![IG@-G<V6TLKU`Z4'#]DQ4U\6$"(+\TA7R(:VBU=(F"JL2[
M]L$`=SA$X0/49&>*RX9K+^4N+2:;8E"<6.C-5`;ELG"C[=,$32X*[[3S*PT>
ME17E8$(7XENH[`?.C60U^5AD?*3JZI/D1VN2_0SL4W@CYZ"-15<D-`V!HAZ`
MA"4O8-AFAL-04`2>=/'.`#/-)X90]!"%0O`&BL=GH!Z`R>C:3IWPYH`<1W78
M0TO$IF:IXHP%OX-EX8\E^@637-B=L-B$*91W%@G.GV8P'3,ILE>(*-(",:F"
MS(78&!-LXCSA9@,J_^B1!?JY&.OD;"\G5)J`1033&5V@5Y).?ED*VXSLS+*%
MBB!"^@01\^T&A?=;E[>2`$:P5BQ)F$L(%Z%<`]+",@=1=H\'L[@`00//=C_0
MC*P[\)OU0@#CB;0G$H_F7N*ZSZ99C"HD^>GV+GR*%\>W%BL#D[L=L`;P0"L:
MO.I01['%9"Q?D<FFTQBL47+I'>@SWE(6%.VP/0K)KX(9B2[,>4'%1TA[@ZER
M3;4L=@U5):0*2-Z>.VR-B)Y@\(7^[#[V)&KS\R&N4J[T%*SUKCWJNMW!T#5&
MXO(C==+K^#8BIT0DC%*^/`JW\!"=ZH,K,WHY('!0XH_M;-P#C*5QF,;JY6R&
MH0W"53"$1X(>:5B<@'?=4<_M#/JX+Y&?F3-=\B)8$:N>),'LRE=L61EON`O\
M<":U7/WTB'L9]Q]9RKE*,$5)#B\N5[H$J'*!LKRFOBV=`NY9U5+D"6!4!H`C
M+L"\P\0<'@V@2P2,ZG09DXO`9#2!/\<2P::@:3+_;4#)-3'<_WM@_#,ITG>$
M4=9N6W96J4B@[[,P$&6=S'S09,-4WMCQ?$Y7[/N'L,/2HD]C1E`Z30)2;307
M$JAC1,(#JVV]]304P8KB`F0^E4)VQ4S)T<23L8.EM(GBRP:SDNSR[V(,_>3H
M,C-&P@F@?[Q2(JK*-M-;BN-D*)+"Z9:67#L6QQ_Y=(%E@@5F3_DSS:($TX<9
M017.0-V1+;U\)J4,KY]PK+%WX**Y`Y3[S!3GVLHP:L?B4;.YT"SFS1H^-<.)
M9AEF/:_:.FXT!SW<I""SYT#5YRFZY!O-,<&61\QXENZ$DN3@Q!934ZQ(GX7*
MBT##$J.E6*H2^%;99ZJV0A9R/TF1JP*T"7A!F^8,IQ!(10Q=7"=LU\E7@>4-
M4NTTSDZ1CUBXEY3D/`HE4&XE\[3K'GFP$&*P%-#QC%)6(Y'_G;N=.7L6IX(S
M49GO287&-X)FD%B2[6!K]?UA-KMT`A\4:8917.CXFH>/&057((JBLJHL[&Q*
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MW1&S!#;,\#/]1N@23+@6A7E.&)`06;/D3N/A3'Y_8WX>Z?3Z."S%0ER()3-2
M^BCL&V*)1MR?7;<=+O]Z?G)Z=/+U\S'5<QV=G5[`"?Q8GX(N(XOF`4?`T+?8
M_2%V,^<!&'O-&/G0;#$YX/(PO-N/;_$<HX4%@MO#$H;C[S%Y-"]X>C,;R.+N
MVYMRU"@J\T'=&"8_Q_ABPB%9F7RHJE!S+`FLE@HW$<IF6A3J,_)D4+JKR+[&
M4O64^1:-Y!4XO=Q+DDK/NZ`7IY!"`SU0M1V6^7QV<>%\/3X';O[RY>S4N?C;
M^/RX#F>--7^@$JRE7V267U,^!\N&IUXI8#/,0!;2%1#YK&A+=U[>>$$HM$%5
M[0?FQ!M$I)??\GX0\``UA-#W-Z(&$:KM0(7UI/DN&!].T%(JZOH+EY,V)9[Q
MR(:"A7@L64<T@*E:MC:*)$(:+&"%E$XZ*=.-/>E_1X68*7'6Q)TH)BAR,H-8
MF!"[$.!XJB`H"&"8ZZK/N:`,T_=)0RQN%)5`044LLP@SEP>\]F9L$)9\P"ZK
M\B`6@[@\QBT>\QE2FF)0XY0%_V>2?8P<&_+!LG@J5OH4JHO+R8VSF-GW3AN*
M[8=0&E)OX;L\9TN9;\7JM:$*BL+V4D8W%X.@/X!)A(58C/03-`.R0"ZY%H+G
MDK+!^#K#.[DAVF:IS$+;8.:P65*_>;JQE@R]DIJD3(9W3),LWLG=`TN>*BF]
MG*9:IOI/9_X$%L:SR9#=VNV>VVGWW>&P3[,;M=UV=^1V.X>NSK=<$:/[KB8A
MDJ_CR^/3RXM:\,UOOK#_@__X/)J5DD.'%RFZ+%0J8Z=(?ULV`'.HN2*!#CL'
M^"RD.*7^UB)9!4]3FE'L?(;%5O/<4**Q4,MU\F4<E;Q(+!:;D;J/-CG%R]%3
MKWQ2-A!"1$FBX6JA[R)@P?C\Z&^$8_#Q^-?CSV=?OP`G.,?_^GI\>G%\40_V
M_(T27G/2!1.1)T8B64E(]1EP?VK>R4JF`4:%\,&BVD3*_(IB15N*H2IZ6/HI
M%\]@@HG$3-DL4DP,=CVRI8Q11EU@1N>J='M=HR_"/:JGEG)H[Z<5O3=.S6I>
M3A22;1XZ!D,PVM.?UG*C,<?<U`_#)=YYT17G"K[']$FZ]*;F)RH/W0:S[!J9
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MYUE)A'YWX+:&AX^\F39%@V?8BDZS^?=N?KLS=`_;H]W<_.>2?;]=@RGR0$5"
MOZ`Z!WW+%55>]FE%H?]&;\IU)K+)HV"]`VD25$H:^FNQQZ9/R`-G93\XVKQ&
M@Y[;ZW6?;=/6(-1+*:<-$ST7$W7;0[?;Z^\X$U5*8O8!>D%>R%,F9O1I?'+N
M_#K^_(U02C^=G(Y/CT[&GYV3TXO+\V]?%!_OMB,#4R]A%4SE\@D1V?66<?IS
M2HENKE9BK3K2179[\1U1"LV\OF;QM4$RI7(J-;S!<R_`4NN056Z4D\W4D$^<
M9"Q7<H'(=RQ?D:TH]4LH2J(_1VHO/"K>I\`DE@(/1;:VR%(1$0N-KVV8"!C[
M>]=V._V6.VSU,;2%'N\E@688%4-B()R.*/X@]!J1XX?!EB!%B'F$&I+MR4O`
M>#JI9A)OOP2-P?)D<'1\*K/N@SDKWV4I@]-KS&@E9Z9"P(G/RE3XJ$A'EJ9:
M'H@':D6Q;=F+NI:[\UG/RA>9440%<)A1QUS-M`M!AEN*H8<E9EVS8C.S.FOF
M9]2*FH53;.Q-(5\K*H'&5ARC`.$;O#QE`ZHI$Y@.BO/!D&01-5]1>8V^;<PK
MXSOO)0MQ^$,_NLJN72617R`^S3!;?V8!#X2W`E7_\&7)9T8I'^PY`5;'SW.1
M-&"#0&-'5SFPKH`JP>QO!)/`+2G.!@O$LI7K).-;0W%#*40<ND>![#,O\Y2Z
M*A[IMP0*U+D(@%"!.P.TCD'$$(J$$EM.:Y)7=?S/;R>7OZO7D//I[-RY.#[_
M]>3H^,+Y>G[VZ\G'XX_.A]^=L\N_'9\[EW\;GY8/ZO&7KY_/?C\6,:DMQZ-$
MA15E]*G\CR5<X0WNY!66^],.I;Q_O1%EX2W<6'Z*D+]EZ%M,@Q!I_0H+E&GC
MI?2DN$59[1`E]LVX+'/R5!8NJZ?>7!RO'U0>E84F>\&!?\`.I)0:K.H;5ZJ#
MV(A5OW<$*$E)W)`H,M8E\CYT4E&P#5/14>!Q>%J\0<([9^%[F)B.R#'Z:K96
ML:.R!$8*_:B*:KQP0V,1>>B9=,>46(2W$X)<:CA[[?=VTAH"S4KJ2DJRP3OO
MJX`("-Z35?-R[DBM;XA8C2R"Z")G&XFWLH^09-TRX7Q'7#(L`FDK3%OXV74\
M(]S@G[0/M[/_>]Y[6P5O\=,G76BPX\X80KTKY?D.D0/NV(TY@^VZH4IWA6]@
M&S"_!?,=BH.E,Y.R,RS=C/!=L)HEX5A7LF">$A@8UH)9\L'3\P@I<P\YA3A/
MPL"*BGN1*O&^!GK4WN1Q>Y)=^Z;853:F1$:/N/W.P4HFW(DHCO:!@G,_8"%Q
M#D5G,2$L9P>'+NAJ[E#%.2_*^+=/\^D:--=S;AG,J>]GI1P.N3HPKC!I%R4+
M'#,D"^PLDN;&YP7=^TR*^>9%9FQ>1K`MW$:@=$XD+#.+,-6'RF)\:3CP7#':
ME%JH52=?OH+!3PD[H$U]/+GX>G8!UCZ8_I_/3G_9_WSR*ZA4XXN+X\OZ)/(D
M_DT`8U!U()88AJ19\"(DU*:"Q1(N,[H3\-[$.U^38X@\@*9:HEI^U.9A@6E]
M4_H#X<#Z,B-6MQ\U_P,#\.>&BRR90BRZ$P'0D&;L_-I*J(REH(B\HK87!!\1
M\:I%0K;RM;):,0K6U++6@CY+5:4ROSGFW;"Z<LI=8\/OL8Q0HX@_X.TGW[MD
MJA2DI*35(!7X#/]!D_U$?JS-A.-*4FFG%TXY+B-/P9\%6)%-(%<B!UX0R##'
M.+VHG)[F+;+D;38H`2;R<DF;6NI1UKZRIGC*<\*PLC(QR_]%HE>91*NQZ65J
M:1T`$#X<GQY_.B$/WM'9Z:_'YQ<G9Z?.IV/9AXC]]?+DP^=C*BL#2VK\^QA^
MJ\=QOV026#JOYKYL#"%\6R7\0F$0I:I)7ARRA%][4]G;D'M!4EY3AEO/[7^I
M"Q<8_*5+LJ@1$*5A?&ZD<3.`(10O>)7"BO_#VSP8URU;?M'STRD:+SJ\ZR=/
MH^`8BQ^./LF"E-]$3P'SHJMRTN`280AN4Q1PZBY/(=2I]I`Z4];'@LL@TS<I
MH/OFWM37W+:TBYR08@"2'R;I"3@B$Z4'3%K)%$F)'\<*SY7!F?VJKXY47<J$
M1X^B'(Y9!'4XP>?'OQZ??CN&_STZ^^7TI"@D>^RDCKPPF"2!Z_S-"V]\="O!
MA$![VK]O5FK0PD#1P#_LS[T%V)@_W;=N.^+&;T6YNN*?IT1WYDQD0+<*/!"I
M:Q5PE28AR='+`1VIE=<T3PFH!36_HJ*QN-YT@*+"&;H*)<9R(2#ZSF%_Y+:&
M_3(E&?8%3RCG2C>YAF8Q-6K!-WP1X%6<)POEH2"201D)-J&A#+$7CB^.G$&K
MO]\9:1M;H&*>\S'/E3$5/!9E5E]H5@J`IAY%B&9JAZ%;GZ$*L'I8!1Y#GYHB
MP(N%"BU;`7MC\RQ01/29"5+HK/5G[B6H6U5LFA7'9<LN(0JC4BFCZCJ\#E(%
M-$4)@3D())IA',4P.DD+8TX`%/UID7^.IR00^I@"]N(S1[4.G<PRV$M#R2IG
MA"_U$@8K$[#`2%&$;!RJPF92PE;"5D,]$MC?54`UX/;*&,RZ=N\5S@T_+,(>
M5*U#B'+\)I0(CV$($B#!PC:M0=9EM1L3$5##,)XRK9;PP:E6BR_8W#T+!137
M>]'2Q'*6*\Q7JA'CM=98-8)FJ(`I*M&]%G;FN`#A(^)%S`1#D2M`.OGD#2^=
M7+E4I:BIT4]U6!8Z3UE-<,#J=C.LHD-@T(CS,);GEYUB9ORXP-/!84H7FC`^
M.;D$3`M'@-04%"0S?&T6)U)4#W^FVE,_36EX$?)C#4L8A`P;RC$Z,<K]FL5^
M:K1)6?A>)&<GE%[+K5M)E"+<Q-'`<!I:U8UE-G50R="K?2GW!-%K8@0I5?:%
M2S,085C=3JTQJ:%>HMO)(%3\`"GX$SFCR,-O[J#B1OU9.JPT/[B`WN7M%GDX
MFFHBA=IMCFP$LL5KZE$`NM=]C]X30557/0D4+66+)-P*`QQ,C3AS[%T6T%<B
MJ(PB-0GZC&UG3M2E<H\5WOBR+X)P7TCONNI>5]F*(>M<T9T,[`B\2BD;K,00
M3O05,PQARK;NO,AM3%TC8N,E5HK?5+%J/7B(%1'#_<K:X@GUGABA4%OL;MZ2
M2YP3D"6[E!%X/67G%GG*<A?8W6SS'"AH*8C5Q@OS527J@%'(^=%N?94_T1:K
MB'LJ<&5JDE>^@%6Q;&`&2(1L<77)7B'BDE:N+#4-J;1$J37Y7A+Y"G#_/<33
MV8_,!9N"((V<XGD&KR!>;Z2>**NN29R/Z0\:P5AP#.B#H=2,@PUKUX0YUNI[
M0[WJ2S03%XH]C.]'U_BT&E\M.9(*91NK4.F>PVI4([?`*TF/-2XK@[4?N[Q:
MJ(D=VS:S]*A4B&18`0CCK'S9&Z7#V[N(K7R*("!QQ$V7D*7EX5;(XVJ.53(6
MT002"/8L0VNO,/%X8V&1C62&[>6Y+\WKO6K$JI*J?M<\3\XH!%99,,]9&R<)
M&%D^5EK65@4U))N5,T]5KXI`IM0\`O0"-"'+=JO(X0DLVKY46]A+5[`V@BG%
MA;/-YJ&I6E#`XJH^-6LG4T*:S64/MGJA888FJ>-"=RK;HR4-<_5]-/'+FU2>
MS8'B@++I%$7T4"0Y3H)YGC!/`IE\ZN`4?\+T1ODGTSM?M)97<'Y9?I^.-6I7
M<HJ(@7)1%_98Z7YF_2X3'\$X6?H(0XXT:W"D/X=%*M6]%SWQ0HUO-1M2UR;*
MIZ,FI_E"X%5SU'LZE`HTK,2?5$'P;8>0@_?J;M!:>&\^'I^?_#J^//GUV/E\
M,OYP\OGD\N3X@B`_CCZ/+RX(>%*%N-MRAH!P5@(K^_Y^`;55I(ZK:3)[B'J\
MF/@S2R59\4CZGL18@KG=&-AC.>IWS'NO#L<N'X.+>7X.GIA4;^K(4*!MF)-G
MN9E8S*V9(&5(SYC_IJ7,S?SOS"L8YV5\,%W39QE'V%AE/XCVV0^8(D1A]SJX
M6DCIX.4`4T_VS[1OI5!(T/[QM;;-(E.GW*,`?7)%@D;Y/2(SQ#/J(A1=EIOE
MHB>'$J)@=XZKI7^9=CI<@6JY@]ES1G@\R-E&*?.68&\QRI3CQ%T6;CE@MT60
MB=RZ`J$MHPW2'7_2[2^%?3'!%TH)*Q=?X?T")ZTJ''D6.>-E$H0.16Y:A]0Z
MA@?0(GC551[,V*U#U0\S1FD3GK3H'%]@`&.3NVB&_:]XRWD>@O\TOI!]XL=&
M3$/>#?+A(WHM9RP^!LAX/D21SC9J]_=[+9=(&^!2/Q;RQQ((!^W@;_[L"E^-
M>T%/*`\KZ\"KJ1BK6*LA7$X407(B!0F+57Q5L-@N2.X@'5TEIT$.(ZNP%'/M
M[#8"DL33/XK).GM+S.:*\Q2&/#ZY_.2TAOO]]RXQ>^4MB:%\LC*62P2<Q<XK
M(.3]I;.(085E?6I9EK,2*#(.L:VHBL1S)&\#-:6CD*IE]D,1BVU36&8?"^GD
MJ`]R-9J"UW_FP,MSYH&R)M;JIU<T?I4A/"P!0-T\U$'DS&9#O)RKZ$F1EC5?
MN;HB"Z8\ADRR@<E^Q]:JJ:_TQL-V;C)"1^DV*65=VK<,A8CBI8T4I'%%*Q7Y
M+LH;S6L/9R`PL[3.AG,O"'E:$(O*:Z4W&K5U-Q'_@W9Q\MR>L6@*%]Z9(/\B
M[HS)>E+.W/J\'*UHR%`DZ11Y.=JDC"R=\A(H:<%:^V9,JFBB<EB7#DJ_&7FU
M5>E)Q1J-=97J_8S,6V[DL<)&HG:1VVE.2'DI*F#D:1`Y1.B"B!?^>\%=1?(N
M5\QT05^WDK_SXU].+B[/227'?#[*[QV?GX]/?SG^4H)IW#93J)D,BI,]GL#5
MSU'2L0^%]X<O[4BMM98B^&@7;U%:43KXG`!62Q5,=%JI5BZ`@V5-Z9;]%)6H
MK`BHPVW#C./H3IJO9J,4*66*G'1%%HLJP+LB[\=<M*:[)J6T)`HV4O(>*]Z4
MM9FEDDZ0S!.J'S=2/[A37V2)\)@R^6'Y%'R6-5-!\;("0@8OI?)1JSXBFE(+
MZE)?4$J/M(ZF^$.8LLG]B7>*@"CDV?!]+>SAB\NSHW_L?QA?'']$4&P$NAP_
M/3%O(V62BV48WP&Y2J"T3"@BK`(=IV6>@&A,?0&@2\?"$KJG(<J=(K%W)4OK
MYB>7LTJ1?U446JMC,4G+LRI+5RJ;Q#YS%Z$W"T2P<"^7CP&_/68\<37$WF8>
M4V\]UNP@\--26P)68#2S0,;#@4-EBK<6I7'(Y'(+O]7*HCAY`K`Y+NN;K*E*
M="?P@LY4>9^/NJ"U_XF2>RR'4`ZJ1#10FQ+MS?PYG7S/<CR941M3V28;$70(
M7L+,%WAV>?3APWNM[$I?))'G@.8A-X>J&12AQ/'19>H9"UMK.\ABT?HH`CI;
M5C`A+!QY/ZGS,'N]Z9J!%:&_#6R329Z1T_D.L[:I<(H;TJI=."BVUDXI>LT^
MD4#9]D(*!1'O#UQJ`&J.%<-!"PBBN]"-"[VT*`52/.JI,!2-HE4JHIP\@FK&
M;<2I2"Y4>(9W>*J@D$:0:DWU/O*4B6!,2IF,C1QD!V'YIN=\"!!_'JCZV<M`
M'MGHSB+4R.@X"+,%R>!B<R0SN'2>^?FL)%5Q[[1;[^N1S7!R"O?-L7,Y_I>"
MK+Q5U[#LL.%]%S58U/S-P.:0HD)+R%7XBFD(.!+J;<084]+U66=BI5N74D-4
M%C'E@J)[ZQ68`A.8F<8"8)UFP]RAQ5J9?8`?4;[K/*0<=?2M^9HYCD^S\@(2
M`A2\]Q=@LF`7I&(-:7G>O++,$`8+V6.E@M*L^UK1]9#;1J8MG2=PF?BIIL&E
M!=@)U=')9<H'+%>I$%&T;=31DRT`1KB5AYA;9%Z!=Z'[8S"I@T0'OGEFX2J\
M]14)A1;ZQ$_-<)$0221TO>_$-'PE>RRB*@T[;*$(9[Q0D\N<Z')5FDK<P^`/
M"F5B*1XAM:,>33#RY2!;>2#;0DIU@H11CRI15N[R:,%_14+;6\Z*SA26M]F<
M:+R]&TC*!4OFQ#,%3^`0!>@XU?N5=M(^)8\`MA4@DV(K44U!U5^?F[[W-%/N
M],*`9ZDQF+@OB0W%;<*NOT@#&N(N`-E[HQXR6VW-=GY\=*QU:#L_.X6?CU3#
M?,L1%\(-(<";PC.-J>]:E[8DCN*<)P<)U`W0`W5?&YPS=)>KB1T8,#]>^#B;
M*^<$'TR=2R_]P_D4)U/_O;6^?0S?1X8@#W60Y>R`'Z$GE-RC7W.P7:?"&^\Q
MT[/BHKGPIP)C"SGX^#OS%*'VRO&HN"7-Q$2\#"+#20K:C"3.0H58FM%[64N=
M)17K%E_D0$:6*L"BE10HT--,2#A12E%8X\_3%ZUHG;A>+T1+$\6/_B2SM%NL
M6=?$WH&]S'6;1^Y4K6!U2:L70J^D1E'/Y11Y%S-5>!ZIQ1=9SI*TPKCA6.7[
M9NV$R-WNS?"SLQI9D@:Z#^O^9\>"JU[\$=$BV7*V!CRZ&N=]O?'+6.Y#RR:N
MQFTO1W&K>B"4:6)PJK[1;YDX]RF(.P3[_#QGZKE9XR7Z(VR>;;XFH'D%2]`)
M/K#DEY<_4[M)N&+.8PX#>\+Q`1K.:SCO.0EG\)NVAFV+_`UU.>FU[NERTN[\
MH&O'E$@^RS?"2GP:W3?7\*+U\(87H[[;:K4V2/6:=#MI-O_^S>\<MMWN<-AL
M_EO<_.;DO^'-[PQ;;G_0V<W-W[+!6Z$..;@/+*Q<I=0\D,R5+]HD"S^P;\QS
MO7JMYC"*P-J=)3>[J+U\X+9'HUU;<K.+3G,6Z[BDI^UBSQWIX(7U77*-O!Z5
M2_OLW3J?@F1!BH#IU6@8]HD,V^VY`]D6>'<6W>RC]O*.VQLUU\?VE_2T791U
MH!UK%X?FF&Y_2<T&%Q_6(T;^T$#791QY?^9!E)%.4476>@?;'AM6LW%$'>9U
MOX>M.VB!G3O8A(?-FD"Q34=KPSW/S3UM=S@</,M&-9SSNCGG^6_LAJD:IGI5
M3%4CO])*FJ@-[`-J,PQ_&UJ875,?,[VYYB8VB";S@J:+E:%I$LXLSB>AOQ:[
MJ+/;1`3V@;-:S[,^ZKG#PV?1'%4.6D6HEY+4#1,]%Q-U6VT7Y'7#1`T3/9Z)
MVH>M3:4(-4ST5IFH,^R[O>Y&D@RWR$25.B+[@$K-\;/PV<L+Q8P^CW]S/IV<
M?Z&Z1WW"-*L7+WA$R,[\"AME=(HB=JV1W]<DQEK<.+ECN5*$*%*TXA1#8<?&
M$/$7<H:XLO2QHWSHW2*L[:*`9);-)M_U#C$R:$+Y"6!!63VN/@CSBV\9E!]5
M!N/@2N<+,88^:5#_0X;*0"T"P[NB%PU.A7(C"%+,F(V@#Q9K9M=@+EQ=%\5Q
MU*#.^20::O"R=_%(>4K&PR7D@(4W$TT,^6S$!%VS]T"IDX,KVB7.\BFG%;;9
ME`"[0*EW+`C+P'C*LS+[[1&&$AO!]Y*T:,4)U,:$N24BMT51OJ@%+/'9Z?B?
MWTY.+Y5#M>4#]?<\\ATP("L/U"6!Q#&(AK&`HS-/`1XS&4EPG9-H>N#L293S
M_GL.]<5."PC8:X809L6GQ;?,9"E]&8M/0"(ILR)D9XY>:B`AX9=OO8`@Z?&+
M8>C,?:33TH^\$"?`L):GV#-;A^.0HZ0@+#AXP57B+:@.FH$_SKUI%B<I0^_D
M$X\9J@%\2Y^-K,-&>/Y]%9)U68@`XN8]G!3;.]QC"LW0;^\M&,0,,4D432E"
MBT<)!/RIVN683H5NN:NGIVA[//C!E8V2A4`*1`<RUBP\UKJ<2R!4EWID(]CM
M4@),.V)%U&+10Q`#Q%6XJP(28VA3W18Q:6>-@US`$E2@"P@<@K_\/_O[SO_^
M[<NOW?_SO_\U7>;??X_ZA[/_#&^N?K^+OGW,;W\9)H?#?W3^_>WR+@V'-]/_
MM,*_9__]X^?1^',T_SZ\.OO7-`O^]=L?B]^^_#@?MB;77[__V3K]<-K^_>O'
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M[Z>UE[?;N`L/C'VOJ@\O2L$U'^>^K3S\@7;$LQEU]Y>1KE,F^EI7XSC?(KCN
M@'/^8P!CO[ZUGOIF1>]K7B\O9WX@$V\BW+(K8J?F%>XVNJR.'-[G[9'0`%7S
M:DBFDPS57S0('BLPWAS!Q@N%7`VQ5A.K$FKB1>7U\X)-/%:8ZVSE4_,[]!V<
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M7_C[1J??C!W;=P_;P\<1LSF+]=G';LMM=7?'K_1Z_1%4!8)`HFJ_GT:A>$[6
M[P_=0;__2'(V0JP^.[G7'H[<4;O3*!2[NX>TA;UN<QIKL*0GJX9-8>FVO!&E
ML$:[41Z>B\D[_:X['#3>B#HLZ:G*0Z_CMH:--V*'][#=;KN#T48Z!C>GL8DP
MUD2#V)130FE6\^B^)RJ9E`K2%2K&4_;MI=OLJ.]>W3SG?I#W.LSK?@#\?F=C
M`/A6-EOCY#T;I1KN>6[NV6L/!^ZH8)_M\\\C-:F&;UZ4;[H]N,D:J=-PSZ.X
MI]US6Z--Y,YNDW?JZ&X2=.@<])^@(I;)<QEG7EBH\^V?JQ3%36XD+>`%S1LK
M?],DG%F<PT+78BMU=IMHB_3`6:T7+'.[O9Y[>-BMFL,&-FX-8KV4\&X8Z;D8
M:6\TZKCMP<@RZ>VPT7-HC@W[/!?[=-S>H...9`E-#1BHD4.[R$B]+K*2"%/N
M*A-5:I/L`P]H0Y_!;Y/D1_'CLC3]>1QQ-<^Y#!9^ZISZM\YYO/`BE_W!I9[&
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M9O/OW_S-IC\W^[]K^]\<_C>\^:`D#/N;P&)X^:U_71ZO3JLU6E,M:IQA3ZVC
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M&A9_HK!JDLUKLJ0G.B.&J/5W[&>S<4;LP`ZVW:%0&G9GR<TN:B\?NJU!=U>6
M_'K=$#PS$W6'3E-(^@)1C;;;'ATV:L3VE]0X(IK-Y/^:0UF7)3UM'P?=@652
M=5WSZ_)"4"8F*1*#RJR(AK^?QM^]P[[;[77M.UKG93<[J;U\KW?8`S-V,YTI
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M7XY//QY_=,:G'YWSXXO+\27\<G%\?G)\@0VF,`'N[/37X_/+DP^?CYW3L\OC
M"PM7OOBT3Z(B38_M&K4MFP$;PL:)1EG(8^=^FGG8NA[7PCIGZ0)B7&+KKTF\
M"-(T3NXXA^_A5K+)V`8VC@NSA.C[[XEYB1>NXQ`$7DJ,`*\")@+6EV^*K#@)
M<#9N@CA/X7#`]W)X\>2.'\/%THONG#V1<]5I_6SK#J:QIFFOB<?;/^.I*Q;Z
M-0G@=W4E+CNQ85@69AZ^%?[+4CPQ.(#RZ$'I_=OAE$N8DI4?>#(GEUM+T;L5
M3SV<:M@G<ZQWO,F/2Y)KJE"3V,Z+'._J*O&O8'S<YQX"SMC@[=)K>)Y8(<X3
M&&>QB".@00Q78)I/_BW$3Y0%LR#,LR".M(WT9O_.TXS(CBN8AOF,1%)\&SGD
MDL#U3'%5L,@I#D#;IXVR\#(2Q?!R77:V#O"(P0HC]KCD8X-'L5=@DD\S)O7@
M)"Z]8.:\Z_=@X6U<HL=Z0!/Q9_[<`SF+Y"HU&12#9=<P^RMV8&:<BDSJ*B]Q
MG3#X,P]FM(LS;^%=$2VUQ;U#L`R@/;V73:>+P\&9HAF**:CO-!8'=T&0>$0`
MFHZXY.0N2V9QWG7;77A'3XQ7/B;X%!YANH[@VWD4P(G98XS[#7\1`L/+'`\N
MCN^PMH13X%WKH--REGZB+1&?<QW?FU[3C[A=:9!FN`_(6I'/&,W&9]HACF;T
M]1(G+O-D>NVE</]Z20*\B"PI_R8'+P]DXVAE0?YW/YD&J<^YT[(T_9`X7DH:
MPC0))B3=B9*5Y]E476"C?#PG!X8ZMO4+#%5,8BTN.$&W]&$#X0^<ZW7N8W^V
MW.&5X@V'-HXVW9<>$F8&G^M'$*1)XN,6$Z-'40XB41Y724)BS3G<7Z`21[A_
MV'I4&:U@_%L_!(60?^/`^0VUJ30NWN\`0T57/E^PRA^Z8@5D4!0QSI6I<^V'
M\E[$:U1<M#"TQETESG*5=XL+>1XG"S^!VQ9.$AXC7)-\CTFJ*([V;=_$?8#!
M:3]G%3NIK0V^%"3JNTI@"(,#NL;F<1C&MZ1<DA6@TSK-%\![H+"FC!@Y;3O0
M:\5]0T*I&$SJZ<N8'35VR:E<N8+;F`JA#24WE3]_`U,$G:98+%=MX&$Q&90S
M*"OUOL;\H%3/8#V%FJ@'FQZ&Z=*;`CWY$><'EC[A!J#VR>,$@NPKAXWEN.$[
MA;WTEJG_DR-^6B4MMIK&PJ<_&L#LPR#R]X%7P1J'!;7[JWL#XIYPI3.52LQ3
MS'*E/=Z],WDN?\ICY_#.N(`V,0OK--;PG92">KJ>NIFIO=`FU2F:=__Q<,HG
MY#<N!"M.XL,(_^"W/Z.;<:+'F1\F.;8ZLP<>GW;;'?0&;KO3?_I<7VH+ZYHR
M^>#U4W1Z=^B^/H-V#CJJ,_R1DE3ZZE]^@H]PX+?A%+V:D[0U=_TGT*2]*?FF
MT58`77H9IS@&673"7R?4\<(MZHS-U9G^_ENPR#.P$%'GAA\]9^9/,K1UX%UY
MD%[3V(J[7OH88$;)C/P?Y$OZ-+[XX(POCIS>L+7?!Z/T(XRS_R6>!7,0-6@J
MI1:7U7'I/;`FC]DZ8)\N4M-;A',4'@#=G+P%DQ8F#Y^1M3;QT?<&Q@10#<S,
M.P<F,H>OH%D+5B+\GS@MF^"%EQ8=GL5[#K2U;\?!\`%L>'+M*18<&DR:#R;Q
M]U,_0T?A38#?,9SCS+NXAN\E+0X0-^TT)Y,D$.-$=$K,<"1E@G.?7)+,@J:=
M#`L7N]PXKC.YC)%*7E>84+"@*<T],*AOO#!7K.UB+DM8\'?Z)NSTNZ[;&AV2
M8U=9`[+'-/32%!B2\3K(P.`&6/-&8X`P\"9!&&1W0"/D/.8.W[OPV9EQ#M_7
MP1$.1SGU_\PIUN:B5ZXL#L@O<8LDQW.*"W;".(4S91YE[;"C&Z^#:+;N8:>'
M=&)^BO2G]1;=6../LL:'#[;&SWUO^B?L&G,ZTO'?28-OPU;YYFSQUD9L\>ZH
M#P>IOY-;L].V^&<?Q-T4+I<[5)O$U<%"LW0C66\C_*>(_8TZ>>IGE;P)@WZO
MX[;[J`^TMV"&O'\L![T:D_XS4SLT->,1*>P;L'SK=P*?XA=XAL2]9_,%2(UR
M,Q?AVW4'C,DNMD2![['FRJPB<D4H"<@Z8IN28L!*Y$D>!Y;UO[C1\YOO7'LW
M/ECW5WE$*7MY2F9ND9BEQHS1BDPHE<;3HE5%<)X'(9E:,,G)CD)3$>S0"?X9
MR)/F"3DZLFLPLV[U@*C(;22[!T:;Q7!QH<!C3@S^$+DFT&OB+YF%A#X&/2#J
MA6$-<@@[K=:(5:'7,57PC/59'EGKY&5&3Y''TV%I0[?7P?2ZXA#`0W_WHJ)5
M`4L*A5.19^A`8@R4E4Y(F9OPN&!,/TB)CQSX7R.;S)9(\ZYU8+;_6<(;*,)_
MX'Q4<T]3N-Y9KBD[XU^\9'I=G-9;,X%`2<I@LZ&1WG4H.*BFR!7*L$CO*J]/
M)E<A0?MN?]`1&4GLI`E/G6U?-)KS78(YM3M#=P3?+[(92N29D,.+$A<L";Z*
MDXD2,4K)1SS7"#Z`H\S<?=P_4D[QO&>P?DO="TPTYGG%;+F!X5MCZ2>NYG:!
MOR97+#NJW7>[W2$*7$E13$^.4E^G]UI[7@<WU,?CH^,O'X[/<>\'*Z7&-F<Y
MSLS[S87]&-))T!/.Y5)L-R<3#NB+5:5#-%.O2DSO2<6=4F3-ZQQWOW1H#Q46
MU)>U'5)^&?^NMKW_=GJLM(JKX=:?1'!J[FB'>(IYZY`=42](20.RY7^6S^.[
M;I_)3)8BAX+$8Y<]BDM_%F1TB]S`@8Y93GB1K%VQZXPW>,8H3E"AJ9BF792J
MDE2DF;*$LC6'T;KXF3IA)I.ZT(L,6I&?W?I^I/8&A%O2FABKG*%V2Q:%K,7N
MGG;06(ZI(IO-+%,NZ%G$!H:E%039W8$VU+=E.7#"#[S!%Q5W5YGDI&D7Y@1=
M^$+A)%T09+\?@)+JX7RFU^P&AYO8D`(DV&WIN'D$_!BDK`3"ENUG;IZ2G%M%
MIUIH\.,YK(JE-@/%6`ZEE@*J7Z"B,D>+/Z5I/`U(9Y&Z_\2/_'D`?PUM42C2
M!KM==]CMZQLKM!]N##SH(!5AS2(4*6N-9DS_%TMPX`0EU@@G%BD9D2A38.2I
M4`C]^9P]4N@2"S^[CF<UL"#*V:W%5J3JR:L@L'9T37*3`9AY?V"B<NA-_7*%
MEM28+`+.JC>C`$!AU82WGMLAOTE?VHN_'"@-&Q[QUW<L>WJ/EVQ*)6TKG>J?
M&/?^#MS+N,[YL<(OZSC'R,L[2,=F$W=W$S<1DFB$S)/X\XFQL@K^+:^B=$%N
M*(F\V<<M[V-[M_;QN:*?_^N8_JV>=77BQ;#SX#2=K]+-RK5YI<3\25O1I.EL
MKF2FW]I0Z[M=WI0ZS*%NC-&V5_SOP+9L1H(^6%`^^((8<SP!Z<70Q>0N7%>;
M>?DFF/^1N1KJ-#KNJ+6!OG6[1?MFXT'8]=U6=Q-HL&]52WQTO2@OFG]K?/^L
M+W^$X.MO[+*O%RG>[LL?S@05&$]U)D4MDQ3+R3(%[)"`3=+"?"Q+Q@;\U&V[
M_3['?1KVW$&_0X6*'&U'@;,1N30\?<:8E!H<LL6"6B(6!+\6$;GPKAX%@&<1
MI0Q.XCSC`;.NR&,I\.@$L;/;N(`VM#,,3J\T7W[WD2NJF,@3(G6N\_?X.G(^
M`+G],'2);/A6'!8V(V394?%B&<(\,W.6WA5FX65.CKN5!1D^@(,$.``-?7P@
M1G=N#IRQGUV'<>1\\6=XS6LY>B?1E&9`3Q](H+B+?.E3^L!1G">262\R#M!T
M!))C'B=1X)5'FW-XO2.,ZM[A-R^\R/D8^%>Q"P^E2((#ISO<QQW:!WERV.T.
M>X0]6!Y(0?S[[-VF>9`I('X\KT/2"!-$_2O$#4P()LP&:H<(1HDWQ:)=`_!-
M`".Q6+*.?F:.94'1P_1!E@M30!CFA'`D=@*&10XYT"7H`Y@.>'V<7^6P]Z"2
M<B:_966D_"W&X4Y!P!-#7?@9<`I5,DJT,`=T.S@<E`-:0LMR$#WN3F/D(AW8
MDAA92!NDKY=>$]!15,K+D'/"G`Q9F^F'?"LD]BJ!/KH$A.7`P\"]=YCV&)CP
M(90V4*YR]0BJBQYSB(5G-#`(%L+Z\[_S;,3RE,0FS8(4L2I]5I?+.8^8!.7+
M,O'_G<,A\AG_,7*5!Q+S!?*Q^EA,Q!')ML%<I<Z[;JOXJ\X5+&^%N%,\S>DC
M'N.L=Q53D#^&>V2F-=LLV#3Q9SDC<E%R+`!>WW'\0+R:X)[P0CBW<(SU"<&"
M\-L!STPZ*(DM];W;N08^%:!A**=LS,Z6SE`05^<LNY(?I-/%>=<NMJ$@+&5M
M==Q>=^CV9#&CW,-J/#)BW#EFJ0B&D?<_\E:<&CE6+*5+?HO!RTUQ')R<8+"(
M;R'B''@LZ]KB5B?TXGJD/5D34,L,6E!;`!V;E>[OACR=G7*()0#G7BJ*T]O=
M]_705_[^[;.:*#K^]LNWB\O[4T6W/&L"(@Y96B"_@AZ2,*KNU&`P<L&B-'-&
M*1F0IXO2@9W#]:1EC2JWN3UEE&:ID+>8:U42HQRSG#AZC(H$)3%BK2Q!(V!F
M_SXE)V*6&DMN+E4TZ%Q9F=,Y@JG`NH#T?_@9QW=PYF$<)SP_L:W+DJDO(!=!
M-_2#D*.?8BICGW^H)>5+0Z`LWTHIANRH%1FZ)%1XGN;,:;O=[@!!T[0\33F6
MFJB9EH%3JZHZ+/BN'*<2I-8U1ZCU,AV_`^BL0`:S*URG]D1"@7!U#I;*:)`*
M?='(?5P86DY!-]0Z?(Y!7`"#^#<<#&*>TPCS(`*9A-LQL2E,7)L!A=R?>CG'
M&ZV``BGAB<A1-$J0@LNKL!!3/BO6S6=$,V3IN'<ZC;P5:!]V@(]:7!,2Y86Q
M:X#8-54@*!J%-?O$)'=E7JV>2FO972OQ\%CVX#X:#CJNT*U1NQ*IKX;@62-Y
MM4B0+<L@\R:46OH!W*QS/T'UH.#1:9RB5S6:Y@FO\"IL(9/L/($8#E\Q0H9(
M9*AR#%KN$`&-A/5`Q8'+`#XM%BG9CB>\3WRJ"I%)P&NLO#Q0)1F4==>!8>_-
M]%U]3YD#UC??UY[56YT);(44P2S>=;>@.E7NN;+M[D\QVJ#CMM(#N]GLJZYE
M.]9)I5)G]#(YG0U!-AC6JS/GE][\TDU.'\,,LO*@HNWH?7&-Y\@H?7-T>W@&
MYW.%QS>$>=8?6`)BZO*?.W5R]'(81TKRUT.[XFXR):ZS5D!4?7NW^QP)<-OL
M*MUL_@-:BY/MLYN;_US2;TWPNDI]:-,)C\^F-E;=;2_44O+A$%,=M]_?1/K:
M`Q=;5SMHU_:OW7('AZ.=V;\:9MUL*LC4[9`WO!QDJ@G^R-G1Y1GBS10^I=.S
M7R4$3=V#2V?3+,;M02^4`J=1CC"]ZW7+<"/&3J\!/V*&CLP)\5B2F)1"4G5J
M%?@A(H!T:9G?HT;D`"0%+)HRH!V09`S<'!9N/<Q5DK^HL#MJ4&@-(!(&/5*(
MA2HG>PEHH[\2D(0<I7*+#'J5XU%EV)#JZ%-Y-O>"AE1BA&CM&13`$`L,YV^^
ML_"]E)!BR`6KQR0L[O52)[5U<#JDD]MTKRL!#'2G*E$,GBY6;O^IS4F,Q",'
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MOR:I`Y^./YQ_&Y__SO"2;+E6ZJ'?SAS/(N>3/TFHGU^[(]IC*NE5G5'+;;7[
M$J.$IY70.=%WPW-2?TK)+LLD1LB4&$:-[*T&NP(9QV@VR0JY)6J00+?@AU(4
M3[.3_VXP4+SX8@P#BD=/\=*GAU!#'+X570$\74M?7A8[O_@+8$[GBX>I0\XG
MN-I=YW,V.Q#98>QS-=U+-/&;ACEK-JI)J!CNIX"0N5"X*<UOYH19L_03-!Q<
MPH9A:W69B+`(3CY6QA*$>'(09D651L'NSBV6SH.95$LO,*N/0_\*I@1C,`$.
M/'$XZJOKD7A&ZI;PIEBFW"QX3'1_U)KZF/PBZ*4/)K+$*+L-'V=Y;5*&$&W0
M3X1W$2QW2:A%K#]YB4E*D"VL)QV7D[`JOL\3'^A)P@@H>N$O,R:Q!#Q,,2L\
M-G7H,*@A&K#,M2+7CE?)AW<D,/T_<U@Z<#6A[NE`!9QGG+U1ZX?W8I\\&-F[
MDFEGC+N0V*B+AC'=/I-`UT9I&A4)=MAX=AD3F@[0_4,8QTCB*^?SP=<#1T\B
MQ'<6YMT7AI0A!`4>E[UVZ[V3)1XU&IQY=RGN_]2?%<ANZE`*I9";7!5.`AN2
M?0\6^<(@HHFZUSKH\OYM#K*-_2'>84P1-9\0VT/GI*_XH$6`6+JD%E.$T;MN
MMV4+:*Y.;L3)5$_97&>G5<[.U)(QN31F?+%?RL6T"%,)#+)ZCEIW4=?D^@>C
MA$AX#'.L]7%"7"ZEN,9ER%#:7K:?+F**K(TB8HQD0159!T=$VSX+S,7Z."+Z
M]EE@142W:3B&56@BY=,LT#$"-=ESV]*33AO'T8HRUMJ86N-2_U(OF?%M8V!$
MC*2I#1N-\6^ZA`6FB)$IC0.ZGYF>GP:+((1#$D_),A)(7]8^P'(Z<B*,^-RZ
M(&@KI34?O_1<4ZJCW<35:87;82R9=CSQHC^2?)E-[_@[ZG"U_5;&8_$G64E9
M>M<;CMS><%`@W]C.Y"IX&`MN"T-,$X`O^@[+5HJEG&U4$6:S<C=.<?0D\$OY
M(#P(^Z1L#1HZC3`-ZW&B3K1&J*[DN)+Z1PQ.)OXBGI'<,'8.+@NT`_C=;,7R
M4Z[6+WR8XM,*G9[M"*B?-\&,G6-V)]+STU++35VO*I,>3U4>>J1.D5[%E*IU
MU"A=Q['K5(H6Q693TJ+*8ZQ4J59J4>869K<^HK;N=2HU*YLNI:!7*O+>SZ7F
MN%I9L]]DRECXCCI(I?$411+#0%(X!V4P,KC+K1O_ABIRS!5)]B%E@=W"MTPI
MQD#T3.#`"4V/J68AW!N9EUG&4<%;:3K\N2BG,PC4KV@ACZJ3:6N1GL*-/;[`
M,G@RG=S2V;2H5$8S87S*Q?=/J#LX6V-4:"/E0A0QSK%P#?!.`,X>*1=S&F/B
MPY%Y[^+RPA`E('H2?`:;["W+QV/FX^:PQX"SO?=PD\#Y%WR7,HUZ+WC/BW:F
M)G:A:D:PU2Q#V."]`!Y"T$/V=6EA>:$"O6TC]6V<AP(WEV^B)"]/1@BPH`D=
M@+!LF"+^*8KU<23$;,F\)=A=_G:/$.YF2N%59B@<AI$MY@($GMS)DJB2>;.Z
MV;*D!+>"%)4</@I8(D2A6;TO&@6K8^U-:$LBAT5ZY6Y-O7":,]5'Y47N)?8)
M#E=;(JBHJ#'CYHN3:QP5H27S([.GBUG!>UQ_U_GS/;-'^"GRIK#.1'<NBZ'X
MJ4)-TX<WY]B$6SL.QOB&@-U#H,UD%OHI[?_MM<\TUQR$@1PL2.E(I-?T-?'G
M]P8$]4DD#18FQ9@8E";G;01G^CI8BAL.[C,>`9?L:TR0W?/DJYTF/BEJ0/S#
M@\/#'VKBLU5679;H4ZZV*RJ66X+'-L>2KDS"IA-^/L%4>.%Z3@2S+<GA<KVB
M(B"$S"NVPN`'IN)():8`WC1-RHX[[`S=SK!3=1]@Y6-4P"J6[$1];MRYT6VK
M<*.7%HXM*5J:#AQEP?XL"'.&2%W86'P7=*M>,9FM.K!T&^.5AUYIILUK'DNZ
M-4P=K/RRDE](Z*]XNRRY)0<V&=.@X!HS4;MM1[<601CCA)M:L]@PWIJ=N[>U
M!<[\,"";)$9T^W>=?M<='O8.6H=([5N0>:CD1>G<)_#W>0YW(;^F*J`J-6^P
M@),$G0B=$E38BR<JS\@4MG9M,(-'0K32/8WWL0"IG^2(>5]R@RNN:WEGX].1
M0T)3.<_2US[+?25`0"+0MC0I!H@D'L-?G\53AJO*AD_\8#&!:\RO(!'?!6\9
MIS^GW%7/VWFDA&?OD5)*JY8V:BHM)@W;_-87&\BD,5]!9S1P>Z.N,P=.".](
M3:<[6HH+?58EZ2'V.04"I7.OA.5?1/CD35OILRP-.I.JD>*D$YHE,`J:1[J_
M@TE9PB<E,<7BA:Y4R6%IQ>H+QW])*Y*#27_;Y3V'19J1>98+K&7%.`M])I6)
M#4$1"1:IZKHA9T20+O/,%U7@AOR&Z<>%>8KC,'6.DT%U"N&)*2D=VG+H'<6Z
M6;,,Y/?Z7,EZ;P[#1.=4H]A1F63R)"OW@4TBNW8=T,Z9-!@%$C5ML\I,4]19
M51H42AD_+Q63(YUIX';[=&4?;#]L/$X9LY=2L"TG@K4UXBHR&L0&(].]0JZ?
M&3Y#!V""6OT$A3N/5L&X<'N0Q[6,\F%$416K6ZI?=!8FF0I@7?C@E*F@V`2K
MC9]?ZGU!S_G?,Y!6>9!>RY8197#H,$Z-^`;I[Z7GBFGHL?##0==MM4=Z+R8E
M140B`514_H,&<@T:.=-GMI1__N(0`,^89#J\+\?SW"=[+F660DDKWDRRXQM,
M,AT]/,G4'?5[[G`PW"SMWTRBZ9/2YS^CKHI],*@'D`REF-V@%+EKGTB]T_S5
M=Z].WK^?;>HPK_N/U=[HL.T.>X<5(O/)V_7PX_7^86*FKB4,.BTZ!WT+\VK'
M+$Y34YMXCH.TSFR>G6EI$F`1YZ"9K,4GF[Z-'CBKM=++N8+W;)NV!J&>\[+:
M6M;Y6<0UX4Y;:7U(A5:L2B)&)^;Q]\R/R$E01(,-U[GJ5C6_SCVK9'PR4]F:
M`WYIT]XMXY7\H"Z:`IAB2,[Z#,'LF`5C9B_(D83%)>(T'S%.`ZL55;#E=$@S
M%.O!+&;2FD$/%PP@K!09>**>C_.0/)_DN+G!G&"-H:Q]+X>]EML?CH3GCG_"
MLSI3X7HK<Y_TM>$`_9%[.'I(2K@8!9[DO0LI'Z_=_P%]/8L`C')NHY>S/DM3
M,><B9U[ND24]/')+T/&F>;1+OE665Y0RRK,,Z2+E@,4!&)<QUX$1L^3Y!<+\
MRJ<\VXW<'I;@[A'SG%V@Y\SF"D'#CZ),]NCL,\11R^SCK.8@.8\]P4OOK2%6
M;6G5`=<U(JRZ>+8&7->+L);I1.%6;XXIXV5Q1;YG-0Y;/M$4;=5G90V^JKM=
MBK6V!VJL5:.6$F718AA%P)<.B27NJCO&UHS"BKBKZF`MR,2<9T7'P/L86[)R
M>:"RDUAF9UW[H>KCM4=+C74])':ZY5P4FU/.=OM4>^4:MYQRB?6&[K#57J-#
M>N.4:YQR[-'&*><XPV'7[8\ZFS!V&H=<XY!K'')@G0X[?7<T:E>(R\8AUSCD
M&H?<0QQR3+7;P.0:=YPRH\O[0-K4,N"6I8.[CLFVLI^M`LRF'SZFCU<!L[VD
M_GW8@+(].]A,`\I6KXUN0-G>'BC;L`%E>W'37'___79$K\&];D#9#"%85U"V
M]J';:W4W_.:W!,IV%A574^=0B9#SHB4EG$V9WQ@JL*>;^]^7`8]\ZB6!^*2*
MP=.A]/B$U7E%EK(H0B;"KGYW/.1=CJR*^(`&$T>3+>]'.?ZZEF[_O/&7K^<G
MG^\#^]INB.A$Z0-8QOGB0&HBD%-T3;0D#YB-%!D:EZV3H@W/0O\.!XXB"#>1
MP2`[FI61;\H<<%];0A,+J=S%3UW5VAT)-<P;JM?7+XW*-H2.P#VK[D!H$&MU
M/T*U!:&VJ.WPV+U-#U?U.-0)>4_+PY5=#C5"KNIYN+K'H;G&54T/[^UQJ*]1
M@^S8J@BKQ&6TI=YH\(OZNB0:HW:?;IM!__[M])B+Z<Z*_K=;EM-_SR.?BVGS
M(A2P$JF(?"^]U-()-O*OXBS@E<ORN="[!?$(K"@+*@4/LRITM;JOS*5LRF.>
MPH3O/6>I8S/60L'EYO9M`1IQ&U>+[XBW76#9!G):>Z+A2:?ULZ0"VZM*H%?6
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M,P^P=O4DFAZX$GM'#/HM\ZYADY-ES&TK9>P3KLW*$=%FPWI]*;H)H`X8VP`[
M%5J;&$(JM[.?*-G3*\5QOA;%_(2MJPW&99"H1>:2QYI4/#IDJO.>R<EL%6(0
M!<.7I2]2RJC<!%4=5X],^71I$U-(5X;;.,"\.VMRL+Y468),E$7[2GN'SBZN
M>3T5-/>"&4-DMB2N<1N#F4_B'BX/=,&1FB^3/$6E3]QR',5!62[[AMK'GM6(
M!Q:PG\J]Z[`I,4L*&]1+P7>HHI86(RE@#W1M$K0>!SE@BP=FS3E<>J3!*!N:
MJ%#7)0"?8C2D$IP=Y@,_2"CV.N"+7>KL80."+6X!A9LX/L0*:](5"+#Q4L5G
M$"SFJM;FTM?P6IBI+%.-"4?)2*Z7-]A,S;DN#U1:'>6/\W3RR7ML:56!/,R!
M\?2-ECAY!2HP7>E[70UIKE"&"6C/,#M-W#TE\EP%B:<Y)Q8+?X;`D7!!K,;*
MV[,("T4'/BJ^SM"!%367\#ZBF&/'LJ1]FP-/'P.3>>%2\3+:$B]2U/LC/R"]
M64$BYG4<VOI2CGRL@?Y4L("1A6XU\K7$?+8@F*L?POE&AL=]5;YO@=L!R3F]
M1K@N(;[8[UQVN7C@69)""M=5^[T*<\2_6XQ:7'D&I-N[7K^0LNSJ$OG_T>Q'
MF"6*+>/JY*J=@),IEEO"PS0N!./4,,_II0(B\U&"R!BP>'PC;'>2J6*\9T5#
M>YWW9+P5H,64_`W+-Q"7!(7%M6"E%C"RE5J&/I!P>?]P2FD48M]>02C&KF!R
M,NXLK<W15\=9$2X-F/4RCE2073$9-E1Q7Y8G)-2FU$=L:>6-Z[RB0FWB8Q6O
M+&T^UPSN5SHYTKC4"3FT$$5I"/2*W3@.[[M@<*.YEI1?5(QY$-EVR>WOXB6\
MJ^GP9TUP"JIJH"B*'J+0B$-O8IV&3B-S5M:B/0GA&=ZY9>&E"0%YP`M>+!U4
M!/J+(X;M79B"5K@_J<8%Z)B.$:U5@;%AAX>K.>QE#)7'9L0I9+$N[V]PP<%4
M7-B!DMABL(05LA@GSI4#G2FXLN`Q;LA`I7%+CB2K)Z10V4J&`V<)<=M:UZ<"
M9<7<WFKW6:<254T]XAH!U\K7+L\L;>'$]Y)4D>2H`"4\X`4V*-YT7A3E"S6J
MH8QEQ<W4U3=U!6U;>*3T@(3]9@LKP>1Q]P8P4,9\@VY1&*C=U9J5A4HRAR#'
M;#9-+82=*2#SR@,9NB=\E]=!><7UK/J9;'O*YZ%KF%RI)&]@D`JL-<]Z<7G+
M91A,Z9VZ;N.R6C6V8$WM"2SU10*&?Q;?1K<(K,Y"/T!(HB9JB$EAO-%L#;^7
MX\AS%B@*V6W`]#&+_E4&UB\N"3L,8HI"A<U$4]>4-@/<D-`7R(P>IJYU6F:\
M:-OVS;U5?BJ,J@0CMAN?H4_BLHP6KI>X`BG*",3F6!60Q(5EOJH^5HF`;!!H
M6,[Z<4C#Q=)LA;!\\+6PAO6+^HE@PV;)ZP-J7'6QH#1940[&^QJ$U@Q+?LTF
M$_H*U9X3#VDR86B06L^)BFO'[#9AL,&*[A/W]ILPQ)^M^P2&92D3_`K/GJ]Y
M'RV(X_SV4FPRK@JK.J3=HK!XR7`@J2HS6J4QIHB#%8D&-$9VXI(^6/:]&`>&
M1>Q4RDS`O&6^PPK=,M`II:VF2M^13D]4SK+03\LZG1Y/*-(4W$%WX'8'O=7X
MP$(\:@J\FJ!@H@*+*0D>,\CT0%4'M1OAMI8ZC<D4*W2<^]2:\O(J=)SUM!K]
M&):4'%6KT3&(I4ZSU!69IVDR)4U6YG#P+7I"(QQY%A_9!Z<.8?C[>LZ(B$33
M<Z9&/6?.1.[$J!(3R+DDM8Q)W&I0(%N4K=1A8P(G`H1ZPC9-0X*78I6_RU?W
MC81MPHP$/%]!E),766C^:BJ8/1.,N8=\Q)BEP6&4><YTW`2YU),114QS,!2E
MK$+Q+K_DQH-S*>PZ(3C*LRHN++$TT9^76H0=."7_BMX;0&I'M@U1@I%=MW]X
MZ!ZVN\94+;<_S5TZG.84%](5^5NAR%/@4WRYO+1;!7U7[N),9"52:36L,B&I
M"`2:4EXK.T0'^OJN?>5>MBZ6=>,LPP+)N*:Z4*F<T#HO,)#XN6@(PRY*-!Z9
MZ\Q(#.`P*,9P.J-_DQNKSF+56TNH55([!!:Z4Z&0^;;<QWR&Y*,3IT\2K4*\
M[MG!QG$7K)\182[?B?",.:D[\C#@K`K0;1$0X3;9.Y;<AC/T4'-BII:.,`[[
M1+98NXA5C7FLZB,M_=<XS!>^;2LT)VH<BCO$.4-YRY1RA#Y)G`]Y&/H@)9P/
M,5R]G&LMV4NV-S-3=>$+'8-_AVW,#?N.>6]S58,46YD5@_I,$,]*;3LQ9QN]
MDTHD3"=1Y/SN7<>Q\XDZ&')4>G3@\J8*.F$4YK,(4^G\MYXCU^"1:T]7GF\]
M2MWEF`BL$0G8U)3\3#[N0A]GQ@SN,E?8#8OEC@(6:.J`G,&;P&7A8](QX28'
M!6_!FQ8(3!W\0`>)FN4^/<',<]Y+$8CBLT\*,:MG[5@:8JK26(0=(MZIB>GW
M7F'/G&C89A6AADPAMBY#V2_!#7?B(KL1332SH"`0K0-/FS(:'F,&\A:#G;>@
MB9/&:5C`WA2[L)?;KTCU'R@ENE!'<;1O]H97S)3J+M"@@:A9)-5I*>4EONL.
M6FY[U'=MC>70<^R%E=YE(\\&^([N7CIY(>7&^`%=-I3W@?[S/%%"^?@;\\X?
ME&>%@D2L"$\#]1.SME'F:6V=6FC?%\=?+X^_?#@^KZZIJ$6R[IG:&[KK5F:#
M7>23=)H$2_6061+`N(J/,M=2:9'>ERT@HGU)*1VV4#X82^)!,SJL6WMNB42E
M%?W3F1%2BLE9%:DBL50BO%F3A=INKUND"QEI5#Q8+Z)&A614"6R'.[/<<=:L
M++S^5R[8.M0]RQKVNNX`FX^0OC"'*XA:)%N<S[;"$?3URO%C;/@\;(](07E0
M]4BD=U)B;IINNZV6DKB6\"?,6IWV6K,TV+QBUFO-4YL/S+K7[0_[NGMIY;Y-
M5((;@5V8Q1)+0X%7A-#E45`NNX6TQO:5O.^9SIY[;6STB<RTX/4JIGA@83^%
M4E>)@E6G[![*>5@#!AA2ICJ\&[#X+;M#E0SBTOUD!KFTK'4\.!ZE98')&5RA
MRX4*\[1T.CT"+LZ*\(*L07&IZ%ACB-8,-%&&H"6WW6,0VYQN6HM[?<^*37M$
MDWN>&&;UACR@Q[W>>%5QHG(14E@T15_/<N].T+R11(GI)L9K2VE(M$[;5<I'
M2'5,"RUG[0"%K>B)5L81A:F`$)[X>LI1,2EB#%=/A6-[AP8=1M4FJ/<PMVG$
M\\RBV"(K"_]IT9X^855<$5;I88T=3\M-?.K`R)$F93FI'$HQ2+)KO\HG0M=-
M>"=1:(C)S?;?JH^N)E42E.VT"IZG$%,:/H\2N']M`#VC!J"G`>C1)MX`]#0`
M/14+V%6`GGX#T+,+`#W=8=_M-P`]#4#/K@#T=/K]#;_Y+0'T5,,MK-7S1'4[
MC]RV!&(HD!?64:=?!A.GO=I_N]5)JJ@XUG2!"L>BQ8:DDIDJK^T:;EIC;JO=
MM?=X9W4^J7#6KN.?+9\TQ:O99?UVN"=HI4]6BU7:^U%85\AJ/9EC5E_4/7[:
MU0M:L2+=3UOE\#3WK.0!E;*J!X/VUG)]ENED]=>:WEK=/VN$/-?PUJZ:JQ[3
M7=-I2Y,=KD(I<M;SVMJ\M(9`7=MK:W/3ZHQ51C6K2K#4G+AEGZTQ059=S3RY
MW74\N>4^1XJOZF&.7"UY1QGI8:Y<S7EK\WJMY<N]OT;DG+ONHNQ!KEWFRJV(
M83_,LUL%FO%0UVZES'F08U=SY>KWS@,<NX8O5Z?6VJY=Q9-K\-7:GMT.>78+
M1ZXQ$DJ0ASEV%5>NC4,?YMFMS`M+:Z!?G41*G[DB76[O`1>7[=9R1NT.&J)K
M7E7JC+9Q71FS-:?UZ/O*DM"IU-0FK'@B51)R2;@+#)64)@UB6B:R:_RH'+!R
MV[(RF(\@0:F9F38O$$#%M)1L(VJ*A-HLY3?EI!257?TU8.1J4RC.,THYMQM#
M1F(SH9_`?S58$^$7$9?B?\[XVR_?+B[7,8:V.NL*/*P5$%@21E3;B6Y_Z`[Z
M`^0W&S0H'1VXD+BDO?9F`K?3G%0%D&?K4#FH9-?`^0@HM4]#&)"*$Q=P,"%3
MXV$3X0IAP(N-<=AQ?I6G.J`D`[O]C5=RB<)$6E%A]Z&`,^!`+69>47AS.(3_
M^L,5A3>%0-5F5%:PM\E$VP0!?=<!OCOL##3BR,J-]8%`#6%=Q@5]$`RH;C]I
MH*!F$<4VMZ^4>M>NJ=NFE'?7Z597>U@3[RQ^")9YM\J#4Y8E][ISUO'>E(=\
M<**=ZKNQZ;KWY*1U^EUW..#>&S&4<?Z$4%5T2F+;AV5^#3I]M]WK;B3SJVW`
M#JTDVRSFIH=9!ZO<%.QRJ$K=XAS649(23=4Y`GNNG+6E6OSM8=^P^'6Y8+?_
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M*S!M&ILD4^(;H$R>*-V#L:1-FA;]/F:JVB8Y0"JK*YQE;=?$=C2]6[40;M]`
M?0H-/U/'9<7"R%K21RZ7+D*/]\6_L/07KGJXZ1@((]&<`0SQ2D)",IP[1C6B
M!M>7JL%F6:?WGL%.@&II\[07U7L&YZ$NXX>P.RY_`5S'"%^B'5&0A(G/!XAE
M$QY61(P/+!3,`GF:X5>+!.(%Q@QS0LZ$"ZP[%7:#^TP0,M*B!Q7P?7.J&Z7J
MPHBN^0,N`-E/$R\-L`"3%=O-+`61UPR<RW'9[<V`#0L()X3=N#.T,\*RUH*Q
MQ]_]!3#CB>`."]RBI,][61OL&:89:7.W0`:*2>:3,)@Z$GW8(LYJX,T<.Y].
M3L_'CM*W9I+$?_C)_LP'ID\H^<2/KKPKYOBF?'`KK@)\@\$$V+M:("*&7SQN
MC;S^ID/.(+P@/2X>XV_QF#F&%I()E-U7L:?%4'N:J37Z@==_XWX`Q]*QQ.BJ
MT_D!]A$4`!S/4PI,U6`((5;C,8IOD6%8R)EN05:P:ILSQOL,:"0P9X*K"*%1
MURH/&[5&[K!SR&\02SS4YE0TH'H*Y\)JV#5]!1RL35P8,W9N<2<HS$<'%B]5
M2V2%86+8!A6CI64K(E:E1^&R4%]%&B(1'4\[OXN%O"<SO0;GZY)JH*5L)#B`
MHNZX?":8/P$68PZC'$\E"Z<8=XPW`;<;E=>%WJU9RD3B&EN@L)`=JUU'*:6T
M!\`Y)G[(`=TK*GY\$IMDQJ'"4;*0O?F<V6]P95QP:=!#^&&E'%5)"LA#]MA'
M9^\\!^6FWQJ\KUQIJ:2UN"]5_QG=&K(,AE:KTZ4$?ZTO2@4H30F\+F*G)2%F
M`Z4_#JDPGMB-)+TQ(R'YRXW&F,=%<3(6MH:FIDG#HO`]H@1F"%EH90:E6TJE
MHJ$6QXL\O"*<DRJB6@5R+3S"U4%$:<N(HGK&J2+X9,G3R4#F@SW9[KFM4=_2
MPVK%.O_R8Y[N7WG>\J?/<72%*!5@26:7_O?L0PC2]J_\Z;^(;Y%"SPV>8]`A
MLSNLK4+C-(S1D2*?)*@@^.7<G__/?TV[__<3[%8;S"]<YV7<;</B\<?_^NLS
M4;IP$EP>.X,#Y_B?WTXN?W<NS\>G%^.CRY.STWI$!CY:B]"JJLZ4Q`F##SH]
MM]?NNOW!2+'%D)'``LHHE4:Y18.B>V45H`IB13&,3(*V+B.35B#GZU89.B*3
MHE!#B5P*YN88[%(?J$*K:+NCUL`=#0^Y@2?RHZJBK<-"/]!S#QB&BL!<4OUV
M<0(2Q9/J%U>P\0)F'K?MW[R;8Y>NVSGLN"VI=[$KA5*Y8MBWY(8\W,Q.23B$
M)_NK=OF2PY0PN-]U.R.WVQGJ)#;]JF553_'CT%P/G+,Y2PI1HA6$P03+<D<#
M8/31R'`^ZRY\6HN:X<+0X3%_EY0QU?.%-LS%_L@@4NGVIPN7><<1%)39/_"@
MK0^;>3I;K2YZ[/CK.3;5UY`B'ZR(E?WI)$*_/?(<?3C7H2_%)JAT[PQA)X?W
MT]T>Y1!$9UH='YT(AYN>L!L8`U2@_L"(J8G^D@3`O`C1!&SM70FZ7/M+(%P&
M%_H1:!X!X<G`\F:!IV`V*)H.]7YB:85Y%$P9Z&)U,BL7`%JV:-EIQ@D!6RN_
MEY+Q!V9T$G\GL$.8MI:>8<1,QK*S!`+#%;EKO<[0[??:JI2U<V69*2L/F.S;
M2OBTI*7)7=;D87_@=OJM=4^:NL>:`TXC8YEP^L+*5-0]:#I-V]UZ(7AO4G@.
M"..OM\95JV`-1[[%"A+H5](.E,9C/4`J3R+GBW=G=.1&O-9X%LSO>.I5*=V/
M&1<6^1ZE(!%RWJ6E:%.<"FY#<&:RYLPT1%7QY\BZM?#4ENB#<H]P[S!`'\Q9
M*D(:?.>8=/S^,5"'O')BAZ=<5`Q^DZ2$\+X5TF%M,2H%.XL:RBU$P#A;XKA\
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M3G^%LSGQ+""+/`U=!'X)T)*_F1>S:(0N]SM31N+PJTAY(A5=::R[D$OR#=>G
M#S8%;7]BR`4OA:MR`LN2V-RUN/1$FX-2^F+)6K)PBYKXI]XUI<"**"HH`FFE
M$6B3>*92F58Y'0CA4UZ_>L:>R,-\%82C3OYD+;H0")^<SN06%D\5C%@5SS0E
M;2IA>.JA;YIZH92G<+N00!6`3X7?E344`+V?<@/F0>CSIG[ZLK!(FPA;)/_<
M:]U:3,:E/V5JC4)$.YEKX"VY"*CN0O`J0R1%6C'E!ZE%A[3XDZ"2/794(I@J
MB7/K_E(#1UN%CV%K$(^5FZ7+:?/V@L;!*<#Z"R^)A6-0">IUA^Z(E#9S+K;`
MIC&,%GJ@A5IBI<7".90_)LR%@4^\)IODHD:T\,!0S!<8=23]0&,SE9[%J^_O
MB0<O9/FSVG@8W.29,JR9$&$A<SQT"]$"2PZ-D413VNMJ/\4TRTT47F4XR^M1
M+W7Q:%./#HQ0@J&%ES;=L05TILD,E$[*KCDD,SIF(P$.'?E7<8:M&N0**F(S
M/."69:$O%';+)&>LA8E;9(DH\\$;CBF\:.XL"L\N"3U<$:,+-ISU[D00%LU?
MV\GS2AHP:[R18;T+.QKW2YJ__/@`/?6O6LSC#+GD<]'SHG[1CI)J.SIPSB[_
M=GSN''T[/S\^O00%=_SAY//)Y4E=RK9LL2^+!&36-.ODPO?<'$OM14(^2RRY
M3U@@G[<ZE3B"`5QPZ4_K.:(*Y#X[/E\UII\54>HAT'V"BON(+P.D/&@O,PDK
M1IV<EJG_DR-^6D7IY\*`"T&GWK^F<G8$C^I;`+/4$3:+-_3B+R_CP'4L^VQ,
MJ8QD58$3J,ZQA/MFW8*:$^G5[Y`43E7SJ">--@%UUDB')_&>A@@Y*2-"_NP\
MCC?+JW@4$F0]"-CLW@[NWB;$RC."B`X[/UAV9J5\U[$7C:\\?#,48,M[Y_)<
M)^JQ<]@TNN@]Q\2*XJC.9]CMN9U19Q.ZT2YO2QWF4#?6P#JS;G>P@ZSQ7%)T
M31S:I]T<0F"&_I7'NFA5B.AZWF`[\/)U,)DU1:+7<CN]C4C)>I'B[;[\$4S0
M';B'K9UB@KJJDP]>_T=_[B<8$2VY*W=A"W;@Y0\_"J`8='JOC0QO]^6/88#A
M:(<88*<50@J4[0ZMK2]_L+=GI4]AJS-[H!75Z[C]T<A8Q([M7\,\6V$>T#B[
M`QW,J,[[5U>%4_2X$K'?3C^('LHXERS[60V<JW'R'=JE]7FY`Y0"=I[%^23T
MM^#/>M2DUE-G2G-MNZU.Q^T5WJX=WLB&B[;%1:-6S^V.-N(QW;K`9A]LHR52
M:M9^!*++@NO<>$D0YZF*\&GM6KZR-GHU+FJ9@*PX9WC8<3OM%L']!#/,_J-T
MW2"B+JBITZ-,J[[C3>(;_SVEF!HK2WQO>NUSX+0@8\#2K"PES3#Q3V`/\B1]
M2N0S5Y;X-X%/F5?L+JI*Z<:L[2Q(&(23>(7.FQSST(Z;0+FR,Y$/6-2CJW":
M8B`%5&?0/70/^R/'@^V9!I3=J"1W\M94\,=R(W4YD/!_*REH?.M$`BR53$;3
M,)]IV)[Z&'+&K,XYI5?.V"8Y>ZGOEW?O_5JE@45=SQHIC'K6XR<O2'[%2M+B
MNVE-\AT%\2C=\?#`^30^.7=^'7_^=NQ\.1Y??#L__G)\>ED+`,C?1/XA3/+B
M@S.^.')&"#_(GJF8N#,^_6B<R8\G%T>?S_`[%SQ)84_!6^$#EQ"=3=0J<W[\
M2*)$25.?E[2H#"T!4KVL5%U<(!D5IQUU3>I+@T!&*B@:G/`@"@A.@E?K4/6F
M68U\A7FYA.*W7(8!JW?`)%"X%!%6"(L6E,G5HSZ6DUX4I?`2E0IR2GQJ1DV-
MA(RV$G@RA$%X#2D,,V/GD`F2.-)J^I4ME?FNK#!W"G+M*H:WIC\IB+=FN;@N
M<&D+IJPRI>"2"*5AM&_P#:O.K`)5*N:DO/(Z\!/,J;O[J0XG];-_XX=.^R?G
MGSF)7M[QB/=70I@25C3#_L[K]>E^G9I@P)PHV"NH;NS*UMGYR3F;8$TP[2]?
M*]O#(%KF;.YY%,OO:)S*O\18G?2`)(DG5'E,Q=]\1%",O!K4`;$U=W]ROBDK
M,M:`&%C:.HS#9:YKR]N))2;R()6T!BF/6&'<`B3P(O@/._AY:L&JSRW$H0K'
MF'W?X!>D`I:I&%3R;KP@%'J0'\DZS+(`J`%C7!J8&7C;2)AN^[7C!$:)K5)H
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M.>1UHUH]#OD%#$66793=>\!8%M8]9"F</_=]\X0LUW6/=:<YUB_,H`W5=O=8
M/P=E'B(J2N[0RH-N.>;=YIB_#,-69CT\,4WM?QW3O]6Y&I8-XWZ=7N_!Y;4?
M"Q_D9R,7[4E,5+-2RHTD%I4FNNEZRV?+,E(GW49\:G?8ZF]&4M1LD^LPAX;1
MZ-_^_BL4(G680\-?#7\U_-5<E"^@H#Y8#WUPUC'51#R#A=VDK+]8X<-&CTE3
M^/`FN6@SEWG#/`WS[.;^-<S3W%^;T>_8!ULHN_J:!-@3F#5"R*Z#!#N-I!B!
M_C/W$FS]8&_HU3)&4@LH_MEEF2=*`86KY\@+D'7>@`DS["U-IO7VUIV^VQH,
MW,->K^@BH:;VITIZIL;/:K(FUC=-?#\J,@@]%FW8OYA>QR%O".A9,KP6\<P/
MK?CTO"$:7SN54;'L3DKZ]9Q)$,6+P$QOA]5GV"6.1J9,>/ENV1Z@6*R'R-SZ
M$'IK%I:1K+Q3>PDV0EK$B3&.["O`7,LPA+)A/%]R&B33?)%FU+A.Z>6M;AIU
M$:#$5]:!BW7?0>K(FA08C==Z[+=;KH,%4LZO1?)K,=B74MYH!*Q8E%"YK$B0
M>A"R=_#>,O@'@T-YAU:J/I`3$FQ8AY9ZER6`]3C/4"[Q!@)%(`KV'P45<CMK
M-ZAQ*!R&G#7=QFQUQGWRL&F',(BP3:N-SSDC^-@ZP2A]8ITZETD0,KAYI>I2
MWSZJ]G.=O^?A'9.:^)\SSJ_R-&,/MUL_6,HV]6Y`<L`+?YDQ4:2_6GF2)LD[
MSN+Z^?'1*07?Q*%F,VHS6+3D92W+E41O;+67Y*6&4,4P>09BY3^B&>('<>0^
M\R/'1\/:%_P.G<"?-.:LY+>M(N<_5ZIQ%B\?&ROKMZH\20]"!GD^M>Q)\WP$
MV/$I]M[\PGIO'MM[;[Z@"PIV]B$!TLTJ9>=!^H<SQRH]60",Y1\6LFTDMK[6
M5I4FV#IH=7YP]E$A[OWPT&EM8&.>F?YCWOV6]0>B6NZY?CEMD?:=/I"^[]SY
M7F(1XJ_W6!R+[;B)4=$&#=B"+K"U?>FW#P[Q3+0[HX/^#]O8EY<B_RS`MK/1
M[)F`?1]#_-,XLFA8.V?$7I;+N)R4)UM3\U]0AF&,.VJH5Q3;"3VX?#>6"A=Y
M<I92KZUH@61EB-[7AHFXJA/VFRXR>X+FUZD`-U\CQ:U2VWN-26ZK:'AX/S[\
M8U,QZT,W9I?:JJ/4;VVN,HK3MOMX]JP/[;;*G>T*$NY$IO`YK])>S74H?8O<
M3<N8ZI?-S,Z&3>O`IM9TW6=@TR/AK[R'3XK>M:31K/XR4W&*-M\V`I8>`&4)
M3.D\M)>MJ-\L`1!L1,EM>'93/&OMX/0,/`MBL`2<<2][`=.L$H@V>7B'D2+;
MN*5O?_6"V5I%FE-O&61F6.8ISK^&7Y_*K\,=5@5J5<S_9`?)\V<3OIJ4C.;E
MS<N;E[^JE^^PW_^C%:=L$VK.1GS/[YR.VVIUW-'AP+K\>O+#<]*C[;9;0_>P
MUVKH`?_VD"#]PX';ZRDX"&^>)IU!UQV,#M\_!X\\9DJUH]$[+3?TJ8)^JU&M
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MUPU('<N`E)U++&QR_J"`U#D+2-W+7&=:.*K9X(T)T,J"H!=QK#P;%E-W8`G4
M=`[ZJW&SGL_5HD1`UYJ5OJ,O@S;Q@=?YJ65^*G=B_\5[[;8-6+0KX";NF^(Z
MT!*M?L\=MC?4+%"AIG5GUZ'@,^]TPW7;Y[J!>SAJN=W>L.&ZANM>C.OV.F[K
M<.0>]C?0[7W3++<)UV?#:K5AM;Y[V!VX[=;AJQ)PSZ7>_G8=9)8D?)TDZ^2[
M/(9QGVO<2KNF@L5?XM5K`5'L[KJ;K7PUZVZV\M6LN]G*G5_W6XXDHR-0CR(;
M;;JQ,C_)IQG#R^%=W\<+-A0&;<]]:FLX<XZ4R"^U["X/Q/MIXN,2QJ-8&8LG
MJ]W(.8:.MB1EJA[O&"Z"HWKD68LTFWN_,O1\3[39F%8Y]JSP4'5K\I5]QO]*
M8\B>Y!?77N)?QR%0+#W^,P^RNW$THS]^P%E_]>ZHTK4F;<I+5,96Y>W6@7-Q
M>7;T#^?H[,O7X].+\>7)V>DZY'J12+W2.)H"W"Q`'_P'!D^1QON,-:;Q`C@B
MM3$`PBA$J9^J`%GL6<;9,<?XN4*FYB>G0,R1HP#'3C-$N,)&XE/>_#K,"9\A
M3E,,C.$LX#RSP9T9.Y?F4*P#-C6M7B.7!+^GY@'<LR%O/`V@L%;Q8F*SYJ9J
M0`+C)V<?__:,Z0+/=O\_)I*UVBB_)$Y446\L$V\6_0H6;<`;V<]7L^3-NIY>
M@SQ[<]'[RF[:#>$>1KB'YC(TA&LX[F4YKI'Q.W>M-RMM5OKF5OI<8="G=EQL
M58>'GR[3J#M.I9='^'4>:[PU>0Q/GJ$%FW<#Z8&#MMOK;41UK$D.0\-Q]>:X
M3K_C#AN.:SCNQ3ANT#IT^ZUNPW$-Q[W4K>KV#P_=P_;F^SF^X>Q`J[OE]=GP
M3<I+D[W4;&6SE<U6-ENYX^NNFQ]MH[XSC43KN<^<()J&.<M1="(_L^\T9CAM
M1G-<UQ!X+C[;C/*_:=U_(_J^-J\-.M(>J^,_UR8V3/123+1!WUC#1&^5B3;H
M[FJ8Z*TRT88]6%MDI,9KI<RF,:I>S;J;K7PUZVZV\M6LN]G*G5_W6_):?5BO
MNJYQ1NV6]K[7.FBUGLG<>J#6O@G<HX9Q7I)QV@WC-(S3,$[#."_&.)V=9)Q*
M/9%]L"W$%`W!89+XWA^I$^<9(8Y@4#*.J!<\0PLQ!KDOA%F%[*#KRA5`#VM!
M.V@;40'TL!:T@S:4`?2P?IN,!NOAU7HO&]B#9M$-UD.#]=!@/325]SM!N`;K
MH>&X>G-<W;SHMAKJA[K.5?K\ZJ<9!X),,\09Y/;.9ESELI;K6?FJHL;HH>58
MSS&-U@_K^!+460QZ[G#8-3[8=4HT+/"`LKM^UQT=CC8AXNM%BX8)UF>";OLY
MJGUK0(N&"=9G@M&P[[:'&U'V7IX6SZ4Z;2=C\22:)CYB,GNA!N?--"9G$<^"
M.:Q`59_JXCO9[:R;4:?=,4]'W5?>;*;V\@Z(LH>UA:_!DIM=M+Z\.9(U6=+3
M-K-W>.BV1QNQ--YV4N/C]0KA@!&5M6K+C""[=HZ.SUC/CF"*?R,GC<V10_'I
MYE1LXE0<#MS!8-A(M^TOJ=G'9A]!<3QLN:W61F)%S4YN=R<[?;??'^S.3M;1
MAZ&$ZQX=`U))\S%(,).-A7^NU"9=3]RBEXXOWIOC*:.&]_O`ZC"O^_V#FS7&
MK`RV3<=IPT`-`S4,U#!0PT`-`]6?@>KJF]H>3)SET:=O:5/#](A9-=AO#1.]
M#!,UV&\-$S78;PT3;9^)&NRW>F92-4[US3K5=W?=S5:^FG4W6_EJUMULY<ZO
MNW%%-1T+WHR:WWBM&B9JO%8-$VV=B1JO5<-$C=>J\5K9-J4QJE[-NINM?#7K
M;K;RU:R[V<J=7_=;\EHU'0M>I?;>="QH&*<!GF\8IV&<AG%V@'&:C@6;Z5CP
MFP]JW,R)XLP)TC1',/\[IX2G68WWKZW=BOXO85\/G'$8(N@4CD,O8#'/\CY:
M`Z")/T4NFJDS,?H-F,0VIB!;#KC.[74PO78R#,#"N.^X_[OHHB#&>">=FBYB
M62S]:1;<^.&="]0J!6:7WET2PP+Q%=2>0<Y(#%6$<VD!WA37"M3&%4UC5,!9
M!#BB8A2/06;`_R!R5UKF%H>!=_D)@^PZ*,2(<U%0=KW"!AMQV3:OWD_GVM-7
M&,5.`$NZK[=$N9L$[TJA#97>LXSJ:9M\L'(=+=S%Q*<7&5,VQ[*O87+GO,/+
M[*"2_/K^/8BU2Y,VYT2[L6(5E9,V>($6(?N$K+T'VMZMO12-_CJ-UE\(3;QS
MH!Y=$JBV)B+/(4Q5:9KX-P&,49G5`?_?<_[,O23SD_".%IDZ\SC1Y."U%UW!
M=+*8M6Q)LV`!L@#//5*?`'6\6R^9X:-S/\AR;`)C$:CXNFF6(_2?_"(-D01^
M-/4/J&7--%_DV%'FIF@.,S>8PYO].V>`/QEUN9&C)3@Q^-WQ0/Y),*!%G&3!
M?]B:`T-^(>M<1<%_F/#$`7%&\4P?6RX<B,1H,CO0V.U2:6DS5Y]E$R;Q2=/3
M&-(XDA5R[M9#29^"/D`@B5%VH)%F.ZQ&RQ:L<!/C]H5!=H>$8EP7,[I>!W".
M$SA(Q7>L%!1#A<%<P88LN@=IXQKLP>::P@4`(P3PO86?7<<<Y=P!&L[\=)H$
MDV+'+XZ/_E]O&:<_PTMRN/&`'4%V@!B/]:T1IX$_>,.!I^`$+:CS$=Z:6<+Y
M7"Q@FB>)+X"EBO/`("\96`2=3#BG,SQG<9Y(8L$P[!OK-R=ZULT^XYL1YQGH
M!-&,G4(O@TOXAM&#]W?R$F4K85'XD4Y-CSI/6;0C/#,I[U^5_K26-"U:,MD;
M+U4W:U*I]:B63()TW)O9.FB3^LX-CBFLPENF_D^.^*DJ1+JV@_:!@=L01,W^
MM8\&#2RGW3?!@TLC;-88?/&7ESLD="R;?/^47@TQFIVH"S%V;2?*[H>*5E#J
M''^CAQ_?YVLK%-I$N*R1QHT,V(&7-S*@UB]_B>T9@P#SKGR[F*HG?1H!73^^
M:P1T77;B+4B`>KS\)3;GW%]X011$5U7SJ">-&A']"GCO-"<7G.)MWRT:O?H-
M.O[N)]-@0WAPS?9L>GN."K^_\6E]2=2([JVSGI:6--&10!_'FN557&`(^)']
MU)K-V_+F?4V"J;^#U&NVSKGTDP6&BG_WO22U?*.^A&PNAJTS:.-V:7:BV8FW
MMA.;$+R;K-_C"3$#['G\,.K_2KE`&U`ZE:[+]\[@N;:_3G-HV2:Q1O&".J_V
MT.T/.FZK,WA=M-G%.6RBN&63O-$ZZ':K7OMV=N6USF$-#EG#W34X:(]VDD<V
M<[\^^!I]L/IP;$^=W045QOKR!YO;+Z;9/=$1<*\X[;CMMMI$U9C/#NWB;KU\
M$Q?K8W9?FT;KH+,A(++=(O_K??F:KL#2A$8'PQWC@KJ9HF7,&#Q50?30BX.`
MCG><':T75@?(H52R;TW-?-3D'@/Q>.@.AB-W<-C=\=UL7MZ\O'GYJWIYY<7)
M/M@"ML8X,ZLL7:Q@37RJ*O:6RR3^3O7-X9WS[G!PZ(ZZ`UOM=1XI!=.E<O)I
MG&8"<`*M5J7NW"31TKNC<FB70U>(8NX$3-TDF#+("=E+7:!DF-7;:H7IQ%>+
MN6-02!S/N>45"8[',E]%=;=8FABH?=`:.7<8ISVP[-G+E]E&M@W#PN`R(LJU
M!RMS(O^*:N;+2PHB(&6$R`4W7IC[3AI@73-2>1K&*5)\B:D%K(S:@^N9E_4C
MA$%?)S1B'3"0`^27B1_&MS2405^?YZF)P2T)A<8R-"[;#LE/(N?O.7!_0>H/
M,<(:(+0)E9%[0"F?>(2P4?(PDZFZ8@SO*O$))L6Y#;)K>()_$7@8.10.V4TP
M`_K'R3(FL`)O=A.D<6("8*1^<@/T2P\0R8&&)1Z'<\-VL!C78R@",/.Y;Z?W
MN[[;:B&\A42K0.*O5U#^EQ_S=/_*\Y8_41+1=1R">I<>_YD'V=TXFM$?/^`9
M_\I/]"5H<A]"&/^O<NB_R"&FU_XL#_VS.:&3E`8[C3/_-R^A6O>SY!RYJAB+
MRNKAEW-__C__->W^WT])O&B/EPGNU67<;<-9P1__ZZ_/+4A/SRZ/X>I0<&Z*
MGWX;GY^/3R\OZB`_QDZ:+^";=WB@;QE9$7XCN$%DAJ>B%P4IL+*?^@3'0++@
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MT-E&`L,FNDS4:P/N>_D+Y`*NEP?6.NAL0N;M%O5?[\O?AA"LFT'ZX'6?I&F^
MD6*T-\H`ST6+3L<];/?<?K=)XWNCMV&[Q6S%MI(D_W8VXO6^_&W(Q5VQ!8^P
MIT48^K,?C[\O@\1L<?,*]OSMEICM]=Q>9^0.^\/&EGQCM^=PDY[6W=J&U_OR
MYN[<":.R*KAI)$R^/KOS[=ZU_;Y[V&^[W<X&^K[62^K4^N5UNG.YQ=HQBB1>
M_S:\WI<_AA?0;='?'4+LBK$J[U5>2T0E`V_X7GUKM=W-%=M<L<T5^_I>_I:O
M6/;!%DJ_+ZF--3;21>L4+%4D1<K:JA>=I(TZ7DT6>&F:+WC-<9ZR6E39$9LZ
M97M!PNN,@V@>)PNUV;P8118-NJP^%G[%\FT<[%;<^3EVAOZ/*$_\$$3Q(I`]
M%91U??:RC`J,61MEK#;&AQ;QS`]!67!9NW9KH6-Y1RNZ;3^TZ["]:+&ZT-&2
MP#9Z2#5CI4&]%=^)R!!O60Z6>JS.@_0/9Y[XR"5P^GV$#``6LNA5#S_C2AJ@
M*F>PVO,EQ9Z8QFA->:???#_`U0=*5>^''27*<[GU?KL.,J,FUUQ]I9H^E@`%
M2G_Y#:@\:Y#UN5CM?O8J,]=P!+S59S`75:^HX^)KX"FN7)($ZKR)0P_OKNQN
METB[`;X:=0[:*+1&@X/!9H36;G/54P65Y*A9@&@AT6PSK4-VAI].X\C?I2/T
M<)U?`55Y+"+*7_E;)+;*1W_N)XD_._=O_"CW/P8IHOSDB5\3$!5!+8:@TCE0
MJ/UQ?/YU[!R=G5Z>CX\NG?'I1^?\^//X\AC_]]?CTV_'\+]'9[^<GER>G)V6
MKNQ*Q?QYT552.)OI-$_1$@HB!W?*`;OA%K0+4FOQKV#4>,X5PE!%A`@TY1WB
M='E`EA`C`=@Q%_XRXX9(BZ.MH"&#P#U^-(6!;^/D#_QBFD^ORY05+\`9G4VS
M&`?!`0Z<LRADL$&(QL40C/;H_\J3IH_Q'C%>_/G<1\@8-"`3>G[I@1!$4"+J
M:.1DMS'\&83?U;5QH.;X'.)%I?GDW]S(8ZOD7EUNF('9R$TX-"E)-ACT)F**
MJ:5\-C%?"LP&;5RQ'H/.3FEQ7@`6+-FZSB((P?Z(T1K&$1G$&"P'C)-KL(*=
MB>]'CC>]#N!$Z:G#BF'Y9PY$`5)7V)%@.G/[.UW/I'Q6SOTBUHPFQD'[H,V/
MX:C3;O_L_);`S056.8B?A&"L@,_]>1`%M#]`)'-`I`#(%"`X85KY7NA,PCB>
M.4N@$/H6Z-'T+@6N)D[VIC2Z?@HBH%N:(F`1OGVI8FC)?1*H<012UNV/W,ZH
M=V`PWA<O`C5?'+DT0($*TP1^+@9B:''`F1BV)PZ'70JR\EE`H+,HSH`$2]Q;
M?&_$3P',E&%S9+`%\*6$OAQD3AGN3HR4QB'BZL'C'@QX#=R!!^GN__66<?HS
MG;,XR1C4%QYO1*^+V)1A!5.0"!KW(;MZ3B1:M@K\IHD/#(#]@P7EN+_%$\>+
MSI].>9`6B-F'S-JB*2!98!/@0<04`YK-Z(4G7Q&_+$.)`*-)WTYQND!!@M-%
M5`$B_>'?B=FG^`Y6\2T%&N*K+>1.:>N[`>E`$(!^R#2A);P7]@F8"RZW68P;
M&G-)F&<XSAU_K<F@,Q]F%=(4R.>5@R`EHM%4)CXL#5'LX/_#_WJW7H*G6!G)
MD*Y6(4V$H_`(>]J9P%&831!`SN"&F8_(;LX<KE\26#`7I(98&9\2#F)POLF@
M"V_FT\MG/KKSC+?3GL79W=(GLL.'E4XY>I(-4PAKW%!<%OZ%RT([G>5<#VIP
M0>MBKN/L[SN?O$F"`LE.GE25;]+M"4PWC;VK/*0SM$^>*_SC?NHO4[PBRZ*/
MR;GR+NV-+XZ_7OQ^\9YO_($RD6)SF-#,\@D>W]3/=!A*4#J8X&2OQUMW,8FO
M_"B8`D\G<V^*WLT90RJ\IOL&SNY$WJ9RMT,O77CP!I!`7H;\5BEEW[5'7;<[
M&+XJ$7O)P1-QSIZXUFCN.KV+I4Q1B4LY[F)*UP\H".+^MS&3KBW`J0GC)7.;
M$_HE6'CR=@3>O@Y(G?`BT"*`NWTZ;V52I?D2(2%3)AG@3:A4N?PZ):;!,;TP
M1+%+&*Q3($`2S*Z,SJ]T#:=I#%_/.%+J-:R!$2?Q@9<SA@H[1>F-$']WRIG7
M!2*%%>:P&.`U3FT80]X\-U+P@"RYB5'RP=@ZL8%/%D'&A1`0=`X:52V`6,N2
MI*,I3!_PQL5-Y3M,RQQ_''^]Y(?=HC#%R(S!-&#WZ]1;9CEJR4R>`-VF>9+B
MN;0H2\6=O<!-PKA-H2WA]X%)EB$HZ*M4)VT;W_4Z`[?7Z1VL?ZHMFU<^Y&N?
M:Y,\^D%?^V"?9"I?*6P*.BWZ;6",@FIX#">DK0BM91F@`HKS"KV)06^%RO!*
M+X'!X`>801I0;@JR*]"<*5\<GU788AJ]Y6VZ\#TTSYD,"7CRZ(0<B#@-@R'P
MEM<I/_-!]4NSA&$N(XBOU&1P7F@U<?[BBH9Z=4MFP@UB%X=<D84=4R(\UU9,
M^8L'&![F`I4`I6^\T"9P2;2$:2Q5%HU"9.LA>C/I:U[H)0';F0A.,G*Y_SU(
M2>RD=(K@%SC4MFW#R)OO.ABD3$`TTB)N_3`DFPR%IL^-:P''*T6ASD=6X5.X
M<>YWOORU[*TY`GL^R,C$&D<S;!Z/LXE@/6GM/#<%/9GOIGO@')U]^7)R^>7X
M]/*"W#7HNSDY_>7X].CD^&(MVCV[X/Y\_,OXL_-E?'EY?%Z3*>&V,74&6!S_
MUW6FH1<L4O*3H";O>%?HH,B<7!HL("^"R"L0HHOK%PXFG>E)GF)(/Q4HZ?!)
M.,/8>AZ2+P@D2G!%1P\VCMZW6A\HOJ_[;X((+V?=#,DC+D31-42#Y='<NX$3
MA9($#+1IC+1CTXJG(%!<\EXYGA:)!UD&QEIRY\R\!5P2L*`Y+LQUX!+Q0AH=
M1$L0_1O>R%(10,A<!Y.@`.(N%I6GS,("&S(D%04%(-B<:%O!8[,</4DQNFVN
MO"O\`EHZ>+\84H3#)J/?JPX:"0I4HF*"#D%D`%`;+13'!:%A+'1-G4`<")]M
M"SF\/"DI$9?<1_9B+D"\?5%M93R5*B#C\E9;<NDNO'-P%0FD_<29YW0'L3_`
M179&]SA\*;+HE1^\!/<,YX*W:N%HQ7LW\!-RLR)CHH+!]4R\CXWUH9I`9BL0
M`=40XH*$/'RP3#25Y7)#_TIO"P0\,O5]?"C5#:!M"30P)&L!+GZB^I=;AZ;?
M&_W">%F'H.)P[RJS$,RQ4%S`U1V3,7K';FRF-,!XBU1XDY31/-*9P!`O[Q>Y
M@IFI`6^GWUR18`2*:7CG*G9(0+XD\H;3J";O,#![>MF[@=OJ]:D#`CG::)QW
M;6SI5_S1U8=07[V>.O'L^W96[%N/.Z>-B`7(#%CYC'1=-%6^PTF9J1J?&(SH
MQK86)(.RA6`LXBBS&7F-@<S,I5ZXZBU,(%])>B%K"8*Y:,H@<`7`YZ#"@U[)
M?=.!*CZ*P8I>)C`P8G(S?W$+FR"LX9PJM+J'*6E&1.YS[$4IAH;2RP3N=AB"
MY-XY&!K!#4KJ.JIZNK('=B']<'Y\='SRZ_C#Y^/M!S'.>*>.=I^XN$4"*"&R
M^NSX7Z#9`C]?)GF*=0/P(VV$]*J4](0]%`KLA>P!^B[[PWNX=K#S##=?P6B8
M!DN\(`5GE:70.Q"(1;.-*.+><C+'\9R`B91[XMIVWHT.Z=OZS:.]9/`#CD4)
M"'B_`WNCJ85G+<+`(QJS>AS/FTYA_>1$#R+L'POG=.\"CB&%*OOOK0TL4.JJ
M!#`(/\$8FTS<`R$IK$P@(ESX%/(#B8@A?I*,7A3E%/4Q="K2-^"(Y@GUH_`R
M9N$5CG6^MRQ8<(I'GO_5G)7TO\ON/\4<@9*H"G'OPXD@!5%!SDMJ5L7:N1\C
M(&L?584\FG&+M'POX9=+4JVX)+5WE8:G]8/R(MTR++?V8/N'"R[W3_XDR5$/
MEVVB"B9:>D'Y$A4<;XAAQKN<.<)81*5$ARCDT)Q=.VRK3*7R7=\][/6MK/JQ
MB+^RZT5M80+2`91]$/B:9KEJ.2GP#E[KXORJTS>65JS&L@KGW=`=#<!('L.Z
MN<I,$BJ*C6.``U%CI?@6`WIQ)N084^29UHT3\Z.4^FU%5,6*!"RS[L0+2:RD
MU[Y/3BJ8AQ&*?JA7XU$7F*7MSSG;\J^HD,-(4>HQ\VT'KK_^@4Q%^3H^OY3>
MC6V>T(^Y+\*?>`:FWC+(,/9TC<Y-,IMO>08#6D@LBX'):7,LDD#2";H@?DE%
M1!(LJR!6P[0DQDI!36FZ\R=1'\0$VP@U=1"^:*52-'OB7WOA7(A-T*R6:):I
M5T-A2TZG7DI:']SQ129&'HG;AC7!POP/=)O>!+,<?7M5Z0E!HC33&MM/!BVL
MC$GN:I$J.(ZW_NP^NDA"O!NTAVY_V'*-,R]:V=&IC_"LSMB&"LG(DVS$I04B
MAE&K<')83_W]=T=QLA]P(FUMO&2"P/%-J>77ED^O/+J4CC4X<"Z^?;@X_N>W
MX]-+!_/(ZM&:2PFS7&,T`8MF:-]](J:2?D%1>(55[:J/R,!BX7M6CP/*F,XZ
MQ35B38R2]PKZW("I\&I/,_@#,[4HIL!R0>C>LZ8`D-8=2"_@\??I-?6P(3NJ
MB`UD"L.Q7!#5[29#+HP:[+0LX,3SM"0P"O\->I3(`X+G?XR9EX@QKHRX%)$)
M&,"VJ%IX\[#KH!<);:M#LCN]#I9+:C@X"[RK*$ZS8"I\EK2YE@RY-&;"P_\>
MI^1N)><GRRH`\0=J..4C8LT#"YM,R25+W&%F/<Q$K):4HP5MV[NVV^MVA*+-
M;"VAOL+=,<_#T)!U0FOV,AG\#<KZ90>5YT`)&:<V9\,\2-*,)4$F;!>]T!?^
M[ML@#$7S3\K>X<8:R7/KF>F(I+V:.&84;98[305/L,NH(\^X)!VWCSJZC@OL
M$Q#6J=-Q._V^VQZ-6-].NOB4]JIJ*\@B2ED</W%X2ZF?0'ERYP+!F45*AQH&
M5FS62(_GJ;IQZF,53EBR9\F&DM8D>:T=[^HJP::FIG>G\.BTX9(>'O;1\L0G
M>'F/,B_1@;3<T;3D`><]35FH.5_R*U<9`TL9\]#S*YQ-A9>/FX*U<!4_"S^U
M6X=NOW.H<%.)A4B\<$7+0FK6^30A=A+J&*L7G>$&@LV$[E1M'["HU!R+59ER
M39+/ALT1]#O@3/H$M4/^&=U=@0(`+">5)^B-R416SL7^"#;T*J"`.J6M%A<@
M1:19!:TAG<8+9G:BW#SWZ:$9>L:[<//)-JV4W^]\!84-CQ"ZK=B?3+\!ND^0
MH?"[S!4N"<:N8=*Q2<SO<YW1IMBG/LJ_2D>/]$0I38!](H'XQ-1<S4[1<+"&
MQ3FJ@?OB>43I"'3Y5FL-08H4,H,)F+P*5^\4U2]Y9RK,#Z9"I]]:1Q]1*D>J
ME/"_X@!_^?'[)`F92_K_!U!+`P04````"``O5E!`1<8FHGX)``"D:0``%0`<
M`&%E;60M,C`Q,3$R,S%?8V%L+GAM;%54"0`#BB4]3XHE/4]U>`L``00E#@``
M!#D!``#M7=MRXK@6?9^J\P\^F9>9ZJ+-)6DFJ4Y7$7)I.@E0D'329VIJRM@"
M-+$E1[(3R-<?R1C"Q;*-;6$\,_T2XABM[;5TV7MKR_WYOZ62<@40()H##&4P
M56#S%\?Z52DI36S9?1TJ+>2PO^H.?`'L&GH!A/W._CYV'/M$55]?7S_J[%:J
M0P(H=HD.*+^@E$I?%/[O/S]]YB!-`CC$B7(W=I5+,%`JGY3*T4GM\*164^[O
MFDJU7*G.OL2^84+T--`H4":6B>CIP1+89$#,CYB,U&JY7%/G-Q[,[CR9\`LK
M][_6O+LKQ\?'JO?7Q:T4!MW(FJVHC[<W?7T,+*T$$74TI',`"D^H=_$&ZYH#
M,8IAER*\@_]6FM]6XI=*E6JI5ODXH<;!EQESBO*98!/TP%#Q3#]QIC8X/:#0
MLDUND7=M3,#P]$`#EL%:J50JU5D;/_,K?S+%*#:AP;D_TTS^)/TQ`,Z!PAN^
M[[56GD$#SMC$R`(&U#63RZCRVU1A*ZH40UN((8.^PSY;`*6P=;TA==XEL[6W
MJ='QI8E?DQNZ:(%9Z%G'[M1=T^ME-\R6%2O!Q`'(`,;<3MY:.AG?:6'0)M97
MX$S>VS&9HYG:`)BG!RXMC33-_K-!*7!HTR7$4VJ9.=\BK]L/-3KP^K[_/94S
MJ@+3H?,K'L>E<L4?`C\'`Z@I3.4DR[#0:U?]LK!J2;L&6350(_K<`O9Q0[C5
M&<*_0Z6N97FME2#KQ_/O#PFV(F1P\/K#8V(`<GI0.5!>`1R-'?[1HS01H>=@
M"!B@<0D1[TM-3!W:!E)Z@0AJM3_L)?-"EGPQJNMB)!N'NHY=Y-`>T`%\T08F
M8!@RAV487@%4">?+EZ:6B31M[`#:0,8-UM#.](D&+8!(,9CSE3K,1"G/UP74
M>8>2(4T`2@&T".+&)_\H$_*[!-@:-"XF-D`4,-4[SAB0F5TR9`C%*X`@X7SY
MTGS*9G&1)L([W;E3';A*K(H@=)\2=WELLWAZVF6^N,,4O'AVH<TC%4E>5"C>
MOG3YX+X>1I3(D4HJ"YOJ-#2";(J;6<1`+B:ZZ1H0C:XP-EZA:4I:&*)Q]W6H
MQ"--Y%@E#4!L3*%#Y<U/:PA[$>4%!QFK3`C<HD0LWT!M`$WH0"`SS@]`23.&
MY_Y]5YMR7V4'D=`:TG*OSJ.OB%4+"H/6:1*L=,E&J0ON<`^8/.W4U8CD?A2"
MEN_4&4^0,+*R7N>\\$K^``F"R7DBC:=%(#_9KF#^C@I?-G>D1@3B>T9_KZ6)
MXDV4%DCL:!`6\_(]L-TLAJ%X^3OJ,:>R4-(RS1W,0E]=)RXP=J-0!&)!AE$4
M;Z(L0AJ9=JA/@0>/D"I?DGHFXZ;O8/UIC$W6).4QM3.5H44`2JI]/&Q9&'F-
M?M=,5TJ.=@,C7]]1K-/JHKA.3-8)JX9A0&ZJ9G8U:+104[.AHTE)AHB@\A_`
M\<004I7IMM\Y>`$F]E)A?4<;@0N>I;<)I.`<#*$.'3:YNY;KA1/G+H%HM/X-
M.>Y+:JN*,-ZR('\SG"AEDJEI(&,WDWLDYAXE0D))658V9.$5I$2*\F1!=PEF
M)*\025VK1-I5?=)ZZ5;B"+MC\^)&-O;\C3(I:>)-D.0I@2[!0T"IMW1<`CGV
M;F#DVY&%&JWM`:WQ(O9NDLV>V@`3-I#\[)MOBY0Y,Q@I[YDRE@PBEK).3LZJ
MDDV&U#`LB"!UB)=+D"A+%&0!!DDD:\+T9<K9=39?WV`J=WY=@DGL,_>8$X9<
M.1/KHNW\PY00:99[S#L;4<6A>_P0`6-C<SXJ+1['.Y'P^\/M]]H?OS_JMCOY
M@8Z.C;?ZR^C'%-V?NZ]7=7)<OZ[^=7\WI6;]17\KF]^<#^K-;XT;-)S41YU'
MW8&/#T_6PZTZK)<'X^[DN=P^:U=^=,]-^UOOP]>GSMA2+WJX_E@^UO07]6KH
M?OU^K+;_USXS[:NW5JW6J]SVFXUAHWQQ6[^N-6OEGGW\-)VV;^^>55R[J/>&
M;50^O&LYS4-X??V`K%NCVWSLC9#9O>A5QL^3H\8=G4XO[\\^?3!JUR.S]N'(
M<1R]^?6;_=SY;KOU:K=]_=B[J3Z!M[_&U:^#Z];U60<;P\JD<7KZA]+L]_Q#
M&@EWCQ!>54?BU"P&2S%Y76D04=ZE`.V@BPEOVX5TS/W-SO`<#*0D)J-!\Y\Z
M(J5=67*B6<S84>MJ4]XZG36_"NF55TMQF2-!"Z9;#!;%/ETBW>X1`9H)WX#!
M^PSO,AWTODDD1;4HR'Q=NJWTBF0OTZ+U>;GOO*YT9IZDJK<@I+P]CZVT$;$E
MW(9.OGVVTV4W`C'W7<ZM1(JB3[`CG7;XS&97:1()D(HZ?%;8VMQ^+J5:@-K`
MD1NGK@+L@4,0],"!@=/R;?L8"$8^2?3`%K@QN:6X%X=^$\XQ_!@4:Z)+\`MD
MMIQ-[RG/FR\D;?!#^][N@*2N'A<]^8KW3QRP6VJZ,@96Z<JTB!?8!.C0LY]]
M-H%'"S(:%B8.?/.NR]E*CH&;LQ>?2K-XQ&8<B?7'&@%G&K.3O^:#S9+2]!,@
M[<%RDD(S$7WBY'KBK4`=`(->,MM;E+K\_'AG^*`1HB%9AR)#$?-W^%/I%L6G
MG'!-9P;O($9;ALFYO#Z=2H&\95HN_*Z]5P[!9MMY'[C$I`_("]0![9"FJ4%+
MRC#;SH""C[HMV1;6'&\EM?>2GG=D?DB@A=9.#=P!8D$4L/0)WOFS17/%7-^V
M)BW38N1ECZ<SG+TNA9GJY:)Y9@#2V5DU*=6F<;$+/A;C<^Q+^ULV:R$+2PC0
M>&'D[&<+;;Z`14YV+`9ND<.'>,3Z8AYG%#YL@OHOHYB_ZVAG+_%(:$FA_:.D
M[,_3`6790]H_C,>#V(VC1;L=Y*&6_,TZ03SVYYT@HU?`19JQ>I0Y%_773"BF
M:Y:8\+G@0=7=_U;,[(>H6Y30;!P4^;<68Q\4C%N<43G,Y*"/P-@6B]1H;EL_
M0>@ICD'XY4EWN*$_NY``X3N@9%9[Q4#?T_4DI"\$58'%H7ES/RE%%]X`7G^!
MU$YDW0#=VZ4DJ9Z;M`HKH[.<BA:IA5RFHB#T5">R%ML&2]DP6?Y.&-R>3C8A
M:HOV7S:(E/!RQ8#-GJ4S\KO;/UL&W=L))H&&`EI#SI.F''NF"?19ZM)[ZX_<
MW&%<Z/W,(R0:DB'\9EI=W`/VHOI\^?U-,F048A5:-S&#FYO8J0)%ST86R6!C
M/?4@0ZP0M'S#PV@:U@JQ8@>3D8=C"ONX@2YK9"5381\W<.2&G[<-K#W]O/C?
M@[P)ZO]02P,$%`````@`+U900&:'80M]$P``Q$X!`!4`'`!A96UD+3(P,3$Q
M,C,Q7V1E9BYX;6Q55`D``XHE/4^*)3U/=7@+``$$)0X```0Y`0``[5U;<]NZ
M$7[O3/^#FKZTD]&1;,7Q<2;IC"S;.3YV;(VL7$X[G0Q$0A(:"E``TK'RZPOP
M(I/B1;P`)-6B+\V1I=WEMTM\V,4">/N7;K?S'F)(@0W-SFS30:._V:N_=[J=
M$5FM'PS4N<8V_ZMAHT?(/\./D/+_YG]?VO;Z3:_WX\>/7PS^568@"AEQJ`&9
M^*#3[?ZC(_[WYS^]%4I&%`H5;SK3I=.Y@K/.T>O.T<F;P:LW@T'GXW34.>X?
M'7L_XK^P$/XV`PQVGE869N]>A)0]S:CU"Z&+WG&_/^@%7WSA??/-D_@@\OT?
M`_?;1V=G9SWWK]NO,I3T12[VJ/?EP^V#L80KT$68V0`;0@%#;YC[X2TQ@(T(
MSF%7)_4;XK^ZP=>ZXJ/NT7%W</3+$S.W)O+OF/9635C`2<_[XPL7L$[G+246
MG,!YQWW&-_9F#=^]8&BUMH3I[F=+"N?O7@"X,KFZHZ.C8T_97\4G7[EK&;&0
M*9QT#BSQR`]+".T7'2'XX^0Z\K``VDN+X!4TD0$LX>^>^%HO54KO'UXLJ#/T
MZQA0B.TEM(5)3([=NT+5/,8UYH;`!YO_>\6UE3=]5U`O>`7EVCL";'EED1_E
M#=U*X!;*L.Z.V+"8->XOY+E3B.L7MZ`O$X!^&0/Z'@CR;"AE1%]FJ/HBRQGB
M62+3C))V]&5'9Q5;),=I)5/D1VPU<Y3$;D63%$1Q58O4Q'-EJU1$=G6C%,6X
M!,/41;L,XU3%O13;)+T!%\1PQ.QNB,U+;"-[<XWGA*[<C*28B9F2MD`":N0U
M-B79"7(5D>6<N,]@(JZ7<35=$\Z!8_$YKZ\F;/M6!L)VC_^DYW^G%_]Y\!(K
M-I:L`,*E;?5^'0H"%=8NN0AJ.#/8W6HN9G"2@/`[KP1B%YKN"JYFD!;$-_+3
MYV%3A9G`LHH9)W[P;!(/5H21>+MNN?*(6?#)AMB$9F"8^'6UC'L;95RQ18R(
M-DL4,`@-E%E@!JUW+QS670"P_KK-'[F5\)K_DR7"Y3[T'+"9^^3^CWMBJ.I!
MRV;!)^[@U>T?^:6-OV9H"459>:.G8);B7UD&>QJ"\3'BUR&-VLSC(##%#XE\
M,>/_9D[)*H]?;)(.!*$FI.]></;RHOF-0;#-P^W2<K_%WPBX"(H%U9!_,"`&
M%)'A$U(;,1%%SV;+=4/B.)KIEDCD);HDBM#6,]L1HCCVOL"/F*VA@>8(FA<^
M1RG`/U59+SS8R'5#G'PS?9`4@Q%7I`,6=H=<9WSMU^X.U;X(9FUJG"$`\]UQ
M%`VN8AX9,@9M-IPQ6ZQ@J'#"C@9EI+`S02I/#[N05('9*PP[5)3(LZ!.*RDG
M_E)9\.Y',/D9!'I93QH=QLL%JJB'JPA/5VX30;D_-,)!Z3V^#"`OX!QRI>85
MPF(J/"+,9G=0R:N?IBHZBVTIXJDX1<>#<J.N81`'VVP"#8@>Q:2(2_8M4S(&
M9^D["&]D(^:[Y+B"2T0QB@VQ>4L`KLTO^Y4>A'-R8.=[:%#!0VZ;!63VLP(5
M+DG0<A`^2$+'!_U5!=#'%*X!,B^?UGQ>"[F/[^TEI)XY*N#/U'<0CLA&S'?)
M217R<$6I9(N(@H9`+Q*`\=G[[KA3I8(PIF0-J;T96\!;"/CNH+7((A3-FC+U
M->R-/.&?A9:,E)6/=``O$!_A/&NXX,LGPW),A!?O"3%_H.?RH&1FV*^WE;E9
M,>0BDZF2*<::,,1M4483.QJ:+"KDR22B<$3G0I580-WPWV0D)\=/?)3?&=Z+
M5V9N$9@ABS^:.WU]L(GQ;4DL+I+Q[`\9R"Y4K<DOK4%LLVM@15&ID'B%9U5A
MC27J8TD_;P#B<B&U6SQ+Q$+"-";(H,=@([*#&JH-.YK"IC<R=\^(LJ12PRY0
MY<>:[;CFP"F90$NL1(\!%88H=$.&MJ9>CF*.R((K/)$L7^]1_RXDJ6FZVIP3
M_D2$H@-^R5*^MT=&S$-K\L(>C2H79Z6Z9!]R4F:6%Y"B1R!V,X6L4CE.9>EK
M0<DG[VB5"9N$4IQ7^#`,ZD"S'L_LT7@PK\T^Y*)%N2KNJ=$O!_VRI(+EN^)U
MA?>D'A^T!_Z<`1B&/P/Y*BG&B*Q6R!;)I<A].%G9""\@-K@:-:R>KJZY9*-4
M`I@+P4CQM'BN7;6\L:>@<4AP[\=#SCQWM2+85?,)6(Z2Y<J8CJ92NQ*!'L6F
M>GH]-$WW<8$U!LB\QB.P1C90LA:0IJI)!B[H@52T9*S17,!':!%WW>?!!@MX
M*5:GUQ0Q&%AF&,[*<5/["X?R06[W%VHRC<I6'<CK)0/_ZNM`8:/%.J"]4>'5
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M*0E:";%[OQ9':O,YC;^U2VD0IRL[A/0U`ZJ==>K2.]SFD#%W,?`*JHGRF(X&
MAY&]H;>SH6T''`DL>@MFA`ZQZ7<W^W8H66Q)UM1H<:`0_FE0R5BF]L[UM[CT
MH;GB&`@K1`>G0G_L4WDHK\5>Z"2<R1`SJ!9J:/;=R!F2F?00.RBF(OQ>FG]+
MF%H'A-2T_Y2H1'!V^N^+]^BY/9R^&SW!A5KT,G[>VEG[WN>6T#K_GIO(A(L@
MN\>73\)M#F)+8=/]_`+.E,PY]RMMLEML?Z1%1OO]`,HX:0%LW-973V14C7O^
MDI*)Z5ZEA^.F'`!*.+WJ(Z806&*11H2%B(I[_+S[18F3]JELJBVOF'OV`A>>
M,U4Z(XE/'[P(4#:/3='47"-X,5>D`15A\*HN<$WR;%'L@K"F`W1!!*@(WY??
MBG5',(G.T12^#7LT-KA3KIA/]B$G9:=<K9YIFU.*Q6AT/_8^MU38.W$';;59
M7E3!02S$[V`BX>BV2T`Q]QX+FH[.`4.&H"!D.;::QI1]*EN;%^;&++QEM)17
M/D.T6')1PT?^=BW@G2-,OI_'FB]<S2I\5,R`0UBQ*`BI[\+3EO2^;^]>E-$=
M$L-)M[3HEA;=TJ);6G1+2ZS\'0R\[(H;MJVP#\75VB4.A\LKK,V$6A"6\D<$
M_'\E`J6B;7]N4/8<RJ'Y'X=YQSZ($\\XN1C(/3]=2)\2<9`ZM_4C$QVW55\+
M6;H:3!P28W3[MD@#4P*U7,`UY2.D>U\D_[<%792P.5P1:J.?_HV4\E^R7'K;
MZ,%BP%7NZPLR2C[G)RM13%'FD11-C?8:[/5"&CS5M^;H%=E2#LF_#EMES\Z8
M$@-"T^5%L15(;`2_GW\&E`*LZMJ'3(W-SM!RQ^I.VV`FAG(Z=/PBLL$)K8;5
MC;":)CMT2CDD$2LI]Q%LO>ONV>(D%7CYBM`'2!^1P>VD(PL@-46@8@8<X+M4
M$&$I/=&ZR:$0,>5M;7A5KC#P'`'BW-MKO',0[A32%<()<[>4'*B`N'9.T`J#
MLK-P6^Y\M=#<^W[NW8O'WU^WL<A=D&'>P>DJWHW<NIL=WO:^)_DQC)Z$6NIR
MA27`"\C"6:YW5PDV2U^X4$QD&T>L4M!$%ZA*]@49?(@4ITAY_W^-XW<:JND2
MRJ&WL0L!2H5HM(LH#ZR5=ZO%U?@7DP77A-9V0UY)2YJ[=$"!B_-A+^>RL;3P
M\L_>%S6IV,GB];['F9;\3_D]'_8RSN[=JSMZ+TDC#M\QH;F^SQI<O0MW]3Y=
M?QU@3,DC,J%YODE=$5"T"I97>X-^K;9`EAO>TF7\N)77/`5BLA:-LX0=UJ)Q
M)BS5J_G!OI,I&1K?'41AZBV@2HK'^;6WY%W*$:5)VWKRP%MYIAM3MGMK:"TN
MC"EM3:-`5=_%X932M)$TV":86B.7)6D_S/>O"+REMW#%K=Q6AV1P69:PP^*R
M3%BJSPLG/+4,=E&&+UE3\>:DZFHN:RL8@-'#@=*0DW,+^W8]-53H5M4JD*6N
M)8-80>]D`EBYD29YN3MTE&5]70-AI:V9-51P5@J<$F;MD8BP+&AXJQ+NNZNV
M*)U7]4&.@[EQE="JDS(U2;"XQIE?DO;#'#2+P%MZA3M0YFJ"%!%SMQRFPG<9
MVEJ_)S`+*2EN4`7X`1QLY#U^K%_@[5^ZW<Z_/G_X-/CWO[X8:^?I#WQR9OX\
M?5S\L<$?+YP?[T_IV>G-\7\^3C?,.GTT?O:MW^V7O=M?A[=X_G2ZN/_"WY4O
MG[^M/G_HS4_[L^7XZ7O_[OSNZ(_QA;7^??+RMV_WRU7O<D).O_3/@/'8>S]W
M?OMTUKO[Y]VYM7[_\WHPF!Q]>!@-Y\/^Y8?3F\%HT)^LS[YM-G<?IM][9'!Y
M.IG?X?ZKZ;4]>H5N;C[CU0=S//HR66!K?#DY6GY_.AE.V69S]?'\]4MS<+.P
M!B]/;-LV1K_]OOY^_VGMG!Z/[VZ^?'D@BY/!].+DY^KU`).[ES?K_N^+=^_^
MW1D]3+K=DF<[/3CKM;==#%ABG=\BS!&[(>?!`'6-YX2NW-:`8A<SEA'<XML!
M*J"UTS11+@$7]^%Y-SM-E]`;9JX(+9QZ[Q'3WI$@-Q#AKHA*9Z4(19QJU:RB
M154T>!1'_MA*.B9EBY&$9-KKC)F")Y&C*X0^IJ7I?*P,_'&HJJU7I8YL=P0+
M&Y_+BMBL6@*4I:NU,T*YB/J._;72CJ^9?8VY0,<[=&U;:#F'V+T_$%C>AV([
M[A4$MJ/FZJ92=K1X4E`-7]^Q9R7W9PJES\TFP8CL*X?FE*06NE+>RT("FYPI
M5`GG[?M9#+Y*.V.V^H).6K$!E`LTW?9H[)5B/B-[F6&_*+1%.JE%(TMNMTI7
MW/*)HAJP`XHMNZ,Z7#2-BK_&#]"V/;JXGP?]8W"1=/3]WNT#!84WU6:K\H5(
MV(Y0%/)JAT;P![(`8X@;[[?5^[N#GO>?!%UH&S[VD*2+C5,<75)T8U7K6OQ<
M%F\9[;@N17BWTWG3>&\.[][D^/PXD>=X@`;_IJH*>#6#_E?'`TGN2FCDK?E4
M,/%P^KIK90;K0\#T(6#Z$#!]"%CL7`.Z`-C?)?E\,*-W`LR8YXZBTA/900FL
MK=WLN0(TY2_GN:6H^42ZC6WNPE/GF*1;MQL@^;X^ZU/3O*9Y3?.:YNNC^5OT
MW4$FLC<U47:FOH,XDCX;L?C=/DTPJ:!23:.:1C6-:AK5-%H#C3Z@!7:K\=CV
M=\V+2BM/S0P$F5)"S:GY(*@U+XHM(5DW8=4TJVE6TZRF64VS-=!LL&A:0Z*:
MINH@B#05I[8PIU?KU=RIN5-SI^9.S9UU5'H)7HCSB`4WJ"WQ)BIJ[?:%/?CL
M;C1IB"_[N@5*,Z9F3,V8FC'K*^J*UMDEL;@8YG50B]&XIOPSO_+6,VL!'-O"
MMKH72?.MYEO-MYIO:^!;[\K0X!1YT5TCSAF_`"NP@#L=JU&WI%VOFD]4JRNY
MA3!I2P/OECHU;6K:U+2I:5/39@UIJGOA3NB2C[HVW^10>Q#[:?+`URZ&U8U'
MFF,UQVJ.U1Q;%\=>`43=(Q-"9YLI9==LA>T]CR@G8`D'D31(I[H;21.J)E1-
MJ)I0ZUM;70(*(VN"0VRZ'YX#)BZ9]*_L4KK$6M2&5E>,RR/;FJ;@ONYTTFRL
MV5BSL6;CFMG86$+3L>#]/+E7QS]=DMW3"5HL5=-R:6,.X.SL"DC'[BAME*5U
MAY3F:<W3FJ<U3]?(TQ=P#BF%Y@0^0NS4U8J<0VO["])YH&M955KW4FF"U02K
M"583;&T$*V[!0;9;(!UB<T3<$X@@-NIKJRIH0>LW_Q1%M#4[@'2KE:9@3<&:
M@C4%UTO!MP1@YMYH,Z7`A)PTW`[="30@>A2Q41<3ES/D(-:(2V+<LH5BW;FE
M^5GSL^9GS<]U\O,$6F(KZAA0>\/9`S/@WE=7%RL747\07%P(SQ8RL.[7TARL
M.5ASL.;@&ONUG!F#WQUNQ>6C^C;I5&6'L+TW`ZH6;.J]((8C'H%GX)?8=F]K
MGA.Z<B_P^S]);4V(OGK//H$+Q&S1_G8'5AG$RJ#QRX(\<D\ASUK^CUTC4Z6V
MMU,A'8C2XX40&838E'^O.J81::U=?(H_=WSB7`C$D4,IEW7%Y^3`^@,">HG-
M"VY!=4!3);<Z><G&9.?2\++C@5@Z)-CMDW7WK[![QV8VP";""UFC0Z:.UKL@
M#TZ^,P85G3%V9A8RKBP";%G8AT6V>BA)0,!']57)\63(]9E"YY4%),1R5%R+
MV^`3GMU'\B0ZFRP!Y05D!D5K.Y0^24`T++7=<X=D('QX7Y>:._CC"Y=)@77-
M9[A/-W`C;>C=$=OF;"(##!_@TW!T%$;8H]()7!,J^F.$,4[&I+T@T,G26SY,
M9"/CH_YKV5'#D_Z)6`ZV`=U<(0M2:8#OBCV,R(Z!X6-\5B6R75DC;L""4&DC
M1U3H@<S2=I`($I)R29TG\C.TK!M,?N`'"!C!T+QFS'FVLRK,:>(/!/!4=`+H
MCRKETV-($3&EY8')8ML^<J2`$2!\7')Z'(A]SBVO^"<2QN<TP2WGPE0\`J#+
M9W=1T9X?E8`=%MWNB70&)`'>K_9NPGW;$S)G@$'WB_\%4$L#!!0````(`"]6
M4$"'P5P/<R4``$:]`0`5`!P`865M9"TR,#$Q,3(S,5]L86(N>&UL550)``.*
M)3U/BB4]3W5X"P`!!"4.```$.0$``.T]:W/;.)+?K^K^`RYSM974^*5X$D\R
MCRI9EAU-;$DKR7G<U-8434$V-Q2ID)1CS:\_`'R(I``0`$E`,W=7=35>!>AN
MH)N-?J'Q\W\='H(KZ,'`BN`<W&V`TWL>+5^`0]#SEZNI[8"!%Z%_M2/G$:+?
MO$<8H/^-_OTABE9OCX^_??MV9*.AH>T$,/37@0U#_`,X//P5X/_[S__X&2/I
M!1"C>`MF#VMP">]`YS7HO'I[^L/;TU-P.^N!ER>=E_$D-,-UO"]W5@C!T]+U
MPE^>Y9`]W07ND1_<'[\\.3D]3@<^BT>^?<(_%,9_.R6C.V_>O#DF_YH-#1W:
M0`2V<_SIYGIJ/\"E=>AX861Y-D80.F]#\N.U;UN1XWL"=`'F"/R_#M-AA_BG
MP\[+P]/.T5,X?_9KO',`_!SX+IS`!2"DOXTV*_C+L]!9KEQ,$?GM(8`+.B5N
M$!SC^<<>O,>;C[&\P5@ZKS&6[Y*?9S`(X;5U!]UG``^_G0R8*WM3`)B;>:R5
M9"5J31`Z\R/+5=O;[<P<R2[^X1J15B`:/D70F\-Y2C:&PQ%.@H9\"AE@#-JW
M"T!=+.5^D,(DF']Y9L'E_`^D!T+?=>:8SG/+Q=_']`'"*.S>A1%6%L7]PW/0
M_G0ZG9>Q?'\G".4X52$Q@9B"`HFIQI%9=Y23=H65_>'>N42#H&G>/=IZ[_!V
M^NS7_#R03`3QS)^/"8)?B^OH!L7=M@([I0?]6;&09,2Q[2,TJ^C0S2]G$?A+
M63Y%OM3ZCW]MF"EN+7Z<R#$$_)Y._M>6-W\?[IS$GXW45[T.#^\M:_5'-PR9
M7W&R7K+6A17>D04G$X_QUWT,W2A,?R'?^^%))SG1OF-@:%R2F)\WG0#&Y]R=
M3ONS:5XZM(H'GQU8'#BK:4-ITKY/-@FT[S'>4>JG]U?96?)A*1R6ZR"`7L3[
MM%@')'5FC@@=!R*-!M8A&(\%%AEL\MSC;?E6FS*75E"@+1]P+"*HAUIA@_?F
M'*NWVR<Y^U;ZP.I9X4,;QQ2!J\7,R6-D?5?HGW(<-J$O\_N<UY(9U:531XJ)
M%W`!D7#,+QT/FS0]/XS"(6S%_&"ATGUH,NA@"$`Z&BS(<,>[!S:>8?8,K6!;
M7DQXRZUAK=JVO_:B<`)MZ#Q:=RY$,!,]TXKMRL.GW>SB$,.R:I,I(,CF&+;"
M!!A8L,FJUJPN2T,_@F'7FU_[EJ=-H*J1ZI:J2HH8HH7G4<7*B%P),S,O7&)+
M5Y<P$DB'8;0%W89(4;#HEJ%=$AA"DP[<&WW$9E%>4!CK4Y>,<0!7EC/O/ZV@
M%T(D@J/H`0:QI=R&C'#QZ986'C$,N4FF`!C/"8'ES8&/IP&;X8*:D2<1QN8E
MJW(OZD;VVC2."@A:B=SG<BG5:V3(#DFKL,7$7"R*9_;LK*N.KO%7,(@V8[0K
M$9*P_M>ULUHBN"TY7%Q\^G4-FQBFKHFG$!T#T_$'P(.1\?"P""^+ZJ5B^;6,
M&[1K#CH+8V%%$/M/MKN>(U_URO?GWQS7;<G<J<;;=,2TPOBI)(@E:E8$L7>&
M)6V5_(T.`CRS+&^&C"-A%I?,);$=J1$&O(`K/W2BL#V;J81!:VBPB)L9(XH'
MF8X)T1A1#`7M+*9.[+`]CF\Y;<**X9HO>V2VL.T5U6^:9`NN'>O.<9W((2[Y
M-/+M+P^^.X=!>`$7CNU$4HDT<6AZDVO"=#&DX7K0/1]<#V:#_A1TAQ=@.AOU
MWK\;75_T)]-_6.@[^PE<]"\'O<',F*VBQLTL:R2W0QKS=E*$T7)YXKPSGC37
MR4.E;&`^P9C'II!LITTWDG&G$%*1=L_-,)][Y["AG!)FK51_%IY!"2\5GYNR
M9_GX^ARHE9E/<S5C:X-#I!K2<B5,>L2'3T15(FX5CS9MR7%914O`458I6QN5
M^0-K./,GT,4UC6,KP#+8HJQPL.F,$K#)8'EW:P@B'P3Q%"0W05'-FW'V*EE7
M</SX:ZZA:DCFKGT]0T.C-0Y`(8"3CJ5H%V.YV&K-PEI;G=A`<ET)AYXTB4@%
MQN,=@Z!5>>%3P[[)D$X"7EZ,2`P2^`LP=\+X%#!=DR;$WD*U6O6&Y#]HR1!D
MX#Q:^)I<SIIJ\R3CX=-?SL8FAAFO3*<`E^:XF#K3!-A8#&=6K%P]IQ(G?VT[
M6,.Y'IFJP*A9??&I89O6>#R2J:_KY/;/W%I:]SG1,B%68KS,"Y;`ZI5U%8&M
M4:3V0$,QZ&!(T:A03$+73\;$2$)^&M=)>H1&D[Q4IF*$Y:585;(_\B(F*HU+
M2<]?+IT(5Q;@B"^RNB+'NX>>C1"T8W6ST>F-`G$H89K;V0R2^"_,`<])76WG
MY0NCAY<`.XM6-G\3E&[1U4T!5B3]M%XRET_TY6>DR:%XHMG$GDP:2"AYIRO@
MKY"P8_-@/Q)T#?)"_J9K_MOW/0+^@^6N6REQW\&A,W);1LY1Z[X'0CSN`(=K
MP2,>#?[[Y.CDI`-6R+H,'ZP`_@1>OCHY.#DA_Q__A,Z!=?3@!\Z?R'>Q0AQQ
MN8`V7-ZA.:>=`]PHIT..BALD&0_93S^!SLF/!V_.S@Y>G?Q(_AW]^</KLX/3
MUYT4L!.&V#<BY=+K"#>VP458$D@.``*S@J0;D+LQ[JRSI*U\&NTPK$Y>:SYW
M</,?RQU;SGS@]:R5@XR_5A);#%3:KYK1Z6!YX-EH@(O9#QT/V/$$T^7X%:PK
M)+HX2U:WBR\@^FQ\4G([C:Q[V,<W25:!$\)4"=OV>KDF*9*+=8"^S?*,=B*)
MM:EJ3`/3.C:UM9?LR[;D4+>V\TW75#8E-<7`92/[5T.3YHT07(H>;=J0;@H6
M([&$73JXL80P;VU^]^/+SME/8%XR^4T((YMI>>%B++:1N%.IAJP]R:G$V8+?
M*!&1HM+$E:E<7(K8=N&N1U,6,5-'M2B_&6$L]MXTX-B,K6`4(`V(%".Q*,<P
MF&+[NF5?AXE6>U:YDB0!IRCG$SU'%N*%[[I6$&X=HQ?&15""XPQ_@[L]RLF;
M'`("+>QF[F++$KB#3G]PE4&)B,#M.-=FK3H!-C+$BKKX!O1:#'=`8@1:)"E!
MI=N=9=`A(D-Q`&7/!*?(,:[0Y%9:+[M3@#K:QI*TR$T>GW'AR1$C(D&YN-N>
MB1&%BUQ9*B]<7J!V>IJ2LY(DCD:+T0HW)7?0ORHW%:X`ISOM(TZ:2)/A+00<
MO-W",.(=*G*2VMA68&NTIHKD:*OL1<SB&_WVR-^7B>HYI@E\A-Z:=;VKF3-G
M!X>V.V`L"A@Z8=+_T!_>]J>F8^LLIN2/$.J2-'NO-!IHWVRZK[3/\J^TOR=E
M9:GTJ;7YB6DWX5+$C"_JRG^$@8=U%T!\(1L)@GB*\9A$F1\T[M>M.HZUM7>?
M=*%J5<VRD;6@%BI5+I,:5I7HN#_IS@;#*]#_-.X/IP4M;*0\M(IWA0)1[FJU
M7FSBDD+3SKL[S[A\^Q=G0YVW',:!OX!A2)+8E[`=';Z#0V<I3ADYNX-7-@PL
MH/&:7!9?2IVZ=I=6(]6*M)X?=+UY<OTR$;56DF9T3'HCQ70BF&VW-@B@>X!/
M^W#M1J0BRIMG=VU#&#PZMJF>"F(<+*3!V(M7];CB%^)<!+0[7SJ>@Q44+@%K
M48ZJ4.I4-!6TL.S(>!:1):LPSZPD"3(S+U(B&U!#.^T<@5I,31/I^QTBN/EZ
M/QV==;HU>X>-Q2:N.5-+\630!I[M+^&U'[8K&SDTS;],)2P<6RHJ'8_KT71O
MG(Y='E$%H[0ZE?`$"3>2"VZ)E,4PI1(%G.EZ^SVQ"6%Q?_:N/TD='_!\,.R-
M;OKFZB4$F9&%B2O6J['K$Y\2JM])W?K]N/_1&`MJM7VZLAPOQ!\W#$=>_PE_
M\&LG?,#AM-'B`MZU$D:J1MIHC%&\2+F2,%9C1S0%^!XZ]_-32/,--,EX@$.8
MR04C4F@O:L0[K$V2<,+`B@C(@T.M!$`JD1J2O$K"*B0OA%'DPE3JK*2K@I.^
MV(&=FG)?!5/2*,SX0H1%:'_4I?'6"Z#EXO(L+/=X5T?>ME=(*[)8A=+`)8T*
MDA@R^!P/?H&ET'Y`OT,D=F!A.6F]*-&".\UC-F:]:D%^YT509'-JG,3I,S7(
M:X]%O+58#0.3WI@?G8BJEX>V+\?@@W77SS:DTOB\HSU&1%FVJM.=`TD,Q=A"
M;%EP\I@:%!QQ546GI4I^'#)JC\2%PC&&N)17J1RCP7"&ON<7'?P6]4T%QB93
MQ^+RPR>*UV?([,$EQKZ=SD+\E2I?;M`J1R9$:%85!905H2143,ZPY/C"-VKP
M1/-W:*3DJBV1@E&[T>,B`B.72PLDL'K"]F?%<+$1@:`QHR`$.RM1]\'Z5N`A
M60K3>U?G5NC8V%!RW'74SAV7*I0ZTY85M##$Y+P['?3(BQ07@^O;6?^""`T8
M]R>@-[JY&0W!]%UWTJ^^M6="O`0YGA<XD5VJX85]A,[]`X+3?42:[1X.U[C%
MRFBQ<X6"H&U#(N4(T%R-*T4<0V`_]@=7[["<=C_T)]VK/AC>WIPC:1U=%@1V
M"D:WL^D,"3;.FY$K]9V?P*ZT8[F.\9L_/I6$)R_<\OLK?<RFI?]S?%+/67<`
M>E;X<.GZWZ0O\\B"U5DWJD@C^W9/#`AP[HM@8(!`,_O$B#*_\[=%5/9-QP%:
M@S[&]1\9QIJ^<6"6P2>J&B@%=HD6D=4:='&G,H6WH$2!Z=<V@I2Q=`R6L@61
M,LSL7(61E8%X:U:S2/)Q*VXR.Z-/BTA01=4=(@S;#XVA@W$GS9=E\<S3'6>4
MQB(T"+CHWPT_LR+M6*N_M->=_WL=Q@U^\8L^F#K'A0@!!CWST1^8I[=(]0^\
MNJJX*5QZ:[H:HIK983&#'C\*E<`G#[1@4<2_XK]MK#W6(4G<5^IZ[1JC83'*
M%$J3FZ^Q&JU!LFEJJD&AV8>[5G\5":I53'<!5XA/#KD\C_YV(?X#5^$O_2!R
M_B2_MQ$S$L*K];T\`8+8[Z)G4^.[&+DYQB,\,APNO:(NMB%U^G,FX5#LP2UQ
M(J8U>6-@TEM`0B>"UY`?W.'1P,X--]N;D\NP0G].]EI;JA*;55V^%BH/I3ZD
MG50L)@4\^8F&LQ'ME<G6.E7&@6]#."?^%FX(9J&%C!8?K2"PO):J9/D8-2<=
M^-0P/OA+7'^XM((OR$+*RA"1#&2]SK\E\T'T8$4@7-^%\.L:,<W=@&\P@.76
M<89N'@LPOG0/N6JKZCU"-D14(U-*0[%0'HW>Y@:[!#!?;?5BZSLKLTX*.DS7
MEW%812L,*J^T3@>:K=21(Q>9.*GT7?K!-+F:/0IZKN4L6]%=<@1H5F52Q,EI
MMOS[)9EN(^6RJ[A?6?*8R,(/*%?D#0FJDK04ZB.E-[0Y72)I,`F4CU,CRN(E
M]?OP'FL[=?5J7;%(;&`K(?AMMH%7>E,8L6WI>!1/B1'?E`#7O#LT]^TU-BP+
MY*HMEE4HG0#`$H9?D\9R9Y=>F`;1%HS9>)(\;[.0D>1.M5(ER`U)RQ%(TQPU
M>/GWY:1Z&\M\J&:TN$0P/1LY>^3R&:D_2UY9;\.H$<:MV9X1I8N5&,E-3R_+
M9L_5QW<6X0(&`39;4MA(A$/C3]G+RD+AJ2J9/5,LKB`V0Y@/=H<A).#SCVY(
ME5C(@=2;OI,CCE5K$0,I95$('"**.2OKK<&V`6J\W6;OY;=*8TY-GCJVR2S&
M249N[._/UEHAR8%G(YL=/ST6_W?@=>U8:TV@#9'EC@[?5IQ[$;S:6S^+4,4Z
M`9.!.+^;C#3NPLDPMWA747`;&A6\<0#QLY47B:&0Q+'2^Y+Q5Z!'%(4HT1K*
M5*.1V9>33,WN7.?N8L>ZU6Q!53W)X,NQ\*[5BIPR/Y^QM<'?#DX7QWT]<BI=
MKY;E4F)8M$5HK-+"JWAN3K3M->(X<D;V*<963U+$5';E+K8JZDDOU+$5&)/Q
M$@D:'Y]1))%53[.&<?U8W!UW%0\VG:%2E``IV:5LCVKL)ZD@&P?^HS.'\_,-
MLY:L#5F5P&Z@1ZHX=:PTJD@1HVF!E9>`4C&WS![)BNEN7?[`>X1A4S=J>,#,
MWJCA4"9XH\9)(>SGC1H!/M(O9E3MC)D;-154B=RHH3)L_V[4M,4XA?MV67%0
MTD)OYG?MKVLG@$@=(044;<9HPW&'(?SL,GDNOI6:,G'L1OI)B=/'\H\140\6
M=HS]!5@EDXDG`=.9I@\Q>0F@M6`4W"%56VL'S<"+T#[C?%Y[T9QJI(;[@C()
M8]XYBBL=R361%<*2E@.E?Z]@Z5'3?9%)%KNYHDC=%?5.-`Q[C:*;-=K[-.S[
M8^]3J!.U]VE'NFE5*2\!`O8^:X_JV_M9&KD)>Y\'S*R]SZ%,T-[?UA'LI;TO
MP$>ZV5BU,V;L_0JJ1.Q]*L/VS]YOBW$U[/T)7&5-LW$E5!H7:^/(8N)JJ]R6
M=T*QB&$FMAS$@)7E@B";F-;,92F!0L'1S_]U>`A^_WCSX?1?OW^R5^NGS]ZK
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M$D6MM?Q`D"@A:;2S^5@60VBO<<%SK`$I96&F95*`_6R%R-^I.D<QP^6FF-<:
M0S8T[/L3LJ%05Q6R624@P-V&ZID9KLN7%P*!J`UKFU2/<H(#!HX_+Y<PM"&9
M'&R-%\I6R2&;%H[<.<E0<GT)`3"J"*MYEQ>HBO6V$$M;$6S3R`JB*D9P`S!6
M!.[@O>/A5MLDGT7@&OZZ,66L;=ZYV]7@=O8];K@A1=_A;";$!864;=S/C>RH
M1:2GZ]4J?H/.<O$U)M</U[AO==8Y=N`M_&!);CY)1:>5`&NLV%,FDM6M*`>*
MW(=+8!%?)8V/(GV8P3,;P:[#]RPHJKQ]NES06E32%*T\E_<B[&V4V_+7=[.(
M^QA7\*\#=*#-'F!\*E_Z@726K`),\\^05V;'^!3Q\F+D/L><3"4QD?AXPBU"
MC#8:%>=6(:4BL`^:KD=+D,2TP#B\V9M^GJTQ2JW?Q[8R/&['A/$@#Z(-KZJ,
M0G<?H2+ZBE</#9OM#';0GCG,KT<Y[QFWS9Y93SC/TZ($[&#1'0S?)8$I"'@@
MB/!(X\X'FSVEVQVTM<E'L/GFQM#WL$;:%N9X\[JE-$WATMM"H2&J%1P:S_<.
MDRYZ61F8-Z\NU-DCRU=-BJJ-886]U]BLH4&R9=TC&9FA6DO_+SN-MSZ_BP8>
M`D8:E.4RW^?0@PO'=BPW_C%$'MTEM")$91O'LA(=>FLG5$AD-DNG-0$DCP4$
M\[BX%@FFEV07OSG1`X#+.SB?DS;8*0ZPB)'0BS#0AW7L!UE/2;.W_.N(6;$?
MNR(/E,(/&-OV)G5J["98\1O#S#H.AHTA!;#QD$1E&T(9\IB2?1=W`+-B(-L>
MNW8*!M]LV(O*#64>9UI<>L-T!C)DB:,=YO78^?=F9HWFIAA5VC!NDBA]T@$Q
M4?D?D<;G:#1<(51HEHC[10DKH,81FU%432^#I]"RWH:\$_HN0RAS1F<='LP>
MU*V+9>$S:X5WNG5K&XM@ZF`S$FA*A_]EA;"1AM=EV`-O"J,H]A9'B[2O#[RW
MW$M8+HNK;'\M";SI:)9$*VPY2@4:8^]*/_J&P@PF'I*:.2X&B[Z<7-S58&]E
M-8&@=%I6V%*-@:DZ=%8UTJ['>Q-Z<"_8K_YX*=*JKA6&#M*@2<ODY(6';>PC
M;4VV0;:VCYL01!LA9:8(6K^9JD8H0Y.5@6&134YLVJ,2&^RJ^:2'1;0Q*LCU
M)"$3XQJ;J=,R5">3IL*:8?K_/9;7*T0@+OZ`O+L3USO$Q0X?\!LN6UNPH$^G
M^/I':]<4ZA&D\P716I0*V'`A?E$QI#D_.%@3.#9V9$@<"MR3KP1]#OX""1`,
MS$;`&Y&IPMN2M7=:]6@?!?>6E[R$@*"'ONO,K>1AU#%B0WHD9J\D6.X4_4+,
MC'";[)K!I^C<Q:\_R:3I6T.NM1ZUK56P[F.,9GW0.0+#[NQVT@>C2W!^.QT,
M^],IZ`XOP'EW.ICB7\>3_K0_G'5G@]'0X/'1MH!E!TRK;%!_L;%AJMHXD1JG
M47,E7M/T,SZ\/)H#4$!$0F]Y5/AXRY"!+3:P10=^QP@!P6BH*J)M(2T\=-D&
MD]2>YKEVD&TY1];E%NP8D6-OU$XQ"7`:`S#B5/'.F9='X'KPS]O!Q6#VV5ST
M3)YAV:D@N0UU/`T*JE;5-A>?[CI8'C$,`<NF%)1BS!U`U8U&E*,(6_.*KG(G
M5.MGG7N/>,]>E#19QWX"WBWD`ZAI+DF0VOJ7R='%TU^G1V!Z>W/3G7S&)O%T
M<#4<7`YZW>$,='N]T>UP-AA>@?'H>M`;]*<FJQW4N+LM093?,?5&)&+(6HF=
MB&'6K?S$R&+596\G@^ULD$[?(S-1CN^%^(;X!BEJQS0)7"<<405#F_ZK((2G
M\'XX`OB_4S#N?NZ>7_>-9@L$F;*3R:_RQ-7+HS699BQ4NA43@PY>>525@VJJ
MXEC0^N*M6%&U7/O>/7[!&(-6]!"Y$+0TS:JF@Z=57AV!WFCXH3^9#9!.V2,-
M(\2;K3-8N?X:MR^HP%OQ^ZB(=":&J!2PO#PT]A"_<`Z(>J%;,V8<.Q[#"AX=
M<[FJ61>2[WGPW3D,PCC1B6LXZMHO\E#UJ1YIVGCJZ/41Z/_S=C#[#&:3[G#:
M[>$<AUGW396A6P].:8-JZ"MAA*TEP860:T]XBU#%<N5R\_]AK?SP)Q"#`1A.
M=>S?D"*4EH2=U+7PGJDJS.P!3!Q;PP7.%];2NH>EQ("4MI0$J<WYDZ.+IR;/
MCG"4:W+;OTB"^-T9^O.B>].]R@>[M"M+-69FFE)A@Q0M?S%,#4I;*PYB96FC
M&&WL=WM)I>UV-DBFY_4=!F#V*H(<+R6%;2<9V0CC^-TBQ"FC%2,JL>WOQ[03
M5=5`7AW/O<=<NQ1*`I[>ZB9QPGAGT8]'8#1[UY^`WNUDTA_.T(G4/1]<#V:&
M\RX*?-Q6'$ENC7H1436B5NJ"!-#J+O6I)HE5O4.>DL]-W<M(IP2G"\4U@MNB
M5B]S:3D!*47--3=1TW)BD#16R0@1Q--K;X[`97<P`1^ZU[=]<-/O3F\G_1ND
MX*9FS1TIGF4:37P[ZA3*<+&TH<CX"+4^6L$EA2%H>`X@DW(ZBY48-A-"$&)I
M7F-5[X/RY=LIOE90B$ATO3GY\=P*X3Q[MU0MQJH*7%_QC"*%W'+SDR,PG8UZ
M[T%O=#/N#Z>EJG(C(=>:;-Y&7NML6(TJ&DFTK81A96G07EDC22`K,)L#4PS,
MXL)M\J^'=Q@@2"'NCTFH*B>%(*W*-JK6*=H/<+YVX6A!#PTGU_["43!Q[A\0
M4OSTD*(R;@:5SBNES9#,U=6=(_"Q.YET2S:H?@7=J"!LU75S.ZCZ>I`T":WJ
M<&5B]+9<5*:3I=,3>/BJ#3_Q=@!2V,`/0`P=Z7<L%WM49UY;J`H*O]9F*S98
M7,`@@/,)?(3>NG8Q@P0XC?$"<:JX*OKE$;CH3L9=7%4UFW1[,W)U<]*_)AFZ
M2?]#?WC;1__MC:Z&@[*I;:",4Y:SN8I.J?VJ$U6H1M6&]A7`JC6^4$T/L_@S
MG@B2F2+5"F9J04797"P+%=H6Y9@#;B?I1,2(1I9USR<%[M"S&\@,*8+65]JE
M1B!7/Y[B>M.;F\&,1%*)<L2:<C"\Z@]+-W4,O+A2B]?;5UC4MZU&U9<<UC8T
MIB0%.NN_Y$ACO>JT!4*B"P4P^ZI5U<2B\&ZA_-ZI%H-=^Y87DJ9GL\":0X2.
MY+^V#QG7UKGU,&@+]=8BLTH!DS^0"=H??"B6^1LH\F^`W[E+`'4W33WFJX2[
M#26L1HCV2^4J5#+O(2!8!R0>@/Y#X!'U'-<%Y$`*J&@SMQ5JB$[Q-H/JIBH&
MA"=Q2^*Q%40;A-(++=+IJ[:25H&K334K$,=5R*^.LO#`N#LI5DT9:`FHS-%<
M/T"U#5)7OA(8VU"Y,NAU*UH)VI@=3>.^XP0$R,/84WVJ(`UY+2J[8\J/YMV%
M\.L:6=7]QQI%"Y50-#_@7$$.5Q.^QBT]SJ?]?][B,E(<*LWEN0R\*2;(H-QK
M82*K5ZX598)O)??$1*:Y+I1)"/,QQ'0\B"?LV8VL*B86<CW<M:L+D@T]*W#\
M6R]<0=M9.'!^X2\MQVM%D)C(=`L2BQ!F%C(>?P!R,\#O\9P]$*0J)A:3AKRU
MJPM2VL8OA=]]<EKJK$Q#I/<"*84"YF719.P!2$>#W_%XTUU^>.PJWOQD+58U
ML'>1W%1#/FG?BT@C\(4?+.,VD5+)8Q%`^MKY"%##RLHE4TFH(IX,<K/WYA5Z
M&<YMD\.B^Z(QP2]^=:Q#89?8;*/9J]:OU'7,/#.#(UKDU:?\JRBX:X?C$8%B
ML4P<@L&`BSB1.XR3W2&=QV4W#&$4]M9!@+0`\Z8J&70`DF&F,V4%FFG'(F51
M"N?A'#I_Q$HQ]U(EJ=@-1^LHC-!YX'CW;"LJA/;1O?]XC.#$!A3ZHVPW">+0
M%1L0(X=Q4"9G8SPSK@<\B`N[0Y";;4IZY-B)Q4EB-[06&*5OJ:9Y@X%G^TO(
M?+8K?6)VFVJ))QB._M%70?N<>>O5NO%9D;[?M=$A',!QX*^0)M^,72NVH="O
MJR5'DV9W&R(?)#!`"N0`$#`'L:&90C+,)?$ETS@GNV&:/R,[@%8(+V#\WX&7
M-$8-MXDX]D<5SP'/T]DO\",Z*8!<,M/T82FR2OI')[H[*A5[.=6*F!]8[L";
MPZ?W<-/8<5H"JRF&Q22@XLR,!P,R&J#A1J+IE4PI'8J4%>HT7:\LQPNO?63K
MA2.O_X2+G=9.^!"_OH@;!;+\#3(1/(^GO@#(6"G.QM<9\'S3GV[E`FG?K>"N
M:([IYAHC5/@:N9%[XW#L4D^MZF"L47=_#G3`6ICM_:<5]$+V>Z[90)".--MW
MHTPW;8\9B]-J-]QZZ$!TG3_A'']K^%,;>=L7%$.6UME.`WA>K'^(]LE--BWI
M%6NCL41H.W174PQAU+/"!V1N/CIS.#_?W(;X1?*!ARC"XM.U$7'9TWVTKP-!
M`!@$2&&`NPUXCL$@0^\%R""!+2C3S!-?-(V/LEMFUO-"/B'B%@ZAQ<$>&8=K
M.Q?$DXWJO<JE"3E6]/W0?/0P1"A3VK6_NNV1M?=?'671$E\=<\ND4\#87D^S
M//&3IGUO?F%%&=/5/2TZ6(V>%I6`JC1>/!B@T0`/-^9I<9F2>EKL%>KTM"9P
ME>B;.(41(O7#BXYLQV-7BLP`R12SB7760FA?)G_1LO>S,3.["-H<0[QTK0;R
M!D5P>C)^.WA9+6G3,0`/,A3#9.YY^G7MKF1/[-3D_<T&3LP,TOZ?F)1%2YR8
MS"VK=6+.T+CF#DH"38?B+B.M.A/Q&.,'87ZOR^=?M@CY(N["AWX!0SMP5ODT
M?0,*.`]5BUO$PEZIC7-CS9S$5=S84<WEU6EV:?C>9<E]-%D.P:Z#H&9IVC_9
M?,]/G9@X89N$[)@'66Y"DJ$&SY,Y+XQ7\3*70SVB^&O7V_2)G<A+#-K</1J.
MG5&5\4R`'8#\-:0],#8DER^7"N7L8"VSX]();<N-G;Y+]!NG5EO6!MD%K>W$
M8I)099[$$U+/G4PQ6454R:6R]4)?L&))6I);BF%^AE;06#R'"5EG^1F+"%:K
MCWAX*B)XPFYH1[^(5#$IE1#N:HU$V.,D<3%QW/-#@0A[DC4O)]/)Y+V(L#.7
MQHNP5^R'N3PZ;A^[TUA0(*N>E9=%&^-65=5R*M+LG"W0^NV0>`31[F53@<4/
M/.,@/=`HII5IJXF](AI+JM:OV_<8%8UOG).N+H)(70Z2EC?LTE$6P*V&**]3
M9W*`E.1*>WMQ(;*8SV?L%1@IIT]D']2B5W&YW0??12Z'%6PN'1<IN_KF'AVL
M]D+)$@'\0LEL,(A'&SO!*OE2K)6D+5(EA11#&Z_O7,>^='TK:DH,\B!U1:AW
M,/-Y'P\$9*2YX"63`T6&EU=5Y\LG,M-#7L&]'S16(%T$JO^"40$_G_%D*$C'
M&BZ-IC*CR/O=I340#,+.82NAH"U@?2ED!@6"<2#BY.]$@0R'@7;X0P\"%=>J
M_2T788>1W<Z_&T6!<[>.2._^R,=QWD*)MIF&"2*>(\]75%;.'Z'KOO?\;]X4
M^3N^!^?XMB\,FE+3+/#Z%3:#$K[JQI,.O^!9()T&XGD&@W-"C"NJ=-[B-3>7
M?X2N3Z[,32/K'O;QW<A5X&"7>^'83M2UD;I9DWS$Q3I`;DAY!NN+SXT#9"#8
MPCX`"720`P]B^&!GHE''K?X&T51'4]M>[Z[<!-X[N">'%PVM90,!?RI4;>D@
M&G:^-MF.!7BP<15"YT=1<U#65Z\709PQF,"5'^`H`VX!U(11R(6NSS+DD5%Q
MAS+)!&630#QK#T($?)Z5;E6REU[G:9:L4]0L7^_:2NNO&(/64[&(NZK;5_+P
ME.$W!:D,H3;WVBZJ$0FX=CPX0'^VVP!NBT6_DU,FH5H@\%!`QNY!PT`FHZC2
M45QEIJF39:!__9(N!?V$_A=^9)-\F_\+4$L#!!0````(`"]64$#1K*@R=14`
M`).!`0`5`!P`865M9"TR,#$Q,3(S,5]P<F4N>&UL550)``.*)3U/BB4]3W5X
M"P`!!"4.```$.0$``.U=_W/:.!;__6;N?^!RO]S-3@I)VLVFT^X,(4G+-@T,
MH5_V;FXZCBU`6R-3RTY"__J3;`,VV,:2)208[2_;4GCOZ?.>I,^3GJ0W_S@^
M;KP#"/A6`)S&P[P!._\*IO]N'#<ZWG1V;\-&%P7D7^T`/@+R&7H$/OD[^?=)
M$,Q>-YM/3T\O;/)5;$,?8"_T;8#I!XWCX]\;]+^__^T-5=+Q`57QNC&<A(T;
M\-`X^;5Q\NKUV<O79V>-3\-.X[1U<AK_B/S"A>C[@X5!XWGJ(OSV**7L^<%W
M7WC^N'G::ITU%U\\BK_Y^IE^D/G^TUGT[9.+BXMF]*_+KV*8]T4B]J3Y]>/M
MO3T!4^L8(AQ8R*8*,'R-HP]O/=L*H(<JV-4H_`;]V_'B:\?TH^.3T^.SDQ?/
MV#GZ/4:NT7CC>RX8@%$C,OUU,)^!MT<83F<NM2CZ;.*#T=LC"TP=(N7DY.0T
MEO%/^LDWXC'LN="AV%]:+FW)_02`X*A!!7\:=#-ML$`P<3TT!0ZT+9>ZL4F_
MUBR4TI1NZ+>^Y0,43$!`3<)B[%X7*J<9740,`?<!^?.4:.,W?5U0<]&SQ-K;
ML?#DQO6>^`U=2B`6BK#NS@L`FS71+\2YDXIKL5O0$@E`B\>`5@R".!NXC&B)
M#-5$))\AL24BS>"THR4Z.NO8(CA.:YDB/F+KF2,E=FN:)"&*ZUHD)YYK6R4C
MLNL;)2G&!1@F+]I%&"<K[H78)J@'7'EV2-E=&SG7*(#!O(M&GC^-$@TV$TLE
M+8&<D72-?"GZ])88EC$9/`<`.<!9&$WEULL4XMY(]+J>G5'ETF3*\Q>:7.L!
MN&^/BN3@]@,.:#I:*ZE824E%?67;0GP\MJS9MR4A'UH/Z_Y-H(I2OI&%'Z*\
M+_EADQK:!&Z`%Y]$IA^W3I+T[Y\%&A:^X[>4.!ITR1^Q5&M76K+PID.N[6<;
M8/GVPB;RQXUXR^;.R3>:LRB-.[8GT%V&ZLCWI@SQ$WC%#O5\!_AOCTY>M,3$
MR;T-D.5#K_T,Y3H@HZCYNP+\R_M(+NA9=++8\^&>"/R$\`S8<`2!<^5-+8BD
M8%^H;#4[*'9!7OAE/%&,5^*-UHM6>A#2.YY28UUB_NF+%`%C#J<VQH7SCY@8
M6M.@"=(;<T8:[7504H'2($:/@.\#YS8&LM"HR*(`^!A$WV3N\)W0IZTI<U`1
M0<C]I=(1,[\5%/."9BJ!?&$M7?&3T14BN6HZ0&DTI6,_;CL__&XMY*\253<0
M47;3\7"`[X"4<:E(E3IV5]5%A2"EZ`6OU[CY8-NVO1`%>`!L`!_I/$9,2IHD
M95HITZ>_#\OA2DWM.W<D70O`),N^]2RT,V]N5ZJ_2RL`E_CU3(5?HRUO@(.5
M93(<F:-%?\_E09.XZJ4*5_5],+.@<_T\`P@#$E*]8`+\N!TRG%:J3W_WE<.5
M./*5DDDQLD'F+)A1H,Q5+(&[F6BM#X\\I-\++/=60,?S9L`/YGW7BE>:?X1P
M1M-%21RT5)]R;U;I>65X":"CO#.=A<:0#.-Q"X@QU\^V&SH0C=]YGO,$75?2
MW+==KZ9I.!MV8O@I9X8X\S`DC9`V&ZYI4+M@524;S`(B@F/6F.SDS7)JNTY^
MW&U.9D)G,28_W$+K`;HP@%$6<A]X]O>)YQ);\!4801L&3(N(U:7IL163NZ#+
M``G_9)5=<&1V6\)^TJ9R+/;F_5R)8YBC,+4(G(N!J)7@VBM;?6M.4\,=K&FM
M:4KO[NP^_RH)S+P%K764!*PD<U.%$`R]`7#I=GG?\FD+)#JO1)N2CLCFOC*L
MA"PK\Z]%RN]W>6J4;M-4=%HN/`*X.=^F67R,AJ8..W+;%HVJ2A38?+@--F5T
M_@KX\-&B)Z12+9$Y?I;I4[T(6744+<5,Y9)RO!!GVWY(5.[$GULT[D?OW`:;
MB,5E?G_NT)'[VR<+D4I\]ZN*[K@;S^GDM(J!F_9<B=/4;1%TO.D4!G3%@>:W
M9/8.(!H#9!,CY7"<8G6*\D*N#+\2?&+J5YC<6G>9;,O"V-[XI\K:&$=*(:(8
MCT2,AR+[/EMN**5J84.'DHR=HRME@5&XUM)V'$@ALMR^!9TNZE@S2,9;*:MD
M!:J436V,?BN$2M5^Z15X!*X7[=O>!]887--RF)D/,5BTQK;#:1BM#5V%/AFP
MUW\A)Q^L;=4^]&(1X'.,SQ=QX"`PIH+KC=#I%M,*@&`N(QYRM"@GL^)Z3O:P
MQR:>XGAOW7QEC5/(<_A6G8KXE5SG;T>ZQDYE-A2B$[/-]2.S:H[2KE]>8T[6
MFI.UYF2M.5E;#+HY66M.UNI\LC:5GI.YK>='BIPH4^\#_WY";)>\E%&H5IL0
MVYA?"M8WB@$4L>11U[V1*;@=!A//AS]7I$B26S?4*>;!S-[<Q$O!PF^A75V,
MPQWY,%&E/(WE].`"*96G%3>,ZH4!O=N4UJOOQ(=I??OJR`QF`L\HJDPNUZ\7
M91\ATM*6<G!OU)O1BX6)X?S)Y19Q_*3#Y)C[D6-6BR>F9-/DFB;7-+FF#HW9
M?:XY`(\`A44G1\1$T88./3IO*=/9Q$7<:9):CI+I(/4TM"@<\UPCJ&J!KX@R
MGGG1.#FP+K7_%"O39A0N[4LE8`D[.\=[:'\$,(XJ*FZ`G+ZUH4/IX+<U;M?.
MZ*_!(Z9,B',CV7KP_#9RDJ-&20.D;!_G:U*\6,;DNB*P5!4*Q6_JN,2BMC.%
M"%++Z6$'B5[<IG)_^N%6\%0NHVVT9"<SH.K.6#&>2V=!@:4Y]3P7+WC=>EBN
M[U)J-$FWJK&6-#PUZIDS'F-R6'3P(8F:V!BFY<.2GVN<B)4UFG^A6=#!_G<6
M1)A&!,`]=/U,HR2$>$(;TQM=@0<I:<!VI<K2M^T1FIG/MJ/',3(6U*5R9@;6
M/%ECI?9D;8QN3962*FQ5NB<.KH`>!Q$5ZN!/R`>62_>0:3328.RAU1E<*>[=
MIE+)8,SFV*VHB:LGYQZ;%U=R$FX61Y^T#*-`DR)JRN;)(I3$[.'6=5S4EK@1
MDAV7UK1OCLN@Q'%%@,B3')$M=Q[RLJQ98N_;HE'5TBB;-[?!QG%+0/%XRGF1
MS@Y]JI\[V>([>\7.-J_RL]LA?S*Y-`\$<O/^K`+E.TO5DOXU5/CO71%T9\"U
MY2,2/WA1MGII86C3.1NZ82"GUG";2HW7#"JC)N1F;RZ'?@%P/"$VM!_)T#`&
M=^'T`?B]T48U762R#/>R&:!ZV*WF;T9015S?HKI(<?FT.&L"3(0X=!9RBHK*
M%I*9:Q19Q8HH/C/%BCH6*W(&&$/1HBE9-"6+IF11A\;LKF1Q.6[<$$N6NW-M
M.X"/')=?5Q6F3=3D,J#JF`B\#-ODFV73'V.4;L\^=WDI4]OY*\3Q)6OT4F?;
M0S:,'B*C%@T]^B(9:=\G3$_)U.V"HG0IG5=SPYKZ5!B2RF^QOP)$K0TC5,F?
M71#!BYSVU/,#^#/Z7$:'KJ173^>S0:?NEO3%Z@@EZU.Z."G-F06:%)=Q;75@
M$4`*GS$RM2><OJQ>=L*R^[FV,"^F*MT&P(D(!#TH3:^4Z8V^6+YO(5FO.)9J
M5$V!*T?\6O%Z*8K*KG]8["399/K?P?9H6HW:E)'+C;EH*7L><!E'T1%X,I$O
MXNG&\^^!_PAMTC:_XUI0SCH?FP%[V6\9,18Q$9L"LEU,OU5KQ_@K6(;U\IU5
MY-'G5+IH[7T5(GT*40Y!+DAO&<3IRH)9$.'?4A5PTW<ZG^J-;HA1)-M&XZC6
M--KWQ?$38S)Z967=JH?CK3VT.HJB=E"KK_U.+#0&.+U4$C]OBASNYP_91.HY
MN++BDCCN7-EB$FD&F0;H1;?Q_[MH\?S?`-B`3`:2]G,KZ57SVAY7:&=+0JM@
MJOC^@DTC^_&3[U>)*:5/O\L-A4J6*'K63T)T5`->W1OL1=&</'!'UT\WWM7:
M[9A1:LGA!$HUX%4]&[G5WNRCI$HB9,T$141_![&QCK7`(YJ\V\UT?ZWO>X_0
M`<[EO'"G3=)>=%7MJD*BWC9U96R%/3E0HU:D2[)6+*I6I$R8Z@R/H5:D%!.!
M+]K7.GT[]-KVCQ#Z@(0:":Y@WG<M1$\^T0<MHL<PI.R&5->N0^>M$-UY9W.K
M8"OP%+:P4.@2B-&8+D')RQ"V*]6CO*BNZS>Q%'<L6^2LG=/.'<[:>=KWL..S
M8"OJFI,ZL_9R_5'$K%TF;(]F[5),1+VUR3M4#\!L>>]#^D%Z&5VU4)>BY)LQ
M<+/761;!IOP2E%0)16KK1U:-49DZ'<9;1K^6HJ>NY"^_+B9UL?_N"HS22O4@
M5#5<7("EPD+!;`"Z+K#CC;UHD)&[VU)5]?Z-UI5!%?@8AB@:G=/4'=+H/.U[
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MX3>%I[`?@BXBYH3Q+<K+!<5+@,`(VM!RXP_I>RTWP`I".:]$<]FA-46JAW`2
M&!<[7."CAJYJ\1:336(PO1RR<#6W8"!@$JB6/-7I!M39;-CM_)`H-6]QSH)>
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M/)_??+K\]1?G[,/8/?OE51`$=N?]'[,?O<^S\/RT?_?A:S"<O>KYWZ_O6N[W
MS^/W=]/W,'QZ>OOV?XW._>#X6.O\7D[L+2C4+F^Q2>_%9$WJHGL0!#$CZ(T6
MU<Q@G/?^V]9S?8S"E=`DF0-*]H@@*]2[?[R1M-^U,(:DK<D9M^1H\>H8ZJ(<
M>DYF!H]6P@7S2D'!*5K-7"H[)GAQ5G7B))KL:2"#)&6,\\7/EAN"5>LSS;X'
M-OFFK!VT>@8=Y#@CR%>"SJKL^N9?BL@1ZZMA_MA"R6G>U56L\?U3_925RY.^
MEKNZI765*P^)T9<NO8F!Z<TQ6<KKI-#FUF!];PV6':T,=PO7#B]SO7`9Z.9Z
M87.]L([7"R\$BQZ)9$2A<!NU"=[2%5KQKA&UP*>"$+:8WWZXA233<DBNM<*B
M3S"TYWPDCT%<C2M*#6G3EK2QQQ,3#3,LS+`PP\)T:,SN65C.T"*5497J4WZW
M<35Z5(Z9P!HD)6PGHCN,Q31PC*)5:!0DUY70!4,Z0T&`^3@/HTC^)6G#>G1E
M/7Q1Q<)\#/$QQ,<0'QT:LWOB4VUTD1);U33O"1FJBN/>TZ*8%_&5F=79XMLF
MPU"?PZ,^%>/&<!T]YB;#=0S7T9GK%`PG,H*I2-6>L)E"I/:?OB3\A7$GRT-C
M^OP$Q85S\ZI40GU.8-B+=NRE4M!4YRZ&N1CF8IB+#HU1L#V5-Y1(V9?*5:1'
M-RYE+`4("3OUH8JMM%CKL*.*]8GGDG;C^*0#%55W]85=JJ$T!TAIN(/+T!P=
MIB5#<PS-T9GF5!Y>Y'3MJLKUZ.ZE=(@!R?VG2.R5R<MWI6@%$[VZ^LJ:6F.P
M5K3-Q)`819KMJL-C1WQ197:O])C,##DRY$A'<E1M5!$X1^F^2545$&$OT*HE
M-QR%R-'#JJFG%FL?KV>09T[,'R:YX8@I<PA>E[G(<!O#;73D-@O!%087&8%5
M1:TV(5:ZWE,)P+T^?9XF0VQ!=F-!/[JP*74C+Q\/JB;)'#X_1/[#%$7FW+DF
M$Y4A/H;XZ$Q\2D<5&2%5KE`3/Y12G2V0"2`YJCD.5XGR_83@F]GQ:R,G^O#2
MPL!9/L;-5_[#*]QL<QT>$ZH;:6;#2X^YS'`CPXUTYD:LXXR4*&.U0?.],WYL
M#^#D5XNOH-J>`"=T06^47U257#:/>_X`CB<$,]I1.&F6&%4BEA4,[]*/=PD-
M1`869DB8(6&&A.G0&`4DC'70D<K&N(U)`Z`O*>/'6@P[4T_.V$NYKY+&#L`C
M0&'M@VX,XLP^WR&R+/9X,IM]FLQ]ADL9+J4SE]H^M,B(JPI:-?%(*3FJ`MXA
M[/UQ%7S35X1A$"W9M9'3\:+;)P&R!=1^<XHVQ_\/D!O5"S-S!X`.DYHA288D
MZ4R2V,88&3'&:($>';^4.[%B>@!7`O"7B]]Z%L+1F\!#WW(``2PJKA\`&\!'
MVAUJ4ZIZ&DQ)U>$1*R$Q9^JJ])@1#<,R#$MGAL4UV,@(-3Y#]J3"BA/E@RFS
MXJUC'P"7WNG0M_Q@3I!#F,QPQ,S:I(M'KJ%:AT>U:L27(5AZ3(B&8!F"I3/!
M8AAB9`08B_H](5-,B!X4A6(O5P\?,/@1$MNN'P'_@;^M4LP]3X?)CRK'C[G=
M29?YR_`APX=TYD.%0XJ4<"I4IDTXE5*=$K#V]?ZF*\\.:;O;R+E&`0SF733R
M_&FDA6>)J$P>6[%W%4&L@Z@#X+=8V@",(16"@CMK6D)S,+!?C+W')OEE'.?D
M#^OA72A5S:C"X@(:W<6@U*0*5/#"F"'Y7GV4,]*44``><+,8K`W;S(AV0I\:
M=T/2*\O]$UC^-7*NR.A5']U"R>H*_CG0+L8G0?Z,K^!_U4UHR8:'HG-`T;%L
MW`L#'%C(@6@L:B0IU;%7_JB"6>*9EW4]TP\?7&C?N)X5B')$6N3>C#@Y:"00
MO^(==MK$!H?:<>-:`J(\*T[1$4`>:-=P2&#]E8N$9^1=`6S[<!81+W'PIJ7N
M#QW)!R7!^KP&'4D&(R+9M]PN8<S/'\!<V)B])E954E-CE%X')H'\-XX%BY34
M>$8>@)GGT^I&FFR%)6M%C*CG2]^C(:4<I<0%%]PC3"S^L^>&!`)_?@-=X`M#
M?UWL_L7\!C"+K*?%.U7&<B-Q'4(\QYXO;(C)"MU#'KB&R@+K.BEF+/@+<-T/
MR'M"]\#"'@).%^,0^**`+Q*_ARXH1&KAC%,!^7X?^-!SA*6F^6+W:;`I`&:!
M^1GO8+.0N\IW;\@G`L;W(L%[-+$68K-`O4;"F94=>U4*\FG1^\/@2^!9@/]J
M12H+5KW?-*G,!PN#Z*__!U!+`P04````"``O5E!`IQ3_(W0*``"I4P``$0`<
M`&%E;60M,C`Q,3$R,S$N>'-D550)``.*)3U/BB4]3W5X"P`!!"4.```$.0$`
M`.U<6W/BN!)^/U7G/VAYVJTI+@Y)F*0FJ3)@,IZ`88S)Y6QM;0E;@'=LV;'D
M),RO/RT;PB6V,9GLE,]9YF5`EEI?]R=UM^0FGWXIE]$5H23`G%AH/$=VZU?N
M_H;*J.6Y_M"TD4HY/#6Y_4B@C3Z2`+[#\QGG_GFU^O3T5#&A*S/M@#`O#$S"
M1`,JER^1^/?O?WT2D[0"(J8X1\8L1!TR1M(IDD[.Z\?G]3H:&2UT5)..XD$P
MXIF=,W-&7(R>78>R\^=QX-@7I;4Y14O%"Z;5HUJM7K4IXYB:I+3H3T,WN;?%
M@RJ?^Z0*/4A@FR7$<3`E7,,N83XVR<8P3/C,\:A++-O$CE`+II,DZ:@N+6=Z
M9ALCGNI+4%+UKM<=1DJ\H/)H#F`>+;^`B\>%K"P>K6::8#:.1BV?1+#*-:F\
M!LRQZ;<D;-+9V5DU>KKL^JKGIG'%XS%F8%SB$)=0WO$"MTTF.'3X1>DAQ(X]
ML8FUE(:):^UM19C0XB^CUN<_J<8/2\OEA)!8'IA2CV-N>_1RT;IH]WV;3KS+
M91NT"OSG2R5T,D&1\N?"<!<E9KN^(]9-U#8+R.2B)#0H+R'^Z>!Q!5`NN^#`
M##R'9%NVZ@>>#SO%!FI6YHL%O!J]:6WQN`IS$J>[@ERJ7KZ;/GY`?KH^,">#
MA1/QM:76^Q%ED<E/5PSFM*F=H-9[*25VS,]6"N8T0R>1K$VU1&\#%$'BPTA7
M=VW[2#H$$>8YMB7"01,[PFT/9X3P$K*M6/L_4[NL(5AB6#%P"4X7`M,0EEGD
MIJ(@MA*$%I)0)(I]JFX/1^BU])`1JT\OH\_;BW@A8=$E>^SF.MD>N6/B+3ZV
M1K]04MW@Y/7.>E>V_AS@`(PQ(UST9SG(VQZQB\NC_%RB7S=E_Y9`[H'9#&95
M"LWDQ=HI;&[WNDS0;H/">A:%+P\8\B:H[XL<%(8=-N;^]+4PFW4<[RF%MY?'
MB9;<8.SX-6,6H:!0%G="/A(3'+C+QYWF<;+&5?1UESL\`3;:-C,=CX4!@2]:
MWU"05$&:;(QT!?4[J#D:JIHR'")9:Z.F/%2'HG6@*T-%,V1#[6O)_!P(2B*H
MML50+<?V.4TDZ:B"NNK7D=I6C?L#`WLP\(H"P4$F`8U$`NH5-!SU>K)^+S;$
M4+W2U([:DC4#R:U6?Z09JG:%!OVNVE*582)#!WX2^7E-4&UW5O`QD:/C2O3_
M$`WD>[G950ZA9!\>$HBHE9*1;W!QELC%206U^MJ-HALJ,+&3EP,I*:0DL5+;
M%>FE6B(GIQ6D0`PQ[I&AR]I0;HEXGNRL#MLDG9%$2G*$=DE*9*51$2%$'RGM
M18B7#?C8EGOR57(D.3"3RDPR-;M"OGAKD$#,QPKJ&Y\5';5&N@[I+]`C-]6N
M:B1'^`,MZ;2D\+([TDOU1&K.*J@CJSJZD;LC!?44>0CGEQYPE.+-_M^XB=Z'
M_7[;NZG_\?N=Z8?/]_3DS/K>>)S>S^FH'3Y=-8*SQO717R-CSIS&H_F]YGSA
M'ZK=CW*73IX;T_Z=R>V[VV_N;:\Z:=3&L\'S0TUK:M+]H.WX7_0/G[_U9VY5
MT;W&7>T,FX_5JTGX^>:LJOU':SK^U7>U7M>EWK`E3^2:TFM<UUOUFNZ??9O/
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M2[D>.;"T@Z4LFG*D4<D7)H*IZ`-L(D6]2;LS.9"SBYQ,=G)E#<FW*-))Y<7A
M#60]Y>1Q(&@W0=D,[<P<CI)O5*13<2W<'"I?1^*`*$+2/^4(\L,<M3TS%.__
M9&HIE-M\KM*)%[@1F)BLS!XY;B9?<;84B$`BBD6B-9G_'.(^53?JW*+6N&VC
M)BYNAV;;];V`(YI8XIA61QF77W8],Y*7,41\*R_'E45363HJUZ7*,[->2H;V
MA"$4CXN6]H.Q'/<F&-E%E2E`(A#K(Z<8^]'`*G$X>Y%57LEZ0;2G95Z7KN8Q
MSO8H89HS81KP?C\,9+U4=3\P'M4R\.1`E%@BFG>Y+`>(R4]>FV%1YAK->E%*
MJV=B\IAQ41E=0G$Q7U2D?`YM-IVJG+ABUY807O2Z*/$@%&5X42\?=/<L(QIG
MA<'";U+;<?!8%.C%?5D(@VT>BJ=7@1?ZRTEL$)^CY&H%<<NL6QJ&@:B>DADK
MEE:)L!:UE:^UZ-IX;#NVJ'J$"#'DGOEMYCD6"5@;G+5I\^)HEA]JJK8+XZQ+
M*HQZ&=A2]2DT7SL8RN,Y5A53_<FJUJTX*NZ!-4/C/I^10'GV1<E87"U8'`TS
ML*7OLF7Y6YIYEJ5UQ6)R7\S5RXS@L.S="3QWL1KH5!8_""J:V\F+-$M=V?HK
M9#RRE.'IQ/2H:3M$([SK,6B!#V*:$1/5L(6VQGLIDKHW5,9"D6GT)^)(KM+%
MC\-LP"H:#!*X-ETHL6X,UZ.$XV">9(X)=M@.>\3/QG&6<U$R`SB:\K>;:0\M
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M.S"@PL&,V6#V"'-_<HN#`%/>!H4>L?C;!<NL9@Z+W5,>0OA49".]4:.LHWDP
MQ=3^'DE;G0Q%"*368.U-2'^R\(S861T:5\[4(,^\Z8!;*([7_]LTR[PT[=I@
M<N!XOI(P@)G->0$MM`?6C!4TM*<T6I"4P]X4+A`4B>1`["R@UGOBS0SZA=X`
MNP"F7YE[D"L2\<<\QKR`>F7#R\AGUZYK8\<HPDNA*=P?<KKZR\`9;7IQ^=?&
M+H;#_J:TXNB^)][4U9Q/SE+?^(_QG/.E8=\8]_]>I;-#4'2CO79=4^@5O@_8
M3*T[V`YNL!.N[8XB1I]\,+/"[0P'9,,EB'>%HK&)&;$&>!Y?[A9/]3<C3W\[
M:,Z(%3IP9DAVE(ODF/4#W9[.0+2`743+O(\>67=V;3(A`9P^=/)(:%CLJ+<'
MULS7K*YKQV\Z8)W!"4#D>82:1?>(;\2='OB['J8L.DD;`;8("(V<+IPE"9P9
M`6&Q[?%C\%-]ATX<$5\'..!S$$P9CJYJBFV+MX!.]YXP*7D(H4%Y+&K(V`DQ
M,R?(*C8MCI*Y4$8L1N6<<3%;[/?^"U!+`0(>`Q0````(`"]64$#D9]L6BZ(`
M`"?5!0`1`!@```````$```"D@0````!A96UD+3(P,3$Q,C,Q+GAM;%54!0`#
MBB4]3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"]64$!%QB:B?@D``*1I
M```5`!@```````$```"D@=:B``!A96UD+3(P,3$Q,C,Q7V-A;"YX;6Q55`4`
M`XHE/4]U>`L``00E#@``!#D!``!02P$"'@,4````"``O5E!`9H=A"WT3``#$
M3@$`%0`8```````!````I(&CK```865M9"TR,#$Q,3(S,5]D968N>&UL550%
M``.*)3U/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+U900(?!7`]S)0``
M1KT!`!4`&````````0```*2!;\```&%E;60M,C`Q,3$R,S%?;&%B+GAM;%54
M!0`#BB4]3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"]64$#1K*@R=14`
M`).!`0`5`!@```````$```"D@3'F``!A96UD+3(P,3$Q,C,Q7W!R92YX;6Q5
M5`4``XHE/4]U>`L``00E#@``!#D!``!02P$"'@,4````"``O5E!`IQ3_(W0*
M``"I4P``$0`8```````!````I('U^P``865M9"TR,#$Q,3(S,2YX<V155`4`
J`XHE/4]U>`L``00E#@``!#D!``!02P4&``````8`!@`:`@``M`8!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 5. CONVERTIBLE NOTES PAYABLE<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 5. CONVERTIBLE NOTES PAYABLE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Convertible Notes Payable consist of the following at

      December 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Unamortized

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Net&#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Accrued

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center; padding-left: 10pt; text-indent: -10pt">

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Principal

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Discount

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Amount

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          Interest&#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 40%; padding-left: 10pt; text-indent: -10pt">

          Amended and Restated Series A 12% Convertible Notes, past

          due

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          900,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          &#8212;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          900,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          135,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          2008 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          25,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          25,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          10,729

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          December 2006 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          17,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          17,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          12,608

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          May &amp; June 2009 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          61,321

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          July &amp; August 2009 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          32,500

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          32,500

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          39,773

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          October &amp; November 2009 10% Convertible Notes, past

          due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          19,688

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          February 2010 10% Convertible Note

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          240,578

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          240,578

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          21,920

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          April 2010 10% Convertible Note

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          13,625

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          September 2010 10% Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          368,100

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          368,100

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          58,361

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          April 2011 10% Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          400,400

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (384,483

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          15,917

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          30,030

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          July and August 2011 10% Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          357,655

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (178,812

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          178,843

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          15,321

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          September 2011 Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          253,760

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (142,073

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          111,687

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">

          November 2011 Convertible Notes

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          525,000

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          (176,800

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          348,200

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          14,085

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          Total &#8211; Convertible Notes

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          3,344,993

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (882,168

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          2,462,825

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          432,461

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Convertible Notes Payable consisted of the following at March

      31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; ">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center">

          Unamortized

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center">

          Net

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: center">

          &#160;

        </td>

        <td style="text-align: center">

          Accrued

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: center; border-bottom: Black 1pt solid">

          Principal

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

        </td>

        <td style="text-align: center; border-bottom: Black 1pt solid">

          Discount

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

        </td>

        <td style="text-align: center; border-bottom: Black 1pt solid">

          Amount

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="text-align: left; border-bottom: Black 1pt solid">

          &#160;

        </td>

        <td style="text-align: center; border-bottom: Black 1pt solid">

          Interest

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 40%; padding-left: 10pt; text-indent: -10pt">

          Amended Series A 10% Convertible Notes, past due

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          900,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          &#8212;

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          900,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 3%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 10%; text-align: right">

          33,750

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          2008 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          25,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          25,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          7,917

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          December 2006 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          17,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          17,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          10,696

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          May &amp; June 2009 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          200,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          200,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          33,292

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          July &amp; August 2009 10% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          87,500

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          87,500

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          32,020

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          October &amp; November 2009 10% Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          205,250

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (17,226

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          188,024

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          30,788

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          February 2010 10% Convertible Note

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          715,578

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          715,578

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          59,273

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          April 2010 10% Convertible Note

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          75,000

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (73,222

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          1,778

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          7,063

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-left: 10pt; text-indent: -10pt">

          June 2010 12% Convertible Notes, past due

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          21,189

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          21,189

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          636

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-left: 10pt; text-indent: -10pt">

          July 2010 6% Convertible Notes

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          495,343

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          (494,770

        </td>

        <td style="text-align: left">

          )

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          573

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td style="text-align: right">

          35,107

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">

          September 2010 10% Convertible Notes

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          739,200

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          (713,990

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          25,210

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          42,709

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">

          &#160;&#160;&#160;&#160;&#160;&#160;&#160;Total -

          Convertible Notes

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          3,481,060

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          (1,299,208

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          )

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          2,181,852

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          293,251

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      All of the Convertible Notes Payable in the above tables are

      unsecured and are presently past due or will be due within

      one year of the December 31, 2011 balance sheet date. As a

      result, we expect to amortize all of the remaining discounts

      during the first half of calendar year 2012.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      AMENDED AND RESTATED SERIES A 12% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In June 2010, we entered into Amended and Restated 12% Series

      A Convertible Promissory Notes (the "Amended and Restated

      Notes") with the holders of certain promissory notes

      previously issued by the Company (&#8220;Amended Series A 10%

      Convertible Notes&#8221; or the "Prior Notes"), and all

      amendments to the Prior Notes.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The Amended and Restated Notes, in the principal amount of

      $900,000, are convertible into an aggregate of 4,500,000

      shares of our common stock subject to antidilution

      adjustments, including down round price protection, and

      matured on December 31, 2010. In connection with the

      restructuring we paid $54,001 of accrued and default interest

      through the date of the restructuring, liquidated damages of

      $205,000 and $54,003 of prepaid interest through the

      expiration date in the aggregate amount of $313,004 through

      the issuance of units ("Units") at a fixed rate of $0.20 per

      Unit, each Unit consisting of one share of our common stock

      and one common stock purchase warrant to purchase one share

      of our common stock at a fixed exercise price of $0.20 per

      share as prescribed in the Amended and Restated Note

      Agreement. &#160;

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In addition to the extension of the expiration date of the

      Amended and Restated Notes to December 31, 2010, we agreed to

      increase the annual interest&#160;rate from ten percent to

      twelve percent. We also agreed to change the exercise prices

      on all of the warrants held by the noteholders to $0.20 per

      share, to change certain formerly contingent warrants to

      non-contingent warrants and to extend the expiration date of

      their warrants to February 2016. The following table

      summarizes the number of shares of our common stock issuable

      upon the conversion of the Amended and Restated Notes or the

      exercise of the various warrants issued or issuable pursuant

      to the Amended and Restated Notes.

    </p><br/><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 86%; line-height: 115%">

          Note Conversion

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $&#160;

        </td>

        <td style="width: 11%; line-height: 115%; text-align: right">

          4,500,000

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="line-height: 115%">

          Warrants

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          11,646,125

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="line-height: 115%">

          Total

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          &#160; $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          16,146,125

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      For accounting purposes, the amendment of the 12% Series A

      Convertible Notes was treated as a debt extinguishment in

      accordance with FASB ASC 470-50, Debt-Modifications and

      Extinguishments, as the terms of the restructured agreements

      were deemed to be substantially different than those of the

      prior agreements.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Based on conversion and exercise price re-set provisions

      included in the Amended and Restated Notes&#160;warrant

      agreements, the embedded conversion feature and the related

      warrants, with an aggregate estimated fair value of

      approximately $3,089,000,&#160;were classified as derivative

      liability instruments (See Note 9).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Consequently, at the amendment date we recorded a loss on

      extinguishment of $2,226,924 as follows:

    </p><br/><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 87%; line-height: 115%">

          Reacquisition price

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 10%; line-height: 115%; text-align: right">

          4,385,925

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="line-height: 115%">

          Less carrying value of notes and related

          instruments&#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">

          (2,159,001

        </td>

        <td style="line-height: 115%">

          )&#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="line-height: 115%">

          Loss on extinguishment&#160;&#160;&#160;&#160;&#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%">

          $

        </td>

        <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">

          2,226,924

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As of December 31, 2010, the Amended and Restated Notes

      matured and as of December 31, 2011 are in default.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We have begun discussions with the noteholders regarding an

      extension to the notes but there can be no assurance that we

      will be able to do so on terms that we deem acceptable or at

      all.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      2008 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      One 2008 10% Convertible Note in the amount of $25,000 which

      matured in January 2010 remains outstanding at December 31,

      2011. This note is convertible into our common stock at $0.50

      per share. During the fiscal year ended March 31, 2011 we

      agreed to convert the $20,000 principal and related accrued

      interest of $5,562 of one holder of the 2008 10% Convertible

      Note into 127,808 shares of common stock based upon a

      conversion ratio of $0.20 per share rather than at the stated

      conversion ratio of $0.50 per share. As a result of this

      change, we recorded a charge of $15,337 as interest expense

      in the fiscal year ended March 31, 2011.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      DECEMBER 2006 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, $17,000 of the December 2006 10% Notes

      remained outstanding and in default. These notes are

      convertible into our common stock at $0.17 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      MAY &amp; JUNE 2009 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In May and June 2009, we raised an aggregate amount of

      $350,000 from the sale to accredited investors of 10%

      convertible notes ("May &amp; June 2009 10% Convertible

      Notes"). The May &amp; June 2009 10% Convertible Notes

      matured at various dates between November 2010 through

      December 2010 and are convertible into our common stock at a

      fixed conversion price of $0.20 per share prior to maturity.

      Upon conversion of the May and June 2009 10% Convertible

      Notes, the&#160;note holders will receive a matching three

      year warrant to purchase unregistered shares of our common

      stock at a price of $0.20 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      After consideration of the warrants, we recorded a discount

      associated with the beneficial conversion feature of $233,735

      related to the May &amp; June 2009 10% Convertible Notes and

      we amortized that discount over the terms of the respective

      convertible notes using the effective interest method.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the May &amp; June 2009 10%

      Convertible Notes have taken place during the fiscal years

      ended March 31, 2011 and 2010:

    </p><br/><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Fiscal Year<br />

          Ended

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="line-height: 115%; text-align: center">

          Fiscal Year<br />

          Ended

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          March 31, 2010

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">

          March 31, 2011

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="width: 72%; line-height: 115%">

          Principal converted

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 11%; line-height: 115%; text-align: right">

          50,000

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

        <td style="width: 1%; line-height: 115%">

          $

        </td>

        <td style="width: 11%; line-height: 115%; text-align: right">

          100,000

        </td>

        <td style="width: 1%; line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; ">

        <td style="line-height: 115%">

          Accrued interest converted

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: right">

          2,803

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          $

        </td>

        <td style="line-height: 115%; text-align: right">

          15,039

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: #EEEEEE">

        <td style="line-height: 115%">

          Warrants issued

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          250,000

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

        <td style="line-height: 115%; text-align: right">

          500,000

        </td>

        <td style="line-height: 115%">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As a result of the warrant issuances, we recorded charges of

      $31,550 and $74,652 as additional interest expense in the

      fiscal years ended March 31, 2010 and 2011, respectively.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On or about June 23, 2011, the holder of the two remaining

      <font style="color: black">May &amp; June 2009 10%

      Convertible Notes, John Barsell,</font> filed a complaint

      against us entitled <i>John E. Barsell v. Aethlon Medical,

      Inc</i>., in the Superior Court of the State of California

      for the County of San Diego, Case No. 37-2011-00093374 (the

      &#8220;Lawsuit&#8221;). The complaint alleged breach of

      contract in connection with certain notes in the aggregate

      principal amount of $200,000 issued by us to Barsell in 2009.

      <font style="color: black">On August 15, 2011, we and Barsell

      signed a Settlement Agreement under which we agreed to repay

      the notes and related accrued interest in cash or in common

      stock, at the election of the Company, on a monthly basis

      over approximately a ten month period of time. In exchange,

      Barsell dismissed the Lawsuit without prejudice. The agreed

      monthly payments are $25,000 if in cash or $30,000 if in

      stock with $25,000 of the $30,000 amount going towards

      principal reduction and the remaining $5,000 as a penalty for

      paying in stock.</font>

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Following the Settlement Agreement and through December 31,

      2011, Barsell converted $125,000 of principal into 2,437,425

      shares of our common stock over five monthly issuances. Those

      share issuances also covered $25,000 in penalties as noted

      above.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the remaining principal balance of

      $75,000 was in default (see Note 13).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      JULY &amp; AUGUST 2009 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In July and August 2009, we raised an aggregate amount of

      $668,250 from the sale to three investment funds of 10%

      convertible notes ("July &amp; August 2009 10% Convertible

      Notes"). Each note carried a one-year term and is convertible

      into our common stock at 80% of market with a floor of $0.15

      cents and a ceiling of $0.25 cents per share. As additional

      consideration, the investors also received 1,336,500 three

      year warrants to purchase our common stock at $0.50 per

      share, although that exercise price is subject to change

      based on certain conditions. The conversion feature may

      additionally be adjusted in the event of future financing by

      the Company. Because the conversion feature and warrant

      exercise price each can be reset based on future events, they

      are classified as derivative liability instruments.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Based on the initial estimated fair value of the conversion

      feature and warrants, we recorded a discount associated with

      the derivative liability of $475,762, which was amortized

      using the effective interest method over the one-year term of

      the notes. Deferred financing costs incurred in connection

      with this financing totaled $60,750, which were capitalized

      and are being amortized using the effective interest method

      over the one-year term of the notes.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the July &amp; August 2009 10%

      Convertible Notes have taken place during the fiscal years

      ended March 31, 2011 and 2010:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Fiscal Year<br />

          Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Fiscal Year<br />

          Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          March 31, 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          March 31, 2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 56%">

          Principal converted

        </td>

        <td style="width: 8%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 12%; text-align: right">

          330,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 8%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 12%; text-align: right">

          250,750

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Accrued interest converted

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          22,559

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          10,698

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the remaining principal balance of

      $32,500 was in default.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      OCTOBER &amp; NOVEMBER 2009 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In October and November 2009, we raised $430,000 from the

      sale to accredited investors of 10% convertible notes

      ("October &amp; November 2009 10% Convertible Notes"). The

      October &amp; November 2009 10% Convertible Notes mature at

      various dates between April 2011 and May 2011 and are

      convertible into our common stock at a fixed&#160;conversion

      price of $0.25 per share prior to maturity. The investors

      also received matching three year warrants to purchase

      unregistered shares of our common stock at a price of $0.25

      per share.&#160;&#160;We measured the fair value of the

      warrants and the beneficial conversion feature of the notes

      and recorded a 100% discount against the principal of the

      notes. We are amortizing this discount using the effective

      interest method over the term of the notes.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the October &amp; November 2009

      10% Convertible Notes took place during the fiscal years

      ended March 31, 2011 and 2010:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Fiscal Year<br />

          Ended

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Fiscal Year<br />

          Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          March 31, 2010

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          March 31, 2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 62%">

          Principal converted

        </td>

        <td style="width: 8%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 12%; text-align: right">

          70,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

        <td style="width: 2%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 12%; text-align: right">

          175,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Accrued interest converted

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          &#8212;

        </td>

        <td style="text-align: left">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          8,750

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the October &amp; November 2009

      10% Convertible Notes took place during the nine months ended

      December 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months<br />

          Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31,<br />

          2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 60%">

          Principal converted

        </td>

        <td style="width: 10%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 12%; text-align: right">

          130,250

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Accrued interest converted

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          21,288

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Deferred financing costs of $20,250 incurred in connection

      with this financing were issued in the form of a convertible

      note with warrants on the same terms as those received by the

      investors.&#160;&#160;We capitalized the $20,250 of deferred

      financing costs and amortized them over the term of the notes

      using the effective interest method.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the remaining principal balance of

      $75,000 was in default.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      FEBRUARY 2010 10% CONVERTIBLE NOTE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On February 12, 2010, we raised $280,015 in cash and received

      a secured promissory note in the amount of $300,000 in

      exchange for the issuance by the Company of a $660,000

      principal amount 10% convertible promissory note (the "Note")

      to Gemini Master Fund, Ltd. ("Gemini"). The Note included an

      original issue discount of ten percent, or $60,000, and an

      origination fee of three percent, or $9,000. We also paid

      legal fees of $10,985. The Note issued by the Company matured

      in February 2011. The terms of the promissory note included a

      maturity date of April 1, 2011, and allowed for prepayments

      of principal and interest by Gemini beginning on September 1,

      2010.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The conversion price per share initially was equal to eighty

      percent (80%) of the average of the three lowest closing bid

      prices of our common stock as reported by Bloomberg L.P. on

      the Principal Market for the ten (10) trading days preceding

      the conversion date, subject to a maximum price per share of

      $0.30 and a minimum price per share of $0.20 (the "Floor

      Price"). The Note is convertible into a maximum of 3,300,000

      shares of our common stock at the minimum price per share of

      $0.20. The investor also received 660,000 three-year warrants

      to purchase shares of our common stock at $0.50 per share,

      although that exercise price is subject to change based on

      certain conditions. The conversion feature, including the

      Floor Price, may additionally be adjusted in the event of

      future financing by the Company. Because the conversion

      feature and warrant exercise price each can be reset based on

      future events, they have been classified as derivative

      liabilities.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The Note also contains other standard adjustment features for

      stock splits, recapitalizations and similar occurrences. The

      Note contains standard events of default related to payment,

      performance of certain covenants and bankruptcy events.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We recorded a debt discount of $478,476 based on the

      estimated fair value of the derivative liabilities associated

      with the warrants and embedded conversion feature which was

      amortized using the effective interest method over the term

      of the note.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In November 2010, certain terms of the Note were modified

      pursuant to a Settlement Agreement (the "Modified Agreement")

      which provides for the modification of the conversion price

      formula to equal eighty percent (80%) of the average of the

      three lowest closing bid prices of the common stock as

      reported by Bloomberg L.P. on the Principal Market for the

      twenty (20) trading days preceding the conversion date in

      lieu of the ten (10) trading days preceding the conversion

      date.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      According to the modified terms, the previous conversion

      floor price was replaced with a maximum share limitation

      under which the maximum number of shares of common stock that

      may be issued to the holder of the Note pursuant to a

      conversion of the Note, combined with an exercise of the

      Exchange Warrant (as defined below), shall not exceed a cap

      determined by (a) dividing the sum of (i) the face amount of

      the Note, plus (ii) an amount equal to all interest that

      would accrue under the Note during its term (assuming no

      payments of principal or interest are made prior to the

      maturity date of the Note), by a price per share of common

      stock equal to $0.20 (subject to equitable adjustment) and

      (b) then adding the sum calculated pursuant to the foregoing

      clause (a) to the maximum number of warrant shares (as

      defined in the Exchange Warrant) that may be acquired by the

      holder thereof upon exercise of the Exchange Warrant

      (regardless of whether such exercise is a cashless exercise).

      In addition, the "maximum ownership percentage" under the

      Note was increased to 9.99%.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In addition to the modifications of the note, we agreed to

      exchange the original warrant for a new common stock purchase

      warrant (the "Exchange Warrant") for the purchase of

      2,727,272 shares of common stock at an initial exercise price

      of $0.231 per share. The Exchange Warrant provides for

      anti-dilution adjustment to the exercise price in the event

      of the issuance of securities by the Company below the

      exercise price, subject to certain exceptions as set forth in

      the Exchange Warrant.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In addition, the Modified Agreement provided that Gemini

      deliver to us $253,794.09 by wire transfer in full payment of

      the promissory note, which represents the outstanding

      principal balance thereof plus all accrued but unpaid

      interest thereon less the origination fee due to Gemini under

      the original transaction documents less reimbursement of

      Gemini's legal expenses. In accordance with the settlement,

      we delivered to Gemini 286,483 freely tradable shares of

      common stock in full satisfaction of the remaining number of

      shares of common stock due under certain conversion notices,

      for a total of $75,000, previously delivered by Gemini to the

      Company. The Modified Agreement provided for the mutual

      release of all claims related to the dispute and the

      revocation of all prior notices of default sent by the

      Company and Gemini to each other.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In connection with the modification to the note and the

      issuance of the Exchange Warrant, the maximum number of

      shares issuable pursuant to the maximum share limitation and

      the exercise in full of the Exchange Warrant was 6,357,272.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As provisions of the Modified Agreement resulted in terms

      that were deemed to be substantially different from the

      original terms, the exchange of debt instruments was

      accounted for as a debt extinguishment and we recorded a loss

      on extinguishment of debt in the amount of $963,018 in the

      fiscal year ended March 31, 2011 as shown below:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 70%">

          Reacquisition price

        </td>

        <td style="width: 10%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 18%; text-align: right">

          1,854,767

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 1pt">

          Less carrying value of notes and related instruments

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          (891,749

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          )

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-bottom: 2.5pt">

          Loss on extinguishment

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          963,018

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On March 21, 2011, we entered into an Extension Agreement

      (the "Extension Agreement") with Gemini.&#160;&#160;The

      Extension Agreement provides for, among other things, the

      extension of the Maturity Date to October 1, 2011, and an

      amendment and restatement of the Note to reflect the revised

      principal amount of $740,578, which amount includes accrued

      interest of $58,981, the remaining principal balance of

      $585,000 and a 15% premium to the principal and accrued

      interest amount in consideration for the extension. In

      addition, the Note as amended provides for a new "share cap

      formula" such that the number of shares of Common Stock

      issuable upon conversion of the Note shall not exceed a cap

      determined by (a) dividing the sum of (i) the revised

      principal amount of the Note ($740,578), plus (ii) an amount

      equal to all interest that would accrue under the Note during

      its term (assuming no payments of principal or interest are

      made after March 21, 2011 but prior to the Maturity Date), by

      a price per share of Common Stock equal to $0.16 (subject to

      adjustment as set forth in the Note) and (b) then adding the

      sum calculated pursuant to the foregoing clause to the

      maximum aggregate number of shares of Common Stock issuable

      under certain warrants held by Gemini (regardless of whether

      such exercise is a cashless exercise).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      As provisions of the Extension Agreement resulted in terms

      that were deemed to be substantially different from the

      original terms, the exchange of debt instruments was

      accounted for as a debt extinguishment and we recorded a loss

      on extinguishment of debt in the amount of $47,701 in the

      fiscal year ended March 31, 2011 as shown below:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 70%">

          Reacquisition price

        </td>

        <td style="width: 10%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 18%; text-align: right">

          773,582

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td style="padding-bottom: 1pt">

          Less carrying value of notes and related instruments

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: left">

          &#160;

        </td>

        <td style="border-bottom: Black 1pt solid; text-align: right">

          (725,881

        </td>

        <td style="padding-bottom: 1pt; text-align: left">

          )

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="padding-bottom: 2.5pt">

          Loss on extinguishment

        </td>

        <td style="padding-bottom: 2.5pt">

          &#160;

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: left">

          $

        </td>

        <td style="border-bottom: Black 2.5pt double; text-align: right">

          47,701

        </td>

        <td style="padding-bottom: 2.5pt; text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the February 2010 10%

      Convertible Note have taken place during the nine months

      ended December 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 90%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months<br />

          Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31,<br />

          2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 67%">

          Principal converted

        </td>

        <td style="width: 10%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 11%; text-align: right">

          475,000

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Accrued interest converted

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          19,403

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On December 29, 2011, we agreed with Gemini to extend the

      expiration date of the Note to April 1, 2012. There was no

      fee or any other consideration exchanged in connection with

      the extension.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      APRIL 2010 10% CONVERTIBLE NOTE

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In April 2010, we raised $75,000 from the sale to an

      accredited investor of a 10% convertible note. The

      convertible note matures in October 2011 and is convertible

      into our common stock at a fixed conversion price of $0.25

      per share prior to maturity. The investor also received three

      year warrants to purchase 300,000 unregistered shares of our

      common stock at a price of $0.25 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We measured the fair value of the warrants and the beneficial

      conversion feature of the notes and recorded a 100% discount

      against the principal of the notes. We are amortizing this

      discount using the effective interest method over the term of

      the note.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the principal balance of $75,000 was in

      default.&#160;

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      JUNE 2010 12% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In June 2010, in connection with the present and past

      negotiations with the law firm representing the holders of

      the "Amended and Restated Notes," we issued two convertible

      notes to that law firm (&#8220;June 2010 12% Convertible

      Notes&#8221;) totaling $64,153 on the same terms as the

      Amended and Restated Notes. That amount represented the

      amount of their legal fees plus accrued interest. During the

      fiscal year ended March 31, 2011, the holder converted to

      common stock one of the convertible notes in the amount of

      $42,964.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      <a id="OLE_LINK3" name="OLE_LINK3">During the three months

      ended September 30, 2011, the holder converted the remaining

      principal balance of $21,189 and accrued interest of $2,598

      to shares of our common stock per the terms of the

      convertible note.</a>

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      JULY 2010 6% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In July 2010, we entered into a Note and Warrant Purchase

      Agreement (the "Purchase Agreement") with Tonaquint, Inc., a

      Utah corporation (the "Investor") whereby we issued and sold,

      and the Investor purchased: (i) a Convertible Promissory Note

      of the Company in the principal amount of $890,000 (the

      "Company Note") and (ii) a Warrant to purchase common stock

      of the Company (the "Warrant"). As consideration for the

      issuance and sale of the Company Note and Warrant, the

      Investor paid cash in the amount of $400,000 and issued two

      Secured Trust Deed Notes to us (the "Trust Notes") each in

      the principal amount of $200,000. The variance of $90,000

      represents fees and expenses paid by us and an original issue

      discount which was recorded as deferred offering costs.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The Company Note is convertible into shares of the Company's

      common stock, at the option of the Investor, at a price per

      share equal to (a) the principal and interest due under the

      Company Note divided by (b) 80% of the average of the closing

      bid price for the three (3) trading days with the lowest

      closing bid prices during the twenty (20) trading days

      immediately preceding the conversion date (the

      &#8220;Conversion Price&#8221;). In no event shall the

      Conversion Price be greater than the "Ceiling Price", which

      is $0.30 per share. The principal and interest subject to

      conversion under the Note shall be eligible for conversion in

      tranches ("Tranches"), as follows: (1) an initial Tranche in

      an amount equal to $450,000 and any interest and/or fees

      accrued thereon under the terms of the Company Note and the

      other Transaction Documents (as defined below and in the

      Purchase Agreement), and (2) two additional subsequent

      Tranches each in an amount equal to $220,000 and any interest

      or fees accrued thereon under the terms of the Company Note

      or the other Transaction Documents. The first subsequent

      Tranche shall correspond to payment of the first Trust Note

      and the second subsequent Tranche shall correspond to payment

      of the second Trust Note (as defined in the Purchase

      Agreement). The Investor's right to convert any of the

      subsequent Tranches is conditioned upon the Investor&#8217;s

      payment in full of the Trust Notes corresponding to such

      subsequent Tranche.&#160;&#160;Accordingly, principal and

      interest under the Company Note may only be converted by the

      Investor in proportion to the amounts paid under each of the

      Trust Notes.&#160;&#160;However, up to $450,000 may be

      converted at the Investor's option at any time, representing

      amounts paid by the Investor on the closing of the

      transaction on July 15, 2010 (the "Closing").&#160;&#160;The

      Company Note bears interest at a rate of 6% per annum. The

      maturity date of the Company Note is July 15, 2011. The

      Company Note contains "anti-dilution" protection, such that

      if the Company issues and sells common stock, or securities

      convertible into or exercisable for common stock of the

      Company, at a price per share that is less than the

      applicable Conversion Price, then the Conversion Price is

      adjusted downward to match such lower issuance price.

      However, in no event will the Conversion Price based on

      anti-dilution adjustments be lower than the "Floor Price"

      which is $0.20 per share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The number of shares of Common Stock that may be issued to

      the lender pursuant to a conversion of this Note, combined

      with an exercise of the Warrant, shall not exceed a cap

      determined by (a) dividing the sum of (i) the face amount of

      this Note, plus (ii) an amount equal to all interest that

      would accrue under this Note during its term (assuming no

      payments of principal or interest are made prior to the

      Maturity Date), by a price per share of Common Stock equal to

      $0.20 (the Floor Price).

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The Company Note also contains other standard adjustment

      features for stock splits, recapitalizations and similar

      occurrences. The Company Note contains standard events of

      default related to payment, performance of certain covenants

      and bankruptcy events. We have granted the Investor a

      security interest in the Trust Notes under the terms of the

      Security Agreement. The sole collateral for the Company's

      payment and performance obligation under the Company Note is

      the Trust Notes.&#160;&#160;The Warrant entitles the Investor

      to purchase 3,636,364 shares of common stock at an exercise

      price of $0.231 per share. The Warrant contains

      "anti-dilution" protection, such that if we issue and sell

      common stock, or securities convertible into or exercisable

      for common stock of the Company, at a price per share that is

      less than the applicable exercise price, then the price is

      adjusted downward to match such lower issuance price. The

      Warrant also contains other standard adjustment features for

      stock splits, recapitalizations and similar occurrences.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We recorded a debt discount of $890,000 based on the

      estimated fair value of the derivative liabilities associated

      with the warrants and embedded conversion feature which was

      amortized using the effective interest method over the term

      of the note.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On June 28, 2011, we entered into a Termination Agreement

      with Tonaquint, Inc. under which both parties agreed to

      terminate the warrant to prevent continuing dilution of our

      common stock and to eliminate confusion or disagreement as to

      the number of shares of common stock available for issuance

      under the warrant in the future. Accordingly, under the

      Termination Agreement we issued 3,599,913 shares of common

      stock upon the final exercise of the warrant, whereupon the

      warrant was terminated and is of no further force or effect.

      The&#160;Termination Agreement also provides for a "Common

      Stock Sale Limitation" on all of our common stock held by

      Tonaquint, Inc. Under the "Common Stock Sale Limitation", the

      daily limitation on the number of shares of common stock

      which Tonaquint, Inc. may sell into the market on any trading

      day is limited to the greater of (i) $5,000 of sales amount,

      or (ii) 10% of the Average Daily Volume of our common stock

      sold on the Over The Counter Bulletin Board, where the

      Average Daily Volume shall mean the average daily volume for

      the prior three month period as reported on each trading day

      on Yahoo Finance with respect to our common stock. Under the

      terms of the Termination Agreement, Tonaquint, Inc. has

      waived and released us from any obligation to pay or perform

      any fees, penalties, costs, or assessments that were or are

      due, or would have become due, under the convertible note,

      the warrant and the note purchase agreement. In consideration

      of the termination of the warrant, the waiving of all fees,

      penalties, the creation of the selling program and other

      factors, we agreed to issue an unsecured non-convertible

      promissory note (the "New Note") in the principal amount of

      $360,185, which provides for annual interest at a rate of 6%,

      payable monthly in either cash or our stock, at our option.

      The New Note has a maturity date of April 30, 2012.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      SEPTEMBER 2010 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On September 3, 2010, we entered into a Subscription

      Agreement with three accredited investors (the

      &#8220;Purchasers&#8221;)&#160;providing for the issuance and

      sale of convertible promissory notes and corresponding

      warrants in the aggregate principal amount of $1,430,000. The

      initial closing under the Subscription Agreement resulted in

      the issuance and sale of (i) convertible promissory notes in

      the aggregate principal amount of $743,600, (ii) five-year

      warrants to purchase an aggregate of 3,718,000 shares of our

      common stock at an exercise price of $0.31125 per share, and

      (iii) five-year warrants to purchase an aggregate of

      3,718,000 shares of our common stock at an exercise price of

      $0.43575 per share. The convertible promissory notes bear

      interest compounded monthly at the annual rate of ten percent

      (10%) and mature on September 3, 2011. The aggregate gross

      cash proceeds were $650,000, the balance of the principal

      amount representing a due diligence fee and an original

      issuance discount. The convertible promissory notes are

      convertible at the option of the holders into shares of our

      common stock at a price per share equal to eighty percent

      (80%) of the average of the three lowest closing bid prices

      of the common stock as reported by Bloomberg L.P. for the

      principal market on which the common stock trades or is

      quoted for the ten (10) trading days preceding the proposed

      conversion date. Subject to adjustment as described in the

      notes, the conversion price may not be more than $0.30 nor

      less than $0.20. There are no registration requirements with

      respect to the shares of common stock underlying the notes or

      the warrants.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The following conversions of the September 2010 10%

      Convertible Note have taken place during the nine months

      ended December 31, 2011:

    </p><br/><table cellpadding="0" cellspacing="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td>

          &#160;

        </td>

        <td colspan="3" style="text-align: center">

          Nine Months<br />

          Ended

        </td>

      </tr>

      <tr style="vertical-align: bottom">

        <td style="text-align: center">

          &#160;

        </td>

        <td style="padding-bottom: 1pt">

          &#160;

        </td>

        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">

          December 31,<br />

          2011

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: rgb(233,228,228)">

        <td style="width: 57%">

          Principal converted

        </td>

        <td style="width: 10%">

          &#160;

        </td>

        <td style="width: 1%; text-align: left">

          $

        </td>

        <td style="width: 11%; text-align: right">

          375,500

        </td>

        <td style="width: 1%; text-align: left">

          &#160;

        </td>

      </tr>

      <tr style="vertical-align: bottom; background-color: White">

        <td>

          Accrued interest converted

        </td>

        <td>

          &#160;

        </td>

        <td style="text-align: left">

          $

        </td>

        <td style="text-align: right">

          19,255

        </td>

        <td style="text-align: left">

          &#160;

        </td>

      </tr>

    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the remaining principal balance of

      $368,100 was in default.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      APRIL 2011 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In April 2011, we entered into a Subscription Agreement with

      two accredited investors (the &#8220;Purchasers&#8221;)

      providing for the issuance and sale of convertible promissory

      notes and corresponding warrants in the aggregate principal

      amount of $385,000. The closing under the Subscription

      Agreement resulted in the issuance and sale by us of (i)

      convertible promissory notes in the aggregate principal

      amount of $385,000, (ii) five-year warrants to purchase an

      aggregate of&#160;4,004,000 shares of our common stock at an

      exercise price of $0.125 per share, and (iii) five-year

      warrants to purchase an aggregate of&#160;4,004,000 shares of

      our common stock at an exercise price of $0.175 per share.

      The convertible promissory notes bear interest compounded

      monthly at the annual rate of ten percent (10%) and mature on

      April 1, 2012.&#160;&#160;The aggregate gross cash proceeds

      to us were $350,000, the balance of the principal amount

      representing a due diligence fee and an original issuance

      discount. The convertible promissory notes are convertible at

      the option of the holders into shares of common stock of the

      Registrant at a price per share equal to eighty percent (80%)

      of the average of the three lowest closing bid prices of the

      common stock as reported by Bloomberg L.P. for the principal

      market on which the common stock trades or is quoted for the

      ten (10) trading days preceding the proposed conversion date.

      Subject to adjustment as described in the notes, the

      conversion price may not be more than $0.20 nor less than

      $0.10. There are no registration requirements with respect to

      the shares of common stock underlying the notes or the

      warrants.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In addition, we issued (i) five-year warrants to purchase an

      aggregate of 812,500 shares of our common stock at an

      exercise price of $0.125 per share, and (iii) five-year

      warrants to purchase an aggregate of&#160;812,500 shares of

      our common stock at an exercise price of $0.175 per share to

      the Purchasers. These warrants were issued as an antidilution

      adjustment under certain common stock purchase warrants held

      by Purchasers that were acquired from us in September 2010.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the outstanding principal balance was

      $400,400.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      JULY &amp; AUGUST 2011 10% CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      During the three months ended September 30, 2011, we raised

      $357,656 in 10% convertible notes. Those notes had a fixed

      conversion price of $0.09 per share and carried an interest

      rate of 10%. The convertible notes mature in July and August

      2012. We also issued those investors five year warrants to

      purchase 3,973,957 shares of common stock at $0.125 per

      share.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We measured the fair value of the warrants and the beneficial

      conversion feature of the notes and recorded a $257,926

      discount against the principal of the notes. We are

      amortizing this discount using the effective interest method

      over the term of the note.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      SEPTEMBER 2011 CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      On September 23, 2011, we entered into a Subscription

      Agreement with two accredited investors (the

      &#8220;Purchasers&#8221;) providing for the issuance and sale

      of convertible promissory notes and corresponding warrants in

      the aggregate principal amount of $253,760. The warrants

      carried a five-year term to purchase an aggregate of

      3,625,143 shares of our common stock at an exercise price of

      $0.10 per share. The convertible promissory notes do not bear

      an interest rate and mature on September 23, 2012. The

      aggregate net cash proceeds to us were $175,000, the balance

      of the principal amount representing a due diligence fee and

      an original issuance discount. The convertible promissory

      notes are convertible at the option of the holders into

      shares of our common stock at a price per share equal to

      seven cents. Subject to adjustments as described in the

      notes, the conversion price may not be more than seven cents.

      There are no registration requirements with respect to the

      shares of common stock underlying the notes or the warrants.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      We measured the fair value of the warrants and the beneficial

      conversion feature of the notes and recorded a $168,804

      discount against the principal of the notes. We are

      amortizing this discount using the effective interest method

      over the term of the note.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOVEMBER 2011 CONVERTIBLE NOTES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      In November 2011, we raised $525,000 in 5% Original Issue

      Discount Unsecured Convertible Debentures from five

      accredited investors pursuant to which the investors

      purchased an aggregate principal amount of $525,000 for an

      aggregate purchase price of $500,000. The debentures bear

      interest at 20% per annum and mature on April 20, 2012. The

      debentures will be convertible at the option of the holders

      at any time into shares of our common stock, at a conversion

      price equal to $0.0779, subject to adjustment. In connection

      with the debentures, the purchasers received warrants to

      purchase 3,369,706 shares of our Common Stock. The warrants

      are exercisable for a period of five years from the date of

      issuance at an exercise price of $0.11, subject to

      adjustment.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Until December 31, 2012, upon any proposed issuance by us of

      our common stock or equivalents (or a combination thereof as

      defined in the subscription agreement) for cash

      consideration, the purchasers may elect, in their sole

      discretion, to exchange all or some of the debentures then

      held by such purchaser for any securities issued in a

      subsequent financing on a $1.00 for $1.00 basis, provided,

      however , this right shall not apply with respect to (i) an

      Exempt Issuance (as defined in the debenture) or (ii) an

      underwritten public offering of our common stock.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      A FINRA registered broker-dealer was engaged as placement

      agent in connection with the private placement.&#160;&#160;We

      paid the placement agent a cash fee in the amount of $50,000

      (representing a 8% sales commission and a 2% unaccountable

      expense allowance) and will issue the placement agent or its

      designees warrants to purchase an aggregate of 808,729 shares

      of common stock at $0.11 per share. The warrants issued to

      the placement agent may be exercised on a cashless basis. In

      the event the placement agent exercises the warrants on a

      cashless basis, we will not receive any proceeds.

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      The securities sold in the private placement were not

      registered under the Securities Act, or the securities laws

      of any state, and were offered and sold in reliance on the

      exemption from registration afforded by Section 4(2) and

      Regulation D (Rule 506) under the Securities Act and

      corresponding provisions of state securities laws, which

      exempt transactions by an issuer not involving any public

      offering. The investors are &#8220;accredited

      investors&#8221; as such term is defined in Regulation D

      promulgated under the Securities Act.&#160;&#160;

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      At December 31, 2011, the interest payable on these notes

      totaled $14,085.&#160;

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-term debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>10</ContextCount>
  <ElementCount>104</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Disclosure - NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note</Role>
      <ShortName>NOTE 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - NOTE 2. LIQUIDITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note0</Role>
      <ShortName>NOTE 2. LIQUIDITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note00</Role>
      <ShortName>NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - NOTE 4. NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note000</Role>
      <ShortName>NOTE 4. NOTES PAYABLE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - NOTE 5. CONVERTIBLE NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note0000</Role>
      <ShortName>NOTE 5. CONVERTIBLE NOTES PAYABLE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - NOTE 6. EQUITY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note00000</Role>
      <ShortName>NOTE 6. EQUITY TRANSACTIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - NOTE 7. ACCRUED LIQUIDATED DAMAGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note000000</Role>
      <ShortName>NOTE 7. ACCRUED LIQUIDATED DAMAGES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - NOTE 8. OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note0000000</Role>
      <ShortName>NOTE 8. OTHER CURRENT LIABILITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - NOTE 9. FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note00000000</Role>
      <ShortName>NOTE 9. FAIR VALUE MEASUREMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - NOTE 10. STOCK COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note000000000</Role>
      <ShortName>NOTE 10. STOCK COMPENSATION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - NOTE 11. WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note0000000000</Role>
      <ShortName>NOTE 11. WARRANTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - NOTE 12. DARPA CONTRACT AND RELATED REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note00000000000</Role>
      <ShortName>NOTE 12. DARPA CONTRACT AND RELATED REVENUE RECOGNITION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - NOTE 13. COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note000000000000</Role>
      <ShortName>NOTE 13. COMMITMENTS AND CONTINGENCIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - NOTE 13. NOTE RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note0000000000000</Role>
      <ShortName>NOTE 13. NOTE RECEIVABLE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - NOTE 15. RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note00000000000000</Role>
      <ShortName>NOTE 15. RELATED PARTIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - NOTE 16. SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aethlonmedical.com/role/Note000000000000000</Role>
      <ShortName>NOTE 16. SUBSEQUENT EVENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 001 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2010'</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals)</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Consolidated Statements of Operations</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Cash Flows</Log>
  </Logs>
  <InputFiles>
    <File>aemd-20111231.xml</File>
    <File>aemd-20111231.xsd</File>
    <File>aemd-20111231_cal.xml</File>
    <File>aemd-20111231_def.xml</File>
    <File>aemd-20111231_lab.xml</File>
    <File>aemd-20111231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTE 15. RELATED PARTIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      NOTE 15. RELATED PARTIES

    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">

      Due to working capital shortages, we have not been able to

      repay certain members of our senior management and board

      members for expenses incurred on behalf of the Company and

      occasionally have been unable to pay those individuals for

      their services. As of December 31, 2011 and March 31, 2011,

      we owed our senior management and board members $617,570,

      which is shown as due to related parties on the accompanying

      balance sheet.

    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 3A<br><br> -Section 04<br><br> -Paragraph b<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 1-4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph k<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
